NCT Number,Status,Conditions,Interventions,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Start Date,Completion Date
NCT04446377,COMPLETED,COVID-19 Disease,DRUG: Apilimod Dimesylate Capsule|OTHER: Placebo,OrphAI Therapeutics,Yale University,ALL,"ADULT, OLDER_ADULT",PHASE2,142,INDUSTRY,INTERVENTIONAL,7/15/2020,4/19/2021
NCT05508477,RECRUITING,COVID-19 Pandemic|COVID-19 Vaccines,BIOLOGICAL: Vaksin Merah Putih - UA SARS-CoV-2 (Vero Cell Inactivated) 5 µg|BIOLOGICAL: CoronaVac Biofarma COVID-19 Vaccine,Dr. Soetomo General Hospital,"Indonesia-MoH|Universitas Airlangga|Biotis Pharmaceuticals, Indonesia",ALL,"ADULT, OLDER_ADULT",PHASE3,4005,OTHER_GOV,INTERVENTIONAL,6/28/2022,5/28/2023
NCT04472494,TERMINATED,COVID-19|SARS-CoV-2,BIOLOGICAL: Abatacept|OTHER: Placebo,Bristol-Myers Squibb,,ALL,"ADULT, OLDER_ADULT",PHASE2,61,INDUSTRY,INTERVENTIONAL,10/14/2020,9/13/2021
NCT04720794,COMPLETED,Covid19|SARS (Severe Acute Respiratory Syndrome)|Corona Virus Infection,DEVICE: Lucira COVID-19 All-In-One test kit,Lucira Health Inc,,ALL,"ADULT, OLDER_ADULT",NA,101,INDUSTRY,INTERVENTIONAL,9/25/2020,10/20/2020
NCT04598594,COMPLETED,Covid19|SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere,"DRUG: Patch, Nicotine|DRUG: Patch, Placebo",Assistance Publique - Hôpitaux de Paris,,ALL,"ADULT, OLDER_ADULT",PHASE3,220,OTHER,INTERVENTIONAL,11/6/2020,6/20/2021
NCT05188677,COMPLETED,COVID-19,"BIOLOGICAL: Candidate vaccine, SCB-2019|BIOLOGICAL: Comirnaty Vaccine|BIOLOGICAL: Vaxzevria Vaccine|BIOLOGICAL: CoronaVac Vaccine",Clover Biopharmaceuticals AUS Pty Ltd,,ALL,"ADULT, OLDER_ADULT",PHASE3,1831,INDUSTRY,INTERVENTIONAL,6/13/2022,6/6/2023
NCT04904471,ACTIVE_NOT_RECRUITING,COVID-19,BIOLOGICAL: Recombinant COVID-19 vaccine (Sf9 cells)|OTHER: Placebo control,"WestVac Biopharma Co., Ltd.",West China Hospital,ALL,"ADULT, OLDER_ADULT",PHASE3,40000,INDUSTRY,INTERVENTIONAL,6/15/2021,12/31/2023
NCT05578391,COMPLETED,COVID-19,BIOLOGICAL: Convalescent plasma,Fundacin Biomedica Galicia Sur,Health Knowledge Agency,ALL,"ADULT, OLDER_ADULT",PHASE2,61,OTHER,INTERVENTIONAL,1/1/2020,3/31/2021
NCT05722691,COMPLETED,COVID-19,DRUG: Double-Stranded RNA sodium salt|DRUG: Placebo,"Promomed, LLC",,ALL,"ADULT, OLDER_ADULT",PHASE3,800,OTHER,INTERVENTIONAL,6/9/2022,1/17/2023
NCT04621071,COMPLETED,COVID-19,DIETARY_SUPPLEMENT: Probiotics (2 strains 10x10^9 UFC)|DIETARY_SUPPLEMENT: Placebo (potato starch and magnesium stearate),Centre de recherche du Centre hospitalier universitaire de Sherbrooke,Lallemand Health Solutions,ALL,"ADULT, OLDER_ADULT",NA,17,OTHER,INTERVENTIONAL,1/12/2021,10/12/2021
NCT04602871,COMPLETED,Covid19,DIAGNOSTIC_TEST: Breath Biopsy,Scentech Medical Technologies Ltd,,ALL,"ADULT, OLDER_ADULT",NA,54,INDUSTRY,INTERVENTIONAL,7/3/2020,1/30/2021
NCT04916639,COMPLETED,SARS-CoV2 Infection (COVID-19)|URTI - Viral Upper Respiratory Tract Infection,DEVICE: Device: Physiomer undiluted seawater nasal spray,Laboratoire de la Mer,EVAMED,ALL,"ADULT, OLDER_ADULT",NA,370,INDUSTRY,INTERVENTIONAL,7/29/2021,3/18/2022
NCT04461379,UNKNOWN,BCG|COVID-19|SARS-CoV2|Corona Virus Infection,BIOLOGICAL: BCG vaccine|OTHER: Placebo,Hospital Universitario Dr. Jose E. Gonzalez,,ALL,"ADULT, OLDER_ADULT",PHASE3,908,OTHER,INTERVENTIONAL,7/21/2020,1/1/2021
NCT04659109,COMPLETED,SARS-CoV Infection|Acute Respiratory Distress Syndrome|COVID-19|ARDS,DRUG: glenzocimab|DRUG: Placebo,Acticor Biotech,,ALL,"ADULT, OLDER_ADULT",PHASE2,60,INDUSTRY,INTERVENTIONAL,12/16/2020,8/6/2021
NCT04365309,UNKNOWN,Novel Coronavirus Pneumonia|Aspirin|Treatment,DRUG: Aspirin 100mg,Xijing Hospital,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,128,OTHER,INTERVENTIONAL,2/10/2020,2020-06
NCT04880109,TERMINATED,COVID-19,DRUG: APX-115|DRUG: Placebo,"Aptabio Therapeutics, Inc.",Covance,ALL,"ADULT, OLDER_ADULT",PHASE2,16,INDIV,INTERVENTIONAL,10/20/2021,4/28/2022
NCT05133609,UNKNOWN,SARS-CoV-2 Infection,BIOLOGICAL: ChAdOx1 nCoV-19 vaccine (AZD1222),Federal University of Espirito Santo,Centro de Pesquisas René Rachou,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,550,OTHER,INTERVENTIONAL,1/15/2021,12/30/2023
NCT05220306,WITHDRAWN,Sars-CoV-2 Infection,DEVICE: Monitoring of vital signs,"AIDAR Health, Inc.","MAXIS, LLC",ALL,"ADULT, OLDER_ADULT",NA,0,INDUSTRY,INTERVENTIONAL,1/27/2022,7/31/2022
NCT04521309,COMPLETED,COVID-19,BIOLOGICAL: SARS-CoV-2 antibody based IVIG therapy,Dow University of Health Sciences,Higher Education Commission (Pakistan),ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,50,OTHER,INTERVENTIONAL,6/19/2020,2/8/2021
NCT05094609,RECRUITING,COVID-19|SARS-CoV2 Infection,BIOLOGICAL: Ad5-triCoV/Mac|BIOLOGICAL: ChAd-triCoV/Mac,McMaster University,Canadian Institutes of Health Research (CIHR),ALL,"ADULT, OLDER_ADULT",PHASE1,30,OTHER,INTERVENTIONAL,1/3/2022,9/30/2024
NCT04312009,COMPLETED,Corona Virus Infection|Acute Respiratory Distress Syndrome|SARS-CoV Infection,DRUG: Losartan|OTHER: Placebo,University of Minnesota,Bill and Melinda Gates Foundation,ALL,"ADULT, OLDER_ADULT",PHASE2,205,OTHER,INTERVENTIONAL,4/13/2020,2/1/2021
NCT04426006,COMPLETED,Sars-CoV2|Serum; Disease,OTHER: PRO-SERO-COV,Institut Bergonié,,ALL,"ADULT, OLDER_ADULT",NA,526,OTHER,INTERVENTIONAL,6/18/2020,10/4/2021
NCT04637906,UNKNOWN,Covid19,DIETARY_SUPPLEMENT: Bioarginina®,"University of Campania ""Luigi Vanvitelli""",,ALL,"ADULT, OLDER_ADULT",NA,290,OTHER,INTERVENTIONAL,11/18/2020,9/18/2021
NCT04708327,UNKNOWN,COVID-19,DRUG: STAT-205,"Cytocom, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE1,24,INDUSTRY,INTERVENTIONAL,12/5/2021,9/30/2022
NCT05209009,ACTIVE_NOT_RECRUITING,Severe Acute Respiratory Syndrome Coronavirus 2,BIOLOGICAL: COVAC-2|BIOLOGICAL: Saline Placebo,University of Saskatchewan,Government of Canada|Government of Saskatchewan|Vaccine Formulation Institute (VFI)|Seppic,ALL,"ADULT, OLDER_ADULT",PHASE2,150,OTHER,INTERVENTIONAL,8/24/2022,2024-08
NCT04878809,COMPLETED,SARS-CoV-2 (COVID-19),OTHER: Escola L'Horitzó|OTHER: Escola John Talabot,"Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia",Escola L'Horitzó|Escola John Talabot,ALL,"CHILD, ADULT, OLDER_ADULT",NA,153,OTHER,INTERVENTIONAL,4/22/2021,6/17/2021
NCT05911906,NOT_YET_RECRUITING,SARS-CoV-2 Infection|COVID-19,DRUG: Remdesivir,University of Derby,University of Exeter|Peninsula Clinical Trials Unit|University Hospitals of Derby and Burton NHS Foundation Trust,ALL,"ADULT, OLDER_ADULT",PHASE4,72,OTHER,INTERVENTIONAL,4/1/2024,12/1/2025
NCT05770206,NOT_YET_RECRUITING,Covid19|Hydrogen-oxygen Gas|AMS-H-03,"DEVICE: Hydrogen-Oxygen Generator with Nebulizer, AMS-H-03|DEVICE: OLO-1 Medical Molecular Sieve Oxygen Generator",Guangzhou Institute of Respiratory Disease,,ALL,"ADULT, OLDER_ADULT",NA,218,OTHER,INTERVENTIONAL,4/1/2023,12/31/2024
NCT04993209,COMPLETED,Coronavirus Infections|Healthy,BIOLOGICAL: NDV-HXP-S 1μg|BIOLOGICAL: NDV-HXP-S 3μg|BIOLOGICAL: NDV-HXP-S 10μg|OTHER: Adsorbed inactivated COVID-19 vaccine (CoronaVac),Butantan Institute,,ALL,"ADULT, OLDER_ADULT",PHASE1,320,OTHER_GOV,INTERVENTIONAL,7/9/2021,11/4/2022
NCT04894227,COMPLETED,COVID-19,BIOLOGICAL: Inactivated SARS-CoV-2 Vaccine (Vero cell）,"Sinovac Research and Development Co., Ltd.",,ALL,ADULT,PHASE4,1080,INDUSTRY,INTERVENTIONAL,5/11/2021,11/30/2021
NCT04399109,UNKNOWN,COVID,DEVICE: TCC-COVID mHealth solution,Dr Sze-Yuan Ooi,The University of New South Wales|The George Institute|South Eastern Sydney Local Health District,ALL,"ADULT, OLDER_ADULT",NA,2000,OTHER_GOV,INTERVENTIONAL,5/20/2020,5/19/2021
NCT05911009,RECRUITING,Long Covid,DRUG: BC 007 or matching placebo,Berlin Cures GmbH,,ALL,"ADULT, OLDER_ADULT",PHASE2,114,INDUSTRY,INTERVENTIONAL,6/16/2023,5/31/2025
NCT04358809,UNKNOWN,COVID-19,DRUG: Suspension of heat killed (autoclaved) Mycobacterium w|OTHER: Placebo,Cadila Pharnmaceuticals,"Council of Scientific and Industrial Research, India",ALL,"ADULT, OLDER_ADULT",PHASE3,480,INDUSTRY,INTERVENTIONAL,6/30/2020,4/30/2021
NCT04701606,UNKNOWN,Covid19,DRUG: Artecom® (pyronaridine-artesunate)|DRUG: Placebo,Shin Poong Pharmaceutical Co. Ltd.,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,402,INDUSTRY,INTERVENTIONAL,3/29/2021,4/15/2022
NCT05059106,UNKNOWN,SARS-CoV-2,BIOLOGICAL: Half dose of ChAdOx1 nCoV-19 (AZD1222)|BIOLOGICAL: Standard dose of ChAdOx1 nCoV-19 (AZD1222),Federal University of Espirito Santo,Centro de Pesquisas René Rachou|Escola Nacional de Saúde Pública Sérgio Arouca/Fiocruz|Oswaldo Cruz Foundation|Escola Superior de Ciências da Santa Casa de Misericórdia de Vitória,ALL,ADULT,PHASE2|PHASE3,29637,OTHER,INTERVENTIONAL,6/1/2021,10/30/2022
NCT04353206,TERMINATED,Covid-19|Sars-CoV2,BIOLOGICAL: Multiple Doses of Anti-SARS-CoV-2 convalescent plasma,Noah Merin,Johns Hopkins University,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,6,OTHER,INTERVENTIONAL,6/27/2020,11/1/2020
NCT04393727,TERMINATED,COVID|SARS-CoV 2,BIOLOGICAL: CONVALESCENT PLASMA,"Azienda Ospedaliero, Universitaria Pisana",,ALL,"ADULT, OLDER_ADULT",PHASE2,1,OTHER,INTERVENTIONAL,5/1/2020,9/30/2020
NCT04388709,WITHDRAWN,SARS-CoV-2,DRUG: Peginterferon Lambda-1A,Icahn School of Medicine at Mount Sinai,Eiger BioPharmaceuticals,ALL,"ADULT, OLDER_ADULT",PHASE2,0,OTHER,INTERVENTIONAL,2020-09,2/5/2021
NCT05549206,NOT_YET_RECRUITING,SARS-CoV-2,BIOLOGICAL: SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine low dose|BIOLOGICAL: SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine high dose|DRUG: Placebo,"AIM Vaccine Co., Ltd.","Ningbo Rongan Biological Pharmaceutical Co., Ltd.|First Affiliated Hospital Bengbu Medical College",ALL,"ADULT, OLDER_ADULT",NA,350,INDUSTRY,INTERVENTIONAL,2023-04,2024-04
NCT04365127,COMPLETED,COVID-19|Sars-CoV2,DRUG: Progesterone 100 MG,Sara Ghandehari,IBSA Institut Biochimique SA,MALE,"ADULT, OLDER_ADULT",PHASE1,40,OTHER,INTERVENTIONAL,4/27/2020,8/20/2020
NCT04470609,COMPLETED,COVID-19,BIOLOGICAL: Low dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule|BIOLOGICAL: Medium dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule|BIOLOGICAL: High dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule|BIOLOGICAL: Placebo on a 0- and 28-day schedule,"Institute of Medical Biology, Chinese Academy of Medical Sciences",West China Second University Hospital|Yunnan Center for Disease Control and Prevention,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,471,OTHER,INTERVENTIONAL,7/10/2020,10/27/2021
NCT05007509,COMPLETED,Covid19|SARS CoV 2 Infection,BIOLOGICAL: COVID-19 vaccine HIPRA 10|BIOLOGICAL: COVID-19 vaccine HIPRA 20|BIOLOGICAL: COVID-19 vaccine HIPRA 40|BIOLOGICAL: Commercial COVID-19 vaccine,"Laboratorios Hipra, S.A.",,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,30,INDUSTRY,INTERVENTIONAL,8/16/2021,9/30/2022
NCT04454606,COMPLETED,COVID|Personal Protective Equipment,DEVICE: Fit test|DEVICE: Filtration Test,Bangkok Metropolitan Administration Medical College and Vajira Hospital,,ALL,ADULT,NA,43,OTHER_GOV,INTERVENTIONAL,5/1/2020,5/31/2020
NCT04345406,NOT_YET_RECRUITING,COVID,DRUG: ACEIs|DRUG: Conventional treatment,Tanta University,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,60,OTHER,INTERVENTIONAL,4/15/2020,12/1/2029
NCT06253806,RECRUITING,COVID-19-Induced Parosmia,DRUG: Stellate Ganglion Block|DRUG: Placebo Sham Injection,Washington University School of Medicine,,ALL,"ADULT, OLDER_ADULT",PHASE2,140,OTHER,INTERVENTIONAL,10/25/2023,2025-08
NCT04363827,UNKNOWN,COVID19|Hydroxychloroquine|Prophylaxis|Treatment|SARS-CoV-2,DRUG: Hydroxychloroquine,Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori,University of Bologna,ALL,"ADULT, OLDER_ADULT",PHASE2,2300,OTHER,INTERVENTIONAL,5/14/2020,2021-09
NCT05817006,ENROLLING_BY_INVITATION,Long COVID,OTHER: Device,Samara State Medical University,,ALL,"CHILD, ADULT",NA,30,OTHER,INTERVENTIONAL,4/16/2023,12/31/2025
NCT04756609,COMPLETED,SARS-CoV Infection|Nurse's Role,PROCEDURE: Systematic offer of nurse-driven SARS-CoV-2 screening combined with usual practice|OTHER: Usual emergency department practice with physician-directed diagnostic testing,Assistance Publique - Hôpitaux de Paris,,ALL,"ADULT, OLDER_ADULT",NA,138352,OTHER,INTERVENTIONAL,3/12/2021,6/15/2021
NCT04590209,NOT_YET_RECRUITING,Adult Patients With Lesions on Fingers or Toes,OTHER: Blood sampling|OTHER: Skin biopsy,Assistance Publique - Hôpitaux de Paris,Institut Cochin,ALL,"ADULT, OLDER_ADULT",NA,25,OTHER,INTERVENTIONAL,2023-01,2023-03
NCT04418206,COMPLETED,Covid 19,OTHER: patients COVID 19,Centre Hospitalier Universitaire de Nice,,ALL,"ADULT, OLDER_ADULT",NA,950,OTHER,INTERVENTIONAL,6/1/2020,7/19/2022
NCT04457609,UNKNOWN,COVID|Pulmonary Infection|Sars-CoV2,DRUG: Oseltamivir|DRUG: Azithromycin|BIOLOGICAL: Umbilical Cord Mesenchymal Stem Cells,Indonesia University,,ALL,"ADULT, OLDER_ADULT",PHASE1,40,OTHER,INTERVENTIONAL,2020-07,2020-09
NCT04409509,COMPLETED,Coronavirus Disease 2019 (COVID-19),"BIOLOGICAL: Garadacimab, Factor XIIa Antagonist Monoclonal Antibody|DRUG: Placebo",CSL Behring,,ALL,"ADULT, OLDER_ADULT",PHASE2,124,INDUSTRY,INTERVENTIONAL,7/1/2020,1/12/2021
NCT04391309,TERMINATED,Coronavirus Disease 2019 (COVID-19)|Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),BIOLOGICAL: anti-CD14|OTHER: Placebo|DRUG: remdesivir,National Institute of Allergy and Infectious Diseases (NIAID),University of Washington|Implicit Bioscience|Vanderbilt University Medical Center|PPD,ALL,"ADULT, OLDER_ADULT",PHASE2,49,NIH,INTERVENTIONAL,4/12/2021,2/4/2022
NCT05616806,NOT_YET_RECRUITING,Long COVID|Distress Tolerance,BEHAVIORAL: iENDURE,Rhode Island Hospital,Brown University,ALL,"ADULT, OLDER_ADULT",NA,10,OTHER,INTERVENTIONAL,7/1/2023,1/1/2025
NCT04470427,COMPLETED,SARS-CoV-2,BIOLOGICAL: mRNA-1273|BIOLOGICAL: Placebo,"ModernaTX, Inc.",Biomedical Advanced Research and Development Authority|National Institute of Allergy and Infectious Diseases (NIAID),ALL,"ADULT, OLDER_ADULT",PHASE3,30000,INDUSTRY,INTERVENTIONAL,7/27/2020,12/29/2022
NCT05783206,COMPLETED,COVID-19,DRUG: MIR 19 ®|COMBINATION_PRODUCT: Standard therapy,National Research Center - Institute of Immunology Federal Medical-Biological Agency of Russia,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,984,OTHER,INTERVENTIONAL,2/10/2022,7/28/2023
NCT05142306,COMPLETED,SARS-CoV-2 Infection,BIOLOGICAL: COVID-HIG,Emergent BioSolutions,United States Department of Defense,ALL,ADULT,PHASE1,23,INDUSTRY,INTERVENTIONAL,12/7/2021,5/31/2022
NCT04619706,TERMINATED,COVID-19,DRUG: FSD201|DRUG: Placebo|OTHER: Standard of Care for Covid-19,"FSD Pharma, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE2,53,INDUSTRY,INTERVENTIONAL,12/14/2020,8/24/2021
NCT04335071,TERMINATED,SARS-CoV-2 Infection,DRUG: Tocilizumab (TCZ)|DRUG: Placebo,"Insel Gruppe AG, University Hospital Bern",Roche Pharma AG,ALL,"ADULT, OLDER_ADULT",PHASE2,5,OTHER,INTERVENTIONAL,4/26/2020,9/27/2020
NCT04528771,ACTIVE_NOT_RECRUITING,SARS-CoV2 Infection|Covid19,DRUG: SNO|DRUG: Nitrogen gas,James Reynolds,Case Western Reserve University,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,24,OTHER,INTERVENTIONAL,8/5/2021,4/30/2025
NCT04350671,UNKNOWN,COVID-19,DRUG: Interferon Beta-1A|DRUG: Lopinavir / Ritonavir|DRUG: Single Dose of Hydroxychloroquine,Shahid Beheshti University of Medical Sciences,,ALL,"ADULT, OLDER_ADULT",PHASE4,40,OTHER,INTERVENTIONAL,4/15/2020,4/24/2020
NCT05557539,RECRUITING,SARS-CoV-2 Infection|Influenza Viral Infections,"BIOLOGICAL: blood samples, urine samples and nasopharyngeal swabs",Cliniques universitaires Saint-Luc- Université Catholique de Louvain,,ALL,"ADULT, OLDER_ADULT",NA,275,OTHER,INTERVENTIONAL,2/7/2022,9/30/2024
NCT04981379,COMPLETED,Covid19,DRUG: Hydroxychloroquine|DRUG: Favipiravir|DRUG: Favipiravir + Hydroxychloroquine|DRUG: Placebo,Health Institutes of Turkey,,ALL,ADULT,PHASE3,1120,OTHER_GOV,INTERVENTIONAL,11/16/2020,2/16/2021
NCT04345991,COMPLETED,Covid19,DRUG: Transfusion of COVID-19 convalescent plasma,Assistance Publique - Hôpitaux de Paris,Etablissement Français du Sang,ALL,"ADULT, OLDER_ADULT",PHASE2,120,OTHER,INTERVENTIONAL,4/15/2020,5/28/2021
NCT05518591,RECRUITING,Psychological Distress|Cancer Recurrence,BEHAVIORAL: Compassion Focused Therapy (CFT) combined with Breathing Pattern Retraining (BPR),University College Dublin,Mater Misericordiae University Hospital|Irish Cancer Society,ALL,"ADULT, OLDER_ADULT",NA,160,OTHER,INTERVENTIONAL,3/25/2022,2023-06
NCT04613271,COMPLETED,Infectious Disease|SARS-CoV Infection|Covid19,DRUG: Favipiravir|DRUG: Azithromycin,Ina-Respond,"Center for Research and Development of Health Resources and Services, National Institute of Health Research and Development (NIHRD), Indonesia",ALL,ADULT,PHASE3,130,OTHER,INTERVENTIONAL,10/15/2020,11/8/2021
NCT04385771,SUSPENDED,Coronavirus Infection|COVID|SARS-CoV 2|Respiratory Failure|Cytokine Storm|Extracorporeal Membrane Oxygenation,DEVICE: vv-ECMO + cytokine adsorption (Cytosorb adsorber)|DEVICE: vv-ECMO only (no cytokine adsorption),Dr. Alexander Supady,"Klinikum Ibbenbüren|Ludwig-Maximilians - University of Munich|University Hospital, Saarland|Klinikum Ludwigsburg|University of Ulm|SLK Kliniken Heilbronn GmbH|Martin-Luther-Universität Halle-Wittenberg",ALL,"ADULT, OLDER_ADULT",NA,80,OTHER,INTERVENTIONAL,9/1/2020,10/31/2021
NCT04405739,COMPLETED,SARS-CoV 2,DRUG: EIDD-2801|DRUG: Placebo,"Ridgeback Biotherapeutics, LP",Merck Sharp & Dohme LLC,ALL,"ADULT, OLDER_ADULT",PHASE2,71,INDUSTRY,INTERVENTIONAL,6/16/2020,2/21/2022
NCT05060939,RECRUITING,COVID-19,DIAGNOSTIC_TEST: COVID-19 vaccinated people,Hospices Civils de Lyon,,ALL,"ADULT, OLDER_ADULT",NA,5000,OTHER,INTERVENTIONAL,8/20/2021,2/20/2024
NCT04525079,COMPLETED,SARS-CoV-2 Infection,DRUG: CT-P59|DRUG: Placebo,Celltrion,,ALL,ADULT,PHASE1,32,INDUSTRY,INTERVENTIONAL,7/18/2020,11/5/2020
NCT04678739,COMPLETED,Covid19|Covid-19 ARDS,DRUG: Remdesivir|DRUG: Tocilizumab,M Abdur Rahim Medical College and Hospital,First Affiliated Hospital Xi'an Jiaotong University|Cox's Bazar 250 Bed District Sadar Hospital|Chattogram General Hospital,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,205,OTHER_GOV,INTERVENTIONAL,8/15/2020,2/10/2021
NCT04913779,UNKNOWN,COVID-19 Pneumonia|COVID-19 Respiratory Infection|Covid19,DRUG: Anti-SARS-CoV-2|DRUG: Placebo,Administracion Nacional de Laboratorios e Institutos de Salud Dr. Carlos G. Malbran,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,200,OTHER_GOV,INTERVENTIONAL,6/1/2021,12/31/2021
NCT05139979,ACTIVE_NOT_RECRUITING,COVID-19|Stress|Shortness of Breath,BEHAVIORAL: Breathing and Wellness Webinar|OTHER: Routine Daily Activity,Beth Israel Deaconess Medical Center,,ALL,"ADULT, OLDER_ADULT",NA,189,OTHER,INTERVENTIONAL,9/15/2021,3/31/2024
NCT04382391,ACTIVE_NOT_RECRUITING,"COVID|Corona Virus Infection|Respiratory Failure|Respiratory Distress Syndrome, Adult|ARDS, Human|SARS (Severe Acute Respiratory Syndrome)",DEVICE: gammaCore® Sapphire (non-invasive vagus nerve stimulator)|OTHER: Standard of care therapies,Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute),ElectroCore INC,ALL,"ADULT, OLDER_ADULT",NA,21,OTHER,INTERVENTIONAL,5/8/2020,12/1/2023
NCT05210179,COMPLETED,COVID-19|Sars-CoV-2 Infection,BIOLOGICAL: TURKOVAC-Dollvet|BIOLOGICAL: TURKOVAC-Koçak,Health Institutes of Turkey,,ALL,ADULT,PHASE2,65,OTHER_GOV,INTERVENTIONAL,1/24/2022,5/2/2023
NCT05765279,COMPLETED,SARS-CoV-2 Infection,DRUG: HH-120 nasal spray 1|DRUG: HH-120 nasal spray 2|DRUG: Placebo Comparator 1|DRUG: Placebo Comparator 2,Beijing Ditan Hospital,,ALL,"ADULT, OLDER_ADULT",NA,281,OTHER,INTERVENTIONAL,10/20/2022,12/6/2022
NCT04929691,UNKNOWN,SARS-CoV-2 Acute Respiratory Disease|COVID-19 Respiratory Infection,DEVICE: CPAP helmet|OTHER: Standard of care non-helmet based CPAP ventilation,New York University,Aliko Dangote Foundation|Nigerian Institute of Medical Research|CDC Foundation,ALL,"ADULT, OLDER_ADULT",NA,370,OTHER,INTERVENTIONAL,11/13/2020,2021-12
NCT04492891,COMPLETED,SARS (Disease),DRUG: Cyclosporine|OTHER: Standard of Care Treatment,"Bryan Burt, MD",Brigham and Women's Hospital,ALL,"ADULT, OLDER_ADULT",PHASE2,47,OTHER,INTERVENTIONAL,11/23/2020,12/10/2021
NCT04351191,TERMINATED,Sars-CoV2|Symptomatic Condition|Covid-19,DRUG: Hydroxychloroquine Sulfate Regular dose|DRUG: Hydroxychloroquine Sulfate Loading Dose|DRUG: Chloroquine|DRUG: Placebo,"Government of Punjab, Specialized Healthcare and Medical Education Department","Mayo Hospital Lahore|Services Hospital, Lahore|Pakistan Kidney and Liver Institute",ALL,ADULT,PHASE4,137,OTHER_GOV,INTERVENTIONAL,4/15/2020,8/30/2020
NCT04391179,COMPLETED,COVID|Corona Virus Infection|Covid-19|SARS-CoV-2 Infection,DRUG: Dipyridamole 100 Milligram(mg)|DRUG: Placebo oral tablet,University of Michigan,,ALL,"ADULT, OLDER_ADULT",PHASE2,99,OTHER,INTERVENTIONAL,5/31/2020,2/22/2021
NCT04390191,TERMINATED,COVID-19|COVID|Coronavirus,DEVICE: Continuous Positive Airway Pressure,Icahn School of Medicine at Mount Sinai,"Itamar Medical LTD|Community Surgical Supply of Toms River, Inc|Philips Healthcare",ALL,"ADULT, OLDER_ADULT",NA,4,OTHER,INTERVENTIONAL,5/7/2020,7/7/2021
NCT06113679,RECRUITING,Post COVID-19 Condition (PCC),DEVICE: RDX-19,EmitBio Inc.,NAMSA,ALL,"ADULT, OLDER_ADULT",NA,60,INDUSTRY,INTERVENTIONAL,10/30/2023,3/30/2024
NCT05566379,RECRUITING,Long COVID|Dysautonomia,OTHER: Mindfulness - Mindful Awareness Practices ( MAPs),"University of California, Los Angeles",,FEMALE,ADULT,NA,30,OTHER,INTERVENTIONAL,2/28/2023,2023-06
NCT05931679,NOT_YET_RECRUITING,COVID 19,DEVICE: VR Headset|OTHER: Traditional Theatre-based simulation,Ottawa Hospital Research Institute,Sunnybrook Research Institute,ALL,"CHILD, ADULT, OLDER_ADULT",NA,45,OTHER,INTERVENTIONAL,2023-07,2025-12
NCT05385991,COMPLETED,SARS-CoV-2 Infection,BIOLOGICAL: ACM-SARS-CoV-2-beta ACM-CpG vaccine candidate (ACM-001),ACM Biolabs,,ALL,ADULT,PHASE1,38,INDUSTRY,INTERVENTIONAL,7/1/2022,8/22/2023
NCT04344379,COMPLETED,SARS-CoV-2 Infection,DRUG: hydroxychloroquine|DRUG: azithromycin|DRUG: hydroxychloroquine placebo,Assistance Publique - Hôpitaux de Paris,,ALL,"ADULT, OLDER_ADULT",PHASE3,122,OTHER,INTERVENTIONAL,4/17/2020,6/18/2020
NCT04834908,TERMINATED,SARS-CoV-2 Infection,BIOLOGICAL: Equine COVID-19 Antiserum|DRUG: Standard of care,Bharat Serums and Vaccines Limited,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,7,INDUSTRY,INTERVENTIONAL,7/27/2021,5/25/2022
NCT05343871,COMPLETED,COVID-19,BIOLOGICAL: Sinovac|BIOLOGICAL: AZD1222|BIOLOGICAL: BNT162b2,Albert B. Sabin Vaccine Institute,Aga Khan University|Oswaldo Cruz Foundation|Stanford University,ALL,ADULT,PHASE4,2354,OTHER,INTERVENTIONAL,7/5/2022,1/11/2024
NCT05732571,RECRUITING,COVID-19|Respiratory Disease,OTHER: Breathing techniques over 12 sessions / 6 weeks inc yoga,University of Nottingham,,ALL,"ADULT, OLDER_ADULT",NA,60,OTHER,INTERVENTIONAL,2/10/2023,6/30/2024
NCT05870839,ACTIVE_NOT_RECRUITING,SARS-CoV|SARS-CoV-2,BIOLOGICAL: VXCO-100,"Vaccine Company, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE1,121,INDUSTRY,INTERVENTIONAL,5/11/2023,7/31/2024
NCT05548439,ACTIVE_NOT_RECRUITING,COVID-19|Coronavirus Infections,BIOLOGICAL: VBI-2901a,VBI Vaccines Inc.,,ALL,ADULT,PHASE1,103,INDUSTRY,INTERVENTIONAL,10/5/2022,2024-02
NCT05523739,COMPLETED,SARS-CoV-2 Infection,DRUG: STI-1558,Zhejiang ACEA Pharmaceutical Co. Ltd.,,ALL,"ADULT, OLDER_ADULT",PHASE1,79,INDUSTRY,INTERVENTIONAL,9/16/2022,3/29/2023
NCT04512079,COMPLETED,COVID-19|SARS-CoV-2,DRUG: Enoxaparin|DRUG: Apixaban,Valentin Fuster,,ALL,"ADULT, OLDER_ADULT",PHASE4,3460,OTHER,INTERVENTIONAL,9/8/2020,12/30/2022
NCT04497649,UNKNOWN,Covid19,DRUG: Sofosbuvir|DRUG: Daclatasvir,Tanta University,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2|PHASE3,100,OTHER,INTERVENTIONAL,7/1/2020,4/10/2021
NCT04647305,COMPLETED,SARS-CoV-2 Infection,OTHER: Closed face shield with Surgical face mask use|OTHER: Surgical face mask use only,"University of Los Andes, Columbia",United Nations,ALL,"ADULT, OLDER_ADULT",NA,233,OTHER,INTERVENTIONAL,1/16/2021,3/4/2021
NCT04922905,COMPLETED,Covid19,OTHER: NEURO +|OTHER: NEURO -,"University Hospital, Toulouse",,ALL,"ADULT, OLDER_ADULT",NA,99,OTHER,INTERVENTIONAL,4/2/2020,4/2/2021
NCT05656105,RECRUITING,SARS CoV-2 Post-Acute Sequelae,DRUG: DPA-714 PET/MRI,University of Alabama at Birmingham,,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,60,OTHER,INTERVENTIONAL,11/10/2023,6/1/2026
NCT06147063,RECRUITING,COVID-19|SARS-CoV-2 Infection,BIOLOGICAL: AZD9838|BIOLOGICAL: Licensed mRNA vaccine,AstraZeneca,,ALL,ADULT,PHASE1,90,INDUSTRY,INTERVENTIONAL,11/27/2023,4/10/2025
NCT05531149,RECRUITING,Respiratory Infection|Pneumonia|Community-acquired Pneumonia|Acute Respiratory Distress Syndrome|COVID-19|Viral Pneumonia|Bacterial Pneumonia|Fungal Pneumonia,DRUG: Trimodulin|DRUG: Placebo (human albumin 1%),Biotest,,ALL,"ADULT, OLDER_ADULT",PHASE3,390,INDUSTRY,INTERVENTIONAL,12/22/2022,8/31/2025
NCT04904549,ACTIVE_NOT_RECRUITING,COVID-19,BIOLOGICAL: SARS-CoV-2 adjuvanted recombinant protein vaccine (monovalent D614) (primary series)|BIOLOGICAL: SARS-CoV-2 adjuvanted recombinant protein vaccine (bivalent D614 + B.1.351) (primary series)|BIOLOGICAL: Placebo|BIOLOGICAL: SARS-CoV-2 adjuvanted recombinant protein vaccine (monovalent B.1.351) (booster dose) >= 4 months after last vaccination|BIOLOGICAL: SARS-CoV-2 adjuvanted recombinant protein vaccine(monovalent D614)(primary series)& SARS-CoV-2 adjuvanted recombinant protein vaccine(monovalent B.1.351)(booster dose)>=4 months after last vaccination,"Sanofi Pasteur, a Sanofi Company",,ALL,"ADULT, OLDER_ADULT",PHASE3,23726,INDUSTRY,INTERVENTIONAL,5/26/2021,1/31/2025
NCT05019963,RECRUITING,Covid19,BEHAVIORAL: NexJ Connected Wellness|OTHER: Usual Care,University of Ottawa,Canadian Institutes of Health Research (CIHR)|Ottawa Hospital Research Institute,ALL,"ADULT, OLDER_ADULT",NA,152,OTHER,INTERVENTIONAL,5/2/2022,2024-09
NCT05354063,ACTIVE_NOT_RECRUITING,SARS-CoV-2,BIOLOGICAL: 20 μg dose of SYS6006|BIOLOGICAL: 30 μg dose of SYS6006|DRUG: Placebo,"CSPC ZhongQi Pharmaceutical Technology Co., Ltd.",,ALL,"ADULT, OLDER_ADULT",PHASE1,40,INDUSTRY,INTERVENTIONAL,6/1/2022,10/1/2023
NCT04327349,UNKNOWN,Coronavirus Infections,BIOLOGICAL: Convalescent Plasma,Mazandaran University of Medical Sciences,,ALL,"ADULT, OLDER_ADULT",NA,30,OTHER,INTERVENTIONAL,3/28/2020,9/30/2020
NCT05220605,COMPLETED,COVID-19 Pneumonia|Bromelains Adverse Reaction|Acetylcysteine Adverse Reaction|Mucus; Plug|COVID-19 Acute Respiratory Distress Syndrome,DRUG: BromAc,Mucpharm Pty Ltd,"St George Hospital, Australia|Mobius Medical Pty Ltd.",ALL,"ADULT, OLDER_ADULT",PHASE1,12,INDUSTRY,INTERVENTIONAL,7/27/2022,8/25/2022
NCT04942405,COMPLETED,Covid19,BIOLOGICAL: TURCOVAC|BIOLOGICAL: CoronaVac,Health Institutes of Turkey,,ALL,ADULT,PHASE3,1290,OTHER_GOV,INTERVENTIONAL,6/21/2021,4/27/2023
NCT05956405,RECRUITING,Mental Health Wellness,BEHAVIORAL: AIR + Mindfulness|BEHAVIORAL: Relaxation condition,Hospital Miguel Servet,,ALL,"ADULT, OLDER_ADULT",NA,100,OTHER,INTERVENTIONAL,9/1/2023,3/31/2024
NCT04979949,COMPLETED,COVID-19|Sars-CoV-2 Infection,BIOLOGICAL: CoronaVac|BIOLOGICAL: Turkovac,Health Institutes of Turkey,,ALL,ADULT,PHASE2,222,OTHER_GOV,INTERVENTIONAL,7/12/2021,6/6/2022
NCT04970563,COMPLETED,Infection by SARS-COV-2|Healthy Controls,OTHER: Body odor samples|OTHER: Body odor samples,Hôpital Européen Marseille,,ALL,"ADULT, OLDER_ADULT",NA,160,OTHER,INTERVENTIONAL,6/21/2021,1/14/2022
NCT04739449,WITHDRAWN,SARS-CoV Infection|Covid19,"BEHAVIORAL: Coaching, Cleaning, Communication, Collaboration",University of Michigan,National Institute on Aging (NIA),ALL,"ADULT, OLDER_ADULT",NA,0,OTHER,INTERVENTIONAL,12/4/2021,2022-03
NCT04951349,COMPLETED,Covid19,DRUG: GX-03|DRUG: Petrolatum ointment,Turn Therapeutics,Gorgas Memorial Institute for Health Studies|Hospital Santo Tomas|Hospital Modular - Covid-19,ALL,"ADULT, OLDER_ADULT",PHASE2,85,INDUSTRY,INTERVENTIONAL,1/21/2021,5/30/2021
NCT04847349,COMPLETED,Covid19,"DIETARY_SUPPLEMENT: OL-1, standard dose|DIETARY_SUPPLEMENT: OL-1, high dose|DIETARY_SUPPLEMENT: Placebo","Rutgers, The State University of New Jersey","Vault Health, Inc.|Danisco USA Inc.",ALL,ADULT,NA,54,OTHER,INTERVENTIONAL,4/13/2021,1/31/2022
NCT05152849,COMPLETED,Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection,DRUG: AXA1125|DRUG: Placebo,"Axcella Health, Inc",,ALL,ADULT,PHASE2,41,INDUSTRY,INTERVENTIONAL,12/15/2021,6/29/2022
NCT04537949,COMPLETED,Covid-19|Protection Against COVID-19,BIOLOGICAL: BNT162b3,BioNTech SE,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,96,INDUSTRY,INTERVENTIONAL,9/9/2020,2/7/2022
NCT05104749,COMPLETED,Post-acute Covid-19 Syndrome,DRUG: Homeopathic Medication|OTHER: Placebo,Southwest College of Naturopathic Medicine,Samueli Institute for Information Biology,ALL,ADULT,PHASE3,77,OTHER,INTERVENTIONAL,9/15/2021,4/22/2022
NCT04969263,COMPLETED,Kidney Transplant Recipients,BIOLOGICAL: mRNA-1273 vaccine (Pfizer/BioNTech)|BIOLOGICAL: mRNA-1273 vaccine (Moderna),National Institute of Allergy and Infectious Diseases (NIAID),PPD,ALL,"ADULT, OLDER_ADULT",PHASE2,81,NIH,INTERVENTIONAL,8/10/2021,3/10/2023
NCT04363749,COMPLETED,Covid19|Neurological Complication,"OTHER: hypoxia : 14.3 and 12.7% FIO2, hypercapnia 7% CO2, inspiratory mechanical constraint",Assistance Publique - Hôpitaux de Paris,,ALL,"ADULT, OLDER_ADULT",NA,50,OTHER,INTERVENTIONAL,4/27/2020,1/11/2021
NCT05009563,UNKNOWN,Coronavirus Infection,RADIATION: FDG-PET/CT,Semmelweis University Heart and Vascular Center,Semmelweis University Department of Pulmonology|Semmelweis University Medical Imaging Centre,ALL,"ADULT, OLDER_ADULT",NA,50,OTHER,INTERVENTIONAL,1/4/2021,1/4/2022
NCT04342663,COMPLETED,COVID 19|Coronavirus,DRUG: Fluvoxamine|DRUG: Placebo,Washington University School of Medicine,,ALL,"ADULT, OLDER_ADULT",PHASE2,152,OTHER,INTERVENTIONAL,4/10/2020,12/12/2020
NCT04711863,SUSPENDED,Severe Acute Respiratory Syndrome Coronavirus 2|Coronavirus Infection|Mild to Moderate COVID-19,DRUG: Fluvoxamine|DRUG: Placebo,Asan Medical Center,,ALL,"ADULT, OLDER_ADULT",PHASE2,400,OTHER,INTERVENTIONAL,1/16/2021,7/31/2021
NCT04662671,COMPLETED,COVID19,DEVICE: RD-X19,EmitBio Inc.,,ALL,"ADULT, OLDER_ADULT",NA,31,INDUSTRY,INTERVENTIONAL,11/18/2020,1/30/2021
NCT04686539,UNKNOWN,Covid19|CBD,DRUG: CBD|DRUG: Placebo,Sheba Medical Center,,ALL,"ADULT, OLDER_ADULT",PHASE1,50,OTHER_GOV,INTERVENTIONAL,1/20/2021,2022-01
NCT04372979,TERMINATED,COVID-19,DRUG: Transfusion of SARS-CoV-2 Convalescent Plasma.|DRUG: Transfusion of standard Plasma.,Direction Centrale du Service de Santé des Armées,"University Hospital, Grenoble",ALL,"ADULT, OLDER_ADULT",PHASE3,18,OTHER,INTERVENTIONAL,9/14/2020,6/1/2021
NCT05713279,ACTIVE_NOT_RECRUITING,COVID-19,DRUG: SOC,"Chengdu Zenitar Biomedical Technology Co., Ltd",,ALL,"ADULT, OLDER_ADULT",NA,66,INDUSTRY,INTERVENTIONAL,1/19/2023,11/30/2023
NCT04746339,TERMINATED,Covid19|Thrombosis,DRUG: Apixaban 2.5 MG|DRUG: Placebo,Brazilian Clinical Research Institute,Hospital Israelita Albert Einstein|Hospital do Coracao|Hospital Sirio-Libanes|Hospital Moinhos de Vento|Hospital Alemão Oswaldo Cruz|Beneficência Portuguesa de São Paulo|Brazilian Research In Intensive Care Network,ALL,"ADULT, OLDER_ADULT",PHASE4,411,OTHER,INTERVENTIONAL,3/4/2021,5/30/2022
NCT04345679,UNKNOWN,COVID 19,BIOLOGICAL: anti-SARS-CoV-2 convalescent plasma,Orthosera Kft.,Semmelweis University|University of Pecs|Hungarian National Blood Service|Humán Bioplazma Kft - Kedrion,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,20,OTHER,INTERVENTIONAL,4/14/2020,9/1/2021
NCT04779879,COMPLETED,Covid19,BIOLOGICAL: Sotrovimab (Gen1)|BIOLOGICAL: Sotrovimab (Gen2)|BIOLOGICAL: Sotrovimab (Gen2),"Vir Biotechnology, Inc.",GlaxoSmithKline,ALL,"ADULT, OLDER_ADULT",PHASE2,354,INDUSTRY,INTERVENTIONAL,2/18/2021,4/6/2022
NCT04469179,UNKNOWN,COVID-19|SARS-CoV2,BIOLOGICAL: SAB-185|OTHER: Normal Saline,"SAb Biotherapeutics, Inc.","Biomedical Advanced Research and Development Authority|Joint Program Executive Office (JPEO) Chemical, Biological, Radiological, and Nuclear Defense (CBRND) Enabling Biotechnologies (EB)",ALL,ADULT,PHASE1,21,INDUSTRY,INTERVENTIONAL,8/20/2020,2021-11
NCT04623671,COMPLETED,Covid19,BIOLOGICAL: CAP-1002|BIOLOGICAL: Placebo,Capricor Inc.,,ALL,"ADULT, OLDER_ADULT",PHASE2,63,INDUSTRY,INTERVENTIONAL,11/15/2020,2/4/2022
NCT05003479,UNKNOWN,COVID-19,"BIOLOGICAL: SARS-CoV-2 Vaccine (Vero Cells), Inactivated|BIOLOGICAL: Placebo","Shenzhen Kangtai Biological Products Co., LTD","Beijing Minhai Biotechnology Co., Ltd|Hunan Provincial Center for Disease Control and Prevention",ALL,CHILD,PHASE1,84,INDUSTRY,INTERVENTIONAL,2021-08,2022-10
NCT04811339,COMPLETED,Diarrhea|COVID-19,"DRUG: Bismuth Subsalicylate 262 milligram (mg) Oral Tablet, Chewable|OTHER: Placebo oral tablet without BSS",University of Cincinnati,Procter and Gamble,ALL,"ADULT, OLDER_ADULT",PHASE4,60,OTHER,INTERVENTIONAL,10/27/2020,8/15/2021
NCT04552379,COMPLETED,SARS-CoV Infection|Interferon|Covid19,BIOLOGICAL: Peginterferon beta-1a,Pontificia Universidad Catolica de Chile,Telethon Kids Institute,ALL,"ADULT, OLDER_ADULT",PHASE3,1173,OTHER,INTERVENTIONAL,12/1/2020,6/30/2021
NCT04765371,COMPLETED,Coronavirus Infection,DRUG: DEXAMETHASONE|DRUG: PREDNISOLONE,Hôpital NOVO,,ALL,"ADULT, OLDER_ADULT",PHASE3,89,OTHER,INTERVENTIONAL,3/3/2021,5/13/2022
NCT04348071,WITHDRAWN,COVID-19,DRUG: Ruxolitinib,"University of Colorado, Denver",,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,0,OTHER,INTERVENTIONAL,2021-07,2021-10
NCT05261139,SUSPENDED,COVID-19,DRUG: nirmatrelvir|DRUG: ritonavir,Pfizer,,ALL,CHILD,PHASE2|PHASE3,160,INDUSTRY,INTERVENTIONAL,3/7/2022,7/3/2027
NCT04668339,TERMINATED,Covid19|SARS-CoV Infection|Corona Virus Infection,"BIOLOGICAL: ARCT-021 single dose priming|BIOLOGICAL: ARCT-021 two lower dose priming|BIOLOGICAL: ARCT-021 two higher dose priming|BIOLOGICAL: Placebo (two doses), priming|BIOLOGICAL: Randomized booster|BIOLOGICAL: Placebo booster","Arcturus Therapeutics, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE2,581,INDUSTRY,INTERVENTIONAL,1/7/2021,3/1/2022
NCT05668039,RECRUITING,Post-Acute COVID-19 Syndrome,PROCEDURE: Enhanced external counterpulsation,Sheba Medical Center,,ALL,"ADULT, OLDER_ADULT",NA,32,OTHER_GOV,INTERVENTIONAL,4/1/2023,2024-07
NCT05074771,COMPLETED,Post-COVID19|Parkinson Disease,DEVICE: ARC intellicare,Camlin Ltd,Università Politecnica delle Marche,ALL,"ADULT, OLDER_ADULT",NA,31,INDUSTRY,INTERVENTIONAL,3/26/2021,3/30/2022
NCT05148871,ACTIVE_NOT_RECRUITING,COVID-19,BIOLOGICAL: Spikogen/Covax-19,Vaxine Pty Ltd,Australian Respiratory and Sleep Medicine Institute|Cinnagen,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,200,INDUSTRY,INTERVENTIONAL,3/1/2022,2/25/2024
NCT05085639,UNKNOWN,Covid19|Healthy,BIOLOGICAL: GLS-5130|BIOLOGICAL: Placebo,"GeneOne Life Science, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE1,30,INDUSTRY,INTERVENTIONAL,2021-11,2022-12
NCT04374279,WITHDRAWN,COVID-19|SARS-CoV 2,DRUG: Bicalutamide 150 Mg Oral Tablet,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,,ALL,"ADULT, OLDER_ADULT",PHASE2,0,OTHER,INTERVENTIONAL,2021-04,2022-01
NCT04414371,UNKNOWN,Stress|Anxiety|Depression|Resilience|Wellbeing|Mood,OTHER: Yoga,"Rutgers, The State University of New Jersey",Harvard Medical School (HMS and HSDM),ALL,"ADULT, OLDER_ADULT",NA,200,OTHER,INTERVENTIONAL,5/20/2020,12/31/2020
NCT05630339,COMPLETED,Post-COVID-19 Syndrome|Long COVID|Vitamin D Deficiency|Magnesium Deficiency,DIETARY_SUPPLEMENT: Magnesium chloride|DIETARY_SUPPLEMENT: Vitamin D|DIETARY_SUPPLEMENT: Inert placebo,"Coordinación de Investigación en Salud, Mexico",Consejo de Ciencia y Tecnología del Estado de Durango,ALL,"ADULT, OLDER_ADULT",NA,150,OTHER_GOV,INTERVENTIONAL,1/30/2022,9/1/2023
NCT04642339,UNKNOWN,Covid19,BIOLOGICAL: Gam-COVID-Vac|BIOLOGICAL: Placebo,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation",Ministerio del Poder Popular para la Salud de la República Bolivariana de Venezuela,ALL,"ADULT, OLDER_ADULT",PHASE3,2000,OTHER,INTERVENTIONAL,2020-11,2021-12
NCT04401579,COMPLETED,COVID-19,OTHER: Placebo|DRUG: Remdesivir|DRUG: Baricitinib,National Institute of Allergy and Infectious Diseases (NIAID),,ALL,"ADULT, OLDER_ADULT",PHASE3,1033,NIH,INTERVENTIONAL,5/8/2020,7/31/2020
NCT05124171,ACTIVE_NOT_RECRUITING,COVID-19|Vaccine Reaction,"BIOLOGICAL: BNT162b2|BIOLOGICAL: CoV2 preS dTM adjuvanted vaccine (D614), Sanofi/GSK|BIOLOGICAL: CoV2 preS dTM adjuvanted vaccine (B.1.351), Sanofi/GSK",Assistance Publique - Hôpitaux de Paris,COVIREIVAC,ALL,"ADULT, OLDER_ADULT",PHASE3,247,OTHER,INTERVENTIONAL,12/8/2021,2022-12
NCT04353271,TERMINATED,Covid 19|Corona Virus Infection,DRUG: Hydroxychloroquine|OTHER: Placebo,University of South Alabama,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,3,OTHER,INTERVENTIONAL,4/17/2020,7/8/2020
NCT05688839,NOT_YET_RECRUITING,Novel COVID-19-Infected Pneumonia,DRUG: Jaktinib hydrochloride tablets|DRUG: placebo,"Suzhou Zelgen Biopharmaceuticals Co.,Ltd",,ALL,"ADULT, OLDER_ADULT",PHASE2,60,INDUSTRY,INTERVENTIONAL,2024-04,2025-03
NCT04435379,COMPLETED,"Infection, Respiratory Tract",BIOLOGICAL: VPM1002|BIOLOGICAL: Placebo,Vakzine Projekt Management GmbH,FGK Clinical Research GmbH,ALL,"ADULT, OLDER_ADULT",PHASE3,2038,INDUSTRY,INTERVENTIONAL,6/18/2020,10/12/2021
NCT04977479,COMPLETED,Systemic Allergic Reaction,"BIOLOGICAL: Pfizer-BioNTech COVID-19 Vaccine (Comirnaty)|OTHER: Placebo|BIOLOGICAL: Pfizer-BioNTech COVID-19 Vaccine, Bivalent",National Institute of Allergy and Infectious Diseases (NIAID),,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,20,NIH,INTERVENTIONAL,9/8/2021,2/22/2023
NCT04416139,UNKNOWN,Covid 19,BIOLOGICAL: Infusion IV of Mesenchymal Stem cells,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,,ALL,"ADULT, OLDER_ADULT",PHASE2,10,OTHER,INTERVENTIONAL,5/1/2020,5/1/2021
NCT05193279,WITHDRAWN,COVID-19,"BIOLOGICAL: Candidate vaccine, SCB-2019",Clover Biopharmaceuticals AUS Pty Ltd,,ALL,CHILD,PHASE2|PHASE3,0,INDUSTRY,INTERVENTIONAL,10/5/2022,12/15/2022
NCT04352608,COMPLETED,COVID-19,BIOLOGICAL: Two doses of medium dosage inactivated SARS-CoV-2 vaccine at the emergency vaccination schedule|BIOLOGICAL: Two doses of high dosage inactivated SARS-CoV-2 vaccine at the emergency vaccination schedule|BIOLOGICAL: Two doses of placebo at the emergency vaccination schedule|BIOLOGICAL: Two doses of medium dosage inactivated SARS-CoV-2 vaccine at the routine vaccination schedule|BIOLOGICAL: Two doses of high dosage inactivated SARS-CoV-2 vaccine at the routine vaccination schedule|BIOLOGICAL: Two doses of placebo at the routine vaccination schedule|BIOLOGICAL: Three doses of medium dosage inactivated SARS-CoV-2 vaccine at the emergency vaccination schedule|BIOLOGICAL: Three doses of high dosage inactivated SARS-CoV-2 vaccine at the emergency vaccination schedule|BIOLOGICAL: Three doses of placebo at the emergency vaccination schedule|BIOLOGICAL: Three doses of medium dosage inactivated SARS-CoV-2 vaccine at the routine vaccination schedule|BIOLOGICAL: Three doses of high dosage inactivated SARS-CoV-2 vaccine at the routine vaccination schedule|BIOLOGICAL: Three doses of placebo at the routine vaccination schedule,"Sinovac Research and Development Co., Ltd.",,ALL,ADULT,PHASE1|PHASE2,744,INDUSTRY,INTERVENTIONAL,4/16/2020,7/24/2021
NCT04729491,COMPLETED,Covid19,DRUG: Dutasteride 0.5 mg|DRUG: Azithromycin|DRUG: Nitazoxanide|DRUG: Placebo,Corpometria Institute,,MALE,"ADULT, OLDER_ADULT",PHASE2|PHASE3,138,OTHER,INTERVENTIONAL,6/30/2020,10/7/2020
NCT04357808,COMPLETED,Covid-19,DRUG: Sarilumab|OTHER: Standar of care,Maria del Rosario Garcia de Vicuña Pinedo,Instituto de Investigación Sanitaria Hospital Universitario de la Princesa,ALL,"ADULT, OLDER_ADULT",PHASE2,30,OTHER,INTERVENTIONAL,4/13/2020,12/4/2020
NCT04802408,RECRUITING,Covid19|SARS-CoV Infection,COMBINATION_PRODUCT: Shampoo and saline|COMBINATION_PRODUCT: Saline and Listerine|COMBINATION_PRODUCT: Shampoo and Listerine|COMBINATION_PRODUCT: Saline and Saline,Milton S. Hershey Medical Center,AXIOM Real Time Metrics|Analytica Ventures LLC,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,200,OTHER,INTERVENTIONAL,10/1/2021,5/30/2025
NCT05160779,UNKNOWN,Sars-CoV-2 Infection,OTHER: Analysis of genetic polymorphisms of vasoactive peptides in COVID-19,Leonardo Paroche de Matos,Prof. Dr. José Antônio Silva Júnior|Msc. Allan Luis Barboza Atum,ALL,"ADULT, OLDER_ADULT",NA,151,OTHER,INTERVENTIONAL,2022-01,2022-02
NCT04402879,UNKNOWN,Severe Acute Respiratory Syndrome Coronavirus 2|COVID-19|Acute Respiratory Distress Syndrome|ARDS|Hypoxemic Respiratory Failure,PROCEDURE: Prone Positioning (PP),University of Calgary,Alberta Health services,ALL,"ADULT, OLDER_ADULT",NA,596,OTHER,INTERVENTIONAL,11/10/2020,6/1/2022
NCT05910879,RECRUITING,Health Behavior|Health Care Utilization|Vaccine Hesitancy,BEHAVIORAL: Self-Affirmation Implementation Intentions (SAII) Intervention|BEHAVIORAL: Promotores de Salud (Health Education),University of Oregon,National Institute on Minority Health and Health Disparities (NIMHD),ALL,"ADULT, OLDER_ADULT",NA,400,OTHER,INTERVENTIONAL,4/22/2023,10/31/2024
NCT05220579,COMPLETED,Coronavirus Infection COVID-19,"DEVICE: Exposure to ""TOR"" device|DEVICE: Exposure to switched off ""TOR"" device",Concern GRANIT,Samara State Medical University,ALL,"ADULT, OLDER_ADULT",NA,236,INDUSTRY,INTERVENTIONAL,12/29/2020,8/12/2021
NCT05002179,COMPLETED,Respiratory Tract Infections|Common Cold,DRUG: Echinaforce Chewable tablets,A. Vogel AG,CONVEX CRO|d.s.h. statistical services GmbH|MediStat Ltd.|Biodome Clinical|Bodimed|PPES lab epigenetic signaling,ALL,"ADULT, OLDER_ADULT",PHASE4,122,INDUSTRY,INTERVENTIONAL,11/20/2020,5/29/2021
NCT05065879,COMPLETED,COVID-19 Pneumonia,BIOLOGICAL: COVAX,China National Biotec Group Company Limited,"Hunan Provincial Center for Disease Control and Prevention|Guizhou Center for Disease Control and Prevention|Center for Disease Control and Prevention, Fujian|Beijing Institute of Biological Products Co Ltd.",ALL,"ADULT, OLDER_ADULT",PHASE4,1440,INDUSTRY,INTERVENTIONAL,10/5/2021,1/5/2022
NCT04969991,TERMINATED,Coronavirus Disease 2019|Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2,DRUG: Varespladib|DRUG: Placebo,"Ophirex, Inc.",Premier Research Group plc,ALL,"ADULT, OLDER_ADULT",PHASE2,18,INDUSTRY,INTERVENTIONAL,6/30/2021,11/22/2022
NCT05668091,RECRUITING,Long COVID,DRUG: Nirmatrelvir|DRUG: Ritonavir|DRUG: Placebo,Harlan M Krumholz,Pfizer,ALL,"ADULT, OLDER_ADULT",PHASE2,100,OTHER,INTERVENTIONAL,4/14/2023,10/31/2024
NCT04356508,UNKNOWN,"COVID-19|SARS-CoV-2|2019-nCoV|Pneumonia, Viral",DRUG: Nivolumab,Dr Gerry Gin Wai Kwok,The University of Hong Kong,ALL,"ADULT, OLDER_ADULT",PHASE2,15,OTHER,INTERVENTIONAL,4/14/2020,8/31/2021
NCT05855408,NOT_YET_RECRUITING,COVID-19,BIOLOGICAL: Intramuscularly administered Ad5-nCoV vaccine|BIOLOGICAL: Aerosolized Ad5-nCoV|BIOLOGICAL: DelNS1-2019-nCoV-RBD-OPT1|BIOLOGICAL: SYS6006,Jiangsu Province Centers for Disease Control and Prevention,,ALL,"ADULT, OLDER_ADULT",PHASE4,10000,NETWORK,INTERVENTIONAL,5/18/2023,12/31/2024
NCT05787379,NOT_YET_RECRUITING,Post-Acute COVID-19 Syndrome,BEHAVIORAL: Concordant Care Training|BEHAVIORAL: Education Packet Training,VA Office of Research and Development,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,348,FED,INTERVENTIONAL,10/1/2024,9/30/2027
NCT04712279,UNKNOWN,Covid19,DRUG: Ivermectin 0.6mg/kg/day|DRUG: Ivermectin 1.0mg/kg/day|DRUG: Placebo|DRUG: Hydroxychloroquine,Corpometria Institute,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,294,OTHER,INTERVENTIONAL,1/25/2021,4/20/2021
NCT04412291,UNKNOWN,Covid-19,DRUG: Anakinra Prefilled Syringe|DRUG: Tocilizumab Prefilled Syringe|DRUG: Standard-of-care treatment,Karolinska University Hospital,Karolinska Institutet,ALL,"ADULT, OLDER_ADULT",PHASE2,120,OTHER,INTERVENTIONAL,6/11/2020,2021-06
NCT04379479,UNKNOWN,COVID-19|SARS-CoV-2 Infection,DRUG: Dialyzable Leukocyte Extract|DRUG: Placebo oral,"National Polytechnic Institute, Mexico",,ALL,"ADULT, OLDER_ADULT",PHASE2,562,OTHER,INTERVENTIONAL,2020-05,2020-12
NCT04842708,COMPLETED,Covid19,DIAGNOSTIC_TEST: vaccination against COVID19,Scentech Medical Technologies Ltd,,ALL,"ADULT, OLDER_ADULT",NA,43,INDUSTRY,INTERVENTIONAL,12/24/2020,12/24/2021
NCT04385108,ACTIVE_NOT_RECRUITING,COVID-19,BIOLOGICAL: Blood collection on admission and longitudinally|BIOLOGICAL: Blood collection on their first consultation and 10 to 14 days later,"University Hospital, Toulouse",,ALL,"ADULT, OLDER_ADULT",NA,400,OTHER,INTERVENTIONAL,3/4/2020,1/7/2025
NCT04984408,NOT_YET_RECRUITING,COVID-19 Disease,BIOLOGICAL: BBIBP-CorV - Inactivated SARS-CoV-2 vaccine (Vero cell)|BIOLOGICAL: influenza season quadrivalent Influenza Vaccine (Flu Quadrivalent),International Vaccine Institute,,ALL,"ADULT, OLDER_ADULT",PHASE3,8825,OTHER,INTERVENTIONAL,10/1/2021,9/30/2024
NCT04631705,COMPLETED,SARS-CoV-2 Infection,BIOLOGICAL: DZIF-10c|BIOLOGICAL: DZIF-10c|DRUG: Placebo|DRUG: Placebo,University of Cologne,ZKS Köln|Boehringer Ingelheim,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,45,OTHER,INTERVENTIONAL,12/14/2020,9/23/2021
NCT04973449,COMPLETED,COVID-19|SARS-CoV-2,BIOLOGICAL: AZD1222|BIOLOGICAL: AZD2816,AstraZeneca,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,2848,INDUSTRY,INTERVENTIONAL,6/27/2021,8/2/2022
NCT04888949,COMPLETED,SARS-CoV-2 Infection( COVID-19 ),BIOLOGICAL: Mesenchymal stem cell|BIOLOGICAL: Placebo,"Rohto Pharmaceutical Co., Ltd.",,ALL,"ADULT, OLDER_ADULT",PHASE2,15,INDUSTRY,INTERVENTIONAL,6/15/2021,5/18/2023
NCT04366063,UNKNOWN,Covid-19,BIOLOGICAL: Cell therapy protocol 1|BIOLOGICAL: Cell therapy protocol 2,Royan Institute,Tehran University of Medical Sciences|Shahid Beheshti University of Medical Sciences,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,60,OTHER_GOV,INTERVENTIONAL,4/5/2020,12/10/2020
NCT05118763,WITHDRAWN,COVID-19 Pandemic,DRUG: INNA-051|OTHER: Placebo,ENA Respiratory Pty Ltd,,ALL,"ADULT, OLDER_ADULT",PHASE2,0,INDUSTRY,INTERVENTIONAL,3/1/2022,12/31/2022
NCT05780463,COMPLETED,COVID-19,DRUG: MP0420|DRUG: Placebo|BIOLOGICAL: Remdesivir,National Institute of Allergy and Infectious Diseases (NIAID),"International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)|University of Copenhagen|Medical Research Council|Kirby Institute|Washington D.C. Veterans Affairs Medical Center|AIDS Clinical Trials Group|National Heart, Lung, and Blood Institute (NHLBI)|US Department of Veterans Affairs|Prevention and Early Treatment of Acute Lung Injury|Cardiothoracic Surgical Trials Network|Molecular Partners AG|University of Minnesota",ALL,"ADULT, OLDER_ADULT",PHASE3,485,NIH,INTERVENTIONAL,6/11/2021,6/8/2023
NCT05238649,ACTIVE_NOT_RECRUITING,COVID-19 Pandemic,BIOLOGICAL: Recombinant SARS-CoV-2 Fusion Protein Vaccine 10μg|BIOLOGICAL: Recombinant SARS-CoV-2 Fusion Protein Vaccine 25μg|BIOLOGICAL: SARS-Cov-2 Vaccine Inactivated,Livzon Pharmaceutical Group Inc.,,ALL,"ADULT, OLDER_ADULT",PHASE2,150,INDUSTRY,INTERVENTIONAL,11/10/2021,1/28/2023
NCT04639349,UNKNOWN,Chronic Obstructive Pulmonary Disease,BEHAVIORAL: exercise group|OTHER: control group,Cairo University,,MALE,"ADULT, OLDER_ADULT",NA,40,OTHER,INTERVENTIONAL,11/19/2020,3/1/2021
NCT04592549,COMPLETED,SARS-CoV-2,DRUG: ADM03820|OTHER: Placebo,Ology Bioservices,Enabling Biotechnologies (EB),ALL,ADULT,PHASE1,48,INDUSTRY,INTERVENTIONAL,12/4/2020,10/6/2023
NCT05069649,COMPLETED,Immunization Against COVID-19,DRUG: Ergoferon|DRUG: Placebo,Materia Medica Holding,,ALL,"ADULT, OLDER_ADULT",PHASE3,1057,INDUSTRY,INTERVENTIONAL,10/6/2021,4/14/2022
NCT05272605,COMPLETED,SARS-CoV-2,BIOLOGICAL: Adjuvanted SARS-CoV-2 beta variant RBD recombinant protein vaccine (DoCo-Pro-RBD-1 + MF59)|BIOLOGICAL: SARS-CoV-2 beta variant RBD mRNA vaccine|OTHER: Normal Saline,University of Melbourne,Southern Star Research Pty Ltd.,ALL,ADULT,PHASE1,76,OTHER,INTERVENTIONAL,4/5/2022,4/19/2023
NCT04418505,UNKNOWN,COVID-19,DEVICE: Vielight RX Plus,Vielight Inc.,,ALL,"ADULT, OLDER_ADULT",NA,295,INDUSTRY,INTERVENTIONAL,9/2/2020,9/30/2021
NCT05113849,UNKNOWN,COVID-19,BIOLOGICAL: IN-B009 (Low-dose)|BIOLOGICAL: IN-B009 (High-dose),HK inno.N Corporation,,ALL,ADULT,PHASE1,40,INDUSTRY,INTERVENTIONAL,9/16/2021,2023-02
NCT04565249,TERMINATED,Acute Respiratory Distress Syndrome|SARS-CoV-2,DRUG: PLN-74809|DRUG: Placebo,"Pliant Therapeutics, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE2,6,INDUSTRY,INTERVENTIONAL,10/22/2020,8/2/2021
NCT04673149,UNKNOWN,SARS-CoV-2,BIOLOGICAL: GLS-5310|BIOLOGICAL: Placebo,"GeneOne Life Science, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,183,INDUSTRY,INTERVENTIONAL,12/23/2020,12/31/2022
NCT04579549,COMPLETED,COVID-19|Sars-CoV-2,DEVICE: Saliva Assay,"University of Wisconsin, Madison",National Institutes of Health (NIH),ALL,"CHILD, ADULT, OLDER_ADULT",NA,464,OTHER,INTERVENTIONAL,9/29/2020,3/31/2021
NCT05198063,COMPLETED,Prevention of COVID-19,BIOLOGICAL: Recombinant novel coronavirus vaccine (CHO cells),"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.",,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,300,INDUSTRY,INTERVENTIONAL,1/10/2022,12/6/2022
NCT04635605,ACTIVE_NOT_RECRUITING,SARS-CoV2,DRUG: Methylene Blue|DRUG: Control Test,Fondazione Epatocentro Ticino,,ALL,"ADULT, OLDER_ADULT",PHASE2,64,OTHER,INTERVENTIONAL,11/5/2020,12/31/2023
NCT04895449,COMPLETED,Covid19,BIOLOGICAL: MVA-SARS-2-ST,Universitätsklinikum Hamburg-Eppendorf,German Center for Infection Research|Philipps University Marburg Medical Center|Ludwig-Maximilians - University of Munich|IDT Biologika|Clinical Trial Center North (CTC North GmbH & Co. KG),ALL,ADULT,PHASE1,43,OTHER,INTERVENTIONAL,7/16/2021,11/8/2022
NCT05926505,RECRUITING,Post-Acute COVID-19 Syndrome|Post-Acute COVID-19|Long COVID,DRUG: Placebo|DRUG: Anakinra 149 MG/ML Prefilled Syringe [Kineret],Hellenic Institute for the Study of Sepsis,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,182,OTHER,INTERVENTIONAL,9/6/2023,2025-08
NCT05140005,COMPLETED,Covid 19,DIAGNOSTIC_TEST: GlowTest COVID-19 Antigen Home Test,Arion Bio,CSSi Life Sciences,ALL,"CHILD, ADULT, OLDER_ADULT",NA,33,INDUSTRY,INTERVENTIONAL,12/6/2021,12/17/2021
NCT04463849,COMPLETED,COVID19|BETA-CELL FUNCTION,DIAGNOSTIC_TEST: Stimulation test with arginine infusion in order to verify the possible existence of damage to the beta cell function induced by COVID-19 infection,University of Milan,Luigi Sacco University Hospital,ALL,"ADULT, OLDER_ADULT",NA,90,OTHER,INTERVENTIONAL,6/30/2020,12/31/2021
NCT05914649,NOT_YET_RECRUITING,Postural Orthostatic Tachycardia Syndrome|Post Acute Sequelae of SARS CoV 2 Infection,OTHER: IV normal saline (1500mL infusion)|OTHER: IV normal saline (50mL infusion),University of Calgary,,ALL,ADULT,NA,50,OTHER,INTERVENTIONAL,11/1/2023,12/31/2027
NCT04511949,COMPLETED,Coronavirus Infection,"DIAGNOSTIC_TEST: COVID-19 IgG / IgM rapid test (whole blood, serum, plasma)",Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,500,OTHER,INTERVENTIONAL,7/12/2020,11/30/2020
NCT05722093,NOT_YET_RECRUITING,COVID-19,DRUG: Manzi Guben granules,"Second Affiliated Hospital, School of Medicine, Zhejiang University",The First Affiliated Hospital of Zhejiang Chinese Medical University|Hangzhou Hospital of Traditional Chinese Medicine|Suzhou Hospital of Traditional Chinese Medicine,ALL,"ADULT, OLDER_ADULT",NA,360,OTHER,INTERVENTIONAL,6/1/2023,5/31/2026
NCT04852705,UNKNOWN,COVID-19,"BIOLOGICAL: SARS-CoV-2 Vaccine (Vero Cells), Inactivated|BIOLOGICAL: Placebo","Shenzhen Kangtai Biological Products Co., LTD","Beijing Minhai Biotechnology Co., Ltd",ALL,"ADULT, OLDER_ADULT",PHASE3,28000,INDUSTRY,INTERVENTIONAL,2021-05,2022-11
NCT05679505,COMPLETED,Long COVID|Vagus Nerve Stimulations|Heart Rates|Autonomic Nervous System Disorders,DEVICE: Auricular transcutaneous vagus nerve stimulation,Bahçeşehir University,,ALL,ADULT,NA,40,OTHER,INTERVENTIONAL,10/27/2022,1/4/2023
NCT04340349,UNKNOWN,Hydroxychloroquine|Antimalarials|Enzyme Inhibitors|Antirheumatic Agents,DRUG: Hydroxychloroquine Sulfate|DRUG: Bromhexine 8 MG,Instituto Nacional de Rehabilitacion,,ALL,ADULT,EARLY_PHASE1,214,OTHER_GOV,INTERVENTIONAL,2/1/2021,6/30/2021
NCT05148949,UNKNOWN,COVID-19|Pulmonary Tuberculosis,BIOLOGICAL: Standard dosage inactivated vaccine|BIOLOGICAL: Double dosage inactivated vaccine,Jiangsu Province Centers for Disease Control and Prevention,,ALL,"ADULT, OLDER_ADULT",PHASE4,240,NETWORK,INTERVENTIONAL,12/22/2021,3/10/2023
NCT04457349,COMPLETED,COVID 19,PROCEDURE: Therapeutic Plasma Exchange (TPE),Alexandria University,,ALL,"ADULT, OLDER_ADULT",NA,10,OTHER,INTERVENTIONAL,7/25/2020,1/20/2021
NCT04898205,UNKNOWN,Covid19|Viral Syndrome,OTHER: Treadmill Exercise|OTHER: Concentrated Oxygen|OTHER: Concentrated Air,Noah Greenspan,University of Dayton,ALL,ADULT,NA,24,OTHER,INTERVENTIONAL,1/21/2021,1/20/2022
NCT05823805,NOT_YET_RECRUITING,Schizophrenia|Bipolar Disorder,OTHER: Community Health Worker,Unity Health Toronto,,ALL,"ADULT, OLDER_ADULT",NA,52,OTHER,INTERVENTIONAL,2024-03,2025-03
NCT04397705,UNKNOWN,COVID|Oncology|Haematological Malignancy,DEVICE: Patient Status Engine,The Christie NHS Foundation Trust,,ALL,"ADULT, OLDER_ADULT",PHASE1,30,OTHER,INTERVENTIONAL,10/12/2020,2021-04
NCT04426305,COMPLETED,Covid 19|Social Isolation|Mental Health Impairment,OTHER: community health worker support|OTHER: care as usual,University Ghent,,ALL,"ADULT, OLDER_ADULT",NA,140,OTHER,INTERVENTIONAL,5/21/2020,10/30/2020
NCT05163652,UNKNOWN,SARS-CoV-2 Infection,"BIOLOGICAL: SARS-CoV-2 Vaccine, Inactivated (Vero Cell)",Chinese Academy of Medical Sciences,Yunnan Center for Disease Control and Prevention,ALL,"ADULT, OLDER_ADULT",PHASE3,432,OTHER,INTERVENTIONAL,12/18/2021,10/30/2022
NCT04327505,TERMINATED,"SARS (Severe Acute Respiratory Syndrome)|Cytokine Storm|ARDS, Human|COVID-19|Sars-CoV2|Acute Respiratory Failure",DRUG: Hyperbaric oxygen,Karolinska Institutet,"Karolinska Trial Alliance|University of California, San Diego|Blekinge County Council Hospital|JK Biostatistics AB|The Swedish Research Council|University of Regensburg",ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,34,OTHER,INTERVENTIONAL,6/3/2020,12/1/2022
NCT05665205,NOT_YET_RECRUITING,COVID-19,OTHER: Aerobic plus strength group|OTHER: Aerobic group,Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz,,ALL,"ADULT, OLDER_ADULT",NA,20,OTHER,INTERVENTIONAL,1/30/2023,8/30/2023
NCT05096052,NOT_YET_RECRUITING,COVID-19|COVID-19 Pandemic|COVID-19 Respiratory Infection|SARS-CoV2 Infection|Cytokine Release Syndrome,DRUG: Galactomannan|DRUG: PLACEBO,Bioxytran Inc.,ALKE RESEARCH PRIVATE LIMITED|Research Consultancy,ALL,"ADULT, OLDER_ADULT",PHASE3,408,INDUSTRY,INTERVENTIONAL,4/1/2022,9/25/2022
NCT05047952,COMPLETED,Post-COVID-19 Condition|Post-COVID-19 Syndrome|Cognitive Impairment,DRUG: Vortioxetine|DRUG: Placebo,Brain and Cognition Discovery Foundation,,ALL,"ADULT, OLDER_ADULT",PHASE2,200,OTHER,INTERVENTIONAL,9/16/2021,2/22/2023
NCT05311852,COMPLETED,Fatigue|Cognitive Deficit|COVID-19|Neurophysiologic Abnormality,DIETARY_SUPPLEMENT: palmitoylethanolamide co-ultramicronized with antioxidant flavonoid luteolin (PEA-LUT)|DIETARY_SUPPLEMENT: Placebo,"Department of Neurorehabilitation, Hospital of Vipiteno-Sterzing (BZ) Italy",I.R.C.C.S. Fondazione Santa Lucia,ALL,"ADULT, OLDER_ADULT",NA,34,NETWORK,INTERVENTIONAL,8/16/2021,3/15/2022
NCT05079152,UNKNOWN,"Influenza, Human|Pneumonia, Pneumococcal|COVID-19 Pneumonia",BIOLOGICAL: COVAX+PPV23;COVAX+IIV4|BIOLOGICAL: COVAX only (1st and 2nd dose)|BIOLOGICAL: PPV23 for the 1st dose and IIV4 for the 2nd dose,China National Biotec Group Company Limited,"Chengdu Institute of Biological Products Co.,Ltd.|Changchun Institute of Biological Products Co., Ltd.|Wuhan Institute of Biological Products Co., Ltd|Hubei Provincial Center for Disease Control and Prevention|Guangdong Center for Disease Prevention and Control|Henan Center for Disease Control and Prevention",ALL,"ADULT, OLDER_ADULT",PHASE4,1404,INDUSTRY,INTERVENTIONAL,5/6/2021,2021-12
NCT05089305,UNKNOWN,COVID-19,DRUG: Ozone plasma,"Centro Universitario de Ciencias de la Salud, Mexico",,ALL,"ADULT, OLDER_ADULT",PHASE2,35,OTHER,INTERVENTIONAL,9/4/2021,12/21/2022
NCT04874805,WITHDRAWN,Hypoxemia|Covid-19,OTHER: Measurement of oxygen saturation,Assistance Publique - Hôpitaux de Paris,,ALL,"ADULT, OLDER_ADULT",NA,0,OTHER,INTERVENTIONAL,5/2/2022,5/2/2022
NCT05055505,COMPLETED,SARS-CoV2 Infection,DIAGNOSTIC_TEST: Take home saliva kits,The Hospital for Sick Children,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,120,OTHER,INTERVENTIONAL,9/14/2021,6/30/2022
NCT05925127,ACTIVE_NOT_RECRUITING,COVID-19,BIOLOGICAL: NVX-CoV2373 (5μg)|BIOLOGICAL: NVX-CoV2601 (5μg)|BIOLOGICAL: NVX-CoV2601(5μg)|BIOLOGICAL: NVX-CoV2601 (35μg)|BIOLOGICAL: NVX-CoV2601(35μg)|BIOLOGICAL: NVX-CoV2601(50μg)|BIOLOGICAL: Bivalent BA.4/5,Novavax,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,1980,INDUSTRY,INTERVENTIONAL,10/16/2023,11/14/2024
NCT04341727,TERMINATED,Coronavirus Infection,DRUG: Hydroxychloroquine Sulfate|DRUG: Azithromycin|DRUG: Chloroquine Sulfate,Washington University School of Medicine,,ALL,"ADULT, OLDER_ADULT",PHASE3,31,OTHER,INTERVENTIONAL,4/4/2020,4/1/2021
NCT05689827,COMPLETED,Asthenia|COVID-19,DRUG: Ethyl methyl hydroxypyridine succinate + Meldonium|DRUG: Placebo,"Promomed, LLC",,ALL,"ADULT, OLDER_ADULT",PHASE4,160,OTHER,INTERVENTIONAL,4/5/2022,11/10/2022
NCT04695704,RECRUITING,Covid19|SARS (Disease),DRUG: Montelukast|OTHER: placebo,Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina,Institut Català de la Salut,ALL,"ADULT, OLDER_ADULT",PHASE3,284,OTHER,INTERVENTIONAL,8/1/2021,8/31/2023
NCT05075304,COMPLETED,COVID-19,DRUG: BDB-001 injection|DRUG: BDB-001 injection|DRUG: BDB-001 injection,"Staidson (Beijing) Biopharmaceuticals Co., Ltd",Beijing Defengrui Biotechnology Co. Ltd,ALL,ADULT,PHASE1,18,INDUSTRY,INTERVENTIONAL,2/21/2020,4/14/2020
NCT05435027,ACTIVE_NOT_RECRUITING,COVID-19|SARS-CoV-2,"DRUG: GRT-R912, samRNA-Spikebeta-TCE11|DRUG: GRT-R914, samRNA-Spikebeta-TCE9|DRUG: GRT-R918, samRNA-SpikeOmicron-N-TCE11","Gritstone bio, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE1,342,INDUSTRY,INTERVENTIONAL,2/28/2022,2024-03
NCT04763304,COMPLETED,Personal Protective Equipment|Self Contamination,OTHER: Gown personal protective equipment (PPE-G) suit|OTHER: Coverall personal protective equipment (PPE-C) suit,Hospital Italiano de Buenos Aires,,ALL,"ADULT, OLDER_ADULT",NA,60,OTHER,INTERVENTIONAL,9/1/2020,11/18/2020
NCT06191393,RECRUITING,SARS-CoV-2 Infection|Influenza A|Influenza B,DIAGNOSTIC_TEST: Aptitude Medical Systems Metrix COVID/Flu Test,Aptitude Medical Systems,Biomedical Advanced Research and Development Authority,ALL,"CHILD, ADULT, OLDER_ADULT",NA,1000,INDUSTRY,INTERVENTIONAL,11/20/2023,5/14/2024
NCT05972993,ACTIVE_NOT_RECRUITING,COVID-19,BIOLOGICAL: mRNA-CR-04 vaccine 10μg|BIOLOGICAL: mRNA-CR-04 vaccine 30μg|BIOLOGICAL: mRNA-CR-04 vaccine 100μg|DRUG: Placebo,GlaxoSmithKline,,ALL,ADULT,PHASE1,72,INDUSTRY,INTERVENTIONAL,8/7/2023,10/15/2024
NCT04480593,COMPLETED,Covid19,DRUG: Brazilian Green Propolis Extract (EPP-AF)|OTHER: Standard care,D'Or Institute for Research and Education,Hospital Sao Rafael,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,120,OTHER,INTERVENTIONAL,6/2/2020,8/30/2020
NCT04371393,TERMINATED,Mesenchymal Stromal Cells|Remestemcel-L|Acute Respiratory Distress Syndrome|COVID,BIOLOGICAL: Remestemcel-L|DRUG: Placebo,Icahn School of Medicine at Mount Sinai,"Mesoblast, Inc.|National Heart, Lung, and Blood Institute (NHLBI)",ALL,"ADULT, OLDER_ADULT",PHASE3,223,OTHER,INTERVENTIONAL,4/30/2020,1/2/2022
NCT04306393,COMPLETED,SARS (Severe Acute Respiratory Syndrome)|Coronavirus,DRUG: Nitric Oxide Gas,Massachusetts General Hospital,"Xijing Hospital|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico|Niguarda Hospital",ALL,"ADULT, OLDER_ADULT",PHASE2,200,OTHER,INTERVENTIONAL,3/21/2020,6/15/2022
NCT04328493,COMPLETED,SARS-CoV-2 Infection|COVID-19,DRUG: Chloroquine phosphate,"Oxford University Clinical Research Unit, Vietnam","Ministry of Health, Vietnam|Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam|Cu Chi COVID Hospital, Vietnam|Can Gio COVID Hospital, Vietnam|Cho Ray Hospital|National Hospital for Tropical Diseases, Hanoi, Vietnam|Department of Health, Ho Chi Minh city",ALL,"ADULT, OLDER_ADULT",PHASE2,10,OTHER,INTERVENTIONAL,4/7/2020,9/10/2020
NCT04825093,RECRUITING,Pregnancy Complications|Covid19,DIETARY_SUPPLEMENT: Vitamin D supplementation in pregnant women,Universidad de Granada,,FEMALE,"ADULT, OLDER_ADULT",NA,500,OTHER,INTERVENTIONAL,9/29/2021,12/30/2024
NCT04477993,TERMINATED,Severe Acute Respiratory Syndrome Coronavirus 2|SARS-CoV2,DRUG: Janus Kinase Inhibitor (ruxolitinib)|OTHER: Placebo,Vanderson Geraldo Rocha,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,5,OTHER,INTERVENTIONAL,8/14/2020,3/29/2021
NCT04401293,COMPLETED,Sars-CoV2|COVID,DRUG: Enoxaparin|DRUG: Prophylactic/Intermediate Dose Enoxaparin,Northwell Health,,ALL,"ADULT, OLDER_ADULT",PHASE3,257,OTHER,INTERVENTIONAL,4/26/2020,5/14/2021
NCT04649879,COMPLETED,Covid19,BIOLOGICAL: SARS-CoV-2 convalescent plasma|OTHER: Standard of care,Joakim Dillner,Karolinska Institutet|Danderyd Hospital|Falu Hospital,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,59,OTHER,INTERVENTIONAL,12/3/2020,1/26/2022
NCT04416308,COMPLETED,Coronavirus,DIAGNOSTIC_TEST: NG test|DIAGNOSTIC_TEST: Blood test|BEHAVIORAL: Self-questionnary,Rennes University Hospital,Fonds NOMINOE,ALL,"ADULT, OLDER_ADULT",NA,9453,OTHER,INTERVENTIONAL,5/29/2020,10/12/2020
NCT04365608,COMPLETED,Intubation Complication|Intubation; Difficult or Failed|Cardiac Arrest|Influenza|Safety Issues,PROCEDURE: Direct laryngoscopy|PROCEDURE: Vie Scope laryngoscopy,Lazarski University,Poznan University of Medical Sciences|Wroclaw Medical University|Medical University of Bialystok,ALL,"ADULT, OLDER_ADULT",NA,90,OTHER,INTERVENTIONAL,3/20/2020,12/10/2020
NCT04337008,UNKNOWN,COVID 19,OTHER: blood draw,Assistance Publique Hopitaux De Marseille,,ALL,"ADULT, OLDER_ADULT",NA,50,OTHER,INTERVENTIONAL,4/3/2020,7/31/2020
NCT05119608,RECRUITING,COVID-19|Mental Health Disorder,BEHAVIORAL: CBT/ACT,Region Skane,Region Stockholm|Lund University|Karolinska Institutet,ALL,"ADULT, OLDER_ADULT",NA,40,OTHER,INTERVENTIONAL,11/1/2021,11/15/2025
NCT05877508,ACTIVE_NOT_RECRUITING,Long COVID|Post-Acute Sequela of COVID-19|Post-Acute COVID-19,DRUG: AER002|OTHER: Placebo,"Michael Peluso, MD",Aerium Therapeutics|Patient-Led Research Collaborative|PolyBio Research Foundation,ALL,"ADULT, OLDER_ADULT",PHASE2,30,OTHER,INTERVENTIONAL,8/1/2023,7/31/2025
NCT04646109,COMPLETED,COVID-19,DRUG: Ivermectin,Afyonkarahisar Health Sciences University,NeuTec Pharma,ALL,"ADULT, OLDER_ADULT",PHASE3,66,OTHER,INTERVENTIONAL,5/11/2020,9/2/2020
NCT04889209,COMPLETED,COVID-19,BIOLOGICAL: Ad26.COV2.S|BIOLOGICAL: BNT162b2|BIOLOGICAL: mRNA-1273|BIOLOGICAL: mRNA-1273.211|BIOLOGICAL: mRNA-1273.222|BIOLOGICAL: SARS-CoV-2 rS/M1,National Institute of Allergy and Infectious Diseases (NIAID),,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,867,NIH,INTERVENTIONAL,5/28/2021,6/16/2023
NCT05514691,COMPLETED,COVID-19 Virus Infection|COVID-19|Coronavirus Disease-19|COVID-19 Pandemic|SARS-CoV-2 Infection,"DIAGNOSTIC_TEST: iStatis COVID-19 Ag Rapid Test|DIAGNOSTIC_TEST: ""COVID-19 RT-PCR Test EUA Number: EUA200011, Company: Laboratory Corporation of America (""Labcorp"")",bioLytical Laboratories,,ALL,"ADULT, OLDER_ADULT",NA,129,INDUSTRY,INTERVENTIONAL,1/13/2022,1/27/2022
NCT04387409,UNKNOWN,"Infection, Respiratory Tract",BIOLOGICAL: VPM1002|BIOLOGICAL: Placebo,Vakzine Projekt Management GmbH,FGK Clinical Research GmbH,ALL,"ADULT, OLDER_ADULT",PHASE3,59,INDUSTRY,INTERVENTIONAL,5/25/2020,5/1/2021
NCT04545008,TERMINATED,Covid19,DRUG: Famotidine|DRUG: N-Acetyl cysteine,Prisma Health-Upstate,Clemson University,ALL,"ADULT, OLDER_ADULT",PHASE1,2,OTHER,INTERVENTIONAL,10/20/2020,6/2/2021
NCT04537208,COMPLETED,COVID-19 (Healthy Volunteers),BIOLOGICAL: CoV2 preS dTM-AF03 (low-dose)|BIOLOGICAL: CoV2 preS dTM-AF03 (high-dose)|BIOLOGICAL: CoV2 preS dTM-AS03 (low-dose)|BIOLOGICAL: CoV2 preS dTM-AS03 (high-dose)|BIOLOGICAL: CoV2 preS dTM (high-dose) without adjuvant|BIOLOGICAL: Placebo (0.9% normal saline),"Sanofi Pasteur, a Sanofi Company",GlaxoSmithKline,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,441,INDUSTRY,INTERVENTIONAL,9/3/2020,11/19/2021
NCT05880108,NOT_YET_RECRUITING,Post-COVID Conditions|Obesity,BEHAVIORAL: 12-weeks of Weight Loss|BEHAVIORAL: 12-weeks of Weight Stability,VA Office of Research and Development,South Texas Veterans Health Care System|Baltimore VA Medical Center,ALL,"ADULT, OLDER_ADULT",NA,150,FED,INTERVENTIONAL,3/1/2024,9/30/2028
NCT05421208,RECRUITING,Post-acute COVID-19 Syndrome|Postural Tachycardia Syndrome (POTS)|Long COVID|SARS CoV 2 Infection,DIAGNOSTIC_TEST: Levels of inflammatory cytokine ( IL-6) in post-COVID-19 POTS and controls|DIAGNOSTIC_TEST: Levels of inflammatory cytokine ( IL-6) in controls|DIAGNOSTIC_TEST: Effect on inflammation after chronic PNS stimulation,Vanderbilt University Medical Center,American Heart Association,ALL,"ADULT, OLDER_ADULT",NA,60,OTHER,INTERVENTIONAL,6/1/2022,7/1/2026
NCT04672291,COMPLETED,COVID - 19,DRUG: Poly-ICLC (Hiltonol®) or Placebo|DRUG: Poly-ICLC (Hiltonol®) or Placebo,"Oncovir, Inc.",University of Calgary,ALL,"ADULT, OLDER_ADULT",PHASE1,43,INDUSTRY,INTERVENTIONAL,7/21/2021,4/1/2023
NCT04563208,COMPLETED,Covid19|SARS-CoV Infection,DRUG: Placebo|DRUG: DuACT,"University of Witwatersrand, South Africa",SynaVir,ALL,"ADULT, OLDER_ADULT",PHASE2,80,OTHER,INTERVENTIONAL,12/9/2020,2/28/2022
NCT04435808,TERMINATED,COVID-19,DRUG: Hydroxychloroquine,University of New Mexico,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,1,OTHER,INTERVENTIONAL,4/14/2020,7/15/2020
NCT04421508,TERMINATED,COVID-19|Coronavirus|Coronavirus Infection,COMBINATION_PRODUCT: INOpulse|COMBINATION_PRODUCT: Placebo,Bellerophon Pulse Technologies,,ALL,"ADULT, OLDER_ADULT",PHASE3,191,INDUSTRY,INTERVENTIONAL,7/12/2020,1/22/2021
NCT05765591,COMPLETED,Post-COVID-19 Syndrome,OTHER: Balneotherapy and aquatic exercises,Parc de Salut Mar,Caldes de Montbui's City Council|Consorcio Centro de Investigación Biomédica en Red (CIBER)|European Regional Development Fund,ALL,"ADULT, OLDER_ADULT",NA,98,OTHER,INTERVENTIONAL,3/29/2022,1/31/2023
NCT04703608,UNKNOWN,Covid-19,DRUG: Ivermectin|DRUG: ASP|DRUG: Placebo,London School of Hygiene and Tropical Medicine,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,1200,OTHER,INTERVENTIONAL,1/22/2021,2022-07
NCT05676008,ACTIVE_NOT_RECRUITING,Post-Acute COVID-19 Syndrome,BEHAVIORAL: Microdosing of mindfulness,"University of California, Davis",,ALL,"ADULT, OLDER_ADULT",NA,400,OTHER,INTERVENTIONAL,1/12/2023,2025-04
NCT04394208,UNKNOWN,COVID-19|Viral Pneumonia Human Coronavirus,DRUG: Silymarin|DRUG: Placebo,Cairo University,,ALL,"ADULT, OLDER_ADULT",PHASE3,50,OTHER,INTERVENTIONAL,8/16/2020,2/28/2021
NCT04366271,WITHDRAWN,COVID,BIOLOGICAL: Mesenchymal cells|DRUG: Standard of care,"Hospital Infantil Universitario Niño Jesús, Madrid, Spain",Apices Soluciones S.L.,ALL,"ADULT, OLDER_ADULT",PHASE2,0,OTHER,INTERVENTIONAL,5/7/2020,5/31/2021
NCT04748471,UNKNOWN,Prevention of COVID19,BIOLOGICAL: mRNA-1273,Assistance Publique - Hôpitaux de Paris,"Institut National de la Santé Et de la Recherche Médicale, France",ALL,"ADULT, OLDER_ADULT",PHASE2,180,OTHER,INTERVENTIONAL,2/10/2021,1/25/2023
NCT05519839,ACTIVE_NOT_RECRUITING,COVID-19|Influenza,DRUG: CIC Vaccine|DRUG: CIC Vaccine|DRUG: qNIV Vaccine|DRUG: SARS-CoV-2 rS Vaccine|DRUG: Influenza Vaccine|DRUG: CIC Vaccine,Novavax,,ALL,"ADULT, OLDER_ADULT",PHASE2,1579,INDUSTRY,INTERVENTIONAL,12/30/2022,12/24/2023
NCT06223971,RECRUITING,COVID Long-Haul,DRUG: [11C]CPPC Injection|DRUG: [11C]CPPC Injection,Johns Hopkins University,Radiological Society of North America,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,6,OTHER,INTERVENTIONAL,2024-02,2024-08
NCT04659239,UNKNOWN,COVID-19,BIOLOGICAL: Inactivated SARS-CoV-2 Vaccine (Vero cell)|BIOLOGICAL: Placebo,Chinese Academy of Medical Sciences,,ALL,"ADULT, OLDER_ADULT",PHASE3,34020,OTHER,INTERVENTIONAL,1/28/2021,2022-07
NCT05115071,COMPLETED,"Birth, First|COVID-19|Fear of Childbirth",BEHAVIORAL: Childbirth preparation education,Pamukkale University,,FEMALE,"ADULT, OLDER_ADULT",NA,44,OTHER,INTERVENTIONAL,11/8/2021,12/10/2021
NCT04365439,UNKNOWN,Blood Plasma Therapy|COVID,BIOLOGICAL: Blood plasma,Enos Bernasconi,,ALL,"ADULT, OLDER_ADULT",NA,11,OTHER,INTERVENTIONAL,7/20/2020,6/30/2021
NCT04661839,COMPLETED,COVID-19,BIOLOGICAL: COVID-HIGIV|OTHER: Placebo (saline),Emergent BioSolutions,United States Department of Defense,ALL,ADULT,PHASE1,28,INDUSTRY,INTERVENTIONAL,12/24/2020,7/27/2021
NCT04540939,RECRUITING,Trauma,BEHAVIORAL: Mindfulness-Based Cognitive Therapy|BEHAVIORAL: Muscle Relaxation Therapy,University of Michigan,National Center for Complementary and Integrative Health (NCCIH)|Ohio State University,ALL,"ADULT, OLDER_ADULT",NA,60,OTHER,INTERVENTIONAL,10/19/2020,6/30/2024
NCT04978571,RECRUITING,Post-Concussion Syndrome|COVID Long-Haul|COVID-19,"DEVICE: percutaneous electrical nerve-field stimulation, PENFS|DEVICE: percutaneous electrical nerve-field stimulation, PENFS (sham device)|DEVICE: percutaneous electrical nerve-field stimulation, PENFS (COVID active device)",Children's Hospital of Orange County,Innovative Health Solutions,ALL,"CHILD, ADULT",NA,125,OTHER,INTERVENTIONAL,2/1/2021,2026-12
NCT04613739,COMPLETED,Asthma,BEHAVIORAL: insurance navigation,Harvard Pilgrim Health Care,"Patient-Centered Outcomes Research Institute|Asthma and Allergy Foundation of America|University of North Carolina, Chapel Hill|Harvard School of Public Health (HSPH)",ALL,"CHILD, ADULT",NA,56,OTHER,INTERVENTIONAL,12/8/2020,9/1/2021
NCT05918939,RECRUITING,COVID-19 Pandemic|COVID-19 Vaccines,BIOLOGICAL: Vaksin Merah Putih - UA SARS-CoV-2 (Vero Cell Inactivated) 5 µg|BIOLOGICAL: CoronaVac Biofarma COVID-1 9 Vaccine 3 µg,Dr. Soetomo General Hospital,"Indonesia-MoH|Universitas Airlangga|Biotis Pharmaceuticals, Indonesia",ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,350,OTHER_GOV,INTERVENTIONAL,9/5/2022,9/5/2023
NCT04487639,COMPLETED,Sperm Preservation in Oncological Patients|Fertility|Cryopreservation,"DIAGNOSTIC_TEST: SARS-CoV-2 research in nasopharyngeal swab, sperm and serologics","University Hospital, Clermont-Ferrand",Agence de La Biomédecine,MALE,ADULT,NA,129,OTHER,INTERVENTIONAL,7/10/2020,12/31/2023
NCT05268939,COMPLETED,COVID-19|Influenza A|Influenza Type B|RSV Infection,DIAGNOSTIC_TEST: LumiraDx SARS-CoV-2 & Flu A/B test|DIAGNOSTIC_TEST: LumiraDx SARS-CoV-2 & RSV test,LumiraDx UK Limited,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,668,INDUSTRY,INTERVENTIONAL,1/4/2022,3/14/2023
NCT04405271,UNKNOWN,Healthcare Workers|COVID-19|SARS-CoV 2,DRUG: Emtricitabine/Tenofovir Alafenamide 200 MG-25 MG Oral Tablet|DRUG: Placebo,Hospital Italiano de Buenos Aires,Sociedad Argentina de Infectología (SADI) (Argentine Society of Infectious Diseases),ALL,"ADULT, OLDER_ADULT",PHASE3,1378,OTHER,INTERVENTIONAL,7/31/2020,11/15/2020
NCT05631171,COMPLETED,Post-Acute COVID19 Syndrome|Fatigue,BEHAVIORAL: Adhera® Fatigue Digital Program,"Adhera Health, Inc.",Institut Català de la Salut|Andaluz Health Service,ALL,"ADULT, OLDER_ADULT",NA,58,INDUSTRY,INTERVENTIONAL,12/13/2022,6/30/2023
NCT04797871,COMPLETED,"Covid19|SARS-CoV2|Fatigue Syndrome, Chronic|Stress, Psychological|Pain, Chronic",BEHAVIORAL: Resistance training|BEHAVIORAL: Standard care,Universidad Pública de Navarra,Fundacion Miguel Servet|Complejo Hospitalario de Navarra,ALL,ADULT,NA,100,OTHER,INTERVENTIONAL,3/8/2021,9/18/2022
NCT05507671,ACTIVE_NOT_RECRUITING,COVID-19,BIOLOGICAL: BCG (Bacillus Calmette-Guérin) vaccine|OTHER: Placebo,Oswaldo Cruz Foundation,University of Sao Paulo|Federal University of Juiz de Fora,ALL,"ADULT, OLDER_ADULT",PHASE3,556,OTHER,INTERVENTIONAL,5/27/2021,12/31/2023
NCT04817371,RECRUITING,Covid19,DEVICE: Volatile Organic Compounds analysis (e-noses)|OTHER: Canine odor detection of Volatile Organic Compounds|DEVICE: Volatile Organic Compounds analysis (mass spectrometry)|DEVICE: Volatile Organic Compounds analysis in sweat (mass spectrometry),Hopital Foch,,ALL,"ADULT, OLDER_ADULT",NA,192,OTHER,INTERVENTIONAL,3/1/2021,2022-09
NCT04940871,TERMINATED,Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),DRUG: Favipiravir HU 200 mg hard capsules|DRUG: Placebo HU,University of Pecs,Hungarian Ministry of Innovation and Technology,ALL,"ADULT, OLDER_ADULT",PHASE2,1,OTHER,INTERVENTIONAL,11/25/2021,11/29/2021
NCT04381871,UNKNOWN,COVID 19,DIETARY_SUPPLEMENT: Acacia Senegal|DIETARY_SUPPLEMENT: Pectin,Al-Neelain University,University of Khartoum,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2|PHASE3,110,OTHER,INTERVENTIONAL,6/1/2020,9/1/2020
NCT04358939,COMPLETED,Acute Respiratory Distress Syndrome|COVID-19,OTHER: Prone decubitus,"University Hospital, Tours",,ALL,"ADULT, OLDER_ADULT",NA,405,OTHER,INTERVENTIONAL,4/27/2020,2/21/2021
NCT04436471,COMPLETED,Preventive Immunization COVID-19,BIOLOGICAL: Gam-COVID-Vac,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation",Acellena Contract Drug Research and Development,ALL,ADULT,PHASE1|PHASE2,38,OTHER,INTERVENTIONAL,6/17/2020,8/10/2020
NCT05965739,ENROLLING_BY_INVITATION,Long COVID|Long Covid19|Long Covid-19,OTHER: BrainHQ/Active Comparator Activity|OTHER: BrainHQ|OTHER: PASC CoRE|DEVICE: tDCS-active|DEVICE: tDCS-sham,Duke University,,ALL,"ADULT, OLDER_ADULT",NA,315,OTHER,INTERVENTIONAL,9/1/2023,2024-12
NCT04679909,COMPLETED,Healthy Volunteers,BIOLOGICAL: AdCOVID|OTHER: Placebo,"Altimmune, Inc.",,ALL,ADULT,PHASE1,92,INDUSTRY,INTERVENTIONAL,2/25/2021,12/21/2022
NCT04480606,UNKNOWN,Exercise Program,BEHAVIORAL: Home exercise program,Istinye University,,ALL,OLDER_ADULT,NA,88,OTHER,INTERVENTIONAL,8/1/2020,11/20/2020
NCT04540406,COMPLETED,Suspected or Confirmed COVID-19,DRUG: NBT-NM108|OTHER: Usual Care Only,Notitia Biotechnologies Company,University of South Florida|Rutgers University,ALL,"ADULT, OLDER_ADULT",PHASE2,44,INDUSTRY,INTERVENTIONAL,11/2/2021,3/14/2022
NCT05614427,COMPLETED,SARS-CoV-2 Infection,DIAGNOSTIC_TEST: Innova Lateral Flow Test,Alder Hey Children's NHS Foundation Trust,,ALL,CHILD,NA,449,OTHER,INTERVENTIONAL,3/26/2021,4/20/2022
NCT06038617,RECRUITING,Fever After Vaccination|Fever|Seizures Fever,BIOLOGICAL: mRNA COVID-19 Vaccine|BIOLOGICAL: Routine Childhood Vaccinations,Duke University,"Kaiser Permanente|Columbia University|Children's Hospital Medical Center, Cincinnati|Centers for Disease Control and Prevention",ALL,CHILD,PHASE4,600,OTHER,INTERVENTIONAL,10/30/2023,2024-12
NCT04261426,UNKNOWN,2019-nCoV,DRUG: Intravenous Immunoglobulin|OTHER: Standard care,Peking Union Medical College Hospital,Tongji Hospital,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,80,OTHER,INTERVENTIONAL,2/10/2020,6/30/2020
NCT04605926,WITHDRAWN,Coronavirus,BIOLOGICAL: EQ001|BIOLOGICAL: EQ001 Placebo,Equillium,Biocon Limited,ALL,"ADULT, OLDER_ADULT",PHASE3,0,INDUSTRY,INTERVENTIONAL,2020-11,2021-06
NCT04657809,COMPLETED,Anosmia,COMBINATION_PRODUCT: Insulin film|DEVICE: Fast dissolving film,Soad Ali,Minia University,ALL,"ADULT, OLDER_ADULT",PHASE2,40,OTHER,INTERVENTIONAL,10/1/2020,3/20/2021
NCT05973006,ACTIVE_NOT_RECRUITING,COVID-19,BIOLOGICAL: NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine|BIOLOGICAL: Prototype/XBB.1.5 Bivalent Vaccine (5 µg),Novavax,,ALL,"CHILD, ADULT",PHASE3,400,INDUSTRY,INTERVENTIONAL,8/16/2023,3/22/2024
NCT04358406,COMPLETED,Sars-CoV2,DRUG: Recombinant human plasma gelsolin (Rhu-pGSN)|OTHER: Placebo,BioAegis Therapeutics Inc.,,ALL,"ADULT, OLDER_ADULT",PHASE2,64,INDUSTRY,INTERVENTIONAL,7/30/2020,1/28/2022
NCT05077306,COMPLETED,SARS-CoV2 Infection,OTHER: music therapy group,Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari,,ALL,"ADULT, OLDER_ADULT",NA,40,OTHER,INTERVENTIONAL,4/15/2021,6/30/2021
NCT04366817,COMPLETED,Post Partum Depression,BEHAVIORAL: psychological assessment,Assistance Publique - Hôpitaux de Paris,,FEMALE,"ADULT, OLDER_ADULT",NA,287,OTHER,INTERVENTIONAL,4/27/2020,2/17/2021
NCT04255017,UNKNOWN,2019-nCoV,DRUG: Abidol hydrochloride|DRUG: Oseltamivir|DRUG: Lopinavir/ritonavir,Tongji Hospital,,ALL,"ADULT, OLDER_ADULT",PHASE4,400,OTHER,INTERVENTIONAL,2/1/2020,7/1/2020
NCT04450004,COMPLETED,SARS-CoV 2,BIOLOGICAL: Intramuscular Vaccine,Medicago,,ALL,ADULT,PHASE1,180,INDUSTRY,INTERVENTIONAL,7/10/2020,8/30/2021
NCT04494204,COMPLETED,Treatment of Covid-19 Virus Infection,COMBINATION_PRODUCT: Immunofree tablets and Reginmune capsule,PUNEET MITTAL,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,100,NETWORK,INTERVENTIONAL,8/7/2020,12/20/2020
NCT04346017,COMPLETED,COVID-19,DIAGNOSTIC_TEST: Cytokines dosage|DIAGNOSTIC_TEST: Complement dosage,Francis Corazza,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,63,OTHER,INTERVENTIONAL,3/20/2020,11/23/2020
NCT04385017,COMPLETED,COVID-19 by SARS-CoV-2 Infection,OTHER: COVID-19 patients,Centre Hospitalier Universitaire de Nice,,ALL,"ADULT, OLDER_ADULT",NA,99,OTHER,INTERVENTIONAL,5/11/2020,12/30/2022
NCT05012826,RECRUITING,Covid19|SARS-CoV-2 Infection,OTHER: Osteopathic Manipulative Treatment in addition to Physiotherapy|OTHER: Physiotherapy,Centro Universitário Augusto Motta,Instituto Brasileiro de Osteopatia,ALL,"ADULT, OLDER_ADULT",NA,104,OTHER,INTERVENTIONAL,9/20/2021,7/6/2023
NCT04457726,UNKNOWN,COVID-19,BIOLOGICAL: SARS-CoV-2 Specific T Cells,KK Women's and Children's Hospital,"Duke-NUS Graduate Medical School|National University Hospital, Singapore|Singapore General Hospital|Sengkang General Hospital|Changi General Hospital",ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1|PHASE2,18,OTHER_GOV,INTERVENTIONAL,7/1/2020,2022-12
NCT04890626,UNKNOWN,SARS-CoV-2 Infection,DRUG: Emtricitabine/Tenofovir Disoproxil Fumarate 200 MG-245 MG Oral Tablet [TRUVADA]|DRUG: Baricitinib + dexamethasone|DRUG: Dexamethasone,Instituto de Investigación Hospital Universitario La Paz,,ALL,"ADULT, OLDER_ADULT",PHASE3,2193,OTHER,INTERVENTIONAL,4/4/2020,11/30/2022
NCT04955626,COMPLETED,SARS-CoV-2 Infection|COVID-19,BIOLOGICAL: BNT162b2|OTHER: Placebo|BIOLOGICAL: BNT162b2 OMI|BIOLOGICAL: Combination BNT162b2 and BNT162b2 OMI|BIOLOGICAL: Combination (Bivalent) BNT162b2 and BNT162b2 OMI,BioNTech SE,Pfizer,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,16385,INDUSTRY,INTERVENTIONAL,7/1/2021,5/25/2023
NCT05729204,COMPLETED,SARS-CoV2 Infection,OTHER: Hypertonic seawater solution,Larissa University Hospital,,ALL,"ADULT, OLDER_ADULT",NA,56,OTHER,INTERVENTIONAL,6/1/2022,12/31/2022
NCT04734717,UNKNOWN,Covid19|Motility Disorder|Balance,DIAGNOSTIC_TEST: Neurology test,Somogy Megyei Kaposi Mór Teaching Hospital,,ALL,"ADULT, OLDER_ADULT",NA,2,OTHER,INTERVENTIONAL,1/12/2021,4/12/2021
NCT04540926,UNKNOWN,COVID 19 Pneumonia,DRUG: Cyclosporin A,Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,200,OTHER_GOV,INTERVENTIONAL,2020-09,9/30/2020
NCT04388826,COMPLETED,"Respiratory Distress Syndrome, Adult",DRUG: Veru-111,Veru Inc.,,ALL,"ADULT, OLDER_ADULT",PHASE2,39,INDUSTRY,INTERVENTIONAL,6/18/2020,8/13/2021
NCT05965726,ENROLLING_BY_INVITATION,Long COVID-19|Long COVID,DRUG: Paxlovid 25 day dosing|DRUG: Paxlovid 15 day dosing|DRUG: Control,Kanecia Obie Zimmerman,,ALL,"ADULT, OLDER_ADULT",PHASE2,900,OTHER,INTERVENTIONAL,7/26/2023,2024-07
NCT05846126,RECRUITING,Post-COVID Syndrome,BEHAVIORAL: RehabCovid_Telematic|BEHAVIORAL: RehabCovid_ImmersiveVR|BEHAVIORAL: Control_Condition,Consorci Sanitari de Terrassa,University of Barcelona|Universitat de Girona|Unitat Assistencial i Preventiva de l'Esport- Centre d'Alt rendiment|Politecnic University of Catalonia|Corporación Fisiogestión,ALL,"ADULT, OLDER_ADULT",NA,158,OTHER,INTERVENTIONAL,5/1/2023,12/31/2024
NCT04693026,UNKNOWN,Covid19|Covid-19 ARDS,DRUG: Remdesivir|DRUG: Baricitinib|DRUG: Tocilizumab,M Abdur Rahim Medical College and Hospital,First affiliated Hospital Xi'an Jiaoting University,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,150,OTHER_GOV,INTERVENTIONAL,9/10/2020,3/5/2021
NCT05060991,UNKNOWN,COVID-19|Immunosuppression|Vaccine Response Impaired,DRUG: Reduction in antimetabolite immunosuppression,"University of California, Davis",CareDx,ALL,"ADULT, OLDER_ADULT",PHASE4,50,OTHER,INTERVENTIONAL,9/24/2021,1/24/2023
NCT04894409,COMPLETED,Coronavirus Disease 2019 (COVID-19),DEVICE: Mouthwash and nose rinse with the AgNPs solution|DEVICE: Mouthwashes and nose rinse in a conventional way,"Cluster de Bioeconomia de Baja California, A.C",Bionag SAPI de CV|General Hospital Tijuana,ALL,"ADULT, OLDER_ADULT",NA,231,OTHER,INTERVENTIONAL,4/24/2020,9/29/2020
NCT05947617,NOT_YET_RECRUITING,Post-Acute COVID-19 Syndrome|Cognitive Impairment|Neurological Complication,DRUG: VIX001,"Neobiosis, LLC",,ALL,"ADULT, OLDER_ADULT",PHASE1,9,INDUSTRY,INTERVENTIONAL,10/1/2023,9/1/2025
NCT04671017,COMPLETED,SARS-CoV-2 Virus Infection,BIOLOGICAL: VLA2001,Valneva Austria GmbH,"National Institute for Health Research, United Kingdom",ALL,ADULT,PHASE1|PHASE2,153,INDUSTRY,INTERVENTIONAL,12/16/2020,4/6/2022
NCT04751617,UNKNOWN,Covid19,PROCEDURE: Pulmonary rehabilitation,University of Rzeszow,,ALL,"ADULT, OLDER_ADULT",NA,60,OTHER,INTERVENTIONAL,1/1/2021,3/31/2021
NCT04525417,COMPLETED,Covid-19 Immune Status of Healthcare Workers,DIAGNOSTIC_TEST: AAZ Covid-19 rapid test,Groupe d'Etude sur le Risque d'Exposition des Soignants aux Agents Infectieux,,ALL,"ADULT, OLDER_ADULT",NA,75,NETWORK,INTERVENTIONAL,4/25/2020,10/25/2020
NCT04394117,COMPLETED,Coronavirus Disease 2019|COVID-19,DRUG: Angiotensin Receptor Blockers|OTHER: Placebo,The George Institute,,ALL,"ADULT, OLDER_ADULT",PHASE4,787,OTHER,INTERVENTIONAL,6/19/2020,1/17/2022
NCT04335552,TERMINATED,SARS-CoV-2,OTHER: Standard of care|DRUG: Hydroxychloroquine|DRUG: Azithromycin,Duke University,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,11,OTHER,INTERVENTIONAL,4/17/2020,6/26/2020
NCT04351152,UNKNOWN,Coronavirus Disease 2019 (COVID-19) Pneumonia,BIOLOGICAL: Lenzilumab|DRUG: Standard of Care,"Humanigen, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE3,520,INDUSTRY,INTERVENTIONAL,5/5/2020,2021-03
NCT04522817,WITHDRAWN,Covid-19,BIOLOGICAL: CLBS119,"Lisata Therapeutics, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE1,0,INDUSTRY,INTERVENTIONAL,10/5/2020,2021-05
NCT04776317,COMPLETED,COVID-19,"BIOLOGICAL: ChAdV68-S|BIOLOGICAL: ChAdV68-S-TCE|BIOLOGICAL: SAM-LNP-S|BIOLOGICAL: SAM-LNP-S-TCE|OTHER: Sodium Chloride, 0.9%",National Institute of Allergy and Infectious Diseases (NIAID),"Gritstone bio, Inc.",ALL,"ADULT, OLDER_ADULT",PHASE1,81,NIH,INTERVENTIONAL,3/18/2021,9/15/2023
NCT04834726,COMPLETED,Covid19,BEHAVIORAL: Opt-In (Call-Back)|BEHAVIORAL: Opt-in (In-Bound)|BEHAVIORAL: Standard Message|BEHAVIORAL: Clinician Endorsement|BEHAVIORAL: Scarcity|BEHAVIORAL: Opt-Out Framing|BEHAVIORAL: Phone Call,University of Pennsylvania,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,19554,OTHER,INTERVENTIONAL,4/29/2021,7/6/2021
NCT05248217,COMPLETED,"Burn Out|Addiction, Smartphone",BEHAVIORAL: healthcare workers,Kutahya Health Sciences University,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,183,OTHER,INTERVENTIONAL,2/25/2021,10/27/2021
NCT04361526,UNKNOWN,Coronavirus Infection|Acute Respiratory Distress Syndrome|COVID,DEVICE: Cytokine Adsorption,Manuel Castellà,,ALL,"ADULT, OLDER_ADULT",NA,40,OTHER,INTERVENTIONAL,4/17/2020,2020-07
NCT05827926,ACTIVE_NOT_RECRUITING,SARS-CoV-2|Influenza,BIOLOGICAL: Fluarix|BIOLOGICAL: mRNA-1083.1|BIOLOGICAL: mRNA-1083.2|BIOLOGICAL: mRNA-1083.3|BIOLOGICAL: mRNA-1010.4|BIOLOGICAL: mRNA-1283.222|BIOLOGICAL: mRNA-1273.222|BIOLOGICAL: mRNA-1010|BIOLOGICAL: Fluzone HD,"ModernaTX, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,1231,INDUSTRY,INTERVENTIONAL,4/14/2023,11/29/2024
NCT05749926,ACTIVE_NOT_RECRUITING,Vaccine Reaction|COVID-19,BIOLOGICAL: Comirnaty® BNT162b2 /Omicron BA.4-5 vaccine (Pfizer-BioNTech)|BIOLOGICAL: VidPrevtyn® Beta vaccine (Sanofi/GSK),Assistance Publique - Hôpitaux de Paris,IREIVAC/COVIREIVAC Network,ALL,"ADULT, OLDER_ADULT",PHASE3,248,OTHER,INTERVENTIONAL,5/16/2023,7/12/2024
NCT05532904,RECRUITING,Post COVID-19 Condition,BEHAVIORAL: Personalized multidisciplinary day-hospital intervention,Assistance Publique - Hôpitaux de Paris,,ALL,"ADULT, OLDER_ADULT",NA,130,OTHER,INTERVENTIONAL,1/18/2023,2025-09
NCT05233826,COMPLETED,COVID-19|SARS-CoV-2,BIOLOGICAL: COVI-VAC,"Codagenix, Inc",,ALL,"ADULT, OLDER_ADULT",PHASE1,20,INDUSTRY,INTERVENTIONAL,4/14/2022,12/22/2022
NCT04347226,TERMINATED,Solid Tumor|Sars-CoV2|Hematological Malignancy,DRUG: BMS-986253,Matthew Dallos,Bristol-Myers Squibb,ALL,"ADULT, OLDER_ADULT",PHASE2,43,OTHER,INTERVENTIONAL,4/16/2020,3/1/2021
NCT04425317,COMPLETED,Infertility|COVID|IVF,DIAGNOSTIC_TEST: Blood sample,CRG UZ Brussel,,FEMALE,"CHILD, ADULT",NA,16,OTHER,INTERVENTIONAL,9/10/2020,1/1/2022
NCT05530317,RECRUITING,Long COVID|COVID-19,BEHAVIORAL: Cardiac Rehabilitation,"University of California, San Francisco",,ALL,"ADULT, OLDER_ADULT",NA,25,OTHER,INTERVENTIONAL,2022-12,2024-09
NCT05379517,NOT_YET_RECRUITING,COVID-19,DEVICE: Pulsed ectromagnetid field therapy|OTHER: Pulmonary rehabilitation program (PRP),University of Malaga,,ALL,"ADULT, OLDER_ADULT",NA,33,OTHER,INTERVENTIONAL,9/15/2022,12/30/2022
NCT05185817,UNKNOWN,Hematopoietic Stem Cell Transplantation (HSCT)|COVID-19 Vaccines|Immune System Tolerance,BIOLOGICAL: Pasocovac vaccine,Tehran University of Medical Sciences,,ALL,"ADULT, OLDER_ADULT",PHASE2,100,OTHER,INTERVENTIONAL,11/1/2021,7/1/2023
NCT05079217,UNKNOWN,COVID-19,BIOLOGICAL: High-dosage SARS-CoV-2 vaccine|BIOLOGICAL: Medium-dosage SARS-CoV-2 vaccine,"Sinovac Biotech Co., Ltd",,ALL,"ADULT, OLDER_ADULT",PHASE4,1200,INDUSTRY,INTERVENTIONAL,12/17/2021,6/1/2022
NCT04398004,COMPLETED,COVID-19|Virus Diseases|Corona Virus Infection,DRUG: Clarithromycin,Hellenic Institute for the Study of Sepsis,,ALL,"ADULT, OLDER_ADULT",PHASE2,90,OTHER,INTERVENTIONAL,5/6/2020,11/30/2020
NCT05833217,NOT_YET_RECRUITING,Long COVID|Insulin Resistance|Insulin Sensitivity,PROCEDURE: Adipose Tissue Biopsy|DIAGNOSTIC_TEST: Steady State Plasma Glucose (SSPG) Test,Stanford University,,ALL,"ADULT, OLDER_ADULT",NA,55,OTHER,INTERVENTIONAL,5/2/2023,12/31/2025
NCT04313127,COMPLETED,COVID-19,BIOLOGICAL: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector),CanSino Biologics Inc.,"Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China|Jiangsu Province Centers for Disease Control and Prevention|Hubei Provincial Center for Disease Control and Prevention|Tongji Hospital",ALL,ADULT,PHASE1,108,INDUSTRY,INTERVENTIONAL,3/16/2020,2/20/2021
NCT04492527,COMPLETED,"Chronic Disease|Aging|Aging Problems|Health Behavior|Multiple Chronic Conditions|Chronic Illness|Chronic Illnesses, Multiple|Healthy Lifestyle|Healthy Aging|Aging Well|Healthy Life Style|Self-management|Self Care",BEHAVIORAL: Telehealth coaching sessions,University of British Columbia,,ALL,OLDER_ADULT,NA,75,OTHER,INTERVENTIONAL,7/28/2020,6/30/2021
NCT05467904,NOT_YET_RECRUITING,Post-acute COVID-19 Syndrome,"OTHER: Xltranplus, Xltran","LUCINDA BATEMAN, MD","Endourage, LLC",ALL,"ADULT, OLDER_ADULT",NA,111,OTHER,INTERVENTIONAL,2022-10,2023-10
NCT04898127,WITHDRAWN,Covid19,DIAGNOSTIC_TEST: SARS-CoV-2 antigen rapid test,Norwegian Institute of Public Health,University of Oslo,ALL,ADULT,NA,0,OTHER_GOV,INTERVENTIONAL,2021-05,2021-12
NCT04798027,TERMINATED,COVID-19,BIOLOGICAL: SARS-CoV-2 mRNA vaccine formulation 1|BIOLOGICAL: SARS-CoV-2 mRNA vaccine formulation 2|BIOLOGICAL: SARS-CoV-2 mRNA vaccine formulation 3|BIOLOGICAL: Placebo (0.9% normal saline),"Sanofi Pasteur, a Sanofi Company",,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,182,INDUSTRY,INTERVENTIONAL,3/12/2021,6/27/2022
NCT04447404,TERMINATED,SARS-CoV-2,DRUG: DUR-928|DRUG: Placebo,Durect,,ALL,"ADULT, OLDER_ADULT",PHASE2,2,INDUSTRY,INTERVENTIONAL,9/21/2020,3/4/2021
NCT04349371,TERMINATED,COVID|Coronavirus Infection,DRUG: Chloroquine|DRUG: Placebo oral tablet,Columbia University,,ALL,"ADULT, OLDER_ADULT",PHASE2,8,OTHER,INTERVENTIONAL,4/21/2020,2/10/2021
NCT05217771,UNKNOWN,Rehabilitation,OTHER: High tone power therapy group,October 6 University,,ALL,ADULT,NA,56,OTHER,INTERVENTIONAL,11/10/2021,11/20/2022
NCT04527471,COMPLETED,Coronavirus Infection|Covid-19|SARS-CoV-2,DRUG: Ensifentrine Dose 1|DRUG: Placebo pMDI,Verona Pharma Inc,,ALL,"ADULT, OLDER_ADULT",PHASE2,45,INDUSTRY,INTERVENTIONAL,9/4/2020,5/1/2021
NCT04523571,COMPLETED,SARS-CoV-2,BIOLOGICAL: BNT162b1|OTHER: Placebo,BioNTech SE,Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.,ALL,"ADULT, OLDER_ADULT",PHASE1,144,INDUSTRY,INTERVENTIONAL,7/28/2020,8/10/2021
NCT05181709,ACTIVE_NOT_RECRUITING,SARS-CoV-2,DRUG: Sodium Chloride|BIOLOGICAL: NDV-HXP-S IN low dose|BIOLOGICAL: NDV-HXP-S IM low dose|BIOLOGICAL: NDV-HXP-S IN high dose|BIOLOGICAL: NDV-HXP-S IM high dose,Sean Liu,,ALL,ADULT,PHASE1,35,OTHER,INTERVENTIONAL,2/1/2022,4/20/2024
NCT05490108,ACTIVE_NOT_RECRUITING,SARS-CoV-2 Infection|COVID-19,BIOLOGICAL: ZR202-CoV|BIOLOGICAL: ZR202a-CoV|BIOLOGICAL: Comirnaty®,"Shanghai Zerun Biotechnology Co.,Ltd",,ALL,ADULT,PHASE1|PHASE2,60,INDUSTRY,INTERVENTIONAL,6/2/2022,2023-08
NCT05525208,RECRUITING,COVID-19,BIOLOGICAL: SARS-CoV-2 subunit protein recombinant vaccine|BIOLOGICAL: Active Comparator,PT Bio Farma,Universitas Padjadjaran|Udayana University,ALL,"ADULT, OLDER_ADULT",PHASE2,900,INDUSTRY,INTERVENTIONAL,9/1/2022,3/30/2023
NCT04719208,UNKNOWN,Covid19,OTHER: Water (E) Mouth rinse with the solution provided|OTHER: Chlorhexidine gluconate (A) Mouth rinse with the solution provided|OTHER: Hydrogen peroxide (B) Mouth rinse with the solution provided|OTHER: Betadine (C) Mouth rinse with the solution provided|OTHER: Alcohol mouthwash (Listerine) (D) Mouth rinse with the solution provided,Augusta University,,ALL,"ADULT, OLDER_ADULT",NA,60,OTHER,INTERVENTIONAL,10/6/2020,2023-12
NCT05543408,ACTIVE_NOT_RECRUITING,COVID-19|Long COVID|Post-COVID-19 Syndrome,BEHAVIORAL: EXERCISE,Universidad San Jorge,,ALL,"ADULT, OLDER_ADULT",NA,40,OTHER,INTERVENTIONAL,5/3/2022,10/31/2022
NCT04405908,COMPLETED,COVID-19,BIOLOGICAL: SCB-2019|BIOLOGICAL: SCB-2019 with AS03 adjuvant|BIOLOGICAL: SCB-2019 with CpG 1018 adjuvant plus Alum adjuvant|BIOLOGICAL: SCB-2019 with Alum adjuvant,Clover Biopharmaceuticals AUS Pty Ltd,,ALL,"ADULT, OLDER_ADULT",PHASE1,166,INDUSTRY,INTERVENTIONAL,6/19/2020,12/8/2021
NCT04992208,COMPLETED,COVID-19,BIOLOGICAL: Experimental Group,"Sinovac Life Sciences Co., Ltd.",,ALL,CHILD,PHASE4,31041,INDUSTRY,INTERVENTIONAL,7/24/2021,8/31/2023
NCT04668209,TERMINATED,Coronavirus,DRUG: Silmitasertib,University of Arizona,"Senhwa Biosciences, Inc.",ALL,"ADULT, OLDER_ADULT",PHASE2,31,OTHER,INTERVENTIONAL,1/21/2021,10/19/2022
NCT05656508,COMPLETED,COVID-19 Vaccine,BIOLOGICAL: ARVAC-CG vaccine (recombinant protein vaccine against SARS-CoV-2),Laboratorio Pablo Cassara S.R.L.,"Universidad Nacional de San Martín (UNSAM)|National Council of Scientific and Technical Research, Argentina",ALL,ADULT,PHASE1,80,INDUSTRY,INTERVENTIONAL,4/20/2022,10/29/2023
NCT05890508,NOT_YET_RECRUITING,Long Covid19|Neuropsychiatric Symptoms|Electro-acupuncture,DEVICE: Acupuncture|DEVICE: Sham-acupuncture,Hong Kong Baptist University,,ALL,"ADULT, OLDER_ADULT",NA,150,OTHER,INTERVENTIONAL,6/30/2023,4/30/2025
NCT05965752,ENROLLING_BY_INVITATION,Long COVID|Long Covid19|Long Covid-19,OTHER: BrainHQ/Active Comparator Activity|OTHER: BrainHQ|OTHER: PASC CoRE|DEVICE: tDCS-active|DEVICE: tDCS-sham,Duke University,,ALL,"ADULT, OLDER_ADULT",NA,315,OTHER,INTERVENTIONAL,9/1/2023,2024-12
NCT04374552,WITHDRAWN,SARS-CoV-2 Infection,DRUG: Hydroxychloroquine sulfate &Azithromycin|DRUG: Placebo,"Rutgers, The State University of New Jersey",,ALL,"ADULT, OLDER_ADULT",PHASE2,0,OTHER,INTERVENTIONAL,5/5/2020,2021-04
NCT04425252,COMPLETED,COVID-19,DRUG: Brequinar|OTHER: Standard of Care,"Clear Creek Bio, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,25,INDUSTRY,INTERVENTIONAL,8/19/2020,1/12/2021
NCT04453852,COMPLETED,Coronavirus Infection|COVID,BIOLOGICAL: COVID19 vaccine|BIOLOGICAL: Saline,Vaxine Pty Ltd,Central Adelaide Local Health Network Incorporated,ALL,"ADULT, OLDER_ADULT",PHASE1,40,INDUSTRY,INTERVENTIONAL,6/30/2020,4/14/2021
NCT05967052,RECRUITING,"Chronic Fatigue Syndrome|COVID-19, Long Haul",DRUG: Pregabalin|BEHAVIORAL: Independent walking training|DRUG: Placebo|BEHAVIORAL: Gradual movement therapy in the ward|BEHAVIORAL: Telerehabilitation|BEHAVIORAL: Psychotherapy,"National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland","Medical Research Agency, Poland",ALL,"ADULT, OLDER_ADULT",PHASE2,132,NETWORK,INTERVENTIONAL,10/24/2023,3/1/2028
NCT04386252,WITHDRAWN,COVID-19,BIOLOGICAL: AV-COVID-19,"Aivita Biomedical, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,0,INDUSTRY,INTERVENTIONAL,2023-01,2024-01
NCT04299152,UNKNOWN,Severe Acute Respiratory Syndrome (SARS) Pneumonia,COMBINATION_PRODUCT: Stem Cell Educator-Treated Mononuclear Cells Apheresis,Throne Biotechnologies Inc.,,ALL,ADULT,PHASE2,20,INDUSTRY,INTERVENTIONAL,11/10/2021,6/10/2022
NCT05571852,COMPLETED,Post-Acute COVID-19|Long COVID,DEVICE: CogniFit's CCT Post COVID-19,Universidad Antonio de Nebrija,,ALL,"ADULT, OLDER_ADULT",NA,73,OTHER,INTERVENTIONAL,12/1/2021,2/28/2022
NCT04483752,UNKNOWN,CoV2 SARS Pneumonia,OTHER: CHEST CT SCAN,Centre Chirurgical Marie Lannelongue,,ALL,"ADULT, OLDER_ADULT",NA,100,OTHER,INTERVENTIONAL,6/8/2020,12/24/2022
NCT05430152,NOT_YET_RECRUITING,Post-Viral Fatigue Syndrome,DRUG: Low-Dose Naltrexone|OTHER: Placebo,University of British Columbia,BC Women's Hospital & Health Centre|Canadian Institutes of Health Research (CIHR)|Provincial Health Services Authority,ALL,"ADULT, OLDER_ADULT",PHASE2,160,OTHER,INTERVENTIONAL,2023-12,2024-06
NCT05184205,COMPLETED,COVID-19 Respiratory Infection|SARS-CoV-2 Acute Respiratory Disease,DEVICE: Nasal Photodisinfection|DEVICE: Sham Comparator: Control,Ondine Biomedical Inc.,University of Navarra,ALL,"ADULT, OLDER_ADULT",NA,100,INDUSTRY,INTERVENTIONAL,12/20/2021,5/30/2022
NCT04355052,UNKNOWN,COVID - 19,DRUG: hydroxychloroquine in combination with camostat mesylate|DRUG: Hydroxychloroquine in combination of Azithromycin,Sheba Medical Center,,ALL,"ADULT, OLDER_ADULT",PHASE3,250,OTHER_GOV,INTERVENTIONAL,4/11/2020,12/11/2020
NCT05713305,RECRUITING,SARS-CoV-2 Infection|Staff Attitude|Anxiety|Mental Health Issue,PROCEDURE: Online-based self-help psychological intervention|PROCEDURE: Provide online mental health knowledge,"Second Affiliated Hospital, School of Medicine, Zhejiang University",,ALL,"ADULT, OLDER_ADULT",NA,110,OTHER,INTERVENTIONAL,1/18/2023,9/20/2023
NCT04361552,WITHDRAWN,Cerebrovascular Accident|Chronic Obstructive Pulmonary Disease|Chronic Renal Failure|Coronary Artery Disease|Diabetes Mellitus|Malignant Neoplasm|SARS Coronavirus 2 Infection,OTHER: Best Practice|BIOLOGICAL: Tocilizumab,Emory University,National Cancer Institute (NCI),ALL,"ADULT, OLDER_ADULT",PHASE3,0,OTHER,INTERVENTIONAL,4/7/2020,6/2/2020
NCT04695652,COMPLETED,Covid19 Vaccine,BIOLOGICAL: MVC-COV1901(S protein with adjuvant)|BIOLOGICAL: MVC-COV1901(Saline),Medigen Vaccine Biologics Corp.,,ALL,"ADULT, OLDER_ADULT",PHASE2,3854,INDUSTRY,INTERVENTIONAL,12/30/2020,10/29/2021
NCT05684952,RECRUITING,Long COVID,DRUG: Shenlingcao Oral Liquid,Hong Kong Baptist University,"Jiangzhong Pharmaceutical Co., Ltd.",ALL,"ADULT, OLDER_ADULT",PHASE2,152,OTHER,INTERVENTIONAL,5/30/2023,2/1/2024
NCT04412252,WITHDRAWN,COVID-19,DRUG: Tofacitinib|OTHER: Placebo,Pfizer,,ALL,"ADULT, OLDER_ADULT",PHASE2,0,INDUSTRY,INTERVENTIONAL,7/6/2020,10/18/2020
NCT04280705,COMPLETED,COVID-19,OTHER: Placebo|DRUG: Remdesivir,National Institute of Allergy and Infectious Diseases (NIAID),,ALL,"ADULT, OLDER_ADULT",PHASE3,1062,NIH,INTERVENTIONAL,2/21/2020,5/21/2020
NCT05792852,NOT_YET_RECRUITING,Disabilities Multiple,BEHAVIORAL: ENGAGE,University of Illinois at Chicago,National Center for Advancing Translational Sciences (NCATS),ALL,"ADULT, OLDER_ADULT",NA,21,OTHER,INTERVENTIONAL,4/1/2023,12/30/2023
NCT06037005,ACTIVE_NOT_RECRUITING,Trauma and Stressor Related Disorders,OTHER: Cognitive Behavioral Therapy Group,Necmettin Erbakan University,,ALL,"ADULT, OLDER_ADULT",NA,60,OTHER,INTERVENTIONAL,5/10/2022,11/30/2023
NCT05567952,ACTIVE_NOT_RECRUITING,COVID-19,DRUG: nirmatrelvir|DRUG: ritonavir|DRUG: placebo for nirmatrelvir,Pfizer,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,436,INDUSTRY,INTERVENTIONAL,10/19/2022,2/15/2024
NCT04406493,UNKNOWN,ARDS|COVID,DIAGNOSTIC_TEST: Lung impedance technique,Hillel Yaffe Medical Center,,ALL,"ADULT, OLDER_ADULT",NA,50,OTHER_GOV,INTERVENTIONAL,4/28/2020,4/28/2021
NCT05122182,TERMINATED,COVID-19|SARS-CoV2 Infection,DRUG: Candesartan Cilexetil|DRUG: Repagermanium|DRUG: Candesartan Placebo|DRUG: Repagermanium Placebo,University of Sydney,"The George Institute for Global Health, India",ALL,"ADULT, OLDER_ADULT",PHASE2,49,OTHER,INTERVENTIONAL,1/7/2022,1/28/2023
NCT05197582,COMPLETED,COVID-19 Pandemic,OTHER: tele-monitoring,Yuksek Ihtisas University,,ALL,"ADULT, OLDER_ADULT",NA,56,OTHER,INTERVENTIONAL,1/1/2021,9/1/2021
NCT04644120,COMPLETED,CoronaVirus Disease-2019 (COVID-19),DRUG: ABBV-47D11|DRUG: Placebo for ABBV-47D11|DRUG: ABBV-2B04|DRUG: Placebo for ABBV-2B04,AbbVie,,ALL,"ADULT, OLDER_ADULT",PHASE1,25,INDUSTRY,INTERVENTIONAL,12/10/2020,8/24/2021
NCT06237049,RECRUITING,"Influenza, Human|SARS-CoV-2 Infection|COVID-19",BIOLOGICAL: BNT162b2 (Omi XBB.1.5)/RIV|BIOLOGICAL: BNT162b2 (Omi XBB.1.5)|BIOLOGICAL: RIV|OTHER: Normal saline placebo,Pfizer,,ALL,"ADULT, OLDER_ADULT",PHASE2,640,INDUSTRY,INTERVENTIONAL,1/31/2024,9/13/2024
NCT04732949,COMPLETED,Severe Acute Respiratory Syndrome Coronavirus 2|COVID-19,DRUG: SNG001|DRUG: Placebo,Synairgen Research Ltd.,,ALL,"ADULT, OLDER_ADULT",PHASE3,623,INDUSTRY,INTERVENTIONAL,1/12/2021,2/10/2022
NCT04700163,COMPLETED,Covid19,BIOLOGICAL: C144-LS and C-135-LS,Rockefeller University,,ALL,"ADULT, OLDER_ADULT",PHASE1,23,OTHER,INTERVENTIONAL,1/11/2021,2/2/2022
NCT04377620,TERMINATED,COVID-19,DRUG: Placebo|DRUG: Ruxolitinib,Incyte Corporation,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,211,INDUSTRY,INTERVENTIONAL,5/24/2020,2/26/2021
NCT04346420,COMPLETED,COVID|Hypoxemia,OTHER: Standard interface|DEVICE: Double-Trunk Mask,Cliniques universitaires Saint-Luc- Université Catholique de Louvain,,ALL,"ADULT, OLDER_ADULT",NA,12,OTHER,INTERVENTIONAL,4/9/2020,5/1/2020
NCT04342182,TERMINATED,COVID-19,BIOLOGICAL: Convalescent plasma,Erasmus Medical Center,Prothya Biosolutions,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,86,OTHER,INTERVENTIONAL,4/8/2020,9/30/2020
NCT05162482,NOT_YET_RECRUITING,COVID 19 Vaccine,"BIOLOGICAL: BIBP (CNBG, Sinopharm) WIV|BIOLOGICAL: CanSinoBIO|BIOLOGICAL: AstraZeneca ChAdOx","Aga Khan University Hospital, Pakistan","Coalition for Epidemic Preparedness Innovations|University of Oxford|International Vaccine Institute|Harvard Medical School (HMS and HSDM)|Chughtai Lab|National Institute of Health, Pakistan",ALL,"ADULT, OLDER_ADULT",PHASE2,1680,OTHER,INTERVENTIONAL,3/1/2022,6/30/2024
NCT04372082,WITHDRAWN,Sars-CoV2,OTHER: Standard of care (SOC)|DRUG: Hydroxychloroquine|DRUG: Association of diltiazem and niclosamide,"University Hospital, Lille",I-site University Lille North Europe,ALL,"ADULT, OLDER_ADULT",PHASE3,0,OTHER,INTERVENTIONAL,2020-05,2023-05
NCT04802382,ACTIVE_NOT_RECRUITING,Corona Virus Infection|Covid19|SARS-CoV Infection,DRUG: Placebo administration|DIAGNOSTIC_TEST: Confirm SARS-CoV-2 infection|PROCEDURE: Physical Examination|PROCEDURE: Vital Signs|DIAGNOSTIC_TEST: Hematology blood test|DIAGNOSTIC_TEST: Biochemistry blood test|OTHER: NEWS score|DIAGNOSTIC_TEST: PK test|DIAGNOSTIC_TEST: blood test for inflammatory markers|DIAGNOSTIC_TEST: D-dimer test|OTHER: VAS scale|DIAGNOSTIC_TEST: Urine pregnancy test for women of childbearing potential|PROCEDURE: ECG|OTHER: COVID-19-Impact on Quality of Life Questionnaire|DRUG: CimetrA-1|DRUG: CimetrA-2,MGC Pharmaceuticals d.o.o,,ALL,"ADULT, OLDER_ADULT",PHASE3,252,INDUSTRY,INTERVENTIONAL,6/11/2021,2023-04
NCT05021016,COMPLETED,Covid19,BIOLOGICAL: EpiVacCorona (EpiVacCorona vaccine based on peptide antigens for the prevention of COVID-19),"Federal Budgetary Research Institution State Research Center of Virology and Biotechnology ""Vector""",,ALL,"ADULT, OLDER_ADULT",PHASE3,150,OTHER_GOV,INTERVENTIONAL,11/19/2020,1/30/2021
NCT05346120,WITHDRAWN,Post COVID -19 Depression,BIOLOGICAL: allogeneic marrow stromal cells (MSCs),Sean Savitz,,ALL,"ADULT, OLDER_ADULT",PHASE2,0,OTHER,INTERVENTIONAL,5/25/2022,5/1/2024
NCT04519320,ACTIVE_NOT_RECRUITING,Sars-CoV2,DIAGNOSTIC_TEST: Pulmonary function testing,Centre Hospitalier Universitaire de Besancon,,ALL,"ADULT, OLDER_ADULT",NA,140,OTHER,INTERVENTIONAL,5/18/2020,8/18/2025
NCT04895982,COMPLETED,"SARS-CoV-2 Infection, COVID19",BIOLOGICAL: BNT162b2,BioNTech SE,Pfizer,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,124,INDUSTRY,INTERVENTIONAL,10/15/2021,7/23/2023
NCT04718220,ACTIVE_NOT_RECRUITING,Covid19|Pregnancy Related|Maternal Complication of Pregnancy|Coronavirus|Neonatal Infection|Prenatal Stress|Preterm Birth,DIAGNOSTIC_TEST: Antibody testing for SARS-CoV-2 IgG|DIAGNOSTIC_TEST: Testing for SARS-CoV-2 RNA|DIAGNOSTIC_TEST: Testing for SARS-CoV-2 IgM/IgG,Washington University School of Medicine,Mercy Research,FEMALE,"CHILD, ADULT, OLDER_ADULT",NA,420,OTHER,INTERVENTIONAL,3/1/2021,2024-08
NCT04459520,COMPLETED,COVID-19,BEHAVIORAL: Positive COVID Test Result - Hypothetical Scenario|BEHAVIORAL: Negative COVID Test Result - Hypothetical Scenario|BEHAVIORAL: Unavailable COVID Test Result - Hypothetical Scenario,"University of California, Los Angeles",,ALL,"ADULT, OLDER_ADULT",NA,1400,OTHER,INTERVENTIONAL,7/23/2020,7/29/2020
NCT05057182,ACTIVE_NOT_RECRUITING,COVID 19 Vaccine,BIOLOGICAL: BNT162b2,The University of Hong Kong,,ALL,"ADULT, OLDER_ADULT",PHASE4,300,OTHER,INTERVENTIONAL,10/18/2021,12/31/2024
NCT04739020,UNKNOWN,SARS-CoV-2 Infection|Covid19,DIAGNOSTIC_TEST: Resp-Aer-Meter|DIAGNOSTIC_TEST: Spirometry|DIAGNOSTIC_TEST: Qualitative and quantitative virus PCR of respiratory secretions in patients with high aerosol concentrations,Johann Wolfgang Goethe University Hospital,Palas GmbH,ALL,"CHILD, ADULT, OLDER_ADULT",NA,525,OTHER,INTERVENTIONAL,1/18/2021,12/31/2021
NCT04940182,COMPLETED,Sars-CoV-2 Infection,DRUG: XC221|DRUG: Placebo,RSV Therapeutics LLC,,ALL,"ADULT, OLDER_ADULT",PHASE3,274,INDUSTRY,INTERVENTIONAL,6/26/2021,11/14/2022
NCT05050682,COMPLETED,Healthy,DRUG: PF-07304814,Pfizer,,ALL,ADULT,PHASE1,5,INDUSTRY,INTERVENTIONAL,10/7/2021,12/10/2021
NCT04365582,WITHDRAWN,COVID,DRUG: Azithromycin|DRUG: Hydroxychloroquine|DRUG: Lopinavir 200Mg/Ritonavir 50Mg Tab,Fondation Hôpital Saint-Joseph,,ALL,"ADULT, OLDER_ADULT",PHASE3,0,OTHER,INTERVENTIONAL,5/7/2020,4/19/2021
NCT04957082,COMPLETED,SARS-CoV2 Infection,BEHAVIORAL: Culturally Targeted SARS-CoV-2 Communication|BEHAVIORAL: General SARS-CoV-2 Communication,Michigan State University,National Cancer Institute (NCI)|Johns Hopkins University,ALL,"ADULT, OLDER_ADULT",NA,525,OTHER,INTERVENTIONAL,8/4/2021,12/19/2022
NCT05450120,ACTIVE_NOT_RECRUITING,COVID-19 Acute Respiratory Distress Syndrome,OTHER: Functional Rehabilitation|OTHER: Neuromuscular Electrical Stimulation,Universidade Federal de Sao Carlos,,ALL,"ADULT, OLDER_ADULT",NA,88,OTHER,INTERVENTIONAL,5/1/2020,12/1/2022
NCT04323345,UNKNOWN,COVID-19,DIETARY_SUPPLEMENT: Natural Honey|OTHER: Standard Care,Misr University for Science and Technology,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,1000,OTHER,INTERVENTIONAL,4/15/2020,1/15/2021
NCT05697068,RECRUITING,SARS-CoV-2 Infection,BEHAVIORAL: COVID Prevention Program (CPP),San Diego State University,Family Health Centers of San Diego,ALL,"ADULT, OLDER_ADULT",NA,256,OTHER,INTERVENTIONAL,4/11/2022,10/31/2025
NCT04333368,COMPLETED,Severe Acute Respiratory Syndrome Coronavirus 2|Severe Acute Respiratory Distress Syndrome,BIOLOGICAL: Umbilical cord Wharton's jelly-derived human|OTHER: NaCl 0.9%,Assistance Publique - Hôpitaux de Paris,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,47,OTHER,INTERVENTIONAL,4/6/2020,10/26/2021
NCT04594668,UNKNOWN,"ARDS, Human|COVID",DRUG: Senicapoc,University of Aarhus,Aarhus University Hospital|Odense University Hospital|Aalborg University Hospital|Hvidovre University Hospital,ALL,"ADULT, OLDER_ADULT",PHASE2,46,OTHER,INTERVENTIONAL,4/24/2020,12/31/2021
NCT04669015,RECRUITING,Covid19,BIOLOGICAL: Novaferon|BIOLOGICAL: Placebo,Genova Inc.,,ALL,"ADULT, OLDER_ADULT",PHASE3,914,INDUSTRY,INTERVENTIONAL,6/10/2021,2022-08
NCT05017168,COMPLETED,SARS-CoV-2 Infection,DRUG: CT-P63|DRUG: Placebo,Celltrion,,ALL,ADULT,PHASE1,24,INDUSTRY,INTERVENTIONAL,10/11/2021,1/25/2022
NCT04944368,COMPLETED,Covid19,BIOLOGICAL: SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant|BIOLOGICAL: Saline placebo,Cinnagen,Vaxine Pty Ltd,ALL,"ADULT, OLDER_ADULT",PHASE2,400,INDUSTRY,INTERVENTIONAL,5/30/2021,12/30/2021
NCT05780268,COMPLETED,COVID-19,BIOLOGICAL: LY3819253|BIOLOGICAL: Placebo|BIOLOGICAL: Remdesivir,National Institute of Allergy and Infectious Diseases (NIAID),"International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)|University of Copenhagen|Medical Research Council|Kirby Institute|Washington D.C. Veterans Affairs Medical Center|AIDS Clinical Trials Group|National Heart, Lung, and Blood Institute (NHLBI)|US Department of Veterans Affairs|Prevention and Early Treatment of Acute Lung Injury|Cardiothoracic Surgical Trials Network|Eli Lilly and Company|University of Minnesota",ALL,"ADULT, OLDER_ADULT",PHASE3,314,NIH,INTERVENTIONAL,8/5/2020,2/1/2021
NCT05252468,COMPLETED,COVID-19|Upper Respiratory Tract Infections,DEVICE: TaffiX™,Nasus Pharma,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,693,INDUSTRY,INTERVENTIONAL,5/19/2021,12/2/2021
NCT04604145,COMPLETED,SARS-CoV Infection|Polymerase Chain Reaction|Laboratory Testing,DIAGNOSTIC_TEST: SARS-CoV-2 testing on the Eppendorf Thermal Cycler PCR system using self-collected saliva as the specimen,David Grant U.S. Air Force Medical Center,,ALL,"ADULT, OLDER_ADULT",NA,60,FED,INTERVENTIONAL,2/3/2021,8/18/2021
NCT05951920,RECRUITING,COVID-19,PROCEDURE: Lymph node aspiration / Blood sampling,Assistance Publique - Hôpitaux de Paris,,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,12,OTHER,INTERVENTIONAL,7/5/2023,2023-09
NCT04937582,COMPLETED,COVID 19,DIAGNOSTIC_TEST: Cognitive assessment|DIAGNOSTIC_TEST: Imaging|DIAGNOSTIC_TEST: Routine care|OTHER: Psychiatric evaluation|OTHER: Psychiatric evaluation,"Central Hospital, Nancy, France","Centre Hospitalier Universitaire de Besancon|University Hospital, Strasbourg, France|Centre Hospitalier Régional Metz-Thionville|Centre hospitalier Epinal|Hopitaux Civils de Colmar",ALL,"ADULT, OLDER_ADULT",NA,76,OTHER,INTERVENTIONAL,8/23/2021,9/27/2023
NCT04632082,UNKNOWN,Mental Health Wellness 1|COVID|Emotional Distress|Depressive Symptoms|Anxiety Symptoms|Irritability|Telepsychotherapy,BEHAVIORAL: Telepsychoeducation with personalized videos|BEHAVIORAL: Telepsychoeducation without personalized videos,Hospital de Clinicas de Porto Alegre,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,2200,OTHER,INTERVENTIONAL,11/5/2020,7/20/2021
NCT04357782,COMPLETED,COVID-19|Hypoxia,DRUG: L-ascorbic acid,Hunter Holmes Mcguire Veteran Affairs Medical Center,McGuire Research Institute,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,20,FED,INTERVENTIONAL,4/16/2020,10/13/2020
NCT05638620,ACTIVE_NOT_RECRUITING,"Post Acute COVID-19 Syndrome|Long COVID|Long Covid19|COVID-19 Recurrent|Post-Acute COVID-19|Post-Acute COVID-19 Infection|SARS-CoV2 Infection|Post Acute Sequelae of COVID-19|Dysautonomia|Dysautonomia Like Disorder|Dysautonomia Orthostatic Hypotension Syndrome|Post COVID-19 Condition|Post-COVID Syndrome|Post COVID-19 Condition, Unspecified|Post-COVID-19 Syndrome",DRUG: stellate ganglion block with 0.5% bupivacaine,"Jonathann Kuo, MD",,ALL,"ADULT, OLDER_ADULT",PHASE1,20,OTHER,INTERVENTIONAL,1/3/2023,12/30/2023
NCT04520620,WITHDRAWN,Sars-CoV2,DRUG: Lovenox 40 MG in 0.4 mL Prefilled Syringe|DEVICE: Ultrasound of the lower limbs,Centre Hospitalier Universitaire de Saint Etienne,CHU Saint-Etienne - Laboratoire de Pharmacologie - Toxicologie - Gaz du sang,ALL,"ADULT, OLDER_ADULT",PHASE4,0,OTHER,INTERVENTIONAL,5/2/2020,7/10/2020
NCT05155982,WITHDRAWN,Severe Acute Respiratory Syndrome Coronavirus 2,BIOLOGICAL: COVAC-1|BIOLOGICAL: Saline Placebo,University of Saskatchewan,Government of Canada|Government of Saskatchewan,ALL,"ADULT, OLDER_ADULT",PHASE1,0,OTHER,INTERVENTIONAL,2022-06,2023-10
NCT04420182,COMPLETED,Covid-19,OTHER: Virtual Care at Home,Lawson Health Research Institute,Cardiac Arrhythmia Network of Canada,ALL,"ADULT, OLDER_ADULT",NA,817,OTHER,INTERVENTIONAL,8/17/2020,2/4/2022
NCT05033145,COMPLETED,COVID-19,DRUG: AZVUDINE|DRUG: AZVUDINE placebo,HRH Pharmaceuticals Limited,"GALZU INSTITUTE OF RESEARCH, TEACHING, SCIENCE AND APPLIED TECHNOLOGY, Brazil|Clinical Research Unit / High Complexity Center (CRU/HCC) / Galzu Institute",ALL,"ADULT, OLDER_ADULT",PHASE3,312,OTHER,INTERVENTIONAL,1/15/2022,7/27/2022
NCT04476745,COMPLETED,Cytokine Storm,DIETARY_SUPPLEMENT: Vitamin D3,Applied Science Private University,,ALL,"ADULT, OLDER_ADULT",NA,100,OTHER,INTERVENTIONAL,10/5/2020,4/15/2021
NCT05233345,COMPLETED,Occupational Balance|Well-being|Quality of Life|Occupational Therapy|Refugee|Children,BEHAVIORAL: Occupational Therapy,Hacettepe University,,ALL,CHILD,NA,52,OTHER,INTERVENTIONAL,12/13/2020,3/30/2021
NCT04367545,COMPLETED,COVID|RT-ddPCR Multiplex,DIAGNOSTIC_TEST: Saliva collection,"University Hospital, Rouen",,ALL,"ADULT, OLDER_ADULT",NA,130,OTHER,INTERVENTIONAL,4/16/2020,5/17/2020
NCT04663945,COMPLETED,Covid-19|Deconditioning,BEHAVIORAL: Biobehavioral Tele-rehabilitation Sessions,"University of Colorado, Denver",National Institute on Aging (NIA),ALL,"ADULT, OLDER_ADULT",NA,49,OTHER,INTERVENTIONAL,12/11/2020,12/27/2021
NCT04528368,UNKNOWN,COVID-19,BIOLOGICAL: Convalescent plasma,D'Or Institute for Research and Education,Hospital do Coracao,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,60,OTHER,INTERVENTIONAL,12/11/2020,1/30/2022
NCT05633420,COMPLETED,COVID-19,DRUG: Pyramax,Shin Poong Pharmaceutical Co. Ltd.,,ALL,"ADULT, OLDER_ADULT",PHASE2,20,INDUSTRY,INTERVENTIONAL,7/24/2022,11/20/2022
NCT05920616,ENROLLING_BY_INVITATION,COVID-19|COVID Long-Haul,OTHER: Magnetic Resonance Imaging|OTHER: Ultra-High Resolution Computed Tomography (CT) Scan,Johns Hopkins University,"Canon Medical Systems, USA",ALL,"ADULT, OLDER_ADULT",NA,210,OTHER,INTERVENTIONAL,10/14/2020,10/31/2026
NCT05000216,ACTIVE_NOT_RECRUITING,Rheumatoid Arthritis (RA)|Systemic Lupus Erythematosus (SLE)|Pemphigus Vulgaris|Multiple Sclerosis (MS)|Systemic Sclerosis (SSc)|Pediatric SLE|Juvenile Idiopathic Arthritis (JIA)|Juvenile Dermatomyositis (JDM)|Pediatric-Onset Multiple Sclerosis (POMS),"BIOLOGICAL: Moderna mRNA-1273|BIOLOGICAL: BNT162b2|BIOLOGICAL: Ad26.COV2.S|DRUG: Continue IS (MMF or MPA)|DRUG: Continue IS (MTX)|BIOLOGICAL: Continue IS (B cell depletion therapy)|BIOLOGICAL: Monovalent [B.1.351] CoV2 preS dTM-AS03|DRUG: Withhold IS (MMF or MPA)|DRUG: Withhold IS (MTX)|DRUG: Withhold IS (B cell depletion therapy)|BIOLOGICAL: Moderna mRNA-1273, Bivalent|BIOLOGICAL: BNT162b2, Bivalent",National Institute of Allergy and Infectious Diseases (NIAID),"Autoimmunity Centers of Excellence|Rho Federal Systems Division, Inc.",ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,257,NIH,INTERVENTIONAL,8/13/2021,4/22/2024
NCT04359316,UNKNOWN,COVID-19,DRUG: Hydroxychloroquine|DRUG: Azithromycin,Shahid Beheshti University of Medical Sciences,,ALL,"ADULT, OLDER_ADULT",PHASE4,40,OTHER,INTERVENTIONAL,4/20/2020,5/5/2020
NCT05329220,COMPLETED,COVID-19 Disease,BIOLOGICAL: ABNCoV2|BIOLOGICAL: Comirnaty,Bavarian Nordic,,ALL,"ADULT, OLDER_ADULT",PHASE3,4223,INDUSTRY,INTERVENTIONAL,8/31/2022,10/5/2023
NCT04750720,COMPLETED,Covid19|SARS-CoV-2,OTHER: Sampling by venipuncture (and eventually by nasopharyngeal swab),Centre Hospitalier Régional d'Orléans,Institut Pasteur,ALL,"ADULT, OLDER_ADULT",NA,187,OTHER,INTERVENTIONAL,8/27/2020,3/7/2022
NCT05225220,COMPLETED,Post COVID-19|Cognitive Dysfunction,"DEVICE: Parasym Device (of Parasym Ltd, UK) using Transcutaneous Vagus Nerve Stimulation (t-VNS)",Casa Colina Hospital and Centers for Healthcare,,FEMALE,"ADULT, OLDER_ADULT",NA,25,OTHER,INTERVENTIONAL,3/1/2022,1/6/2023
NCT04407182,COMPLETED,Covid-19|Sars-CoV2|Diabete Mellitus|Cardiopathy|Pulmonary Disease|Renal Disease|Liver Diseases,DIETARY_SUPPLEMENT: Viusid and Asbrip,Catalysis SL,,ALL,"ADULT, OLDER_ADULT",PHASE2,60,INDUSTRY,INTERVENTIONAL,5/4/2020,10/1/2020
NCT06144320,NOT_YET_RECRUITING,Brain Fog,OTHER: Acupuncture,China Medical University Hospital,,ALL,"ADULT, OLDER_ADULT",NA,40,OTHER,INTERVENTIONAL,2023-11,2023-11
NCT04751682,COMPLETED,SARS-CoV Infection,BIOLOGICAL: BBV154 Vaccine|BIOLOGICAL: Placebo,Bharat Biotech International Limited,,ALL,ADULT,PHASE1,175,INDUSTRY,INTERVENTIONAL,3/1/2021,11/30/2021
NCT04425720,COMPLETED,COVID,DEVICE: LifeSignals Biosensor 1AX*|OTHER: Standard of Care,Montefiore Medical Center,,ALL,"ADULT, OLDER_ADULT",NA,300,OTHER,INTERVENTIONAL,9/1/2020,12/10/2021
NCT04992182,UNKNOWN,Covid19,BIOLOGICAL: Placebo|BIOLOGICAL: Inactivated vaccine booster|BIOLOGICAL: mRNA vaccine booster|DRUG: Viral vector vaccine booster,Universidad del Desarrollo,"Ministry of Health, Chile|University of Chile|Pontificia Universidad Catolica de Chile",ALL,"ADULT, OLDER_ADULT",PHASE2,534,OTHER,INTERVENTIONAL,7/8/2021,6/30/2022
NCT04875520,ACTIVE_NOT_RECRUITING,Covid19,OTHER: Screening testing strategy|OTHER: No screening testing strategy,Washington University School of Medicine,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,2474,OTHER,INTERVENTIONAL,5/7/2021,12/31/2023
NCT04665193,COMPLETED,Asymptomatic Condition|Healthy,DIAGNOSTIC_TEST: Rapid Antigen Test,University of British Columbia,Vancouver Airport Authority|WestJet Airlines|Providence Health & Services|KLM Royal Dutch Airlines,ALL,"CHILD, ADULT, OLDER_ADULT",NA,592,OTHER,INTERVENTIONAL,11/23/2020,4/28/2021
NCT05491993,RECRUITING,COVID-19|Sars-CoV-2 Infection,DIAGNOSTIC_TEST: Sky Medical™ Rapid Antigen Test,"Sky Medical Supplies & Equipments, LLC",,ALL,"CHILD, ADULT, OLDER_ADULT",NA,200,INDUSTRY,INTERVENTIONAL,2/22/2022,1/11/2023
NCT04321993,ACTIVE_NOT_RECRUITING,COVID-19,DRUG: Baricitinib (janus kinase inhibitor)|DRUG: Remdesivir (antiviral) + barictinib (janus kinase inhibitor)|DRUG: Remdesivir (antiviral)|DRUG: Tocilizumab (interleukin 6 inhibitor),Lisa Barrett,Nova Scotia Health Authority|Dalhousie University,ALL,"ADULT, OLDER_ADULT",PHASE2,363,OTHER,INTERVENTIONAL,4/17/2020,2024-04
NCT05008393,COMPLETED,Covid19|COVID-19 Pneumonia,DRUG: PJS-539 Dose 1|DRUG: PJS-539 Dose 2|DRUG: Placebo,Hospital do Coracao,Covicept,ALL,"ADULT, OLDER_ADULT",PHASE2,153,OTHER,INTERVENTIONAL,9/25/2021,3/4/2022
NCT04322682,TERMINATED,Corona Virus Infection,DRUG: Colchicine|DRUG: Placebo oral tablet,Montreal Heart Institute,"National Heart, Lung, and Blood Institute (NHLBI)|Bill and Melinda Gates Foundation|The Government of Quebec|DACIMA Software",ALL,"ADULT, OLDER_ADULT",PHASE3,4506,OTHER,INTERVENTIONAL,3/23/2020,1/21/2021
NCT04437875,COMPLETED,Preventive Immunization COVID-19,BIOLOGICAL: Gam-COVID-Vac Lyo,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation",Acellena Contract Drug Research and Development,ALL,ADULT,PHASE1|PHASE2,38,OTHER,INTERVENTIONAL,6/17/2020,8/10/2020
NCT04490850,COMPLETED,Coronavirus Infection|Severe Acute Respiratory Syndrome|SARS-CoV Infection|Covid19,PROCEDURE: Blood sample,Institut Pasteur,"Institut Pasteur de la Guyane|Laboratoire de biologie médicale, Institut Pasteur de la Guyane|Laboratoire de biologie médicale de Kourou, French Guiana|Laboratoire de biologie médicale du Centre hospitalier de Saint-Laurent du Maroni, French Guiana|Eurofins|Centres Délocalisés de Prévention et de Soins, Centre Hospitalier Andrée Rosemon de Cayenne, Frech Guiana",ALL,"CHILD, ADULT, OLDER_ADULT",NA,3541,INDUSTRY,INTERVENTIONAL,7/15/2020,9/24/2021
NCT04354259,COMPLETED,Sars-CoV2|Covid-19,DRUG: Peginterferon Lambda-1A|OTHER: placebo,"University Health Network, Toronto",Michael Garron Hospital,ALL,"ADULT, OLDER_ADULT",PHASE2,157,OTHER,INTERVENTIONAL,5/13/2020,12/8/2022
NCT04422275,WITHDRAWN,Anosmia,DRUG: Budesonide|BEHAVIORAL: High-Concentration Essential Oil|DRUG: Placebo|BEHAVIORAL: Low-Concentration Essential Oil,Washington University School of Medicine,,ALL,"ADULT, OLDER_ADULT",PHASE2,0,OTHER,INTERVENTIONAL,6/1/2021,12/31/2023
NCT05938075,ACTIVE_NOT_RECRUITING,SARS-CoV|SARS-CoV-2,BIOLOGICAL: VXCO-100|BIOLOGICAL: COVID-19 mRNA vaccine,"Vaccine Company, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE1,130,INDUSTRY,INTERVENTIONAL,8/4/2023,8/31/2024
NCT05330975,ACTIVE_NOT_RECRUITING,Respiratory Syncytial Virus,BIOLOGICAL: Placebo|BIOLOGICAL: mRNA-1345|BIOLOGICAL: Afluria® Quadrivalent|BIOLOGICAL: mRNA-1273.214,"ModernaTX, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE3,3800,INDUSTRY,INTERVENTIONAL,4/1/2022,1/6/2025
NCT04350450,WITHDRAWN,COVID|Coronavirus|COVID-19,DRUG: Hydroxychloroquine,Montefiore Medical Center,,ALL,"ADULT, OLDER_ADULT",PHASE2,0,OTHER,INTERVENTIONAL,2020-04,2020-08
NCT04834375,COMPLETED,Covid19,DRUG: Weight-based dexamethasone dose,Northwell Health,,ALL,"ADULT, OLDER_ADULT",PHASE3,142,OTHER,INTERVENTIONAL,3/19/2021,3/29/2022
NCT05043350,COMPLETED,Covid19,DRUG: Loratadine|DRUG: Famotidine,Ain Shams University,Nasr City Insurance Hospital,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2|PHASE3,214,OTHER,INTERVENTIONAL,9/13/2021,7/30/2022
NCT05239975,WITHDRAWN,COVID-19|SARS-CoV2 Infection,BIOLOGICAL: SCTV01C|BIOLOGICAL: Comirnaty,Sinocelltech Ltd.,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,0,INDUSTRY,INTERVENTIONAL,4/25/2022,2/1/2023
NCT04639375,UNKNOWN,SARS-CoV-2,BIOLOGICAL: Vaccinated with polio vaccine (IPV),E-MO Biology Inc,,ALL,"ADULT, OLDER_ADULT",PHASE4,300,INDUSTRY,INTERVENTIONAL,11/15/2020,6/12/2022
NCT05276375,RECRUITING,COVID-19,DRUG: Bronchipret,Dr. Frank Behrens,Bionorica SE,ALL,"ADULT, OLDER_ADULT",PHASE2,30,OTHER,INTERVENTIONAL,1/14/2022,11/30/2022
NCT05096845,ACTIVE_NOT_RECRUITING,COVID-19 Pandemic,BIOLOGICAL: Recombinant SARS-CoV-2 fusion protein vaccine (V-01)|OTHER: Blank Preparation of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01),Livzon Pharmaceutical Group Inc.,,ALL,"ADULT, OLDER_ADULT",PHASE3,22500,INDUSTRY,INTERVENTIONAL,8/25/2021,6/14/2023
NCT04982068,ACTIVE_NOT_RECRUITING,COVID-19,BIOLOGICAL: 202-CoV low adjuvant dose|BIOLOGICAL: 202-CoV low antigen dose|BIOLOGICAL: 202-CoV standard dose|OTHER: Placebo,"Shanghai Zerun Biotechnology Co.,Ltd","Walvax Biotechnology Co., Ltd.",ALL,"ADULT, OLDER_ADULT",PHASE1,72,INDUSTRY,INTERVENTIONAL,7/12/2021,2023-06
NCT04640168,COMPLETED,COVID-19,DRUG: Baricitinib|DRUG: Dexamethasone|OTHER: Placebo|DRUG: Remdesivir,National Institute of Allergy and Infectious Diseases (NIAID),,ALL,"ADULT, OLDER_ADULT",PHASE3,1010,NIH,INTERVENTIONAL,12/2/2020,6/18/2021
NCT04828668,COMPLETED,Covid 19,DIETARY_SUPPLEMENT: Targeted Wellness Formula C™ Sublingual Drops - 1200mg - 30 mL (Formula C),"Endourage, LLC",,ALL,"ADULT, OLDER_ADULT",NA,32,INDUSTRY,INTERVENTIONAL,4/2/2021,2/14/2022
NCT05074368,COMPLETED,Healthy Adult Volunteers,BIOLOGICAL: ChAdOx1-nCov-19 (Astra-Zeneca)|BIOLOGICAL: SARS-CoV-2 messenger RNA-1273 (Moderna) vaccine,National Taiwan University Hospital,"Taoyuan General Hospital, Ministry of Health and Welfare,Taoyuan,Taiwan",ALL,"ADULT, OLDER_ADULT",NA,499,OTHER,INTERVENTIONAL,7/6/2021,5/18/2022
NCT05745545,RECRUITING,SARS-CoV-2,BIOLOGICAL: SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine|DRUG: Saline solution,"AIM Vaccine Co., Ltd.","First Affiliated Hospital Bengbu Medical College|Ningbo Rongan Biological Pharmaceutical Co., Ltd.",ALL,"ADULT, OLDER_ADULT",NA,3200,INDUSTRY,INTERVENTIONAL,1/4/2023,2023-11
NCT04844268,RECRUITING,SARS-CoV-2,BIOLOGICAL: Cohort 1 VACCINE RNA MCTI CIMATEC HDT (HDT-301) vaccine|BIOLOGICAL: Cohort 2 RNA VACCINE MCTI CIMATEC HDT(HDT-301) vaccine|BIOLOGICAL: Cohort 3 VACCINE RNA MCTI CIMATEC HDT(HDT-301) vaccine|BIOLOGICAL: Placebo,SENAI CIMATEC,,ALL,ADULT,PHASE1,90,OTHER,INTERVENTIONAL,1/13/2022,2022-10
NCT04359615,UNKNOWN,COVID-19,DRUG: Favipiravir|DRUG: Hydroxychloroquine,Shahid Beheshti University of Medical Sciences,,ALL,"ADULT, OLDER_ADULT",PHASE4,40,OTHER,INTERVENTIONAL,4/20/2020,5/5/2020
NCT05463068,COMPLETED,COVID-19|SARS-CoV-2 Infection,DRUG: NVX-Cov2373,Novavax,,ALL,ADULT,PHASE3,911,INDUSTRY,INTERVENTIONAL,7/11/2022,9/1/2022
NCT04413968,COMPLETED,Coronavirus|Coronavirus Infection|Covid19|Sars-CoV2,DIAGNOSTIC_TEST: Rapid detection test|DIAGNOSTIC_TEST: Nasopharyngeal swab|DIAGNOSTIC_TEST: Stool collection,Assistance Publique - Hôpitaux de Paris,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,600,OTHER,INTERVENTIONAL,6/2/2020,10/2/2020
NCT04699916,COMPLETED,Sedation Complication|Covid19,OTHER: EEG based protocol for deep sedation,University of Chile,,ALL,"ADULT, OLDER_ADULT",NA,50,OTHER,INTERVENTIONAL,1/4/2021,9/23/2021
NCT04386850,UNKNOWN,COVID 19,DRUG: Oral 25-Hydroxyvitamin D3,Tehran University of Medical Sciences,Boston University,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,1500,OTHER,INTERVENTIONAL,4/14/2020,3/15/2021
NCT04969250,COMPLETED,Covid19,BIOLOGICAL: Moderna mRNA-1273 COVID-19 vaccine|BIOLOGICAL: Pfizer BNT162b2 COVID-19 vaccine,International Network for Strategic Initiatives in Global HIV Trials (INSIGHT),"University of Minnesota|National Institute of Allergy and Infectious Diseases (NIAID)|University of Copenhagen|Kirby Institute|Washington D.C. Veterans Affairs Medical Center|AIDS Clinical Trials Group|National Heart, Lung, and Blood Institute (NHLBI)|US Department of Veterans Affairs|Prevention and Early Treatment of Acute Lung Injury|Cardiothoracic Surgical Trials Network|Medical Research Council",ALL,"ADULT, OLDER_ADULT",PHASE4,66,NETWORK,INTERVENTIONAL,8/25/2021,12/21/2022
NCT04483375,COMPLETED,Coronavirus Disease 2019(COVID-19),BIOLOGICAL: SCTA01|OTHER: Placebo,Sinocelltech Ltd.,,ALL,"ADULT, OLDER_ADULT",PHASE1,33,INDUSTRY,INTERVENTIONAL,7/24/2020,11/17/2020
NCT04508075,COMPLETED,SARS-CoV2 Infection,BIOLOGICAL: SARS-CoV-2 vaccine (inactivated)|BIOLOGICAL: Placebo,PT Bio Farma,"Faculty of Medicine Universitas Padjadjaran|National Intitute of Health Research and Development, Ministry of Health Republic of Indonesia|Sinovac Life Sciences Co., Ltd.",ALL,ADULT,PHASE3,1620,INDUSTRY,INTERVENTIONAL,8/10/2020,8/31/2021
NCT04326075,COMPLETED,CPAP Ventilation|COVID-19|Emergency Departments,DEVICE: CPAP treatment,Mario Negri Institute for Pharmacological Research,,ALL,"ADULT, OLDER_ADULT",NA,68,OTHER,INTERVENTIONAL,12/1/2020,12/15/2022
NCT04511650,TERMINATED,COVID-19|Acute Respiratory Distress Syndrome (ARDS),DRUG: Razuprotafib Subcutaneous Solution|DRUG: Placebo Subcutaneous Solution,"EyePoint Pharmaceuticals, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE2,31,INDUSTRY,INTERVENTIONAL,10/21/2020,2/26/2021
NCT04542850,COMPLETED,SARS-CoV 2|COVID-19,DIETARY_SUPPLEMENT: 5-ALA-Phosphate + SFC (5-ALA + SFC),Royal College of Surgeons in Ireland - Medical University of Bahrain,Bahrain Defence Force Hospital|Salmaniya Medical Complex,ALL,"ADULT, OLDER_ADULT",NA,15,OTHER,INTERVENTIONAL,11/15/2020,10/28/2021
NCT04913675,COMPLETED,Covid19,BIOLOGICAL: sotrovimab|BIOLOGICAL: sotrovimab|BIOLOGICAL: sotrovimab|BIOLOGICAL: sotrovimab|BIOLOGICAL: Sotrovimab|BIOLOGICAL: Sotrovimab|BIOLOGICAL: Sotrovimab,"Vir Biotechnology, Inc.",GlaxoSmithKline,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,1065,INDUSTRY,INTERVENTIONAL,6/10/2021,3/24/2023
NCT04847050,COMPLETED,Solid Tumor Malignancy|Hematologic Malignancy|Leukemia|Lymphoma|Multiple Myeloma,BIOLOGICAL: mRNA-1273,National Cancer Institute (NCI),,ALL,"ADULT, OLDER_ADULT",PHASE2,19,NIH,INTERVENTIONAL,4/28/2021,5/25/2023
NCT05175950,ACTIVE_NOT_RECRUITING,COVID-19 (Healthy Volunteers),BIOLOGICAL: SARS-CoV-2 Recombinant Protein Nanoparticle Vaccine (GBP510) (RBD of SARS-CoV-2 25ug / dose) Adjuvanted with AS03|OTHER: Normal saline,Korea University Guro Hospital,Korean Center for Disease Control and Prevention,ALL,"ADULT, OLDER_ADULT",PHASE2,770,OTHER,INTERVENTIONAL,1/24/2022,2023-11
NCT04389450,TERMINATED,COVID|ARDS,BIOLOGICAL: PLX-PAD|BIOLOGICAL: Placebo,Pluristem Ltd.,,ALL,"ADULT, OLDER_ADULT",PHASE2,66,INDUSTRY,INTERVENTIONAL,10/1/2020,6/7/2023
NCT04392115,UNKNOWN,Comorbidities and Coexisting Conditions|Social Isolation,BEHAVIORAL: The PREPARE program,Ottawa Hospital Research Institute,,ALL,OLDER_ADULT,NA,372,OTHER,INTERVENTIONAL,6/15/2020,9/15/2021
NCT04581915,TERMINATED,Covid19,DRUG: Triazavirin (Riamilovir)|OTHER: Placebo,Wits Health Consortium (Pty) Ltd,PharmaCentrix (Pty) Ltd|Perinatal HIV Research Unit of the University of the Witswatersrand,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,74,OTHER,INTERVENTIONAL,9/8/2020,4/20/2021
NCT04346615,TERMINATED,COVID-19 Infection,DRUG: Zavegepant (BHV-3500)|DRUG: Placebo,Pfizer,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,44,INDUSTRY,INTERVENTIONAL,4/25/2020,4/29/2022
NCT05238415,COMPLETED,Long-COVID|Post-COVID|Psychosomatic Disorder|Psychological Distress|Psychological Disease|Psychological Disorder|Psychological Impairment|Psychological Adjustment|Physiological Disease|Physiological Disorder|Physiological Impairment|Physiological Adjustment|Healthy Lifestyle,DIAGNOSTIC_TEST: Psychological and Physiological Assessments,Prof. Dr. Sonia Lippke,Dr. Becker Hospital Group|Dr. Becker Kiliani Clinic|Dr. Becker Clinic Möhnesee|Johannesbad Reha Clinics Bad Füssing|Reha-Centre Bad Kötzting,ALL,ADULT,NA,192,OTHER,INTERVENTIONAL,12/15/2021,6/30/2023
NCT05441215,RECRUITING,Healthy Participants,DRUG: nirmatrelvir|DRUG: ritonavir,Pfizer,,FEMALE,ADULT,PHASE1,8,INDUSTRY,INTERVENTIONAL,12/12/2022,12/15/2023
NCT05858515,NOT_YET_RECRUITING,Post-Acute COVID-19 Syndrome,DRUG: Baricitinib 4 MG|DRUG: Placebo,Vanderbilt University Medical Center,"Emory University|University of California, San Francisco|University of Minnesota|Vanderbilt University|Yale University",ALL,"ADULT, OLDER_ADULT",PHASE3,550,OTHER,INTERVENTIONAL,3/4/2024,12/30/2029
NCT05539950,NOT_YET_RECRUITING,Post Acute COVID-19 Syndrome,OTHER: Cardiopulmonary rehabilitation|OTHER: Health education,Taipei Medical University Shuang Ho Hospital,,ALL,"ADULT, OLDER_ADULT",NA,40,OTHER,INTERVENTIONAL,10/1/2022,12/31/2024
NCT04275245,COMPLETED,Coronavirus Disease 2019 (COVID-19),DRUG: Meplazumab for Injection,Tang-Du Hospital,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,17,OTHER,INTERVENTIONAL,2/3/2020,3/9/2020
NCT03331445,TERMINATED,Respiratory Tract Infections|Corona Virus Infection,DRUG: Nitric Oxide 0.5 % / Nitrogen 99.5 % Gas for Inhalation,Chris Miller,Mallinckrodt,ALL,"ADULT, OLDER_ADULT",PHASE2,13,INDUSTRY,INTERVENTIONAL,10/24/2017,6/30/2021
NCT04412668,COMPLETED,SARS-CoV-2 (COVID-19) Severe Pneumonia,DRUG: Efzofitimod 1 mg/kg|DRUG: Efzofitimod 3 mg/kg|DRUG: Placebo,"aTyr Pharma, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE2,36,INDUSTRY,INTERVENTIONAL,6/4/2020,10/23/2020
NCT04607915,COMPLETED,Type 2 Diabetes,BEHAVIORAL: Intervention for TECC Model,Centre for Addiction and Mental Health,,ALL,"ADULT, OLDER_ADULT",NA,31,OTHER,INTERVENTIONAL,5/4/2021,6/30/2022
NCT04899245,COMPLETED,Children With Medical Complexity (CMC)|COVID-19,DIAGNOSTIC_TEST: BinaxNOW Rapid Antigen System,"University of Wisconsin, Madison",Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD),ALL,"ADULT, OLDER_ADULT",NA,71,OTHER,INTERVENTIONAL,5/4/2021,9/1/2023
NCT05087368,UNKNOWN,Covid19,BIOLOGICAL: ChAdOx1-S COVID-19 Vaccine(Fiocruz/Oxford-AstraZeneca)|BIOLOGICAL: CoronaVac (Sinovac Biotech)|BIOLOGICAL: Adjuvanted Recombinant SARS-CoV-2 TrimericS-protein Subunit Vaccine (SCB-2019 - Clover),D'Or Institute for Research and Education,Bill and Melinda Gates Foundation|Instituto Fernandes Figueira,ALL,"ADULT, OLDER_ADULT",PHASE2,520,OTHER,INTERVENTIONAL,12/1/2021,4/1/2022
NCT04649515,TERMINATED,Coronavirus Disease-2019 (COVID-19),BIOLOGICAL: TY027|BIOLOGICAL: TY027|OTHER: 0.9% saline,Tychan Pte Ltd.,,ALL,"ADULT, OLDER_ADULT",PHASE3,17,INDUSTRY,INTERVENTIONAL,12/4/2020,3/4/2022
NCT04952350,UNKNOWN,Covid19|SARS-CoV2 Infection|COVID-19 Pneumonia,DRUG: Atorvastatin 40 Mg Oral Tablet|OTHER: Placebo,Mansoura University,,ALL,"ADULT, OLDER_ADULT",PHASE3,220,OTHER,INTERVENTIONAL,8/14/2021,2022-04
NCT05204550,RECRUITING,COVID-19,DRUG: unfractionated heparin|DRUG: 0.9%sodium chloride,Murdoch Childrens Research Institute,"University of Melbourne|Northern Hospital, Australia|Monash University|The Peter Doherty Institute for Infection and Immunity|St Vincent's Hospital Melbourne",ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2|PHASE3,1100,OTHER,INTERVENTIONAL,1/30/2023,6/1/2026
NCT04884750,RECRUITING,Pandemics,BEHAVIORAL: ECA-ACE Vaccination Promotion Intervention,Northeastern University,Boston University|Boston Medical Center|Georgia Institute of Technology,ALL,"ADULT, OLDER_ADULT",NA,600,OTHER,INTERVENTIONAL,12/12/2022,12/1/2025
NCT04364815,WITHDRAWN,COVID-19,DRUG: Hydroxychloroquine plus standard preventive measures|DRUG: Placebo plus standard preventive measures,University of the Philippines,,ALL,ADULT,PHASE3,0,OTHER,INTERVENTIONAL,2020-12,2021-05
NCT04370015,UNKNOWN,SARS-CoV-2|Healthcare Workers,DRUG: Hydroxychloroquine|DRUG: Placebo oral tablet,"Services Institute of Medical Sciences, Pakistan",,ALL,ADULT,NA,374,OTHER_GOV,INTERVENTIONAL,5/15/2020,10/15/2020
NCT04377750,UNKNOWN,Covid19 Pneumonia,DRUG: Tocilizumab,Hadassah Medical Organization,Sheba Medical Center|Wolfson Medical Center,ALL,"ADULT, OLDER_ADULT",PHASE4,500,OTHER,INTERVENTIONAL,4/8/2020,5/8/2021
NCT05624450,RECRUITING,Viral Lung Infection and Acute Respiratory Failure,DRUG: Tozorakimab|DRUG: Placebo,AstraZeneca,,ALL,"ADULT, OLDER_ADULT",PHASE3,2902,INDUSTRY,INTERVENTIONAL,12/13/2022,3/17/2025
NCT04684550,WITHDRAWN,SARS-CoV Infection|Covid19|Infection Viral,DRUG: Stabilized hypochlorous acid|DRUG: Placebo,Hospital Universitario San Ignacio,Pontificia Universidad Javeriana,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,0,OTHER,INTERVENTIONAL,2/15/2021,8/15/2021
NCT06147050,NOT_YET_RECRUITING,Long COVID,DRUG: Metformin|OTHER: Placebo,"Trust for Vaccines and Immunization, Pakistan",,ALL,"CHILD, ADULT",PHASE3,16,OTHER,INTERVENTIONAL,2024-01,2024-12
NCT05289115,RECRUITING,Coronavirus|COVID-19 Respiratory Infection,DEVICE: Experimental group/ Active HD-tDCS|DEVICE: Control Group / Sham Group,Federal University of Paraíba,,ALL,"ADULT, OLDER_ADULT",NA,30,OTHER,INTERVENTIONAL,9/14/2021,7/14/2022
NCT05182515,UNKNOWN,COVID-19,DRUG: Therapeutic plasma exchange,Centre Hospitalier St Anne,,ALL,"ADULT, OLDER_ADULT",PHASE3,50,OTHER,INTERVENTIONAL,12/22/2021,3/22/2022
NCT04591015,COMPLETED,"Diabetes Mellitus, Type 2|Covid19",BEHAVIORAL: Hospital: DD-CA|BEHAVIORAL: Hospital: Usual Care (UC),Scripps Whittier Diabetes Institute,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),ALL,"ADULT, OLDER_ADULT",PHASE3,172,OTHER,INTERVENTIONAL,2/1/2021,8/31/2022
NCT04935515,COMPLETED,COVID -19,"DRUG: Oral Antibiotic, Antihistamine, Anti-inflammatory, Multivitamins|DRUG: Oral low dose steroid|DRUG: Intravenous Antibiotics with Low dose steroid.|DRUG: Oral anti-coagulant","Manimarane Arjunan, MD,DM (Cardiology)",UR Anoop Research Group,ALL,"ADULT, OLDER_ADULT",NA,25,OTHER,INTERVENTIONAL,4/15/2021,6/6/2021
NCT05027815,TERMINATED,Acute Respiratory Distress Syndrome Due to Disease Caused by 2019-nCoV,BIOLOGICAL: Cryopreserved Ex Vivo Expanded Polyclonal CD4+CD127lo/-CD25+ T Regulatory Cells,Jeffrey Bluestone,National Institute of Allergy and Infectious Diseases (NIAID)|Immune Tolerance Network (ITN),ALL,"ADULT, OLDER_ADULT",PHASE1,7,OTHER,INTERVENTIONAL,9/23/2021,3/2/2022
NCT04871815,COMPLETED,Long COVID,DRUG: sodium pyruvate nasal spray,"Cellular Sciences, inc.",Missouri State University|Dynamic DNA Labs|Trinity Health Care|Family First Medical Research Center,ALL,ADULT,PHASE2|PHASE3,22,INDUSTRY,INTERVENTIONAL,4/27/2021,3/7/2022
NCT04425915,COMPLETED,COVID,BIOLOGICAL: Convalescent Plasma|OTHER: Standard of Care,"Institute of Liver and Biliary Sciences, India",,ALL,"ADULT, OLDER_ADULT",PHASE3,400,OTHER,INTERVENTIONAL,6/14/2020,12/15/2020
NCT04516915,COMPLETED,Covid 19,DRUG: IMU-838|DRUG: Oseltamivir,University Hospitals Coventry and Warwickshire NHS Trust,Immunic AG|University of Warwick|MODEPHARMA,ALL,"ADULT, OLDER_ADULT",PHASE2,38,OTHER,INTERVENTIONAL,6/15/2020,9/21/2022
NCT05226390,TERMINATED,COVID-19 Vaccines,BIOLOGICAL: MVA-SARS-2-ST,Hannover Medical School,German Center for Infection Research|IDT Biologika|Universitätsklinikum Hamburg-Eppendorf,ALL,ADULT,PHASE1,23,OTHER,INTERVENTIONAL,2/24/2022,11/21/2023
NCT05217797,COMPLETED,COVID-19|Respiratory Tract Infections,BEHAVIORAL: Wearing glasses (any type),Norwegian Institute of Public Health,University of Basel,ALL,"ADULT, OLDER_ADULT",NA,3717,OTHER_GOV,INTERVENTIONAL,2/2/2021,12/1/2022
NCT04397497,UNKNOWN,"Covid-19|Acute Respiratory Failure|ARDS, Human|Sars-CoV2|Viral Pneumonia",DRUG: Mavrilimumab|DRUG: Placebo,Ospedale San Raffaele,,ALL,"ADULT, OLDER_ADULT",PHASE2,50,OTHER,INTERVENTIONAL,5/22/2020,11/22/2020
NCT04848467,WITHDRAWN,SARS-CoV-2 Infection|Coronavirus Disease 2019 (COVID-19),BIOLOGICAL: SARS-CoV-2 mRNA Vaccine (CVnCoV)|BIOLOGICAL: Quadrivalent influenza vaccine (QIV)|OTHER: Placebo,Bayer,CureVac,ALL,"ADULT, OLDER_ADULT",PHASE3,0,INDUSTRY,INTERVENTIONAL,10/1/2021,11/15/2022
NCT05855356,RECRUITING,Post-Acute COVID-19 Syndrome|Dysautonomia,PROCEDURE: Rehabilitation|PROCEDURE: Standard of Care,Evangelismos Hospital,National and Kapodistrian University of Athens|LONG COVID GREECE|414 Military Hospital of Special Diseases,ALL,"ADULT, OLDER_ADULT",NA,50,OTHER,INTERVENTIONAL,2/1/2023,3/27/2024
NCT06095297,NOT_YET_RECRUITING,Long COVID|Brain Fog|Cognitive Impairment|Cognitive Dysfunction|Post-Acute COVID-19 Syndrome,BEHAVIORAL: Speed of Processing Training|BEHAVIORAL: In-lab Instrumental Activities of Daily Living Training|BEHAVIORAL: In-lab Brain Health Training|BEHAVIORAL: Transfer Package|BEHAVIORAL: Follow Up Phone Calls|BEHAVIORAL: Vocational Rehabilitation|BEHAVIORAL: Peer Mentoring,University of Alabama at Birmingham,"National Institute on Disability, Independent Living, and Rehabilitation Research",ALL,"ADULT, OLDER_ADULT",NA,40,OTHER,INTERVENTIONAL,2024-02,2027-02
NCT04860297,COMPLETED,SARS-CoV-2,BIOLOGICAL: mRNA-1273,"ModernaTX, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE3,234,INDUSTRY,INTERVENTIONAL,4/16/2021,5/22/2023
NCT06108297,NOT_YET_RECRUITING,Long COVID,DIETARY_SUPPLEMENT: Lithium,State University of New York at Buffalo,,ALL,"ADULT, OLDER_ADULT",PHASE1,40,OTHER,INTERVENTIONAL,2023-11,2024-07
NCT05419167,ACTIVE_NOT_RECRUITING,Psychological|Mental Health Issue|Prenatal Stress|Maternal Distress|COVID-19 Pandemic,BEHAVIORAL: STEP-COVID,Université du Québec à Trois-Rivières,Public Health Agency of Canada (PHAC)|Canada Research Chairs Endowment of the Federal Government of Canada,FEMALE,"ADULT, OLDER_ADULT",PHASE1,100,OTHER,INTERVENTIONAL,9/1/2020,12/10/2022
NCT04542967,COMPLETED,Severe COVID-19 Disease,BIOLOGICAL: Biological,Hospital Central Militar,,ALL,"ADULT, OLDER_ADULT",PHASE2,150,OTHER_GOV,INTERVENTIONAL,6/23/2020,9/30/2020
NCT04251767,WITHDRAWN,COVID-19 Complicated With Refractory Intestinal Infections,OTHER: washed microbiota transplantation|OTHER: placebo,The Second Hospital of Nanjing Medical University,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,0,OTHER,INTERVENTIONAL,2/5/2020,4/30/2020
NCT04375397,COMPLETED,CoronaVirus Induced Disease-2019 (COVID-19),DRUG: Ibrutinib|DRUG: Placebo,AbbVie,Janssen Research & Development LLC; Pharmacyclics LLC (An AbbVie Company),ALL,"ADULT, OLDER_ADULT",PHASE2,46,INDUSTRY,INTERVENTIONAL,6/6/2020,6/8/2021
NCT05960097,ACTIVE_NOT_RECRUITING,SARS-CoV-2,BIOLOGICAL: CV0701 Bivalent High dose|BIOLOGICAL: CV0701 Bivalent Medium dose|BIOLOGICAL: CV0701 Bivalent Low dose|BIOLOGICAL: CV0601 Monovalent High dose|BIOLOGICAL: Control vaccine|BIOLOGICAL: CV0801 Monovalent,GlaxoSmithKline,CureVac,ALL,"ADULT, OLDER_ADULT",PHASE2,664,INDUSTRY,INTERVENTIONAL,8/1/2023,9/5/2024
NCT04324190,UNKNOWN,COVID-19|Psychosocial Stress|Mental Health,BEHAVIORAL: Guided online support program|BEHAVIORAL: WHO recommendations (waiting condition),Gunther Meinlschmidt,Selfapy GmbH,ALL,"ADULT, OLDER_ADULT",NA,600,OTHER,INTERVENTIONAL,4/8/2020,2021-12
NCT04330690,ACTIVE_NOT_RECRUITING,COVID-19,DRUG: Artesunate|DRUG: Imatinib|DRUG: Infliximab|DRUG: Dexamethasone|DRUG: LSALT Peptide,Sunnybrook Health Sciences Centre,AbbVie|Apotex Inc.|World Health Organization|University of British Columbia|Arch Biopartners Inc.,ALL,"ADULT, OLDER_ADULT",PHASE3,2900,OTHER,INTERVENTIONAL,3/18/2020,5/18/2024
NCT04396067,UNKNOWN,COVID-19,DRUG: Aerosolized 13 cis retinoic acid|DRUG: Aerosolized All trans retinoic acid|OTHER: Placebo,Kafrelsheikh University,Damietta University,ALL,"ADULT, OLDER_ADULT",PHASE2,360,OTHER,INTERVENTIONAL,2020-10,2020-12
NCT04500067,COMPLETED,Covid19|Pneumonia,DRUG: IVIG,Biopharma Plasma LLC,Lviv National Medical University|Vinnitsa National Medical University,ALL,"ADULT, OLDER_ADULT",PHASE3,76,INDUSTRY,INTERVENTIONAL,5/7/2020,9/15/2020
NCT04348656,TERMINATED,COVID-19,BIOLOGICAL: Convalescent plasma,Hamilton Health Sciences Corporation,Canadian Blood Services|Héma-Québec|University of Toronto|Université de Montréal|Weill Medical College of Cornell University|New York Blood Center,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,940,OTHER,INTERVENTIONAL,3/14/2020,6/16/2021
NCT05220397,ACTIVE_NOT_RECRUITING,Kidney Transplant Recipient,BIOLOGICAL: Janssen Ad26.CoV2.S Vaccine|OTHER: Reduction in Immunosuppression Medication|OTHER: Maintenance in Immunosuppression Medication,Mark Stegall,"Janssen Scientific Affairs, LLC",ALL,"ADULT, OLDER_ADULT",PHASE3,1200,OTHER,INTERVENTIONAL,4/11/2022,2025-03
NCT05897190,COMPLETED,SARS-CoV-2,BIOLOGICAL: SARS-CoV-2 mRNA vaccine (RBMRNA-405)|BIOLOGICAL: CoronaVac®,"Argorna Pharmaceuticals Co., LTD",,ALL,"ADULT, OLDER_ADULT",PHASE1,60,INDUSTRY,INTERVENTIONAL,5/16/2022,5/12/2023
NCT05231590,COMPLETED,COVID-19,BIOLOGICAL: Low-dose SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant|BIOLOGICAL: SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant,Cinnagen,Vaxine Pty Ltd,ALL,"CHILD, ADULT",PHASE3,581,INDUSTRY,INTERVENTIONAL,2/23/2022,9/30/2022
NCT05797597,RECRUITING,AERD - Aspirin Exacerbated Respiratory Disease,DRUG: Aspirin 300 Mg Oral Tablet|DRUG: Placebo,Lucyna Mastalerz,,ALL,"ADULT, OLDER_ADULT",PHASE3,76,OTHER,INTERVENTIONAL,12/7/2022,2/28/2025
NCT05501067,RECRUITING,Post Covid,OTHER: tai chi exercise|OTHER: no intervention,Beni-Suef University,,ALL,"ADULT, OLDER_ADULT",NA,60,OTHER,INTERVENTIONAL,11/10/2022,12/28/2023
NCT04346667,TERMINATED,SARS-CoV-2|Coronavirus Infection|Asymptomatic Condition|COVID-19,DRUG: Hydroxychloroquine Sulfate Regular dose|DRUG: Hydroxychloroquine Sulfate Loading Dose|DRUG: Chloroquine|DRUG: Placebo,"Government of Punjab, Specialized Healthcare and Medical Education Department","Mayo Hospital Lahore|Services Institute of Medical Sciences, Pakistan|Pakistan Kidney and Liver Institute|Forman Christian College, Pakistan|Harvard School of Public Health (HSPH)",ALL,ADULT,PHASE4,125,OTHER_GOV,INTERVENTIONAL,4/14/2020,8/30/2020
NCT05648097,RECRUITING,COVID-19,DEVICE: Baldachin,"Insel Gruppe AG, University Hospital Bern",,ALL,"ADULT, OLDER_ADULT",NA,104,OTHER,INTERVENTIONAL,9/13/2023,11/30/2024
NCT05543590,WITHDRAWN,Long-Haul COVID-19,DRUG: Plasmapheresis|OTHER: Blood collection|OTHER: Stool samples|OTHER: PET scan|OTHER: Cycle ergometer stress test|OTHER: Questionnaires at baseline|OTHER: Medical consultations,Hôpital Européen Marseille,,ALL,"ADULT, OLDER_ADULT",NA,0,OTHER,INTERVENTIONAL,2023-02,2025-10
NCT04536090,UNKNOWN,COVID-19,DRUG: Isoquercetin (IQC-950AN),Institut de Recherches Cliniques de Montreal,"Pharmascience Inc.|SCiAN Services, Inc.|Quercis Pharma AG",ALL,"ADULT, OLDER_ADULT",PHASE2,150,OTHER,INTERVENTIONAL,2022-01,2023-06
NCT05886790,RECRUITING,COVID-19,BIOLOGICAL: Prototype and Omicron BA.4/5 Bivalent Recombinant COVID-19 Vaccine(Adenovirus Type 5 Vector) For Inhalation|BIOLOGICAL: Bivalent COVID-19 mRNA Vaccine|BIOLOGICAL: Recombinant COVID-19 Vaccine (Adenovirus Type 5 Vector) For Inhalation,Zhongnan Hospital,"Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China",ALL,"ADULT, OLDER_ADULT",NA,450,OTHER,INTERVENTIONAL,5/30/2023,5/29/2024
NCT04407390,WITHDRAWN,COVID,DIETARY_SUPPLEMENT: Nicotinamide riboside|DIETARY_SUPPLEMENT: Placebo,University of Copenhagen,Bispebjerg Hospital|Elysium Health,ALL,OLDER_ADULT,PHASE2,0,OTHER,INTERVENTIONAL,6/1/2020,5/1/2022
NCT05299333,RECRUITING,COVID-19|Pulmonary Fibrosis,OTHER: Exercise,Istanbul University - Cerrahpasa (IUC),,ALL,"ADULT, OLDER_ADULT",NA,30,OTHER,INTERVENTIONAL,9/4/2022,6/7/2024
NCT05181683,COMPLETED,Healthy|Chronic Stable Illness,DRUG: Casirivimab+Imdevimab,Regeneron Pharmaceuticals,,ALL,"ADULT, OLDER_ADULT",PHASE1,45,INDUSTRY,INTERVENTIONAL,1/7/2022,6/3/2022
NCT04402983,COMPLETED,Covid19|Telerehabilitation|Physical Therapy,OTHER: Physiotherapy,Istanbul Medipol University Hospital,,ALL,"ADULT, OLDER_ADULT",NA,34,OTHER,INTERVENTIONAL,5/27/2020,12/1/2020
NCT04941183,TERMINATED,Covid19,DRUG: NTR-441|DRUG: Placebo,Neutrolis,,ALL,"ADULT, OLDER_ADULT",PHASE1,52,INDUSTRY,INTERVENTIONAL,4/14/2021,6/6/2023
NCT05067933,COMPLETED,COVID-19,DRUG: VXA-CoV2-1.1-S|OTHER: Placebo Tablets,Vaxart,,ALL,"ADULT, OLDER_ADULT",PHASE2,66,INDUSTRY,INTERVENTIONAL,10/1/2021,8/1/2023
NCT04880161,COMPLETED,Covid19,BIOLOGICAL: Ampion|OTHER: Placebo,Ampio Pharmaceuticals. Inc.,,ALL,"ADULT, OLDER_ADULT",PHASE1,32,INDUSTRY,INTERVENTIONAL,7/26/2021,2/21/2022
NCT05541861,ACTIVE_NOT_RECRUITING,SARS-CoV-2 Infection|COVID-19,BIOLOGICAL: BNT162b2 Bivalent (original/Omicron BA.4/BA.5) 30 µg|BIOLOGICAL: BNT162b4 5 µg|BIOLOGICAL: BNT162b4 10 µg|BIOLOGICAL: BNT162b4 15 µg|BIOLOGICAL: BNT162b4 30 µg|BIOLOGICAL: BNT162b2 Monovalent (OMI XBB.1.5) 30 µg,BioNTech SE,Pfizer,ALL,"ADULT, OLDER_ADULT",PHASE1,360,INDUSTRY,INTERVENTIONAL,11/8/2022,2024-10
NCT05602961,WITHDRAWN,COVID-19,DRUG: GLB-COV2-043|DRUG: BNT162b2/COMIRNATY®,"GreenLight Biosciences, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,0,INDUSTRY,INTERVENTIONAL,2/21/2023,2024-09
NCT04864561,COMPLETED,SARS-CoV-2 Virus Infection,BIOLOGICAL: VLA2001|BIOLOGICAL: AZD1222|BIOLOGICAL: VLA2001 - adolescent part|BIOLOGICAL: Placebo,Valneva Austria GmbH,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,4034,INDUSTRY,INTERVENTIONAL,4/26/2021,3/13/2023
NCT04373161,COMPLETED,Sars-CoV2|COVID-19|COVID,DEVICE: Home Pulse Oximetry Monitoring,Swedish Hospital,,ALL,"ADULT, OLDER_ADULT",NA,209,OTHER,INTERVENTIONAL,3/20/2020,4/22/2020
NCT05669261,NOT_YET_RECRUITING,Long COVID,PROCEDURE: Adipose Tissue Harvest|BIOLOGICAL: ATCell,American CryoStem Corporation,,ALL,"ADULT, OLDER_ADULT",PHASE1,20,INDUSTRY,INTERVENTIONAL,8/1/2023,2/1/2024
NCT04590261,NOT_YET_RECRUITING,Covid-19; SARS-Cov2,OTHER: Blood sampling|OTHER: Nasal Brushing,Assistance Publique - Hôpitaux de Paris,"Institut National de la Santé Et de la Recherche Médicale, France",ALL,"ADULT, OLDER_ADULT",NA,120,OTHER,INTERVENTIONAL,2022-12,2025-12
NCT04391829,UNKNOWN,COVID-19|Sars-CoV2|Corona Virus Infection|Semen,DIAGNOSTIC_TEST: Ejaculated semen sample,Universitair Ziekenhuis Brussel,,MALE,ADULT,NA,20,OTHER,INTERVENTIONAL,8/31/2020,8/31/2021
NCT04806529,WITHDRAWN,Influenza,DRUG: Adjuvanted SARS-CoV-2 Subunit vaccine (aCoV2)|DRUG: Comparator,Seqirus,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,0,INDUSTRY,INTERVENTIONAL,12/15/2020,4/9/2022
NCT04425629,TERMINATED,COVID-19,DRUG: casirivimab+imdevimab combination therapy,Regeneron Pharmaceuticals,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,10078,INDUSTRY,INTERVENTIONAL,6/16/2020,6/9/2022
NCT06042777,NOT_YET_RECRUITING,Long Covid19,BEHAVIORAL: Acupuncture and TCM-based lifestyle management,The Hong Kong Polytechnic University,,ALL,"ADULT, OLDER_ADULT",NA,100,OTHER,INTERVENTIONAL,9/30/2023,8/31/2024
NCT04345861,TERMINATED,"Coronavirus Infection|Pneumonia, Viral",DRUG: Hydroxychloroquine + placebo|DRUG: hydroxychloroquine + azithromycin,"University Hospital, Montpellier",,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,7,OTHER,INTERVENTIONAL,4/11/2020,4/9/2021
NCT05024461,UNKNOWN,Covid19,DIAGNOSTIC_TEST: Salivary test for COVID19,Centre Hospitalier de Cayenne,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,1159,OTHER,INTERVENTIONAL,8/10/2020,11/12/2021
NCT04348461,SUSPENDED,COVID|Respiratory Distress Syndrome,DRUG: Allogeneic and expanded adipose tissue-derived mesenchymal stromal cells,Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz,"Instituto de Investigación Sanitaria y Biomédica de Alicante|Hospital General Universitario Gregorio Marañon|Clinica Universidad de Navarra, Universidad de Navarra|University of Salamanca|Hospital General Universitario de Alicante|Hospital Clínico Universitario Virgen de la Arrixaca",ALL,"ADULT, OLDER_ADULT",PHASE2,100,OTHER,INTERVENTIONAL,5/6/2020,9/30/2021
NCT05371561,COMPLETED,COVID-19|Infections|COVID-19 Virus Infection,DEVICE: reusable respirators,Fayoum University,,ALL,CHILD,NA,52,OTHER,INTERVENTIONAL,4/1/2022,5/1/2022
NCT04390061,UNKNOWN,"Pneumonitis, Interstitial|COVID-19",DRUG: Tofacitinib|DRUG: Hydroxychloroquine,Università Politecnica delle Marche,"Azienda Ospedaliera Ospedali Riuniti Marche Nord|Ospedale Civile Santo Spirito, Pescara|Università Magna Grecia, Catanzaro|ASST Papa Giovanni XXIII, Bergamo|Azienda Ospedaliero Universitaria Policlinico Umberto I, Roma|ASST Cremona, Cremona|Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milano|Ospedale di Circolo e Fondazione Macchi, Varese",ALL,"ADULT, OLDER_ADULT",PHASE2,116,OTHER,INTERVENTIONAL,2020-06,2020-10
NCT05524532,RECRUITING,Post Acute COVID-19 Syndrome,DIETARY_SUPPLEMENT: Immulina TM|DIETARY_SUPPLEMENT: Placebo,University of Mississippi Medical Center,National Institute of General Medical Sciences (NIGMS),ALL,"ADULT, OLDER_ADULT",NA,120,OTHER,INTERVENTIONAL,7/20/2023,3/31/2025
NCT04335032,UNKNOWN,SARS-CoV-2,DRUG: Eicosapentaenoic acid gastro-resistant capsules|DRUG: Placebo,S.L.A. Pharma AG,,ALL,"ADULT, OLDER_ADULT",PHASE3,284,INDUSTRY,INTERVENTIONAL,1/8/2021,12/1/2021
NCT04441918,UNKNOWN,COVID-19; and High Infection Risk of SARS-CoV-2,COMBINATION_PRODUCT: JS016 (anti-SARS-CoV-2 monoclonal antibody),"Shanghai Junshi Bioscience Co., Ltd.",,ALL,"CHILD, ADULT",PHASE1,40,OTHER,INTERVENTIONAL,6/5/2020,12/11/2020
NCT05525832,COMPLETED,SARS-CoV2 Infection,OTHER: Normal saline,Larissa University Hospital,,ALL,"ADULT, OLDER_ADULT",NA,50,OTHER,INTERVENTIONAL,6/1/2021,10/1/2021
NCT05212532,UNKNOWN,COVID-19 Pneumonia|COVID-19 Respiratory Infection|COVID-19 Acute Respiratory Distress Syndrome,DRUG: EOM613,EOM Pharmaceuticals,,ALL,"ADULT, OLDER_ADULT",PHASE1,40,INDUSTRY,INTERVENTIONAL,8/9/2021,3/30/2022
NCT05077332,ACTIVE_NOT_RECRUITING,2019 Novel Coronavirus Disease|2019 Novel Coronavirus Infection|2019-nCoV Disease|2019-nCoV Infection|COVID-19 Pandemic|COVID-19 Virus Disease|COVID-19 Virus Infection|Covid19|Coronavirus Disease 2019|SARS-CoV-2 Infection|SARS-CoV-2 Acute Respiratory Disease|COVID-19,DRUG: Famotidine|DRUG: Celecoxib|OTHER: Placebo,Leidos Life Sciences,United States Department of Defense,ALL,"ADULT, OLDER_ADULT",PHASE2,2000,INDUSTRY,INTERVENTIONAL,12/29/2021,2025-01
NCT04414618,COMPLETED,Coronavirus Infections,DRUG: Opaganib|DRUG: Placebo,RedHill Biopharma Limited,,ALL,"ADULT, OLDER_ADULT",PHASE2,42,INDUSTRY,INTERVENTIONAL,7/2/2020,12/23/2020
NCT04394377,COMPLETED,Coronavirus Infection,DRUG: Group 1: Rivaroxaban 20mg/d followed by enoxaparin/unfractionated heparin when needed|DRUG: Group 2: control group with enoxaparin 40mg/d,Brazilian Clinical Research Institute,Hospital Israelita Albert Einstein|Hospital do Coracao|Hospital Sirio-Libanes|Hospital Moinhos de Vento|Hospital Alemão Oswaldo Cruz|Beneficência Portuguesa de São Paulo|Brazilian Research In Intensive Care Network,ALL,"ADULT, OLDER_ADULT",PHASE4,615,OTHER,INTERVENTIONAL,6/21/2020,5/30/2021
NCT04364594,COMPLETED,COVID 19|Pulmonary Disease,DIAGNOSTIC_TEST: conjunctival swab,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,,ALL,"ADULT, OLDER_ADULT",NA,50,OTHER,INTERVENTIONAL,3/26/2020,5/30/2020
NCT05677932,RECRUITING,Post COVID-19 Condition,DEVICE: Bright light therapy|DEVICE: Dim red light therapy,Chinese University of Hong Kong,,ALL,"ADULT, OLDER_ADULT",NA,36,OTHER,INTERVENTIONAL,2/15/2023,4/30/2024
NCT04445194,UNKNOWN,Coronavirus,BIOLOGICAL: Recombinant new coronavirus vaccine (CHO cell) low-dose group|BIOLOGICAL: Recombinant new coronavirus vaccine (CHO cells) high-dose group|BIOLOGICAL: Recombinant new coronavirus vaccine (CHO cells) placebo group,"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.",The Second Affiliated Hospital of Chongqing Medical University|Beijing Chao Yang Hospital,ALL,ADULT,PHASE1,50,INDUSTRY,INTERVENTIONAL,6/22/2020,9/20/2021
NCT04743232,SUSPENDED,Covid19|Cardiac Arrest,OTHER: Decision tool for clinicians,Erasmus Medical Center,,ALL,"ADULT, OLDER_ADULT",NA,200,OTHER,INTERVENTIONAL,3/1/2021,1/31/2025
NCT05931432,RECRUITING,"Depression, Anxiety|Satisfaction|Well-being",OTHER: Comprehensive Well-Being Intervention,University of Pennsylvania,Pennsylvania Department of Health,ALL,"ADULT, OLDER_ADULT",NA,300,OTHER,INTERVENTIONAL,10/12/2023,3/1/2026
NCT05864118,RECRUITING,Respiratory Tract Infections,DIAGNOSTIC_TEST: Respiratory pathogen panel PCR test|DIAGNOSTIC_TEST: COVID-19 antibody test,University of Nebraska,,ALL,"ADULT, OLDER_ADULT",NA,1000,OTHER,INTERVENTIONAL,8/21/2023,2024-12
NCT06020118,ACTIVE_NOT_RECRUITING,Influenza|COVID-19,BIOLOGICAL: Simultaneous Vaccination (Influenza Vaccine and mRNA COVID booster)|BIOLOGICAL: Sequential Vaccination (Influenza vaccine then mRNA COVID booster)|BIOLOGICAL: Sequential Vaccination (mRNA COVID booster then Influenza vaccine),Duke University,Centers for Disease Control and Prevention|Arizona State University|University Hospitals Cleveland Medical Center|University of Pittsburgh|Washington University School of Medicine|Valleywise Health|VA Northeast Ohio Health Care|Senders Pediatrics,ALL,"CHILD, ADULT",PHASE4,800,OTHER,INTERVENTIONAL,9/25/2023,5/15/2024
NCT04563702,COMPLETED,Covid19,BIOLOGICAL: VXA-CoV2-1,Vaxart,,ALL,ADULT,PHASE1,35,INDUSTRY,INTERVENTIONAL,9/21/2020,10/10/2021
NCT05546502,RECRUITING,Vaccine Reaction|Vaccine Adverse Reaction,BIOLOGICAL: SARS-CoV-2 Protein Subunit Recombinant Vaccine|BIOLOGICAL: Active Comparator,PT Bio Farma,"Center for Child Health Universitas Gadjah Mada (CCH-PRO UGM|Cipto Mangunkusumo Hospital/Department of Child Health, Faculty of Medicine, University of Indonesia, Jakarta|Faculty of Medicine, Andalas University",ALL,CHILD,PHASE3,1050,INDUSTRY,INTERVENTIONAL,10/9/2022,1/31/2024
NCT04282902,UNKNOWN,Novel Coronavirus Pneumonia|Pneumonia|Pirfenidone,DRUG: pirfenidone,Huilan Zhang,,ALL,"ADULT, OLDER_ADULT",PHASE3,294,OTHER,INTERVENTIONAL,2/4/2020,6/1/2020
NCT05584202,RECRUITING,SARS-CoV-2,BIOLOGICAL: mRNA-1273.214|OTHER: Placebo,"ModernaTX, Inc.",,ALL,CHILD,PHASE2,700,INDUSTRY,INTERVENTIONAL,9/30/2022,3/8/2025
NCT04402918,COMPLETED,Sars-CoV2,DIAGNOSTIC_TEST: biological samples day of delivery,Centre Hospitalier Universitaire de Besancon,,FEMALE,"ADULT, OLDER_ADULT",NA,160,OTHER,INTERVENTIONAL,5/17/2020,8/2/2021
NCT04348513,TERMINATED,Pulmonary Infection|Covid-19,DRUG: T3 solution for injection|DRUG: Placebo,Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.,Attikon Hospital,ALL,"ADULT, OLDER_ADULT",PHASE2,5,INDUSTRY,INTERVENTIONAL,5/29/2020,4/19/2021
NCT04656613,UNKNOWN,Covid19|SARS-CoV Infection,BIOLOGICAL: Gam-COVID-Vac|OTHER: placebo,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation",PDC-CRO,ALL,"ADULT, OLDER_ADULT",PHASE3,1000,OTHER,INTERVENTIONAL,2020-12,2021-12
NCT04530370,UNKNOWN,Covid19,BIOLOGICAL: recovered covid 19 patients plasma,South Valley University,,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,30,OTHER,INTERVENTIONAL,5/29/2020,9/1/2020
NCT04551911,COMPLETED,Covid19|Coronavirus|SARS-CoV-2 Infection,DRUG: Rayaldee 30Mcg Extended-Release (ER) Capsule|DRUG: Placebo,"OPKO Health, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE2,171,INDUSTRY,INTERVENTIONAL,10/26/2020,10/8/2021
NCT05168813,ACTIVE_NOT_RECRUITING,SARS-CoV-2 Infection|HIV Infections|COVID-19,BIOLOGICAL: Moderna mRNA-1273|BIOLOGICAL: Vaccine 3 Dose|BIOLOGICAL: Vaccine 2 Dose,COVID-19 Prevention Network,"National Institute of Allergy and Infectious Diseases (NIAID)|Medical Research Council, South Africa",ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,14232,NETWORK,INTERVENTIONAL,12/1/2021,4/12/2024
NCT05228613,COMPLETED,COVID-19,BIOLOGICAL: SARS-CoV-2 protein subunit recombinant vaccine|BIOLOGICAL: SARS-CoV-2 inactivated vaccine,PT Bio Farma,"Fakultas Kedokteran Universitas Indonesia|Faculty of Medicine, Diponegoro University, Semarang",ALL,"ADULT, OLDER_ADULT",PHASE1,175,INDUSTRY,INTERVENTIONAL,2/16/2022,1/24/2023
NCT05731570,RECRUITING,Long Covid19,BEHAVIORAL: Cognitive rehabilitation,"University College, London",Bangor University|St George's University Hospitals NHS Foundation Trust|University of Brighton|University Hospital Southampton NHS Foundation Trust|Greater Manchester Mental Health NHS Foundation Trust,ALL,ADULT,NA,120,OTHER,INTERVENTIONAL,2/14/2023,2024-02
NCT05109611,ACTIVE_NOT_RECRUITING,SARS-CoV-2 Infection,DRUG: Nitric Oxide|DEVICE: Nasal spray with isotonic saline,Sanotize Research and Development corp.,,ALL,"ADULT, OLDER_ADULT",PHASE3,1389,INDUSTRY,INTERVENTIONAL,11/20/2021,4/30/2024
NCT04402970,COMPLETED,SARS-CoV 2|ARDS,DRUG: Dornase Alfa Inhalation Solution,University of Missouri-Columbia,,ALL,"ADULT, OLDER_ADULT",PHASE3,30,OTHER,INTERVENTIONAL,6/19/2020,12/31/2020
NCT04472611,COMPLETED,SARS-CoV-2,DRUG: Standard of Care (SOC) and Colchicine+Rosuvastatin,Yale University,,ALL,"ADULT, OLDER_ADULT",PHASE3,250,OTHER,INTERVENTIONAL,10/30/2020,3/30/2022
NCT04690413,COMPLETED,COVID-19|SARS-CoV-2|Coronavirus,DEVICE: NOWDx COVID-19 Test,"NOWDiagnostics, Inc.",,ALL,"ADULT, OLDER_ADULT",NA,129,INDUSTRY,INTERVENTIONAL,9/1/2020,12/31/2020
NCT04537299,ENROLLING_BY_INVITATION,Covid19|SARS-CoV Infection,DRUG: Fisetin|DRUG: Placebo,Mayo Clinic,National Institute on Aging (NIA),ALL,OLDER_ADULT,PHASE2,150,OTHER,INTERVENTIONAL,4/29/2022,11/30/2025
NCT05710770,RECRUITING,ME/CFS|Post-COVID ME/CFS,DEVICE: Immunoadsorption,"Charite University, Berlin, Germany",,ALL,"ADULT, OLDER_ADULT",NA,66,OTHER,INTERVENTIONAL,10/1/2023,2025-02
NCT04566770,COMPLETED,COVID-19,BIOLOGICAL: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)|BIOLOGICAL: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) -placebo,CanSino Biologics Inc.,Beijing Institute of Biotechnology|Jiangsu Province Centers for Disease Control and Prevention,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,480,INDUSTRY,INTERVENTIONAL,9/24/2020,1/19/2022
NCT04856111,ACTIVE_NOT_RECRUITING,Novel Coronavirus-induced Lung Fibrosis,DRUG: Pirfenidone|DRUG: Nintedanib,Postgraduate Institute of Medical Education and Research,,ALL,"ADULT, OLDER_ADULT",PHASE4,48,OTHER_GOV,INTERVENTIONAL,3/17/2021,11/30/2022
NCT05204511,COMPLETED,Long COVID-19|Post-COVID-19 Syndrome|COVID-19,OTHER: endurance training|OTHER: concurrent training,University of Vienna,,ALL,"ADULT, OLDER_ADULT",NA,66,OTHER,INTERVENTIONAL,2/10/2022,5/31/2023
NCT04934111,RECRUITING,COVID-19,DRUG: LNP-nCOV saRNA-02 Vaccine,MRC/UVRI and LSHTM Uganda Research Unit,,ALL,ADULT,PHASE1,42,OTHER,INTERVENTIONAL,12/2/2021,12/31/2022
NCT04896970,WITHDRAWN,SARS-CoV-2,OTHER: Concert,"University Hospital, Montpellier",,ALL,ADULT,NA,0,OTHER,INTERVENTIONAL,2021-06,2021-07
NCT05614011,RECRUITING,COVID-19,DIAGNOSTIC_TEST: RT-PCR Test|DIAGNOSTIC_TEST: Real-time PCR Test,QuantuMDx Group Ltd,New Day Diagnostics|PathAI|Bright Research Center,ALL,"ADULT, OLDER_ADULT",NA,550,INDUSTRY,INTERVENTIONAL,11/28/2022,2023-05
NCT04519411,WITHDRAWN,COVID 19,DIAGNOSTIC_TEST: Transpulmonary pressure measurements,Mayo Clinic,,ALL,CHILD,NA,0,OTHER,INTERVENTIONAL,5/21/2020,2022-12
NCT04360811,COMPLETED,Pregnancy,DIAGNOSTIC_TEST: COVID 19 diagnostic test by PCR,"University Hospital, Toulouse",,FEMALE,"ADULT, OLDER_ADULT",NA,2494,OTHER,INTERVENTIONAL,4/17/2020,3/31/2022
NCT04360824,COMPLETED,COVID 19 Associated Coagulopathy,DRUG: Intermediate dose thromboprophylaxis|DRUG: Standard of Care thromboprophylaxis,University of Iowa,,ALL,"ADULT, OLDER_ADULT",PHASE4,176,OTHER,INTERVENTIONAL,5/6/2020,4/16/2021
NCT05007457,UNKNOWN,Respiratory Failure|Sars-CoV-2|Covid19|ARDS|Interstitial Pneumonia|Respiratory Rehabilitation|Dyspnea|Quality of Life|Coronavirus Infections,OTHER: Telerehabilitation,IRCCS Azienda Ospedaliero-Universitaria di Bologna,,ALL,"ADULT, OLDER_ADULT",NA,100,OTHER,INTERVENTIONAL,6/12/2021,6/12/2023
NCT04359901,COMPLETED,COVID,BIOLOGICAL: SARILUMAB,Westyn Branch-Elliman,,ALL,"ADULT, OLDER_ADULT",PHASE2,50,FED,INTERVENTIONAL,4/10/2020,8/2/2021
NCT05047601,COMPLETED,COVID-19,DRUG: PF-07321332|DRUG: Placebo for PF-07321332|DRUG: Placebo for Ritonavir|DRUG: Ritonavir,Pfizer,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,2954,INDUSTRY,INTERVENTIONAL,9/9/2021,4/12/2022
NCT05601180,ACTIVE_NOT_RECRUITING,Asthma|Chronic Obstructive Pulmonary Disease|Long COVID,OTHER: Respicure®|OTHER: Standard of care,Beker Laboratories,,ALL,"ADULT, OLDER_ADULT",NA,480,INDUSTRY,INTERVENTIONAL,10/27/2022,2024-07
NCT04649424,COMPLETED,Covid19,DEVICE: CanSwab,Orthopaedic Innovation Centre,,ALL,"ADULT, OLDER_ADULT",NA,169,OTHER,INTERVENTIONAL,12/22/2020,4/13/2021
NCT04474340,UNKNOWN,"Moderate COVID-19 Pneumonia, Severe COVID-19 Pneumonia|Pneumonia, Viral",DRUG: COVID-19 Convalscent Plasma,"Ministry of Health, Kuwait",,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1,300,OTHER_GOV,INTERVENTIONAL,5/21/2020,12/30/2020
NCT04357340,COMPLETED,Covid-19|Pneumonia|SARS Pneumonia,OTHER: Pulmonary Physiotherapy Techniques,Tehran University of Medical Sciences,,ALL,"ADULT, OLDER_ADULT",NA,40,OTHER,INTERVENTIONAL,4/2/2020,5/30/2020
NCT04703140,TERMINATED,COVID-19|SARS-CoV-2,DIAGNOSTIC_TEST: Rapid Diagnostic Test vs PCR,CMC Ambroise Paré,,ALL,"ADULT, OLDER_ADULT",NA,192,OTHER,INTERVENTIONAL,1/27/2021,5/4/2021
NCT06205524,RECRUITING,COVID-19|COVID-19 Immunisation,BIOLOGICAL: TI-0010|BIOLOGICAL: Placebo,National Drug Clinical Trial Institute of the Second Affiliated Hospital of Bengbu Medical College,Therorna,ALL,ADULT,PHASE1,100,OTHER,INTERVENTIONAL,7/10/2023,2/1/2025
NCT04480424,COMPLETED,COVID-19,BIOLOGICAL: GAMUNEX-C|DRUG: Standard Medical Treatment,Grifols Therapeutics LLC,,ALL,"ADULT, OLDER_ADULT",PHASE2,100,INDUSTRY,INTERVENTIONAL,9/17/2020,10/25/2021
NCT05135624,RECRUITING,SARS CoV 2 Infection|Pneumonia,DRUG: SP16 (6mg)|OTHER: Placebo|DRUG: SP16 (12 mg),"Serpin Pharma, LLC",University of Virginia,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,20,OTHER,INTERVENTIONAL,12/1/2021,2024-03
NCT05121740,COMPLETED,COVID-19 Infection,DRUG: Plitidepsin 1.5 mg / day|DRUG: Plitidepsin 2.0 mg / day|DRUG: Plitidepsin 2.5 mg / day,PharmaMar,Apices Soluciones S.L.,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,34,INDUSTRY,INTERVENTIONAL,1/18/2022,3/16/2022
NCT04729140,UNKNOWN,Covid19,DRUG: Ivermectin Tablets|DRUG: Doxycycline Tablets|DRUG: Placebo,"Max Health, Subsero Health",,ALL,"ADULT, OLDER_ADULT",PHASE4,150,OTHER,INTERVENTIONAL,12/28/2020,3/28/2022
NCT04954157,COMPLETED,Hypoxia|SARS-CoV-2 Acute Respiratory Disease|Carotid Bodies,DIAGNOSTIC_TEST: Phase-1: Breath Holding Test|DIAGNOSTIC_TEST: Phase 2: 6-Minute Walk Test (6MWT),University of Chicago,,ALL,"ADULT, OLDER_ADULT",NA,80,OTHER,INTERVENTIONAL,6/29/2020,4/21/2022
NCT04795557,COMPLETED,Covid19,DIETARY_SUPPLEMENT: ADAPT-232 oral solution|OTHER: Placebo oral solution,Swedish Herbal Institute AB,"National Family Medicine Training Centre, Georgia|Tbilisi State Medical University|Phytomed AB",ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,100,INDUSTRY,INTERVENTIONAL,4/19/2021,12/26/2021
NCT06142240,RECRUITING,Persistent COVID-19,OTHER: exercise programe,Facultat de ciencies de la Salut Universitat Ramon Llull,,ALL,ADULT,NA,40,OTHER,INTERVENTIONAL,6/1/2023,9/1/2025
NCT04582201,ACTIVE_NOT_RECRUITING,"Respiratory Distress Syndrome, Adult",DRUG: agenT-797,MiNK Therapeutics,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,20,INDUSTRY,INTERVENTIONAL,9/21/2020,9/30/2023
NCT04449380,TERMINATED,COVID-19 Virus Infection,DRUG: Interferon-ß-1a|COMBINATION_PRODUCT: Standard of Care (SOC),Emanuele Bosi,,ALL,"ADULT, OLDER_ADULT",PHASE2,56,OTHER,INTERVENTIONAL,11/2/2020,3/30/2021
NCT04432324,COMPLETED,COVID-19,BIOLOGICAL: Intravenous Immune Globulin|DRUG: Standard Medical Treatment,"Instituto Grifols, S.A.",,ALL,"ADULT, OLDER_ADULT",PHASE2,100,INDUSTRY,INTERVENTIONAL,6/2/2020,3/3/2021
NCT04350580,COMPLETED,Acute Respiratory Distress Syndrome|COVID-19,DRUG: Human immunoglobulin|DRUG: Placebo,Centre Hospitalier St Anne,Groupe Hospitalier Universitaire Paris psychiatrie & neurosciences|Laboratoire français de Fractionnement et de Biotechnologies,ALL,"ADULT, OLDER_ADULT",PHASE3,146,OTHER,INTERVENTIONAL,4/11/2020,2/20/2021
NCT05107440,COMPLETED,COVID-19,OTHER: BREATHE,University of Calgary,,ALL,"ADULT, OLDER_ADULT",NA,27,OTHER,INTERVENTIONAL,1/3/2022,10/13/2022
NCT05977140,RECRUITING,Healthy Volunteers,DRUG: CDI-988|DRUG: Placebo,"Cocrystal Pharma, Inc.",Cocrystal Pharma Australia Pty Ltd.|Nucleus Network Pty Ltd.|Beyond Drug Development Pty Ltd.|Resolutum Global Pty Ltd.,ALL,ADULT,PHASE1,56,INDUSTRY,INTERVENTIONAL,9/27/2023,2024-11
NCT04790240,UNKNOWN,Covid19 Virus Infection,DIETARY_SUPPLEMENT: Inflammation (I)|DIETARY_SUPPLEMENT: Inflammation (II)|DIETARY_SUPPLEMENT: Inflammation (III)|DRUG: Standard of care,"All Natural Medicine Clinic, LLC",,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1|PHASE2,120,OTHER,INTERVENTIONAL,2/1/2021,2023-03
NCT05109624,COMPLETED,COVID-19 Acute Respiratory Distress Syndrome,PROCEDURE: prolonged prone position ventilation,Ain Shams University,,ALL,"ADULT, OLDER_ADULT",NA,52,OTHER,INTERVENTIONAL,10/1/2021,1/1/2022
NCT04954040,UNKNOWN,Acute Respiratory Distress Syndrome|Covid19,DRUG: Hydroxychloroquine Pill + Azithromycin Pill|DRUG: SOC,Maimónides Biomedical Research Institute of Córdoba,,ALL,"ADULT, OLDER_ADULT",PHASE2,132,OTHER,INTERVENTIONAL,2/10/2021,2021-12
NCT05739513,COMPLETED,COVID-19,DIAGNOSTIC_TEST: miRNA analysis in plasma,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,,ALL,"ADULT, OLDER_ADULT",NA,120,OTHER,INTERVENTIONAL,12/7/2020,7/12/2021
NCT05091411,UNKNOWN,Coronavirus Disease 2019,BIOLOGICAL: Recombinant new coronavirus vaccine (CHO cell) group,"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.",,ALL,ADULT,PHASE3,1680,INDUSTRY,INTERVENTIONAL,9/9/2021,2022-12
NCT04912011,UNKNOWN,COVID-19 Pneumonia,DRUG: Canrenoate Potassium|DRUG: Normal Saline,Pomeranian Medical University Szczecin,,ALL,"ADULT, OLDER_ADULT",PHASE4,50,OTHER,INTERVENTIONAL,1/1/2021,12/31/2021
NCT04392713,UNKNOWN,COVID,DRUG: Ivermectin 6 MG Oral Tablet (2 tablets),"Combined Military Hospital, Pakistan",,ALL,"CHILD, ADULT, OLDER_ADULT",NA,100,OTHER,INTERVENTIONAL,4/15/2020,2020-07
NCT04438070,UNKNOWN,COVID-19,DIAGNOSTIC_TEST: COVID-19 Swab,St. Joseph's Healthcare Hamilton,Timothy O'Shea|Marek Smieja|Lawrence Mbuagbaw,ALL,"ADULT, OLDER_ADULT",NA,400,OTHER,INTERVENTIONAL,4/10/2020,2020-06
NCT04465513,COMPLETED,COVID|Covid-19,DIETARY_SUPPLEMENT: Best Standard of Care + CARDIO|DIETARY_SUPPLEMENT: Best Standard of Care,Hofseth Biocare ASA,KGK Science Inc.,ALL,"ADULT, OLDER_ADULT",NA,14,INDUSTRY,INTERVENTIONAL,8/31/2020,10/4/2021
NCT05911113,COMPLETED,Post-COVID-19 Syndrome,OTHER: sensory re-education training|OTHER: traditional treatment,Cairo University,,ALL,ADULT,NA,40,OTHER,INTERVENTIONAL,6/26/2023,10/30/2023
NCT05112913,ACTIVE_NOT_RECRUITING,COVID-19,BIOLOGICAL: Inactivated SARS-CoV-2 Vaccine (Vero cell) Lot 1 of the workshop 2|BIOLOGICAL: Inactivated SARS-CoV-2 Vaccine (Vero cell) Lot 2 of the workshop 2|BIOLOGICAL: Inactivated SARS-CoV-2 Vaccine (Vero cell) Lot 3 of the workshop 2|BIOLOGICAL: Inactivated SARS-CoV-2 Vaccine (Vero cell) Lot 1 of the workshop 3|BIOLOGICAL: Inactivated SARS-CoV-2 Vaccine (Vero cell) Lot 2 of the workshop 3|BIOLOGICAL: Inactivated SARS-CoV-2 Vaccine (Vero cell) Lot 3 of the workshop 3|BIOLOGICAL: Inactivated SARS-CoV-2 Vaccine (Vero cell) Lot 1 of the workshop 1,"Sinovac Research and Development Co., Ltd.",,ALL,CHILD,PHASE4,2520,INDUSTRY,INTERVENTIONAL,7/27/2021,12/25/2023
NCT05557513,COMPLETED,COVID-19 Pandemic,DEVICE: STANDARD Q COVID-19 Ag Test,University of Oxford,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,1310,OTHER,INTERVENTIONAL,8/18/2022,12/31/2022
NCT05011513,TERMINATED,COVID-19,DRUG: PF-07321332|DRUG: Ritonavir|DRUG: Placebo|DRUG: Placebo,Pfizer,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,1440,INDUSTRY,INTERVENTIONAL,8/25/2021,7/25/2022
NCT05188469,ACTIVE_NOT_RECRUITING,COVID-19 Vaccine,DRUG: EG-COVID-003|DRUG: EG-COVID-001|DRUG: A: EG-COVID|DRUG: B: EG-COVID|DRUG: C: EG-COVARo,EyeGene Inc.,Novotech (Australia) Pty Limited,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,67,OTHER,INTERVENTIONAL,3/22/2022,4/1/2024
NCT04535869,UNKNOWN,COVID-19,DRUG: Sofosbuvir 400 MG plus Daclatasvir 200mg,Mansoura University,,ALL,"ADULT, OLDER_ADULT",PHASE3,50,OTHER,INTERVENTIONAL,12/28/2020,9/3/2021
NCT04394169,COMPLETED,Post ICU Syndrome|Chronic Pain|Covid-19,BEHAVIORAL: Intervention program,Hospital Clinic of Barcelona,,ALL,"ADULT, OLDER_ADULT",NA,102,OTHER,INTERVENTIONAL,5/25/2020,10/22/2021
NCT05258669,RECRUITING,COVID-19,BIOLOGICAL: BBV152,Ocugen,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,400,INDUSTRY,INTERVENTIONAL,2/20/2022,10/31/2023
NCT04750278,TERMINATED,Severe to Critical COVID 19 With Associated ARDS,DRUG: FP-025 100 mg|DRUG: FP-025 300 mg|DRUG: Placebo,"Foresee Pharmaceuticals Co., Ltd.",,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,90,INDUSTRY,INTERVENTIONAL,4/6/2021,4/18/2022
NCT05602558,NOT_YET_RECRUITING,COVID-19,BIOLOGICAL: LYB001|BIOLOGICAL: Placebo,"Yantai Patronus Biotech Co., Ltd.",,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,18000,INDUSTRY,INTERVENTIONAL,2022-12,2024-02
NCT04427878,UNKNOWN,Covid-19 Patients,PROCEDURE: biopsies of subcutaneous adipose tissue,Centre Hospitalier Universitaire de Nice,,ALL,"ADULT, OLDER_ADULT",NA,5,OTHER,INTERVENTIONAL,7/1/2020,7/9/2021
NCT04747158,COMPLETED,SARS-CoV-2 Infection|COVID-19 Infection,BIOLOGICAL: Convalescent plasma,Universidad Nacional de Asunción,"Consejo Nacional de Ciencias y Tecnología, Paraguay|Ministerio de Salud Pública y Bienestar Social, Paraguay|Centro de información y recursos para el desarrollo, Paraguay",ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,350,OTHER,INTERVENTIONAL,8/10/2020,1/10/2021
NCT05438602,COMPLETED,COVID-19,DRUG: Nirmatrelvir|DRUG: Ritonavir|DRUG: Placebo for nirmatrelvir|DRUG: Placebo for ritonavir,Pfizer,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,157,INDUSTRY,INTERVENTIONAL,8/3/2022,11/13/2023
NCT04468958,COMPLETED,COVID-19|SARS-CoV2,BIOLOGICAL: SAB-185|OTHER: Normal saline,"SAb Biotherapeutics, Inc.","Department of Health and Human Services|JPEO, Chemical, Biological, Radiological, and Nuclear Defense (CBRND) Enabling Biotechnologies (EB)",ALL,ADULT,PHASE1,28,INDUSTRY,INTERVENTIONAL,7/1/2020,12/23/2020
NCT04575558,WITHDRAWN,Sars-CoV2,DRUG: Hydroxychloroquine and Azithromycin,Latin American Cooperative Oncology Group,Oncoclínicas,ALL,"ADULT, OLDER_ADULT",PHASE2,0,OTHER,INTERVENTIONAL,6/30/2020,10/30/2020
NCT05007678,COMPLETED,COVID-19,DRUG: leflunomide,Ashford and St. Peter's Hospitals NHS Trust,,ALL,"ADULT, OLDER_ADULT",PHASE3,178,OTHER,INTERVENTIONAL,9/16/2020,7/1/2022
NCT04860258,TERMINATED,Coronavirus|Covid19|SARS-CoV-2|Severe Acute Respiratory Syndrome,BIOLOGICAL: CVnCoV Vaccine,CureVac,,ALL,"ADULT, OLDER_ADULT",PHASE3,129,INDUSTRY,INTERVENTIONAL,4/22/2021,9/21/2021
NCT04979858,COMPLETED,Covid19|SARS-CoV2 Infection,DEVICE: Focal Mask,Georgia Institute of Technology,,ALL,"ADULT, OLDER_ADULT",NA,201,OTHER,INTERVENTIONAL,9/6/2021,3/15/2022
NCT05753202,ACTIVE_NOT_RECRUITING,COVID-19|Post-COVID-19 Syndrome|Post COVID-19 Condition,DEVICE: transcranial current direct stimulation,"Hospital San Carlos, Madrid",,ALL,"ADULT, OLDER_ADULT",NA,40,OTHER,INTERVENTIONAL,3/1/2023,6/30/2024
NCT04459702,WITHDRAWN,COVID|COVID-19|Corona Virus Infection|Coronavirus Infection|Coronavirus Sars-Associated as Cause of Disease Classified Elsewhere|Coronavirus-19|SARS-CoV 2|SARS Pneumonia,DRUG: hydroxychloroquine|DRUG: Azithromycin|DRUG: Ritonavir|DRUG: Lopinavir,ProgenaBiome,Big Corona Ltd.,ALL,"ADULT, OLDER_ADULT",PHASE2,0,OTHER,INTERVENTIONAL,2020-07,2021-12
NCT04939402,RECRUITING,SARS-CoV-2|Covid19,DIAGNOSTIC_TEST: Serological testing,Universitair Ziekenhuis Brussel,,ALL,"ADULT, OLDER_ADULT",NA,200,OTHER,INTERVENTIONAL,5/5/2021,2028-06
NCT05198102,COMPLETED,Prevention of COVID-19,BIOLOGICAL: Recombinant novel coronavirus vaccine (CHO cells),"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.",,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,300,INDUSTRY,INTERVENTIONAL,12/29/2021,7/19/2022
NCT05465902,NOT_YET_RECRUITING,COVID-19|SARS-CoV-2 Infection,"BIOLOGICAL: Recombinant COVID-19 variant Vaccine (Sf9 Cell)|BIOLOGICAL: COVID-19 Vaccine (Vero Cell), Inactivated|BIOLOGICAL: mRNA COVID-19 vaccine (Moderna)|BIOLOGICAL: Viral Vector COVID-19 vaccine (AstraZeneca)","WestVac Biopharma Co., Ltd.",,ALL,"ADULT, OLDER_ADULT",PHASE2,600,INDUSTRY,INTERVENTIONAL,2023-07,2023-12
NCT05197478,UNKNOWN,COVID-19|Lifestyle Factors,"OTHER: Mini Nutritional Assessment ,Pıtsburg Sleep Qualıty Scale, Short Physical Activity Survey",Fatih Sultan Mehmet Training and Research Hospital,,ALL,"ADULT, OLDER_ADULT",NA,66,OTHER,INTERVENTIONAL,1/1/2021,2/1/2022
NCT05430958,WITHDRAWN,Coronavirus Infection,DRUG: INO-4800|DRUG: INO-9112|DEVICE: CELLECTRA® 2000,Inovio Pharmaceuticals,,ALL,"ADULT, OLDER_ADULT",PHASE1,0,INDUSTRY,INTERVENTIONAL,2022-10,2024-03
NCT04513158,RECRUITING,Covid19,BIOLOGICAL: Convalescent Plasma,"Joseph M. Flynn, D.O., MPH",,ALL,"ADULT, OLDER_ADULT",PHASE2,100,OTHER,INTERVENTIONAL,8/14/2020,12/31/2021
NCT04847102,UNKNOWN,COVID-19|SARS-CoV-2,BIOLOGICAL: SARS-CoV-2 mRNA Vaccine|BIOLOGICAL: Placebo,"Walvax Biotechnology Co., Ltd.","Abogen Biosciences Co. Ltd.|Yuxi Walvax Biotechnology Co., Ltd.",ALL,"ADULT, OLDER_ADULT",PHASE3,28000,INDUSTRY,INTERVENTIONAL,7/22/2021,5/30/2023
NCT05293678,COMPLETED,Healthy,DRUG: REGN15160 (IV)|DRUG: Matching Placebo (IV)|DRUG: REGN15160 (SC)|DRUG: Matching Placebo (SC),Regeneron Pharmaceuticals,,ALL,ADULT,PHASE1,104,INDUSTRY,INTERVENTIONAL,4/12/2022,1/26/2023
NCT05209178,COMPLETED,COVID-19 Pandemic,DIAGNOSTIC_TEST: Collection of nasal and oropharyngeal specimen for COVID19 antigen test,"Rigshospitalet, Denmark","Emergency Medical Services, Capital Region, Denmark|Technical University of Denmark|Copenhagen Medical A/S",ALL,"CHILD, ADULT, OLDER_ADULT",NA,3070,OTHER,INTERVENTIONAL,2/4/2022,5/6/2022
NCT04436458,WITHDRAWN,COVID,DRUG: Niclosamide Oral Tablet|DRUG: Placebo,"First Wave BioPharma, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE2,0,INDUSTRY,INTERVENTIONAL,1/20/2022,1/20/2022
NCT06095258,NOT_YET_RECRUITING,Long COVID,DRUG: Traditional Chinese medicine treatment|DRUG: Western medicine treatment,Chinese University of Hong Kong,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,162,OTHER,INTERVENTIONAL,12/1/2023,2/28/2026
NCT04610502,COMPLETED,Covid19,BIOLOGICAL: Administration of Equine immunoglobulin anti SARS-CoV-2,Caja Costarricense de Seguro Social,Universidad de Costa Rica|Ministry of Health Costa Rica,ALL,"ADULT, OLDER_ADULT",PHASE2,26,OTHER_GOV,INTERVENTIONAL,9/6/2020,12/6/2020
NCT04530578,UNKNOWN,Covid19|Pneumonia,DRUG: Heparin sodium|DRUG: Enoxaparin,"Clinica San Camilo, Argentina",,ALL,"ADULT, OLDER_ADULT",PHASE4,200,OTHER,INTERVENTIONAL,6/1/2020,6/1/2021
NCT05031858,UNKNOWN,COVID-19 Acute Respiratory Distress Syndrome,OTHER: Respiratory physiotherapy,NUMEN Foundation,Hospital de Emergencias Enfermera Isabel Zendal de Madrid,ALL,"ADULT, OLDER_ADULT",NA,40,OTHER,INTERVENTIONAL,9/25/2021,4/15/2022
NCT04666558,COMPLETED,Cancer|Lung Diseases|Liver Diseases,OTHER: Exercise & Nutrition|OTHER: Exercise & Nutrition,University of Alberta,Alberta Innovates Health Solutions,ALL,"ADULT, OLDER_ADULT",NA,216,OTHER,INTERVENTIONAL,11/30/2020,8/31/2022
NCT05293223,ACTIVE_NOT_RECRUITING,COVID-19 Vaccine,BIOLOGICAL: Ad5-nCov,Fundación Huésped,Dalhousie University|CanSino Biologics Inc.,ALL,"ADULT, OLDER_ADULT",PHASE2,450,OTHER,INTERVENTIONAL,10/1/2021,4/15/2023
NCT04756323,UNKNOWN,COVID-19,BIOLOGICAL: medium dosage inactivated SARS-CoV-2 vaccine|BIOLOGICAL: high dosage inactivated SARS-CoV-2 vaccine|BIOLOGICAL: Placebo,"Beijing Minhai Biotechnology Co., Ltd","Shenzhen Kangtai Biological Products Co., LTD|Jiangsu Province Centers for Disease Control and Prevention",ALL,"ADULT, OLDER_ADULT",PHASE2,1000,INDUSTRY,INTERVENTIONAL,10/27/2020,2/28/2022
NCT04335123,COMPLETED,COVID-19,DRUG: Losartan,University of Kansas Medical Center,,ALL,"ADULT, OLDER_ADULT",PHASE1,34,OTHER,INTERVENTIONAL,4/4/2020,8/17/2020
NCT04397523,COMPLETED,Convalescent Plasma|COVID-19|SARS-CoV 2,BIOLOGICAL: anti-SARS-CoV-2 convalescent plasma,Institute for Transfusion Medicine of RNM,"University Clinic for Infectious Diseases, North Macedonia",ALL,"ADULT, OLDER_ADULT",NA,200,OTHER_GOV,INTERVENTIONAL,4/30/2020,5/10/2021
NCT04370223,UNKNOWN,COVID-19 Pneumonia,BIOLOGICAL: Ozone auto-hemotherapy,Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta,Clinica Nuestra Senora del Rosario,ALL,"ADULT, OLDER_ADULT",PHASE3,208,OTHER,INTERVENTIONAL,5/25/2020,12/25/2020
NCT04683328,UNKNOWN,Covid19,BIOLOGICAL: SCTA01|BIOLOGICAL: SCTA01 Placebo,Sinocelltech Ltd.,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,560,INDUSTRY,INTERVENTIONAL,2/25/2021,11/25/2021
NCT06082258,NOT_YET_RECRUITING,Post-acute COVID-19 Syndrome,OTHER: Training in the management of functional disorders|OTHER: Reimbursement of 3 long consultations,Assistance Publique - Hôpitaux de Paris,"ANRS, Emerging Infectious Diseases",ALL,"ADULT, OLDER_ADULT",NA,672,OTHER,INTERVENTIONAL,2023-11,2025-03
NCT05334758,COMPLETED,COVID-19,DEVICE: Bio-Self COVID-19 Antigen Home Test|DEVICE: Standard of Care COVID-19 Test|DIAGNOSTIC_TEST: RT-PCR Test,"BioTeke USA, LLC",CSSi Life Sciences,ALL,"CHILD, ADULT, OLDER_ADULT",NA,282,INDUSTRY,INTERVENTIONAL,5/12/2022,7/25/2022
NCT05897541,RECRUITING,SARS-CoV-2 Infection,DRUG: S-217622|DRUG: Placebo,Shionogi,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,2200,INDUSTRY,INTERVENTIONAL,6/9/2023,2/28/2024
NCT04381936,RECRUITING,Severe Acute Respiratory Syndrome,DRUG: Lopinavir-Ritonavir|DRUG: Corticosteroid|DRUG: Hydroxychloroquine|DRUG: Azithromycin|BIOLOGICAL: Convalescent plasma|DRUG: Tocilizumab|BIOLOGICAL: Immunoglobulin|DRUG: Synthetic neutralising antibodies|DRUG: Aspirin|DRUG: Colchicine|DRUG: Baricitinib|DRUG: Anakinra|DRUG: Dimethyl fumarate|DRUG: High Dose Corticosteroid|DRUG: Empagliflozin|DRUG: Sotrovimab|DRUG: Molnupiravir|DRUG: Paxlovid|DRUG: Baloxavir Marboxil|DRUG: Oseltamivir|DRUG: Low-dose corticosteroids: Dexamethasone|DRUG: Low-dose corticosteroids: Dexamethasone,University of Oxford,"UK Research and Innovation|National Institute for Health Research, United Kingdom|Wellcome|Bill and Melinda Gates Foundation|Department for International Development, United Kingdom|Health Data Research UK|Medical Research Council Population Health Research Unit|NIHR Clinical Trials Unit Support Funding|NIHR Health Protection Research Unit in Emerging and Zoonotic Infections|Flu Lab",ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,70000,OTHER,INTERVENTIONAL,3/19/2020,6/30/2036
NCT04595136,UNKNOWN,SARS-CoV-2 Infection,DRUG: Drug COVID19-0001-USR|DRUG: normal saline,United Medical Specialties,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,60,OTHER,INTERVENTIONAL,11/2/2020,8/30/2021
NCT05033223,COMPLETED,Post Traumatic Stress Disorder,OTHER: PTSD evaluation of emergency room staff 9 and 12 months after the end of second lockdown in France during COvid-19 pandemic,Hospices Civils de Lyon,,ALL,"ADULT, OLDER_ADULT",NA,71,OTHER,INTERVENTIONAL,10/12/2021,1/16/2022
NCT04859023,COMPLETED,SARS-CoV Infection,DIAGNOSTIC_TEST: saliva sample combined to an anterior nare self-swabbing (Self-samples)|DIAGNOSTIC_TEST: saliva sample (Self-sample)|OTHER: Survey of SARS-COV-19 knowledge|OTHER: Survey of acceptability of the different self-samples.,Centre Hospitalier Universitaire de Saint Etienne,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,10000,OTHER,INTERVENTIONAL,2/22/2021,2/28/2021
NCT04410328,COMPLETED,Covid19,DRUG: Dipyridamole ER 200mg/ Aspirin 25mg orally/enterally AND Standard of care|OTHER: Standard of care,"Rutgers, The State University of New Jersey",Boehringer Ingelheim,ALL,"ADULT, OLDER_ADULT",PHASE3,99,OTHER,INTERVENTIONAL,10/21/2020,10/15/2021
NCT04321928,TERMINATED,SARS-CoV-2|Coronavirus|COVID-19|2019-nCoV|2019nCoV,BEHAVIORAL: Personalized health education|BEHAVIORAL: General health education,University of Pecs,,ALL,"ADULT, OLDER_ADULT",NA,449,OTHER,INTERVENTIONAL,4/1/2020,9/30/2021
NCT06002841,NOT_YET_RECRUITING,Severe Acute Respiratory Syndrome (SARS)|Acute Respiratory Distress Syndrome (ARDS)|Pneumonia,BIOLOGICAL: intravenous treatment with EVs|BIOLOGICAL: intravenous treatment with placebo solution,D'Or Institute for Research and Education,Hospital Sao Rafael|Rio de Janeiro State Research Supporting Foundation (FAPERJ)|Oswaldo Cruz Foundation,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,15,OTHER,INTERVENTIONAL,2/1/2024,6/1/2025
NCT04354428,TERMINATED,COVID-19|SARS-CoV-2,DRUG: Ascorbic Acid|DRUG: Hydroxychloroquine Sulfate|DRUG: Azithromycin|DRUG: Folic Acid|DRUG: Lopinavir 200 MG / Ritonavir 50 MG [Kaletra],University of Washington,Bill and Melinda Gates Foundation,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,289,OTHER,INTERVENTIONAL,4/16/2020,11/30/2020
NCT05780541,TERMINATED,COVID-19,DRUG: PF-07304814|DRUG: Placebo|BIOLOGICAL: Remdesivir,National Institute of Allergy and Infectious Diseases (NIAID),"International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)|University of Copenhagen|Medical Research Council|Kirby Institute|Washington D.C. Veterans Affairs Medical Center|AIDS Clinical Trials Group|National Heart, Lung, and Blood Institute (NHLBI)|US Department of Veterans Affairs|Prevention and Early Treatment of Acute Lung Injury|Cardiothoracic Surgical Trials Network|Pfizer|University of Minnesota",ALL,"ADULT, OLDER_ADULT",PHASE3,58,NIH,INTERVENTIONAL,9/15/2021,7/14/2023
NCT04610541,UNKNOWN,SARS-CoV-2 Infection,DRUG: Remdesivir-HU,University of Pecs,HECRIN Consortium|Hungarian Ministry of Innovation and Technology,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,2000,OTHER,INTERVENTIONAL,10/12/2020,11/30/2021
NCT04854941,COMPLETED,Coronavirus Infection,OTHER: Probiotics,I.M. Sechenov First Moscow State Medical University,,ALL,"ADULT, OLDER_ADULT",NA,200,OTHER,INTERVENTIONAL,12/10/2020,4/10/2021
NCT05148936,UNKNOWN,Covid19,OTHER: COVID-19 Testing Home-based (Aim 1)|OTHER: COVID-19 Testing Mobile (Aim 1)|OTHER: COVID-19 Testing Mobile Approach 1 (Aim 2)|OTHER: COVID-19 Testing Mobile Approach 2 (Aim 2),San Diego State University,National Cancer Institute (NCI),ALL,"CHILD, ADULT, OLDER_ADULT",NA,42000,OTHER,INTERVENTIONAL,10/25/2020,2022-06
NCT04615936,COMPLETED,COVID-19|Corona Virus Infection|SARS-CoV 2,OTHER: Methylene-Blue Photodisinfection,Sunnybrook Health Sciences Centre,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,45,OTHER,INTERVENTIONAL,10/13/2020,10/19/2021
NCT04489628,WITHDRAWN,SARS-CoV Infection,DRUG: Vitamin D3 or Placebo|DEVICE: Doctella telehealth monitoring,University Hospitals Cleveland Medical Center,Northwestern University,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,0,OTHER,INTERVENTIONAL,8/1/2020,6/1/2021
NCT05616728,RECRUITING,COVID-19,DRUG: EDP-235|DRUG: Placebo,"Enanta Pharmaceuticals, Inc",,ALL,ADULT,PHASE2,200,INDUSTRY,INTERVENTIONAL,11/10/2022,2023-03
NCT04682041,COMPLETED,Covid19,DIETARY_SUPPLEMENT: Bovine Plasma-Derived Immunoglobulin Concentrate|OTHER: Standard of care,"Entera Health, Inc","Lemus Buhils, SL|Clinical Research Unit, IMIM (Hospital del Mar Medical Research Institute)",ALL,"ADULT, OLDER_ADULT",NA,200,INDUSTRY,INTERVENTIONAL,12/22/2020,2/21/2022
NCT04847141,TERMINATED,COVID-19|Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection,BIOLOGICAL: C19-IG 20%|DRUG: 0.9% Sodium chloride,Grifols Therapeutics LLC,,ALL,"ADULT, OLDER_ADULT",PHASE3,465,INDUSTRY,INTERVENTIONAL,4/28/2021,12/27/2021
NCT04441684,COMPLETED,SARS-CoV-2 Serological Status|SARS-CoV-2 Seroprevalence,DIAGNOSTIC_TEST: Blood sample for serological test,"University Hospital, Strasbourg, France",,ALL,"ADULT, OLDER_ADULT",NA,1466,OTHER,INTERVENTIONAL,4/17/2020,7/16/2021
NCT04522128,COMPLETED,COVID|Quality of Life|Behavior|Social Isolation,BEHAVIORAL: Behaviour Change Technique Intervention to Improve Quality of Life,University of Manchester,,ALL,"ADULT, OLDER_ADULT",NA,274,OTHER,INTERVENTIONAL,5/22/2020,9/1/2021
NCT04619628,COMPLETED,COVID-19,BIOLOGICAL: COVI-VAC|OTHER: Placebo,"Codagenix, Inc",,ALL,ADULT,PHASE1,48,INDUSTRY,INTERVENTIONAL,12/11/2020,5/30/2022
NCT05126628,COMPLETED,COVID-19,DRUG: Proxalutamide|DRUG: Placebo,Corpometria Institute,"Hospital da Brigada Militar de Porto Alegre, Porto Alegre, Brazil|Hospital Arcanjo Sao Miguel, Gramado, Brazil|Hospital Unimed Chapeco, Chapeco, Brazil",ALL,"ADULT, OLDER_ADULT",PHASE3,133,OTHER,INTERVENTIONAL,3/6/2021,4/15/2021
NCT04708236,WITHDRAWN,COVID-19,DRUG: ORTD-1 low dose|DRUG: ORTD-1 mid dose|DRUG: ORTD-1 high dose|OTHER: Vehicle control,"Oryn Therapeutics, LLC",,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,0,INDUSTRY,INTERVENTIONAL,2021-04,2021-07
NCT04619680,ACTIVE_NOT_RECRUITING,Pulmonary Fibrosis|Interstitial Lung Disease|Respiratory Disease,DRUG: Nintedanib|DRUG: Placebo,Icahn School of Medicine at Mount Sinai,Boehringer Ingelheim,ALL,"ADULT, OLDER_ADULT",PHASE4,103,OTHER,INTERVENTIONAL,11/18/2020,2024-04
NCT05354024,ACTIVE_NOT_RECRUITING,Coronavirus Infections|Healthy,BIOLOGICAL: NDV-HXP-S 10μg|BIOLOGICAL: BNT162b2 30μg,Butantan Institute,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,4400,OTHER_GOV,INTERVENTIONAL,2/28/2023,9/25/2024
NCT04362124,WITHDRAWN,COVID-19,BIOLOGICAL: vaccine BCG|OTHER: Placebo,Universidad de Antioquia,,ALL,"ADULT, OLDER_ADULT",PHASE3,0,OTHER,INTERVENTIONAL,2020-08,2021-11
NCT05254301,RECRUITING,COVID-19,OTHER: Intervention group,Universitair Ziekenhuis Brussel,Vrije Universiteit Brussel,ALL,"ADULT, OLDER_ADULT",NA,66,OTHER,INTERVENTIONAL,4/24/2022,2024-03
NCT05281601,ACTIVE_NOT_RECRUITING,SARS-CoV-2,DRUG: AZD7442,AstraZeneca,,ALL,CHILD,PHASE1,46,INDUSTRY,INTERVENTIONAL,3/21/2022,3/29/2024
NCT04798001,RECRUITING,Covid19,"BIOLOGICAL: Investigational vaccine against SARS-CoV-2 [MV-014-212] Dosage 1, Single Dose, Intranasal Drops|BIOLOGICAL: Investigational vaccine against SARS-CoV-2 [MV-014-212] Dosage 2, Single Dose, Intranasal Drops|BIOLOGICAL: Investigational vaccine against SARS-CoV-2 [MV-014-212] Dosage 3, Single Dose, Intranasal Drops|BIOLOGICAL: Investigational vaccine against SARS-CoV-2 [MV-014-212] Dosage 3, Two Doses, Intranasal Drops|BIOLOGICAL: Investigational vaccine against SARS-CoV-2 [MV-014-212] Dosage 3, Single Dose, Intranasal Spray","Meissa Vaccines, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE1,130,INDUSTRY,INTERVENTIONAL,4/12/2021,10/31/2022
NCT05923424,RECRUITING,Healthy Volunteers,DRUG: REGN17092|DRUG: Matching Placebo,Regeneron Pharmaceuticals,,ALL,ADULT,PHASE1,128,INDUSTRY,INTERVENTIONAL,11/28/2023,4/30/2025
NCT05040724,UNKNOWN,To Assess the Reduction in the Viral Load of SARS-CoV-2 in Patients Receiving Ivermectin Compared to Those Receiving Standard Care,DRUG: Ivermectin,Raincy Montfermeil Hospital Group,,ALL,"ADULT, OLDER_ADULT",PHASE3,200,NETWORK,INTERVENTIONAL,5/28/2021,2022-06
NCT04956224,COMPLETED,SARS-CoV-2 Virus Infection,BIOLOGICAL: VLA2001,Valneva Austria GmbH,,ALL,"ADULT, OLDER_ADULT",PHASE3,306,INDUSTRY,INTERVENTIONAL,8/9/2021,11/18/2022
NCT04608201,COMPLETED,SARS-COV2,DRUG: Nicotine 7 mg/ 24h Transdermal Patch - 24 Hour|DRUG: Placebo of NICOTINE Transdermal patch,Assistance Publique - Hôpitaux de Paris,,ALL,"ADULT, OLDER_ADULT",PHASE3,32,OTHER,INTERVENTIONAL,12/9/2020,11/5/2021
NCT04391101,UNKNOWN,SARS-Cov-2,DRUG: Convalescent plasma,Hospital San Vicente Fundación,Clínica León XIII|Grupo de Inmunodeficiencias primarias Universidad de Antioquia|Clínica Universitaria Bolivariana|Hospital Pablo Tobón Uribe|Clínica Rosario El Tesoro|Clínica Las Américas|Clínica Cardiovid,ALL,"ADULT, OLDER_ADULT",PHASE3,231,OTHER,INTERVENTIONAL,2020-06,2021-12
NCT04382924,COMPLETED,COVID,DRUG: NP-120 (Ifenprodil),Algernon Pharmaceuticals,Novotech (Australia),ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,168,INDUSTRY,INTERVENTIONAL,8/5/2020,1/26/2021
NCT04353180,UNKNOWN,COVID19,DRUG: Drug Isotretinoin (13 cis retinoic acid ) capsules+standard treatment|DRUG: Isotretinoin(Aerosolized 13 cis retinoic acid) +standard treatment|DRUG: Isotretinoin (13 cis retinoic acid ) capsules|DRUG: Aerosolized 13 cis retinoic acid|DRUG: Standard treatment,Kafrelsheikh University,"1-Foshan University Laboratory of Emerging Infectious Disease Institute of Translational Medicine The First Hospital of Jilin University China|2-Montefiore Health System and Albert Einstein College of Medicine, Newyork, United States of America (U.S.A).|2-Faculty of Science, Kafrelsheikh University, Egypt.",ALL,"ADULT, OLDER_ADULT",PHASE3,100000,OTHER,INTERVENTIONAL,2021-08,2021-11
NCT04476680,UNKNOWN,SARS-CoV Infection|Vitamin D Deficiency|Covid19|Acute Respiratory Tract Infection,DIETARY_SUPPLEMENT: Vitamin D,Royal Centre for Defence Medicine,Leeds Beckett University|Liverpool John Moores University,ALL,ADULT,NA,900,OTHER_GOV,INTERVENTIONAL,9/1/2020,4/28/2021
NCT05800080,NOT_YET_RECRUITING,Gastric Cancer,DRUG: Penpulimab combined with Anlotinib Hydrochloride Capsules and chemotherapy;Cadonilimab combined with Anlotinib Hydrochloride Capsules and chemotherapy,Xijing Hospital,,ALL,"ADULT, OLDER_ADULT",NA,114,OTHER,INTERVENTIONAL,2023-04,2025-02
NCT06141824,COMPLETED,COVID-19|Influenza,DEVICE: Lucira COVID-19 & Flu Test,Lucira Health Inc,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,1066,INDUSTRY,INTERVENTIONAL,10/11/2022,2/16/2023
NCT05054101,WITHDRAWN,PTSD,OTHER: Real-time assessment using the VieCovid2020 smartphone application,Assistance Publique - Hôpitaux de Paris,,ALL,"ADULT, OLDER_ADULT",NA,0,OTHER,INTERVENTIONAL,12/15/2021,6/15/2023
NCT05220280,RECRUITING,Covid19|Coronavirus Disease 2019|SARS-CoV-2 Acute Respiratory Disease,DRUG: Imatinib|DRUG: Infliximab,Clinical Urology and Epidemiology Working Group,University of Helsinki|World Health Organization|Helsinki University Central Hospital|Hyvinkää Hospital|Kanta-Häme Central Hospital|Kuopio University Hospital|City of Helsinki|Oulu University Hospital|Porvoo Hospital|Seinajoki Central Hospital|Mikkeli Central Hospital|Tampere University Hospital,ALL,"ADULT, OLDER_ADULT",PHASE4,400,OTHER_GOV,INTERVENTIONAL,2/6/2022,2025-12
NCT04588480,COMPLETED,SARS-CoV-2 Infection|COVID-19,BIOLOGICAL: BNT162b2|OTHER: Placebo,BioNTech SE,Pfizer,ALL,"ADULT, OLDER_ADULT",PHASE4,160,INDUSTRY,INTERVENTIONAL,10/21/2020,11/25/2021
NCT04932824,COMPLETED,COVID-19,BIOLOGICAL: SCB-2019,Clover Biopharmaceuticals AUS Pty Ltd,,ALL,"ADULT, OLDER_ADULT",PHASE1,137,INDUSTRY,INTERVENTIONAL,1/19/2021,12/16/2021
NCT04495101,COMPLETED,COVID-19,BIOLOGICAL: Prolastin|DRUG: Standard Medical Treatment,"Instituto Grifols, S.A.",,ALL,"ADULT, OLDER_ADULT",PHASE2,100,INDUSTRY,INTERVENTIONAL,7/29/2020,6/10/2021
NCT04365101,ACTIVE_NOT_RECRUITING,"Coronavirus|Coronavirus Infection|Severe Acute Respiratory Syndrome Coronavirus 2|Pneumonia|Pneumonia, Viral|Lung Diseases|Respiratory Tract Disease|Respiratory Tract Infections|Coronaviridae Infections|Nidovirales Infections|RNA Virus Infections|Virus Disease|Immunologic Disease|ARDS|Immunologic Factors|Physiological Effects of Drugs|Antiviral Agents|Anti-infective Agents|Analgesics|Antimetabolites, Antineoplastic",BIOLOGICAL: CYNK-001,Celularity Incorporated,Access to Advanced Health Institute (AAHI)|Lung Biotechnology PBC|California Institute for Regenerative Medicine (CIRM),ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,86,INDUSTRY,INTERVENTIONAL,5/13/2020,6/30/2022
NCT04743401,COMPLETED,COVID 19|Rehabilitation|Inpatient|Hospitalized,OTHER: Tele-exergaming Tablet,VA Office of Research and Development,Baylor College of Medicine,ALL,"ADULT, OLDER_ADULT",NA,54,FED,INTERVENTIONAL,7/5/2021,12/31/2023
NCT05008380,COMPLETED,COVID-19 Pneumonia,PROCEDURE: prone positioning,University of Milano Bicocca,,ALL,"ADULT, OLDER_ADULT",NA,96,OTHER,INTERVENTIONAL,8/16/2021,8/3/2022
NCT04633980,COMPLETED,Covid-19,"DRUG: Mixture 3,6% H2 in N2 (96.4%)","University Hospital, Grenoble",,ALL,"ADULT, OLDER_ADULT",PHASE1,12,OTHER,INTERVENTIONAL,12/1/2020,5/23/2023
NCT04762680,ACTIVE_NOT_RECRUITING,COVID-19,"BIOLOGICAL: SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 1|BIOLOGICAL: SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 2|BIOLOGICAL: SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 3|BIOLOGICAL: SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (D614)-AS03, Dosage A|BIOLOGICAL: SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03|BIOLOGICAL: SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (D614)-AS03, Dosage B|BIOLOGICAL: SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03 Alternative Exploratory Formulation 1|BIOLOGICAL: SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03 Alternative Exploratory Formulation 2|BIOLOGICAL: SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03 Alternative Exploratory Formulation 3|BIOLOGICAL: SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03 Alternative Exploratory Formulation 4|BIOLOGICAL: SARS-CoV-2 adjuvanted recombinant protein vaccine, bivalent (D614+B.1.351)-AS03","Sanofi Pasteur, a Sanofi Company",GlaxoSmithKline,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,3385,INDUSTRY,INTERVENTIONAL,2/24/2021,7/16/2024
NCT04345601,COMPLETED,Sars-CoV2|Acute Respiratory Distress Syndrome|COVID-19,BIOLOGICAL: Mesenchymal Stromal Cells|OTHER: Supportive Care,Baylor College of Medicine,"Center for Cell and Gene Therapy, Baylor College of Medicine|The Methodist Hospital Research Institute",ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,28,OTHER,INTERVENTIONAL,2/12/2021,1/10/2023
NCT04631380,COMPLETED,Covid19,OTHER: PRAYER,Hospital do Coracao,,ALL,"ADULT, OLDER_ADULT",NA,200,OTHER,INTERVENTIONAL,8/1/2020,1/1/2022
NCT05822180,COMPLETED,COVID-19 Pneumonia,"DRUG: NANOS1 , argent colloïdal ,","General Administration of Military Health, Tunisia",,ALL,"ADULT, OLDER_ADULT",PHASE3,116,NETWORK,INTERVENTIONAL,1/1/2021,2/20/2022
NCT04359680,ACTIVE_NOT_RECRUITING,COVID-19|Viral Respiratory Illnesses,DRUG: Nitazoxanide|DRUG: Placebo|DIETARY_SUPPLEMENT: Vitamin Super B-Complex,Romark Laboratories L.C.,,ALL,"ADULT, OLDER_ADULT",PHASE3,1407,INDUSTRY,INTERVENTIONAL,5/13/2020,2024-05
NCT05439824,ACTIVE_NOT_RECRUITING,SARS-CoV-2 Infection,BIOLOGICAL: SYS6006 20 μg|BIOLOGICAL: SYS6006 30 μg|BIOLOGICAL: Placebo,"CSPC ZhongQi Pharmaceutical Technology Co., Ltd.",,ALL,"ADULT, OLDER_ADULT",PHASE2,450,INDUSTRY,INTERVENTIONAL,6/28/2022,6/28/2023
NCT04708340,ACTIVE_NOT_RECRUITING,COVID-19|Acute Respiratory Distress Syndrome|SARS-CoV-2|Hypoxemia,DRUG: Rejuveinix (RJX) Active Comparator|DRUG: Placebo Comparator,"Reven Pharmaceuticals, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,237,INDUSTRY,INTERVENTIONAL,3/25/2021,2023-02
NCT05925140,RECRUITING,COVID-19|Hospitalized COVID-19 Patients,DRUG: Lopinavir / Ritonavir|DRUG: Remdesivir (RDV)|DRUG: Tocilizumab|OTHER: Corticosteroid Therapy-enhanced Standard Care (CTSC),Lebanese University,Hospital Saydet Zgharta University Medical Center,ALL,"ADULT, OLDER_ADULT",PHASE1,1000,OTHER,INTERVENTIONAL,3/28/2020,12/30/2025
NCT04889040,TERMINATED,COVID-19,DRUG: RO7496998|DRUG: Placebo,Hoffmann-La Roche,"Atea Pharmaceuticals, Inc.",ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,216,INDUSTRY,INTERVENTIONAL,4/28/2021,12/2/2021
NCT04642040,UNKNOWN,Covid19|Covid19 Pneumonia|SARS-CoV 2 Pneumonia,OTHER: Pulmonary Rehabilitation,Sisli Hamidiye Etfal Training and Research Hospital,,ALL,"ADULT, OLDER_ADULT",NA,100,OTHER,INTERVENTIONAL,6/30/2020,2021-01
NCT04731324,COMPLETED,Healthy,DRUG: ZYIL1 capsule,Zydus Lifesciences Limited,,ALL,ADULT,PHASE1,30,INDUSTRY,INTERVENTIONAL,12/28/2020,6/12/2021
NCT04441424,COMPLETED,IMMUNOTHERAPY,BIOLOGICAL: Convalescent plasma|DRUG: Hydroxychloroquin with Azithromycin,Alkarkh Health Directorate-Baghdad,,ALL,"ADULT, OLDER_ADULT",NA,49,OTHER_GOV,INTERVENTIONAL,4/3/2020,6/1/2020
NCT04371640,WITHDRAWN,SARS-CoV-2|Covid-19,DRUG: Sirolimus 1 MG/ML|DRUG: Placebo,Walter K. Kraft,,ALL,"ADULT, OLDER_ADULT",PHASE1,0,OTHER,INTERVENTIONAL,7/6/2020,7/30/2021
NCT04480957,COMPLETED,SARS-CoV-2,BIOLOGICAL: ARCT-021 Dose 1|BIOLOGICAL: ARCT-021 Dose 2|BIOLOGICAL: ARCT-021 Dose 3|BIOLOGICAL: ARCT-021 Dose 4|BIOLOGICAL: ARCT-021 Dose Regimen 1|BIOLOGICAL: ARCT-021 Dose Regimen 2|OTHER: Placebo,"Arcturus Therapeutics, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,106,INDUSTRY,INTERVENTIONAL,8/4/2020,1/29/2021
NCT04479540,COMPLETED,"Pneumonia, Viral",RADIATION: Angiography scanner,Hopital Foch,"Hospital Ambroise Paré Paris|University Hospital, Brest",ALL,"ADULT, OLDER_ADULT",NA,117,OTHER,INTERVENTIONAL,5/26/2020,3/5/2022
NCT04765540,COMPLETED,Hand Washing|Handwashing|Covid19,BEHAVIORAL: Low Intensity Nudges|BEHAVIORAL: High Intensity Activities|BEHAVIORAL: BRAC's business-as-usual,The Behavioural Insights Team,"Brac|BRAC Institute of Governance and Development|Unilever U.K. Central Resources Limited|D2 Technologies Ltd, Bangladesh|Foreign, Commonwealth and Development Office, U.K.",ALL,"CHILD, ADULT, OLDER_ADULT",NA,855,OTHER,INTERVENTIONAL,1/3/2021,5/6/2021
NCT04547140,TERMINATED,COVID-19,BIOLOGICAL: Liquid Alpha1-Proteinase Inhibitor (Human)|DRUG: Placebo|DRUG: Standard Medical Treatment,Grifols Therapeutics LLC,,ALL,"ADULT, OLDER_ADULT",PHASE2,57,INDUSTRY,INTERVENTIONAL,1/29/2021,1/28/2022
NCT04913740,UNKNOWN,Associated Skin Lesions,OTHER: Ointment and dressing for external use,"Second Affiliated Hospital, School of Medicine, Zhejiang University",,ALL,"CHILD, ADULT, OLDER_ADULT",NA,170,OTHER,INTERVENTIONAL,6/1/2021,1/1/2022
NCT04504240,COMPLETED,Covid19,DRUG: Famotidine 20 MG,Chattogram General Hospital,M Abdur Rahim Medical College and Hospital|First Affiliated Hospital Xi'an Jiaotong University,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,208,OTHER_GOV,INTERVENTIONAL,8/1/2020,4/15/2021
NCT05458440,RECRUITING,COVID-19,OTHER: Generation of a biobank allowing the cryopreservation of leucocytes from COVID19 convalescent donors,"Central Hospital, Nancy, France",,ALL,"ADULT, OLDER_ADULT",NA,32,OTHER,INTERVENTIONAL,9/1/2022,1/15/2024
NCT04977024,RECRUITING,COVID-19 Infection|Hematopoietic and Lymphoid System Neoplasm|Leukemia|Lymphoma|Plasma Cell Myeloma,BIOLOGICAL: COVID-19 Vaccine|OTHER: Diagnostic Laboratory Biomarker Analysis|BIOLOGICAL: Synthetic MVA-based SARS-CoV-2 Vaccine GEO-CM04S1,"GeoVax, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE2,240,INDUSTRY,INTERVENTIONAL,9/27/2021,3/31/2026
NCT04801940,UNKNOWN,Covid19,DRUG: Apixaban|DRUG: Atorvastatin,Cambridge University Hospitals NHS Foundation Trust,University of Liverpool|Cambridge University Hospitals NHS Foundation Trust (joint Sponsor)|The University of Cambridge (joint Sponsor),ALL,"ADULT, OLDER_ADULT",PHASE3,2631,OTHER,INTERVENTIONAL,5/19/2021,1/31/2024
NCT04721457,COMPLETED,SARS-CoV-2|COVID-19|Mouthwashes|Viral Load|Polymerase Chain Reaction|Coronavirus|Covid19|Saliva,DRUG: Distilled Water|DRUG: 1% Povidone Iodine (PVP-I)|DRUG: 1.5% Hydrogen Peroxide (H2O2)|DRUG: 0.075% Cetylpyridinium Chloride (CPC)|DRUG: 0.1% Sodium Hypochlorite|OTHER: No rinse group,King Abdulaziz University,,ALL,"ADULT, OLDER_ADULT",PHASE4,90,OTHER,INTERVENTIONAL,1/3/2021,12/10/2021
NCT04405999,COMPLETED,Increased Risk of SARS-CoV-2 Infection,DRUG: Bromhexine Hydrochloride,"Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health",,ALL,"ADULT, OLDER_ADULT",PHASE4,50,OTHER,INTERVENTIONAL,5/14/2020,8/31/2020
NCT04852770,UNKNOWN,Posttraumatic Stress Disorder|Covid19,BEHAVIORAL: Trial-Based Cognitive Therapy|BEHAVIORAL: Mindfulness-Based Health Promotion|BEHAVIORAL: Positive psychotherapy,Fundação Bahiana de Infectologia,Mente Aberta,ALL,ADULT,NA,135,OTHER,INTERVENTIONAL,4/23/2021,11/30/2021
NCT04516811,UNKNOWN,COVID-19|SARS-CoV-2 Infection|Severe Acute Respiratory Syndrome Coronavirus 2,BIOLOGICAL: COVID-19 convalescent plasma (CCP) plus standard of care (SOC)|BIOLOGICAL: Standard of care (SOC) plus placebo,South African National Blood Service,,ALL,"ADULT, OLDER_ADULT",PHASE3,600,OTHER,INTERVENTIONAL,9/21/2020,7/31/2022
NCT05126511,COMPLETED,POST-Covid 19|Anxiety,DEVICE: Application of CES via ear clips|DEVICE: Sham: No application of CES via ear clips,Schön Klinik Berchtesgadener Land,,ALL,"ADULT, OLDER_ADULT",NA,40,OTHER,INTERVENTIONAL,11/19/2021,3/31/2022
NCT05764070,COMPLETED,Post-COVID-19 Syndrome,DEVICE: non-invasive auricular vagus stimulation|DEVICE: Placebo Non Invasive Vagus Stimulation,Istanbul Medipol University Hospital,,ALL,ADULT,NA,44,OTHER,INTERVENTIONAL,3/9/2023,8/4/2023
NCT05043311,UNKNOWN,COVID-19|SARS-CoV-2 Infection,BIOLOGICAL: SCTV01C|OTHER: Placebo,Sinocelltech Ltd.,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,300,INDUSTRY,INTERVENTIONAL,12/22/2021,1/1/2023
NCT06085911,NOT_YET_RECRUITING,Rehabilitation|Post-Acute COVID-19 Syndrome|Post-Infectious Disorders,BEHAVIORAL: One day course|BEHAVIORAL: Individual follow-ups,University Hospital of North Norway,University of Bergen|Oslo University Hospital|Norwegian University of Science and Technology,ALL,"ADULT, OLDER_ADULT",NA,60,OTHER,INTERVENTIONAL,2023-11,2025-11
NCT04878211,COMPLETED,Relapsing Multiple Sclerosis (RMS),DRUG: Ofatumumab|BIOLOGICAL: mRNA COVID-19 vaccine|DRUG: interferon or glatiramer acetate,Novartis Pharmaceuticals,,ALL,ADULT,PHASE4,24,INDUSTRY,INTERVENTIONAL,6/10/2021,4/14/2023
NCT04445311,UNKNOWN,COVID,DRUG: Ivermectin,Zagazig University,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,100,OTHER_GOV,INTERVENTIONAL,5/31/2020,8/15/2020
NCT04473170,COMPLETED,Coronavirus Disease 2019 (COVID-19),BIOLOGICAL: Autologous Non-Hematopoietic Peripheral Blood Stem Cells (NHPBSC)|DRUG: COVID-19 standard care,Abu Dhabi Stem Cells Center,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,146,OTHER_GOV,INTERVENTIONAL,4/4/2020,7/14/2020
NCT04405570,COMPLETED,"SARS-CoV-2 Infection, COVID-19",DRUG: Molnupiravir 200 mg|DRUG: Molnupiravir 400 mg|DRUG: Molnupiravir 800 mg|DRUG: Placebo (PBO),"Ridgeback Biotherapeutics, LP",Merck Sharp & Dohme LLC,ALL,"ADULT, OLDER_ADULT",PHASE2,204,INDUSTRY,INTERVENTIONAL,6/19/2020,2/21/2021
NCT04354870,COMPLETED,COVID-19,DRUG: Hydroxychloroquine (HCQ),NYU Langone Health,,ALL,"ADULT, OLDER_ADULT",PHASE2,130,OTHER,INTERVENTIONAL,4/3/2020,10/1/2020
NCT04527211,UNKNOWN,Covid19|Healthcare Worker Patient Transmission,DRUG: Ivermectin,Javeriana University,,ALL,"ADULT, OLDER_ADULT",PHASE3,550,OTHER,INTERVENTIONAL,9/7/2020,12/16/2020
NCT04945811,COMPLETED,Covid19 Positive Patients,DIAGNOSTIC_TEST: Interlukein 6 and procalcitonin serum levels,FARAH AFZAL,,ALL,"ADULT, OLDER_ADULT",NA,100,OTHER,INTERVENTIONAL,4/1/2020,5/30/2021
NCT04771611,COMPLETED,Covid19|Coronavirus Infection,DRUG: Fisetin|DRUG: Placebo,"James L. Kirkland, MD, PhD",,ALL,"ADULT, OLDER_ADULT",PHASE2,55,OTHER,INTERVENTIONAL,7/14/2021,9/27/2022
NCT05393999,WITHDRAWN,SARS-CoV2 Infection|SARS-CoV-2 Acute Respiratory Disease|Myeloma|Leukemia|Lymphoma|Immune Thrombocytopenia|Thrombotic Thrombocytopenic Purpura (TTP),BIOLOGICAL: BMS-986414|BIOLOGICAL: BMS-986413,Imperial College Healthcare NHS Trust,Imperial College London|University of Oxford|Oxford University Hospitals NHS Trust,ALL,"ADULT, OLDER_ADULT",PHASE2,0,OTHER,INTERVENTIONAL,11/29/2021,3/4/2022
NCT06055270,NOT_YET_RECRUITING,Parosmia,PROCEDURE: Stellate Ganglion Block|OTHER: Placebo,Lawson Health Research Institute,,ALL,"ADULT, OLDER_ADULT",PHASE3,44,OTHER,INTERVENTIONAL,1/15/2024,5/15/2026
NCT04395911,COMPLETED,AKI|ARDS|COVID,DEVICE: SCD,SeaStar Medical,,ALL,"ADULT, OLDER_ADULT",NA,22,INDUSTRY,INTERVENTIONAL,9/10/2020,7/21/2021
NCT04261270,UNKNOWN,2019-nCoV Pneumonia,DRUG: ASC09F+Oseltamivir|DRUG: Ritonavir+Oseltamivir|DRUG: Oseltamivir,Tongji Hospital,,ALL,ADULT,PHASE3,60,OTHER,INTERVENTIONAL,2/1/2020,7/1/2020
NCT04480411,WITHDRAWN,Diagnoses Disease|Covid19,BEHAVIORAL: Doctorgram Patient Kit,Stanford University,,ALL,"ADULT, OLDER_ADULT",NA,0,OTHER,INTERVENTIONAL,2022-01,2022-12
NCT05841498,RECRUITING,Post-COVID-19 Syndrome|Post-COVID Syndrome|Post COVID-19 Condition,DEVICE: Immunoadsorption|DEVICE: Sham-apheresis,University Medical Center Mainz,,ALL,"ADULT, OLDER_ADULT",NA,40,OTHER,INTERVENTIONAL,5/8/2023,2024-03
NCT04362813,COMPLETED,Cytokine Release Syndrome (CRS) in Patients With COVID-19-induced Pneumonia,DRUG: Canakinumab|DRUG: Placebo,Novartis Pharmaceuticals,,ALL,"ADULT, OLDER_ADULT",PHASE3,454,INDUSTRY,INTERVENTIONAL,4/30/2020,12/22/2020
NCT04383613,UNKNOWN,Covid-19|ARDS,OTHER: Prone positioning,Unity Health Toronto,"Sunnybrook Health Sciences Centre|Sinai Health System|Toronto General Hospital|University Health Network, Toronto|William Osler Health System",ALL,"ADULT, OLDER_ADULT",NA,340,OTHER,INTERVENTIONAL,5/15/2020,6/1/2021
NCT04771013,COMPLETED,COVID-19,BIOLOGICAL: Thymic peptides,Universidad Católica de Honduras,Pontificia Universidad Catolica de Chile,ALL,"ADULT, OLDER_ADULT",PHASE2,22,OTHER,INTERVENTIONAL,2/10/2021,5/14/2021
NCT05077969,TERMINATED,2019 Novel Coronavirus Disease|2019 Novel Coronavirus Infection|2019-nCoV Disease|2019-nCoV Infection|COVID-19|COVID-19 Pandemic|COVID-19 Virus Disease|COVID-19 Virus Infection|Covid19|Coronavirus Disease 2019|SARS-CoV2 Infection|SARS-CoV-2 Acute Respiratory Disease,DRUG: Famotidine|DRUG: Celecoxib|DRUG: Placebo,Leidos Life Sciences,United States Department of Defense,ALL,"ADULT, OLDER_ADULT",PHASE2,9,INDUSTRY,INTERVENTIONAL,12/29/2021,7/8/2022
NCT04448769,COMPLETED,Coronavirus Infection|Prevalence,BIOLOGICAL: Anti-SARS-CoV-2 IgT seropositivity,"Central Hospital, Nancy, France",University of Lorraine|Métropole du Grand Nancy,ALL,"CHILD, ADULT, OLDER_ADULT",NA,2006,OTHER,INTERVENTIONAL,6/26/2020,7/24/2020
NCT04499313,UNKNOWN,Covid19|ARDS,DRUG: Dexamethasone|DRUG: Methylprednisolone,Chattogram General Hospital,Health Science Center of Xi'an Jiaotong University,ALL,"ADULT, OLDER_ADULT",PHASE3,60,OTHER_GOV,INTERVENTIONAL,8/2/2020,11/30/2020
NCT05595369,ENROLLING_BY_INVITATION,Long COVID|Long Covid19,DRUG: Experimental: Paxlovid 25 day dosing|DRUG: Experimental: Paxlovid 15 day dosing|DRUG: Placebo Comparator: Control,Kanecia Obie Zimmerman,,ALL,"ADULT, OLDER_ADULT",PHASE2,900,OTHER,INTERVENTIONAL,7/26/2023,2024-07
NCT05157269,NOT_YET_RECRUITING,COVID-19,DRUG: Nitazoxanide|DRUG: Placebo|DIETARY_SUPPLEMENT: Vitamin Super-B Complex,Romark Laboratories L.C.,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,600,INDUSTRY,INTERVENTIONAL,2024-08,2025-03
NCT06217211,RECRUITING,SARS CoV 2 Infection|Muscle Disorder|Fatigue,DIETARY_SUPPLEMENT: Remolacha,Hospital de Mataró,,ALL,"ADULT, OLDER_ADULT",NA,30,OTHER,INTERVENTIONAL,11/13/2023,5/31/2024
NCT04403269,UNKNOWN,Sars-CoV2,DRUG: IgIV,Versailles Hospital,,ALL,OLDER_ADULT,PHASE2,35,OTHER,INTERVENTIONAL,5/5/2020,5/5/2021
NCT05447013,RECRUITING,Severe COVID-19,BIOLOGICAL: Coronavirus-2-specific T cells|OTHER: standard of care (SOC),George Papanicolaou Hospital,General Hospital Of Thessaloniki Ippokratio,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,182,OTHER,INTERVENTIONAL,6/2/2021,12/31/2022
NCT04609969,COMPLETED,Covid19|SARS-CoV-2 Infection,DIAGNOSTIC_TEST: RT-qPCR test|DIAGNOSTIC_TEST: COVID-VIRO® test,Centre Hospitalier Régional d'Orléans,,ALL,"ADULT, OLDER_ADULT",NA,200,OTHER,INTERVENTIONAL,10/13/2020,10/17/2020
NCT05049213,COMPLETED,Covid19|SARS-CoV 2 Infection,DRUG: Carrageenan nasal spray and 1% PVP- mouthwash and gargle,National Taiwan University Hospital,,ALL,"ADULT, OLDER_ADULT",PHASE4,7,OTHER,INTERVENTIONAL,6/24/2022,8/1/2022
NCT04954469,COMPLETED,Immune Deficiency Disease,BIOLOGICAL: CoVAC-1,University Hospital Tuebingen,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,54,OTHER,INTERVENTIONAL,6/30/2021,4/30/2023
NCT04910269,RECRUITING,COVID|SARS-CoV2 Infection|Covid19,BIOLOGICAL: Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG)|OTHER: Placebo,University of Minnesota,National Institute of Allergy and Infectious Diseases (NIAID)|National Institutes of Health (NIH)|International Network for Strategic Initiatives in Global HIV Trials (INSIGHT),ALL,"ADULT, OLDER_ADULT",PHASE3,820,OTHER,INTERVENTIONAL,8/6/2021,8/1/2024
NCT04961359,COMPLETED,Coronavirus,BIOLOGICAL: Recombinant new coronavirus vaccine (CHO cell) group|BIOLOGICAL: Recombinant new coronavirus vaccine (CHO cells) placebo group,"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.",,ALL,CHILD,PHASE1,75,INDUSTRY,INTERVENTIONAL,7/3/2021,4/6/2023
NCT05851859,NOT_YET_RECRUITING,Long COVID,OTHER: Cardiac coherence,Centre Hospitalier Universitaire de la Réunion,,ALL,"ADULT, OLDER_ADULT",NA,200,OTHER,INTERVENTIONAL,10/1/2023,6/1/2026
NCT05029856,WITHDRAWN,Covid19,BIOLOGICAL: SII B.1.351|BIOLOGICAL: SII B.1.351|BIOLOGICAL: SII Bivalent|BIOLOGICAL: SII Bivalent|BIOLOGICAL: SII B.1.617.2,Novavax,,ALL,ADULT,PHASE1|PHASE2,0,INDUSTRY,INTERVENTIONAL,2/4/2022,2022-08
NCT04811859,UNKNOWN,Covid19|Infective Pneumonia,OTHER: Inspiratory Muscle Training,Istinye University,,ALL,"ADULT, OLDER_ADULT",NA,40,OTHER,INTERVENTIONAL,1/10/2021,3/10/2022
NCT04978259,RECRUITING,Covid19,DRUG: Remdesivir,Clinical Urology and Epidemiology Working Group,University of Helsinki|World Health Organization|Helsinki University Central Hospital|Hyvinkää Hospital|Kanta-Häme Central Hospital|Kuopio University Hospital|Oulu University Hospital|Porvoo Hospital|Seinajoki Central Hospital|Mikkeli Central Hospital|Tampere University Hospital,ALL,"ADULT, OLDER_ADULT",PHASE4,202,OTHER_GOV,INTERVENTIONAL,7/24/2021,12/31/2023
NCT05005559,COMPLETED,Covid19,BIOLOGICAL: SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant|BIOLOGICAL: Saline placebo,Cinnagen,Vaxine Pty Ltd,ALL,ADULT,PHASE3,16876,INDUSTRY,INTERVENTIONAL,8/7/2021,3/10/2022
NCT04716556,COMPLETED,"Covid19|Coronavirus Infection|Pneumonia, Viral",BIOLOGICAL: Convalescent plasma,Istituto Superiore di Sanità,Gruppo Italiano Malattie EMatologiche dell'Adulto|Agenzia Italiana del Farmaco,ALL,"ADULT, OLDER_ADULT",NA,474,OTHER,INTERVENTIONAL,7/16/2020,5/31/2021
NCT04359303,UNKNOWN,COVID,OTHER: Systemic indirect endovenous ozone therapy,Javier Hidalgo Tallón,Sociedad Española de Ozonoterapia,ALL,"ADULT, OLDER_ADULT",PHASE3,50,OTHER,INTERVENTIONAL,2020-07,2020-12
NCT04613050,COMPLETED,Covid 19 Infection,OTHER: Respiratory Training|OTHER: Aerobic training,Cairo University,,ALL,ADULT,NA,80,OTHER,INTERVENTIONAL,7/2/2020,10/30/2022
NCT06247059,NOT_YET_RECRUITING,SARS-CoV2 Infection|Influenza Viral Infections|Respiratory Viral Infection,DEVICE: Box Fan|DEVICE: UV Germicidal Irradiation Lamp Unit|DEVICE: Combined: Box Fan and UV Germicidal Irradiation Lamp Units,Stanford University,"Centers for Disease Control and Prevention|International Centre for Diarrhoeal Disease Research, Bangladesh",ALL,CHILD,NA,20000,OTHER,INTERVENTIONAL,2024-12,2026-03
NCT04788459,TERMINATED,COVID-19|Protection Against COVID-19 and Infections With SARS-CoV- 2|COVID-19 Immunisation,BIOLOGICAL: COVID-eVax|DEVICE: Cliniporator® and EPSGun,Takis,Rottapharm Biotech,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,68,INDUSTRY,INTERVENTIONAL,2/25/2021,12/7/2021
NCT04896606,RECRUITING,Covid19,OTHER: Standard of Care|BIOLOGICAL: SARS-CoV2-CTLS,New York Medical College,Children's Hospital of Philadelphia|Medical College of Wisconsin|Nationwide Children's Hospital,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,50,OTHER,INTERVENTIONAL,9/20/2021,12/31/2025
NCT04371406,WITHDRAWN,Covid-19,DRUG: Hydroxychloroquine and Azithromycin|DIETARY_SUPPLEMENT: Azinc,Assistance Publique - Hôpitaux de Paris,,ALL,"ADULT, OLDER_ADULT",PHASE3,0,OTHER,INTERVENTIONAL,2020-04,2020-09
NCT05172206,ACTIVE_NOT_RECRUITING,COVID-19|Long-COVID,OTHER: symptom-focused rehabilitation|OTHER: usual care,Schön Klinik Berchtesgadener Land,Bavarian State Office for Health and Food Safety|Praxis im Zentrum Erlangen|Pneumologen Lichterfelde Berlin|Pneumopraxis Marburg|COVID ambulance Philipps-University Marburg|Pneumologie Elisenhof Munich|COVID ambulance Pneumology LMU Munich|COVID ambulance psychology LMU Munich|University Clinic Augsburg|COVID ambulance Schön Klinik Schönau,ALL,"ADULT, OLDER_ADULT",NA,132,OTHER,INTERVENTIONAL,5/20/2022,12/31/2023
NCT04403906,UNKNOWN,COVID|SARS-CoV 2,DIAGNOSTIC_TEST: PCL COV05 - COVID 19 Ag Rapid FIA test (Rapid Antigen Test),Somerset NHS Foundation Trust,,ALL,"ADULT, OLDER_ADULT",NA,200,OTHER,INTERVENTIONAL,2020-06,2021-08
NCT05239806,UNKNOWN,COVID-19|SARS-CoV-2 Infection,BIOLOGICAL: SCTV01C|BIOLOGICAL: SCTV01E|BIOLOGICAL: Sinopharm inactivated COVID-19 vaccine|BIOLOGICAL: Comirnaty|BIOLOGICAL: SCTV01E,Sinocelltech Ltd.,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,400,INDUSTRY,INTERVENTIONAL,4/1/2022,8/1/2023
NCT04379154,COMPLETED,COVID-19,DEVICE: Volatile Organic Compounds analysis,Hopital Foch,,ALL,"ADULT, OLDER_ADULT",NA,65,OTHER,INTERVENTIONAL,4/14/2020,6/1/2021
NCT06172803,RECRUITING,"Long Covid19|Exercise Intolerance, Riboflavin-Responsive",BEHAVIORAL: Restoring Energy with Sub-symptom Threshold Aerobic Rehabilitation Exercise|BEHAVIORAL: Light Stretching/Breathing Exercises,Columbia University,New York University,ALL,"ADULT, OLDER_ADULT",NA,20,OTHER,INTERVENTIONAL,10/1/2023,2024-01
NCT04820803,COMPLETED,COVID-19|SARS-CoV-2 Infection,OTHER: ORAL INTERVENTION WITH CETYLPYRIDINIUM CHLORIDE|OTHER: PLACEBO,Rosa Tarrago,Dentaid SL,ALL,"ADULT, OLDER_ADULT",NA,80,OTHER,INTERVENTIONAL,2/3/2021,6/30/2021
NCT04685603,UNKNOWN,COVID-19,BIOLOGICAL: AV-COVID-19,Indonesia-MoH,"Aivita Biomedical, Inc.|PT AIVITA Biomedika Indonesia|National Institute of Health Research and Development, Ministry of Health Republic of Indonesia|RSUP Dr. Kariadi Semarang, indonesia|Faculty of Medicine University of Diponegoro, Indonesia",ALL,"ADULT, OLDER_ADULT",PHASE1,27,OTHER_GOV,INTERVENTIONAL,12/7/2020,1/31/2022
NCT04358003,COMPLETED,Respiratory Failure|ARDS,DEVICE: Marker Therapeutics D2000 Cartridge (D2000) for use with the Spectra Optia® Apheresis System (Optia SPD Protocol),Marker Therapeutics AG,Terumo BCT,ALL,"ADULT, OLDER_ADULT",NA,107,INDUSTRY,INTERVENTIONAL,5/20/2020,4/1/2022
NCT05178654,WITHDRAWN,Healthy Participants,DRUG: [14C]PF-07321332,Pfizer,,MALE,"ADULT, OLDER_ADULT",PHASE1,0,INDUSTRY,INTERVENTIONAL,2/22/2022,4/1/2022
NCT04561154,RECRUITING,SARS-COV2|COVID19,OTHER: questionnaire,Centre Hospitalier le Mans,,ALL,"ADULT, OLDER_ADULT",NA,134,OTHER,INTERVENTIONAL,6/11/2020,6/11/2022
NCT04427254,TERMINATED,COVID19,"DRUG: Cerebrospinal fluid sampling, meningeal and brain parenchyma biopsies",Fondation Ophtalmologique Adolphe de Rothschild,,ALL,"ADULT, OLDER_ADULT",NA,2,NETWORK,INTERVENTIONAL,6/26/2020,11/25/2022
NCT04398303,UNKNOWN,COVID-19 Pneumonia,BIOLOGICAL: ACT-20-MSC|BIOLOGICAL: ACT-20-CM|BIOLOGICAL: Placebo,Aspire Health Science,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,70,OTHER,INTERVENTIONAL,2020-05,2020-10
NCT04363203,SUSPENDED,SARS-CoV-2|COVID-19,DRUG: Hydroxychloroquine|DRUG: Azithromycin|DRUG: Placebo oral tablet,Salomeh Keyhani MD,San Francisco VA Health Care System,ALL,"ADULT, OLDER_ADULT",PHASE3,300,FED,INTERVENTIONAL,4/30/2020,2021-08
NCT04399356,COMPLETED,COVID-19,DRUG: Niclosamide|DRUG: Placebo|OTHER: Telehealth monitoring,Tufts Medical Center,,ALL,"ADULT, OLDER_ADULT",PHASE2,73,OTHER,INTERVENTIONAL,10/1/2020,8/19/2021
NCT05611554,ACTIVE_NOT_RECRUITING,Parent-Child Relations|Parental Stress,BEHAVIORAL: ACT,Universidad Europea de Madrid,,ALL,"ADULT, OLDER_ADULT",NA,21,OTHER,INTERVENTIONAL,12/1/2021,2/15/2023
NCT05951803,ENROLLING_BY_INVITATION,Insomnia Chronic|Anxiety|Depression|Sleep Quality|Life Quality,BEHAVIORAL: Brief Behavioral Intervention in Insomnia,Hospital General de Mexico,,ALL,ADULT,NA,36,OTHER_GOV,INTERVENTIONAL,6/23/2023,2/1/2024
NCT04257656,TERMINATED,COVID-19|Remdesivir|SARS-CoV-2,DRUG: Remdesivir|DRUG: Remdesivir placebo,Capital Medical University,,ALL,"ADULT, OLDER_ADULT",PHASE3,237,OTHER,INTERVENTIONAL,2/6/2020,4/10/2020
NCT04668950,COMPLETED,Covid19|Coronavirus,DRUG: Fluvoxamine|DRUG: Placebo,Washington University School of Medicine,Covid-19 Early Treatment Fund|McGill University Health Centre Department of Medicine Clinical Practice Assessment Unit|Cures Within Reach,ALL,"ADULT, OLDER_ADULT",PHASE3,670,OTHER,INTERVENTIONAL,12/22/2020,9/28/2021
NCT04530656,COMPLETED,COVID-19,"BIOLOGICAL: Two doses of middle-dose recombinant SARS-CoV-2 vaccine (Sf9 Cell) at the schedule of day 0, 28|BIOLOGICAL: Two doses of high-dose recombinant SARS-CoV-2 vaccine (Sf9 Cell) at the schedule of day 0, 28|BIOLOGICAL: Three doses of high-dose recombinant SARS-CoV-2 vaccine (Sf9 Cell) at the schedule of day 0, 14, 28|BIOLOGICAL: Two doses of placebo at the schedule of day 0, 28（middle-dose group）|BIOLOGICAL: Two doses of placebo at the schedule of day 0, 28（high-dose group）|BIOLOGICAL: Three doses of placebo at the schedule of day 0, 14, 28（high-dose group）",Jiangsu Province Centers for Disease Control and Prevention,West China Hospital,ALL,"ADULT, OLDER_ADULT",PHASE1,168,NETWORK,INTERVENTIONAL,8/28/2020,11/23/2021
NCT04866303,COMPLETED,SARS-CoV-2|Covid19,DIAGNOSTIC_TEST: Home-based SARS-CoV-2 test kit,Montana State University,National Institute of General Medical Sciences (NIGMS)|University of Washington|Fred Hutchinson Cancer Center|Salish Kootenai College,ALL,"ADULT, OLDER_ADULT",NA,273,OTHER,INTERVENTIONAL,4/26/2021,3/9/2022
NCT04883203,COMPLETED,Covid19,DRUG: Vit-D 0.2 MG/ML Oral Solution [Calcidol]|DRUG: Physiological Irrigating Solution,University of Monastir,Loussaief Chawki|Nissaf Ben Alaya|Cyrine Ben Nasrallah|Manel Ben Belgacem|Hela Abroug|Imen Zemni|Manel Ben fredj|Wafa Dhouib,ALL,"ADULT, OLDER_ADULT",PHASE3,130,OTHER,INTERVENTIONAL,4/22/2020,10/31/2020
NCT04987554,UNKNOWN,SARS-CoV-2 Infection,DIETARY_SUPPLEMENT: glycophosphopeptical AM3|OTHER: Placebo,University of Valladolid,Instituto de Salud Carlos III|Sanidad de Castilla y León,ALL,"ADULT, OLDER_ADULT",NA,120,OTHER,INTERVENTIONAL,4/1/2021,12/31/2022
NCT05897203,RECRUITING,Acute Respiratory Infection,DRUG: TAZCOV|DRUG: Vidicine,Makerere University,"Makerere University Lung Institute|MRC/UVRI and LSHTM Uganda Research Unit|Directorate of Government Analytical Laboratories|Makerere University College of Veterinary Medicine, Animal Resources and Bio-security|Makerere University Biomedical Research Centre|Natural Chemotherapeutics Research Institute",ALL,"ADULT, OLDER_ADULT",PHASE2,510,OTHER,INTERVENTIONAL,3/3/2023,2024-01
NCT05270954,ACTIVE_NOT_RECRUITING,COVID-19,BIOLOGICAL: Betuvax-CoV-2|DRUG: Placebo,"Human Stem Cell Institute, Russia",Betuvax LLC|CEG BIO LLC,ALL,ADULT,PHASE1|PHASE2,116,OTHER,INTERVENTIONAL,10/14/2021,7/24/2022
NCT05077254,RECRUITING,Kidney Transplant Recipients|Liver Transplant Recipients,BIOLOGICAL: Pfizer-BioNTech COVID-19 Vaccine 2023-2024|BIOLOGICAL: Moderna COVID-19 Vaccine 2023-2024|DRUG: SOC IS Regimen|DRUG: SOC IS Reduction,National Institute of Allergy and Infectious Diseases (NIAID),PPD|Johns Hopkins University,ALL,"ADULT, OLDER_ADULT",PHASE2,400,NIH,INTERVENTIONAL,12/6/2021,3/4/2025
NCT04868903,ACTIVE_NOT_RECRUITING,SARS-CoV-2 Infection,DIETARY_SUPPLEMENT: Vitamin D3,University of Chicago,Rush University Medical Center,ALL,"ADULT, OLDER_ADULT",NA,2000,OTHER,INTERVENTIONAL,11/30/2020,12/30/2024
NCT05611203,RECRUITING,SARS-CoV Infection|Coronavirus|Corona Virus Infection,PROCEDURE: An Oropharyngeal swab,"Rigshospitalet, Denmark",,ALL,"ADULT, OLDER_ADULT",NA,1000,OTHER,INTERVENTIONAL,11/10/2022,3/2/2023
NCT04570254,COMPLETED,"Pneumonia, Viral|Covid19|ARDS|Oxidative Stress",DRUG: Vitamin C|DRUG: Vitamin E|DRUG: Melatonin|DRUG: N-acetyl cysteine|DRUG: Pentoxifylline,Unidad Temporal COVID-19 en Centro Citibanamex,Instituto Nacional de Cardiologia Ignacio Chavez|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,ALL,"CHILD, ADULT, OLDER_ADULT",NA,110,OTHER,INTERVENTIONAL,8/19/2020,12/1/2020
NCT04408456,COMPLETED,CoVID-19,DRUG: HCQ|OTHER: Standard therapy,Postgraduate Institute of Medical Education and Research,,ALL,"ADULT, OLDER_ADULT",PHASE3,325,OTHER_GOV,INTERVENTIONAL,3/1/2020,7/31/2020
NCT05305456,COMPLETED,Novel Coronavirus Pneumonia,DRUG: Tanreqing capsule|DRUG: Tanreqing capsule simulator,"Jiangsu Famous Medical Technology Co., Ltd.",Ruijin Hospital,ALL,"ADULT, OLDER_ADULT",PHASE3,480,INDUSTRY,INTERVENTIONAL,3/28/2022,8/31/2022
NCT05238454,UNKNOWN,COVID-19|SARS-CoV-2 Infection,BIOLOGICAL: SCTV01C|BIOLOGICAL: Sinopharm inactivated COVID-19 vaccine|BIOLOGICAL: Comirnaty,Sinocelltech Ltd.,,ALL,"ADULT, OLDER_ADULT",PHASE2,600,INDUSTRY,INTERVENTIONAL,3/20/2022,12/1/2022
NCT04347954,COMPLETED,COVID-19,DRUG: Povidone-Iodine 2%|DRUG: Povidone-Iodine 0.5%|DRUG: Isotonic saline 0.9%,Stanford University,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,47,OTHER,INTERVENTIONAL,8/15/2020,12/13/2020
NCT05481203,COMPLETED,Anxiety|Fear,BEHAVIORAL: The Kaleidescope|BEHAVIORAL: The visual illusion cards,Ondokuz Mayıs University,,ALL,CHILD,NA,114,OTHER,INTERVENTIONAL,3/1/2022,7/1/2022
NCT05690503,RECRUITING,Post-acute Sequelae of COVID-19|Depressive Symptoms|Cognitive Dysfunction,DRUG: CI-581a|DRUG: CI-581b,New York State Psychiatric Institute,,ALL,"ADULT, OLDER_ADULT",PHASE2,12,OTHER,INTERVENTIONAL,3/20/2023,12/31/2023
NCT04366856,COMPLETED,COVID|ARDS,BEHAVIORAL: 1: Prone positioning|BEHAVIORAL: 2: No instruction regarding positioning,Assistance Publique - Hôpitaux de Paris,,ALL,"ADULT, OLDER_ADULT",NA,446,OTHER,INTERVENTIONAL,6/26/2020,9/23/2021
NCT04507256,COMPLETED,COVID-19,COMBINATION_PRODUCT: AZD7442|OTHER: Placebo,AstraZeneca,Parexel,ALL,ADULT,PHASE1,60,INDUSTRY,INTERVENTIONAL,8/18/2020,10/19/2021
NCT04510454,COMPLETED,Cancer|COVID,DIAGNOSTIC_TEST: Nasopharyngeal and throat/oropharyngeal swabs analyses by RT-PCR and ddPCR,Centre Leon Berard,,ALL,"ADULT, OLDER_ADULT",NA,100,OTHER,INTERVENTIONAL,11/2/2020,10/12/2021
NCT04646603,UNKNOWN,"COVID-19|ARDS, Human|Stem Cells|Regeneration",DRUG: MRG-001|DRUG: Placebo,MedRegen LLC,ICON plc|Johns Hopkins University,ALL,"ADULT, OLDER_ADULT",PHASE2,40,INDUSTRY,INTERVENTIONAL,12/1/2021,7/1/2022
NCT04359654,COMPLETED,COVID19|Hypoxia,DRUG: Dornase Alfa Inhalation Solution [Pulmozyme],"University College, London",,ALL,"ADULT, OLDER_ADULT",PHASE2,41,OTHER,INTERVENTIONAL,6/16/2020,11/5/2021
NCT04352803,NOT_YET_RECRUITING,Covid-19 Pneumonia|Cyotokine Storm,BIOLOGICAL: Autologous Adipose MSC's,Regeneris Medical,,ALL,"ADULT, OLDER_ADULT",PHASE1,20,OTHER,INTERVENTIONAL,2020-04,2026-04
NCT04390503,TERMINATED,SARS-CoV 2|COVID-19,BIOLOGICAL: Convalescent Plasma (anti-SARS-CoV-2 plasma)|BIOLOGICAL: Control (albumin 5%),Andrew Eisenberger,,ALL,"ADULT, OLDER_ADULT",PHASE2,89,OTHER,INTERVENTIONAL,3/12/2021,1/6/2022
NCT03376854,WITHDRAWN,"Respiratory Distress Syndrome, Adult|Sars-CoV2",DEVICE: Hypothermia|DRUG: Neuromuscular Blocking Agents|DEVICE: Standard of Care,"University of Maryland, Baltimore",,ALL,"ADULT, OLDER_ADULT",PHASE2,0,OTHER,INTERVENTIONAL,5/1/2018,4/27/2021
NCT04630054,COMPLETED,Covid19,DEVICE: Face mask|BEHAVIORAL: Face mask awareness,Yale University,Stanford University|Innovations for Poverty Action|North South University,ALL,"ADULT, OLDER_ADULT",NA,350000,OTHER,INTERVENTIONAL,11/15/2020,6/29/2021
NCT05715554,COMPLETED,Post-COVID Syndrome,OTHER: Homeopathy,Innowage Limited,Gyansanjeevani India|Collaborative Homeopathy Research Network,ALL,"ADULT, OLDER_ADULT",NA,69,INDUSTRY,INTERVENTIONAL,8/6/2022,1/12/2023
NCT04948203,RECRUITING,Pulmonary Fibrosis|COVID-19 Pneumonia|Long COVID,DRUG: Sirolimus,University of Chicago,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,60,OTHER,INTERVENTIONAL,7/9/2021,2024-06
NCT04527354,COMPLETED,SARS-CoV-2 Infection|Fibrosis Lung,DRUG: Treamid|DRUG: Placebo,PHARMENTERPRISES LLC,,ALL,"ADULT, OLDER_ADULT",PHASE2,60,INDUSTRY,INTERVENTIONAL,9/1/2020,2/10/2021
NCT05706454,RECRUITING,COVID-19 Pneumonia|COVID-19 Respiratory Infection,DRUG: Ramatroban|DRUG: Placebo,KARE Biosciences,"JSS Medical Research Inc.|Biomedical Advanced Research and Development Authority|Open Philanthropy|Charak Laboratories India Pvt. Ltd|Charak Foundation|BioLink Life Sciences, Inc.",ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,324,INDUSTRY,INTERVENTIONAL,11/10/2022,5/31/2026
NCT05705154,RECRUITING,Post-COVID-19 Syndrome|Anxiety|Breathlessness,BEHAVIORAL: Psychology interventions,Royal Brompton & Harefield NHS Foundation Trust,Guy's and St Thomas' NHS Foundation Trust|University College London Hospitals,ALL,"CHILD, ADULT",NA,40,OTHER,INTERVENTIONAL,4/30/2023,3/30/2024
NCT04595903,TERMINATED,COVID-19,DEVICE: Hemopurifier,Aethlon Medical Inc.,,ALL,"ADULT, OLDER_ADULT",NA,1,INDUSTRY,INTERVENTIONAL,6/1/2022,11/14/2022
NCT05904054,ACTIVE_NOT_RECRUITING,COVID-19,BIOLOGICAL: SARS-CoV-2 DNA Vaccine (ICCOV),Immuno Cure 3 Limited,The University of Hong Kong,ALL,"ADULT, OLDER_ADULT",PHASE2,31,INDUSTRY,INTERVENTIONAL,6/15/2023,5/31/2024
NCT04805203,TERMINATED,Multiple Myeloma|Covid19,OTHER: blood sample analyses,Intergroupe Francophone du Myelome,,ALL,"ADULT, OLDER_ADULT",NA,139,NETWORK,INTERVENTIONAL,12/16/2020,12/31/2022
NCT05659459,SUSPENDED,COVID-19,DRUG: KIN001|DRUG: KIN001-Placebo,Kinarus AG,,ALL,"ADULT, OLDER_ADULT",PHASE2,400,INDUSTRY,INTERVENTIONAL,8/25/2022,10/31/2025
NCT05704803,COMPLETED,COVID-19 Pandemic,DIAGNOSTIC_TEST: Diagnostic Test: IN Vitro,3EO Health,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,202,INDUSTRY,INTERVENTIONAL,4/11/2022,4/30/2023
NCT05769803,ACTIVE_NOT_RECRUITING,Sars-CoV-2 Infection,DIAGNOSTIC_TEST: Nasal and mouth swab,IRCCS Sacro Cuore Don Calabria di Negrar,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,61,OTHER,INTERVENTIONAL,3/14/2022,9/30/2023
NCT04707703,TERMINATED,Severe Acute Respiratory Syndrome Coronavirus 2|Aspergillosis Invasive,DRUG: Isavuconazonium Injection [Cresemba]|DRUG: Placebo,"Jeffrey Jenks, MD, MPH","Astellas Pharma Global Development, Inc.",ALL,"ADULT, OLDER_ADULT",PHASE3,8,OTHER,INTERVENTIONAL,3/16/2021,10/25/2021
NCT04516954,UNKNOWN,COVID 19,BIOLOGICAL: Convalescent COVID 19 Plasma,Vinmec Research Institute of Stem Cell and Gene Technology,"National Institute of Hygiene and Epidemiology, Vietnam|National Hospital for Tropical Diseases, Hanoi, Vietnam|National Institute of Hematology and Blood Transfusion, Vietnam",ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,10,OTHER,INTERVENTIONAL,8/1/2020,12/30/2020
NCT04778059,TERMINATED,"2019 Novel Coronavirus Infection|COVID-19 Virus Infection|SARS Coronavirus 2 Infection|SARS-CoV-2 Infection|Respiratory Distress Syndrome, Adult|Adult Respiratory Distress Syndrome",DRUG: USB002|DRUG: Placebo,"US Biotest, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE2,21,INDUSTRY,INTERVENTIONAL,7/27/2021,5/10/2022
NCT04410354,TERMINATED,COVID-19,DRUG: Merimepodib|DRUG: Matching Placebo|DRUG: Remdesivir,"ViralClear Pharmaceuticals, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE2,44,INDUSTRY,INTERVENTIONAL,6/16/2020,12/1/2020
NCT04784754,WITHDRAWN,COVID-19,DRUG: Melatonin|DRUG: Placebo,State University of New York at Buffalo,National Center for Advancing Translational Sciences (NCATS),ALL,"ADULT, OLDER_ADULT",PHASE2,0,OTHER,INTERVENTIONAL,4/1/2021,12/31/2022
NCT04854759,UNKNOWN,COVID-19|SARS-CoV-2,DRUG: Amantadine Hydrochloride|DRUG: Placebo,Independent Public Clinical Hospital No. 4 in Lublin,,ALL,"ADULT, OLDER_ADULT",PHASE3,200,OTHER,INTERVENTIONAL,3/15/2021,5/31/2022
NCT04516759,COMPLETED,Covid19,DRUG: AZD1656|OTHER: Placebo,St George Street Capital,,ALL,"ADULT, OLDER_ADULT",PHASE2,170,OTHER,INTERVENTIONAL,8/12/2020,5/12/2021
NCT04964154,UNKNOWN,Covid19 Virus Infection,BEHAVIORAL: Protect Your Elders Campaign,North Carolina Central University,Lumbee Tribe of North Carolina|University of North Carolina at Pembroke,ALL,"ADULT, OLDER_ADULT",NA,4000,OTHER,INTERVENTIONAL,2/17/2021,6/30/2022
NCT05200754,UNKNOWN,SARS-CoV-2 Infection,OTHER: Convalescent/Vaccine-boosted Plasma (CP/PVP),Carsten Müller-Tidow,German Federal Ministry of Education and Research|Institut für Klinische Transfusionsmedizin und Zelltherapie Heidelberg gGmbH,ALL,"ADULT, OLDER_ADULT",PHASE2,174,OTHER,INTERVENTIONAL,9/3/2020,2022-06
NCT04941105,COMPLETED,Sars-CoV-2 Infection,DRUG: Evolocumab|DRUG: Saline solution,Collegium Medicum w Bydgoszczy,,ALL,"ADULT, OLDER_ADULT",PHASE3,60,OTHER,INTERVENTIONAL,6/1/2021,5/17/2022
NCT05952505,NOT_YET_RECRUITING,SARS-CoV-2 Infection|Varicella|Measles|Mumps|Rubella,BIOLOGICAL: Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine|BIOLOGICAL: Inactivated SARS-CoV-2 vaccine coadministered with MMR|BIOLOGICAL: Inactivated SARS-CoV-2 vaccine administered alone,Shanghai Municipal Center for Disease Control and Prevention,China National Biotec Group Company Limited,ALL,CHILD,PHASE4,540,OTHER,INTERVENTIONAL,2023-08,2024-12
NCT04602949,COMPLETED,Covid19,DIAGNOSTIC_TEST: Breath Biopsy Analysis,Scentech Medical Technologies Ltd,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,2558,INDUSTRY,INTERVENTIONAL,11/12/2020,1/18/2023
NCT06039449,ACTIVE_NOT_RECRUITING,COVID-19|SARS-CoV-2,DRUG: VYD222|DRUG: Normal saline,"Invivyd, Inc.",,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,790,INDUSTRY,INTERVENTIONAL,9/8/2023,2024-11
NCT04343963,UNKNOWN,COVID-19|SARS-CoV-2,DRUG: Pyridostigmine Bromide|DRUG: Placebo,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,436,OTHER,INTERVENTIONAL,4/4/2020,4/30/2021
NCT05360563,NOT_YET_RECRUITING,Long COVID|Post-acute COVID-19 Syndrome,OTHER: Home-based physical training,University of Sao Paulo,,ALL,"ADULT, OLDER_ADULT",NA,94,OTHER,INTERVENTIONAL,2022-05,2024-02
NCT04273763,UNKNOWN,Novel Coronavirus Pneumonia|2019-nCoV,DRUG: Bromhexine Hydrochloride Tablets|DRUG: Arbidol Hydrochloride Granules|DRUG: Recombinant Human Interferon α2b Spray,Second Affiliated Hospital of Wenzhou Medical University,"Wanbangde Pharmaceutical Group Co., LTD",ALL,"ADULT, OLDER_ADULT",NA,18,OTHER,INTERVENTIONAL,2/16/2020,6/1/2020
NCT04561063,COMPLETED,Covid19|SARS-CoV Infection,DRUG: Nitazoxanide|DRUG: Sofosbuvir/Daclatasvir,"University of Witwatersrand, South Africa",,ALL,"ADULT, OLDER_ADULT",PHASE2,1950,OTHER,INTERVENTIONAL,12/8/2020,2/28/2022
NCT04458363,COMPLETED,COVID,BIOLOGICAL: Convalescent Plasma (CP)|DRUG: Standard COVID-19 therapies,Emory University,,ALL,"CHILD, ADULT",EARLY_PHASE1,3,OTHER,INTERVENTIONAL,7/4/2020,9/1/2020
NCT04584593,UNKNOWN,Covid19,BIOLOGICAL: Sample,"University Hospital, Toulouse",,MALE,ADULT,NA,50,OTHER,INTERVENTIONAL,10/2/2020,2022-02
NCT06048393,RECRUITING,COVID-19,DRUG: SA55 nasal spray,"Sinovac Life Sciences Co., Ltd.",,ALL,"ADULT, OLDER_ADULT",PHASE1,80,INDUSTRY,INTERVENTIONAL,5/31/2023,10/31/2023
NCT04321616,UNKNOWN,SARS-CoV Infection|COVID 19|Acute Respiratory Distress Syndrome ARDS,DRUG: Hydroxychloroquine|DRUG: Remdesivir|OTHER: (Standard of Care) SoC,Oslo University Hospital,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,700,OTHER,INTERVENTIONAL,3/28/2020,2020-11
NCT04428268,WITHDRAWN,COVID-19 Pneumonia,DRUG: Chloroquine Phosphate Tablets,Hospital Universitario Dr. Jose E. Gonzalez,,ALL,"ADULT, OLDER_ADULT",PHASE2,0,OTHER,INTERVENTIONAL,3/10/2020,2/16/2021
NCT04381845,RECRUITING,COVID|Psychiatric Disorders,DIAGNOSTIC_TEST: COVID19 immunization testing,Assistance Publique - Hôpitaux de Paris,"Institut National de la Santé Et de la Recherche Médicale, France",ALL,"ADULT, OLDER_ADULT",NA,200,OTHER,INTERVENTIONAL,1/10/2021,12/10/2023
NCT04455815,TERMINATED,COVID-19 Infection,DRUG: Camostat,Cancer Research UK,Latus Therapeutics,ALL,"ADULT, OLDER_ADULT",PHASE2,34,OTHER,INTERVENTIONAL,9/23/2020,3/3/2022
NCT04308668,COMPLETED,Corona Virus Infection|Acute Respiratory Distress Syndrome|SARS-CoV Infection|Coronavirus|Coronavirus Infections,DRUG: Hydroxychloroquine|OTHER: Placebo,University of Minnesota,McGill University Health Centre/Research Institute of the McGill University Health Centre|University of Manitoba|University of Alberta,ALL,"ADULT, OLDER_ADULT",PHASE3,1312,OTHER,INTERVENTIONAL,3/17/2020,5/20/2020
NCT05614245,WITHDRAWN,COVID-19|Coronavirus Infections,BIOLOGICAL: VBI-2901e,VBI Vaccines Inc.,,ALL,ADULT,PHASE1,0,INDUSTRY,INTERVENTIONAL,2023-03,2024-06
NCT04506268,COMPLETED,Covid19,BEHAVIORAL: Opt-out Recruitment Email|BEHAVIORAL: Opt-in Recruitment Email,University of Pennsylvania,,ALL,"ADULT, OLDER_ADULT",NA,412,OTHER,INTERVENTIONAL,9/9/2020,10/30/2020
NCT04439045,COMPLETED,SARS-CoV-2 Infection,BIOLOGICAL: VPM1002|OTHER: Placebo,"University Health Network, Toronto",Serum Institute of India Pvt. Ltd.|Max Planck Institute for Infection Biology|Verity Pharmaceuticals Inc.,ALL,"ADULT, OLDER_ADULT",PHASE3,122,OTHER,INTERVENTIONAL,6/24/2020,9/9/2021
NCT04367168,TERMINATED,COVID,DRUG: Colchicine|DRUG: Placebo oral tablet,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,,ALL,"ADULT, OLDER_ADULT",PHASE2,116,OTHER,INTERVENTIONAL,5/27/2020,8/16/2021
NCT04343768,COMPLETED,COVID-19,DRUG: Hydroxychloroquine|DRUG: Lopinavir / Ritonavir|DRUG: Interferon Beta-1A|DRUG: Interferon Beta-1B,Shahid Beheshti University of Medical Sciences,,ALL,"ADULT, OLDER_ADULT",PHASE2,60,OTHER,INTERVENTIONAL,4/9/2020,4/27/2020
NCT04872075,COMPLETED,Covid19,OTHER: Concert|DIAGNOSTIC_TEST: Rapid nasopharyngeal antigen test for Sars-Cov-2|DIAGNOSTIC_TEST: Saliva Sample,Assistance Publique - Hôpitaux de Paris,PRODISS|WEEZEVENT,ALL,ADULT,NA,6678,OTHER,INTERVENTIONAL,5/26/2021,6/13/2021
NCT05107375,COMPLETED,Coronavirus Disease 2019,BIOLOGICAL: Tetravalent influenza virus lysis vaccine|BIOLOGICAL: Recombinant new coronavirus vaccine (CHO cell) group,"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.",,ALL,"ADULT, OLDER_ADULT",PHASE3,299,INDUSTRY,INTERVENTIONAL,9/3/2021,3/4/2022
NCT04401150,COMPLETED,Vitamin C|COVID-19|Hospitalized Patients,DRUG: Vitamin C|DRUG: Control,Université de Sherbrooke,Lotte & John Hecht Memorial Foundation,ALL,"ADULT, OLDER_ADULT",PHASE3,392,OTHER,INTERVENTIONAL,8/14/2020,12/6/2022
NCT05516550,NOT_YET_RECRUITING,SARS-CoV-2 Infection|Lung Fibrosis,DRUG: Treamid|DRUG: Treamid twice a day|DRUG: Treamid once a day|DRUG: Placebo,PHARMENTERPRISES LLC,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,412,INDUSTRY,INTERVENTIONAL,2022-08,2022-12
NCT04813575,UNKNOWN,Covid19|Pulmonary Fibrosis|Organising Pneumonia|Thromboembolism,OTHER: Cryo lung biopsies,King Faisal Specialist Hospital & Research Center,,ALL,"ADULT, OLDER_ADULT",NA,60,OTHER,INTERVENTIONAL,8/1/2021,6/1/2022
NCT04536350,TERMINATED,Covid19|Corona Virus Infection|ARDS|Aviptadil,DRUG: Aviptadil 67μg|DRUG: Placebo 0.9% NaCl solution,Prof. Dr. Jörg Leuppi,,ALL,"ADULT, OLDER_ADULT",PHASE2,83,OTHER,INTERVENTIONAL,5/18/2021,6/14/2023
NCT05172050,COMPLETED,SARS CoV 2 Infection,DRUG: Raloxifene|OTHER: Placebo,Dompé Farmaceutici S.p.A,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,61,INDUSTRY,INTERVENTIONAL,1/22/2021,6/12/2021
NCT04597775,UNKNOWN,SARS-CoV Infection,DRUG: hydroxychloroquine,"Regional Center for Disease Control and Prevention, Jordan","Farhat Hached Hospital, Tunisia|Fattouma Bourguiba, Tunisia",ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,93,OTHER,INTERVENTIONAL,10/27/2020,1/31/2021
NCT04488575,TERMINATED,Covid19,DRUG: EDP1815|DRUG: Placebo,"Evelo Biosciences, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE2,16,INDUSTRY,INTERVENTIONAL,8/26/2020,5/19/2021
NCT04527575,COMPLETED,Covid19,"BIOLOGICAL: EpiVacCorona (EpiVacCorona vaccine based on peptide antigens for the prevention of COVID-19)|OTHER: Placebo (sodium chloride bufus, solvent for the preparation of dosage forms for injection 0.9%)","Federal Budgetary Research Institution State Research Center of Virology and Biotechnology ""Vector""",,ALL,ADULT,PHASE1|PHASE2,100,OTHER_GOV,INTERVENTIONAL,7/27/2020,12/30/2021
NCT04539275,TERMINATED,COVID-19,DRUG: Convalescent Plasma|OTHER: Masked Saline Placebo,VA Office of Research and Development,,ALL,"ADULT, OLDER_ADULT",PHASE3,75,FED,INTERVENTIONAL,11/16/2020,9/30/2021
NCT05381675,COMPLETED,COVID-19|Dyspnea,OTHER: Tele-rehabillitation|OTHER: Prescribed Exercise Program,Harran University,,ALL,"ADULT, OLDER_ADULT",NA,60,OTHER,INTERVENTIONAL,5/20/2022,8/1/2023
NCT05018975,WITHDRAWN,COVID-19 Acute Respiratory Distress Syndrome|Cytokine Release Syndrome,DRUG: Tazemetostat,Loma Linda University,,ALL,"ADULT, OLDER_ADULT",PHASE2,0,OTHER,INTERVENTIONAL,2022-01,9/21/2023
NCT04891250,WITHDRAWN,SARS-CoV-2|Ivermectin,DRUG: Ivermectin|OTHER: Prophylaxis,Centre for Infectious Disease Research in Zambia,"Ministry of Health, Zambia|University of Zambia",ALL,"ADULT, OLDER_ADULT",PHASE4,0,OTHER,INTERVENTIONAL,2021-10,2022-06
NCT04932850,COMPLETED,COVID-19 Virus Disease,BIOLOGICAL: MAD0004J08|OTHER: Placebo,Toscana Life Sciences Sviluppo s.r.l.,Cross Research S.A.,ALL,ADULT,PHASE1,30,INDUSTRY,INTERVENTIONAL,3/1/2021,10/20/2021
NCT04363450,UNKNOWN,COVID-19|Corona Virus Infection|Wuhan Coronavirus|Prophylaxis|Healthcare Worker|Sars-CoV2|Hydroxychloroquine,DRUG: Hydroxychloroquine|DRUG: Placebo,Louisiana State University Health Sciences Center in New Orleans,Lafayette General Health|University of Louisiana at Lafayette,ALL,"ADULT, OLDER_ADULT",PHASE3,1700,OTHER,INTERVENTIONAL,4/27/2020,6/1/2021
NCT05928468,ACTIVE_NOT_RECRUITING,COVID-19,BIOLOGICAL: LYB002V14|BIOLOGICAL: LYB002V14A|BIOLOGICAL: LYB002CA,"Guangzhou Patronus Biotech Co., Ltd.","Yantai Patronus Biotech Co., Ltd.|Afﬁliated Hospital of North Sichuan Medical College",ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,210,INDUSTRY,INTERVENTIONAL,4/25/2023,11/30/2023
NCT05035550,COMPLETED,Stress|Anxiety|Depression,BEHAVIORAL: Non-Deceptive Placebo,Michigan State University,,ALL,ADULT,NA,64,OTHER,INTERVENTIONAL,2/4/2021,5/5/2021
NCT04615975,UNKNOWN,Covid19,DIETARY_SUPPLEMENT: Ketogenic diet with phytoextracts,University of Padova,San Bortolo Hospital - Vicenza,ALL,"ADULT, OLDER_ADULT",NA,28,OTHER,INTERVENTIONAL,11/1/2020,8/30/2021
NCT05552950,RECRUITING,SARS CoV 2 Infection,BIOLOGICAL: BioBlock® antiviral nasal spray,Chemi-Pharm AS,,ALL,ADULT,PHASE4,2000,INDUSTRY,INTERVENTIONAL,5/1/2022,12/30/2023
NCT05787275,COMPLETED,Corona Virus Infection,OTHER: diaphragmatic positioning|OTHER: incentive spirometer|OTHER: Control,Beni-Suef University,,ALL,ADULT,NA,90,OTHER,INTERVENTIONAL,10/1/2022,2/2/2023
NCT05089045,COMPLETED,Coronavirus Disease 2019,BIOLOGICAL: Recombinant new coronavirus vaccine (CHO cell) group,"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.",,ALL,"ADULT, OLDER_ADULT",NA,360,INDUSTRY,INTERVENTIONAL,8/31/2021,9/30/2021
NCT05156645,WITHDRAWN,COVID-19,DRUG: SCTA01 and SCTA01C|DRUG: Placebo,Sinocelltech Ltd.,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,0,INDUSTRY,INTERVENTIONAL,1/15/2022,12/1/2022
NCT05395845,NOT_YET_RECRUITING,Anosmia,BIOLOGICAL: platelets rich plasma,Aya abdelnasser hassani,,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,88,OTHER,INTERVENTIONAL,6/1/2022,1/1/2023
NCT04841759,COMPLETED,COVID-19,OTHER: Exercise,Medical University of Vienna,,ALL,"ADULT, OLDER_ADULT",NA,46,OTHER,INTERVENTIONAL,4/1/2021,12/22/2021
NCT04342650,COMPLETED,COVID-19|SARS-CoV Infection|Severe Acute Respiratory Syndrome (SARS) Pneumonia|Clinical Trial,DRUG: Chloroquine Diphosphate|DRUG: Placebo oral tablet,Fundação de Medicina Tropical Dr. Heitor Vieira Dourado,,ALL,"ADULT, OLDER_ADULT",PHASE2,152,OTHER,INTERVENTIONAL,4/8/2020,6/8/2020
NCT04492475,COMPLETED,COVID-19,DRUG: Interferon beta-1a|OTHER: Placebo|DRUG: Remdesivir,National Institute of Allergy and Infectious Diseases (NIAID),,ALL,"ADULT, OLDER_ADULT",PHASE3,969,NIH,INTERVENTIONAL,8/5/2020,12/21/2020
NCT04363775,COMPLETED,Tracheal Intubation|Infection|Projection,DEVICE: The standard Macintosh laryngoscope|DEVICE: The Vie Scope laryngoscope,Lazarski University,Poznan University of Medical Sciences|Wroclaw Medical University|Medical University of Bialystok,ALL,"ADULT, OLDER_ADULT",NA,35,OTHER,INTERVENTIONAL,1/20/2020,2/25/2020
NCT05007275,ACTIVE_NOT_RECRUITING,Covid19|SARS-CoV-2 Infection,BIOLOGICAL: 1x10^9 vp AZD1222|BIOLOGICAL: 5x10^9 vp AZD1222|BIOLOGICAL: 1x10^10 vp AZD1222,Imperial College London,University of Oxford|AstraZeneca,ALL,ADULT,PHASE1,28,OTHER,INTERVENTIONAL,10/10/2021,2024-06
NCT04627675,COMPLETED,SARS-CoV-2,DRUG: CORVax|DRUG: IL-12 plasmid|DEVICE: Cliniporator,Providence Health & Services,OncoSec Medical Incorporated,ALL,"ADULT, OLDER_ADULT",PHASE1,16,OTHER,INTERVENTIONAL,12/30/2020,12/28/2022
NCT04352959,COMPLETED,COVID19|Mouthwash|Saliva,DEVICE: mouthrinse with bêta-cyclodextrin and citrox|DEVICE: mouthrinse without bêta-cyclodextrin and citrox,Claude Bernard University,Hospices Civils de Lyon,ALL,"ADULT, OLDER_ADULT",NA,176,OTHER,INTERVENTIONAL,4/27/2020,12/11/2020
NCT05148754,COMPLETED,Covid19|HIV-1-infection,DRUG: Elsulfavirine,Viriom,,ALL,ADULT,PHASE1,15,INDUSTRY,INTERVENTIONAL,1/23/2021,8/16/2021
NCT05543603,COMPLETED,covid19,DRUG: Lacer Clorhexidina Colutorio|DRUG: Lacer Clorhexidine 0.20% Colutorio|DRUG: Gingilacer Encías Delicadas Colutorio|DRUG: Distilled water,Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana,Hospital Universitario Fundación Jiménez Díaz|Hospital Universitario Infanta Elena,ALL,"ADULT, OLDER_ADULT",NA,48,OTHER,INTERVENTIONAL,4/13/2021,1/8/2022
NCT05246059,COMPLETED,Anosmia|SARS CoV 2 Infection,OTHER: Olfactory Training,"University College, London",,ALL,"ADULT, OLDER_ADULT",NA,63,OTHER,INTERVENTIONAL,6/3/2020,8/8/2021
NCT04892459,COMPLETED,COVID-19,BIOLOGICAL: Recombinant SARS-CoV-2 Ad5 vectored vaccine|BIOLOGICAL: Inactive SARS-CoV-2 vaccine (Vero cell),Jiangsu Province Centers for Disease Control and Prevention,CanSino Biologics Inc.,ALL,ADULT,PHASE4,300,NETWORK,INTERVENTIONAL,5/25/2021,12/25/2021
NCT05470803,NOT_YET_RECRUITING,COVID-19,BIOLOGICAL: AstraZeneca/Fiocruz|BIOLOGICAL: Pfizer/Wyeth|BIOLOGICAL: Clover SCB-2019,D'Or Institute for Research and Education,Bill and Melinda Gates Foundation|University of Oxford,ALL,"ADULT, OLDER_ADULT",PHASE3,360,OTHER,INTERVENTIONAL,2022-08,2023-08
NCT05642754,NOT_YET_RECRUITING,COVID-19,OTHER: Overall uncertainty language,Trustees of Dartmouth College,Norwegian Institute of Public Health,ALL,"ADULT, OLDER_ADULT",NA,960,OTHER,INTERVENTIONAL,2022-12,2023-03
NCT05283954,WITHDRAWN,SARS-CoV2 Infection|COVID-19,"DRUG: Combination regimen: Fluoxetine, Prednisolone, Ivermectin|DRUG: Combination regimen: Albendazole, Vitamin C",Oriol Mitja,"National Department of Health, Papua New Guinea|Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia",ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,0,OTHER,INTERVENTIONAL,5/1/2022,7/30/2022
NCT05463354,RECRUITING,COVID-19|SARS-CoV-2 Infection,"BIOLOGICAL: Recombinant COVID-19 Vaccine (Sf9 Cell)|BIOLOGICAL: COVID-19 Vaccine (Vero Cell), Inactivated","WestVac Biopharma Co., Ltd.",,ALL,"ADULT, OLDER_ADULT",PHASE2,450,INDUSTRY,INTERVENTIONAL,7/11/2022,2023-07
NCT04924803,RECRUITING,Covid19,BEHAVIORAL: No video|BEHAVIORAL: Video Text,New York University,New York Harm Reduction Educators|National Institute on Drug Abuse (NIDA),ALL,"ADULT, OLDER_ADULT",NA,500,OTHER,INTERVENTIONAL,6/21/2022,4/1/2025
NCT05659654,COMPLETED,COVID-19,DRUG: Ursodeoxycholic acid,"Institute of Hematology & Blood Diseases Hospital, China",,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,95,OTHER,INTERVENTIONAL,12/16/2022,3/8/2023
NCT04477954,TERMINATED,Covid19,COMBINATION_PRODUCT: Hyperbaric Oxygen,Asociación Argentina de Medicina Hiperbárica e Investigación,Hospital de Infecciosas Francisco Javier Muniz|Hospital General de Agudos D. F. Santojanni|Hospital Central de San Isidro Dr. Melchor Angel Posse,ALL,"ADULT, OLDER_ADULT",PHASE2,40,OTHER,INTERVENTIONAL,7/6/2020,12/30/2020
NCT05672654,WITHDRAWN,HIV Seropositivity|Immunodeficiency|Vaccination Reaction|Covid19,DIAGNOSTIC_TEST: Blood draw,"University Hospital, Ghent",,ALL,"CHILD, ADULT, OLDER_ADULT",NA,0,OTHER,INTERVENTIONAL,5/10/2021,9/1/2023
NCT05043259,ACTIVE_NOT_RECRUITING,COVID-19,BIOLOGICAL: inactive SARS-CoV-2 vaccine (Vero cell)|BIOLOGICAL: Low dose aerosolized Ad5-nCoV|BIOLOGICAL: High dose aerosolized Ad5-nCoV,Jiangsu Province Centers for Disease Control and Prevention,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,420,NETWORK,INTERVENTIONAL,9/13/2021,12/30/2022
NCT04599959,COMPLETED,Covid-19,DIAGNOSTIC_TEST: Sampling of SARS-CoV-2 RNA from nasopharyngeal swab specimen or saliva collected via Salivette Cortisol,Boehringer Ingelheim,,ALL,"ADULT, OLDER_ADULT",NA,151,INDUSTRY,INTERVENTIONAL,10/26/2020,1/20/2021
NCT05109559,RECRUITING,SARS-CoV-2 Infection,BIOLOGICAL: Full dose of Ad26.COV2. 5x10^10vp|BIOLOGICAL: Half dose of Ad26.COV2. 2.5x10^10vp|BIOLOGICAL: Full dose of Ad26.COV2. 5x10^10vp,Mahidol University,"National Vaccine Institute, Thailand|International Vaccine Institute|Janssen Pharmaceuticals",ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,690,OTHER,INTERVENTIONAL,12/20/2021,2024-12
NCT04473690,COMPLETED,Covid19,BIOLOGICAL: Low Dose of KBP-COVID-19|BIOLOGICAL: High Dose of KBP-COVID-19|BIOLOGICAL: Placebo,KBio Inc,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,101,INDUSTRY,INTERVENTIONAL,12/30/2020,10/14/2022
NCT04945590,NOT_YET_RECRUITING,Covid19,BEHAVIORAL: Virtual Intervention Program,Mayo Clinic,,ALL,"ADULT, OLDER_ADULT",NA,25,OTHER,INTERVENTIONAL,2023-12,2023-12
NCT05395390,RECRUITING,OSA|Covid19|Residual Symptoms of COVID 19|COPD,BEHAVIORAL: Exercise (Resistance Training,Texas A&M University,,ALL,"ADULT, OLDER_ADULT",NA,200,OTHER,INTERVENTIONAL,2/2/2021,5/5/2024
NCT04326790,TERMINATED,Corona Virus Disease 19 (Covid 19),DRUG: Colchicine|DRUG: Standard treatment,National and Kapodistrian University of Athens,,ALL,"ADULT, OLDER_ADULT",PHASE2,105,OTHER,INTERVENTIONAL,4/3/2020,4/27/2020
NCT05407597,COMPLETED,SARS CoV 2 Infection,DRUG: Icatibant|DRUG: 0.9% Sodium Chloride Injection,Belfast Health and Social Care Trust,"Queen's University, Belfast",ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,32,OTHER,INTERVENTIONAL,5/16/2022,7/7/2023
NCT04395456,UNKNOWN,Acute Respiratory Distress Syndrome Due to SARS-CoV-2 Infection (Severe COVID19),DRUG: AMY-101|OTHER: WFI 5% glucose,Amyndas Pharmaceuticals S.A.,,ALL,"ADULT, OLDER_ADULT",PHASE2,144,INDUSTRY,INTERVENTIONAL,2021-09,2022-12
NCT05278390,RECRUITING,SARS-CoV-2 Infections|Respiratory Failure With Hypoxia,RADIATION: Thoracic CT scan,"University Hospital, Strasbourg, France",REGION GRAND EST|E-MEDIA|VISIBLE PATIENT,ALL,"ADULT, OLDER_ADULT",NA,500,OTHER,INTERVENTIONAL,6/13/2022,2025-06
NCT04646590,UNKNOWN,Prevention of COVID-19|Safety and Efficacy,BIOLOGICAL: Recombinant new coronavirus vaccine (CHO cell) group|BIOLOGICAL: Recombinant new coronavirus vaccine (CHO cells) placebo group,"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.",,ALL,"ADULT, OLDER_ADULT",PHASE3,28904,INDUSTRY,INTERVENTIONAL,12/16/2020,2022-12
NCT05785390,RECRUITING,COVID-19,DRUG: NP-101|OTHER: Placebo,Novatek Pharmaceuticals,,ALL,"ADULT, OLDER_ADULT",PHASE2,308,INDUSTRY,INTERVENTIONAL,2/22/2023,12/22/2023
NCT04682197,ACTIVE_NOT_RECRUITING,Health Personnel|Stress|Anxiety|Insomnia|Hyperarousal|Corona Virus Infection|Covid19,DEVICE: Cereset Research,Wake Forest University Health Sciences,"The Susanne Marcus Collins Foundation, Inc",ALL,"ADULT, OLDER_ADULT",NA,144,OTHER,INTERVENTIONAL,12/14/2021,2025-03
NCT04285190,WITHDRAWN,Coronavirus Disease 2019|Novel Coronavirus Pneumonia,DRUG: T89,"Tasly Pharmaceuticals, Inc.",,ALL,"ADULT, OLDER_ADULT",NA,0,INDUSTRY,INTERVENTIONAL,2/26/2020,4/20/2020
NCT04936997,COMPLETED,Covid19|Cancer|Malignancy|Vaccine Response Impaired,BIOLOGICAL: SARS-COV2 Pfizer Vaccine,University of Arizona,,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,20,OTHER,INTERVENTIONAL,6/7/2021,5/8/2022
NCT05279456,ACTIVE_NOT_RECRUITING,COVID-19,BIOLOGICAL: Advax-CpG55.2 adjuvanted recombinant spike protein,Vaxine Pty Ltd,Australian Respiratory and Sleep Medicine Institute,ALL,"ADULT, OLDER_ADULT",PHASE3,39,INDUSTRY,INTERVENTIONAL,8/15/2022,12/31/2023
NCT04359290,COMPLETED,"ARDS, Human|COVID",DRUG: Ruxolitinib administration,Philipps University Marburg Medical Center,,ALL,"ADULT, OLDER_ADULT",PHASE2,15,OTHER,INTERVENTIONAL,7/1/2020,7/30/2021
NCT04346797,UNKNOWN,SARS-CoV-2|COVID19,DRUG: Eculizumab,Assistance Publique - Hôpitaux de Paris,,ALL,"ADULT, OLDER_ADULT",PHASE2,120,OTHER,INTERVENTIONAL,4/16/2020,12/31/2020
NCT04304690,COMPLETED,Sars-CoV2,OTHER: blood sample,Assistance Publique - Hôpitaux de Paris,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,1177,OTHER,INTERVENTIONAL,3/16/2020,7/7/2021
NCT05472090,COMPLETED,Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection|COVID-19|Long COVID|Long Haul COVID,DRUG: TNX-102 SL|DRUG: Placebo SL Tablet,"Tonix Pharmaceuticals, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE2,63,INDUSTRY,INTERVENTIONAL,8/18/2022,7/27/2023
NCT05254990,RECRUITING,Infectious Pneumonia|Severe COVID-19,DRUG: Reparixin|OTHER: Placebo,Dompé Farmaceutici S.p.A,,ALL,"ADULT, OLDER_ADULT",PHASE3,526,INDUSTRY,INTERVENTIONAL,4/6/2022,2024-10
NCT05629897,NOT_YET_RECRUITING,COVID-19|Neuro-Degenerative Disease|Psychological|SARS CoV 2 Infection,OTHER: Sessions of cognitive stimulation,Fundacin Biomedica Galicia Sur,Centro de Investigación Biomédica en Red de Salud Mental|Galician South Health Research Institute,ALL,"ADULT, OLDER_ADULT",NA,88,OTHER,INTERVENTIONAL,12/14/2022,2023-11
NCT04949490,COMPLETED,COVID-19|SARS-CoV-2 Infection,BIOLOGICAL: BNT162b2s01|BIOLOGICAL: BNT162b2,BioNTech SE,,ALL,"ADULT, OLDER_ADULT",PHASE2,137,INDUSTRY,INTERVENTIONAL,7/26/2021,9/16/2022
NCT04911790,COMPLETED,COVID-19,BIOLOGICAL: Experimental Group,"Sinovac Research and Development Co., Ltd.",,ALL,"ADULT, OLDER_ADULT",PHASE4,131650,INDUSTRY,INTERVENTIONAL,6/5/2021,8/31/2023
NCT04636697,ACTIVE_NOT_RECRUITING,SARS-CoV-2 Infection,DRUG: Intramuscular injection|BIOLOGICAL: Intramuscular vaccine,Medicago,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,30918,INDUSTRY,INTERVENTIONAL,11/19/2020,4/30/2022
NCT05435456,COMPLETED,COVID-19,OTHER: Exercise,Halic University,,ALL,"ADULT, OLDER_ADULT",NA,76,OTHER,INTERVENTIONAL,1/18/2021,7/8/2021
NCT04400890,TERMINATED,COVID-19,DRUG: Resveratrol|DIETARY_SUPPLEMENT: Vitamin D3,"Marvin McCreary, MD",,ALL,"ADULT, OLDER_ADULT",PHASE2,105,OTHER,INTERVENTIONAL,9/13/2020,3/1/2021
NCT04286503,UNKNOWN,Novel Coronavirus Infectious Disease (COVID-19),DRUG: Carrimycin|DRUG: lopinavir/ritonavir tablets or Arbidol or chloroquine phosphate|DRUG: basic treatment,Beijing YouAn Hospital,"Shenyang Tonglian Group CO., Ltd|Cancer Institute and Hospital, Chinese Academy of Medical Sciences|Huangshi Central Hospital, China|Shenyang Pharmaceutical University|First Affiliated Hospital of Chongqing Medical University|The Second Affiliated Hospital of Harbin Medical University|No.2 People's Hospital of Fuyang City|First Affiliated Hospital Bengbu Medical College|Renmin Hospital of Wuhan University|The Sixth People's Hospital of Shenyang|Nanyang Central Hospital",ALL,"ADULT, OLDER_ADULT",PHASE4,520,OTHER,INTERVENTIONAL,2/23/2020,2/28/2021
NCT04323527,COMPLETED,SARS-CoV Infection|Severe Acute Respiratory Syndrome (SARS) Pneumonia,DRUG: Chloroquine diphosphate,Fundação de Medicina Tropical Dr. Heitor Vieira Dourado,Marcus Vinícius Guimarães de Lacerda|Mayla Gabriela Silva Borba|Wuelton Marcelo Monteiro|Gisely Cardoso de Melo|Fernando Fonseca de Almeida e Val|Felipe Gomes Naveca|Maria Paula Gomes Mourão|Ludmila Abrahão Hajjar|Jorge Souza Mendonça,ALL,"ADULT, OLDER_ADULT",PHASE2,278,OTHER,INTERVENTIONAL,3/23/2020,6/7/2020
NCT05167227,ACTIVE_NOT_RECRUITING,SARS-CoV-2 Acute Respiratory Disease|Myalgic Encephalomyelitis|Chronic Fatigue Syndrome|Post-acute Sequelae of SARS-COV-2 Infection|Post COVID-19 Condition,OTHER: Extension for Community Healthcare Outcomes,Family Health Centers of San Diego,,ALL,"ADULT, OLDER_ADULT",NA,20,OTHER,INTERVENTIONAL,11/30/2021,10/31/2024
NCT04528927,WITHDRAWN,COVID 19|Patients Hospitalized,DRUG: HCQ|DRUG: Azithromycin|DRUG: Doxycycline|DIETARY_SUPPLEMENT: Zinc,Abderrahmane Mami Hospital,Eshmoun Clinical Research Center|Datametrix,ALL,"ADULT, OLDER_ADULT",PHASE3,0,OTHER,INTERVENTIONAL,5/15/2020,7/15/2020
NCT04388527,COMPLETED,Covid-19,BIOLOGICAL: COVID-19 Convalescent Plasma,University of Pennsylvania,,ALL,"ADULT, OLDER_ADULT",PHASE1,32,OTHER,INTERVENTIONAL,4/30/2020,1/30/2021
NCT04962906,COMPLETED,COVID-19 Vaccines,DRUG: Gam-COVID-Vac / Gam-COVID-Vac,Ministerio de Salud de Ciudad Autónoma de Buenos Aires,,ALL,"ADULT, OLDER_ADULT",PHASE2,192,OTHER_GOV,INTERVENTIONAL,7/5/2021,8/15/2021
NCT04392427,UNKNOWN,COVID|Drug Effect,"DRUG: Treatment group: will receive a combination of Nitazoxanide, Ribavirin and Ivermectin for a duration of seven days :",Mansoura University,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,100,OTHER,INTERVENTIONAL,2020-10,2022-05
NCT05184127,COMPLETED,COVID-19,DRUG: MIR 19 ®|COMBINATION_PRODUCT: Standard COVID-19 therapy,National Research Center - Institute of Immunology Federal Medical-Biological Agency of Russia,St. Petersburg Research Institute of Vaccines and Sera,ALL,"ADULT, OLDER_ADULT",PHASE2,156,OTHER,INTERVENTIONAL,4/27/2021,9/7/2021
NCT04568356,COMPLETED,SARS CoV-2,DIAGNOSTIC_TEST: Direct Antigen Tests for COVID-19,"E25Bio, Inc.","SCRI Development Innovations, LLC",ALL,"ADULT, OLDER_ADULT",NA,200,INDUSTRY,INTERVENTIONAL,4/24/2020,9/24/2020
NCT04937556,COMPLETED,Covid19,DIETARY_SUPPLEMENT: Probiotic: Lactobacillus salivarius + Vit D + Zinc|DIETARY_SUPPLEMENT: Placebo,ProbiSearch SL,,ALL,"ADULT, OLDER_ADULT",NA,41,INDUSTRY,INTERVENTIONAL,10/25/2021,4/30/2022
NCT04448756,COMPLETED,Coronavirus Disease 2019,DRUG: M5049|DRUG: M5049|DRUG: Placebo,"EMD Serono Research & Development Institute, Inc.","Merck KGaA, Darmstadt, Germany",ALL,"ADULT, OLDER_ADULT",PHASE2,149,INDUSTRY,INTERVENTIONAL,7/29/2020,8/16/2021
NCT04320056,UNKNOWN,Coronavirus|Pneumonia|Oxygen Toxicity,OTHER: Standard administration of oxygen flow|DEVICE: Automated oxygen administration - FreeO2,Laval University,,ALL,"ADULT, OLDER_ADULT",NA,216,OTHER,INTERVENTIONAL,4/20/2020,10/31/2021
NCT06068556,NOT_YET_RECRUITING,COVID-19,BIOLOGICAL: GamCovidVac-M vector vaccine for the prevention of COVID-19 with altered antigenic composition,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation",,ALL,CHILD,PHASE3,50,OTHER,INTERVENTIONAL,2023-10,2024-12
NCT04655625,COMPLETED,COVID-19,BIOLOGICAL: Group A (AG0302-COVID19)|BIOLOGICAL: Group A (Placebo)|BIOLOGICAL: Group B (AG0302-COVID19)|BIOLOGICAL: Group B (Placebo),"AnGes, Inc.",Japan Agency for Medical Research and Development,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,500,INDUSTRY,INTERVENTIONAL,11/23/2020,2/1/2022
NCT04269525,UNKNOWN,"Pneumonia, Viral|Pneumonia, Ventilator-Associated",BIOLOGICAL: UC-MSCs,ZhiYong Peng,Tuohua Biological Technology Co. Ltd,ALL,"ADULT, OLDER_ADULT",PHASE2,16,OTHER,INTERVENTIONAL,2/6/2020,12/30/2020
NCT06063330,COMPLETED,COVID-19|Infectious Disease|Symptomatic COVID-19 Infection Laboratory-Confirmed|SARS CoV 2 Infection,COMBINATION_PRODUCT: RQ-001|OTHER: Placebo,"Red Queen Therapeutics, Inc.",PPD,ALL,ADULT,PHASE1,66,INDUSTRY,INTERVENTIONAL,9/27/2023,1/3/2024
NCT04333355,TERMINATED,COVID-19,BIOLOGICAL: Convalescent Plasma,Hospital San Jose Tec de Monterrey,Tecnologico de Monterrey,ALL,"ADULT, OLDER_ADULT",PHASE1,12,OTHER,INTERVENTIONAL,5/8/2020,8/20/2020
NCT04954092,UNKNOWN,Covid19|Vaccine Preventable Disease,BIOLOGICAL: Gam-COVID-vac M|BIOLOGICAL: Placebo,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation",Moscow Healthcare Department,ALL,CHILD,PHASE2|PHASE3,3000,OTHER,INTERVENTIONAL,7/5/2021,12/31/2023
NCT05178225,COMPLETED,COVID-19 Respiratory Infection,DIETARY_SUPPLEMENT: ubiquinol (reduced coenzyme Q10)|OTHER: mountain spa rehabilitation|DIAGNOSTIC_TEST: 2x14 ml of peripheral blood collected in a tube with anticoagulant,Comenius University,"Sanatórium of Dr. Guhr, n.o.|Kaneka Pharma Europe N.V.",ALL,"ADULT, OLDER_ADULT",NA,51,OTHER,INTERVENTIONAL,5/1/2021,1/1/2022
NCT04349592,COMPLETED,Covid19,DRUG: Hydroxychloroquine|DRUG: Azithromycin|OTHER: Placebo Tablet|OTHER: Placebo capsules,Hamad Medical Corporation,,ALL,"ADULT, OLDER_ADULT",NA,456,INDUSTRY,INTERVENTIONAL,4/14/2020,8/30/2020
NCT05389592,NOT_YET_RECRUITING,Cognitive Impairment|Post-Acute Sequelae of SARS-CoV-2 Infection|COVID-19,PROCEDURE: Active tDCS and cognitive training|PROCEDURE: Sham tDCS and cognitive training,University of Sao Paulo,Fundação de Amparo à Pesquisa do Estado de São Paulo,ALL,"ADULT, OLDER_ADULT",NA,60,OTHER,INTERVENTIONAL,6/30/2022,3/30/2023
NCT04522830,COMPLETED,SARS-CoV-2 Infection,DRUG: BTL-TML-COVID|DRUG: Placebo,"Beech Tree Labs, Inc.",Norwich Clinical Research Associates Ltd.|Curavit Clinical Research,ALL,"ADULT, OLDER_ADULT",PHASE2,28,INDUSTRY,INTERVENTIONAL,7/30/2020,2/28/2021
NCT05077930,COMPLETED,COVID-19|Convalescent Plasma|SARS-CoV-2|Pneumonia|Coronavirus Infections|Respiratory Tract Diseases,BIOLOGICAL: Convalescent plasma|DRUG: Standard of care,Tânia Portella Costa,"Centro de Hematologia e Hemoterapia do Paraná - Hemepar|Fundação Oswaldo Cruz, Instituto Carlos Chagas, ICC Paraná|Science Valley Research Institute",ALL,"ADULT, OLDER_ADULT",PHASE2,38,OTHER,INTERVENTIONAL,1/6/2022,4/7/2022
NCT04442230,TERMINATED,Coronavirus Infection,BIOLOGICAL: NasoVAX|OTHER: Placebo,"Altimmune, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE2,48,INDUSTRY,INTERVENTIONAL,10/10/2020,2/15/2021
NCT04590430,COMPLETED,Healthy,DRUG: HFB30132A|OTHER: Placebo,HiFiBiO Therapeutics,,ALL,ADULT,PHASE1,24,INDUSTRY,INTERVENTIONAL,10/20/2020,7/26/2021
NCT04484025,ENROLLING_BY_INVITATION,Covid19|Corona Virus Infection|Coronavirus|Coronavirus Infection,DRUG: Ebselen|DRUG: Placebo,"Sound Pharmaceuticals, Incorporated",,ALL,"ADULT, OLDER_ADULT",PHASE2,60,INDUSTRY,INTERVENTIONAL,10/12/2021,12/31/2023
NCT05398692,RECRUITING,Long Haul COVID or Post Acute Sequella of COVID - PASC (U09.9),OTHER: Virtual vs On Site Pulmonary Rehabilitation,Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center,,ALL,"ADULT, OLDER_ADULT",NA,40,OTHER,INTERVENTIONAL,2/2/2022,2/2/2025
NCT06231225,NOT_YET_RECRUITING,COVID-19 Pandemic|Diabetes|Hypertension|Cardiac Disease|Long COVID,BEHAVIORAL: Incentive Spirometer respiratory training,National Taipei University of Nursing and Health Sciences,Tri-Service General Hospital,ALL,"ADULT, OLDER_ADULT",NA,100,OTHER,INTERVENTIONAL,7/1/2024,8/1/2026
NCT04565392,WITHDRAWN,Covid19,DRUG: Famotidine 20 milligram tablet,drpykessupplements.com,,ALL,"ADULT, OLDER_ADULT",PHASE4,0,INDUSTRY,INTERVENTIONAL,5/1/2021,1/31/2022
NCT05977192,NOT_YET_RECRUITING,Vaccination Hesitancy,BEHAVIORAL: Standard MI|BEHAVIORAL: Intensive MI|BEHAVIORAL: MOTIVACC|BEHAVIORAL: Ecological momentary assessment (EMA) messages,Oklahoma State University,,ALL,"ADULT, OLDER_ADULT",NA,60,OTHER,INTERVENTIONAL,12/1/2023,12/31/2023
NCT05382130,COMPLETED,COVID-19,DIAGNOSTIC_TEST: Test all,Elizabeth Glaser Pediatric AIDS Foundation,"UNITAID|Kenya Ministry of Health|Ministry of Public Health, Cameroon",ALL,"CHILD, ADULT, OLDER_ADULT",NA,152082,OTHER,INTERVENTIONAL,5/17/2022,3/31/2023
NCT04916821,UNKNOWN,SARS-CoV2 Infection,DIETARY_SUPPLEMENT: propolis,Trabzon Kanuni Education and Research Hospital,,ALL,ADULT,NA,45,OTHER,INTERVENTIONAL,5/15/2021,8/15/2021
NCT04944121,ACTIVE_NOT_RECRUITING,Post-acute Corona Virus 19 (COVID-19) (Long COVID),DRUG: RSLV-132|DRUG: Sodium Chloride 0.9%,Resolve Therapeutics,,ALL,"ADULT, OLDER_ADULT",PHASE2,70,INDUSTRY,INTERVENTIONAL,6/25/2021,3/31/2023
NCT04990531,UNKNOWN,Sars-CoV-2 Infection|Lung Fibrosis|Covid19,DIAGNOSTIC_TEST: Low-field magnetic resonance imaging|DIAGNOSTIC_TEST: Blood sample,University of Erlangen-Nürnberg Medical School,,ALL,"CHILD, ADULT",NA,68,OTHER,INTERVENTIONAL,8/9/2021,1/1/2022
NCT04842721,WITHDRAWN,Covid19,DRUG: Hypertonic Saturated Saline Mouth Rinse Active Arm|OTHER: Placebo Plain Water Mouth Rinse Arm,Rafik Batroussy,,ALL,"ADULT, OLDER_ADULT",PHASE2,0,OTHER,INTERVENTIONAL,2021-07,2021-12
NCT05074121,NOT_YET_RECRUITING,Covid19|COVID-19 Pneumonia|COVID-19 Respiratory Infection|COVID-19 Lower Respiratory Infection|SARS-CoV2 Infection|SARS-CoV-2 Acute Respiratory Disease|SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere|Oxidative Stress,DRUG: N-acetylcysteine|OTHER: Placebo,Cambridge Health Alliance,The Thoracic Foundation|Alturix,ALL,"ADULT, OLDER_ADULT",PHASE2,200,OTHER,INTERVENTIONAL,3/31/2024,2/1/2025
NCT04418531,WITHDRAWN,"Pneumonia, Viral|Corona Virus Infection",BIOLOGICAL: Anti-coronavirus antibodies (immunoglobulins) obtained with DFPP form convalescent patients,Piero Luigi Ruggenenti,Aferetica,ALL,"ADULT, OLDER_ADULT",NA,0,OTHER,INTERVENTIONAL,6/1/2020,9/21/2022
NCT05128721,UNKNOWN,COVID-19|Vaccine Reaction|Vaccine Adverse Reaction,BIOLOGICAL: Covi Vax,"National Research Centre, Egypt",,ALL,ADULT,PHASE1,72,OTHER,INTERVENTIONAL,11/14/2021,5/23/2023
NCT04354831,COMPLETED,COVID-19,BIOLOGICAL: anti-SARS-CoV-2 convalescent plasma,Medical College of Wisconsin,Froedtert Hospital,ALL,"ADULT, OLDER_ADULT",PHASE2,131,OTHER,INTERVENTIONAL,5/11/2020,2/10/2021
NCT05855421,RECRUITING,Depressive Symptoms|Depression|Anxiety|Insomnia|Quality of Life,DEVICE: Auricular Acupuncture,Universidade do Sul de Santa Catarina,University of Sao Paulo,ALL,ADULT,NA,280,OTHER_GOV,INTERVENTIONAL,3/1/2023,5/1/2025
NCT04324021,TERMINATED,SARS-CoV-2,BIOLOGICAL: Emapalumab|BIOLOGICAL: Anakinra,Swedish Orphan Biovitrum,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,16,INDUSTRY,INTERVENTIONAL,4/2/2020,11/13/2020
NCT04409821,COMPLETED,Posttraumatic Stress Disorder|Prolonged Grief Disorder|COVID,BEHAVIORAL: Tele-delivered psychological intervention,"Rigshospitalet, Denmark",,ALL,"ADULT, OLDER_ADULT",NA,40,OTHER,INTERVENTIONAL,5/29/2020,5/31/2022
NCT04705831,UNKNOWN,Post-Viral Fatigue Syndrome|Post-Viral Disorder (Disorder)|Covid19,DRUG: Ruconest,IMMUNOe Research Centers,,ALL,"ADULT, OLDER_ADULT",PHASE4,40,INDUSTRY,INTERVENTIONAL,12/30/2020,2022-01
NCT05279430,COMPLETED,COVID-19 Pneumonia,BEHAVIORAL: Inspiratory muscle training,Fundación para la Investigación del Hospital Clínico de Valencia,,ALL,"ADULT, OLDER_ADULT",NA,26,OTHER,INTERVENTIONAL,1/30/2022,8/1/2022
NCT04851821,COMPLETED,a Randomized Double-blind Study|Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)|PHYTOTHERAPIE,DRUG: Quercetin,Hôpital Universitaire Sahloul,,ALL,"ADULT, OLDER_ADULT",PHASE1,80,OTHER,INTERVENTIONAL,1/4/2021,6/30/2021
NCT05475821,TERMINATED,Healthy Volunteers,DRUG: ABBV-990|DRUG: Placebo for ABBV-990,AbbVie,,ALL,"ADULT, OLDER_ADULT",PHASE1,24,INDUSTRY,INTERVENTIONAL,7/25/2022,9/26/2022
NCT04273321,COMPLETED,COVID-19|Novel Coronavirus Pneumonia,DRUG: Methylprednisolone,Beijing Chao Yang Hospital,,ALL,"ADULT, OLDER_ADULT",NA,86,OTHER,INTERVENTIONAL,2/14/2020,4/15/2020
NCT04842331,WITHDRAWN,Respiratory Viral Infection|Respiratory Tract Diseases|COVID-19 Respiratory Infection,DRUG: RESP301 (a nitric oxide generating solution)|DRUG: Standard of Care (SOC),Thirty Respiratory Limited,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,0,INDUSTRY,INTERVENTIONAL,2021-09,2022-01
NCT04560231,UNKNOWN,SARS-CoV Infection,DRUG: Remdesivir,Lahore General Hospital,,ALL,"CHILD, ADULT, OLDER_ADULT",EARLY_PHASE1,30,OTHER_GOV,INTERVENTIONAL,6/1/2020,11/30/2020
NCT05164731,UNKNOWN,SARS-CoV2 Infection,"BIOLOGICAL: SARS-CoV-2 Vaccine, Inactivated (Vero Cell)",Chinese Academy of Medical Sciences,Yunnan Center for Disease Control and Prevention,ALL,"ADULT, OLDER_ADULT",PHASE3,880,OTHER,INTERVENTIONAL,12/16/2021,10/30/2022
NCT04485130,TERMINATED,Covid19,DRUG: Disulfiram|DRUG: Placebo,"University of California, San Francisco",,ALL,"ADULT, OLDER_ADULT",PHASE2,11,OTHER,INTERVENTIONAL,8/18/2021,2/28/2022
NCT04838821,UNKNOWN,Covid19,BIOLOGICAL: Anti SARS-CoV-2 equine hyperimmune serum|BIOLOGICAL: placebo,Caja Costarricense de Seguro Social,Universidad de Costa Rica|Ministry of Health Costa Rica,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,156,OTHER_GOV,INTERVENTIONAL,3/29/2021,9/29/2021
NCT04954131,UNKNOWN,COVID-19,"BIOLOGICAL: Candidate Vaccine, SCB-2019|OTHER: Placebo","Zhejiang Clover Biopharmaceuticals, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE2,766,INDUSTRY,INTERVENTIONAL,8/10/2021,11/15/2022
NCT04332042,UNKNOWN,SARS-COv2 Related Interstitial Pneumonia,DRUG: Tofacitinib,Università Politecnica delle Marche,,ALL,"ADULT, OLDER_ADULT",PHASE2,50,OTHER,INTERVENTIONAL,4/10/2020,7/10/2020
NCT05918965,RECRUITING,Vagus Nerve Diseases|Long COVID|Long Covid19|Post-COVID-19 Syndrome|Post-COVID Syndrome|Post COVID-19 Condition|Post COVID Condition,DEVICE: transcutaneous electrical vagal neurostimulation,Medical University of Vienna,,FEMALE,"ADULT, OLDER_ADULT",NA,45,OTHER,INTERVENTIONAL,3/22/2023,3/1/2025
NCT04346589,TERMINATED,"Pneumonia, Ventilator-Associated|Coronavirus Infection",BIOLOGICAL: Anti-coronavirus antibodies (immunoglobulins)obtained with DFPP from convalescent patients,A.O. Ospedale Papa Giovanni XXIII,Aferetica - Italy (BO),ALL,"ADULT, OLDER_ADULT",NA,9,OTHER,INTERVENTIONAL,4/15/2020,10/27/2022
NCT05501288,COMPLETED,Coronavirus Disease 2019,DRUG: Huashi Baidu granule|DRUG: compound pholcodine oral solution,Shanghai Children's Medical Center,,ALL,"CHILD, ADULT",NA,108,OTHER,INTERVENTIONAL,5/1/2022,6/30/2022
NCT04456088,WITHDRAWN,"COVID-19|SARS-CoV 2|Respiratory Disease|Pneumonia, Viral|Corona Virus Infection",COMBINATION_PRODUCT: 150 ppm Nitric Oxide delivered through LungFit Delivery System|COMBINATION_PRODUCT: 80 ppm Nitric Oxide delivered through LungFit Delivery System,Beyond Air Inc.,,ALL,"ADULT, OLDER_ADULT",PHASE2,0,INDUSTRY,INTERVENTIONAL,7/15/2020,12/15/2020
NCT04742842,COMPLETED,SARS-CoV2 COVID-19,BIOLOGICAL: COVIGEN C19 0.8 mg ID or Placebo ID|BIOLOGICAL: COVIGEN C19 2.0 mg IM or Placebo IM|BIOLOGICAL: COVIGEN C19 4.0 mg IM or Placebo IM|BIOLOGICAL: COVIGEN C20 1.0mg vaccine ID,University of Sydney,"Bionet Co., Ltd|Technovalia|Telethon Kids Institute|Institute for Clinical Pathology and Medical Research",ALL,"ADULT, OLDER_ADULT",PHASE1,68,OTHER,INTERVENTIONAL,6/21/2021,7/30/2023
NCT04563689,COMPLETED,Covid19,OTHER: CHX0.12+CPC0.05 oral rinse (PerioAidActive Control)|OTHER: placebo rinse,Dentaid SL,,ALL,"ADULT, OLDER_ADULT",NA,23,INDUSTRY,INTERVENTIONAL,6/18/2020,10/23/2020
NCT04399889,TERMINATED,COVID|Corona Virus Infection|COVID19,BIOLOGICAL: Human cord tissue mesenchymal stromal cells (hCT-MSC) manufactured by Duke University.|OTHER: Placebo,"Joanne Kurtzberg, MD",The Marcus Foundation,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,12,OTHER,INTERVENTIONAL,6/18/2020,2/16/2022
NCT04952389,COMPLETED,Olfactory Dysfunction|COVID-19,DEVICE: Acupuncture Therapy|DRUG: Budesonide|OTHER: Olfactory Training,Mayo Clinic,,ALL,"ADULT, OLDER_ADULT",NA,32,OTHER,INTERVENTIONAL,12/7/2021,6/9/2023
NCT03554265,COMPLETED,Traumatic Brain Injury|Fatigue|Cognitive Impairment|COVID-19,DRUG: Somatropin,"The University of Texas Medical Branch, Galveston",,ALL,"ADULT, OLDER_ADULT",PHASE3,83,OTHER,INTERVENTIONAL,8/6/2018,10/4/2023
NCT04423042,UNKNOWN,Covid19|COVID-19|Severe Acute Respiratory Syndrome Coronavirus 2|Coronavirus|Inflammation,BIOLOGICAL: Tocilizumab,University of Calgary,,ALL,"ADULT, OLDER_ADULT",PHASE3,30,OTHER,INTERVENTIONAL,7/30/2020,2021-06
NCT05204589,ACTIVE_NOT_RECRUITING,COVID-19,BIOLOGICAL: Aerosolized Ad5-nCoV|BIOLOGICAL: Inactivated SARS-CoV-2 vaccine,Jiangsu Province Centers for Disease Control and Prevention,Anhui Provincial Center for Disease Control and Prevention|Shandong Province Centers for Disease Control and Prevention|Hunan Provincial Center for Disease Control and Prevention|Yunnan Center for Disease Control and Prevention|Chongqing Center for Disease Control and Prevention,ALL,"ADULT, OLDER_ADULT",PHASE3,10420,NETWORK,INTERVENTIONAL,1/22/2022,9/1/2022
NCT04366089,UNKNOWN,"COVID|SARS-CoV 2|Pneumonia, Viral|Coronavirus Infection","OTHER: Oxygen-ozone therapy, probiotic supplementation and Standard of care|DIETARY_SUPPLEMENT: SivoMixx (200 billion)|DRUG: Azithromycin|DRUG: hydroxychloroquine","Roberto Poscia MD, PhD",,ALL,"ADULT, OLDER_ADULT",PHASE2,152,OTHER,INTERVENTIONAL,3/26/2020,12/31/2020
NCT04674189,COMPLETED,Coronavirus|Covid19|SARS-CoV-2|Severe Acute Respiratory Syndrome,BIOLOGICAL: CVnCoV Vaccine|DRUG: Placebo,CureVac,German Federal Ministry of Education and Research,ALL,"ADULT, OLDER_ADULT",PHASE3,2357,INDUSTRY,INTERVENTIONAL,12/23/2020,6/8/2022
NCT04839042,RECRUITING,Covid19,BIOLOGICAL: SC-Ad6-1|BIOLOGICAL: SC-Ad6-1|BIOLOGICAL: SC-Ad6-1,Moat Biotechnology Corporation,,ALL,ADULT,PHASE1,190,INDUSTRY,INTERVENTIONAL,6/28/2021,12/31/2023
NCT04351542,COMPLETED,Flu Like Illness,DIETARY_SUPPLEMENT: Ayurveda|OTHER: Usual Care,Aarogyam UK,,ALL,ADULT,NA,32,OTHER,INTERVENTIONAL,3/6/2020,4/12/2020
NCT04374565,COMPLETED,Corona Virus Infection|SARS-CoV 2|SARS Pneumonia|Pneumonia,DRUG: High-Titer Anti-SARS-CoV-2 (COVID 19) Convalescent Plasma,University of Virginia,,ALL,"ADULT, OLDER_ADULT",PHASE2,29,OTHER,INTERVENTIONAL,5/5/2020,3/5/2021
NCT04834089,UNKNOWN,Immunosuppression|Cancer|COVID-19|Other Complication of Kidney Transplant|Chemotherapy|Renal Disease|Diabetes Mellitus|Cardiovascular Diseases|Chronic Obstructive Pulmonary Disease,BIOLOGICAL: AntiSARS-CoV-2 Serum|OTHER: Placebo,Butantan Institute,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,618,OTHER_GOV,INTERVENTIONAL,2021-05,2022-05
NCT04377165,TERMINATED,COVID|Influenza|Gastroenteritis,BEHAVIORAL: Gamification|BEHAVIORAL: Newsfeed function,The University of Queensland,,ALL,"ADULT, OLDER_ADULT",NA,34,OTHER,INTERVENTIONAL,5/6/2020,8/26/2020
NCT04445389,UNKNOWN,SARS-CoV-2,DRUG: GX-19|DRUG: Saline,"Genexine, Inc.",,ALL,ADULT,PHASE1|PHASE2,60,INDUSTRY,INTERVENTIONAL,6/17/2020,3/30/2022
NCT05550142,ACTIVE_NOT_RECRUITING,SARS-CoV-2,BIOLOGICAL: SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine Low dose|BIOLOGICAL: SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine High dose|DRUG: Placebo,"AIM Vaccine Co., Ltd.","Ningbo Rongan Biological Pharmaceutical Co., Ltd.|First Affiliated Hospital Bengbu Medical College",ALL,"ADULT, OLDER_ADULT",NA,54,INDUSTRY,INTERVENTIONAL,9/16/2022,2024-03
NCT04369365,COMPLETED,COVID,DRUG: Azithromycin 500 milligram (mg) oral Tablet|DRUG: Placebo,Prof. Dr. Matthias Preusser,,ALL,"ADULT, OLDER_ADULT",PHASE2,74,OTHER,INTERVENTIONAL,4/27/2020,6/15/2021
NCT04760821,UNKNOWN,Acute Respiratory Distress Syndrome|Covid19|Myocardial Injury,DRUG: Trimetazidine,"Ministry of Health, Brazil",InCor Heart Institute,ALL,"ADULT, OLDER_ADULT",PHASE2,80,OTHER_GOV,INTERVENTIONAL,12/10/2020,4/30/2021
NCT05890521,RECRUITING,COVID-19,BIOLOGICAL: Recombinant new coronavirus vaccine (CHO cell),"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.",Hunan Provincial Center for Disease Control and Prevention|Guizhou Center for Disease Control and Prevention|Hainan Center for Disease Control & Prevention,ALL,"ADULT, OLDER_ADULT",PHASE4,100000,INDUSTRY,INTERVENTIONAL,4/2/2022,2023-06
NCT04318431,COMPLETED,Covid19,DIAGNOSTIC_TEST: Data collection and rhinopharyngeal swab,Centre Hospitalier Intercommunal Creteil,Association Clinique Thérapeutique Infantile du val de Marne,ALL,CHILD,NA,605,OTHER,INTERVENTIONAL,4/14/2020,6/1/2020
NCT04808921,WITHDRAWN,SARS-CoV-2|Covid-19|Coronavirus,"DIAGNOSTIC_TEST: Xiamen Wiz Biotech Co., Ltd. SARS-CoV-2 Antigen Rapid Test","Sky Medical Supplies & Equipments, LLC",,ALL,"CHILD, ADULT, OLDER_ADULT",NA,0,INDUSTRY,INTERVENTIONAL,1/9/2021,1/28/2021
NCT04930965,COMPLETED,Covid19|Vaccine Refusal,BEHAVIORAL: Community health worker engagement,Tulane University,National Institutes of Health (NIH),ALL,"ADULT, OLDER_ADULT",NA,56,OTHER,INTERVENTIONAL,10/5/2021,2/28/2023
NCT04844489,COMPLETED,Autoimmune or Autoinflammatory Diseases|HIV|Multiple Sclerosis|Solid Tumors or Cancers|Solid Organ Transplant,OTHER: Blood samples for the study of the humoral response to SARS-CoV-2 variants and of the cellular response after vaccination against COVID-19,Assistance Publique - Hôpitaux de Paris,,ALL,"ADULT, OLDER_ADULT",NA,377,OTHER,INTERVENTIONAL,4/16/2021,12/31/2022
NCT05311865,COMPLETED,Healthy Participant,OTHER: Club event,"ANRS, Emerging Infectious Diseases",Cerballiance|Kappa Santé,ALL,ADULT,NA,1216,OTHER_GOV,INTERVENTIONAL,9/4/2021,2/26/2022
NCT04810065,COMPLETED,Long Covid,OTHER: SingStrong: Strong lungs through Song,University of Limerick,,ALL,"ADULT, OLDER_ADULT",NA,30,OTHER,INTERVENTIONAL,3/29/2021,9/1/2021
NCT04344431,UNKNOWN,Covid-19,COMBINATION_PRODUCT: Hyperbaric oxygen treatment (HBOT) i.e. inhalation of pressurized oxygen delivered by a hyperbaric chamber (drug/device),Direction Centrale du Service de Santé des Armées,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,100,OTHER,INTERVENTIONAL,4/14/2020,2022-04
NCT04863131,COMPLETED,COVID-19,BIOLOGICAL: EXG-5003|BIOLOGICAL: Placebo,Fujita Health University,"Elixirgen Therapeutics, Inc.",ALL,ADULT,PHASE1|PHASE2,40,OTHER,INTERVENTIONAL,4/28/2021,1/24/2023
NCT04365231,WITHDRAWN,COVID19,DRUG: Hydroxychloroquine and azithromycin treatment|OTHER: conventional management of patients,"Hospital St. Joseph, Marseille, France",,FEMALE,"ADULT, OLDER_ADULT",PHASE3,0,OTHER,INTERVENTIONAL,4/1/2020,4/1/2021
NCT06113731,RECRUITING,SARS-CoV-2 Infection,"BIOLOGICAL: COVID-19 mRNA Vaccine (ZSVG-02-O)|BIOLOGICAL: COVID-19 mRNA Vaccine (ZSVG-02-O)|BIOLOGICAL: COVID-19 Vaccine (Vero Cell) ,Inactivated",CNBG-Virogin Biotech (Shanghai) Ltd.,,ALL,"ADULT, OLDER_ADULT",PHASE2,980,INDUSTRY,INTERVENTIONAL,7/10/2023,2024-10
NCT04907331,UNKNOWN,SARS-CoV2 Infection,BIOLOGICAL: Vaxzevria|BIOLOGICAL: Comirnaty,Medical University Innsbruck,Medical University of Graz|Medical University of Vienna,ALL,"ADULT, OLDER_ADULT",PHASE2,3000,OTHER,INTERVENTIONAL,5/10/2021,12/30/2021
NCT04414631,TERMINATED,Coronavirus Infections,DRUG: Conestat alfa,"University Hospital, Basel, Switzerland",Pharming Technologies B.V.,ALL,"ADULT, OLDER_ADULT",PHASE2,80,OTHER,INTERVENTIONAL,8/6/2020,9/15/2021
NCT04792021,COMPLETED,Corona Virus Disease 19 (Covid19)|Corona Virus Infection|Severe Acute Respiratory Syndrome Coronavirus 2(SARS-CoV2),DRUG: N-acetylcysteine,Ain Shams University,Misr International University,ALL,"ADULT, OLDER_ADULT",PHASE3,60,OTHER,INTERVENTIONAL,3/9/2021,4/1/2022
NCT04749121,COMPLETED,Covid19,DEVICE: UVC Irradiation|DRUG: UVC Irradiation|DEVICE: Fit test|DEVICE: Tensile strength,Bangkok Metropolitan Administration Medical College and Vajira Hospital,,ALL,ADULT,NA,20,OTHER_GOV,INTERVENTIONAL,4/1/2020,2/5/2021
NCT04649021,COMPLETED,SARS-CoV-2,BIOLOGICAL: BNT162b2|OTHER: Placebo,BioNTech SE,Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.,ALL,"ADULT, OLDER_ADULT",PHASE2,950,INDUSTRY,INTERVENTIONAL,12/4/2020,1/9/2022
NCT04319731,COMPLETED,SARS CoV-2 Infection,BIOLOGICAL: Human Amniotic Fluid,University of Utah,,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,10,OTHER,INTERVENTIONAL,3/20/2020,6/9/2020
NCT04382131,UNKNOWN,Upper Respiratory Tract Infections|Virus|COVID|Virus Shedding|Virus Diseases,OTHER: NaCl Solution,University of Edinburgh,,ALL,"ADULT, OLDER_ADULT",NA,405,OTHER,INTERVENTIONAL,6/23/2020,10/31/2020
NCT05263921,COMPLETED,Bioavailability,DRUG: PF-07321332/ritonavir|DRUG: PF-07321332/ritonavir|DRUG: PF-07321332/ritonavir|DRUG: PF-07321332/ritonavir,Pfizer,,ALL,"ADULT, OLDER_ADULT",PHASE1,12,INDUSTRY,INTERVENTIONAL,3/10/2022,5/19/2022
NCT05943821,RECRUITING,Cardiovascular Diseases|Uric Acid,DRUG: Allopurinol 200 mg|DRUG: Optional intervention,Poznan University of Medical Sciences,,ALL,"ADULT, OLDER_ADULT",PHASE3,1116,OTHER,INTERVENTIONAL,9/1/2023,7/31/2028
NCT05454631,RECRUITING,Chronic Obstructive Pulmonary Disease,DEVICE: surgical mask (5 different types),Assistance Publique - Hôpitaux de Paris,,ALL,"ADULT, OLDER_ADULT",NA,50,OTHER,INTERVENTIONAL,2/6/2023,10/30/2023
NCT04367831,COMPLETED,COVID-19|Venous Thromboses|Arterial Thrombosis,DRUG: Enoxaparin Prophylactic Dose|DRUG: Heparin Infusion|DRUG: Heparin SC|DRUG: Enoxaparin/Lovenox Intermediate Dose,Columbia University,,ALL,"ADULT, OLDER_ADULT",PHASE4,94,OTHER,INTERVENTIONAL,5/2/2020,5/12/2021
NCT04919031,COMPLETED,Covid19|Hypertension|Corona Persistent Symptoms,DEVICE: Inspiratory muscle trainer|OTHER: diaphragmatic release,Cairo University,,MALE,ADULT,NA,90,OTHER,INTERVENTIONAL,8/1/2021,12/1/2022
NCT04523831,COMPLETED,Covid19,DRUG: Ivermectin and Doxycycline|DRUG: Standard of care,Dhaka Medical College,,ALL,"ADULT, OLDER_ADULT",PHASE3,400,OTHER,INTERVENTIONAL,6/1/2020,9/10/2020
NCT05445531,RECRUITING,COVID-19|COVID-19 Respiratory Infection|Long COVID,DIAGNOSTIC_TEST: Low-field magnetic resonance imaging|DIAGNOSTIC_TEST: Nailfold capillaroscopy|DIAGNOSTIC_TEST: Spiroergometry|DIAGNOSTIC_TEST: Realtime deformability cytometry,University of Erlangen-Nürnberg Medical School,,ALL,CHILD,NA,111,OTHER,INTERVENTIONAL,7/8/2022,3/31/2023
NCT05752331,COMPLETED,Long COVID,BEHAVIORAL: Physical activity behavioural modification,Bournemouth University,,ALL,"ADULT, OLDER_ADULT",NA,32,OTHER,INTERVENTIONAL,11/1/2022,6/15/2023
NCT04419025,COMPLETED,COVID|Sars-CoV2|SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere|Oxidative Stress,DRUG: N-acetylcysteine,Cambridge Health Alliance,,ALL,"ADULT, OLDER_ADULT",PHASE2,165,OTHER,INTERVENTIONAL,9/23/2020,5/14/2021
NCT04379492,WITHDRAWN,COVID-19|COVID19|Sars-CoV2|SARS-Cov-2,DRUG: Hydroxychloroquine|OTHER: Placebo,Memorial Sloan Kettering Cancer Center,,ALL,"ADULT, OLDER_ADULT",PHASE2,0,OTHER,INTERVENTIONAL,5/5/2020,9/25/2020
NCT04293692,WITHDRAWN,COVID-19,BIOLOGICAL: UC-MSCs|OTHER: Placebo,Puren Hospital Affiliated to Wuhan University of Science and Technology,"Wuhan Hamilton Bio-technology Co., Ltd",ALL,"ADULT, OLDER_ADULT",NA,0,OTHER,INTERVENTIONAL,2/24/2020,2/25/2020
NCT05197725,WITHDRAWN,Covid19,DEVICE: Face mask|BEHAVIORAL: Face mask awareness|BEHAVIORAL: Face mask promotion through community values or individual information,Yale University,"Stanford University|University of California, Berkeley|Innovations for Poverty Action|North South University",FEMALE,"CHILD, ADULT, OLDER_ADULT",NA,0,OTHER,INTERVENTIONAL,2/4/2023,5/30/2023
NCT05639192,TERMINATED,COVID-19,BIOLOGICAL: Asunercept|OTHER: Placebo,Apogenix GmbH,,ALL,"ADULT, OLDER_ADULT",PHASE3,34,INDUSTRY,INTERVENTIONAL,11/3/2022,8/18/2023
NCT04840992,COMPLETED,COVID-19,BIOLOGICAL: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) for Inhalation|BIOLOGICAL: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)|BIOLOGICAL: Placebo for Inhalation|BIOLOGICAL: Placebo,CanSino Biologics Inc.,Beijing Institute of Biotechnology|Jiangsu Province Centers for Disease Control and Prevention,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,840,INDUSTRY,INTERVENTIONAL,4/21/2021,8/9/2022
NCT06042855,RECRUITING,Covid19,OTHER: Placebo|DRUG: Metformin,"Susanna Naggie, MD",National Center for Advancing Translational Sciences (NCATS)|Vanderbilt University Medical Center,ALL,"ADULT, OLDER_ADULT",PHASE3,15000,OTHER,INTERVENTIONAL,9/5/2023,2024-06
NCT04646655,COMPLETED,Covid19|Thrombosis,DRUG: Enoxaparin,ASST Fatebenefratelli Sacco,Massimo Arquati|Riccardo Colombo|Umberto Russo|Manuela Nebuloni|Spinello Antinori,ALL,"ADULT, OLDER_ADULT",PHASE3,142,OTHER,INTERVENTIONAL,7/27/2020,4/30/2023
NCT04461925,UNKNOWN,COVID-19 Pneumonia,PROCEDURE: Placenta-Derived MMSCs; Cryopreserved Placenta-Derived Multipotent Mesenchymal Stromal Cells|DRUG: Antibiotics|DRUG: Hormones|DRUG: Anticoagulant Therapy|DEVICE: Оxygen therapy,Institute of Cell Therapy,Kyiv City Clinical Hospital # 4,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,30,INDUSTRY,INTERVENTIONAL,5/2/2020,2021-12
NCT05201625,UNKNOWN,COVID-19,DIAGNOSTIC_TEST: real time PCR,Sohag University,,ALL,"ADULT, OLDER_ADULT",NA,90,OTHER,INTERVENTIONAL,12/15/2021,2022-12
NCT04519125,UNKNOWN,Severe Acute Respiratory Syndrome Coronavirus 2|COVID-19,DRUG: Tenofovir/ Emtricitabine ( 300 mg / 200 mg daily during 60 days) + Personal Protective Equipment (PPE)|OTHER: Placebo (1 tablet daily during 60 days) + Personal Protective Equipment (PPE),Hospital Universitario San Ignacio,"Pontificia Universidad Javeriana|Hospital Universitario Nacional de Colombia|Hospital de la Samaritana, Sede Bogotá y Sede Zipaquirá|Hospital Universitario San Jorge, Pereira.|Fundación Universitaria Autónoma de Las Américas|Universidad Tecnológica de Pereira|Colsanitas",ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,950,OTHER,INTERVENTIONAL,8/30/2020,4/1/2021
NCT04333225,COMPLETED,COVID-19,DRUG: Hydroxychloroquine,Baylor Research Institute,,ALL,"ADULT, OLDER_ADULT",PHASE2,221,OTHER,INTERVENTIONAL,4/3/2020,6/30/2020
NCT04409925,COMPLETED,COVID-19 Infection,DRUG: rhDNase I,McGill University Health Centre/Research Institute of the McGill University Health Centre,Hamilton Health Sciences Corporation|Hoffmann-La Roche|Exactis Innovation,ALL,"ADULT, OLDER_ADULT",PHASE1,15,OTHER,INTERVENTIONAL,12/25/2020,8/1/2021
NCT04550325,COMPLETED,"Covid19|Pneumonia, Viral",BIOLOGICAL: Kamada Anti-SARS-CoV-2,"Kamada, Ltd.",,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,12,INDUSTRY,INTERVENTIONAL,8/5/2020,11/26/2020
NCT04878042,WITHDRAWN,COVID-19,DEVICE: Hydrogen peroxide|DEVICE: Placebo,EPISTATA,,ALL,"ADULT, OLDER_ADULT",NA,0,NETWORK,INTERVENTIONAL,4/9/2021,2021-07
NCT04602442,UNKNOWN,Covid19|SARS-CoV-2 PNEUMONIA|COVID-19,DRUG: EXO 1 inhalation|DRUG: EXO 2 inhalation|DRUG: Placebo inhalation,Olga Tyumina,Clinics of the Federal State Budgetary Educational Institution SSMU|Samara Regional Clinical Hospital V.D. Seredavin,ALL,"ADULT, OLDER_ADULT",PHASE2,90,OTHER,INTERVENTIONAL,10/1/2020,12/30/2021
NCT05364242,COMPLETED,SARS-CoV-2 Infection,BIOLOGICAL: VLA2001,Valneva Austria GmbH,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,178,INDUSTRY,INTERVENTIONAL,5/9/2022,5/22/2023
NCT04371965,COMPLETED,COVID-19,DRUG: Povidone-Iodine,Poitiers University Hospital,,ALL,"ADULT, OLDER_ADULT",PHASE2,24,OTHER,INTERVENTIONAL,9/1/2020,10/23/2020
NCT04868942,WITHDRAWN,Corona Virus Infection,OTHER: Assisting to the event,"ANRS, Emerging Infectious Diseases",Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale|Faculté des Sciences Médicales et Paramédicales,ALL,ADULT,NA,0,OTHER_GOV,INTERVENTIONAL,5/1/2021,5/1/2022
NCT04927065,COMPLETED,SARS-CoV-2,BIOLOGICAL: mRNA-1273.211|BIOLOGICAL: mRNA-1273|BIOLOGICAL: mRNA-1273.617.2|BIOLOGICAL: mRNA-1273.213|BIOLOGICAL: mRNA-1273.529|BIOLOGICAL: mRNA-1273.214|BIOLOGICAL: mRNA-1273.222|BIOLOGICAL: mRNA-1273.815|BIOLOGICAL: mRNA-1273.231,"ModernaTX, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,5404,INDUSTRY,INTERVENTIONAL,5/28/2021,11/17/2023
NCT05001542,COMPLETED,"Moral Injury|Distress, Emotional",OTHER: Educational moral injury video,Unity Health Toronto,Toronto Metropolitan University|University of Toronto|University of Ontario Institute of Technology|McMaster University,ALL,"ADULT, OLDER_ADULT",NA,15,OTHER,INTERVENTIONAL,5/31/2021,8/30/2021
NCT05228665,RECRUITING,COVID-19,BEHAVIORAL: Heart Rate Variability Biofeedback (HRV-B),University of Leeds,University of Manchester|Leeds Comunity Healthcare NHS Trust,ALL,"ADULT, OLDER_ADULT",NA,30,OTHER,INTERVENTIONAL,1/24/2022,3/31/2024
NCT04760730,COMPLETED,COVID-19,BIOLOGICAL: AZD1222|BIOLOGICAL: rAd26-S,R-Pharm,AstraZeneca,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,100,INDUSTRY,INTERVENTIONAL,7/13/2021,7/26/2022
NCT04662021,UNKNOWN,Anxiety Depression Disorder,OTHER: Aerobic Exercises,Cairo University,,FEMALE,ADULT,NA,40,OTHER,INTERVENTIONAL,12/10/2020,2/25/2021
NCT05429021,RECRUITING,SARS-CoV2 Infection|COVID-19,DRUG: IMM-BCP-01|DRUG: Placebo,"Immunome, Inc.",United States Department of Defense,ALL,ADULT,PHASE1,36,INDUSTRY,INTERVENTIONAL,6/3/2022,2023-04
NCT04526821,TERMINATED,SARS-CoV-2,DRUG: Bovine Lactoferrin|DIETARY_SUPPLEMENT: Maltodextrin,Universidad Peruana Cayetano Heredia,Hospital Nacional Arzobispo Loayza,ALL,ADULT,PHASE2,209,OTHER,INTERVENTIONAL,10/17/2020,2/10/2021
NCT04427631,UNKNOWN,"Hearing Impaired Children|Glue Ear|Hearing Loss, Conductive",DEVICE: Bone conduction headphones,Cambridgeshire Community Services NHS Trust,Cambridge University Hospitals NHS Foundation Trust,ALL,CHILD,NA,20,OTHER,INTERVENTIONAL,6/22/2020,6/1/2021
NCT04885530,ACTIVE_NOT_RECRUITING,Covid19,DRUG: Ivermectin|DRUG: Fluvoxamine|DRUG: Fluticasone|OTHER: Placebo|DRUG: Montelukast|DRUG: Metformin,"Susanna Naggie, MD",National Center for Advancing Translational Sciences (NCATS)|Vanderbilt University Medical Center,ALL,"ADULT, OLDER_ADULT",PHASE3,15000,OTHER,INTERVENTIONAL,6/8/2021,2024-06
NCT06063031,ACTIVE_NOT_RECRUITING,Post-COVID Condition,DIETARY_SUPPLEMENT: Active|OTHER: Placebo,Instituto de Investigación Sanitaria Aragón,Solutex GC S.L.,ALL,"ADULT, OLDER_ADULT",NA,146,OTHER,INTERVENTIONAL,9/26/2022,1/30/2024
NCT04780321,COMPLETED,COVID-19,BIOLOGICAL: Recombinant Human Anti-SARS-CoV-2 Monoclonal Antibody(25mg/kg;50mg/kg;100mg/kg)|DRUG: Placebo,"Shanghai Junshi Bioscience Co., Ltd.",,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,62,OTHER,INTERVENTIONAL,10/30/2020,8/31/2021
NCT06202521,NOT_YET_RECRUITING,Community-acquired Pneumonia|SARS-CoV-2 -Associated Pneumonia|Influenza With Pneumonia,DRUG: CX-4945 (SARS-CoV-2 domain)|DRUG: Placebo (SARS-CoV-2 domain)|DRUG: CX-4945 (Influenza virus domain)|DRUG: Placebo (Influenza virus domain),"Senhwa Biosciences, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE2,136,INDUSTRY,INTERVENTIONAL,2024-03,2025-06
NCT04766931,COMPLETED,Covid19,DRUG: FB2001|DRUG: FB2001 Placebo,Frontier Biotechnologies Inc.,,ALL,ADULT,PHASE1,88,INDUSTRY,INTERVENTIONAL,3/17/2021,8/12/2022
NCT04537130,UNKNOWN,Pulmonary Fibrosis|Covid19,BIOLOGICAL: IN01 vaccine,Instituto Oncológico Dr Rosell,IN3BIO|PANGAEA,ALL,"ADULT, OLDER_ADULT",PHASE1,40,OTHER,INTERVENTIONAL,12/1/2020,2022-06
NCT04558021,UNKNOWN,Covid19,DRUG: Niclosamide suspension|OTHER: Placebo,Imuneks Farma ilac San. Tic. A.S.,,ALL,"ADULT, OLDER_ADULT",PHASE3,200,INDUSTRY,INTERVENTIONAL,10/8/2020,2/14/2021
NCT04928430,TERMINATED,COVID-19,DRUG: XAV-19|DRUG: Placebo,Xenothera SAS,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,290,INDUSTRY,INTERVENTIONAL,4/28/2021,11/28/2022
NCT04405921,UNKNOWN,SARS-CoV-2 Pneumonia|COVID-19,DRUG: Hydroxychloroquine 200 Mg Oral Tablet|DRUG: Azithromycin 250 MG,Centre Hôpital Universitaire Farhat Hached,,ALL,"ADULT, OLDER_ADULT",PHASE3,200,OTHER,INTERVENTIONAL,2020-07,2021-03
NCT04335786,TERMINATED,Acute Respiratory Distress Syndrome|SARS-CoV-2|COVID|COVID-19|Severe Acute Respiratory Syndrome,DRUG: Valsartan (Diovan)|DRUG: Placebo oral tablet,Radboud University Medical Center,,ALL,"ADULT, OLDER_ADULT",PHASE4,23,OTHER,INTERVENTIONAL,4/17/2020,5/25/2021
NCT04487886,COMPLETED,COVID-19,DRUG: Duvelisib|DRUG: Placebo,Emory University,"Verastem, Inc.",ALL,"ADULT, OLDER_ADULT",PHASE2,47,OTHER,INTERVENTIONAL,11/18/2020,6/10/2021
NCT04345419,COMPLETED,COVID,DRUG: Remdesivir|OTHER: Standard of care treatment,Tanta University,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2|PHASE3,200,OTHER,INTERVENTIONAL,6/16/2020,12/1/2020
NCT04350086,WITHDRAWN,COVID-19 Infection|Sars-cov-2|Respiratory Failure|Palliative Situation,DRUG: Treatment with Dexmedetomidine,"University Hospital, Limoges",,ALL,"ADULT, OLDER_ADULT",PHASE4,0,OTHER,INTERVENTIONAL,4/20/2020,11/20/2020
NCT05732285,RECRUITING,Neurocognitive Disorders|Cognitive Dysfunction|Traumatic Brain Injury|Multiple Sclerosis|Mild Cognitive Impairment,BEHAVIORAL: CRT|BEHAVIORAL: CBT|BEHAVIORAL: Modifiable lifestyle factors|BEHAVIORAL: Usual care Psychoeducation,University of Michigan,,ALL,"ADULT, OLDER_ADULT",NA,56,OTHER,INTERVENTIONAL,9/1/2023,3/30/2025
NCT04452565,UNKNOWN,Coronavirus Infection|Severe Acute Respiratory Infection|Severe Acute Respiratory Syndrome Coronavirus 2,DRUG: Drug: NA-831|COMBINATION_PRODUCT: NA-831 and Atazanavir|COMBINATION_PRODUCT: NA-831and Dexamethasone|COMBINATION_PRODUCT: Atazanavir and Dexamethasone,"NeuroActiva, Inc.","Biomed Industries, Inc.",ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,525,INDUSTRY,INTERVENTIONAL,6/15/2022,12/15/2023
NCT05045989,COMPLETED,Covid19,BEHAVIORAL: Residence-based testing participation pilot (SARS-CoV-2 testing with relaxed social distancing restrictions),University of Nottingham,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,152,OTHER,INTERVENTIONAL,4/1/2021,7/31/2021
NCT04341389,COMPLETED,COVID-19,BIOLOGICAL: Recombinant novel coronavirus vaccine (Adenovirus type 5 vector)|OTHER: Placebo,"Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China",CanSino Biologics Inc.|Jiangsu Province Centers for Disease Control and Prevention|Hubei Provincial Center for Disease Control and Prevention|Zhongnan Hospital,ALL,"ADULT, OLDER_ADULT",PHASE2,508,OTHER,INTERVENTIONAL,4/12/2020,12/31/2020
NCT04362189,TERMINATED,COVID-19,BIOLOGICAL: HB-adMSC|OTHER: Placebo,Hope Biosciences Stem Cell Research Foundation,River Oaks Hospital and Clinics|Hope Biosciences|United Memorial Medical Center,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,48,OTHER,INTERVENTIONAL,6/30/2020,9/30/2021
NCT05372588,ACTIVE_NOT_RECRUITING,COVID-19|SARS CoV 2 Infection,DRUG: NVX-CoV2515|DRUG: NVX-Cov2373|DRUG: NVX-CoV2373 + NVX-CoV2515|DRUG: NVX-CoV2540|DRUG: NVX-CoV2373 + NVX-CoV2540,Novavax,,ALL,ADULT,PHASE3,1340,INDUSTRY,INTERVENTIONAL,5/25/2022,2/11/2024
NCT04522089,COMPLETED,COVID-19,BIOLOGICAL: AdimrSC-2f,Adimmune Corporation,,ALL,ADULT,PHASE1,68,INDUSTRY,INTERVENTIONAL,8/24/2020,5/6/2021
NCT04610489,TERMINATED,Covid-19,DIAGNOSTIC_TEST: Quidel Sofia SARS Antigen FIA,Carilion Clinic,,ALL,"ADULT, OLDER_ADULT",NA,117,OTHER,INTERVENTIONAL,11/13/2020,3/10/2021
NCT04497389,COMPLETED,SARS CoV-2,BIOLOGICAL: Human Amniotic Fluid,University of Utah,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,47,OTHER,INTERVENTIONAL,10/28/2020,2/15/2023
NCT05445089,COMPLETED,COVID-19|COVID-19 Pneumonia|COVID-19 Respiratory Infection|COVID-19 Acute Respiratory Distress Syndrome|COVID-19 Lower Respiratory Infection,DRUG: Carvacrol|OTHER: Control group,Instituto Venezolano de Investigaciones Cientificas,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,600,OTHER,INTERVENTIONAL,8/1/2020,12/15/2020
NCT05497089,ACTIVE_NOT_RECRUITING,Post-COVID-19 Syndrome,DRUG: Temelimab 54mg/kg|DRUG: Placebo,GeNeuro SA,,ALL,"ADULT, OLDER_ADULT",PHASE2,200,INDUSTRY,INTERVENTIONAL,8/29/2022,6/30/2024
NCT04801888,COMPLETED,COVID-19|Influenza,"BIOLOGICAL: Two doses of inactivated SARS-CoV-2 vaccine at the schedule of day 0,28 and one dose Quadrivalent Influenza Vaccine on day 0 or day 28.|BIOLOGICAL: Two doses of inactivated SARS-CoV-2 vaccine at the schedule of day 0,28 and one dose Quadrivalent Influenza Vaccine on day 14.","Sinovac Research and Development Co., Ltd.",,ALL,ADULT,PHASE4,480,INDUSTRY,INTERVENTIONAL,3/23/2021,5/28/2021
NCT05507489,RECRUITING,"COVID-19|Child, Only",DRUG: Jinzhen oral liquid or Jinhuaqinggan granules,The Affiliated Hospital of Qingdao University,,ALL,"CHILD, ADULT",NA,240,OTHER,INTERVENTIONAL,3/18/2022,3/17/2023
NCT05105789,COMPLETED,Sars-CoV-2 Infection|COVID-19,"DIAGNOSTIC_TEST: BinaxNOW Test|DIAGNOSTIC_TEST: ""Lollipop"" swab","University of Wisconsin, Madison",,ALL,"CHILD, ADULT, OLDER_ADULT",NA,100,OTHER,INTERVENTIONAL,10/11/2021,5/21/2023
NCT05874089,RECRUITING,Long COVID,DIETARY_SUPPLEMENT: VSL#3®|DIETARY_SUPPLEMENT: Placebo,"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico",,ALL,"ADULT, OLDER_ADULT",NA,96,OTHER,INTERVENTIONAL,11/3/2022,11/3/2023
NCT04922788,ACTIVE_NOT_RECRUITING,SARS-CoV-2 Infection|COVID-19,BIOLOGICAL: Nanocovax|BIOLOGICAL: Placebo,Nanogen Pharmaceutical Biotechnology Joint Stock Company,,ALL,"ADULT, OLDER_ADULT",PHASE3,13000,INDUSTRY,INTERVENTIONAL,6/7/2021,12/7/2022
NCT06161688,NOT_YET_RECRUITING,Long COVID|Post Acute Sequelae of COVID-19|Post-Acute COVID-19,DRUG: Ensitrelvir|OTHER: Placebo,Timothy Henrich,Shionogi Inc.,ALL,"ADULT, OLDER_ADULT",PHASE2,40,OTHER,INTERVENTIONAL,1/1/2024,12/31/2025
NCT05142514,ACTIVE_NOT_RECRUITING,COVID-19|SARS-CoV-2 Acute Respiratory Disease,BIOLOGICAL: COVID-19 Vaccine HIPRA|BIOLOGICAL: Cominarty (Pfizer-BioNtech),"Hipra Scientific, S.L.U","Laboratorios Hipra, S.A.|National Institute of Hygiene and Epidemiology, Vietnam",ALL,ADULT,PHASE2,256,INDUSTRY,INTERVENTIONAL,11/11/2021,12/27/2022
NCT04344600,TERMINATED,Sars-CoV-2 Infection,DRUG: Peginterferon lambda alfa-1a subcutaneous injection|OTHER: Saline,Johns Hopkins University,Eiger BioPharmaceuticals,ALL,"ADULT, OLDER_ADULT",PHASE2,6,OTHER,INTERVENTIONAL,6/29/2020,9/24/2021
NCT04830800,COMPLETED,"COVID-19 Disease|SARS Pneumonia|Pneumonia, Viral|COVID-19 Vaccine",BIOLOGICAL: COVIVAC|BIOLOGICAL: Phosphate-buffered saline,"Institute of Vaccines and Medical Biologicals, Vietnam","National Institute of Hygiene and Epidemiology, Vietnam|Hanoi Medical University|Center for Disease Control of Thai Binh Province",ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,420,INDUSTRY,INTERVENTIONAL,3/10/2021,3/11/2022
NCT06032000,RECRUITING,COVID-19 Infection|COVID-19 Vaccine Adverse Reaction,BIOLOGICAL: LEM-mR203|BIOLOGICAL: Placebo,Lemonex,,ALL,ADULT,PHASE1,20,INDUSTRY,INTERVENTIONAL,11/6/2023,2025-02
NCT04514900,COMPLETED,Obesity,BEHAVIORAL: Video Chat +Personalized Feedback|BEHAVIORAL: Video Chat + Basic Feedback|BEHAVIORAL: Discussion Board for Social Support +Basic Feedback|BEHAVIORAL: Discussion Board for Social Support+Personalized Feedback,University of South Carolina,University of Vermont|University of Tennessee,ALL,"ADULT, OLDER_ADULT",NA,73,OTHER,INTERVENTIONAL,9/23/2020,3/8/2021
NCT04323800,COMPLETED,Coronavirus|Convalescence,BIOLOGICAL: Anti- SARS-CoV-2 Plasma|BIOLOGICAL: SARS-CoV-2 non-immune Plasma,Johns Hopkins University,,ALL,"ADULT, OLDER_ADULT",PHASE2,180,OTHER,INTERVENTIONAL,6/10/2020,6/22/2021
NCT04339712,COMPLETED,COVID-19|Virus Diseases|Macrophage Activation Syndrome|Corona Virus Infection,DRUG: Anakinra|DRUG: Tocilizumab,Hellenic Institute for the Study of Sepsis,,ALL,"ADULT, OLDER_ADULT",PHASE2,102,OTHER,INTERVENTIONAL,4/2/2020,1/8/2021
NCT04572412,COMPLETED,Covid19,RADIATION: Low dose Radiotherapy,Lancashire Teaching Hospitals NHS Foundation Trust,NIHR Lancashire Clinical Research Facility,ALL,"ADULT, OLDER_ADULT",NA,2,OTHER,INTERVENTIONAL,11/25/2020,6/30/2022
NCT04482712,WITHDRAWN,Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)|Respiratory Failure|Sars-CoV2,DRUG: Rapamycin|DRUG: Placebo,The University of Texas Health Science Center at San Antonio,The Claude D. Pepper Older Americans Independence Centers,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,0,OTHER,INTERVENTIONAL,2021-04,2023-01
NCT04573855,UNKNOWN,Covid19,BIOLOGICAL: Anti-SARS-CoV-2 immunoglobulin,D'Or Institute for Research and Education,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,41,OTHER,INTERVENTIONAL,12/1/2020,3/31/2021
NCT04459455,COMPLETED,Anxiety,BEHAVIORAL: Contain COVID Anxiety SSI|BEHAVIORAL: Remain COVID Free SSI,Stony Brook University,,ALL,"ADULT, OLDER_ADULT",NA,500,OTHER,INTERVENTIONAL,8/19/2020,10/15/2020
NCT05928455,ACTIVE_NOT_RECRUITING,COVID-19|Vaccine Reaction,BIOLOGICAL: LYB001|BIOLOGICAL: CoronaVac,"Guangzhou Patronus Biotech Co., Ltd.","Yantai Patronus Biotech Co., Ltd.|Afﬁliated Hospital of North Sichuan Medical College",ALL,ADULT,EARLY_PHASE1,120,INDUSTRY,INTERVENTIONAL,5/14/2022,6/30/2023
NCT05601167,COMPLETED,COVID-19,DRUG: nirmatrelvir/ritonavir|DRUG: Standard of care,"Promomed, LLC",Sponsor GmbH,ALL,"ADULT, OLDER_ADULT",PHASE3,264,OTHER,INTERVENTIONAL,2/17/2021,6/1/2022
NCT05182567,ACTIVE_NOT_RECRUITING,COVID-19|Healthy,DRUG: GLS-5310 (Group 1)|DRUG: GLS-5310 (Group 2)|DRUG: GLS-5310 (Group 3)|DRUG: GLS-5310 (Group 4),"GeneOne Life Science, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE1,69,INDUSTRY,INTERVENTIONAL,5/23/2022,2023-12
NCT04371367,COMPLETED,COVID,BIOLOGICAL: avdoralimab|OTHER: Placebo,Assistance Publique Hopitaux De Marseille,Innate Pharma,ALL,"ADULT, OLDER_ADULT",PHASE2,208,OTHER,INTERVENTIONAL,4/27/2020,3/30/2021
NCT04627467,COMPLETED,Covid19,DRUG: Chloroquine,Fundacion Clinica Valle del Lili,,ALL,"ADULT, OLDER_ADULT",PHASE2,3217,OTHER,INTERVENTIONAL,3/28/2020,9/30/2021
NCT04637867,COMPLETED,Infection Viral,"OTHER: Collection of blood, salivary and nasopharyngeal samples.",Hospices Civils de Lyon,,ALL,"ADULT, OLDER_ADULT",NA,189,OTHER,INTERVENTIONAL,11/23/2020,5/12/2021
NCT04302519,UNKNOWN,COVID-19,BIOLOGICAL: Dental pulp mesenchymal stem cells,"CAR-T (Shanghai) Biotechnology Co., Ltd.",,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,24,INDUSTRY,INTERVENTIONAL,3/5/2020,7/30/2021
NCT04587219,UNKNOWN,Coronavirus Infection,BIOLOGICAL: Gam-COVID-Vac,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation",,ALL,"ADULT, OLDER_ADULT",PHASE2,110,OTHER,INTERVENTIONAL,10/22/2020,4/30/2021
NCT04569266,COMPLETED,Dyspnea,OTHER: Specific exercise rehabilitation treatment|OTHER: No specific exercise rehabilitation treatment,Fondation Hôpital Saint-Joseph,,ALL,"ADULT, OLDER_ADULT",NA,63,OTHER,INTERVENTIONAL,8/7/2020,4/30/2023
NCT04382066,COMPLETED,COVID-19,DRUG: Plitidepsin 1.5 mg/day|DRUG: Plitidepsin 2.0 mg/day|DRUG: Plitidepsin 2.5 mg/day,PharmaMar,Apices Soluciones S.L.,ALL,"ADULT, OLDER_ADULT",PHASE1,46,INDUSTRY,INTERVENTIONAL,5/12/2020,11/26/2020
NCT04402866,COMPLETED,Acute Lung Injury (ALI) Associated With COVID-19|Lung Inflammation Associated With COVID-19,DRUG: TD-0903|DRUG: Placebo,Theravance Biopharma,,ALL,"ADULT, OLDER_ADULT",PHASE2,235,INDUSTRY,INTERVENTIONAL,6/24/2020,4/21/2021
NCT04952766,COMPLETED,Kidney Transplant|Myeloma|Cancer|Hematologic Malignancy|Multiple Sclerosis|Hypergammaglobulinemia|Malignant Tumor|Hiv|Diabetes Type 2,BIOLOGICAL: Biological samples,Centre Hospitalier Régional d'Orléans,,ALL,"ADULT, OLDER_ADULT",PHASE4,196,OTHER,INTERVENTIONAL,3/26/2021,2/6/2022
NCT05135585,COMPLETED,SARS-CoV-2 Acute Respiratory Disease,OTHER: Blood sample collection|OTHER: Questionnaires,Institut Pasteur,Centre Hospitalier Spécialisé de Nouvelle-Calédonie|Direction de l'Action Sanitaire et Sociale|Centre Hospitalier Territorial de Nouvelle-Calédonie|Agence sanitaire et sociale de la Nouvelle Calédonie,ALL,"ADULT, OLDER_ADULT",NA,680,INDUSTRY,INTERVENTIONAL,12/1/2021,9/17/2022
NCT04466085,UNKNOWN,Coronavirus,BIOLOGICAL: Recombinant new coronavirus vaccine (CHO cell) low-dose group|BIOLOGICAL: Recombinant new coronavirus vaccine (CHO cells) high-dose group|BIOLOGICAL: Recombinant new coronavirus vaccine (CHO cells) placebo group,"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.",,ALL,ADULT,PHASE2,900,INDUSTRY,INTERVENTIONAL,7/12/2020,12/15/2021
NCT04590586,COMPLETED,COVID-19,DRUG: Standard of care|DRUG: Apremilast|DRUG: Apremilast placebo|DRUG: Lanadelumab|DRUG: Lanadelumab placebo|DRUG: Zilucoplan|DRUG: Zilucoplan placebo,Amgen,,ALL,"ADULT, OLDER_ADULT",PHASE3,515,INDUSTRY,INTERVENTIONAL,11/24/2020,8/3/2021
NCT04884685,COMPLETED,COVID-19,BIOLOGICAL: SARS-CoV-2 Inactivated Vaccine|BIOLOGICAL: Placebo,"Sinovac Life Sciences Co., Ltd.",,ALL,CHILD,PHASE2,500,INDUSTRY,INTERVENTIONAL,5/3/2021,6/20/2022
NCT04644185,UNKNOWN,Covid19,DRUG: SCTA01|OTHER: Placebo,Sinocelltech Ltd.,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,795,INDUSTRY,INTERVENTIONAL,3/27/2021,12/27/2021
NCT05434585,ACTIVE_NOT_RECRUITING,COVID-19,BIOLOGICAL: ABO1009-DP|BIOLOGICAL: ABO-CoV.617.2|OTHER: Placebo,"Suzhou Abogen Biosciences Co., Ltd.",,ALL,"ADULT, OLDER_ADULT",PHASE1,60,INDUSTRY,INTERVENTIONAL,7/8/2022,8/30/2023
NCT05465785,UNKNOWN,COVID-19|SARS-CoV-2 Pneumonia,BIOLOGICAL: Recombinant COVID-19 vaccine (Sf9 cell),"WestVac Biopharma Co., Ltd.",,ALL,ADULT,NA,892,INDUSTRY,INTERVENTIONAL,2022-07,2023-04
NCT05373485,ACTIVE_NOT_RECRUITING,COVID-19,BIOLOGICAL: COVID-19 mRNA vaccine|BIOLOGICAL: Placebo,CanSino Biologics Inc.,,ALL,"ADULT, OLDER_ADULT",PHASE1,150,INDUSTRY,INTERVENTIONAL,5/20/2022,12/20/2023
NCT05933512,NOT_YET_RECRUITING,COVID-19|SARS-CoV-2 Infection,BIOLOGICAL: SCTV01E-2|BIOLOGICAL: SCTV01E,Sinocelltech Ltd.,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,600,INDUSTRY,INTERVENTIONAL,8/10/2023,11/10/2024
NCT04685512,COMPLETED,Covid19,DRUG: tenofovir disoproxil and emtricitabine,"University Hospital, Caen",,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,60,OTHER,INTERVENTIONAL,11/18/2020,5/1/2021
NCT05946512,RECRUITING,Post COVID-19 Condition|Somatic Symptom Disorder,BEHAVIORAL: yoga|BEHAVIORAL: social contact,Medical University Innsbruck,,ALL,ADULT,NA,320,OTHER,INTERVENTIONAL,7/24/2023,1/1/2027
NCT05160766,COMPLETED,Vaccination Reaction|COVID-19|Vaccination; Infection,BIOLOGICAL: Comirnaty(BTN162b2)|BIOLOGICAL: Spikevax (mRNA-1273),"Oliver Cornely, MD",European Commission|VACCELERATE,ALL,OLDER_ADULT,PHASE2,323,OTHER,INTERVENTIONAL,11/8/2021,9/13/2023
NCT04990466,WITHDRAWN,COVID-19,DRUG: IIBR-100|DRUG: Active Comparator,"NeuroRx, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,0,INDUSTRY,INTERVENTIONAL,9/30/2021,2/28/2022
NCT05205083,UNKNOWN,COVID-19,BIOLOGICAL: Recombinant novel coronavirus vaccine (CHO cells),"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.",Zhejiang Provincial Center for Disease Control and Prevention,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,480,INDUSTRY,INTERVENTIONAL,11/10/2021,2022-07
NCT04636333,RECRUITING,COVID-19,"BIOLOGICAL: Two doses of middle-dose recombinant SARS-CoV-2 vaccine (CHO Cell) at the schedule of day 0, 14|BIOLOGICAL: Three doses of middle-dose recombinant SARS-CoV-2 vaccine (CHO Cell) at the schedule of day 0, 14, 28|BIOLOGICAL: Two doses of high-dose recombinant SARS-CoV-2 vaccine (CHO Cell) at the schedule of day 0, 14|BIOLOGICAL: Three doses of high-dose recombinant SARS-CoV-2 vaccine (CHO Cell) at the schedule of day 0, 14, 28|BIOLOGICAL: Two doses of placebo at the schedule of day 0, 14 #middle-dose group#|BIOLOGICAL: Three doses of placebo at the schedule of day 0, 14, 28 #middle-dose group#|BIOLOGICAL: Two doses of placebo at the schedule of day 0, 14 #High-dose group#|BIOLOGICAL: Three doses of placebo at the schedule of day 0, 14, 28 #High-dose group#",Jiangsu Province Centers for Disease Control and Prevention,"Academy of Military Medical Sciences，Academy of Military Sciences，PLA|ZHONGYIANKE Biotech Co, Ltd.|LIAONINGMAOKANGYUAN Biotech Co, Ltd",ALL,"ADULT, OLDER_ADULT",PHASE1,216,NETWORK,INTERVENTIONAL,10/30/2020,7/7/2022
NCT05433285,COMPLETED,COVID-19,BIOLOGICAL: COVID-19 Protein Subunit Recombinant Vaccine|BIOLOGICAL: Active Comparator,PT Bio Farma,Fakultas Kedokteran Universitas Indonesia|Faculty of Medicine Universitas Diponegoro|Faculty of Medicine Universitas Andalas|Faculty of Medicine Universitas Hassanudin,ALL,"ADULT, OLDER_ADULT",PHASE3,4050,INDUSTRY,INTERVENTIONAL,6/7/2022,8/31/2023
NCT05032885,COMPLETED,Respiratory Insufficiency|Anxiety State,OTHER: physiotherapy,Hospital Universitario Getafe,,ALL,"ADULT, OLDER_ADULT",NA,122,OTHER,INTERVENTIONAL,4/4/2021,9/30/2022
NCT04481685,COMPLETED,Covid19,DRUG: ATI-450|DRUG: Placebo,University of Kansas Medical Center,,ALL,"ADULT, OLDER_ADULT",PHASE2,20,OTHER,INTERVENTIONAL,7/20/2020,6/1/2021
NCT04537585,UNKNOWN,Covid19,"COMBINATION_PRODUCT: Tomeka®|DRUG: ""Vernonia amygdalina""","Guyguy K Tshima, MD",Centre Médical de Kinshasa (CMK),ALL,"CHILD, ADULT, OLDER_ADULT",NA,2000,OTHER,INTERVENTIONAL,2020-11,2022-12
NCT04596085,COMPLETED,Covid19,DIETARY_SUPPLEMENT: Investigational Product - ViraCide|OTHER: Placebo - Starch Powder Soft gels,"The Herb, Inc",ProRelix Services LLP,ALL,"ADULT, OLDER_ADULT",NA,118,INDUSTRY,INTERVENTIONAL,9/16/2020,12/12/2020
NCT05043285,UNKNOWN,COVID-19|SARS-CoV-2 Infection,BIOLOGICAL: SCTV01C|OTHER: Placebo,Sinocelltech Ltd.,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,300,INDUSTRY,INTERVENTIONAL,12/22/2021,1/1/2023
NCT06025812,NOT_YET_RECRUITING,Coronavirus,BIOLOGICAL: Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)|BIOLOGICAL: Recombinant novel coronavirus protein vaccine (CHO cells),"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.",,ALL,"ADULT, OLDER_ADULT",NA,160,INDUSTRY,INTERVENTIONAL,9/20/2023,6/30/2024
NCT06027255,NOT_YET_RECRUITING,Long COVID|POTS - Postural Orthostatic Tachycardia Syndrome|Autonomic Dysfunction,"DIAGNOSTIC_TEST: IL-6|DIAGNOSTIC_TEST: cytokines (IL-17, and IFN-ɣ)|BEHAVIORAL: Compass 31",Vanderbilt University Medical Center,American Heart Association,ALL,"ADULT, OLDER_ADULT",NA,150,OTHER,INTERVENTIONAL,1/30/2024,10/31/2026
NCT04788355,COMPLETED,Complication,DRUG: Control group (standard hospital treatment)|DRUG: Group Hydroxychloroquine|DRUG: Group Hydroxychloroquine and apixaban|DRUG: Group Apixaban,Universidade do Vale do Sapucai,Pfizer|Apsen Farmaceutica S.A.|Dermadia|Methodos Laboratory|Biofarma,ALL,"ADULT, OLDER_ADULT",PHASE3,176,OTHER,INTERVENTIONAL,7/1/2020,12/23/2020
NCT05286255,NOT_YET_RECRUITING,COVID-19 Pneumonia|Viral Pneumonia,BIOLOGICAL: Allogeneic Mesenchymal Stromal Cells,Medical University of South Carolina,"Pandorum International, Inc.",ALL,"ADULT, OLDER_ADULT",PHASE1,10,OTHER,INTERVENTIONAL,2024-09,2027-05
NCT05000255,RECRUITING,"Loneliness|Depression, Anxiety|Self Efficacy|Social Support|Covid19|Psychology","BEHAVIORAL: Intervention 1: According to DGP|BEHAVIORAL: Intervention 2: According to Cacioppo ""E.A.S.E.""","Annette Reichardt, MD",Jacobs University Bremen gGmbH,ALL,"ADULT, OLDER_ADULT",NA,300,OTHER,INTERVENTIONAL,1/18/2021,9/30/2025
NCT04334512,RECRUITING,COVID-19|Corona Virus Infection|Coronavirus-19|Sars-CoV2,DRUG: Hydroxychloroquine|DRUG: Azithromycin|DIETARY_SUPPLEMENT: Vitamin C|DIETARY_SUPPLEMENT: Vitamin D|DIETARY_SUPPLEMENT: Zinc,ProgenaBiome,DSCS CRO,ALL,"ADULT, OLDER_ADULT",PHASE2,600,OTHER,INTERVENTIONAL,6/22/2020,2024-09
NCT04343755,TERMINATED,COVID-19,BIOLOGICAL: Convalescent Plasma,Hackensack Meridian Health,,ALL,"ADULT, OLDER_ADULT",PHASE2,52,OTHER,INTERVENTIONAL,4/9/2020,4/26/2023
NCT06214455,RECRUITING,Long Covid19|Long COVID,"OTHER: Low sugar diet and 10-12 hour eating window|OTHER: Low sugar diet, 8 hour eating window and fasting",Pacific Northwest University of Health Sciences,,ALL,"ADULT, OLDER_ADULT",NA,180,OTHER,INTERVENTIONAL,11/4/2022,7/30/2025
NCT04710316,UNKNOWN,Covid19,DIAGNOSTIC_TEST: SARS-CoV-2 screening by molecular biology|DIAGNOSTIC_TEST: Serological screening,"Institut National de la Santé Et de la Recherche Médicale, France",,ALL,"ADULT, OLDER_ADULT",NA,450,OTHER_GOV,INTERVENTIONAL,2/15/2021,9/30/2022
NCT04818216,COMPLETED,SARS-CoV-2 Infection|Acute Kidney Injury,DRUG: Placebo|DRUG: Nicotinamide riboside,The University of Texas Health Science Center at San Antonio,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),ALL,"ADULT, OLDER_ADULT",PHASE2,28,OTHER,INTERVENTIONAL,6/11/2021,1/3/2022
NCT05074745,UNKNOWN,SARS-CoV-2|COVID-19,DIAGNOSTIC_TEST: ELISA POCT vs RT-PCR,Centre Scientifique de Monaco,"Department of Health Affairs, Monaco",ALL,"ADULT, OLDER_ADULT",NA,1500,OTHER,INTERVENTIONAL,2/18/2021,12/30/2021
NCT04798716,NOT_YET_RECRUITING,Covid19|Novel Coronavirus Pneumonia|Acute Respiratory Distress Syndrome,DRUG: MSC-exosomes delivered intravenously every other day on an escalating dose: (2:4:8)|DRUG: MSC-exosomes delivered intravenously every other day on an escalating dose (8:4:8)|DRUG: MSC-exosomes delivered intravenously every other day (8:8:8),AVEM HealthCare,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,55,INDUSTRY,INTERVENTIONAL,2023-09,2024-12
NCT04479163,COMPLETED,COVID,BIOLOGICAL: Convalescent Plasma|OTHER: Placebo,Fundacion Infant,,ALL,OLDER_ADULT,NA,165,OTHER,INTERVENTIONAL,6/4/2020,10/25/2020
NCT05568693,ENROLLING_BY_INVITATION,Corona Virus Disease 2019(COVID-19),BIOLOGICAL: 0.3ml of mRNA vaccine,Yu Qin,,ALL,"ADULT, OLDER_ADULT",NA,800,OTHER,INTERVENTIONAL,9/21/2022,3/21/2023
NCT04698993,TERMINATED,Covid19,DIAGNOSTIC_TEST: Dräger Antigen Test SARS-CoV-2,Drägerwerk AG & Co. KGaA,,ALL,"ADULT, OLDER_ADULT",NA,388,INDUSTRY,INTERVENTIONAL,2/12/2021,3/22/2021
NCT05677893,COMPLETED,Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (Disorder),DRUG: MBS-COV|OTHER: Placebo,"Oneness Biotech Co., Ltd.",,ALL,ADULT,PHASE1,44,INDUSTRY,INTERVENTIONAL,11/7/2022,3/30/2023
NCT04376593,ENROLLING_BY_INVITATION,COVID-19|SARS-CoV-2 Infection,DRUG: 18F-αvβ6-BP,"University of California, Davis",,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,10,OTHER,INTERVENTIONAL,5/1/2020,2024-06
NCT04542993,TERMINATED,Covid19|SARS-CoV Infection,DIETARY_SUPPLEMENT: Zinc Picolinate|DIETARY_SUPPLEMENT: Resveratrol|DIETARY_SUPPLEMENT: Zinc Picolinate Placebo|DIETARY_SUPPLEMENT: Resveratrol Placebo,Swedish Medical Center,,ALL,"ADULT, OLDER_ADULT",PHASE2,45,OTHER,INTERVENTIONAL,9/8/2020,2/5/2021
NCT06091293,ACTIVE_NOT_RECRUITING,Long COVID|Long Covid19,BEHAVIORAL: Narrative Intervention for Long COVID-19 (NICO),"University of Colorado, Denver",,ALL,"ADULT, OLDER_ADULT",NA,12,OTHER,INTERVENTIONAL,10/11/2022,2/8/2024
NCT04364893,UNKNOWN,Corona Virus Infection|COVID-19,OTHER: Suspension or Maintenance of Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors,D'Or Institute for Research and Education,Brazilian Clinical Research Institute,ALL,"ADULT, OLDER_ADULT",NA,700,OTHER,INTERVENTIONAL,4/9/2020,12/1/2020
NCT04962893,COMPLETED,Covid19,BIOLOGICAL: SARS-CoV-2 VLP Vaccine-Wuhan|BIOLOGICAL: SARS-CoV-2 VLP Vaccine-Alpha (British) variant|BIOLOGICAL: SARS-CoV-2 VLP Vaccine-Wuhan+Alpha variant,"Ihsan GURSEL, PhD, Prof.",The Scientific and Technological Research Council of Turkey|Nobel Pharmaceuticals|MonitorCRO,ALL,ADULT,PHASE2,349,OTHER,INTERVENTIONAL,6/26/2021,1/16/2022
NCT04579393,COMPLETED,Coronavirus Disease 2019,DRUG: Placebo|DRUG: fostamatinib,"National Heart, Lung, and Blood Institute (NHLBI)",,ALL,"ADULT, OLDER_ADULT",PHASE2,59,NIH,INTERVENTIONAL,10/8/2020,4/30/2021
NCT04425616,ACTIVE_NOT_RECRUITING,Cancer|COVID,OTHER: Exercise|BEHAVIORAL: Psychological and Behaviour Change Support|OTHER: Nutrition,University Hospital Southampton NHS Foundation Trust,Macmillan Cancer Support|CanRehab Trust|Wessex Cancer Alliance,ALL,"ADULT, OLDER_ADULT",NA,1100,OTHER,INTERVENTIONAL,6/4/2020,3/31/2024
NCT04347382,COMPLETED,Coronavirus Infection|Sars-CoV2,DRUG: Honey|DRUG: Nigella Sativa / Black Cumin|DRUG: Placebos,Sohaib Ashraf,,ALL,"ADULT, OLDER_ADULT",PHASE3,313,OTHER,INTERVENTIONAL,4/30/2020,8/30/2020
NCT04395716,WITHDRAWN,COVID|Covid-19|Corona Virus Infection|Sars-CoV2|Coronavirus-19|SARS Pneumonia|SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere,BIOLOGICAL: ResCure™,ProgenaBiome,"Rinati Skin, LLC",ALL,"ADULT, OLDER_ADULT",PHASE1,0,OTHER,INTERVENTIONAL,2020-01,2021-11
NCT06137716,COMPLETED,Robotic Exoskeleton|Post-acute Covid-19 Syndrome|Rehabilitation Outcome|Physical And Rehabilitation Medicine,DEVICE: Training with a Robotic Hand Exoskeleton,University of Valladolid,Centro Hospitalario Padre Benito Menni,ALL,"ADULT, OLDER_ADULT",NA,13,OTHER,INTERVENTIONAL,7/1/2022,2/1/2023
NCT05040763,ACTIVE_NOT_RECRUITING,COVID-19|SARS-CoV-2 Infection,DIAGNOSTIC_TEST: Buccal Swabc- Copan flocked swab|DIAGNOSTIC_TEST: Standard of Care COVID-19 swab,University of Calgary,Health Canada,ALL,CHILD,NA,2882,OTHER,INTERVENTIONAL,11/10/2021,12/31/2023
NCT04307563,COMPLETED,Anxiety Depression|Burnout,BEHAVIORAL: Mindfulness session,Stanford University,,ALL,"ADULT, OLDER_ADULT",NA,52,OTHER,INTERVENTIONAL,9/1/2021,7/5/2022
NCT05705193,RECRUITING,Post-Acute COVID-19 Syndrome,OTHER: NeuroFlex (computerized gamified tasks),UConn Health,,ALL,"ADULT, OLDER_ADULT",NA,40,OTHER,INTERVENTIONAL,4/7/2023,12/1/2024
NCT04510493,COMPLETED,"Coronavirus Infection|Diabetes Mellitus, Type 2",DRUG: Canakinumab|DRUG: Placebo,"University Hospital, Basel, Switzerland",Novartis|Swiss National Science Foundation,ALL,"ADULT, OLDER_ADULT",PHASE3,116,OTHER,INTERVENTIONAL,10/23/2020,8/17/2021
NCT05465863,COMPLETED,Chronic Kidney Disease 5D|Chronic Kidney Disease 5T,BIOLOGICAL: SARS-CoV-2 mRNA BNT162b2 vaccine (Pfizer-BioNTech®),Istanbul University - Cerrahpasa (IUC),,ALL,"CHILD, ADULT",NA,101,OTHER,INTERVENTIONAL,9/1/2021,3/1/2022
NCT04414293,UNKNOWN,"COVID|Pneumonia, Viral",RADIATION: Lung Low Dose Radiation,Hospital Provincial de Castellon,,ALL,OLDER_ADULT,NA,41,OTHER,INTERVENTIONAL,10/1/2020,12/31/2021
NCT04410016,COMPLETED,Mental Health Wellness 1,OTHER: Staff Wellbeing Centres,University of Nottingham,Nottingham University Hospitals NHS Trust,ALL,"CHILD, ADULT, OLDER_ADULT",NA,819,OTHER,INTERVENTIONAL,5/25/2020,10/30/2020
NCT05543616,RECRUITING,SARS-CoV-2 Virus|Severe Acute Respiratory Syndrome Coronavirus 2|COVID-19,BIOLOGICAL: Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 3 microgram dose|BIOLOGICAL: Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 6 microgram dose|BIOLOGICAL: Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 10 microgram dose|BIOLOGICAL: Variant-adapted BNT162b2 (Omicron XBB.1.5) Substudy A Ph 2/3 Selected Dose|BIOLOGICAL: Variant-adapted BNT162b2 (Omicron XBB.1.5) 3 microgram dose|BIOLOGICAL: Variant-adapted BNT162b2 (Omicron XBB.1.5) 6 microgram dose|BIOLOGICAL: Variant-adapted BNT162b2 (Omicron XBB.1.5) 10 microgram dose,BioNTech SE,Pfizer,ALL,CHILD,PHASE2|PHASE3,3692,INDUSTRY,INTERVENTIONAL,9/23/2022,8/11/2025
NCT04564716,UNKNOWN,Covid19,BIOLOGICAL: Gam-COVID-Vac|OTHER: Placebo,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation",Russian Direct Investment Fund|CRO: iPharma,ALL,ADULT,PHASE3,100,OTHER,INTERVENTIONAL,9/28/2020,4/10/2021
NCT04351516,WITHDRAWN,SARS-CoV 2|COVID-19,DRUG: Hydroxychloroquine|OTHER: Placebo,University Hospital Tuebingen,,ALL,OLDER_ADULT,PHASE2|PHASE3,0,OTHER,INTERVENTIONAL,4/21/2020,5/1/2021
NCT05249816,COMPLETED,Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),BIOLOGICAL: NVX-CoV2373|BIOLOGICAL: BBIBP-CorV vaccine,Cogna Technology Solutions LLC,Novavax,ALL,"ADULT, OLDER_ADULT",PHASE3,1000,INDUSTRY,INTERVENTIONAL,3/18/2022,5/4/2023
NCT04920916,COMPLETED,COVID-19,BIOLOGICAL: Dupilumab|DRUG: Placebo,University of Virginia,"PBM C19 Research, LLC (a COVID-19 research entity of the Paul Manning Foundation)|Virginia Catalyst, Virginia Biosciences Health Research Corporation (VBHRC)",ALL,"ADULT, OLDER_ADULT",PHASE2,40,OTHER,INTERVENTIONAL,5/25/2021,4/18/2023
NCT04495816,COMPLETED,Anosmia|Covid19,DRUG: Omega-3 Fatty Acid Supplement|DRUG: Placebo/Control,Icahn School of Medicine at Mount Sinai,,ALL,"ADULT, OLDER_ADULT",PHASE2,139,OTHER,INTERVENTIONAL,7/15/2020,12/31/2021
NCT04988152,COMPLETED,Covid19,BIOLOGICAL: sotrovimab|OTHER: Placebo to Biologic|BIOLOGICAL: sotrovimab|OTHER: Placebo to Biologic,"Vir Biotechnology, Inc.",GlaxoSmithKline,ALL,"ADULT, OLDER_ADULT",PHASE1,48,INDUSTRY,INTERVENTIONAL,7/6/2021,12/7/2021
NCT04390152,UNKNOWN,Acute Respiratory Distress Syndrome,"DRUG: Wharton's jelly derived Mesenchymal stem cells.|DRUG: Hydroxychloroquine, lopinavir/ritonavir or azithromycin and placebo (standard therapy)",BioXcellerator,Clinical Somer,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,40,INDUSTRY,INTERVENTIONAL,1/13/2020,2022-04
NCT04348305,COMPLETED,Covid-19|Hypoxia,DRUG: Hydrocortisone|DRUG: Sodium Chloride 9mg/mL,Scandinavian Critical Care Trials Group,"Rigshospitalet, Denmark|Copenhagen Trial Unit, Center for Clinical Intervention Research|University of Copenhagen|Aarhus University Hospital",ALL,"ADULT, OLDER_ADULT",PHASE3,30,OTHER,INTERVENTIONAL,4/17/2020,9/8/2021
NCT04608305,COMPLETED,Covid19,"BIOLOGICAL: IIBR-100, low dose (prime)|BIOLOGICAL: IIBR-100 medium dose (prime)|BIOLOGICAL: IIBR-100 high-dose (prime)|BIOLOGICAL: IIBR-100 low-dose (prime-boost)|OTHER: Saline Placebo (single)|OTHER: Saline Placebo (double)|BIOLOGICAL: IIBR-100 medium-dose (prime-boost)|BIOLOGICAL: IIBR-100 high-dose (prime-boost)|BIOLOGICAL: IIBR-100 top-dose (prime-boost)",Israel Institute for Biological Research (IIBR),,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,843,OTHER_GOV,INTERVENTIONAL,10/28/2020,10/3/2022
NCT06012552,RECRUITING,Nervous System Diseases,DRUG: Tianeptine|DRUG: Placebo,Military Institute od Medicine National Research Institute,ABM Industries,ALL,"ADULT, OLDER_ADULT",PHASE2,140,OTHER,INTERVENTIONAL,2/17/2023,10/31/2027
NCT05630352,NOT_YET_RECRUITING,COVID-19,BIOLOGICAL: Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 3 microgram dose|BIOLOGICAL: Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 6 microgram dose|BIOLOGICAL: Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 10 microgram dose|BIOLOGICAL: Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 1 microgram dose,BioNTech SE,Pfizer,ALL,CHILD,PHASE1,120,INDUSTRY,INTERVENTIONAL,1/31/2024,5/16/2025
NCT06171152,NOT_YET_RECRUITING,"Multiple Sclerosis|Long COVID|Long Covid19|Obese|Obesity|Obesity, Morbid|Acute Leukemia in Remission",DRUG: Liraglutide Pen Injector [Saxenda]|OTHER: Medication Diary,University of Chicago,,ALL,ADULT,EARLY_PHASE1,30,OTHER,INTERVENTIONAL,4/1/2024,10/1/2026
NCT05125926,UNKNOWN,COVID-19,BIOLOGICAL: LYB001|BIOLOGICAL: Placebo,"Yantai Patronus Biotech Co., Ltd.",,ALL,"ADULT, OLDER_ADULT",PHASE1,100,INDUSTRY,INTERVENTIONAL,2021-12,2023-04
NCT03590327,RECRUITING,Apathy|Mild Cognitive Impairment|Transcranial Magnetic Stimulation|Loneliness|COVID|Neuropsychiatric Symptoms,DEVICE: Transcranial Magnetic Stimulation,VA Office of Research and Development,Central Arkansas Veterans Healthcare System|University of Arkansas,ALL,"ADULT, OLDER_ADULT",NA,125,FED,INTERVENTIONAL,11/1/2018,10/31/2024
NCT04338906,WITHDRAWN,COVID,DRUG: Camostat Mesilate|DRUG: Placebo|DRUG: Hydroxychloroquine,"Heinrich-Heine University, Duesseldorf","Universitätsklinikum Hamburg-Eppendorf|Goethe University|St. Georg Hospital Leipzig, Germany|Hospital Schwabing Munich, Germany|Missioklinik, Wuerzburg, Germany",ALL,"ADULT, OLDER_ADULT",PHASE4,0,OTHER,INTERVENTIONAL,2020-05,2021-12
NCT05445427,RECRUITING,Post COVID Syndrome|Fatigue|Headache,DEVICE: vagal nerve stimulator,Mayo Clinic,,ALL,"ADULT, OLDER_ADULT",NA,20,OTHER,INTERVENTIONAL,12/21/2022,2024-07
NCT04547127,COMPLETED,COVID-19,BIOLOGICAL: Convalescent anti-SARS-CoV-2 MBT Plasma|DRUG: Standard Medical Treatment,"Instituto Grifols, S.A.",,ALL,"ADULT, OLDER_ADULT",PHASE2,200,INDUSTRY,INTERVENTIONAL,4/29/2020,2/4/2021
NCT05305508,NOT_YET_RECRUITING,COVID-19 Virus Disease,DRUG: Calcium Dobesilate|DRUG: Mannitol,Hervé SPECHBACH,OM Pharma SA,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,74,OTHER,INTERVENTIONAL,2022-05,2023-03
NCT04962308,UNKNOWN,COVID-19,BIOLOGICAL: SARS-CoV-2 Inactivated Vaccine|BIOLOGICAL: The SARS-CoV-2 Inactivated Vaccine,"Sinovac Research and Development Co., Ltd.",,ALL,ADULT,PHASE4,1400,INDUSTRY,INTERVENTIONAL,6/19/2021,12/19/2021
NCT04281693,UNKNOWN,Novel Coronavirus Infection Pneumonia,DIAGNOSTIC_TEST: Standard screening strategy|DIAGNOSTIC_TEST: New screening strategy,Affiliated Hospital to Academy of Military Medical Sciences,Beijing 302 Hospital,ALL,"CHILD, ADULT, OLDER_ADULT",NA,230,OTHER,INTERVENTIONAL,2020-02,2020-03
NCT05040893,ACTIVE_NOT_RECRUITING,COVID-19,BEHAVIORAL: Physiotherapy,University of Calgary,Alberta Health services,ALL,"ADULT, OLDER_ADULT",NA,15,OTHER,INTERVENTIONAL,3/4/2022,11/30/2023
NCT05172193,RECRUITING,COVID-19,BIOLOGICAL: SARS-COV-2 Vaccine (Vero Cell-Sinopharm) Inactivated,PT. Kimia Farma (Persero) Tbk,,ALL,"ADULT, OLDER_ADULT",PHASE2,600,INDUSTRY,INTERVENTIONAL,12/31/2021,9/30/2023
NCT04437693,UNKNOWN,COVID 19,DRUG: Hydroxychloroquine,Hamad Medical Corporation,,ALL,ADULT,PHASE2|PHASE3,500,INDUSTRY,INTERVENTIONAL,8/31/2020,12/31/2021
NCT05187793,ACTIVE_NOT_RECRUITING,COVID-19,DRUG: Olokizumab|DRUG: Standard therapy,R-Pharm,"Federal Budget Institution of Science ""Central Research Institute of Epidemiology"" of the Rospotrebnadzor|Group of companies Medsi, JSС",ALL,"ADULT, OLDER_ADULT",PHASE3,198,INDUSTRY,INTERVENTIONAL,7/8/2021,2023-04
NCT04463004,COMPLETED,COVID-19|Sars-CoV2|Pneumonia,DRUG: Mavrilimumab|DRUG: Placebos,Virginia Commonwealth University,"Kiniksa Pharmaceuticals, Ltd.",ALL,"ADULT, OLDER_ADULT",PHASE2,2,OTHER,INTERVENTIONAL,9/2/2020,11/30/2020
NCT04530604,COMPLETED,COVID|Sars-CoV2|COVID-19|Acute Respiratory Distress Syndrome,DRUG: Defibrotide,Gregory Yanik,Jazz Pharmaceuticals,ALL,"ADULT, OLDER_ADULT",PHASE1,13,OTHER,INTERVENTIONAL,10/1/2020,4/9/2021
NCT04421404,COMPLETED,COVID-19|Sars-CoV2,BIOLOGICAL: COVID-19 Convalescent Plasma (CCP)|BIOLOGICAL: Placebo,"Priscilla Hsue, MD",Vitalant Research Institute|San Francisco General Hospital,ALL,"ADULT, OLDER_ADULT",PHASE2,34,OTHER,INTERVENTIONAL,6/9/2020,4/30/2021
NCT04931004,UNKNOWN,Covid19,DRUG: Mouthwash Product|OTHER: Water rinse,"Rutgers, The State University of New Jersey",Colgate Palmolive|University of Leicester,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,90,OTHER,INTERVENTIONAL,2021-07,2022-02
NCT04462627,COMPLETED,COVID 19,DIAGNOSTIC_TEST: Blood group determination|DIAGNOSTIC_TEST: Antibody titration|DIETARY_SUPPLEMENT: Probiotic,Hanane EL KENZ,,ALL,"ADULT, OLDER_ADULT",NA,566,OTHER,INTERVENTIONAL,4/14/2020,4/11/2022
NCT05668104,COMPLETED,Healthy Subjects|COVID-19 Pneumonia|Irritable Bowel Syndrome|Functional Gastrointestinal Disorders,DIETARY_SUPPLEMENT: Jing Si Herbal Tea Liquid Packet|DIETARY_SUPPLEMENT: Jing Si Herbal Tea Liquid Packet Placebo,Buddhist Tzu Chi General Hospital,,ALL,"ADULT, OLDER_ADULT",NA,32,OTHER,INTERVENTIONAL,1/1/2023,12/31/2023
NCT04357327,COMPLETED,COVID-19|SARS-CoV 2|Corona Virus Infection,DIAGNOSTIC_TEST: rapid salivary test,Università degli Studi dell'Insubria,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,122,OTHER,INTERVENTIONAL,4/16/2020,7/31/2020
NCT04400929,COMPLETED,"COVID|Sars-CoV2|ARDS, Human",DRUG: Sargramostim|OTHER: Normal Saline 0.9%,Singapore General Hospital,,ALL,"ADULT, OLDER_ADULT",PHASE2,2,OTHER,INTERVENTIONAL,6/2/2020,2/4/2022
NCT04361253,TERMINATED,COVID|Infectious Disease,BIOLOGICAL: High-Titer COVID-19 Convalescent Plasma (HT-CCP)|BIOLOGICAL: Standard Plasma (FFP),Brigham and Women's Hospital,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,45,OTHER,INTERVENTIONAL,4/30/2020,6/30/2021
NCT04429529,COMPLETED,Coronavirus Disease-2019 (COVID-19),BIOLOGICAL: TY027|OTHER: 0.9% Saline,Tychan Pte Ltd.,,ALL,ADULT,PHASE1,32,INDUSTRY,INTERVENTIONAL,6/9/2020,1/20/2021
NCT05686629,NOT_YET_RECRUITING,Novel COVID-19-Infected Pneumonia,DRUG: Jaktinib hydrochloride tablets,"Suzhou Zelgen Biopharmaceuticals Co.,Ltd",,ALL,"ADULT, OLDER_ADULT",PHASE2,120,INDUSTRY,INTERVENTIONAL,2024-04,2025-03
NCT04291729,COMPLETED,COVID-19,DRUG: Ganovo+ritonavir+/-Interferon nebulization,The Ninth Hospital of Nanchang,"Ascletis Pharmaceuticals Co., Ltd.",ALL,"ADULT, OLDER_ADULT",PHASE4,11,OTHER,INTERVENTIONAL,2/17/2020,3/19/2020
NCT05167253,WITHDRAWN,COVID-19,BIOLOGICAL: UB-612,"United Biomedical Inc., Asia",,ALL,ADULT,PHASE1,0,INDUSTRY,INTERVENTIONAL,2/15/2022,10/31/2022
NCT04343053,ACTIVE_NOT_RECRUITING,Severe Acute Respiratory Syndrome Coronavirus 2,OTHER: SARS-Cov-2 infection,University Hospital of Ferrara,,ALL,"ADULT, OLDER_ADULT",NA,145,OTHER,INTERVENTIONAL,4/8/2020,11/12/2024
NCT04545060,COMPLETED,Covid19,BIOLOGICAL: VIR-7831 (sotrovimab)|DRUG: Placebo,"Vir Biotechnology, Inc.",GlaxoSmithKline,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,1057,INDUSTRY,INTERVENTIONAL,8/27/2020,9/2/2021
NCT04961229,UNKNOWN,COVID-19 Acute Respiratory Distress Syndrome|Immunosuppression,BIOLOGICAL: The Pfizer mRNA-based BNT162b2 vaccine,dafna yahav,,ALL,"ADULT, OLDER_ADULT",PHASE4,504,OTHER,INTERVENTIONAL,2021-10,2022-07
NCT05608629,COMPLETED,Long COVID|Chronic Fatigue Syndrome,DEVICE: Transcutaneous Non-Invasive Vagus Nerve Stimulation,Icahn School of Medicine at Mount Sinai,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,17,OTHER,INTERVENTIONAL,6/6/2022,12/5/2022
NCT04909853,COMPLETED,Renal Impairment,DRUG: PF-07321332/ritonavir,Pfizer,,ALL,"ADULT, OLDER_ADULT",PHASE1,35,INDUSTRY,INTERVENTIONAL,6/15/2021,10/7/2021
NCT04355429,UNKNOWN,Pneumonia|Coronavirus Infection|COVID-19,DRUG: captopril 25mg,Assistance Publique - Hôpitaux de Paris,,ALL,"ADULT, OLDER_ADULT",PHASE2,230,OTHER,INTERVENTIONAL,5/5/2020,2020-08
NCT04382053,COMPLETED,"COVID-19 Pneumonia, Impaired Respiratory Function",DRUG: DFV890|DRUG: Standard of Care (SoC),Novartis Pharmaceuticals,,ALL,"ADULT, OLDER_ADULT",PHASE2,143,INDUSTRY,INTERVENTIONAL,5/27/2020,12/24/2020
NCT04420260,COMPLETED,COVID,DIETARY_SUPPLEMENT: Group A: oropharygeal spray and immunostimulant emulsion|DIETARY_SUPPLEMENT: Group D:Placebo oropharyngeal spray + Placebo taken PO,Unidad de Investigación Genética Molecular,Universidad de Antioquia,ALL,ADULT,NA,152,NETWORK,INTERVENTIONAL,3/18/2021,7/5/2021
NCT05975060,ACTIVE_NOT_RECRUITING,COVID-19,BIOLOGICAL: XBB.1.5 Vaccine (Booster)|BIOLOGICAL: XBB.1.5 Vaccine (single dose),Novavax,,ALL,ADULT,PHASE2|PHASE3,660,INDUSTRY,INTERVENTIONAL,9/7/2023,7/31/2024
NCT04615429,UNKNOWN,Acute Respiratory Distress Syndrome|COVID-19 Pneumonia,BIOLOGICAL: Mesenchymal stromal cells|OTHER: Placebo,Cristina Avendaño Solá,,ALL,"ADULT, OLDER_ADULT",PHASE2,20,OTHER,INTERVENTIONAL,9/15/2020,2022-02
NCT05534061,COMPLETED,COVID-19 Pandemic,BEHAVIORAL: Connect2Test,University of Oregon,National Institute on Drug Abuse (NIDA),ALL,"ADULT, OLDER_ADULT",NA,349,OTHER,INTERVENTIONAL,8/8/2022,6/30/2023
NCT06008860,RECRUITING,COVID-19,DRUG: Experimental: Primary Cohort|OTHER: Placebo Comparator: Primary Cohort - Placebo,University of Chicago,,ALL,"ADULT, OLDER_ADULT",PHASE4,280,OTHER,INTERVENTIONAL,7/1/2023,2025-07
NCT05142553,ACTIVE_NOT_RECRUITING,COVID-19|SARS-CoV-2 Acute Respiratory Disease,BIOLOGICAL: COVID-19 Vaccine HIPRA|BIOLOGICAL: Cominarty (Pfizer-BioNtech),"Hipra Scientific, S.L.U","Laboratorios Hipra, S.A.",ALL,"ADULT, OLDER_ADULT",PHASE2,887,INDUSTRY,INTERVENTIONAL,11/16/2021,6/1/2023
NCT04334460,COMPLETED,Sars-CoV-2|Covid19,DRUG: BLD-2660,Blade Therapeutics,Clinipace Worldwide,ALL,"ADULT, OLDER_ADULT",PHASE2,120,INDUSTRY,INTERVENTIONAL,5/4/2020,6/21/2021
NCT05752253,COMPLETED,Hereditary Hemorrhagic Telangiectasia,OTHER: Counseling,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,,ALL,"ADULT, OLDER_ADULT",NA,50,OTHER,INTERVENTIONAL,5/5/2020,5/30/2022
NCT05682560,RECRUITING,Long COVID|Post-COVID Syndrome|Post COVID-19 Condition,BIOLOGICAL: RegeneCyte|OTHER: Placebo,"StemCyte, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE2,30,INDUSTRY,INTERVENTIONAL,5/4/2023,2024-10
NCT04713553,COMPLETED,SARS-CoV-2 Infection|COVID-19,BIOLOGICAL: BNT162b2|BIOLOGICAL: BNT162b2.B.1.351,BioNTech SE,Pfizer,ALL,"CHILD, ADULT",PHASE3,1574,INDUSTRY,INTERVENTIONAL,2/15/2021,7/22/2021
NCT04681053,UNKNOWN,COVID-19,DRUG: Ivermectin Powder,Mansoura University,,ALL,"ADULT, OLDER_ADULT",PHASE3,80,OTHER,INTERVENTIONAL,2/25/2021,12/31/2021
NCT04594460,UNKNOWN,Covid19|Hydrogen-oxygen Gas|AMS-H-03,"DEVICE: Hydrogen-Oxygen Generator with Nebulizer, AMS-H-03|DEVICE: OLO-1 Medical Molecular Sieve Oxygen Generator",Guangzhou Institute of Respiratory Disease,,ALL,"ADULT, OLDER_ADULT",NA,198,OTHER,INTERVENTIONAL,10/31/2020,12/31/2021
NCT05513560,RECRUITING,Long COVID|Post COVID Condition|Post Acute Sequelae of COVID-19,DRUG: Ibudilast|DRUG: Pentoxifylline|OTHER: Placebo,"University Health Network, Toronto",,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,1000,OTHER,INTERVENTIONAL,5/31/2023,2025-12
NCT04933929,COMPLETED,Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),BEHAVIORAL: Post-hospitalization nutritional monitoring,Gérond'if,,ALL,OLDER_ADULT,NA,34,OTHER,INTERVENTIONAL,7/27/2020,7/1/2021
NCT04836260,UNKNOWN,Covid19|Immuno-Deficiency|Old Age; Debility,DRUG: SARS-CoV-2 convalescent plasma,"University Hospital, Geneva","University Hospital, Basel, Switzerland|Ospedale Regionale di Lugano|Hôpital Fribourgeois",ALL,"ADULT, OLDER_ADULT",PHASE3,100,OTHER,INTERVENTIONAL,4/8/2021,12/31/2021
NCT04780061,TERMINATED,Covid19,"DRUG: Vitamin D3 50,000 IU|DIETARY_SUPPLEMENT: Vitamin C/Zinc|DIETARY_SUPPLEMENT: Vitamin K2/D|OTHER: Microcrystalline Cellulose Capsule|OTHER: Medium Chain Triglyceride Oil",The Canadian College of Naturopathic Medicine,Ottawa Hospital Research Institute|Vitazan Professional|New Roots Herbal,ALL,"ADULT, OLDER_ADULT",PHASE3,90,OTHER,INTERVENTIONAL,7/12/2021,7/7/2022
NCT05894629,ACTIVE_NOT_RECRUITING,Long COVID|Pain,BEHAVIORAL: Pain Neuroscience Education (PNE)+ Therapeutic Exercise (TE)|BEHAVIORAL: Active Comparator: Usual treatment,University of Valladolid,,ALL,"ADULT, OLDER_ADULT",NA,89,OTHER,INTERVENTIONAL,2/20/2023,9/30/2023
NCT05150860,UNKNOWN,COVID-19,BEHAVIORAL: At-home COVID-19 testing|BEHAVIORAL: Family-based model|BEHAVIORAL: Onsite COVID-19 testing,San Diego State University,Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD),ALL,"CHILD, ADULT, OLDER_ADULT",NA,3000,OTHER,INTERVENTIONAL,10/17/2021,7/30/2023
NCT04373460,COMPLETED,SARS-CoV 2,BIOLOGICAL: SARS-CoV-2 convalescent plasma|BIOLOGICAL: Plasma from a volunteer donor,Johns Hopkins University,State of Maryland|Bloomberg Foundation|United States Department of Defense|National Institute of Allergy and Infectious Diseases (NIAID)|National Center for Advancing Translational Sciences (NCATS),ALL,"ADULT, OLDER_ADULT",PHASE2,1225,OTHER,INTERVENTIONAL,6/3/2020,12/14/2022
NCT04831853,UNKNOWN,Covid19,OTHER: nasopharyngeal swabbing procedure (self swabbing first)|OTHER: nasopharyngeal swabbing procedure (conventionnal swabbing first),"University Hospital, Clermont-Ferrand",,ALL,"ADULT, OLDER_ADULT",NA,400,OTHER,INTERVENTIONAL,2021-04,2021-12
NCT04998253,COMPLETED,Hypoxic Pulmonary Vasoconstriction|Hypoxemia|Acute Respiratory Distress Syndrome|SARS-CoV-2 Acute Respiratory Disease,DRUG: Effects in oxygenation and hypoxic pulmonary vasoconstriction,Unidad Temporal COVID-19 en Centro Citibanamex,,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,24,OTHER,INTERVENTIONAL,10/1/2020,5/15/2021
NCT06142253,NOT_YET_RECRUITING,Long COVID,BEHAVIORAL: WATER+CT|BEHAVIORAL: Usual Care,VA Office of Research and Development,,ALL,"ADULT, OLDER_ADULT",NA,50,FED,INTERVENTIONAL,4/1/2024,12/31/2025
NCT05620160,COMPLETED,Mild to Moderate COVID-19,DRUG: RAY1216|DRUG: Placebo,"Guangdong Raynovent Biotech Co., Ltd",,ALL,"ADULT, OLDER_ADULT",PHASE3,1359,INDUSTRY,INTERVENTIONAL,11/12/2022,3/28/2023
NCT05323461,ACTIVE_NOT_RECRUITING,COVID-19|SARS-CoV-2 Infection,BIOLOGICAL: SCTV01C|BIOLOGICAL: SCTV01E|BIOLOGICAL: Sinopharm inactivated COVID-19 vaccine|BIOLOGICAL: Comirnaty,Sinocelltech Ltd.,,ALL,"ADULT, OLDER_ADULT",PHASE3,1800,INDUSTRY,INTERVENTIONAL,5/30/2022,5/1/2023
NCT04387760,COMPLETED,SARS-CoV 2|COVID-19,DRUG: Hydroxychloroquine|DRUG: Favipiravir|OTHER: Routine care for COVID-19 patients,Royal College of Surgeons in Ireland - Medical University of Bahrain,"Ebrahim Khalil Kanoo Community Medical Center|Hereditary blood Disorder Centre - Salmaniya Medical Complex|Mohammed Bin Khalifa Bin Sulman Al Khalifa Cardiac Centre, Awali|Jidhafs COVID-19 Centre|Sitra FICU|Salmaniya Medical Complex- 6th Floor|Salmaniya Medical Complex- Helipad",ALL,"ADULT, OLDER_ADULT",PHASE2,150,OTHER,INTERVENTIONAL,8/11/2020,4/7/2021
NCT05729360,NOT_YET_RECRUITING,COVID-19,DRUG: GamCoviMab,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation",,ALL,"ADULT, OLDER_ADULT",PHASE2,30,OTHER,INTERVENTIONAL,2023-03,2023-12
NCT04363853,ACTIVE_NOT_RECRUITING,Sars-CoV2,DRUG: Tocilizumab 20 MG/ML,Instituto Nacional de Cancerologia de Mexico,Roche Pharma AG,ALL,"ADULT, OLDER_ADULT",PHASE2,200,OTHER,INTERVENTIONAL,6/1/2020,12/31/2024
NCT04464460,WITHDRAWN,Coronavirus Disease,DRUG: TAK-671|DRUG: TAK-671 Placebo,Takeda,,ALL,"ADULT, OLDER_ADULT",PHASE1,0,INDUSTRY,INTERVENTIONAL,9/25/2020,10/30/2020
NCT05205460,RECRUITING,COVID-19,DEVICE: Home-based telehealth exercise training program|BEHAVIORAL: Education and self-exercise,Tri-Service General Hospital,,ALL,"ADULT, OLDER_ADULT",NA,60,OTHER,INTERVENTIONAL,10/12/2021,10/8/2024
NCT04361461,WITHDRAWN,Coronavirus Infections|SARS-CoV 2|SARS (Severe Acute Respiratory Syndrome)|Pulmonary Disease,DRUG: Hydroxychloroquine Sulfate|DRUG: Hydroxychloroquine Sulfate + Azythromycin,Apsen Farmaceutica S.A.,Federal University of São Paulo,ALL,"ADULT, OLDER_ADULT",PHASE3,0,INDUSTRY,INTERVENTIONAL,4/30/2020,11/4/2020
NCT04455360,COMPLETED,Post Traumatic Stress Disorder|Intensive Care Psychiatric Disorder|Anxiety Disorders|Depression|Critical Care|COVID,OTHER: Eye Movement Desensitisation and Reprocessing Recent traumatic Event Protocol,University Hospital Southampton NHS Foundation Trust,Dorset HealthCare University NHS Foundation Trust,ALL,"ADULT, OLDER_ADULT",NA,26,OTHER,INTERVENTIONAL,10/1/2020,9/20/2021
NCT04402060,COMPLETED,COVID|Covid-19|Coronavirus|Coronavirus Infection|Severe Acute Respiratory Syndrome|Severe Acute Respiratory Syndrome Coronavirus 2|Sars-CoV2|Ards|Acute Respiratory Distress Syndrome,DRUG: APL-9|OTHER: Vehicle Control,"Apellis Pharmaceuticals, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,72,INDUSTRY,INTERVENTIONAL,5/28/2020,2/13/2021
NCT04380961,COMPLETED,Critical Confirmed Coronavirus Disease (COVID)-19,DRUG: Sirukumab|DRUG: Placebo|OTHER: Standard of Care (SOC),"Janssen Pharmaceutica N.V., Belgium",,ALL,"ADULT, OLDER_ADULT",PHASE2,212,INDUSTRY,INTERVENTIONAL,4/24/2020,6/24/2021
NCT05050461,UNKNOWN,"Non-hodgkin Lymphoma,B Cell|Vaccination Failure",OTHER: Immunological analyses,Versailles Hospital,,ALL,"ADULT, OLDER_ADULT",NA,120,OTHER,INTERVENTIONAL,9/20/2021,8/20/2022
NCT04387253,COMPLETED,Identification of the Mother or Fetus Contamination by SARS Cov-2|Research the Presence of Viruses at Different Sites of the Mother and the Fetus or Father|The Survey Builds on a Network Work Already Organized Around the CPDPN of Poitou-Charentes|Analysis Laboratories of the Poitiers CHU,DIAGNOSTIC_TEST: Identification by PCR of the SARS-COV-2 virus in samples taken from the fetus,Poitiers University Hospital,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,28,OTHER,INTERVENTIONAL,5/23/2020,6/17/2022
NCT04435353,UNKNOWN,Respiratory Distress Syndrome|Hypoxemia,DEVICE: VibroLUNG,Astana Medical University,,ALL,"ADULT, OLDER_ADULT",NA,200,OTHER,INTERVENTIONAL,3/22/2020,2/1/2021
NCT04461353,COMPLETED,Severe Acute Respiratory Syndrome Coronavirus 2,DRUG: Aerolized Hydroxychloroquine Sulfate|OTHER: Placebo,"Pulmoquine Therapeutics, Inc",Rockefeller University,ALL,"ADULT, OLDER_ADULT",PHASE1,12,INDUSTRY,INTERVENTIONAL,6/25/2020,8/17/2020
NCT04659460,UNKNOWN,COVID|Corona Virus Infection|Acute Lung Injury|Ischemia Limb|Acute Respiratory Distress Syndrome,DEVICE: Remote Ischemic Conditioning,Unity Health Toronto,Defence Research and Development Canada,ALL,"CHILD, ADULT, OLDER_ADULT",NA,30,OTHER,INTERVENTIONAL,12/15/2020,9/1/2021
NCT05275660,COMPLETED,Healthy,DRUG: HFB30132A|OTHER: Placebo,HiFiBiO Therapeutics,,ALL,ADULT,PHASE1,20,INDUSTRY,INTERVENTIONAL,5/9/2021,2/22/2022
NCT05110560,COMPLETED,Aged,"BEHAVIORAL: ""Stay at Home Take a Step Program (SHTSP)""",Namik Kemal University,,ALL,OLDER_ADULT,NA,32,OTHER,INTERVENTIONAL,6/1/2021,9/1/2021
NCT05076253,COMPLETED,Safety|SARS-CoV2 Infection|Ivermectin Poisoning|Effect of Drug,DRUG: Ivermectin|DRUG: Placebo,Bangkok Metropolitan Administration Medical College and Vajira Hospital,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,72,OTHER_GOV,INTERVENTIONAL,9/1/2021,12/1/2021
NCT04483960,RECRUITING,SARS-CoV-2 Infection (COVID-19),DRUG: Nafamostat Mesilate|DRUG: Enoxaparin|DRUG: Dalteparin|DRUG: Tinzaparin|BIOLOGICAL: Hyperimmune globulin,University of Melbourne,The Peter Doherty Institute for Infection and Immunity|Australasian Society for Infectious Diseases|Middlemore Clinical Trials|The George Institute|Hunter Medical Research Institute|The University of Queensland,ALL,"ADULT, OLDER_ADULT",PHASE3,2400,OTHER,INTERVENTIONAL,7/28/2020,12/31/2024
NCT04344561,TERMINATED,COVID|Hypoxic Respiratory Failure,OTHER: Postural Positioning,Johns Hopkins University,,ALL,"ADULT, OLDER_ADULT",NA,7,OTHER,INTERVENTIONAL,5/25/2020,5/1/2022
NCT04453553,TERMINATED,COVID,DIAGNOSTIC_TEST: Q16 testing|DIAGNOSTIC_TEST: Nasopharyngeal swab and main laboratory,Queen Mary University of London,,ALL,"ADULT, OLDER_ADULT",NA,461,OTHER,INTERVENTIONAL,7/2/2020,10/27/2020
NCT05122260,COMPLETED,COVID-19 Prevention,DRUG: Q-Griffithsin|OTHER: Placebo,Kenneth Palmer,United States Department of Defense,ALL,ADULT,PHASE1,18,OTHER,INTERVENTIONAL,11/11/2021,2/14/2022
NCT04328129,COMPLETED,Coronavirus Infections|Severe Acute Respiratory Syndrome|SARS-CoV Infection,PROCEDURE: Human biological samples,Institut Pasteur,Institut Pasteur de la Guyane|Centre Hospitalier Andrée Rosemon de Cayenne|Institut Pasteur de la Guadeloupe|Centre Hospitalier de la Guadeloupe|Institut Pasteur de Nouvelle-Calédonie|Centre Hospitalier Territorial de Nouvelle-Calédonie,ALL,"CHILD, ADULT, OLDER_ADULT",NA,245,INDUSTRY,INTERVENTIONAL,3/23/2020,9/30/2021
NCT04603729,COMPLETED,Covid 19 Disease,DRUG: Dexamethasone 2 MG/ML|DRUG: Methylprednisolone Injection,Fatima Memorial Hospital,,ALL,"ADULT, OLDER_ADULT",PHASE3,100,OTHER,INTERVENTIONAL,5/30/2020,7/1/2020
NCT05490329,COMPLETED,COVID-19|Vaccine Uptake,BEHAVIORAL: Tough Talks COVID,Florida State University,National Institute on Minority Health and Health Disparities (NIMHD),ALL,ADULT,NA,360,OTHER,INTERVENTIONAL,3/13/2023,12/15/2023
NCT04252885,COMPLETED,Coronavirus Infections,DRUG: Lopinavir and Ritonavir Tablets|DRUG: Arbidol,Guangzhou 8th People's Hospital,,ALL,"ADULT, OLDER_ADULT",PHASE4,86,OTHER,INTERVENTIONAL,1/28/2020,5/31/2020
NCT04842747,COMPLETED,SARS-CoV Infection,DRUG: VERU-111,Veru Inc.,,ALL,"ADULT, OLDER_ADULT",PHASE3,204,INDUSTRY,INTERVENTIONAL,5/18/2021,7/6/2022
NCT04648800,UNKNOWN,Covid19|BCG Vaccination Reaction|SARS-CoV Infection,DRUG: BCG-10 vaccine|DRUG: 0.9% saline,Hanna Czajka,"Medical Research Agency, Poland",ALL,"ADULT, OLDER_ADULT",PHASE3,1000,OTHER,INTERVENTIONAL,7/7/2020,2021-04
NCT04319900,UNKNOWN,Novel Coronavirus Pnuemonia,DRUG: favipiravir tablets+chloroquine phosphatetablets tablets|DRUG: Favipiravir tablets|DRUG: Placebo,Beijing Chao Yang Hospital,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,150,OTHER,INTERVENTIONAL,3/5/2020,6/25/2020
NCT05453487,RECRUITING,COVID-19|Rabies,BIOLOGICAL: coadministration|BIOLOGICAL: COVID-19 vaccine|BIOLOGICAL: rabies vaccine,China National Biotec Group Company Limited,"Guizhou Center for Disease Control and Prevention|Shaanxi Provincial Center for Disease Control and Prevention|Beijing Institute of Biological Products Co Ltd.|Changchun Institute of Biological Products Co., Ltd.",ALL,"ADULT, OLDER_ADULT",PHASE4,360,INDUSTRY,INTERVENTIONAL,7/21/2022,6/30/2023
NCT04403685,TERMINATED,COVID|SARS Pneumonia|Cytokine Release Syndrome,DRUG: Tocilizumab,Beneficência Portuguesa de São Paulo,Hospital do Coracao|Hospital Israelita Albert Einstein|Hospital Sirio-Libanes|Hospital Alemão Oswaldo Cruz|Brazilian Research In Intensive Care Network|Hospital Moinhos de Vento|Brazilian Clinical Research Institute|Federal University of São Paulo,ALL,"ADULT, OLDER_ADULT",PHASE3,129,OTHER,INTERVENTIONAL,5/8/2020,7/21/2020
NCT05274685,COMPLETED,Multi Organ Failure,PROCEDURE: haemodialysis,Sohag University,,ALL,"ADULT, OLDER_ADULT",NA,100,OTHER,INTERVENTIONAL,6/1/2021,1/1/2022
NCT04441385,TERMINATED,COVID-19,DRUG: Maraviroc 300 mg|OTHER: Standard care therapy,Hospital Universitario Infanta Leonor,Hospital Clinic of Barcelona|ViiV Healthcare,ALL,"ADULT, OLDER_ADULT",PHASE2,60,OTHER,INTERVENTIONAL,6/26/2020,2/8/2021
NCT04472585,UNKNOWN,Coronavirus Infection|COVID|Sars-CoV2,DRUG: Ivermectin Injectable Solution|OTHER: Injectable Placebo|DRUG: Zinc|DRUG: Placebo empty capsule|DRUG: Oral Ivermectin,Sohaib Ashraf,,ALL,ADULT,PHASE1|PHASE2,180,OTHER,INTERVENTIONAL,11/14/2020,10/30/2021
NCT04718285,RECRUITING,COVID-19|SARS-CoV-2,DRUG: Montelukast Oral Tablet|DRUG: Montelukast plus Favicovir (Favipiravir)|DRUG: Favicovir (Standard Treatment),Bahçeşehir University,Medipol University|The Scientific and Technological Research Council of Turkey,ALL,"ADULT, OLDER_ADULT",PHASE2,380,OTHER,INTERVENTIONAL,5/15/2021,6/1/2022
NCT04895085,ACTIVE_NOT_RECRUITING,COVID-19|Children With Medical Complexity (CMC),DIAGNOSTIC_TEST: BinaxNOW Rapid Antigen System,"University of Wisconsin, Madison",Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD),ALL,"ADULT, OLDER_ADULT",NA,51,OTHER,INTERVENTIONAL,4/27/2021,9/15/2023
NCT05277285,RECRUITING,COVID-19|Virus Diseases|Corona Virus Infection,DRUG: Sodium Thiosulfate 25% Solution for Injection,Hellenic Institute for the Study of Sepsis,,ALL,"ADULT, OLDER_ADULT",PHASE2,30,OTHER,INTERVENTIONAL,4/1/2022,12/31/2023
NCT04362085,COMPLETED,COVID-19,DRUG: Therapeutic Anticoagulation,Unity Health Toronto,University of Vermont Medical Center|University of Sao Paulo|Hôpital Charles Lemoyne|William Osler Health System|MOUNT SINAI HOSPITAL|Trillium Health Partners|St. Joseph's Health Centre|The Ottawa Hospital|Hopital du Sacre-Coeur de Montreal|Michael Garron Hospital|University of Alberta|Southlake Regional Health Centre|Maisonneuve-Rosemont Hospital|Queen Elizabeth II Health Sciences Centre|Foothills Medical Centre|Rockyview General Hospital|Peter Lougheed Centre|Mater Misericordiae University Hospital|King Saud University Medical City|King Fahad Medical City|King Faisal Specialist Hospital|Versiti|Barnes-Jewish Hospital|Al Ain Hospital,ALL,"ADULT, OLDER_ADULT",PHASE3,465,OTHER,INTERVENTIONAL,5/11/2020,10/14/2021
NCT04497987,COMPLETED,COVID-19|SARS-CoV2,DRUG: Bamlanivimab|DRUG: Placebo|DRUG: Etesevimab,Eli Lilly and Company,"National Institute of Allergy and Infectious Diseases (NIAID)|AbCellera Biologics Inc.|Shanghai Junshi Bioscience Co., Ltd.",ALL,"ADULT, OLDER_ADULT",PHASE3,1180,INDUSTRY,INTERVENTIONAL,8/2/2020,5/20/2021
NCT04389385,UNKNOWN,Corona Virus Infection|Pneumonia,BIOLOGICAL: COVID-19 Specific T Cell derived exosomes (CSTC-Exo),TC Erciyes University,,ALL,"ADULT, OLDER_ADULT",PHASE1,60,OTHER,INTERVENTIONAL,5/1/2020,5/31/2021
NCT05765838,RECRUITING,Influenza|COVID-19|RSV Infection,DIAGNOSTIC_TEST: (NPS right - Nasal swab left - OPS)|DIAGNOSTIC_TEST: (NPS left - Nasal swab right - OPS)|DIAGNOSTIC_TEST: (Nasal swab right - NPS left - OPS)|DIAGNOSTIC_TEST: (Nasal swab left - NPS right - OPS)|DIAGNOSTIC_TEST: (NPS right - OPS - Nasal swab left)|DIAGNOSTIC_TEST: (NPS left - OPS - Nasal swab right)|DIAGNOSTIC_TEST: (Nasal swab right - OPS - NPS left)|DIAGNOSTIC_TEST: (Nasal swab left - OPS - NPS right)|DIAGNOSTIC_TEST: (OPS - NPS right - Nasal swab left)|DIAGNOSTIC_TEST: (OPS - NPS left - Nasal swab right)|DIAGNOSTIC_TEST: (OPS - Nasal swab left - NPS right)|DIAGNOSTIC_TEST: (OPS - Nasal swab right - NPS left),"Rigshospitalet, Denmark",,ALL,"ADULT, OLDER_ADULT",NA,250,OTHER,INTERVENTIONAL,3/3/2023,7/1/2023
NCT05699538,ENROLLING_BY_INVITATION,Long COVID,BEHAVIORAL: Minimal-Dose Home-Based Resistance Exercise,VA Office of Research and Development,,ALL,"ADULT, OLDER_ADULT",NA,52,FED,INTERVENTIONAL,7/31/2023,6/5/2025
NCT04381338,COMPLETED,Corona Virus Disease 19 (COVID-19)|COVID|Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)|Critical Illness,OTHER: Pulmonary and Motor Rehabilitation,University of Padova,"Prof. S Masiero, University of Padova, Italy|Dr. A. Venturin, General Hosipital, Padova, Italy|Dr. I. Tiberio, General Hospital, Padova, Italy|Dr. D. Zampieri, University of Padova, Italy|Dr.ssa M Cattelan, University of Padova, Italy|Prof. P. Zanatta, University Hosiptal, Verona, Italy|Dr.ssa C. Carollo, General Hospital, Padova, Italy|Prof. E. Polati, University Hospital, Verona, Italy|Prof. K. Donadello, University Hospital, Verona, Italy",ALL,"ADULT, OLDER_ADULT",NA,96,OTHER,INTERVENTIONAL,2/28/2020,12/31/2020
NCT05633472,RECRUITING,Post-acute COVID-19 Syndromes,OTHER: Vitamin D|OTHER: Placebo,China Medical University Hospital,,ALL,"CHILD, ADULT",NA,150,OTHER,INTERVENTIONAL,10/18/2022,9/30/2025
NCT04368988,COMPLETED,COVID-19,"BIOLOGICAL: SARS-CoV-2 rS - Phase 1|BIOLOGICAL: SARS-CoV-2 rS/Matrix-M Adjuvant - Phase 1|OTHER: Normal saline solution (NSS), Placebo - Phase 1|OTHER: Normal saline solution (NSS), Placebo - Phase 2|BIOLOGICAL: SARS-CoV-2 rS/Matrix-M Adjuvant, Day 0 - Phase 1|OTHER: Normal saline solution (NSS), Placebo, Day 21 - Phase 1|BIOLOGICAL: SARS-CoV-2 rS/Matrix-M Adjuvant - Phase 2",Novavax,Coalition for Epidemic Preparedness Innovations,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,1419,INDUSTRY,INTERVENTIONAL,5/25/2020,6/1/2022
NCT04320238,UNKNOWN,2019 Novel Coronavirus Infection,DRUG: recombinant human interferon Alpha-1b|DRUG: thymosin alpha 1,Shanghai Jiao Tong University School of Medicine,,ALL,"ADULT, OLDER_ADULT",PHASE3,2944,OTHER,INTERVENTIONAL,1/21/2020,2020-06
NCT04480138,TERMINATED,Covid19,DRUG: Pegylated Interferon-α2b|OTHER: Standard of Care,Zydus Lifesciences Limited,,ALL,"ADULT, OLDER_ADULT",PHASE2,7,INDUSTRY,INTERVENTIONAL,8/11/2020,6/21/2021
NCT04400838,ACTIVE_NOT_RECRUITING,Coronavirus,BIOLOGICAL: ChAdOx1 nCoV-19 (Abs 260)|BIOLOGICAL: MenACWY vaccine|BIOLOGICAL: ChAdOx1 nCoV-19 (Abs 260) + 2.2x10^10vp (qPCR) boost|BIOLOGICAL: Two dose MenACWY vaccine|BIOLOGICAL: ChAdOx1 nCoV-19 (qPCR)|BIOLOGICAL: ChAdOx1 nCoV-19 0.5mL prime plus boost|BIOLOGICAL: Two dose MenACWY vaccine min. 4 weeks apart|BIOLOGICAL: Two dose ChAdOx1 nCoV-19/Covishield 0.5mL|BIOLOGICAL: Two dose ChAdOx1 nCoV-19/Covishield 0.25mL & 0.5mL,University of Oxford,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,12390,OTHER,INTERVENTIONAL,5/28/2020,3/31/2024
NCT06231238,NOT_YET_RECRUITING,Post-COVID-19 Syndrome|Long COVID,BEHAVIORAL: Balance Acceptance and Commitment Therapy,King's College London,,ALL,"ADULT, OLDER_ADULT",PHASE2,196,OTHER,INTERVENTIONAL,2024-03,2025-09
NCT04625738,COMPLETED,COVID19 ARDS,BIOLOGICAL: Ex vivo expanded Wharton's Jelly Mesenchymal Stem Cells|BIOLOGICAL: Placebo,"Central Hospital, Nancy, France",,ALL,"ADULT, OLDER_ADULT",PHASE2,30,OTHER,INTERVENTIONAL,11/6/2020,9/1/2021
NCT06064838,RECRUITING,"Long Covid19|Fatigue Syndrome, Chronic",DIETARY_SUPPLEMENT: Flavonoids,Guillermo Ceballos Reyes,Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado,ALL,"ADULT, OLDER_ADULT",NA,40,OTHER,INTERVENTIONAL,8/1/2023,12/31/2024
NCT04502472,TERMINATED,Covid-19,BIOLOGICAL: Convalescent plasma transfusion,Inova Health Care Services,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,109,OTHER,INTERVENTIONAL,6/6/2020,9/30/2020
NCT04575038,COMPLETED,COVID-19 Infection,DRUG: Brequinar|DRUG: Placebo,"Clear Creek Bio, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE2,115,INDUSTRY,INTERVENTIONAL,11/19/2020,4/28/2021
NCT06013072,COMPLETED,Long COVID,DIETARY_SUPPLEMENT: Dietary Supplement: Experimental|DIETARY_SUPPLEMENT: Dietary Supplement: Placebo,"University of Novi Sad, Faculty of Sport and Physical Education",,ALL,"ADULT, OLDER_ADULT",NA,32,OTHER,INTERVENTIONAL,10/1/2022,1/15/2024
NCT05075538,TERMINATED,Cancer,BIOLOGICAL: Spikevax|BIOLOGICAL: Comirnaty|BIOLOGICAL: Spikevax bivalent Original/Omicron BA.1|BIOLOGICAL: Spikevax bivalent Original/Omicron BA.4-5|BIOLOGICAL: Comirnaty Original/Omicron BA.1|BIOLOGICAL: Comirnaty Original/Omicron BA.4-5|BIOLOGICAL: Comirnaty Omicron XBB.1.5|BIOLOGICAL: Spikevax Omicron XBB.1.5,Jules Bordet Institute,Roche Pharma AG,ALL,"ADULT, OLDER_ADULT",PHASE4,152,OTHER,INTERVENTIONAL,12/1/2021,1/8/2024
NCT04715438,ACTIVE_NOT_RECRUITING,Cancer,BIOLOGICAL: mRNA-1273 SARS-CoV-2 vaccine from Moderna,University Medical Center Groningen,,ALL,"ADULT, OLDER_ADULT",NA,791,OTHER,INTERVENTIONAL,1/8/2021,2025-04
NCT04920838,RECRUITING,Covid19|Covid19 Drug Treatment|Severe Acute Respiratory Syndrome Coronavirus 2|SARS-CoV2 Infection,DRUG: Nitazoxanide and Ciclésonide|DRUG: Telmisartan 20Mg Oral Tablet|DRUG: Paracetamol|DRUG: Fluoxétine and Budésonide,"ANRS, Emerging Infectious Diseases","University of Bordeaux|Institut National de la Santé Et de la Recherche Médicale, France|PACCI Program|Alliance for International Medical Action|Centre Muraz|Barcelona Institute for Global Health",ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,600,OTHER_GOV,INTERVENTIONAL,4/12/2021,2023-08
NCT04384588,UNKNOWN,COVID-19 Infection|Cancer Patients|General Population,BIOLOGICAL: Convalescent Plasma from COVID-19 donors,Fundacion Arturo Lopez Perez,Confederación de la Producción y del Comercio (CPC)|Bolsa de Santiago,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2|PHASE3,100,OTHER,INTERVENTIONAL,4/7/2020,4/6/2021
NCT04476888,COMPLETED,Covid19,BIOLOGICAL: Convalescent Plasma (CP)|OTHER: Drugs and supportive care,Aga Khan University,,ALL,"ADULT, OLDER_ADULT",NA,110,OTHER,INTERVENTIONAL,4/26/2020,10/10/2020
NCT05689177,ENROLLING_BY_INVITATION,Humoral Immunity,BIOLOGICAL: Protein subunit vaccine Soberana Plus (FINLAY-FR-1A) is a vaccine against COVID-19 produced by The Finlay Vaccine Institute and The Centre of Molecular Immunology (Republic of Cuba),Gomel State Medical University,,ALL,"ADULT, OLDER_ADULT",NA,100,OTHER,INTERVENTIONAL,12/9/2022,7/28/2023
NCT05263895,COMPLETED,Bioavailability,DRUG: PF-07321332/ritonavir|DRUG: PF-07321332/ritonavir|DRUG: PF-07321332/ritonavir|DRUG: PF-07321332/ritonavir|DRUG: PF-07321332,Pfizer,,ALL,"ADULT, OLDER_ADULT",PHASE1,12,INDUSTRY,INTERVENTIONAL,3/3/2022,5/16/2022
NCT04464395,COMPLETED,COVID-19,DRUG: CPI-006|OTHER: Standard of Care,"Corvus Pharmaceuticals, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE1,30,INDUSTRY,INTERVENTIONAL,7/1/2020,7/9/2021
NCT05518695,COMPLETED,SARS-CoV-2 Infection,DRUG: BAT2022,Bio-Thera Solutions,,ALL,ADULT,PHASE1,32,INDUSTRY,INTERVENTIONAL,6/9/2022,11/7/2022
NCT04344951,TERMINATED,"Pneumonia, Viral|Covid-19",DRUG: UNIKINON (Chloroquine phosphate) 200mg tablets,Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.,Athens General Hospital Hippokrateio|Athens General Hospital of Thoracic Diseases SOTIRIA|Sismanoglio General Hospital|Divine Providence Hospital Pammakaristos|AHEPA University Hospital|University General Hospital of Ioannina|Corfu General Hospital Agia Irini,ALL,"ADULT, OLDER_ADULT",PHASE2,29,INDUSTRY,INTERVENTIONAL,4/6/2020,11/30/2020
NCT05231512,COMPLETED,Post Covid-19 Respiratory|Dyspnea|SARS-CoV 2,OTHER: Respiratory Music Therapy Protocol,Icahn School of Medicine at Mount Sinai,,ALL,"ADULT, OLDER_ADULT",NA,33,OTHER,INTERVENTIONAL,1/13/2022,3/13/2023
NCT05655351,ACTIVE_NOT_RECRUITING,CORONAVIRUS INFECTIONS,BIOLOGICAL: anti-SARS-Cov-2 vaccination,Centre Hospitalier Universitaire de Nīmes,,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,30,OTHER,INTERVENTIONAL,12/21/2022,3/31/2024
NCT04614948,COMPLETED,Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19,BIOLOGICAL: Ad26.COV2.S|OTHER: Placebo,Janssen Vaccines & Prevention B.V.,,ALL,"ADULT, OLDER_ADULT",PHASE3,31831,INDUSTRY,INTERVENTIONAL,11/12/2020,6/18/2023
NCT04344548,WITHDRAWN,COVID,BIOLOGICAL: Allogeneic NK transfer,Universidad Nacional de Colombia,Fundación Salud de los Andes,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,0,OTHER,INTERVENTIONAL,3/30/2020,10/30/2020
NCT05799651,RECRUITING,SARS-CoV-2,BIOLOGICAL: Glycovax-002,Glycovax Pharma Inc.,Government of Canada|JSS Medical Research Inc.|Avance Clinical Pty Ltd.|Seppic,ALL,ADULT,PHASE1,36,INDUSTRY,INTERVENTIONAL,4/28/2023,2024-08
NCT04552951,UNKNOWN,COVID-19,DRUG: Cholecalciferol,Fundación para la Investigación Biosanitaria del Principado de Asturias,Hospital Universitario Central de Asturias|Instituto de Investigación Sanitaria del Principado de Asturias,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,80,OTHER,INTERVENTIONAL,4/4/2020,12/30/2020
NCT05394012,NOT_YET_RECRUITING,COVID-19,BIOLOGICAL: RQ3013|BIOLOGICAL: Comirnaty,"Walvax Biotechnology Co., Ltd.","Shanghai RNACure Biopharma Co., Ltd.",ALL,ADULT,PHASE1,120,INDUSTRY,INTERVENTIONAL,2022-12,2023-06
NCT04352348,UNKNOWN,COVID-19,OTHER: blood samples|OTHER: feces samples (COVI-BIOME ancillary study)|OTHER: sweat samples (COVIDOG ancillary study)|OTHER: saliva samples|OTHER: 6 minutes walk test|OTHER: Phone call|OTHER: Urine samples,Assistance Publique - Hôpitaux de Paris,,ALL,"ADULT, OLDER_ADULT",NA,2003,OTHER,INTERVENTIONAL,3/31/2020,5/31/2022
NCT06248151,NOT_YET_RECRUITING,Post-Acute COVID-19 Syndrome,BEHAVIORAL: Exercise session|BEHAVIORAL: Control session,University of Nove de Julho,,ALL,"ADULT, OLDER_ADULT",NA,40,OTHER,INTERVENTIONAL,2/15/2024,11/30/2024
NCT04836351,UNKNOWN,Covid19,OTHER: Concentrated rehabilitation for patients with persistent symptoms post COVID-19,Western Norway University of Applied Sciences,Helse-Bergen HF,ALL,"ADULT, OLDER_ADULT",NA,20,OTHER,INTERVENTIONAL,3/1/2021,12/30/2023
NCT04390412,UNKNOWN,COVID|SARS (Severe Acute Respiratory Syndrome),RADIATION: Low Dose Radiotherapy,Shahid Beheshti University of Medical Sciences,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,5,OTHER,INTERVENTIONAL,5/4/2020,2020-12
NCT04887948,COMPLETED,Pneumococcal Disease|COVID-19|SARS-CoV-2 Infection,BIOLOGICAL: 20-valent pneumococcal conjugate vaccine (20vPnC)|BIOLOGICAL: BNT162b2|OTHER: Saline,Pfizer,,ALL,OLDER_ADULT,PHASE3,570,INDUSTRY,INTERVENTIONAL,5/20/2021,12/8/2021
NCT04467151,WITHDRAWN,COVID-19,DRUG: anti-SARS-CoV-2 plasma|OTHER: Placebo,Kashif Khan,,ALL,"ADULT, OLDER_ADULT",PHASE2,0,OTHER,INTERVENTIONAL,2020-10,2021-12
NCT04462848,NOT_YET_RECRUITING,Corona Virus Infection,BIOLOGICAL: anti-SARS-CoV-2 human convalescent plasma,"University of California, Los Angeles",,ALL,CHILD,PHASE1,30,OTHER,INTERVENTIONAL,2020-08,2024-12
NCT04649151,ACTIVE_NOT_RECRUITING,SARS-CoV-2,BIOLOGICAL: mRNA-1273|BIOLOGICAL: Placebo|BIOLOGICAL: mRNA-1273.222,"ModernaTX, Inc.",Biomedical Advanced Research and Development Authority,ALL,"CHILD, ADULT",PHASE2|PHASE3,4331,INDUSTRY,INTERVENTIONAL,12/9/2020,12/9/2024
NCT05543551,COMPLETED,COVID-19 Pandemic,OTHER: Diaphragmatic breathing with Resistance Training|OTHER: diaphragmatic breathing with out resistance training,Riphah International University,,ALL,ADULT,NA,42,OTHER,INTERVENTIONAL,9/2/2022,12/10/2022
NCT04328012,TERMINATED,SARS-CoV-2 Infection,DRUG: Losartan|DRUG: Placebo,Bassett Healthcare,Reid Health|Goshen Health System,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,15,OTHER,INTERVENTIONAL,4/6/2020,12/1/2021
NCT05046548,COMPLETED,Coronavirus Infections|Vaccine,BIOLOGICAL: Vaccine for intramuscular injection|OTHER: Placebo comparator (without active ingredient) for intramuscular injection,Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products,,ALL,ADULT,PHASE1|PHASE2,400,OTHER_GOV,INTERVENTIONAL,10/3/2020,10/1/2021
NCT04790851,COMPLETED,"Influenza, Human|Pneumonia, Pneumococcal|Covid19",BIOLOGICAL: COVAX+IIV4; COVAX+PPV23|BIOLOGICAL: COVAX only (1st and 2nd dose)|BIOLOGICAL: IIV4 for the 1st dose and PPV23 for the 2nd dose,China National Biotec Group Company Limited,"Chengdu Institute of Biological Products Co.,Ltd.|Changchun Institute of Biological Products Co., Ltd.|Beijing Institute of Biological Products Co Ltd.|Sichuan Center for Disease Control and Prevention|Shanghai Municipal Center for Disease Control and Prevention|Shanxi Center for Disease Control and Prevention",ALL,"ADULT, OLDER_ADULT",PHASE4,1133,INDUSTRY,INTERVENTIONAL,3/10/2021,9/5/2021
NCT05394051,ACTIVE_NOT_RECRUITING,"COVID-19|Burnout|Burnout, Professional|Work-related Illness|Work-Related Stress|SARS-CoV-2 Infection",BEHAVIORAL: Positive Affect Regulation sKills (PARK),Northwestern University,,ALL,"ADULT, OLDER_ADULT",NA,555,OTHER,INTERVENTIONAL,12/1/2021,3/31/2024
NCT05005312,COMPLETED,Hepatic Impairment,DRUG: PF-07321332|DRUG: Ritonavir,Pfizer,,ALL,"ADULT, OLDER_ADULT",PHASE1,17,INDUSTRY,INTERVENTIONAL,8/31/2021,12/7/2021
NCT05741112,RECRUITING,Long COVID|Postural Orthostatic Tachycardia Syndrome|Dysautonomia|Myalgic Encephalomyelitis|Chronic Fatigue Syndrome|Long Covid19,DEVICE: Wearable device,Scripps Translational Science Institute,,ALL,"ADULT, OLDER_ADULT",NA,100500,OTHER,INTERVENTIONAL,11/16/2023,12/1/2025
NCT04731051,WITHDRAWN,2019 Novel Coronavirus,DRUG: HCQ01|DRUG: standard of care (SOC) for COVID-19,King Hussein Cancer Center,Amman Pharmaceutical Industries (API)|Sana Pharmaceutical Industry|ACDIMA Biocenter,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,0,OTHER,INTERVENTIONAL,2022-10,2022-12
NCT05947812,NOT_YET_RECRUITING,COVID 19 Disease|Mild to Moderate COVID 19 Disease|SARS-CoV-2|Infectious Disease|Severe Acute Respiratory Syndrome Coronavirus 2,DRUG: Tafenoquine Oral Tablet|DRUG: Placebo,60P Australia Pty Ltd,,ALL,"ADULT, OLDER_ADULT",PHASE2,148,INDUSTRY,INTERVENTIONAL,8/1/2023,4/27/2024
NCT05505448,COMPLETED,Healthy,DRUG: REGN14284|DRUG: Matching Placebo,Regeneron Pharmaceuticals,,ALL,ADULT,PHASE1,48,INDUSTRY,INTERVENTIONAL,9/15/2022,5/30/2023
NCT05255848,NOT_YET_RECRUITING,COVID-19 Pneumonia,DRUG: Unfractionated heparin,"Lady Reading Hospital, Pakistan",,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,180,OTHER_GOV,INTERVENTIONAL,6/20/2022,10/20/2022
NCT04858451,TERMINATED,COPD|Bronchiectasis,DRUG: RESP301,Thirty Respiratory Limited,,ALL,"ADULT, OLDER_ADULT",PHASE2,39,INDUSTRY,INTERVENTIONAL,3/1/2021,5/20/2022
NCT04858412,RECRUITING,Alcoholic Liver Disease|COVID 19 Pneumonia,DIETARY_SUPPLEMENT: β-hydroxy β-methyl butyrate (HMB) enriched amino acid|DIETARY_SUPPLEMENT: Balanced amino acid,The Cleveland Clinic,,ALL,"ADULT, OLDER_ADULT",NA,48,OTHER,INTERVENTIONAL,4/1/2021,3/31/2025
NCT04497948,TERMINATED,COVID-19,DRUG: Acalabrutinib,Acerta Pharma BV,AstraZeneca,ALL,"ADULT, OLDER_ADULT",PHASE1,9,INDUSTRY,INTERVENTIONAL,9/21/2020,11/18/2020
NCT04415151,TERMINATED,COVID-19 Pneumonia,DRUG: Tofacitinib 10 mg|DRUG: Placebo,Yale University,,ALL,"ADULT, OLDER_ADULT",PHASE2,24,OTHER,INTERVENTIONAL,10/14/2020,2/28/2021
NCT05197712,ACTIVE_NOT_RECRUITING,COVID-19 Vaccine,BIOLOGICAL: 25 Baiya SARS-CoV-2 Vax 2|BIOLOGICAL: 50 Baiya SARS-CoV-2 Vax 2,"Baiya Phytopharm Co., Ltd.","National Vaccine Institute, Thailand",ALL,ADULT,PHASE1,24,INDUSTRY,INTERVENTIONAL,3/28/2022,4/10/2024
NCT05112848,COMPLETED,SARS-CoV-2 Infection,BIOLOGICAL: NVX-CoV2373,Novavax,,ALL,"ADULT, OLDER_ADULT",PHASE2,384,INDUSTRY,INTERVENTIONAL,2/28/2022,11/30/2022
NCT04526912,TERMINATED,Acute Lung Injury,DRUG: VIB7734|DRUG: Placebo,Viela Bio,,ALL,"ADULT, OLDER_ADULT",PHASE1,10,INDUSTRY,INTERVENTIONAL,8/28/2020,5/19/2021
NCT05119348,COMPLETED,Covid19|Sars-CoV-2 Infection,OTHER: STOPCOV,Desmond Tutu HIV Foundation,Amsterdam Institute for Global Health and Development|European and Developing Countries Clinical Trials Partnership (EDCTP)|University of Cape Town,ALL,"CHILD, ADULT, OLDER_ADULT",NA,114,OTHER,INTERVENTIONAL,9/14/2020,10/21/2021
NCT04852848,COMPLETED,Health Behavior,BEHAVIORAL: Connect2Test Intervention,University of Oregon,National Institute on Drug Abuse (NIDA),ALL,"ADULT, OLDER_ADULT",NA,205,OTHER,INTERVENTIONAL,4/14/2021,6/30/2021
NCT04550351,UNKNOWN,Coronavirus,BIOLOGICAL: Biological/Vaccine: Recombinant new coronavirus vaccine (CHO cell) low-dose group|BIOLOGICAL: Biological/Vaccine: Recombinant new coronavirus vaccine (CHO cells) high-dose group|BIOLOGICAL: Biological/Vaccine: Recombinant new coronavirus vaccine (CHO cells) placebo group,"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.",,ALL,"ADULT, OLDER_ADULT",PHASE1,50,INDUSTRY,INTERVENTIONAL,8/19/2020,12/31/2021
NCT05329051,NOT_YET_RECRUITING,SARS-CoV-2 Infection|COVID-19,BIOLOGICAL: SCTV01E|BIOLOGICAL: Comirnaty,Sinocelltech Ltd.,,ALL,"ADULT, OLDER_ADULT",PHASE2,400,INDUSTRY,INTERVENTIONAL,7/1/2022,3/1/2023
NCT04720612,ACTIVE_NOT_RECRUITING,Covid19,BIOLOGICAL: Omalizumab|OTHER: Placebo,McGill University Health Centre/Research Institute of the McGill University Health Centre,,ALL,"ADULT, OLDER_ADULT",PHASE2,40,OTHER,INTERVENTIONAL,10/15/2021,12/16/2022
NCT04347512,WITHDRAWN,"Sars-CoV-2, Community-Acquired Pneumonia,COVID-19",DRUG: Hydroxychloroquine and azithromycin treatment arm.|DRUG: Hydroxychloroquine|DRUG: Control arm,"University Hospital, Strasbourg, France",,ALL,"ADULT, OLDER_ADULT",PHASE3,0,OTHER,INTERVENTIONAL,6/2/2020,6/2/2020
NCT04516512,COMPLETED,COVID-19,BIOLOGICAL: Blood draw,Assistance Publique - Hôpitaux de Paris,,ALL,"ADULT, OLDER_ADULT",NA,1044,OTHER,INTERVENTIONAL,1/14/2021,7/8/2021
NCT05023512,WITHDRAWN,Covid19|Vaccination,BEHAVIORAL: Communication about the COVID-19 vaccination from the Massachusetts Department of Public Health,"University of Massachusetts, Worcester","Boston University|National Heart, Lung, and Blood Institute (NHLBI)",ALL,"ADULT, OLDER_ADULT",NA,0,OTHER,INTERVENTIONAL,10/28/2021,9/1/2022
NCT04536051,UNKNOWN,Coronavirus,BIOLOGICAL: ChAdOx1 nCoV-19 single dose + paracetamol|BIOLOGICAL: MenACWY single dose + paracetamol|BIOLOGICAL: ChAdOx1 nCoV-19 two dose + paracetamol|BIOLOGICAL: MenACWY prime & saline placebo boost + paracetamol,University of Oxford,,ALL,"ADULT, OLDER_ADULT",PHASE3,10300,OTHER,INTERVENTIONAL,6/2/2020,2021-09
NCT05007951,ACTIVE_NOT_RECRUITING,Covid19,BIOLOGICAL: GBP510 adjuvanted with AS03 (Receptor-Binding Domain(RBD) 25ug/dose)|BIOLOGICAL: ChAdOx1-S not less than 2.5 × 10^8 infectious units|BIOLOGICAL: GBP510 adjuvanted with AS03 (Receptor-Binding Domain(RBD) 25ug/dose),"SK Bioscience Co., Ltd.",International Vaccine Institute|GlaxoSmithKline|Coalition for Epidemic Preparedness Innovations,ALL,"ADULT, OLDER_ADULT",PHASE3,4036,INDUSTRY,INTERVENTIONAL,8/30/2021,2023-11
NCT04530448,TERMINATED,COVID|Coronavirus|Coronavirus Infection|AKI|Acute Kidney Injury,DRUG: Sodium bicarbonate|OTHER: Standard of Care,West Virginia University,,ALL,"ADULT, OLDER_ADULT",PHASE4,3,OTHER,INTERVENTIONAL,10/5/2020,7/15/2021
NCT04820751,UNKNOWN,Viral Pneumonia|Serotonin Syndrome|Platelet Dysfunction,DRUG: Cyproheptadine Hydrochloride 4 MG,Ciusss de L'Est de l'Île de Montréal,Covid-19 Early Treatment Fund,ALL,"ADULT, OLDER_ADULT",PHASE3,200,OTHER,INTERVENTIONAL,4/10/2021,1/1/2022
NCT05305651,RECRUITING,COVID-19,DRUG: Sotrovimab,GlaxoSmithKline,,ALL,"ADULT, OLDER_ADULT",PHASE4,500,INDUSTRY,INTERVENTIONAL,7/1/2022,11/15/2023
NCT04409886,TERMINATED,"COVID, Coronavirus",BIOLOGICAL: Hyperbaric Oxygen Therapy,Maimonides Medical Center,,ALL,"ADULT, OLDER_ADULT",PHASE4,1,OTHER,INTERVENTIONAL,6/1/2020,1/31/2021
NCT05389319,RECRUITING,COVID-19,BIOLOGICAL: Prime-2-CoV_Beta,University Hospital Tuebingen,FGK Clinical Research GmbH|VisMederi srl|Staburo GmbH|Viedoc Technologies AB,ALL,ADULT,PHASE1,60,OTHER,INTERVENTIONAL,6/24/2022,12/31/2025
NCT04482686,UNKNOWN,COVID|Covid-19|Corona Virus Infection|Coronavirus Infection|Coronavirus-19|SARS-CoV2|SARS-CoV Infection,DRUG: Ivermectin|DRUG: Doxycycline Hcl|DIETARY_SUPPLEMENT: Zinc|DIETARY_SUPPLEMENT: Vitamin D3|DIETARY_SUPPLEMENT: Vitamin C,ProgenaBiome,Topelia Therapeutics,ALL,"ADULT, OLDER_ADULT",PHASE1,31,OTHER,INTERVENTIONAL,12/9/2020,2022-07
NCT04872686,COMPLETED,"Virus Infection, RNA|Effect of Drug|Efficacy, Self",DRUG: 0.6% PVP-I oral and nasal spray to moderately ill COVID-19 positive patient|DRUG: 0.6% PVP-I Oral and nasal spray to asymptomatic to mild COVID-19 patient having multiple comorbidity|DRUG: 0.6% PVP-I Oral and nasal spray to healthy volunteer|OTHER: Oral and nasal spray by distilled water to control group,DR. MALA KHAN,Bangladesh Reference Institute of Chemical Measurements (BRICM),ALL,"ADULT, OLDER_ADULT",PHASE3,798,OTHER_GOV,INTERVENTIONAL,4/10/2021,5/30/2021
NCT04374019,TERMINATED,COVID|Sars-CoV2,DRUG: Ivermectin|DRUG: Camostat Mesilate|DIETARY_SUPPLEMENT: Artemesia annua|DRUG: Artesunate,Susanne Arnold,,ALL,"ADULT, OLDER_ADULT",PHASE2,13,OTHER,INTERVENTIONAL,5/1/2020,1/12/2022
NCT05003466,UNKNOWN,COVID-19,"BIOLOGICAL: SARS-CoV-2 Vaccine (Vero Cells), Inactivated|BIOLOGICAL: Placebo","Shenzhen Kangtai Biological Products Co., LTD","Beijing Minhai Biotechnology Co., Ltd|Hunan Provincial Center for Disease Control and Prevention",ALL,CHILD,PHASE2,480,INDUSTRY,INTERVENTIONAL,2021-09,2023-04
NCT04832919,ACTIVE_NOT_RECRUITING,COVID-19,BEHAVIORAL: Nurse-Community-Family Partnership Intervention,New York University,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,392,OTHER,INTERVENTIONAL,7/23/2021,2023-04
NCT04357366,COMPLETED,COVID-19|Virus Diseases|Corona Virus Infection|Lower Respiratory Tract Infection Viral,DRUG: Anakinra,Hellenic Institute for the Study of Sepsis,,ALL,"ADULT, OLDER_ADULT",PHASE2,1000,OTHER,INTERVENTIONAL,4/15/2020,4/15/2022
NCT04431466,TERMINATED,Coronavirus Infection,DRUG: Ivermectin|OTHER: Standard of Care,Universidade Federal de Sao Carlos,,ALL,"ADULT, OLDER_ADULT",PHASE2,32,OTHER,INTERVENTIONAL,7/1/2020,12/1/2020
NCT04330586,COMPLETED,COVID-19,DRUG: Ciclesonide Metered Dose Inhaler [Alvesco],Korea University Guro Hospital,,ALL,"ADULT, OLDER_ADULT",PHASE2,68,OTHER,INTERVENTIONAL,4/1/2020,3/31/2021
NCT04397666,UNKNOWN,SARS-CoV Infection|Pinkeye,DIAGNOSTIC_TEST: conjunctival RT PCR,Versailles Hospital,,ALL,"ADULT, OLDER_ADULT",NA,68,OTHER,INTERVENTIONAL,5/15/2020,12/15/2021
NCT04408066,SUSPENDED,COVID-19,DIAGNOSTIC_TEST: Sample Collection/Performance Evaluation (A)|DIAGNOSTIC_TEST: Sample Collection/Performance Evaluation (B),LumiraDx UK Limited,,ALL,"ADULT, OLDER_ADULT",NA,2000,INDUSTRY,INTERVENTIONAL,4/30/2020,7/1/2024
NCT04993586,COMPLETED,COVID-19 Lower Respiratory Infection,BIOLOGICAL: AG0302-COVID19 for Intramuscular Injection|BIOLOGICAL: AG0302-COVID19 for Intramuscular Injection|BIOLOGICAL: AG0302-COVID19 for Intramuscular Injection|BIOLOGICAL: AG0302-COVID19 for Intradermal Injection|BIOLOGICAL: AG0302-COVID19 for Intradermal Injection,"AnGes, Inc.",Japan Agency for Medical Research and Development,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,422,INDUSTRY,INTERVENTIONAL,7/29/2021,9/23/2022
NCT04808986,COMPLETED,Covid19,DIAGNOSTIC_TEST: Serological test for the detection of IgG anti-SARS-CoV-2,"Institut National de la Santé Et de la Recherche Médicale, France",,ALL,"CHILD, ADULT, OLDER_ADULT",NA,2817,OTHER_GOV,INTERVENTIONAL,5/10/2021,10/12/2021
NCT04540419,UNKNOWN,Covid19,BIOLOGICAL: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)|BIOLOGICAL: Placebo,NPO Petrovax,CanSino Biologics Inc.,ALL,"ADULT, OLDER_ADULT",PHASE3,500,INDUSTRY,INTERVENTIONAL,9/11/2020,7/31/2021
NCT04432766,WITHDRAWN,COVID-19,DRUG: BAT2020,Bio-Thera Solutions,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,0,INDUSTRY,INTERVENTIONAL,10/20/2020,8/18/2021
NCT04407286,COMPLETED,Covid 19|Vitamin D Deficiency,DIETARY_SUPPLEMENT: Vitamin D3,Arizona State University,Southwest College of Naturopathic Medicine,ALL,"ADULT, OLDER_ADULT",PHASE1,41,OTHER,INTERVENTIONAL,5/19/2020,11/30/2020
NCT05663086,WITHDRAWN,COVID-19,BIOLOGICAL: One dose group|BIOLOGICAL: Two doses group|BIOLOGICAL: Aged 18-59 years|BIOLOGICAL: Aged 60 years old and above,"Guangzhou Patronus Biotech Co., Ltd.","Yantai Patronus Biotech Co., Ltd.",ALL,"ADULT, OLDER_ADULT",PHASE2,0,INDUSTRY,INTERVENTIONAL,1/7/2023,6/27/2023
NCT05890586,COMPLETED,Covid19,DRUG: Fluvoxamine|OTHER: Placebo,"Susanna Naggie, MD",National Center for Advancing Translational Sciences (NCATS)|Vanderbilt University Medical Center,ALL,"ADULT, OLDER_ADULT",PHASE3,1331,OTHER,INTERVENTIONAL,6/8/2021,9/4/2022
NCT05115019,WITHDRAWN,COVID-19,BIOLOGICAL: RUTI® vaccine|BIOLOGICAL: Placebo,PT. Innovative Pharma Solutions,Archivel Farma S.L.|RUTI Immunotherapeutics S.L.,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,0,INDUSTRY,INTERVENTIONAL,2021-12,2022-04
NCT05545319,WITHDRAWN,"Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)|Coronavirus Disease 2019 (COVID-19)|Immunocompromised|Hospitalization|Child, Hospitalized",DRUG: Nirmatrelvir|DRUG: Ritonavir|DRUG: Placebo for nirmatrelvir,Pfizer,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,0,INDUSTRY,INTERVENTIONAL,12/13/2022,1/6/2024
NCT05531019,COMPLETED,Long COVID,DIETARY_SUPPLEMENT: Echinochrome A|OTHER: Control,Fernando Saldarini,"Universidad Nacional de la Patagonia San Juan Bosco|Ministerio de Ciencia, Tecnologia e Innovación, Argentina|Hospital de Infecciosas Francisco Javier Muniz",ALL,ADULT,NA,54,OTHER,INTERVENTIONAL,9/22/2021,12/18/2022
NCT04363866,WITHDRAWN,COVID-19|SARS-CoV-2,DRUG: Hydroxychloroquine|DRUG: Placebo,Oregon Health and Science University,OHSU Knight Cancer Institute,ALL,"ADULT, OLDER_ADULT",PHASE2,0,OTHER,INTERVENTIONAL,2020-08,2021-09
NCT05607147,COMPLETED,SARS-CoV2 Infection,DEVICE: Testing for SARS CoV2 Antigen and Antibody,"Rutgers, The State University of New Jersey",National Institute of Dental and Craniofacial Research (NIDCR),ALL,"ADULT, OLDER_ADULT",NA,10,OTHER,INTERVENTIONAL,1/26/2021,2/11/2021
NCT04605887,RECRUITING,COVID-19,DRUG: Angiotensin 1-7,Rambam Health Care Campus,Constant Therapeutics LLC,ALL,"ADULT, OLDER_ADULT",PHASE2,120,OTHER,INTERVENTIONAL,1/18/2021,2024-04
NCT04293887,UNKNOWN,COVID-19|Recombinant Human Interferon α1β,DRUG: Recombinant human interferon α1β,Tongji Hospital,,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,328,OTHER,INTERVENTIONAL,3/1/2020,6/30/2020
NCT04954287,COMPLETED,Covid19,BIOLOGICAL: CVXGA1 low dose|BIOLOGICAL: CVXGA1 high dose,CyanVac LLC,,ALL,ADULT,PHASE1,72,INDUSTRY,INTERVENTIONAL,8/6/2021,6/10/2023
NCT05012787,TERMINATED,COVID-19,BIOLOGICAL: CpG 1018/Alum-adjuvanted SCB-2019 vaccine|BIOLOGICAL: Havrix|OTHER: Placebo; 0.9% saline,Clover Biopharmaceuticals AUS Pty Ltd,,ALL,"ADULT, OLDER_ADULT",PHASE3,1,INDUSTRY,INTERVENTIONAL,11/12/2021,5/4/2022
NCT04442087,COMPLETED,SARS-CoV2,BIOLOGICAL: Serology SARS-CoV2|BEHAVIORAL: Data collection,Assistance Publique - Hôpitaux de Paris,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,563,OTHER,INTERVENTIONAL,6/19/2020,4/30/2021
NCT05518487,RECRUITING,COVID-19|Kidney Transplant,BIOLOGICAL: Sanofi-GSK monovalent (B.1.351) CoV2 preS dTM-AS03 COVID-19 vaccine,National Institute of Allergy and Infectious Diseases (NIAID),"PPD|Johns Hopkins University|Sanofi Pasteur, a Sanofi Company",ALL,"ADULT, OLDER_ADULT",PHASE2,80,NIH,INTERVENTIONAL,2/20/2023,2025-07
NCT06085547,RECRUITING,SARS-CoV2 Infection,BEHAVIORAL: General SARS-CoV-2 Communication|BEHAVIORAL: Rural-Targeted SARS-CoV-2 Communication,Michigan State University,National Cancer Institute (NCI)|Johns Hopkins University,ALL,"ADULT, OLDER_ADULT",NA,200,OTHER,INTERVENTIONAL,5/1/2023,6/30/2024
NCT04716985,ACTIVE_NOT_RECRUITING,SARS-CoV-2|Covid19|AMBULATORY CARE,DIETARY_SUPPLEMENT: MOLECULAR HYDROGEN|DIETARY_SUPPLEMENT: PLACEBO MAGNESIUM,AGIR à Dom,"Laboratoire TIMC-IMAG|DrinkHRW, British Columbia, Canada",ALL,"ADULT, OLDER_ADULT",NA,700,OTHER,INTERVENTIONAL,1/22/2021,5/22/2023
NCT06189066,RECRUITING,Long Covid,DEVICE: Splenic Ultrasound,SecondWave Systems Inc.,University of Minnesota|MCDC (United States Department of Defense),ALL,"ADULT, OLDER_ADULT",NA,15,INDUSTRY,INTERVENTIONAL,1/3/2024,9/25/2024
NCT04639466,ACTIVE_NOT_RECRUITING,COVID-19 Infection,DRUG: Placebo Administration|BIOLOGICAL: Synthetic MVA-based SARS-CoV-2 Vaccine COH04S1,"GeoVax, Inc.",,ALL,ADULT,PHASE1|PHASE2,189,INDUSTRY,INTERVENTIONAL,11/19/2020,2024-09
NCT04332666,UNKNOWN,Coronavirus|Respiratory Failure|Coronavirus Sars-Associated as Cause of Disease Classified Elsewhere|SARS-CoV-2,DRUG: Angiotensin 1-7|DRUG: Placebos,Erasme University Hospital,Fonds Erasme pour la Recherche Médicale,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,60,OTHER,INTERVENTIONAL,12/30/2021,6/15/2023
NCT05977166,COMPLETED,Post COVID-19 Patients,DEVICE: hyperbaric oxygen therapy|DEVICE: breathing exercise|DRUG: medical treatment,Cairo University,,ALL,"ADULT, OLDER_ADULT",NA,72,OTHER,INTERVENTIONAL,3/7/2022,6/1/2023
NCT05679466,ACTIVE_NOT_RECRUITING,Prevention of COVID-19 Caused by SARS-CoV-2,"BIOLOGICAL: randomized, double-blinded, placebo-controlled",Yu Qin,,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,3300,OTHER,INTERVENTIONAL,12/27/2022,12/31/2023
NCT04420247,COMPLETED,COVID|COVID-19|SARS-CoV 2|Coronavirus|Corona Virus Infection,DRUG: Chloroquine|DRUG: Hydroxychloroquine|OTHER: standard care,Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva,,ALL,"ADULT, OLDER_ADULT",PHASE3,142,OTHER,INTERVENTIONAL,4/16/2020,9/3/2020
NCT05121766,COMPLETED,COVID-19,DRUG: Omega-3 (EPA+DHA)|DRUG: Placebo,Hackensack Meridian Health,,ALL,"ADULT, OLDER_ADULT",PHASE1,32,OTHER,INTERVENTIONAL,1/10/2022,4/21/2023
NCT04522466,TERMINATED,Sars-CoV2,DRUG: Hydroxychloroquine (HCQ),Centre Hospitalier Universitaire de Saint Etienne,CHU Saint-Etienne - Laboratoire de Pharmacologie - Toxicologie - Gaz du sang,ALL,"ADULT, OLDER_ADULT",PHASE3,7,OTHER,INTERVENTIONAL,4/3/2020,5/28/2020
NCT04756466,UNKNOWN,SARS CoV-2 Infection|Elderly,DIETARY_SUPPLEMENT: Placebo|DIETARY_SUPPLEMENT: Lactobacillus,Biosearch S.A.,,ALL,"ADULT, OLDER_ADULT",NA,201,INDUSTRY,INTERVENTIONAL,1/1/2021,12/31/2021
NCT04369066,COMPLETED,Volunteers From the Institute Curie and Institute Pasteur Staff Who Are Not Showing Active SARS-CoV-2 Infection,DIAGNOSTIC_TEST: Blood samples (collection of 5 mL of blood in a dry tube)|DIAGNOSTIC_TEST: Nasopharyngeal swabs,Institut Curie,,ALL,"ADULT, OLDER_ADULT",NA,1971,OTHER,INTERVENTIONAL,4/28/2020,5/13/2022
NCT04894266,TERMINATED,COVID-19 Infection,DRUG: Apabetalone|OTHER: Standard of care,Resverlogix Corp,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,1,INDUSTRY,INTERVENTIONAL,1/14/2022,6/22/2022
NCT04790786,TERMINATED,Covid19,BIOLOGICAL: Lilly Bamlanivimab|BIOLOGICAL: Regeneron Casirivimab + Imdevimab|BIOLOGICAL: Lilly Bamlanivimab + Etesevimab|BIOLOGICAL: Sotrovimab|BIOLOGICAL: Bebtelovimab,Erin McCreary,University of Pittsburgh,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,4571,OTHER,INTERVENTIONAL,3/10/2021,6/16/2022
NCT05599919,COMPLETED,SARS-CoV-2 Infection,DRUG: Nitric Oxide,Sanotize Research and Development corp.,Glenmark Pharmaceuticals Ltd. India,ALL,"ADULT, OLDER_ADULT",PHASE3,306,INDUSTRY,INTERVENTIONAL,11/1/2021,2/2/2022
NCT04842448,ACTIVE_NOT_RECRUITING,"COVID-19|Post COVID-19 Condition|Post COVID-19 Condition, Unspecified|Post COVID Condition|Post-COVID Syndrome|Post-Acute COVID-19 Syndrome",DRUG: Hyperbaric oxygen|PROCEDURE: Sham treatment,Karolinska University Hospital,Karolinska Institutet|Karolinska Trial Alliance|EDC Scandinavia AB|Swedish Heart Lung Foundation|Region Stockholm|The Swedish Research Council,ALL,ADULT,PHASE2,80,OTHER,INTERVENTIONAL,9/15/2021,6/30/2024
NCT05401448,RECRUITING,COVID-19,BIOLOGICAL: Influenza|BIOLOGICAL: MMR vaccines|OTHER: Placebo,Radboud University Medical Center,"Faculdade da Polícia Militar, Goiânia, GO - Brazil",ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,2000,OTHER,INTERVENTIONAL,5/1/2021,2023-03
NCT05946551,NOT_YET_RECRUITING,COVID-19,DRUG: Cetirizine|DRUG: Famotidine|DRUG: Cetirizine Placebo|DRUG: Famotidine Placebo,Emory University,CURE Drug Repurposing Collaboratory (CDRC),ALL,"ADULT, OLDER_ADULT",PHASE3,36,OTHER,INTERVENTIONAL,2024-02,2024-08
NCT05175625,COMPLETED,COVID-19,BIOLOGICAL: SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant|BIOLOGICAL: Saline placebo,Cinnagen,Vaxine Pty Ltd,ALL,"ADULT, OLDER_ADULT",PHASE3,300,INDUSTRY,INTERVENTIONAL,12/15/2021,6/20/2022
NCT04402892,UNKNOWN,COVID-19|SARS-CoV-2 Infection,"OTHER: 35 ml blood, 5 tubes LITHIUM HEPARINATE at each time (hospitalized Patients )|OTHER: 35 ml blood, 5 tubes LITHIUM HEPARINATE at each time (cured Patients)",Assistance Publique - Hôpitaux de Paris,,ALL,"ADULT, OLDER_ADULT",NA,60,OTHER,INTERVENTIONAL,6/1/2020,3/1/2021
NCT04359225,UNKNOWN,Telehealth,OTHER: 3D Telemedicine|OTHER: 2D Telemedicine,NHS Greater Glasgow and Clyde,University of Strathclyde|Glasgow Royal Infirmary,ALL,"CHILD, ADULT, OLDER_ADULT",NA,80,OTHER,INTERVENTIONAL,9/30/2021,12/31/2021
NCT04799392,TERMINATED,COVID-19|SARS-CoV-2|Coronavirus,DEVICE: NOWDx COVID-19 Test,"NOWDiagnostics, Inc.",,ALL,"CHILD, ADULT, OLDER_ADULT",NA,50,INDUSTRY,INTERVENTIONAL,4/1/2021,10/28/2021
NCT04383548,UNKNOWN,COVID19,OTHER: hyper immunoglobulins containing anti-Corona VS2 immunoglobulin,Assiut University,,ALL,ADULT,NA,100,OTHER,INTERVENTIONAL,6/1/2020,1/1/2021
NCT04864548,RECRUITING,Coronavirus,BIOLOGICAL: SARS-CoV-2 virus,University of Oxford,,ALL,ADULT,PHASE1,132,OTHER,INTERVENTIONAL,5/27/2021,2024-03
NCT05939648,ACTIVE_NOT_RECRUITING,SARS-CoV-2,BIOLOGICAL: SARS-CoV-2 Bivalent mRNA Vaccine|OTHER: Saline,"AIM Vaccine Co., Ltd.","Ningbo Rongan Biological Pharmaceutical Co., Ltd.",ALL,"ADULT, OLDER_ADULT",PHASE2,450,INDUSTRY,INTERVENTIONAL,10/9/2023,12/30/2024
NCT04315948,COMPLETED,Corona Virus Infection,DRUG: Remdesivir|DRUG: Lopinavir/ritonavir|DRUG: Interferon Beta-1A|DRUG: Hydroxychloroquine|OTHER: Standard of care|DRUG: AZD7442|OTHER: Placebo,"Institut National de la Santé Et de la Recherche Médicale, France",,ALL,"ADULT, OLDER_ADULT",PHASE3,1552,OTHER_GOV,INTERVENTIONAL,3/22/2020,9/25/2023
NCT05110651,WITHDRAWN,COVID-19|End Stage Renal Disease,DRUG: Hydroxychloroquine,Nicholas Carlson,,ALL,"ADULT, OLDER_ADULT",PHASE4,0,OTHER,INTERVENTIONAL,4/10/2020,10/1/2020
NCT05249855,NOT_YET_RECRUITING,D001452,BEHAVIORAL: Psychological measurement,University of Bucharest,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,400,OTHER,INTERVENTIONAL,5/20/2022,11/15/2022
NCT05119855,COMPLETED,Papillomavirus Infections|Coronavirus Disease (COVID-19),BIOLOGICAL: 9vHPV Vaccine|BIOLOGICAL: mRNA-1273 Vaccine,Merck Sharp & Dohme LLC,,ALL,CHILD,PHASE3,165,INDUSTRY,INTERVENTIONAL,3/28/2022,12/12/2023
NCT04403555,COMPLETED,COVID,DRUG: Ivermectin,Tanta University,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2|PHASE3,164,OTHER,INTERVENTIONAL,6/1/2020,12/1/2020
NCT05428592,NOT_YET_RECRUITING,SARS-CoV-2,BIOLOGICAL: LVRNA009|BIOLOGICAL: CoronaVac®,"AIM Vaccine Co., Ltd.",,ALL,"ADULT, OLDER_ADULT",PHASE3,1100,INDUSTRY,INTERVENTIONAL,2023-04,2024-10
NCT05449392,COMPLETED,COVID-19|SARS-CoV2 Infection,DRUG: Neosporin|OTHER: Vaseline,Yale University,Bill and Melinda Gates Foundation,ALL,ADULT,PHASE1,67,OTHER,INTERVENTIONAL,9/1/2022,9/22/2023
NCT06057025,NOT_YET_RECRUITING,COVID-19,"BIOLOGICAL: ""Sputnik Lite"" vaccine for the prevention of COVID-19 with altered antigenic composition","Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation",,ALL,"ADULT, OLDER_ADULT",PHASE3,50,OTHER,INTERVENTIONAL,2023-09,2024-12
NCT04858425,ACTIVE_NOT_RECRUITING,Covid19,DRUG: Niclosamide|DRUG: Placebo,"First Wave BioPharma, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE2,166,INDUSTRY,INTERVENTIONAL,4/30/2021,2023-05
NCT04439825,COMPLETED,Mood,DRUG: Botulinum Neurotoxin|DRUG: Placebo,DeNova Research,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1,45,OTHER,INTERVENTIONAL,7/20/2020,12/1/2020
NCT04558125,TERMINATED,Pulmonary Embolism|COVID,DRUG: TNKase|DRUG: Placebo|DRUG: Enoxaparin,Cedars-Sinai Medical Center,"Genentech, Inc.",ALL,"ADULT, OLDER_ADULT",PHASE4,2,OTHER,INTERVENTIONAL,9/8/2020,8/8/2021
NCT04382625,WITHDRAWN,SARS-CoV-2 Pneumonia|COVID-19,DRUG: Hydroxychloroquine,Kootenai Health,Washington State University,ALL,"ADULT, OLDER_ADULT",PHASE4,0,OTHER,INTERVENTIONAL,2020-10,6/1/2022
NCT04498325,WITHDRAWN,COVID-19|SARS-CoV-2,"DRUG: NT-I7|DRUG: Placebo|PROCEDURE: Blood for research purposes|PROCEDURE: Blood for pharmacokinetic samples|PROCEDURE: Nasopharyngeal, oropharyngeal, or saliva swab|PROCEDURE: Blood for anti-drug antibody (ADA)",Washington University School of Medicine,NeoImmune Tech,ALL,"ADULT, OLDER_ADULT",PHASE1,0,OTHER,INTERVENTIONAL,7/31/2021,4/30/2022
NCT04909892,WITHDRAWN,Covid19,BIOLOGICAL: COVI-MSC,"Sorrento Therapeutics, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE2,0,INDUSTRY,INTERVENTIONAL,2021-08,2022-01
NCT04949386,UNKNOWN,Post Acute COVID-19 Syndrome|Long COVID|COVID-19 Respiratory Infection,DRUG: S-1226 (8%)|OTHER: Placebo,SolAeroMed Inc.,,ALL,"ADULT, OLDER_ADULT",PHASE2,48,INDUSTRY,INTERVENTIONAL,2021-09,2022-01
NCT05324319,ACTIVE_NOT_RECRUITING,COVID-19,DRUG: Ad26COVS1|DRUG: ChAdOx1 SARS2 Vaccine|DRUG: BNT162B2|DRUG: mRNA-1273,Medical University of Vienna,,ALL,"ADULT, OLDER_ADULT",PHASE2,200,OTHER,INTERVENTIONAL,6/15/2021,12/31/2022
NCT05419219,ENROLLING_BY_INVITATION,Fatigue|Dyspnea|Cognitive Impairment|Muscle Pain,DEVICE: the multi-domain Tai Chi Digital therapy Software Application,Tim Shi,,ALL,"ADULT, OLDER_ADULT",NA,200,OTHER,INTERVENTIONAL,6/1/2022,12/31/2023
NCT04631666,COMPLETED,SARS-CoV-2 Infection,BIOLOGICAL: DZIF-10c|OTHER: Placebo,University of Cologne,ZKS Köln|Boehringer Ingelheim,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,57,OTHER,INTERVENTIONAL,12/8/2020,8/11/2021
NCT05197686,UNKNOWN,Corona Virus Infection|ARDS Due to Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2|Oxygen Deficiency,DEVICE: Oxygen theraphy with high flow nasal cannule|DEVICE: Oxygen theraphy with mask with reservoir,Pomeranian Medical University Szczecin,,ALL,"ADULT, OLDER_ADULT",NA,100,OTHER,INTERVENTIONAL,1/18/2022,12/31/2022
NCT05463419,ACTIVE_NOT_RECRUITING,Covid-19 Vaccine,BIOLOGICAL: PIKA COVID-19 vaccine|BIOLOGICAL: Inactivated Covid-19 vaccine,Yisheng Biopharma (Singapore) Pte. Ltd.,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,5860,INDUSTRY,INTERVENTIONAL,10/3/2022,3/11/2024
NCT04561219,COMPLETED,"Covid19|Corona Virus Infection|Pneumonia, Viral",DRUG: Nitazoxanide|DRUG: Placebo,Universidade Federal do Rio de Janeiro,"Ministry of Science and Technology, Brazil|National Research Council, Brazil|Financiadora de Estudos e Projetos|ATCGen|Hospital Central da Aeronáutica, Rio de Janeiro|Hospital da Força Aérea do Galeão|Hospital Naval Marcilio Dias|Hospital Universitario Pedro Ernesto|Hospital de Força Aérea de São Paulo|Hospital das Clínicas Luzia de Pinho Melo|Complexo Hospitalar Municipal de São Caetano do Sul|Hospital Municipal de Barueri Dr Francisco Moran|Hospital Regional de Sorocaba Dr Adib Domingos Jatene|Hospital Geral de São Mateus Dr Manoel Bifulco|Santa Casa de Misericórdia de Belo Horizonte|Mater Dei Hospital, Brazil|Hospital Eduardo de Menezes|Hospital das Clínicas da Universidade Federal de Pernambuco|Hospital das Forças Armadas, Brazil|Hospital Regional da Asa Norte, Brazil|Complexo Hospitalar do Trabalhador de Curitiba|Hospital Estadual de Doenças Tropicais Dr Anuar Auad|Hospital Geral de Fortaleza",ALL,"ADULT, OLDER_ADULT",PHASE2,500,OTHER,INTERVENTIONAL,4/19/2020,10/2/2020
NCT05911087,NOT_YET_RECRUITING,Immunogenicity|Safety,BIOLOGICAL: Phase II:SWIM816;SARS-Cov-2;|BIOLOGICAL: Phase II:SW-BIC-213;SARS-Cov-2;|BIOLOGICAL: PhaseIII:SWIM816;SARS-Cov-2;|BIOLOGICAL: PhaseIII:Pfizer(Pfizer Bivalent vaccine);SARS-Cov-2；,Stemirna Therapeutics,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,800,INDUSTRY,INTERVENTIONAL,6/20/2023,2/1/2024
NCT04328285,TERMINATED,COVID-19,DRUG: Hydroxychloroquine|DRUG: Placebo of Hydroxychloroquine|DRUG: Lopinavir and ritonavir|DRUG: Placebo of LPV/r Tablets,Centre Hospitalier Universitaire de Saint Etienne,Institut Pasteur,ALL,"ADULT, OLDER_ADULT",PHASE3,118,OTHER,INTERVENTIONAL,4/14/2020,3/30/2022
NCT04515147,COMPLETED,Coronavirus|Covid19|SARS-CoV-2|Severe Acute Respiratory Syndrome,BIOLOGICAL: CVnCoV 6 μg|BIOLOGICAL: CVnCoV 12 μg|BIOLOGICAL: Hepatitis A vaccine|BIOLOGICAL: Pneumococcal vaccine|BIOLOGICAL: CVnCoV 12μg,CureVac,German Federal Ministry of Education and Research,ALL,"ADULT, OLDER_ADULT",PHASE2,668,INDUSTRY,INTERVENTIONAL,9/21/2020,2/21/2022
NCT04412486,COMPLETED,COVID-19,BIOLOGICAL: COVID Convalescent Plasma,"Gailen D. Marshall Jr., MD PhD",University of Mississippi Medical Center,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,86,OTHER,INTERVENTIONAL,6/1/2020,3/23/2023
NCT04467086,COMPLETED,Mechanical Ventilation|Sedation|Critical Illness|COVID,DRUG: Propranolol Hydrochloride,Ottawa Hospital Research Institute,Hamilton Health Sciences Corporation|The Ottawa Hospital|McMaster University|Sinai Health System,ALL,"ADULT, OLDER_ADULT",PHASE3,72,OTHER,INTERVENTIONAL,1/8/2021,11/30/2022
NCT04762186,TERMINATED,Moderate COVID-19-infection,DRUG: human SARS-CoV 2 specific T lymphocytes,Universitätsklinikum Köln,ZKS Köln|Hannover Medical School|Miltenyi Biomedicine GmbH,ALL,"ADULT, OLDER_ADULT",PHASE1,1,OTHER,INTERVENTIONAL,12/8/2021,8/3/2022
NCT04448119,TERMINATED,COVID-19|SARS-CoV-2,DRUG: Favipiravir|DRUG: Favipiravir Placebo,Appili Therapeutics Inc.,"MOUNT SINAI HOSPITAL|Applied Health Research Centre|Sunnybrook Health Sciences Centre|University Health Network, Toronto|University of Toronto",ALL,OLDER_ADULT,PHASE2,67,INDUSTRY,INTERVENTIONAL,10/16/2020,10/30/2021
NCT04380519,COMPLETED,COVID-19,DRUG: RPH-104 80 mg|DRUG: Olokizumab 64 mg|DRUG: Placebo,"R-Pharm International, LLC","Data Management 365|K-Research, LLC",ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,372,INDUSTRY,INTERVENTIONAL,4/23/2020,7/24/2020
NCT04511819,TERMINATED,COVID-19,DRUG: Losmapimod oral tablet|DRUG: Placebo oral tablet,Fulcrum Therapeutics,,ALL,"ADULT, OLDER_ADULT",PHASE3,52,INDUSTRY,INTERVENTIONAL,8/28/2020,3/31/2021
NCT04860219,UNKNOWN,Covid19,DIETARY_SUPPLEMENT: Lactoferrin,Zagazig University,,ALL,"ADULT, OLDER_ADULT",NA,54,OTHER_GOV,INTERVENTIONAL,7/8/2020,4/30/2021
NCT05636319,ACTIVE_NOT_RECRUITING,COVID-19,BIOLOGICAL: ABO1020|BIOLOGICAL: Placebo,"Suzhou Abogen Biosciences Co., Ltd.",,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,14168,INDUSTRY,INTERVENTIONAL,11/23/2022,7/31/2024
NCT04816019,COMPLETED,Coronavirus,BIOLOGICAL: ChAdOx1 nCov-19,University of Oxford,,ALL,ADULT,PHASE1,42,OTHER,INTERVENTIONAL,4/1/2021,9/30/2022
NCT04654325,TERMINATED,SARS-CoV-2,DIAGNOSTIC_TEST: conjunctival swab,Assistance Publique - Hôpitaux de Paris,,ALL,"ADULT, OLDER_ADULT",NA,534,OTHER,INTERVENTIONAL,1/19/2021,4/29/2021
NCT05366192,COMPLETED,Safety Issues,DRUG: Nirmatrelvir and ritonavir stage 1|DRUG: Nirmatrelvir and ritonavir stage 2,RenJi Hospital,,ALL,"ADULT, OLDER_ADULT",PHASE4,18,OTHER,INTERVENTIONAL,5/6/2022,6/8/2022
NCT05993325,NOT_YET_RECRUITING,COVID-19|Vaccines,BIOLOGICAL: AdCLD-CoV19-1 OMI|BIOLOGICAL: Comirnaty Bivalent 0.1mg/mL (tozinameran and riltozinameran),"Cellid Co., Ltd.",,ALL,"ADULT, OLDER_ADULT",PHASE3,4000,INDUSTRY,INTERVENTIONAL,2023-09,2025-05
NCT05055492,COMPLETED,SARS-CoV2 Infection,DIAGNOSTIC_TEST: Take home saliva kits,The Hospital for Sick Children,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,120,OTHER,INTERVENTIONAL,9/14/2021,6/30/2022
NCT04805125,COMPLETED,Immunocompromised Patients,"BIOLOGICAL: Moderna COVID-19 Vaccine, mRNA-1273 (100 μg)|BIOLOGICAL: Pfizer-BioNTech COVID-19 Vaccine BNT162b2 (30 µg)( Comirnaty®)","University Hospital, Basel, Switzerland","Swiss National Science Foundation|ModernaTX, Inc.",ALL,"ADULT, OLDER_ADULT",PHASE3,610,OTHER,INTERVENTIONAL,4/19/2021,9/23/2023
NCT04668625,COMPLETED,COVID-19 (SARS-CoV-2),BEHAVIORAL: Participate in a massive musical event,"Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia",Dr. Bonaventura Clotet Sala|Dr. Josep Mª LLibre Codina|Dr. Boris Revollo Barriga|Dra. Lidia Ruiz Tabuenca|Dr. Ignacio Blanco Guillermo|Dra. Andrea Alemany Ortiz|Dr. Roger Paredes Deiros,ALL,ADULT,NA,1000,OTHER,INTERVENTIONAL,11/30/2020,1/8/2021
NCT04822025,COMPLETED,Covid19 Vaccine,BIOLOGICAL: MVC-COV1901 (High-Dose)|BIOLOGICAL: MVC-COV1901(Mid-Dose),Medigen Vaccine Biologics Corp.,,ALL,OLDER_ADULT,PHASE2,420,INDUSTRY,INTERVENTIONAL,5/20/2021,1/28/2022
NCT05445830,ACTIVE_NOT_RECRUITING,Post-COVID Syndrome,PROCEDURE: High-Intensity-Interval-Exercise|PROCEDURE: Moderate-Intensity-Continuous-Exercise|PROCEDURE: Strength training|PROCEDURE: Baseline assessment|PROCEDURE: 1 year follow-up,Karolinska Institutet,Karolinska University Hospital,ALL,ADULT,NA,62,OTHER,INTERVENTIONAL,9/1/2022,12/31/2024
NCT04950725,COMPLETED,Covid19,BEHAVIORAL: Strength RMT|BEHAVIORAL: Strength RMT and nasal breathing|BEHAVIORAL: Endurance RMT|BEHAVIORAL: Endurance RMT and nasal breathing|BEHAVIORAL: Low dose RMT,Mayo Clinic,,ALL,"ADULT, OLDER_ADULT",NA,2268,OTHER,INTERVENTIONAL,11/1/2021,7/1/2023
NCT04426292,UNKNOWN,Sars-CoV2,DIAGNOSTIC_TEST: Serological testing,Universitair Ziekenhuis Brussel,,ALL,"ADULT, OLDER_ADULT",NA,3500,OTHER,INTERVENTIONAL,5/12/2020,12/25/2021
NCT05760092,RECRUITING,Xerostomia|COVID-19|Long COVID|Persistent COVID-19,COMBINATION_PRODUCT: Institutional standard treatment for xerostomia and Long Covid|RADIATION: Photobiomodulation Therapy|RADIATION: Placebo Photobiomodulation Therapy,University of Nove de Julho,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,10,OTHER,INTERVENTIONAL,3/1/2023,2024-12
NCT04614025,TERMINATED,COVID|ARDS,BIOLOGICAL: PLX-PAD,Pluristem Ltd.,,ALL,"ADULT, OLDER_ADULT",PHASE2,23,INDUSTRY,INTERVENTIONAL,10/19/2020,2/7/2023
NCT04343092,COMPLETED,COVID 19,DRUG: Ivermectin (IVM),University of Baghdad,,ALL,"ADULT, OLDER_ADULT",PHASE1,16,OTHER,INTERVENTIONAL,4/18/2020,6/1/2020
NCT05492292,RECRUITING,Long Covid19,DIAGNOSTIC_TEST: Perfusion brain scintigraphy imaging,Brugmann University Hospital,,ALL,"ADULT, OLDER_ADULT",NA,100,OTHER,INTERVENTIONAL,8/10/2021,12/31/2023
NCT04878055,COMPLETED,"Pneumonia, Viral",DRUG: Reparixin|OTHER: Placebo,Dompé Farmaceutici S.p.A,,ALL,"ADULT, OLDER_ADULT",PHASE3,312,INDUSTRY,INTERVENTIONAL,2/14/2021,10/31/2021
NCT04967755,UNKNOWN,Coronavirus,DRUG: Jing-Si-Herbal-Tea,Yao-Kuang Wu,,ALL,"ADULT, OLDER_ADULT",NA,200,OTHER,INTERVENTIONAL,6/1/2021,9/30/2021
NCT05222425,NOT_YET_RECRUITING,Sars-cov-2,DRUG: Xagrotin|DRUG: Green tea,Biomad AS,,ALL,"ADULT, OLDER_ADULT",PHASE3,3000,INDUSTRY,INTERVENTIONAL,6/1/2022,12/7/2022
NCT04391712,COMPLETED,COVID-19,DEVICE: MLS Laser|OTHER: Regular Inpatient Medical Care,Lowell General Hospital,,ALL,"ADULT, OLDER_ADULT",PHASE2,10,OTHER,INTERVENTIONAL,4/30/2020,7/16/2020
NCT04397692,TERMINATED,"Corona Virus Infection|COVID-19|SARS-CoV 2|Nitric Oxide|Respiratory Disease|Pneumonia, Viral|Inhaled Nitric Oxide",DEVICE: Nitric Oxide delivered via LungFit™ system,Beyond Air Inc.,,ALL,"ADULT, OLDER_ADULT",NA,4,INDUSTRY,INTERVENTIONAL,6/13/2020,9/30/2020
NCT04313322,UNKNOWN,Use of Stem Cells for COVID-19 Treatment,BIOLOGICAL: WJ-MSCs,Stem Cells Arabia,,ALL,"ADULT, OLDER_ADULT",PHASE1,5,OTHER,INTERVENTIONAL,3/16/2020,9/30/2020
NCT04542447,UNKNOWN,Covid19,DRUG: Nuvastatic,Natureceuticals Sdn Bhd,,ALL,"ADULT, OLDER_ADULT",PHASE1,10,INDUSTRY,INTERVENTIONAL,9/1/2020,9/30/2020
NCT04435587,UNKNOWN,Asymptomatic Infections|SARS-CoV2 Infection,DRUG: Ivermectin Pill|DRUG: Combined ART/hydroxychloroquine,Mahidol University,,ALL,"ADULT, OLDER_ADULT",PHASE4,80,OTHER,INTERVENTIONAL,7/13/2020,2021-11
NCT04533347,COMPLETED,COVID 19 Disease,DRUG: Tafenoquine Oral Tablet|DRUG: Placebo,60 Degrees Pharmaceuticals LLC,,ALL,"ADULT, OLDER_ADULT",PHASE2,86,INDUSTRY,INTERVENTIONAL,2/19/2021,6/30/2022
NCT04880122,COMPLETED,SARS-CoV-2 Acute Respiratory Disease,DIAGNOSTIC_TEST: Dried blood spot and venous blood collection,University Ghent,,ALL,"ADULT, OLDER_ADULT",NA,440,OTHER,INTERVENTIONAL,8/1/2020,9/30/2020
NCT04634422,UNKNOWN,"Respiratory Failure|Renal Failure, Acute",PROCEDURE: Plasma exchange and convalescent plasma,Wladimir Szpirt,Aalborg University Hospital|Aarhus University Hospital|Odense University Hospital|Zealand University Hospital,ALL,"ADULT, OLDER_ADULT",NA,220,OTHER,INTERVENTIONAL,11/16/2020,6/30/2022
NCT04467047,UNKNOWN,COVID-19|Sars-CoV2,BIOLOGICAL: Mesenchymal Stromal Cells infusion,Hospital de Clinicas de Porto Alegre,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1,10,OTHER,INTERVENTIONAL,7/25/2020,12/30/2020
NCT04351347,RECRUITING,COVID,DRUG: Ivermectin,Tanta University,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2|PHASE3,300,OTHER,INTERVENTIONAL,6/16/2020,12/1/2030
NCT05364047,ACTIVE_NOT_RECRUITING,COVID-19,BIOLOGICAL: Low-dose of LVRNA009|BIOLOGICAL: Middle-dose of LVRNA009|BIOLOGICAL: High-dose of LVRNA009|OTHER: Placebo,"AIM Vaccine Co., Ltd.",Shulan (Hangzhou) Hospital|Yuncheng Central Hospital,ALL,"ADULT, OLDER_ADULT",PHASE1,144,INDUSTRY,INTERVENTIONAL,7/31/2021,2023-10
NCT04382547,COMPLETED,"COVID|Covid-19|Coronavirus|Pneumonia|Pneumonia, Viral|Pneumonia, Interstitial|Sars-CoV2",BIOLOGICAL: Allogenic pooled olfactory mucosa-derived mesenchymal stem cells|OTHER: Standard treatment according to the Clinical protocols,Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus,Belarusian State Medical University,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,32,OTHER_GOV,INTERVENTIONAL,5/11/2020,6/30/2021
NCT04542122,UNKNOWN,Morals,BEHAVIORAL: Choices and judgements,"University Hospital, Caen","University of Geneva, Switzerland",ALL,"ADULT, OLDER_ADULT",NA,500,OTHER,INTERVENTIONAL,9/3/2020,8/2/2021
NCT04522986,COMPLETED,Severe Acute Respiratory Syndrome Coronavirus 2,BIOLOGICAL: Mesenchymal stem cell,"Rohto Pharmaceutical Co., Ltd.",,ALL,"ADULT, OLDER_ADULT",PHASE1,6,INDUSTRY,INTERVENTIONAL,8/21/2020,2/2/2021
NCT05859919,COMPLETED,Patients With COVID-19,"DRUG: The drug ""Rutan 0.1"".|OTHER: Basic treatment","Research Institute of Virology, Ministry of Health of the Republic of Uzbekistan",,ALL,"ADULT, OLDER_ADULT",PHASE2,57,OTHER_GOV,INTERVENTIONAL,10/12/2020,9/30/2021
NCT04913766,RECRUITING,Depression|Anxiety|Psychological Distress|PTSD,BEHAVIORAL: Problem Management Plus|BEHAVIORAL: Services as Usual,George Washington University,The New School|Duke University|Human Sciences Research Council,ALL,"ADULT, OLDER_ADULT",NA,1500,OTHER,INTERVENTIONAL,11/7/2022,6/30/2026
NCT04613986,UNKNOWN,Severe Covid-19,DEVICE: therapeutic plasmaexchnage,University of Zurich,,ALL,"ADULT, OLDER_ADULT",NA,20,OTHER,INTERVENTIONAL,2021-06,2022-07
NCT05477186,COMPLETED,SARS-CoV-2,BIOLOGICAL: CV0501 (3 μg)|BIOLOGICAL: CV0501 (6 μg)|BIOLOGICAL: CV0501 (12 μg)|BIOLOGICAL: CV0501 (25 μg)|BIOLOGICAL: CV0501 (50 μg)|BIOLOGICAL: CV0501 (75 μg)|BIOLOGICAL: CV0501 (100 μg)|BIOLOGICAL: CV0501 (150 μg)|BIOLOGICAL: CV0501 (200 μg),GlaxoSmithKline,,ALL,"ADULT, OLDER_ADULT",PHASE1,180,INDUSTRY,INTERVENTIONAL,8/12/2022,8/18/2023
NCT04916886,COMPLETED,COVID-19,BIOLOGICAL: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.5ml|BIOLOGICAL: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.3ml,CanSino Biologics Inc.,Jiangsu Province Centers for Disease Control and Prevention,ALL,"CHILD, ADULT",NA,2021,INDUSTRY,INTERVENTIONAL,6/3/2021,7/31/2022
NCT05042466,NOT_YET_RECRUITING,"Trauma, Nervous System",DRUG: Trauma,NWTraumatherapies,World Health Organization,ALL,"ADULT, OLDER_ADULT",PHASE1,30,NETWORK,INTERVENTIONAL,9/3/2023,10/3/2025
NCT04471519,COMPLETED,COVID-19|SARS-CoV-2 Infection,BIOLOGICAL: BBV152A - Phase I|BIOLOGICAL: BBV152B - Phase I|BIOLOGICAL: BBV152C - Phase I|BIOLOGICAL: Placebo - Phase I|BIOLOGICAL: BBV152A - Phase II|BIOLOGICAL: BBV152B - Phase II,Bharat Biotech International Limited,Indian Council of Medical Research,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1|PHASE2,755,INDUSTRY,INTERVENTIONAL,7/15/2020,6/30/2021
NCT05142319,UNKNOWN,COVID-19,BIOLOGICAL: Homologous mRNA booster vaccine|BIOLOGICAL: Heterologous mRNA booster vaccine|BIOLOGICAL: Non-mRNA booster vaccine A|BIOLOGICAL: Non-mRNA booster vaccine B|BIOLOGICAL: Non-mRNA booster vaccine C,Tan Tock Seng Hospital,A*Star|Duke-NUS Graduate Medical School|KK Women's and Children's Hospital,ALL,"ADULT, OLDER_ADULT",PHASE3,600,OTHER,INTERVENTIONAL,10/12/2021,2023-04
NCT05065619,TERMINATED,SARS-CoV-2 Infection,BIOLOGICAL: MT-2766 High dose (3.75 µg)|DRUG: Placebo|BIOLOGICAL: MT-2766 Low dose,Medicago,Mitsubishi Tanabe Pharma Corporation,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,128,INDUSTRY,INTERVENTIONAL,10/2/2021,1/29/2023
NCT04817319,COMPLETED,Contamination by COVID 19 During Oral Care,PROCEDURE: Oral care with/without aerosolization,Assistance Publique - Hôpitaux de Paris,"Institut National de la Santé Et de la Recherche Médicale, France",ALL,"ADULT, OLDER_ADULT",NA,18,OTHER,INTERVENTIONAL,3/22/2021,1/26/2022
NCT04400019,UNKNOWN,Sars-CoV2|Coronavirus Infection|Prevention & Control|Nursing Home|Hydroxychloroquine,DRUG: Hydroxychloroquine Only Product in Oral Dose Form,University of Malaga,Instituto de Investigacion Biomedica de Malaga|Carlos III Health Institute,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,1930,OTHER,INTERVENTIONAL,2020-09,4/1/2021
NCT04608266,TERMINATED,Covid19,DRUG: Camostat Mesylate|DRUG: Placebo,Assistance Publique - Hôpitaux de Paris,,ALL,"ADULT, OLDER_ADULT",PHASE3,70,OTHER,INTERVENTIONAL,12/3/2020,12/2/2021
NCT05954286,RECRUITING,SARS-CoV-2,DRUG: Upamostat|DRUG: Placebo (PO),Henry M. Jackson Foundation for the Advancement of Military Medicine,"Joint Program Executive Office Chemical, Biological, Radiological, and Nuclear Defense Enabling Biotechnologies|FHI Clinical, Inc.|RedHill Biopharma Limited",ALL,"ADULT, OLDER_ADULT",PHASE2,300,OTHER,INTERVENTIONAL,1/29/2024,2024-10
NCT04734886,COMPLETED,Covid19,DIETARY_SUPPLEMENT: L. reuteri DSM 17938 + vitamin D|DIETARY_SUPPLEMENT: Placebo + vitamin D,"Örebro University, Sweden",BioGaia AB,ALL,ADULT,NA,161,OTHER,INTERVENTIONAL,11/27/2020,9/13/2021
NCT04952519,TERMINATED,Patients With Moderate or Severe COVID-19,DRUG: Amantadine,Noblewell,"Medical Research Agency, Poland|Leszek Giec Upper-Silesian Medical Centre of the Silesian Medical University in Katowice, Poland",ALL,"ADULT, OLDER_ADULT",PHASE3,193,INDUSTRY,INTERVENTIONAL,3/30/2021,3/10/2022
NCT04240886,TERMINATED,Invasive Fungal Infections,DRUG: fosmanogepix,Pfizer,,ALL,"ADULT, OLDER_ADULT",PHASE2,21,INDUSTRY,INTERVENTIONAL,1/4/2020,5/9/2022
NCT05544786,COMPLETED,Biological Availability,DRUG: Nirmatrelvir/ ritonavir|DRUG: Nirmatrelvir/Ritonavir|DRUG: Nirmatrelvir/Ritonavir|DRUG: Nirmatrelvir/ritonavir|DRUG: Nirmatrelvir/ritonavir,Pfizer,,ALL,"ADULT, OLDER_ADULT",PHASE1,12,INDUSTRY,INTERVENTIONAL,9/28/2022,11/29/2022
NCT04287686,WITHDRAWN,COVID-19,DRUG: Recombinant human angiotensin-converting enzyme 2 (rhACE2),The First Affiliated Hospital of Guangzhou Medical University,,ALL,"ADULT, OLDER_ADULT",NA,0,OTHER,INTERVENTIONAL,2020-02,2020-04
NCT04416919,UNKNOWN,Coronavirus Infection|Disease Prevention,OTHER: Assembled mask,University of Oklahoma,US Department of Veterans Affairs,ALL,"ADULT, OLDER_ADULT",NA,20,OTHER,INTERVENTIONAL,5/20/2020,7/1/2021
NCT04393051,UNKNOWN,Covid-19|SARS-CoV 2|SARS Pneumonia,DRUG: Baricitinib Oral Tablet,"Azienda Ospedaliero, Universitaria Pisana",,ALL,"ADULT, OLDER_ADULT",PHASE2,126,OTHER,INTERVENTIONAL,5/20/2020,7/30/2020
NCT05705648,RECRUITING,Long COVID,DIETARY_SUPPLEMENT: medium chain triglyceride oil|DIETARY_SUPPLEMENT: Safflower oil,University of Alberta,,ALL,ADULT,NA,100,OTHER,INTERVENTIONAL,10/1/2023,3/1/2026
NCT04978051,COMPLETED,COVID-19 Pneumonia,DRUG: Firazyr|OTHER: SoC,Sebastian Videla,,ALL,"ADULT, OLDER_ADULT",PHASE2,73,OTHER,INTERVENTIONAL,4/12/2021,3/17/2022
NCT04333251,UNKNOWN,"Pneumonia, Interstitial",BIOLOGICAL: high-titer anti-Sars-CoV-2 plasma|OTHER: oxygen therapy,Baylor Research Institute,,ALL,"ADULT, OLDER_ADULT",PHASE1,115,OTHER,INTERVENTIONAL,4/1/2020,12/31/2022
NCT04361448,TERMINATED,Covid-19|SARS-CoV-2|Diagnosis|Polymerase Chain Reaction,OTHER: samling of oropharynx and nasopharynx,Jessa Hospital,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,30,OTHER,INTERVENTIONAL,4/20/2020,6/30/2020
NCT04336748,WITHDRAWN,Sars-CoV2|Infection Viral|Healthcare Worker|Prophylaxis,DRUG: Hydroxychloroquine|DRUG: Placebo,Medical University of Vienna,,ALL,"ADULT, OLDER_ADULT",PHASE3,0,OTHER,INTERVENTIONAL,2020-04,2020-08
NCT05534048,NOT_YET_RECRUITING,SARS-CoV-2 Infection,BIOLOGICAL: PTX-COVID19-B|BIOLOGICAL: Comirnaty®,Everest Medicines (Singapore) Pte. Ltd.,,ALL,"ADULT, OLDER_ADULT",PHASE3,3800,OTHER,INTERVENTIONAL,2/3/2023,12/20/2023
NCT04345848,TERMINATED,COVID|Sars-CoV2,DRUG: Enoxaparin,"University Hospital, Geneva",,ALL,"ADULT, OLDER_ADULT",PHASE3,160,OTHER,INTERVENTIONAL,4/28/2020,6/2/2021
NCT05196451,ACTIVE_NOT_RECRUITING,COVID-19,BEHAVIORAL: Rehabilitation based on CBT principles,"University Hospital, Akershus",,ALL,"CHILD, ADULT, OLDER_ADULT",NA,310,OTHER,INTERVENTIONAL,2/21/2022,3/31/2024
NCT04434248,UNKNOWN,COVID-19,DRUG: Favipiravir|DRUG: Standard of Care,Chromis LLC,Chemical Diversity Research Institute,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,330,INDUSTRY,INTERVENTIONAL,4/23/2020,2020-07
NCT04382651,COMPLETED,"COVID-19 Pneumonia, Impaired Respiratory Function",DRUG: MAS825|OTHER: Placebo|DRUG: Standard of Care (SoC),Novartis Pharmaceuticals,,ALL,"ADULT, OLDER_ADULT",PHASE2,140,INDUSTRY,INTERVENTIONAL,6/11/2020,4/21/2021
NCT04950751,WITHDRAWN,COVID-19,"BIOLOGICAL: candidate vaccine, SCB-2020S",Clover Biopharmaceuticals AUS Pty Ltd,,ALL,"ADULT, OLDER_ADULT",PHASE2,0,INDUSTRY,INTERVENTIONAL,2021-08,2022-04
NCT04896866,COMPLETED,Covid19|COVID-19 Pneumonia|COVID-19 Lower Respiratory Infection|COVID-19 Acute Respiratory Distress Syndrome|SARS-CoV2 Infection|SARS-CoV-2 Acute Respiratory Disease,BEHAVIORAL: Antimicrobial stewardship prospective audit and feedback,University of Alberta,,ALL,"ADULT, OLDER_ADULT",NA,833,OTHER,INTERVENTIONAL,3/1/2021,11/30/2021
NCT06074848,RECRUITING,Long COVID,DEVICE: Transcranial Direct Current Stimulation (tDCS)|BEHAVIORAL: Motor Training|BEHAVIORAL: Cognitive Training,Universidade Federal de Pernambuco,São Paulo State University,ALL,"ADULT, OLDER_ADULT",PHASE2,48,OTHER,INTERVENTIONAL,8/25/2023,6/28/2024
NCT05476848,COMPLETED,"Decay, Dental|Missing Teeth|COVID-19|Cytokine Storm",DIAGNOSTIC_TEST: ELISA test for Cytokines,Ege University,Dokuz Eylul University|Izmir Katip Celebi University|Gazi University|Istanbul Saglik Bilimleri University,ALL,"ADULT, OLDER_ADULT",NA,320,OTHER,INTERVENTIONAL,3/1/2022,8/10/2023
NCT04355351,UNKNOWN,"New Coronavirus Disease (COVID-19), Infection With SARS-CoV-2",OTHER: blood sampling|OTHER: additional blood tubes,Centre Hospitalier Universitaire de Nice,,ALL,"ADULT, OLDER_ADULT",NA,400,OTHER,INTERVENTIONAL,5/5/2020,10/22/2021
NCT05212948,COMPLETED,SARS-CoV-2,DRUG: S-268019-b|DRUG: Placebo,Shionogi,,ALL,"ADULT, OLDER_ADULT",PHASE3,9902,INDUSTRY,INTERVENTIONAL,12/25/2021,7/19/2023
NCT04334148,COMPLETED,COVID-19,DRUG: Hydroxychloroquine|DRUG: Placebo oral tablet,Adrian Hernandez,Patient-Centered Outcomes Research Institute,ALL,"ADULT, OLDER_ADULT",PHASE3,1360,OTHER,INTERVENTIONAL,4/22/2020,1/9/2021
NCT04393948,WITHDRAWN,SARS-CoV 2,RADIATION: Phase 1|RADIATION: Phase 1|RADIATION: Phase 2|RADIATION: Phase 2|RADIATION: Phase 2,Brigham and Women's Hospital,,ALL,"ADULT, OLDER_ADULT",NA,0,OTHER,INTERVENTIONAL,6/19/2020,2021-09
NCT04427566,RECRUITING,COVID-19,RADIATION: Radiation therapy,Ohio State University Comprehensive Cancer Center,,ALL,"ADULT, OLDER_ADULT",PHASE2,24,OTHER,INTERVENTIONAL,7/23/2020,12/31/2021
NCT05167266,ACTIVE_NOT_RECRUITING,COVID-19|Cognitive Dysfunction,BEHAVIORAL: Psychoeducation,University of Liege,"University Hospital, Antwerp",ALL,"ADULT, OLDER_ADULT",NA,130,OTHER,INTERVENTIONAL,3/15/2022,5/31/2024
NCT04352933,UNKNOWN,COVID-19,DRUG: Hydroxychloroquine - Daily dosing|DRUG: Hydroxychloroquine - Weekly Dosing|OTHER: Matched Placebo Hydroxychloroquine,Cambridge University Hospitals NHS Foundation Trust,,ALL,"ADULT, OLDER_ADULT",PHASE3,1000,OTHER,INTERVENTIONAL,5/11/2020,2021-04
NCT04447833,ACTIVE_NOT_RECRUITING,"ARDS, Human|COVID",DRUG: Mesenchymal Stromal Stem Cells - KI-MSC-PL-205,Uppsala University,Uppsala University Hospital,ALL,"ADULT, OLDER_ADULT",PHASE1,7,OTHER,INTERVENTIONAL,6/17/2020,6/30/2025
NCT04323514,UNKNOWN,Hospitalized Patients With Covid-19 Pneumonia,DIETARY_SUPPLEMENT: Vitamin C,University of Palermo,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,500,OTHER,INTERVENTIONAL,3/13/2020,3/13/2021
NCT04591600,COMPLETED,Covid19,DRUG: Ivermectin and Doxycyline|DRUG: Standard of care,Alkarkh Health Directorate-Baghdad,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1|PHASE2,140,OTHER_GOV,INTERVENTIONAL,7/1/2020,10/14/2020
NCT04325633,TERMINATED,COVID-19,DRUG: 1: Naproxen|DRUG: 2: Standard of care,Assistance Publique - Hôpitaux de Paris,,ALL,"ADULT, OLDER_ADULT",PHASE3,30,OTHER,INTERVENTIONAL,4/24/2020,12/15/2020
NCT04495933,UNKNOWN,SARS-CoV2|Covid19,BIOLOGICAL: MF59 adjuvanted SARS-CoV-2 Sclamp vaccine 5mcg|BIOLOGICAL: MF59 adjuvanted SARS-CoV-2 Sclamp vaccine 15mcg|BIOLOGICAL: MF59 adjuvanted SARS-CoV-2 Sclamp vaccine 45mcg|OTHER: Placebo,The University of Queensland,Syneos Health|Coalition for Epidemic Preparedness Innovations,ALL,"ADULT, OLDER_ADULT",PHASE1,216,OTHER,INTERVENTIONAL,7/13/2020,2/2/2022
NCT04490200,COMPLETED,"Covid19|SARS-CoV Infection|Worker-Patient Transmission, Healthcare",DEVICE: VESTA respirator|DEVICE: Conventional N95 respirator,University of Brasilia,"University of Campinas, Brazil|Centro de Pesquisa em Biotecnologia Ltda|Hospital Regional da Asa Norte (HRAN)",ALL,ADULT,NA,300,OTHER,INTERVENTIONAL,3/1/2021,6/28/2023
NCT06255600,RECRUITING,Cardiovascular Diseases|Long Covid19,OTHER: High Definition-transcranial Direct Current Stimulation|DIETARY_SUPPLEMENT: Chlorella Pyrenoidosa,Federal University of Paraíba,City University of New York,ALL,"ADULT, OLDER_ADULT",NA,60,OTHER,INTERVENTIONAL,8/10/2021,6/28/2024
NCT04887233,UNKNOWN,Infection Viral,OTHER: Longan nasal spray|OTHER: Placebo,Chulalongkorn University,,ALL,ADULT,NA,60,OTHER,INTERVENTIONAL,7/1/2021,6/30/2022
NCT05104437,UNKNOWN,COVID-19 Pneumonia,BIOLOGICAL: Covid-19 vaccine (0-1-4 schedule)|BIOLOGICAL: Covid-19 vaccine (0-1-6 schedule),China National Biotec Group Company Limited,"Guizhou Center for Disease Control and Prevention|Hunan Provincial Center for Disease Control and Prevention|Center for Disease Control and Prevention, Fujian|Wuhan Institute of Biological Products Co., Ltd",ALL,"ADULT, OLDER_ADULT",PHASE4,1440,INDUSTRY,INTERVENTIONAL,2021-11,2022-12
NCT04983537,UNKNOWN,COVID-19 Vaccines,DRUG: Gam-COVID-Vac / Gam-COVID-Vac,Ministerio de Salud de Ciudad Autónoma de Buenos Aires,,ALL,OLDER_ADULT,PHASE2,120,OTHER_GOV,INTERVENTIONAL,7/26/2021,9/26/2021
NCT05771714,TERMINATED,COVID-19,DEVICE: CareSuperb COVID-19 Antigen Home Test Kit,"AccessBio, Inc.",,ALL,"CHILD, ADULT, OLDER_ADULT",NA,786,OTHER,INTERVENTIONAL,1/9/2023,5/11/2023
NCT05683600,TERMINATED,COVID-19,BIOLOGICAL: Recombinant SARS-CoV-2 Vaccine (CHO Cell) LYB001|BIOLOGICAL: Placebo,"Guangzhou Patronus Biotech Co., Ltd.","Yantai Patronus Biotech Co., Ltd.",ALL,"ADULT, OLDER_ADULT",PHASE3,3000,INDUSTRY,INTERVENTIONAL,12/29/2022,7/12/2023
NCT05409300,RECRUITING,COVID-19|Vaccine Adverse Reaction|Sars-CoV-2 Infection|Healthy Volunteer,BIOLOGICAL: BBIBP-CorV,"ANRS, Emerging Infectious Diseases","CEPI|Alliance for International Medical Action|Centre National de Formation et de Recherche en Sante Rurale|Institut National de la Santé Et de la Recherche Médicale, France|APHP|Agence Nationale de Sécurité Sanitaire de la Guinée (ANSS Guinée)|Innovative clinical research network in vaccinology (IREIVAC)",ALL,"ADULT, OLDER_ADULT",PHASE2,200,OTHER_GOV,INTERVENTIONAL,4/25/2022,2024-07
NCT04425837,UNKNOWN,Sars-CoV2|Covid-19,BIOLOGICAL: SARS-CoV-2 convalescent plasma treatment|OTHER: Standard care,Fundación Santa Fe de Bogota,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,236,OTHER,INTERVENTIONAL,2020-07,2021-02
NCT04353037,TERMINATED,Coronavirus|Corona Virus Infection,DRUG: Group 1 HCQ|DRUG: Group 2 Placebo,UnitedHealth Group,ProHealth Care Associates|University of Pennsylvania,ALL,"ADULT, OLDER_ADULT",PHASE2,39,INDUSTRY,INTERVENTIONAL,4/7/2020,7/11/2020
NCT04527133,UNKNOWN,COVID-19,DRUG: Aprotinin,Aviron LLC,,ALL,"ADULT, OLDER_ADULT",NA,30,INDUSTRY,INTERVENTIONAL,6/11/2020,8/31/2020
NCT04445337,COMPLETED,COVID 19|ARDS,PROCEDURE: Stellate Ganglion Block,University of Nebraska,,ALL,"ADULT, OLDER_ADULT",NA,1,OTHER,INTERVENTIONAL,11/15/2020,11/1/2021
NCT05260437,COMPLETED,SARS-CoV-2,BIOLOGICAL: CV2CoV (2 µg)|BIOLOGICAL: CV2CoV (4 µg)|BIOLOGICAL: CV2CoV (8 µg)|BIOLOGICAL: CV2CoV (12 µg)|BIOLOGICAL: CV2CoV (16 µg)|BIOLOGICAL: CV2CoV (20 µg),GlaxoSmithKline,CureVac,ALL,"ADULT, OLDER_ADULT",PHASE1,98,INDUSTRY,INTERVENTIONAL,3/24/2022,3/7/2023
NCT05271500,NOT_YET_RECRUITING,Post Covid Syndrome,DEVICE: laser acupuncture,Cairo University,,ALL,ADULT,NA,80,OTHER,INTERVENTIONAL,3/15/2022,7/30/2022
NCT04411433,UNKNOWN,Sars-CoV2|COVID-19,DRUG: Favipiravir (3200 mg + 1200 mg)|DRUG: Favipiravir (3600 mg + 1600 mg)|DRUG: Favipiravir (3200 mg + 1200 mg) combined with Hydroxychloroquine|DRUG: Favipiravir (3200 mg + 1200 mg) combined with Azithromycin|DRUG: Hydroxychloroquine|DRUG: Hydroxychloroquine combined with Azithromycin,"Ministry of Health, Turkey","Hacettepe University, Faculty of Medicine|Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization|Umraniye Education and Research Hospital|SB Istanbul Education and Research Hospital|Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey|Tepecik Training and Research Hospital|Istanbul University - Cerrahpasa (IUC)|Ankara University|Ankara City Hospital Bilkent|Ankara Training and Research Hospital|Ege University Hospital (Application and Research Center)|Kocaeli Derince Education and Research Hospital|Istanbul University|Kayseri City Hospital",ALL,"ADULT, OLDER_ADULT",PHASE3,1008,OTHER_GOV,INTERVENTIONAL,5/8/2020,6/1/2021
NCT05040737,UNKNOWN,SARS-CoV-2 Infection,"DEVICE: PS membrane versus PMMA membrane,",Fundación para la Investigación del Hospital Clínico de Valencia,,ALL,"ADULT, OLDER_ADULT",NA,12,OTHER,INTERVENTIONAL,4/17/2020,12/31/2021
NCT05228314,COMPLETED,COVID-19,"BIOLOGICAL: Candidate vaccine, SCB-2020S|BIOLOGICAL: Candidate vaccine, SCB-2019|OTHER: Squalene based adjuvant|OTHER: CpG/alum adjuvant",Clover Biopharmaceuticals AUS Pty Ltd,,ALL,"ADULT, OLDER_ADULT",PHASE1,153,INDUSTRY,INTERVENTIONAL,5/30/2022,4/23/2023
NCT05812014,RECRUITING,SARS-CoV-2,BIOLOGICAL: SARS-CoV-2 Bivalent mRNA vaccine (LVRNA021)|DRUG: 0.9% sodium chloride solution,"AIM Vaccine Co., Ltd.","LiveRNA Therapeutics Inc.|Ningbo Rongan Biological Pharmaceutical Co., Ltd.",ALL,"ADULT, OLDER_ADULT",PHASE3,9800,INDUSTRY,INTERVENTIONAL,3/25/2023,2024-06
NCT04356833,UNKNOWN,COVID,DRUG: nebulised recombinant tissue-Plasminogen Activator (rt-PA) - Cohort 1|DRUG: nebulised recombinant tissue-Plasminogen Activator (rt-PA) - Cohort 2 IMV|DRUG: nebulised recombinant tissue-Plasminogen Activator (rt-PA) - Cohort 2 NIV,"University College, London",,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,66,OTHER,INTERVENTIONAL,4/22/2020,4/30/2021
NCT05172037,UNKNOWN,Covid19,BIOLOGICAL: Novaferon|BIOLOGICAL: Placebo,Genova Inc.,Tokyo Shinagawa Hospital,ALL,"ADULT, OLDER_ADULT",PHASE3,222,INDUSTRY,INTERVENTIONAL,10/28/2021,2022-06
NCT05047900,COMPLETED,Covid19|SARS-CoV-2|Community Transmissions|Coronavirus Infections,DIAGNOSTIC_TEST: Rapid antigen testing kit,Mahidol University,"Yuvabadhana foundation|Zero COVID Thailand|Chulalongkorn University|Ministry of Health, Thailand",ALL,"CHILD, ADULT, OLDER_ADULT",NA,70000,OTHER,INTERVENTIONAL,11/1/2021,1/13/2023
NCT04554433,UNKNOWN,Covid-19|Drug Effect,DRUG: Ethanol with Asprin,Mansoura University,,ALL,ADULT,PHASE3,80,OTHER,INTERVENTIONAL,12/1/2020,6/1/2022
NCT06026514,RECRUITING,SARS-CoV-2 Infection,BIOLOGICAL: B/HPIV3/S-6P,National Institute of Allergy and Infectious Diseases (NIAID),Johns Hopkins Bloomberg School of Public Health|National Institutes of Health (NIH),ALL,ADULT,PHASE1,30,NIH,INTERVENTIONAL,9/18/2023,2025-06
NCT04954014,TERMINATED,"ARDS, Human|Coronavirus Infection",DRUG: Bevacizumab|DRUG: BAT,Maimónides Biomedical Research Institute of Córdoba,,ALL,"ADULT, OLDER_ADULT",PHASE2,21,OTHER,INTERVENTIONAL,9/1/2020,8/31/2021
NCT04642014,TERMINATED,COVID-19 Convalescent Plasma Treatment,BIOLOGICAL: COVID-19 convalescent plasma treatment,Wroclaw Medical University,"Medical Research Agency, Poland",ALL,"ADULT, OLDER_ADULT",NA,396,OTHER,INTERVENTIONAL,12/22/2020,1/4/2022
NCT04871633,COMPLETED,COVID-19,DRUG: Remdesivir|DRUG: Conventional,King Edward Medical University,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,66,OTHER,INTERVENTIONAL,8/1/2020,12/30/2020
NCT05874037,RECRUITING,Long COVID,DRUG: Fluvoxamine,Washington University School of Medicine,Balvi COVID Fund,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,300,OTHER,INTERVENTIONAL,5/15/2023,5/15/2025
NCT04333914,COMPLETED,SARS-CoV-2 (COVID-19) Infection|Advanced or Metastatic Hematological or Solid Tumor,DRUG: Autophagy inhibitor (GNS651)|OTHER: Standard of care|DRUG: Avdoralimab|DRUG: Monalizumab,Centre Leon Berard,,ALL,"ADULT, OLDER_ADULT",PHASE2,19,OTHER,INTERVENTIONAL,4/15/2020,12/31/2021
NCT04886414,RECRUITING,Covid19,OTHER: Phone-based monitoring|OTHER: Oxygen saturation monitoring|OTHER: Alcohol-based hand sanitizer,Brigham and Women's Hospital,"Centers for Disease Control and Prevention|Ministry of Health, Honduras",ALL,"ADULT, OLDER_ADULT",NA,1892,OTHER,INTERVENTIONAL,3/28/2022,2/28/2023
NCT04502433,TERMINATED,Acute Respiratory Distress Syndrome,DRUG: CUROSURF® (poractant alfa),Chiesi Farmaceutici S.p.A.,,ALL,"ADULT, OLDER_ADULT",PHASE2,22,INDUSTRY,INTERVENTIONAL,1/6/2021,3/17/2022
NCT05104333,UNKNOWN,COVID-19 Pneumonia,BIOLOGICAL: Covid-19 vaccine (0-1-4 schedule)|BIOLOGICAL: Covid-19 vaccine (0-1-6 schedule),China National Biotec Group Company Limited,"Guizhou Center for Disease Control and Prevention|Hunan Provincial Center for Disease Control and Prevention|Center for Disease Control and Prevention, Fujian|Beijing Institute of Biological Products Co Ltd.",ALL,"ADULT, OLDER_ADULT",PHASE4,1440,INDUSTRY,INTERVENTIONAL,2021-11,2022-12
NCT04268537,UNKNOWN,"2019 nCoV, PD-1",DRUG: PD-1 blocking antibody+standard treatment|DRUG: Thymosin+standard treatment|OTHER: standard treatment,"Southeast University, China",,ALL,"ADULT, OLDER_ADULT",PHASE2,120,OTHER,INTERVENTIONAL,2/10/2020,10/31/2020
NCT04492514,UNKNOWN,COVID 19|SARS-CoV 2|Pneumonia,DRUG: Mavrilimumab|DRUG: Placebo,Kristin Hudock,"Kiniksa Pharmaceuticals, Ltd.",ALL,"ADULT, OLDER_ADULT",PHASE2,60,OTHER,INTERVENTIONAL,5/20/2020,5/31/2021
NCT04438837,UNKNOWN,Coronavirus Disease 2019 (COVID-19)|Post-Exposure Prophylaxis,DRUG: Hydroxychloroquine,Rambam Health Care Campus,,ALL,"ADULT, OLDER_ADULT",NA,582,OTHER,INTERVENTIONAL,2020-07,2022-06
NCT04519437,COMPLETED,Healthy|Chronic Stable Illness,DRUG: REGN10933+REGN10987|DRUG: Placebo,Regeneron Pharmaceuticals,,ALL,"ADULT, OLDER_ADULT",PHASE1,974,INDUSTRY,INTERVENTIONAL,7/26/2020,11/22/2021
NCT05840237,RECRUITING,"Post-COVID-19 Syndrome|Fatigue Syndrome, Chronic","OTHER: Anhydrous Enol-Oxaloacetate, a ""Medical Food""|OTHER: White Rice Flour",Terra Biological LLC,Bateman Horne Center,ALL,"ADULT, OLDER_ADULT",NA,70,INDUSTRY,INTERVENTIONAL,6/1/2023,4/30/2024
NCT04379037,COMPLETED,Severe Acute Respiratory Syndrome Coronavirus 2,DEVICE: Transcutaneous Auricular Vagus Nerve Stimulation,Nemechek Technologies,,ALL,"ADULT, OLDER_ADULT",NA,50,INDUSTRY,INTERVENTIONAL,6/27/2020,11/1/2020
NCT05901337,COMPLETED,Covid-19 Patients,COMBINATION_PRODUCT: Cupping therapy with convential medical treatment|DRUG: Convential medical treatment,Cairo University,,ALL,"ADULT, OLDER_ADULT",NA,76,OTHER,INTERVENTIONAL,3/7/2022,6/1/2023
NCT04918914,UNKNOWN,SARS-CoV-2|Hypoxia|ARDS,DRUG: Dapsone 100 MG,Hunt Regional Medical Center,,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,100,OTHER,INTERVENTIONAL,10/18/2020,12/31/2021
NCT04358614,COMPLETED,COVID|Pneumonia,DRUG: Baricitinib 4 MG Oral Tablet,Fabrizio Cantini,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,12,OTHER,INTERVENTIONAL,3/16/2020,4/7/2020
NCT04703114,COMPLETED,Covid19|SARS-CoV-2,DIAGNOSTIC_TEST: Blood count|DIAGNOSTIC_TEST: Blood collection|DIAGNOSTIC_TEST: Nasopharyngeal swab|DIAGNOSTIC_TEST: Saliva samples|DIAGNOSTIC_TEST: Faeces samples|GENETIC: Genetic blood collection|OTHER: Data collection,Assistance Publique - Hôpitaux de Paris,Fonds IMMUNOV,ALL,"ADULT, OLDER_ADULT",NA,57,OTHER,INTERVENTIONAL,2/5/2021,9/15/2021
NCT05850507,ACTIVE_NOT_RECRUITING,Coronavirus,BIOLOGICAL: Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)|BIOLOGICAL: Recombinant novel coronavirus protein vaccine (CHO cells),"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.",,ALL,"ADULT, OLDER_ADULT",NA,450,INDUSTRY,INTERVENTIONAL,3/17/2023,11/10/2023
NCT05710783,COMPLETED,SARS-CoV-2 Infection,BIOLOGICAL: AVX-COVID/12|BIOLOGICAL: ChAdOx-1-S[recombinant],"Laboratorio Avi-Mex, S.A. de C.V.","National Council of Science and Technology, Mexico|Instituto Nacional de Enfermedades Respiratorias",ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,4065,INDUSTRY,INTERVENTIONAL,11/9/2022,9/10/2023
NCT04460443,UNKNOWN,COVID,DRUG: sofosbuvir|DRUG: Sofosbuvir ledipsavir|DRUG: Daclatasvir,Tanta University,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2|PHASE3,60,OTHER,INTERVENTIONAL,8/1/2020,8/31/2021
NCT04967807,ACTIVE_NOT_RECRUITING,Myocardial Injury|Myocarditis|COVID-19 Vaccination|SARS-CoV-2|Cardiac MRI,DIAGNOSTIC_TEST: Cardiac PET/MRI|DIAGNOSTIC_TEST: Blood Biomarkers,"University Health Network, Toronto",,ALL,"CHILD, ADULT, OLDER_ADULT",NA,57,OTHER,INTERVENTIONAL,8/5/2021,8/5/2024
NCT04341207,UNKNOWN,Cancer & COVID 19,DRUG: Hydroxychloroquine|DRUG: Azithromycin,"Gustave Roussy, Cancer Campus, Grand Paris",,ALL,"ADULT, OLDER_ADULT",PHASE2,1000,OTHER,INTERVENTIONAL,4/3/2020,2022-04
NCT04332107,TERMINATED,COVID-19|SARS-CoV-2,DRUG: Azithromycin|DRUG: Placebos,Thomas M. Lietman,Bill and Melinda Gates Foundation|Pfizer|Stanford University,ALL,"ADULT, OLDER_ADULT",PHASE3,263,OTHER,INTERVENTIONAL,5/22/2020,3/30/2021
NCT05405283,ACTIVE_NOT_RECRUITING,COVID-19 Vaccines,"BIOLOGICAL: 2nd booster with Comirnaty® (Pfizer-BioNTech)|BIOLOGICAL: CoV2 preS dTM adjuvanted vaccine (B.1.351), Sanofi/GSK",Assistance Publique - Hôpitaux de Paris,IREIVAC/COVIREIVAC Network,ALL,"ADULT, OLDER_ADULT",PHASE3,189,OTHER,INTERVENTIONAL,6/8/2022,2023-07
NCT05526183,RECRUITING,COVID-19,BIOLOGICAL: Adeno-viral vector vaccine,Ankara City Hospital Bilkent,The Scientific and Technological Research Council of Turkey|MonitorCRO,ALL,ADULT,PHASE1,36,OTHER,INTERVENTIONAL,1/21/2022,3/1/2023
NCT05367843,TERMINATED,SARS-CoV-2 Infection,DRUG: PRIME-2-CoV_Beta,Speransa Therapeutics,,ALL,"ADULT, OLDER_ADULT",PHASE1,103,INDUSTRY,INTERVENTIONAL,6/20/2022,11/8/2023
NCT05492643,RECRUITING,SARS-CoV-2|Safety|Immunotoxicity,BIOLOGICAL: one dose of the study SARS-CoV-2 mRNA Vaccine (SYS6006)|OTHER: Cellular Immunity|OTHER: Humoral Immunity|OTHER: Safety,Zhongnan Hospital,,ALL,"ADULT, OLDER_ADULT",NA,1000,OTHER,INTERVENTIONAL,8/13/2022,3/1/2023
NCT05607043,COMPLETED,SARS-CoV2 Infection,DEVICE: Testing for SARS CoV2 RNA,"Rutgers, The State University of New Jersey",National Institute of Dental and Craniofacial Research (NIDCR),ALL,"ADULT, OLDER_ADULT",NA,11,OTHER,INTERVENTIONAL,1/31/2021,2/25/2021
NCT04830943,COMPLETED,Covid19 Related Anosmia and Aguesia,DRUG: Cerebrolysin,Assiut University,,ALL,ADULT,PHASE3,250,OTHER,INTERVENTIONAL,8/1/2020,10/30/2022
NCT05132907,ACTIVE_NOT_RECRUITING,SARS-CoV2 Infection,BIOLOGICAL: HDT-301,HDT Bio,Kaiser Permanente|Rainier Clinical Research Center|C3 Research Associates,ALL,"ADULT, OLDER_ADULT",PHASE1,63,INDUSTRY,INTERVENTIONAL,1/24/2022,2023-11
NCT04407507,COMPLETED,COVID-19,DRUG: Ivermectin|DRUG: Placebo,Investigacion Biomedica para el Desarrollo de Farmacos S.A. de C.V.,,ALL,"ADULT, OLDER_ADULT",PHASE2,66,OTHER,INTERVENTIONAL,7/1/2020,1/29/2021
NCT04348383,COMPLETED,COVID19,DRUG: Defibrotide|DRUG: Placebo,Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia,,ALL,"ADULT, OLDER_ADULT",PHASE2,156,OTHER,INTERVENTIONAL,4/8/2020,2/28/2023
NCT04405843,COMPLETED,COVID-19,DRUG: Ivermectin Oral Product|DRUG: Placebo,Centro de Estudios en Infectogía Pediatrica,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,476,OTHER,INTERVENTIONAL,7/14/2020,12/21/2020
NCT04501783,COMPLETED,COVID-19,DRUG: Favipiravir|DRUG: Standard of care (SOC)|DRUG: standard concomitant therapy,R-Pharm,,ALL,ADULT,PHASE3,168,INDUSTRY,INTERVENTIONAL,5/20/2020,8/4/2020
NCT04510207,COMPLETED,COVID-19,BIOLOGICAL: Inactivated SARS-CoV-2 Vaccine (Vero cell)|BIOLOGICAL: Inactivated SARS-CoV-2 Vaccine (Vero cell)|BIOLOGICAL: Placebo,China National Biotec Group Company Limited,"G42 Healthcare company|Abu Dhabi Health Services Company|Wuhan Institute of Biological Products Co., Ltd|Beijing Institute of Biological Products Co Ltd.",ALL,"ADULT, OLDER_ADULT",PHASE3,44101,INDUSTRY,INTERVENTIONAL,7/16/2020,12/31/2021
NCT04602507,TERMINATED,Covid19|Severe Acute Respiratory Syndrome,DRUG: Ivermectin|OTHER: Placebo,CES University,,ALL,"ADULT, OLDER_ADULT",PHASE2,75,OTHER,INTERVENTIONAL,12/10/2020,12/9/2021
NCT05128643,UNKNOWN,Coronavirus Disease 2019,BIOLOGICAL: Recombinant novel coronavirus vaccine (CHO cell),"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.",,ALL,"ADULT, OLDER_ADULT",PHASE3,300,INDUSTRY,INTERVENTIONAL,9/17/2021,10/12/2022
NCT04760743,COMPLETED,COVID-19 (Healthy Volunteers),BIOLOGICAL: NBP2001 adjuvanted with alum (RBD 30μg/dose)|BIOLOGICAL: NBP2001 adjuvanted with alum (RBD 50μg/dose)|OTHER: Normal Saline,"SK Bioscience Co., Ltd.",,ALL,ADULT,PHASE1,50,INDUSTRY,INTERVENTIONAL,12/17/2020,3/2/2022
NCT04937543,ACTIVE_NOT_RECRUITING,Covid19,DRUG: inhaled beclametasone|DRUG: Inahaled beclomethasone / formoterol / glycopyrronium,UPECLIN HC FM Botucatu Unesp,Chiesi Farmaceutici S.p.A.,ALL,"ADULT, OLDER_ADULT",PHASE2,50,OTHER,INTERVENTIONAL,6/28/2021,5/20/2022
NCT05000307,COMPLETED,SARS-CoV Infection|Immune System Disorder,DIAGNOSTIC_TEST: Blood sample,"University Hospital, Ghent",,ALL,"ADULT, OLDER_ADULT",NA,79,OTHER,INTERVENTIONAL,7/28/2020,1/27/2021
NCT04474483,TERMINATED,COVID-19,DRUG: Melatonin|OTHER: Placebo (Methylcellulose) capsule,State University of New York at Buffalo,,ALL,"ADULT, OLDER_ADULT",PHASE2,8,OTHER,INTERVENTIONAL,11/6/2020,7/22/2022
NCT05402007,COMPLETED,Post- COVID-19 Syndrome|Exercises|Pulmonary Rehabilitation|COVID-19|Randomized Clinical Trial,OTHER: Pulmonary rehabilitation exercises at the Rehabilitation Center|OTHER: Home Intervention,Centro Universitário Augusto Motta,,ALL,"ADULT, OLDER_ADULT",NA,106,OTHER,INTERVENTIONAL,6/30/2022,3/23/2023
NCT04462783,WITHDRAWN,COVID|Covid-19|SARS-CoV 2,OTHER: Symptoms entered into the CovidX application,University of Michigan,Vironix Health Incorporated,ALL,"ADULT, OLDER_ADULT",NA,0,OTHER,INTERVENTIONAL,2021-06,2021-11
NCT05997290,ACTIVE_NOT_RECRUITING,SARS-CoV-2 Infection|COVID-19,BIOLOGICAL: BNT162b2 (Omi XBB.1.5),BioNTech SE,Pfizer,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2|PHASE3,730,INDUSTRY,INTERVENTIONAL,8/10/2023,3/19/2024
NCT05057897,TERMINATED,"COVID-19, SARS-CoV-2",BIOLOGICAL: AZD1222,AstraZeneca,,ALL,"ADULT, OLDER_ADULT",PHASE4,34,INDUSTRY,INTERVENTIONAL,1/31/2022,4/19/2023
NCT04651790,COMPLETED,Covid19|Vaccines,BIOLOGICAL: SARS-CoV-2 inactivated vaccine,Pontificia Universidad Catolica de Chile,"Ministry of Health, Chile|Sinovac Biotech Co., Ltd",ALL,"ADULT, OLDER_ADULT",PHASE3,2300,OTHER,INTERVENTIONAL,11/27/2020,11/1/2022
NCT04657497,COMPLETED,SARS-CoV-2 Infection (COVID-19),DRUG: FOY-305|DRUG: Placebo,Ono Pharmaceutical Co. Ltd,,ALL,"ADULT, OLDER_ADULT",PHASE3,155,INDUSTRY,INTERVENTIONAL,11/9/2020,4/9/2021
NCT04335097,COMPLETED,COVID 19,DEVICE: Biosensors,Lars Wik,University of Stavanger|Oslo University Hospital|Norwegian Telemedicine|University of the Basque Country (UPV/EHU),ALL,"ADULT, OLDER_ADULT",NA,138,OTHER,INTERVENTIONAL,4/22/2020,9/20/2022
NCT04918797,COMPLETED,SARS-CoV2 Infection,BIOLOGICAL: COVAXIN,Bharat Biotech International Limited,,ALL,"CHILD, ADULT",PHASE2|PHASE3,525,INDUSTRY,INTERVENTIONAL,5/26/2021,1/25/2022
NCT05931497,NOT_YET_RECRUITING,Long COVID,DEVICE: whole body hyperthermia,Massachusetts General Hospital,"University of California, San Francisco",ALL,"ADULT, OLDER_ADULT",NA,21,OTHER,INTERVENTIONAL,10/1/2023,12/1/2024
NCT05667597,ENROLLING_BY_INVITATION,SARS CoV 2 Infection|COVID-19,DIAGNOSTIC_TEST: Humoral immunity,Maria Goossens,Université Libre de Bruxelles|Institute of Tropical Medicine|Mensura EDPB|Erasme University Hospital,ALL,"ADULT, OLDER_ADULT",NA,350,OTHER_GOV,INTERVENTIONAL,1/23/2023,12/31/2024
NCT05019456,UNKNOWN,COVID-19 Respiratory Infection|Influenza,BIOLOGICAL: COVID-19 Vaccine,University of Arizona,,ALL,ADULT,NA,30,OTHER,INTERVENTIONAL,3/9/2021,12/25/2022
NCT05534997,NOT_YET_RECRUITING,Post-COVID-19 Syndrome,OTHER: intensive combined rehabilitation therapy,Cairo University,,ALL,ADULT,NA,60,OTHER,INTERVENTIONAL,10/1/2022,10/1/2023
NCT04513990,UNKNOWN,COVID-19 Infection,PROCEDURE: Biospecimen Collection|OTHER: Questionnaire Administration,M.D. Anderson Cancer Center,National Cancer Institute (NCI)|William Marsh Rice University,ALL,"CHILD, ADULT, OLDER_ADULT",NA,257,OTHER,INTERVENTIONAL,4/9/2020,4/30/2023
NCT05547256,ACTIVE_NOT_RECRUITING,SARS-CoV-2,BIOLOGICAL: COVID-19 Variant (Omicron BA.5) mRNA Vaccine Low dose|BIOLOGICAL: COVID-19 Variant (Omicron BA.5) mRNA Vaccine High dose|DRUG: Placebo,"AIM Vaccine Co., Ltd.","Ningbo Rongan Biological Pharmaceutical Co., Ltd.|First Affiliated Hospital Bengbu Medical College",ALL,"ADULT, OLDER_ADULT",NA,54,INDUSTRY,INTERVENTIONAL,9/13/2022,2024-03
NCT04526990,COMPLETED,COVID-19,BIOLOGICAL: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)|BIOLOGICAL: Placebo,CanSino Biologics Inc.,Beijing Institute of Biotechnology,ALL,"ADULT, OLDER_ADULT",PHASE3,44247,INDUSTRY,INTERVENTIONAL,9/15/2020,10/21/2022
NCT05571397,RECRUITING,Hyperglycemia,DEVICE: Dexcom G6,Ohio State University,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,100,OTHER,INTERVENTIONAL,11/1/2023,8/31/2024
NCT04715997,UNKNOWN,SARS-CoV-2,DRUG: GX-19N|DRUG: Placebo,"Genexine, Inc.",,ALL,ADULT,PHASE1|PHASE2,170,INDUSTRY,INTERVENTIONAL,12/30/2020,6/30/2022
NCT04750343,ACTIVE_NOT_RECRUITING,COVID-19 (Healthy Volunteers),BIOLOGICAL: GBP510 adjuvanted with AS03 (RBD 10μg/dose) - Stage 1|BIOLOGICAL: GBP510 (RBD 10μg/dose) - Stage 1|OTHER: Normal saline (0.9% sodium chloride solution) - Stage 1|BIOLOGICAL: GBP510 adjuvanted with AS03 (RBD 25μg/dose) - Stage 1|BIOLOGICAL: GBP510 (RBD 25μg/dose) - Stage 1|OTHER: Normal saline (0.9% sodium chloride solution) - Stage 1|BIOLOGICAL: GBP510 adjuvanted with AS03 (RBD 10μg/dose) - Stage 2|BIOLOGICAL: GBP510 adjuvanted with AS03 (RBD 25μg/dose)- Stage 2|BIOLOGICAL: GBP510 (RBD 25μg/dose)- Stage 2|OTHER: Normal saline (0.9% sodium chloride solution)- Stage 2,"SK Bioscience Co., Ltd.",Coalition for Epidemic Preparedness Innovations|GlaxoSmithKline,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,328,INDUSTRY,INTERVENTIONAL,2/3/2021,2022-06
NCT05012943,COMPLETED,COVID-19 Vaccines,BIOLOGICAL: ARCT-154 Self-Amplifying RNA SARS-CoV-2 Vaccine|OTHER: Placebo (normal saline)|BIOLOGICAL: Astra Zeneca COVID-19 vaccine,Vinbiocare Biotechnology Joint Stock Company,"Arcturus Therapeutics, Inc.",ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,19494,INDUSTRY,INTERVENTIONAL,8/15/2021,1/18/2023
NCT05993143,TERMINATED,COVID-19|SARS-CoV-2,DRUG: Ivermectin|DRUG: Placebo,Insud Pharma,,ALL,"ADULT, OLDER_ADULT",PHASE3,249,INDUSTRY,INTERVENTIONAL,1/18/2021,7/21/2021
NCT05547243,ACTIVE_NOT_RECRUITING,SARS-CoV-2,"BIOLOGICAL: SARS-CoV-2 mRNA Vaccine, Bivalent Low dose|BIOLOGICAL: SARS-CoV-2 mRNA Vaccine, Bivalent High dose|DRUG: Placebo","AIM Vaccine Co., Ltd.","Ningbo Rongan Biological Pharmaceutical Co., Ltd.|First Affiliated Hospital Bengbu Medical College",ALL,"ADULT, OLDER_ADULT",NA,350,INDUSTRY,INTERVENTIONAL,9/26/2022,2024-03
NCT04333407,TERMINATED,COVID-19,DRUG: Aspirin 75mg|DRUG: Clopidogrel 75mg|DRUG: Rivaroxaban 2.5 MG|DRUG: Atorvastatin 40mg|DRUG: Omeprazole 20mg,Imperial College London,,ALL,"ADULT, OLDER_ADULT",NA,320,OTHER,INTERVENTIONAL,4/3/2020,11/30/2021
NCT04373707,COMPLETED,COVID|Thrombosis|Pulmonary Embolism|Deep Vein Thrombosis,DRUG: Enoxaparin|DRUG: Enoxaparin,"Central Hospital, Nancy, France","Ministry of Health, France|Grand Est Region|University Hospital of Saint-Etienne",ALL,"ADULT, OLDER_ADULT",PHASE4,1000,OTHER,INTERVENTIONAL,5/13/2020,9/14/2021
NCT04403243,COMPLETED,COVID 19,DRUG: Colchicine|DRUG: Ruxolitinib 5 MG|DRUG: Secukinumab 150 MG/ML Subcutaneous Solution [COSENTYX]|OTHER: standard therapy,Lomonosov Moscow State University Medical Research and Educational Center,,ALL,"ADULT, OLDER_ADULT",PHASE2,70,OTHER,INTERVENTIONAL,5/8/2020,8/23/2020
NCT05247307,TERMINATED,COVID-19,BIOLOGICAL: convalescent plasma infusion covid 19,Hospital Galdakao-Usansolo,,ALL,OLDER_ADULT,PHASE3,93,OTHER_GOV,INTERVENTIONAL,3/31/2020,12/31/2021
NCT04568707,COMPLETED,Covid19|Neurologic Manifestations|Psychiatric Manifestations,OTHER: blood sample,Assistance Publique - Hôpitaux de Paris,Brain & Spine Institute (ICM),ALL,"ADULT, OLDER_ADULT",NA,238,OTHER,INTERVENTIONAL,10/23/2020,12/14/2022
NCT04788407,UNKNOWN,Covid19|SARS-CoV-2 Infection|Households Contacts,DRUG: Nitazoxanide|DRUG: Placebo,Fundación Huésped,Ministerio de Salud de Ciudad Autónoma de Buenos Aires|Laboratorios Roemmers S.A.I.C.F.,ALL,"ADULT, OLDER_ADULT",PHASE4,456,OTHER,INTERVENTIONAL,12/1/2020,4/30/2022
NCT04746183,ACTIVE_NOT_RECRUITING,Covid19,DRUG: CST-2: EIDD-2801|DRUG: CST-2: Placebo|DRUG: Nitazoxanide|DRUG: VIR-7832|DRUG: VIR-7831|DRUG: CST-5: Placebo|DRUG: Favipiravir|DRUG: Molnupiravir|DRUG: Paxlovid,University of Liverpool,University of Southampton|Liverpool School of Tropical Medicine|Liverpool University Hospitals NHS Foundation Trust|University of Cambridge,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,600,OTHER,INTERVENTIONAL,7/3/2020,4/30/2024
NCT05157243,NOT_YET_RECRUITING,COVID-19,DRUG: Nitazoxanide|DIETARY_SUPPLEMENT: Vitamin Super-B Complex|DRUG: Placebo|OTHER: Standard of Care,Romark Laboratories L.C.,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,2000,INDUSTRY,INTERVENTIONAL,2024-08,2025-05
NCT04816643,COMPLETED,"SARS-CoV-2 Infection, COVID-19",BIOLOGICAL: Biological/Vaccine: BNT162b2 10mcg|BIOLOGICAL: BNT162b2 20mcg|BIOLOGICAL: BNT162b2 30mcg|OTHER: Placebo|BIOLOGICAL: Biological/Vaccine: BNT162b2 3mcg,BioNTech SE,Pfizer,ALL,CHILD,PHASE2|PHASE3,11837,INDUSTRY,INTERVENTIONAL,3/24/2021,12/8/2023
NCT04261907,TERMINATED,2019-nCoV,DRUG: ASC09/ritonavir group|DRUG: lopinavir/ritonavir group,First Affiliated Hospital of Zhejiang University,"Ascletis Pharmaceuticals Co., Ltd.",ALL,"ADULT, OLDER_ADULT",NA,6,OTHER,INTERVENTIONAL,2/11/2020,4/13/2020
NCT05102643,UNKNOWN,Covid19,BIOLOGICAL: SARS-CoV-2 DNA Vaccine|BIOLOGICAL: Matching placebo,The University of Hong Kong,Immuno Cure 3 Limited,ALL,ADULT,PHASE1,30,OTHER,INTERVENTIONAL,11/18/2021,2022-12
NCT04395807,TERMINATED,COVID|Acute Hypoxemic Respiratory Failure,DEVICE: Helmet CPAP|DEVICE: HFNC,Lund University,Region Skane,ALL,"ADULT, OLDER_ADULT",NA,2,OTHER,INTERVENTIONAL,6/3/2020,4/12/2021
NCT05633407,ACTIVE_NOT_RECRUITING,Postural Orthostatic Tachycardia Syndrome,DRUG: Efgartigimod|DRUG: Placebo,argenx,Iqvia Pty Ltd,ALL,"ADULT, OLDER_ADULT",PHASE2,53,INDUSTRY,INTERVENTIONAL,9/23/2022,11/30/2024
NCT04355897,COMPLETED,COVID 19,BIOLOGICAL: Convalescent COVID 19 Plasma,The Christ Hospital,,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,22,OTHER,INTERVENTIONAL,4/28/2020,8/12/2020
NCT04460690,COMPLETED,COVID-19|Sars-CoV2,DEVICE: Rapid Onsite COVID-19 Detection,"University of Wisconsin, Madison",National Institutes of Health (NIH)|AIDS Vaccine Research Lab,ALL,"CHILD, ADULT, OLDER_ADULT",NA,93,OTHER,INTERVENTIONAL,7/13/2020,3/31/2021
NCT04342897,TERMINATED,COVID-19|Pneumonia,DRUG: LY3127804|DRUG: Placebo,Eli Lilly and Company,,ALL,"ADULT, OLDER_ADULT",PHASE2,95,INDUSTRY,INTERVENTIONAL,4/20/2020,10/12/2020
NCT04312997,COMPLETED,COVID-19,DRUG: PUL-042 Inhalation Solution|DRUG: Placebo,"Pulmotect, Inc.",United States Department of Defense,ALL,"ADULT, OLDER_ADULT",PHASE2,101,INDUSTRY,INTERVENTIONAL,6/16/2020,7/2/2021
NCT04334967,SUSPENDED,COVID-19|Corona Virus Infection|SARS-CoV-2|2019-nCoV|2019 Novel Coronavirus,DRUG: Hydroxychloroquine|DIETARY_SUPPLEMENT: Vitamin C,Providence Health & Services,"Center for Outcomes Research and Education|Providence Cancer Center, Earle A. Chiles Research Institute",ALL,"ADULT, OLDER_ADULT",PHASE4,13,OTHER,INTERVENTIONAL,3/30/2020,5/27/2022
NCT04723290,COMPLETED,Covid19,DIAGNOSTIC_TEST: Serological tests for SARS Cov-2,Grand Hôpital de Charleroi,,ALL,"ADULT, OLDER_ADULT",NA,2817,OTHER,INTERVENTIONAL,6/20/2020,12/31/2020
NCT04445597,RECRUITING,SARS-CoV-2,OTHER: Sampling of tissue,Universitaire Ziekenhuizen KU Leuven,Max Planck Research Unit for Neurogenetics|AZ Sint-Jan Brugge-Oostende AV|Universitair Ziekenhuis Brussel|Hospital Clinic of Barcelona,ALL,"CHILD, ADULT, OLDER_ADULT",NA,150,OTHER,INTERVENTIONAL,5/7/2020,12/31/2024
NCT05652543,COMPLETED,COVID-19 Pandemic,BIOLOGICAL: SCTV01E|BIOLOGICAL: Placebo (normal saline),Sinocelltech Ltd.,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,518,INDUSTRY,INTERVENTIONAL,1/5/2023,1/15/2024
NCT04425707,UNKNOWN,Covid19,DRUG: Ivermectin,"Ministry of Health and Population, Egypt",,ALL,"ADULT, OLDER_ADULT",NA,100,OTHER_GOV,INTERVENTIONAL,6/9/2020,9/1/2020
NCT04645407,COMPLETED,Novel Coronavirus Pneumonia,DRUG: Fuzheng Huayu tablet,ShuGuang Hospital,Hubei Hospital of Traditional Chinese Medicine|Jingmen No.1 People's Hospital,ALL,"ADULT, OLDER_ADULT",PHASE4,66,OTHER,INTERVENTIONAL,2/1/2020,4/15/2020
NCT04408183,TERMINATED,SARS-CoV 2|Infection,DRUG: GLS-1200|DRUG: Placebo,"GeneOne Life Science, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE2,184,INDUSTRY,INTERVENTIONAL,6/10/2020,1/10/2023
NCT05315583,RECRUITING,COVID-19|SARS CoV 2 Infection,OTHER: Collection of biological samples,Centre Hospitalier Régional d'Orléans,,ALL,"ADULT, OLDER_ADULT",NA,400,OTHER,INTERVENTIONAL,12/1/2022,12/1/2026
NCT04524507,COMPLETED,COVID-19,BIOLOGICAL: High-titer Convalescent COVID-19 Plasma (CCP1)|BIOLOGICAL: Standard-titer Convalescent COVID-19 plasma (CCP2),"University of North Carolina, Chapel Hill",,ALL,"ADULT, OLDER_ADULT",PHASE2,56,OTHER,INTERVENTIONAL,8/27/2020,6/4/2021
NCT04452643,WITHDRAWN,Covid19,BIOLOGICAL: BACMUNE (MV130)|OTHER: Placebo,Inmunotek S.L.,,ALL,"ADULT, OLDER_ADULT",PHASE3,0,INDUSTRY,INTERVENTIONAL,2020-10,2021-12
NCT05543707,ACTIVE_NOT_RECRUITING,COVID-19,DRUG: PBI-0451 (Pomotrelvir)|DRUG: Placebo,"Pardes Biosciences, Inc.",,ALL,ADULT,PHASE2,210,INDUSTRY,INTERVENTIONAL,9/21/2022,7/2/2023
NCT04606407,COMPLETED,"Viral Pneumonia|Nitric Oxide|Respiratory Disease|Pneumonia, Viral|Inhaled Nitric Oxide|Covid19|SARS-CoV Infection",DEVICE: LungFit™,Beyond Air Inc.,,ALL,"ADULT, OLDER_ADULT",NA,40,INDUSTRY,INTERVENTIONAL,11/25/2020,8/7/2022
NCT04715607,COMPLETED,SARS-CoV Infection|Covid19|Coronavirus,DIAGNOSTIC_TEST: Sequence of testing.,"Rigshospitalet, Denmark",Hvidovre University Hospital|Region Hovedstadens Apotek,ALL,"CHILD, ADULT, OLDER_ADULT",NA,27947,OTHER,INTERVENTIONAL,1/22/2021,5/31/2021
NCT05780437,ACTIVE_NOT_RECRUITING,COVID-19,BIOLOGICAL: AZD7442|BIOLOGICAL: Placebo|BIOLOGICAL: Remdesivir,National Institute of Allergy and Infectious Diseases (NIAID),"International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)|University of Copenhagen|Medical Research Council|Kirby Institute|Washington D.C. Veterans Affairs Medical Center|AIDS Clinical Trials Group|National Heart, Lung, and Blood Institute (NHLBI)|US Department of Veterans Affairs|Prevention and Early Treatment of Acute Lung Injury|Cardiothoracic Surgical Trials Network|AstraZeneca|University of Minnesota",ALL,"ADULT, OLDER_ADULT",PHASE3,1455,NIH,INTERVENTIONAL,2/5/2021,3/31/2023
NCT04900467,UNKNOWN,Adult Who Received a First Dose of an mRNA Vaccine (Pfizer-BioNTech or Moderna) and Need to Receive a Second Dose,BIOLOGICAL: Pfizer|BIOLOGICAL: Moderna,Assistance Publique - Hôpitaux de Paris,COVIREIVAC,ALL,"ADULT, OLDER_ADULT",NA,418,OTHER,INTERVENTIONAL,5/28/2021,2022-01
NCT04617483,COMPLETED,Covid19,"BIOLOGICAL: Two doses of commercial scale inactivated SARS-CoV-2 vaccine at the schedule of day 0,14|BIOLOGICAL: Two doses of pilot scale inactivated SARS-CoV-2 vaccine at the schedule of day 0,14|BIOLOGICAL: Two doses of pilot scale inactivated SARS-CoV-2 vaccine at the schedule of day 0,14 in elderly","Sinovac Research and Development Co., Ltd.",,ALL,"ADULT, OLDER_ADULT",PHASE3,1040,INDUSTRY,INTERVENTIONAL,10/31/2020,5/31/2021
NCT04466683,ACTIVE_NOT_RECRUITING,Covid-19|Sars-CoV2|Pneumonia,RADIATION: Low dose radiation 35 cGy|RADIATION: High dose radiation 100 cGy,Ohio State University Comprehensive Cancer Center,Varian Medical Systems,ALL,"ADULT, OLDER_ADULT",PHASE2,37,OTHER,INTERVENTIONAL,8/28/2020,12/31/2025
NCT06191367,ACTIVE_NOT_RECRUITING,Lung Fibrosis Interstitial|Post-COVID-19 Syndrome,OTHER: Aerobic Exercises|DEVICE: Incentive Spirometer Device|OTHER: Traditional Chest Physiotherapy,McCarious Nahad Aziz Abdelshaheed Stephens,Cairo University,ALL,"ADULT, OLDER_ADULT",NA,45,OTHER,INTERVENTIONAL,2/1/2022,2024-02
NCT05246137,COMPLETED,COVID-19|SARS-CoV-2 Acute Respiratory Disease,BIOLOGICAL: COVID-19 Vaccine 40 ug/dose,"Hipra Scientific, S.L.U",,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,2646,INDUSTRY,INTERVENTIONAL,2/3/2022,3/3/2023
NCT05199233,ACTIVE_NOT_RECRUITING,COVID-19|Post Acute Sequelae of SARS-CoV-2,DEVICE: Muse S™ Headband system,Mayo Clinic,,ALL,"ADULT, OLDER_ADULT",NA,60,OTHER,INTERVENTIONAL,6/1/2022,2024-12
NCT05194033,COMPLETED,SARS-CoV-2,DIETARY_SUPPLEMENT: Probiotics daily|DIETARY_SUPPLEMENT: Placebo daily,Peking University,"Centers for Disease Control and Prevention, China|Beijing Pinggu District Hospital|Peking University Health Science Center Hospital",ALL,ADULT,NA,31,OTHER,INTERVENTIONAL,3/9/2022,5/19/2022
NCT04858633,UNKNOWN,Covid19|COVID-19 Prevention,DRUG: Hydroxychloroquine (HCQ)|OTHER: Standard care|OTHER: Placebo,Postgraduate Institute of Medical Education and Research,,ALL,"ADULT, OLDER_ADULT",PHASE3,1000,OTHER_GOV,INTERVENTIONAL,3/22/2021,6/30/2021
NCT05289037,COMPLETED,COVID-19,"DRUG: AS03|BIOLOGICAL: BNT162b2|BIOLOGICAL: BNT162b2 (B.1.1.529)|BIOLOGICAL: BNT162b2 (B.1.351)|BIOLOGICAL: BNT162b2 bivalent (wildtype and Omicron BA.1)|BIOLOGICAL: BNT162b2 bivalent (wildtype and Omicron BA.4/BA.5)|BIOLOGICAL: CoV2 preS dTM [B.1.351]|BIOLOGICAL: CoV2 preS dTM/D614|BIOLOGICAL: CoV2 preS dTM/D614+B.1.351|BIOLOGICAL: mRNA-1273|BIOLOGICAL: mRNA-1273.351|BIOLOGICAL: mRNA-1273.529|BIOLOGICAL: mRNA-1273.617.2|OTHER: Sodium Chloride, 0.9%",National Institute of Allergy and Infectious Diseases (NIAID),,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,1270,NIH,INTERVENTIONAL,3/30/2022,11/10/2023
NCT04865237,COMPLETED,Covid19|SARS-CoV Infection|Corona Virus Infection|Coronavirus|COVID-19,BIOLOGICAL: SARS-CoV-2 Virus|DRUG: Remdesivir,Imperial College London,Hvivo|Royal Free Hospital NHS Foundation Trust,ALL,ADULT,NA,36,OTHER,INTERVENTIONAL,3/6/2021,7/11/2022
NCT05633433,RECRUITING,SARS-CoV-2 Infection,DRUG: Azvudine|DRUG: Placebo,Shanghai Henlius Biotech,"Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.|HeNan Sincere Biotech Co., Ltd",ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,1550,INDUSTRY,INTERVENTIONAL,12/29/2022,7/15/2024
NCT05638633,RECRUITING,Post-COVID-19 Syndrome,"DRUG: Prednisolone 20 mg/ 5 mg|DRUG: Vitamin B compound (100mg B1, 50 mg B6, 500 µg B12)|DRUG: Placebo for Vitamin B compound|DRUG: Placebo for Prednisolon",Wuerzburg University Hospital,University Hospital Tuebingen|University Hospital Schleswig-Holstein,ALL,"ADULT, OLDER_ADULT",PHASE3,340,OTHER,INTERVENTIONAL,11/11/2022,12/31/2024
NCT04666233,COMPLETED,Neonates Needing Resuscitation at Birth,PROCEDURE: Neonatal resuscitation with PPE for the prevention of SARS-Cov-2 infection|PROCEDURE: Neonatal resuscitation without PPE for the prevention of SARS-Cov-2 infection,University Hospital Padova,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,48,OTHER,INTERVENTIONAL,3/16/2021,3/23/2021
NCT04264533,TERMINATED,"Vitamin C|Pneumonia, Viral|Pneumonia, Ventilator-Associated",DRUG: VC|DRUG: Sterile Water for Injection,ZhiYong Peng,,ALL,"ADULT, OLDER_ADULT",PHASE2,56,OTHER,INTERVENTIONAL,2/14/2020,3/29/2020
NCT04355533,COMPLETED,COVID-19 Infection,BIOLOGICAL: serology test|BIOLOGICAL: nasopharyngeal swab|BIOLOGICAL: rectal swab|BIOLOGICAL: saliva sample,Assistance Publique - Hôpitaux de Paris,"Institut National de la Santé Et de la Recherche Médicale, France|Commissariat A L'energie Atomique|Institut Pasteur",ALL,"CHILD, ADULT, OLDER_ADULT",NA,1056,OTHER,INTERVENTIONAL,7/29/2020,5/24/2022
NCT04824222,UNKNOWN,Covid19,"DRUG: Human fecal microbiota, MBiotix HBI|DRUG: Placebo|DRUG: SOC",Medical University of Warsaw,Human Biome Institute S.A.,ALL,"ADULT, OLDER_ADULT",PHASE3,366,OTHER,INTERVENTIONAL,2021-04,2022-12
NCT05305547,ACTIVE_NOT_RECRUITING,SARS-CoV-2 Infection,DRUG: S-217622|DRUG: Placebo,Shionogi,National Institute of Allergy and Infectious Diseases (NIAID),ALL,"ADULT, OLDER_ADULT",PHASE3,2093,INDUSTRY,INTERVENTIONAL,8/3/2022,5/24/2024
NCT04838847,WITHDRAWN,Coronavirus|Covid19|SARS-CoV-2|Severe Acute Respiratory Syndrome,BIOLOGICAL: CVnCoV Vaccine,CureVac,,ALL,"ADULT, OLDER_ADULT",PHASE3,0,INDUSTRY,INTERVENTIONAL,10/1/2021,2022-09
NCT04459247,COMPLETED,COVID,DRUG: Vit D,Postgraduate Institute of Medical Education and Research,,ALL,"ADULT, OLDER_ADULT",NA,40,OTHER_GOV,INTERVENTIONAL,6/15/2020,4/10/2021
NCT03808922,RECRUITING,Lower Respiratory Tract Infection|Parainfluenza|Immunocompromised|COVID-19,DRUG: DAS181|DRUG: Placebo|DRUG: DAS181 COVID-19|DRUG: DAS181 OL,"Ansun Biopharma, Inc.",,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,274,INDUSTRY,INTERVENTIONAL,5/23/2019,12/31/2024
NCT04505722,COMPLETED,Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the Protocol,BIOLOGICAL: Ad26.COV2.S|OTHER: Placebo,Janssen Vaccines & Prevention B.V.,,ALL,"ADULT, OLDER_ADULT",PHASE3,44325,INDUSTRY,INTERVENTIONAL,9/7/2020,3/31/2023
NCT05501522,ACTIVE_NOT_RECRUITING,COVID-19,BIOLOGICAL: GBP510 adjuvanted with AS03|OTHER: Placebo (Normal Saline),"SK Bioscience Co., Ltd.",Coalition for Epidemic Preparedness Innovations|International Vaccine Institute|GlaxoSmithKline,ALL,"ADULT, OLDER_ADULT",PHASE3,840,INDUSTRY,INTERVENTIONAL,12/9/2022,2024-08
NCT04761822,COMPLETED,SARS-CoV Infection|COVID-19|Allergic Reaction|Mast Cell Disorder,BIOLOGICAL: Moderna COVID-19 Vaccine|BIOLOGICAL: Pfizer-BioNTech COVID-19 Vaccine|BIOLOGICAL: Placebo,National Institute of Allergy and Infectious Diseases (NIAID),"Immune Tolerance Network (ITN)|Rho Federal Systems Division, Inc.",ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,746,NIH,INTERVENTIONAL,4/7/2021,4/27/2022
NCT04530422,COMPLETED,Covid19,DRUG: Sofosbuvir plus Ledipasvir,Almaza Military Fever Hospital,,ALL,"ADULT, OLDER_ADULT",PHASE3,250,OTHER,INTERVENTIONAL,4/15/2020,7/23/2020
NCT04398147,UNKNOWN,COVID-19,BIOLOGICAL: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)|BIOLOGICAL: Placebo,CanSino Biologics Inc.,Beijing Institute of Biotechnology|Canadian Center for Vaccinology,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,696,INDUSTRY,INTERVENTIONAL,8/1/2020,12/30/2021
NCT05986422,RECRUITING,Post-COVID-19 Syndrome,DRUG: Methylprednisolone,"Charite University, Berlin, Germany",,ALL,"ADULT, OLDER_ADULT",PHASE2,418,OTHER,INTERVENTIONAL,10/1/2023,3/31/2025
NCT04517422,COMPLETED,SARS-CoV Infection,DIETARY_SUPPLEMENT: Probiotics|OTHER: Placebo,"AB Biotics, SA",Innovacion y Desarrollo de Estrategias en Salud|Hospital General Dr. Manuel Gea González|Hospital Angeles del Pedregal,ALL,ADULT,NA,300,INDUSTRY,INTERVENTIONAL,8/19/2020,2/2/2021
NCT05597722,TERMINATED,Cognitive Impairment|Long COVID,BEHAVIORAL: Digital cognitive behavioral intervention-RxWell|DRUG: Amphetamine-Dextroamphetamine,Eva Szigethy,The Beckwith Institute,ALL,"ADULT, OLDER_ADULT",PHASE4,7,OTHER,INTERVENTIONAL,4/4/2023,5/18/2023
NCT04678700,UNKNOWN,Covid19- Coronavirus- Sars-cov-2,OTHER: Chest physiotherapy post-covid19,European University of Madrid,,ALL,"ADULT, OLDER_ADULT",NA,40,OTHER,INTERVENTIONAL,3/1/2021,8/1/2021
NCT04390022,COMPLETED,Covid-19|Coronavirus Infection|SARS-CoV-2 Infection,DRUG: Ivermectin|DRUG: Placebo,"Clinica Universidad de Navarra, Universidad de Navarra",Barcelona Institute for Global Health,ALL,ADULT,PHASE2,24,OTHER,INTERVENTIONAL,7/31/2020,10/9/2020
NCT04364022,COMPLETED,Prevention of COVID-19,DRUG: Lopinavir/ritonavir,Calmy Alexandra,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,326,OTHER,INTERVENTIONAL,4/23/2020,3/24/2021
NCT05054322,UNKNOWN,Covid19,DRUG: Fluticasone Propionate,University of Medicine and Pharmacy at Ho Chi Minh City,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,500,OTHER,INTERVENTIONAL,9/22/2021,8/30/2022
NCT05313022,ACTIVE_NOT_RECRUITING,COVID-19,BIOLOGICAL: ZR-202-CoV|OTHER: Placebo,"Shanghai Zerun Biotechnology Co.,Ltd","Walvax Biotechnology Co., Ltd.",ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,84,INDUSTRY,INTERVENTIONAL,1/18/2022,2023-06
NCT04992247,NOT_YET_RECRUITING,Covid19,BIOLOGICAL: COVI-MSC|BIOLOGICAL: Placebo,"Sorrento Therapeutics, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE2,60,INDUSTRY,INTERVENTIONAL,2024-02,2024-09
NCT05017714,UNKNOWN,SARS-CoV2 Infection,DRUG: Recombinant cytokine gene derived protein injection,Beijing 302 Hospital,,ALL,"ADULT, OLDER_ADULT",PHASE3,300,OTHER,INTERVENTIONAL,8/31/2021,8/31/2022
NCT05373043,RECRUITING,Long-COVID,DIETARY_SUPPLEMENT: Mitoquinone|DIETARY_SUPPLEMENT: Placebo,VA Office of Research and Development,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,300,FED,INTERVENTIONAL,11/1/2022,10/31/2028
NCT02735707,RECRUITING,"Community-acquired Pneumonia, Influenza, COVID-19",DRUG: Ceftriaxone|DRUG: Moxifloxacin or Levofloxacin|DRUG: Piperacillin-tazobactam|DRUG: Ceftaroline|DRUG: Amoxicillin-clavulanate|DRUG: Standard course macrolide|DRUG: Extended course macrolide|OTHER: No systemic corticosteroid|DRUG: Fixed-duration Hydrocortisone|DRUG: Shock-dependent hydrocortisone|DRUG: Fixed-duration higher dose Hydrocortisone|OTHER: No antiviral agent for influenza|DRUG: Five-days oseltamivir|DRUG: Ten-days oseltamivir|OTHER: No antiviral agent for COVID-19|DRUG: Lopinavir / Ritonavir|DRUG: Hydroxychloroquine|DRUG: Hydroxychloroquine + lopinavir/ritonavir|DRUG: Ivermectin|OTHER: No immune modulation for COVID-19|DRUG: Interferon beta-1a|DRUG: Anakinra|DRUG: Tocilizumab|DRUG: Sarilumab|DRUG: Local standard venous thromboprophylaxis|DRUG: Therapeutic dose anticoagulation|DRUG: Conventional low dose thromboprophylaxis|DRUG: Intermediate dose thromboprophylaxis|DRUG: Continuation of therapeutic dose anticoagulation|OTHER: No immunoglobulin|BIOLOGICAL: Convalescent plasma|BIOLOGICAL: Delayed administration of convalescent plasma|OTHER: No vitamin C|DRUG: Vitamin C|OTHER: No antiplatelet|DRUG: Aspirin|DRUG: P2Y12 inhibitor|OTHER: No simvastatin|DRUG: Simvastatin|OTHER: Placebo|DRUG: Eritoran|DRUG: Apremilast|PROCEDURE: Clinician-preferred mechanical ventilation strategy|PROCEDURE: Protocolised mechanical ventilation strategy|OTHER: No renin-angiotensin system inhibitor|DRUG: Angiotensin converting enzyme inhibitor|DRUG: Angiotensin Receptor Blockers|DRUG: ARB + DMX-200|OTHER: No cysteamine|DRUG: Cysteamine|DRUG: Fixed-duration dexamethasone|DRUG: Baloxavir Marboxil|DRUG: Five-days oseltamivir + baloxavir marboxil|DRUG: Ten-days oseltamivir + baloxavir marboxil|OTHER: No endothelial modulator|DRUG: Imatinib,UMC Utrecht,Australian and New Zealand Intensive Care Research Centre|Medical Research Institute of New Zealand|Unity Health|Berry Consultants|Global Coalition for Adaptive Research|University of Pittsburgh Medical Center|Intensive Care National Audit & Research Centre|St. Marianna University School of Medicine|National Intensive Care Surveillance MORU,ALL,"ADULT, OLDER_ADULT",PHASE3,10000,OTHER,INTERVENTIONAL,4/11/2016,2028-02
NCT05092607,UNKNOWN,Respiratory Viral Infection,DIAGNOSTIC_TEST: Venous and Capillary blood sampling,Assistance Publique - Hôpitaux de Paris,,ALL,"ADULT, OLDER_ADULT",NA,1467,OTHER,INTERVENTIONAL,7/15/2021,12/30/2022
NCT04296643,COMPLETED,Coronavirus|N95|Medical Mask,DEVICE: Medical Mask|DEVICE: N95 respirator,McMaster University,University of Alberta,ALL,"ADULT, OLDER_ADULT",PHASE4,1009,OTHER,INTERVENTIONAL,3/1/2020,12/8/2022
NCT04799743,UNKNOWN,Covid-19,DRUG: Resveratrol|DRUG: Placebo capsules,Hong Kong Baptist University,"Hospital Authority, Hong Kong",ALL,"ADULT, OLDER_ADULT",NA,30,OTHER,INTERVENTIONAL,4/1/2021,2022-05
NCT04784897,COMPLETED,COVID-19,DRUG: Brilacidin|DRUG: Placebo|DRUG: Standard of Care (SoC),"Innovation Pharmaceuticals, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE2,120,INDUSTRY,INTERVENTIONAL,2/22/2021,7/30/2021
NCT05745467,WITHDRAWN,SARS-CoV-2 Acute Respiratory Disease,"DRUG: Povidone Iodine 5% Soln,Top,Kit",University of Iowa,3M,ALL,"ADULT, OLDER_ADULT",PHASE4,0,OTHER,INTERVENTIONAL,7/3/2024,4/1/2026
NCT04384497,COMPLETED,COVID-19,BIOLOGICAL: SARS-CoV-2 convalescent plasma,Joakim Dillner,Danderyd Hospital|Karolinska University Hospital|Karolinska Institutet,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,10,OTHER,INTERVENTIONAL,5/7/2020,12/1/2020
NCT05037097,UNKNOWN,COVID-19|SARS-CoV-2 Infection|Corona Virus Infection,BIOLOGICAL: ARCT-165|BIOLOGICAL: ARCT-154|BIOLOGICAL: ARCT-021,"Arcturus Therapeutics, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,72,INDUSTRY,INTERVENTIONAL,8/30/2021,2023-03
NCT04991467,RECRUITING,Parenting|Covid19,BEHAVIORAL: CARE Program and Valera Application with care manager functionality|BEHAVIORAL: Valera Application with care manager functionality|BEHAVIORAL: CARE Program|BEHAVIORAL: Valera Application|BEHAVIORAL: CARE Program and Valera Application,Albert Einstein College of Medicine,National Institute of Mental Health (NIMH),ALL,"ADULT, OLDER_ADULT",NA,360,OTHER,INTERVENTIONAL,12/17/2021,3/31/2026
NCT05417997,COMPLETED,COVID-19 Respiratory Infection|FLU|Cold; Influenza|Bacterial Pneumonia|COVID-19 Pneumonia,DIETARY_SUPPLEMENT: Kunamin®|DRUG: Favipiravir|DRUG: Enoxaparin|DRUG: Lansoprazole|DRUG: Paracetamol|DRUG: Ceftriaxone/ Clarithromycin|DRUG: Methylprednisolone,"RAAS Nutritionals, LLC",Kayseri City Hospital,ALL,"ADULT, OLDER_ADULT",PHASE3,71,INDUSTRY,INTERVENTIONAL,5/29/2021,12/2/2021
NCT05932797,ACTIVE_NOT_RECRUITING,Long COVID-19 Syndrome,OTHER: Multimodal intervention in Long Covid19,Universidad de Magallanes,Teaching Assistance and Research Center of the University of Magallanes CADI-UMAG|Clinical Hospital Dr. Lautaro Navarro Avaria,ALL,"ADULT, OLDER_ADULT",NA,60,OTHER,INTERVENTIONAL,5/3/2023,11/18/2024
NCT04535167,COMPLETED,Viral Disease,DRUG: PF-07304814|DRUG: Placebo,Pfizer,,ALL,"ADULT, OLDER_ADULT",PHASE1,26,INDUSTRY,INTERVENTIONAL,9/9/2020,6/7/2021
NCT04784767,UNKNOWN,SARS-CoV-2 Infection,"BIOLOGICAL: 25 µg SpFN_1B-06-PL + ALFQ (QS21 Adjuvant)|DRUG: Sodium chloride, USP, for injection (0.9% NaCl)|BIOLOGICAL: 50 µg SpFN_1B-06-PL + ALFQ (QS21 Adjuvant)",U.S. Army Medical Research and Development Command,Walter Reed Army Institute of Research (WRAIR)|Henry M. Jackson Foundation for the Advancement of Military Medicine,ALL,ADULT,PHASE1,29,FED,INTERVENTIONAL,4/5/2021,10/30/2023
NCT05352867,COMPLETED,SARS-CoV-2,BIOLOGICAL: SARS-CoV-2 (LVRNA009) 50μg group|BIOLOGICAL: SARS-CoV-2 (LVRNA009) 100μg group|OTHER: Placebo,"AIM Vaccine Co., Ltd.",Hunan Provincial Center for Disease Control and Prevention,ALL,ADULT,PHASE2,420,INDUSTRY,INTERVENTIONAL,3/16/2022,6/21/2023
NCT06167915,NOT_YET_RECRUITING,SARS-CoV-2|COVID-19 Vaccine,BIOLOGICAL: 30μg dose of LYB002V14|BIOLOGICAL: 60μg dose of LYB002V14|BIOLOGICAL: placebo,"Guangzhou Patronus Biotech Co., Ltd.","Yantai Patronus Biotech Co., Ltd.",ALL,"ADULT, OLDER_ADULT",PHASE1,120,INDUSTRY,INTERVENTIONAL,12/26/2023,12/31/2024
NCT04364737,COMPLETED,COVID-19|Coronavirus|Coronavirus Infection,BIOLOGICAL: Convalescent Plasma|OTHER: Saline solution,NYU Langone Health,"National Center for Advancing Translational Sciences (NCATS)|Albert Einstein College of Medicine|Yale University|The University of Texas Health Science Center, Houston|The University of Texas Health Science Center at Tyler|University of Miami",ALL,"ADULT, OLDER_ADULT",PHASE2,941,OTHER,INTERVENTIONAL,4/17/2020,12/12/2022
NCT04359537,UNKNOWN,COVID 19,DRUG: Hydroxychloroquine Sulfate 200 MG|OTHER: Placebo,Shaheed Zulfiqar Ali Bhutto Medical University,,ALL,ADULT,PHASE2,200,OTHER,INTERVENTIONAL,5/1/2020,9/25/2020
NCT04362137,COMPLETED,Cytokine Storm (Covid-19),DRUG: Ruxolitinib|DRUG: Placebo,Novartis Pharmaceuticals,Incyte Corporation,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,432,INDUSTRY,INTERVENTIONAL,5/2/2020,10/17/2020
NCT04330300,SUSPENDED,Hypertension|COVID-19,DRUG: Thiazide or Thiazide-like diuretics|DRUG: Calcium Channel Blockers|DRUG: ACE inhibitor|DRUG: Angiotensin receptor blocker,"National University of Ireland, Galway, Ireland",,ALL,"ADULT, OLDER_ADULT",PHASE4,2414,OTHER,INTERVENTIONAL,4/30/2020,12/1/2021
NCT04608214,COMPLETED,SARS-CoV-2,DRUG: Alisporivir|OTHER: Standard of care (SOC),Assistance Publique - Hôpitaux de Paris,Debiopharm International SA,ALL,"ADULT, OLDER_ADULT",PHASE2,26,OTHER,INTERVENTIONAL,1/8/2021,4/13/2022
NCT05566483,RECRUITING,Post-acute Sequelae of SARS-CoV-2 Infection,BEHAVIORAL: Exercise,"University of Colorado, Denver",,ALL,"ADULT, OLDER_ADULT",NA,30,OTHER,INTERVENTIONAL,3/1/2023,12/31/2023
NCT04444700,COMPLETED,"COVID|Coronavirus Infection|Severe Acute Respiratory Syndrome|Thromboembolism, Venous|Anticoagulants and Bleeding Disorders",DRUG: Therapeutic anticoagulation,University of Sao Paulo General Hospital,Unity Health Toronto|University of Vermont Medical Center,ALL,"ADULT, OLDER_ADULT",PHASE3,465,OTHER,INTERVENTIONAL,7/4/2020,10/14/2021
NCT04466800,COMPLETED,COVID,OTHER: Intervention group_rehabilitation program,Rennes University Hospital,,ALL,"ADULT, OLDER_ADULT",NA,160,OTHER,INTERVENTIONAL,7/30/2020,1/13/2023
NCT05895110,COMPLETED,COVID-19,BIOLOGICAL: Recombinant Novel Coronavirus vaccine (CHO Cells),"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.",,ALL,CHILD,NA,240,INDUSTRY,INTERVENTIONAL,4/29/2022,11/19/2022
NCT04591210,ACTIVE_NOT_RECRUITING,COVID-19|Cardiovascular Diseases,DRUG: Angiotensin converting enzyme inhibitor|DRUG: Angiotensin II Receptor Blockers,Ottawa Heart Institute Research Corporation,,ALL,"ADULT, OLDER_ADULT",PHASE3,1155,OTHER,INTERVENTIONAL,1/27/2021,2025-12
NCT04354610,COMPLETED,COVID 19,PROCEDURE: Biological samples specific to research|PROCEDURE: Clinical examination|PROCEDURE: Telephone follow-up,"Central Hospital, Nancy, France",,ALL,"ADULT, OLDER_ADULT",NA,73,OTHER,INTERVENTIONAL,4/27/2020,3/26/2021
NCT05642910,RECRUITING,SARS-CoV-2 Infection,DRUG: Azvudine|DRUG: Paxlovid group,"Southeast University, China","Hohhot First Hospital, Hohhot, Inner Mongolia, China",ALL,"ADULT, OLDER_ADULT",NA,540,OTHER,INTERVENTIONAL,10/18/2022,4/30/2023
NCT04739410,COMPLETED,Covid19,DRUG: Ivermectin,FMH College of Medicine and Dentistry,,ALL,"ADULT, OLDER_ADULT",PHASE4,50,OTHER,INTERVENTIONAL,5/1/2020,6/30/2020
NCT05311410,RECRUITING,SARS-CoV2 Infection|Viral Load|Oral Diseases|Dental Treatment,OTHER: Non-bloody dental procedures (control group)|PROCEDURE: Bloody dental procedures (study group),University of Sao Paulo General Hospital,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,60,OTHER,INTERVENTIONAL,9/20/2021,10/20/2025
NCT04613310,UNKNOWN,COVID-19|SARS-CoV-2,DIAGNOSTIC_TEST: Rapid Diagnostic Test vs PCR,"Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland",Centre Hospitalier Universitaire Vaudois,ALL,"ADULT, OLDER_ADULT",NA,1250,OTHER,INTERVENTIONAL,9/25/2020,12/31/2020
NCT04388410,UNKNOWN,COVID-19,BIOLOGICAL: convalescent plasma,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,Hospital San Jose Tec de Monterrey|Instituto Nacional de Enfermedades Respiratorias|Instituto Nacional de Cardiologia Ignacio Chavez|Hospital General Dr. Manuel Gea González|Hospital Regional de Alta Especialidad del Bajio|Instituto Nacional de Cancerologia de Mexico,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,410,OTHER,INTERVENTIONAL,8/25/2020,12/31/2020
NCT04405310,COMPLETED,SARS Pneumonia,BIOLOGICAL: Convalescent Plasma of patients with COVID-19|OTHER: placebo (hartmann plus albumine),Grupo Mexicano para el Estudio de la Medicina Intensiva,"Hospital General Naval de Alta Especialidad - Escuela Medico Naval|National Institute of Pediatrics, Mexico|Instituto Nacional de Enfermedades Respiratorias",ALL,"ADULT, OLDER_ADULT",PHASE2,42,OTHER,INTERVENTIONAL,5/20/2020,12/10/2020
NCT04567810,COMPLETED,Covid19,DRUG: anti-SARS-CoV-2 IgY|DRUG: Placebo,Stanford University,,ALL,ADULT,PHASE1,48,OTHER,INTERVENTIONAL,9/18/2020,12/14/2020
NCT04359810,COMPLETED,SARS-CoV-2 Infection,BIOLOGICAL: Convalescent Plasma (anti-SARS-CoV-2 plasma)|BIOLOGICAL: Non-convalescent Plasma (control plasma),Max O'Donnell,"New York Blood Center|Amazon.com, Inc.",ALL,"ADULT, OLDER_ADULT",PHASE2,223,OTHER,INTERVENTIONAL,4/21/2020,12/30/2020
NCT06181292,ACTIVE_NOT_RECRUITING,SARS-CoV2 Infection,BIOLOGICAL: PHH-1V81|BIOLOGICAL: Comirnaty Omicron XBB1.5,"Hipra Scientific, S.L.U",,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,612,INDUSTRY,INTERVENTIONAL,11/13/2023,6/1/2024
NCT05065892,UNKNOWN,COVID-19 Pneumonia,BIOLOGICAL: COVAX,China National Biotec Group Company Limited,"Guizhou Center for Disease Control and Prevention|Hunan Provincial Center for Disease Control and Prevention|Center for Disease Control and Prevention, Fujian|Wuhan Institute of Biological Products Co., Ltd",ALL,"ADULT, OLDER_ADULT",PHASE4,1440,INDUSTRY,INTERVENTIONAL,2021-10,2022-03
NCT04869592,ACTIVE_NOT_RECRUITING,COVID-19,BIOLOGICAL: low-dose Recombinant SARS-CoV-2 Vaccine (CHO cell)|BIOLOGICAL: high-dose Recombinant SARS-CoV-2 Vaccine (CHO cell)|BIOLOGICAL: placebo,"National Vaccine and Serum Institute, China","Lanzhou Institute of Biological Products Co., Ltd|Beijing Zhong Sheng Heng Yi Pharmaceutical Technology Co., Ltd.|Zhengzhou University",ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1|PHASE2,3100,INDUSTRY,INTERVENTIONAL,4/25/2021,2023-03
NCT04681430,COMPLETED,Corona Virus Infection|SARS-CoV-2 Infection|SARS-CoV-2 PCR Test Positive|SARS-CoV-2 Acute Respiratory Disease,BIOLOGICAL: Convalescent plasma|DRUG: Camostat Mesilate|DRUG: Placebo for Camostat Mesilate|OTHER: Standard of Care (SoC),"Heinrich-Heine University, Duesseldorf","The Federal Ministry of Health, Germany (Bundesministerium für Gesundheit, BMG)",ALL,"ADULT, OLDER_ADULT",PHASE2,22,OTHER,INTERVENTIONAL,1/8/2021,10/29/2021
NCT06166030,RECRUITING,Long Covid19|Dietary Supplements|Respiratory Tract Infections|Inflammation,DIETARY_SUPPLEMENT: Nutritional blend (ImmuneRecov).,Federal University of São Paulo,,ALL,"ADULT, OLDER_ADULT",PHASE3,58,OTHER,INTERVENTIONAL,12/10/2023,12/15/2024
NCT04893512,COMPLETED,SARS-CoV-2 (COVID-19),DRUG: Orally Suspension of CoV2-OGEN1,Syneos Health,"US Specialty Formulations, LLC",ALL,ADULT,PHASE1,45,OTHER,INTERVENTIONAL,6/30/2021,11/11/2022
NCT04475302,COMPLETED,COVID,BIOLOGICAL: BCG vaccine (Freeze-dried),"Tuberculosis Research Centre, India","ICMR-National Institute for Research in Tuberculosis, Chennai, Tamil Nadu|All India Institute of Medical Sciences, New Delhi|National Institute for Research in Environmental Health, Bhopal, Madhya Pradesh|National Institute of Occupational Health, Ahmedabad, Gujarat|King Edward Memorial Hospital|National Institute for Implementation Research on Non-Communicable Disease",ALL,"ADULT, OLDER_ADULT",PHASE3,2175,OTHER_GOV,INTERVENTIONAL,7/1/2020,9/20/2021
NCT04380818,UNKNOWN,"Pneumonia, Viral",RADIATION: Low-dose radiotherapy|DRUG: Hydroxychloroquine Sulfate|DRUG: Ritonavir/lopinavir|DRUG: Tocilizumab Injection [Actemra]|DRUG: Azithromycin|DRUG: Corticosteroid|DRUG: Low molecular weight heparin|DEVICE: Oxygen supply,Grupo de Investigación Clínica en Oncología Radioterapia,Hospital Universitario Madrid Sanchinarro|Hospital del Mar|Hospital Universitari Sant Joan de Reus,ALL,"ADULT, OLDER_ADULT",NA,106,OTHER,INTERVENTIONAL,6/5/2020,11/1/2021
NCT05239832,UNKNOWN,COVID-19 Pandemic,BIOLOGICAL: Recombinant SARS-CoV-2 Fusion Protein Vaccine,Livzon Pharmaceutical Group Inc.,,ALL,"ADULT, OLDER_ADULT",PHASE2,34,INDUSTRY,INTERVENTIONAL,8/5/2021,8/5/2022
NCT04635618,UNKNOWN,Mental Disorder|COVID|Emotional Distress|Depression|Anxiety|Irritable Mood,BEHAVIORAL: Cognitive Behavioral Brief-Telepsychotherapy|BEHAVIORAL: Brief Interpersonal Telepsychotherapy|BEHAVIORAL: Telepsychoeducation,Hospital de Clinicas de Porto Alegre,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,999,OTHER,INTERVENTIONAL,11/5/2020,7/20/2021
NCT04340232,WITHDRAWN,COVID-19,DRUG: Baricitinib,"University of Colorado, Denver",,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,0,OTHER,INTERVENTIONAL,2021-03,2021-10
NCT06251518,NOT_YET_RECRUITING,Long COVID|Post COVID-19 Condition,BEHAVIORAL: vimida,Gaia AG,Medical School Hamburg|Institut Long-Covid Rostock,ALL,"ADULT, OLDER_ADULT",NA,160,INDUSTRY,INTERVENTIONAL,4/15/2024,4/15/2025
NCT04954118,COMPLETED,COVID-19 Pneumonia,PROCEDURE: Internal jugular vein cannulation,Bakirkoy Dr. Sadi Konuk Research and Training Hospital,,ALL,"ADULT, OLDER_ADULT",NA,40,OTHER_GOV,INTERVENTIONAL,3/20/2020,9/30/2020
NCT05787418,RECRUITING,COVID-19,DRUG: HH-120 Nasal Spray|DRUG: Placebo,Huahui Health,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,1200,INDUSTRY,INTERVENTIONAL,3/31/2023,6/1/2024
NCT05483829,COMPLETED,Post Acute COVID-19 Syndrome,BEHAVIORAL: Adhera® Fatigue for Long COVID program,"Adhera Health, Inc.",Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol),ALL,"ADULT, OLDER_ADULT",NA,15,INDUSTRY,INTERVENTIONAL,8/1/2022,8/28/2022
NCT04359329,TERMINATED,COVID,DRUG: Estradiol patch,Sharon Nachman,,ALL,"ADULT, OLDER_ADULT",PHASE2,2,OTHER,INTERVENTIONAL,4/20/2020,7/30/2020
NCT05522829,NOT_YET_RECRUITING,COVID-19|SARS-CoV-2 Infection,BIOLOGICAL: SCTV01E-1 on D0|BIOLOGICAL: SCTV01E-1 on D28|BIOLOGICAL: SCTV01E-1 on D150|BIOLOGICAL: SCTV01E on D0|BIOLOGICAL: SCTV01E on D28|BIOLOGICAL: SCTV01E on D150|BIOLOGICAL: SCTV01E-1 on D120|BIOLOGICAL: SCTV01E on D120,Sinocelltech Ltd.,,ALL,"ADULT, OLDER_ADULT",PHASE2,400,INDUSTRY,INTERVENTIONAL,10/15/2022,12/15/2023
NCT04715360,UNKNOWN,"Covid19|Sars-CoV-2 Infection|ARDS, Human|Severe covid19",COMBINATION_PRODUCT: autologous activated platelet-rich plasma|DRUG: Avigan,Hayandra Peduli Foundation,Koja Regional Public Hospital,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,30,OTHER,INTERVENTIONAL,12/29/2020,12/27/2021
NCT04343729,COMPLETED,SARS-CoV Infection|Severe Acute Respiratory Syndrome (SARS) Pneumonia,DRUG: Methylprednisolone Sodium Succinate|DRUG: Placebo solution,Fundação de Medicina Tropical Dr. Heitor Vieira Dourado,,ALL,"ADULT, OLDER_ADULT",PHASE2,416,OTHER,INTERVENTIONAL,4/18/2020,10/20/2020
NCT04446429,COMPLETED,COVID-19|SARS-CoV2|Androgenetic Alopecia|Prostate Cancer|Benign Prostatic Hyperplasia|SARS (Severe Acute Respiratory Syndrome),DRUG: Proxalutamide|OTHER: Standard of Care,"Applied Biology, Inc.",,MALE,"ADULT, OLDER_ADULT",NA,268,INDUSTRY,INTERVENTIONAL,10/21/2020,1/21/2021
NCT04924660,COMPLETED,COVID-19|SARS-CoV-2 Infection|Coronavirus Infection,DRUG: TXA127|DRUG: TRV027|DRUG: Placebo|DRUG: Fostamatinib,Sean Collins,"National Institutes of Health (NIH)|National Heart, Lung, and Blood Institute (NHLBI)",ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,871,OTHER,INTERVENTIONAL,7/15/2021,12/31/2023
NCT04371029,COMPLETED,ARDS|COVID-19,OTHER: PSG,"University Hospital, Bordeaux",,ALL,"ADULT, OLDER_ADULT",NA,17,OTHER,INTERVENTIONAL,4/28/2020,12/9/2020
NCT05171829,UNKNOWN,Sars-CoV-2 Infection|Empowerment|Transmission,OTHER: Track U,Hospital Clinic of Barcelona,Escoles Universitaries Gimbernat|University of Barcelona|Barcelona Institute for Global Health|Universitat Politècnica de Catalunya|Universitat Oberta de Catalunya,ALL,"ADULT, OLDER_ADULT",NA,180,OTHER,INTERVENTIONAL,12/27/2021,5/15/2022
NCT04485429,WITHDRAWN,COVID-19,DRUG: Methylprednisolone|DRUG: Heparin,D'Or Institute for Research and Education,,ALL,"ADULT, OLDER_ADULT",PHASE3,0,OTHER,INTERVENTIONAL,7/20/2020,12/31/2022
NCT04346329,WITHDRAWN,COVID,DRUG: Hydroxychloroquine|DRUG: Placebo oral tablet,Universidad Nacional de Colombia,Fundación Salud de los Andes,ALL,"ADULT, OLDER_ADULT",PHASE3,0,OTHER,INTERVENTIONAL,3/30/2020,10/30/2020
NCT05894564,COMPLETED,Covid19,DRUG: Fluvoxamine|OTHER: Placebo,"Susanna Naggie, MD",National Center for Advancing Translational Sciences (NCATS)|Vanderbilt University Medical Center,ALL,"ADULT, OLDER_ADULT",PHASE3,1188,OTHER,INTERVENTIONAL,8/25/2022,5/30/2023
NCT04422561,COMPLETED,COVID,DRUG: Ivermectin Tablets,Zagazig University,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2|PHASE3,340,OTHER_GOV,INTERVENTIONAL,5/31/2020,7/27/2020
NCT04793464,COMPLETED,Health Behavior|Health Care Utilization,BEHAVIORAL: Promotores de Salud|BEHAVIORAL: Services as usual,University of Oregon,National Institute on Drug Abuse (NIDA)|National Institutes of Health (NIH),ALL,"CHILD, ADULT, OLDER_ADULT",NA,1627,OTHER,INTERVENTIONAL,2/4/2021,12/31/2022
NCT05539664,ACTIVE_NOT_RECRUITING,Covid19|Hydrogen-oxygen Gas|AMS-H-03,"DEVICE: Hydrogen-Oxygen Generator with Nebulizer, AMS-H-03|DEVICE: the hospital routine oxygen supply equipment (wall oxygen or cylinder oxygen)",Ruijin Hospital,,ALL,"ADULT, OLDER_ADULT",NA,188,OTHER,INTERVENTIONAL,5/16/2022,12/30/2022
NCT04343261,COMPLETED,Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)|COVID|Coronavirus,BIOLOGICAL: Convalescent Plasma,Trinity Health Of New England,,ALL,"ADULT, OLDER_ADULT",PHASE2,48,OTHER,INTERVENTIONAL,4/10/2020,8/13/2020
NCT04463264,UNKNOWN,COVID-19,DRUG: Nitazoxanide|DRUG: Placebo,Laboratorios Roemmers S.A.I.C.F.,,ALL,ADULT,PHASE2|PHASE3,135,INDUSTRY,INTERVENTIONAL,6/26/2020,12/26/2020
NCT04381364,UNKNOWN,"Covid-19|Pneumonia, Viral|Sars-CoV2",DRUG: Ciclesonide Inhalation Aerosol,"Ola Blennow, MD, PhD",Karolinska University Hospital|Danderyd Hospital|Centrallasarettet Västerås,ALL,"ADULT, OLDER_ADULT",PHASE2,98,OTHER,INTERVENTIONAL,5/29/2020,1/31/2022
NCT04900961,RECRUITING,Covid19,OTHER: Resistance Exercise,NHS Greater Glasgow and Clyde,University of Glasgow|Chief Scientist Office of the Scottish Government,ALL,"CHILD, ADULT, OLDER_ADULT",NA,220,OTHER,INTERVENTIONAL,6/1/2021,7/31/2033
NCT04737161,WITHDRAWN,Acute Respiratory Distress Syndrome|Covid19,BIOLOGICAL: T regulatory cells,Stanford University,,ALL,"ADULT, OLDER_ADULT",PHASE1,0,OTHER,INTERVENTIONAL,2021-03,2022-09
NCT05037188,TERMINATED,Coronavirus Infection|COVID-19,BIOLOGICAL: Low dose BCD-250 injection|BIOLOGICAL: High dose BCD-250 injection|BIOLOGICAL: Low dose or high dose BCD-250 injection|OTHER: Placebo injection,Biocad,,ALL,ADULT,PHASE1|PHASE2,50,INDUSTRY,INTERVENTIONAL,8/10/2021,4/18/2022
NCT04380688,COMPLETED,COVID-19,DRUG: Acalabrutinib,AstraZeneca,Acerta Pharma BV,ALL,"ADULT, OLDER_ADULT",PHASE2,62,INDUSTRY,INTERVENTIONAL,6/13/2020,11/16/2020
NCT04344288,TERMINATED,Viral Pneumonia Human Coronavirus|COVID-19,DRUG: Prednisone|OTHER: Control group,Hospices Civils de Lyon,,ALL,"ADULT, OLDER_ADULT",PHASE2,11,OTHER,INTERVENTIONAL,4/21/2020,8/18/2020
NCT04453488,UNKNOWN,Covid-19|Sars-CoV2,BIOLOGICAL: RUTI® vaccine|BIOLOGICAL: Placebo,Fundació Institut Germans Trias i Pujol,,ALL,"ADULT, OLDER_ADULT",PHASE3,315,OTHER,INTERVENTIONAL,7/30/2020,2020-12
NCT04748588,TERMINATED,Covid19|Nosocomial Infection|SARS-CoV2 Infection,DRUG: Anti-SARS-CoV-2 mAb,University of Calgary,Sunnybrook Research Institute,ALL,"ADULT, OLDER_ADULT",PHASE4,46,OTHER,INTERVENTIONAL,2/12/2021,1/31/2022
NCT05702788,NOT_YET_RECRUITING,COVID-19|Pneumonia,DRUG: Jaktinib hydrochloride tablets|DRUG: Jaktinib hydrochloride tablets|OTHER: Placebo,"Suzhou Zelgen Biopharmaceuticals Co.,Ltd",,ALL,"ADULT, OLDER_ADULT",PHASE2,168,INDUSTRY,INTERVENTIONAL,2023-12,2024-06
NCT05212688,RECRUITING,COVID-19,OTHER: Acupuncture|OTHER: Active Control,Royal Marsden NHS Foundation Trust,,ALL,"ADULT, OLDER_ADULT",PHASE2,160,OTHER,INTERVENTIONAL,7/19/2022,7/19/2025
NCT06043388,NOT_YET_RECRUITING,COVID-19,BIOLOGICAL: Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)|BIOLOGICAL: Placebo,"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.",Hunan Provincial Center for Disease Control and Prevention,ALL,"ADULT, OLDER_ADULT",PHASE1,100,INDUSTRY,INTERVENTIONAL,2023-09,2024-11
NCT05303402,RECRUITING,SARS CoV 2 Infection,BIOLOGICAL: PHH1-V,"Hipra Scientific, S.L.U","Veristat, Inc.|Asphalion|Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia|Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta",ALL,"ADULT, OLDER_ADULT",PHASE3,400,INDUSTRY,INTERVENTIONAL,5/12/2022,10/20/2023
NCT04570202,COMPLETED,"Depression|Burnout, Professional|Post Traumatic Stress Disorder",BEHAVIORAL: EMDR,"University Hospital, Tours","Institut National de la Santé Et de la Recherche Médicale, France",ALL,"ADULT, OLDER_ADULT",NA,900,OTHER,INTERVENTIONAL,11/20/2020,1/31/2023
NCT04411602,WITHDRAWN,Severe Acute Respiratory Syndrome|COVID,DRUG: SARS-CoV-2 plasma,Ascension South East Michigan,,ALL,"ADULT, OLDER_ADULT",PHASE1,0,OTHER,INTERVENTIONAL,4/7/2020,4/7/2021
NCT04652518,TERMINATED,Covid19|Post-acute COVID-19 Respiratory Disease,DRUG: LYT-100|OTHER: Placebo,PureTech,Clinipace Worldwide|Novotech (Australia) Pty Limited,ALL,"ADULT, OLDER_ADULT",PHASE2,185,INDUSTRY,INTERVENTIONAL,12/11/2020,7/18/2022
NCT05715918,ACTIVE_NOT_RECRUITING,Vaccine,BIOLOGICAL: Vaccine for intramuscular injection|OTHER: Placebo comparator (without active ingredient) for intramuscular injection,Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products,,ALL,CHILD,PHASE3,300,OTHER_GOV,INTERVENTIONAL,4/1/2022,2/1/2024
NCT04500418,TERMINATED,Covid19,DRUG: Cenicriviroc (CVC)|DRUG: Placebo,"Charite University, Berlin, Germany",Allergan,ALL,"ADULT, OLDER_ADULT",PHASE2,45,OTHER,INTERVENTIONAL,8/25/2020,7/27/2021
NCT05858502,NOT_YET_RECRUITING,COVID-19,BIOLOGICAL: Blood sample collection|OTHER: Saliva sample collection|OTHER: Nasopharyngeal and nasal sample collection|OTHER: Exhaled Breath Condensate (EBC),Institut Pasteur,Biogroup Laboratoire de biologie médicale,ALL,"ADULT, OLDER_ADULT",NA,90,INDUSTRY,INTERVENTIONAL,11/1/2023,6/18/2024
NCT05249829,COMPLETED,SARS-CoV-2,BIOLOGICAL: mRNA-1273.529|BIOLOGICAL: mRNA-1273|BIOLOGICAL: mRNA-1273.214,"ModernaTX, Inc.",,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2|PHASE3,3557,INDUSTRY,INTERVENTIONAL,2/16/2022,6/23/2023
NCT04914377,COMPLETED,Covid19,DRUG: TQ Formula/Tab,Novatek Pharmaceuticals,,ALL,"ADULT, OLDER_ADULT",PHASE2,60,INDUSTRY,INTERVENTIONAL,6/8/2021,1/1/2022
NCT05472077,WITHDRAWN,COVID-19|SARS CoV 2 Infection|COVID-19 Pandemic,DIAGNOSTIC_TEST: Lollipop Swab,"University of Wisconsin, Madison",,ALL,"CHILD, ADULT, OLDER_ADULT",NA,0,OTHER,INTERVENTIONAL,2023-07,2023-09
NCT04517123,COMPLETED,"Covid19|Pneumonia, Viral",OTHER: Prone Positioning,Johns Hopkins University,"Duke University|University of North Carolina|University of Miami|University of Pittsburgh|Smith & Nephew, Inc.|Nox Medical Iceland",ALL,"ADULT, OLDER_ADULT",NA,35,OTHER,INTERVENTIONAL,9/1/2020,12/31/2021
NCT04602884,COMPLETED,Covid19,DIAGNOSTIC_TEST: Breath biopsy sampling using the ReCIVA Breath Sampler,Scentech Medical Technologies Ltd,,ALL,ADULT,NA,50,INDUSTRY,INTERVENTIONAL,9/22/2020,12/30/2021
NCT05576623,ACTIVE_NOT_RECRUITING,COVID-19|Vaccines,BIOLOGICAL: AdCLD-CoV19-1 OMI (Part A)|BIOLOGICAL: AdCLD-CoV19-1 OMI (Part B)|OTHER: Placebo (Part B),"Cellid Co., Ltd.",,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,320,INDUSTRY,INTERVENTIONAL,9/14/2022,2024-02
NCT04390178,COMPLETED,COVID-19,BIOLOGICAL: SARS-CoV-2 convalescent plasma,Joakim Dillner,Danderyd Hospital|Karolinska Institutet|Karolinska University Hospital,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,10,OTHER,INTERVENTIONAL,4/10/2020,12/31/2020
NCT05280158,COMPLETED,Lung Transplant Recipient|SARS-CoV-2|Immunosuppression,DRUG: mRNA-1273 (Moderna COVID-19 vaccine),"University of California, Los Angeles","ModernaTX, Inc.",ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,19,OTHER,INTERVENTIONAL,3/10/2022,2/27/2023
NCT04313023,COMPLETED,COVID-19,DRUG: PUL-042 Inhalation Solution|DRUG: Placebo,"Pulmotect, Inc.",United States Department of Defense,ALL,"ADULT, OLDER_ADULT",PHASE2,217,INDUSTRY,INTERVENTIONAL,6/9/2020,7/31/2021
NCT04335084,RECRUITING,COVID-19|Coronavirus Infection|Sars-CoV2|Corona Virus Infection|COVID|Coronavirus|Coronavirus-19|Coronavirus 19,DRUG: Hydroxychloroquine|DIETARY_SUPPLEMENT: Vitamin C|DIETARY_SUPPLEMENT: Vitamin D|DIETARY_SUPPLEMENT: Zinc,ProgenaBiome,DSCS CRO,ALL,"ADULT, OLDER_ADULT",PHASE2,600,OTHER,INTERVENTIONAL,6/22/2020,2025-07
NCT04364802,COMPLETED,COVID-19|SARS-CoV 2,DRUG: Povidone-Iodine Nasal Spray and Gargle|DRUG: Povidone-Iodine Nasal Spray and Gargle|DRUG: Povidone-Iodine Nasal Spray and Gargle,Nikita Gupta,,ALL,"ADULT, OLDER_ADULT",PHASE2,98,OTHER,INTERVENTIONAL,4/29/2020,1/28/2022
NCT04381923,WITHDRAWN,"Severe Acute Respiratory Syndrome Coronavirus 2|Hypoxemic Respiratory Failure|Pneumonia, Viral|COVID",DEVICE: Helmet Continuous Positive Airway Pressure (CPAP)|DEVICE: High Flow Nasal Oxygen (HFNO),University of Pennsylvania,,ALL,"ADULT, OLDER_ADULT",NA,0,OTHER,INTERVENTIONAL,11/15/2021,12/15/2022
NCT04983823,RECRUITING,Heart Failure,OTHER: Heart Failure intervention (Cardiac COVID Disease Management Plan (CC-DMP)|OTHER: Usual care,Baker Heart and Diabetes Institute,,ALL,"ADULT, OLDER_ADULT",NA,820,OTHER,INTERVENTIONAL,11/18/2021,2024-12
NCT04514302,COMPLETED,COVID-19,DRUG: Placebo|DRUG: Anti-SARS-CoV-2 equine immunoglobulin F(ab')2 fragments (INOSARS),Hospital San Jose Tec de Monterrey,Inosan Biopharma,ALL,ADULT,PHASE1,32,OTHER,INTERVENTIONAL,12/7/2021,8/1/2022
NCT04433078,WITHDRAWN,Cytokine Storm|SARS-CoV-2,DRUG: Doxycycline|DRUG: Placebo,Temple University,,ALL,"ADULT, OLDER_ADULT",PHASE2,0,OTHER,INTERVENTIONAL,6/22/2020,4/13/2021
NCT04392323,COMPLETED,Sars-CoV2,DIAGNOSTIC_TEST: COVID-19 PCR and Serology,Northwell Health,,ALL,"ADULT, OLDER_ADULT",NA,111,OTHER,INTERVENTIONAL,5/13/2020,10/4/2020
NCT04652102,COMPLETED,Covid19|SARS-CoV-2,BIOLOGICAL: CVnCoV|BIOLOGICAL: Placebo|BIOLOGICAL: Authorized/licensed vaccines for preventing COVID-19 (AV),CureVac,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,39693,INDUSTRY,INTERVENTIONAL,12/14/2020,6/3/2022
NCT04703478,UNKNOWN,Covid19,OTHER: Breathing exercise,University of Salamanca,,ALL,"ADULT, OLDER_ADULT",NA,20,OTHER,INTERVENTIONAL,1/20/2021,4/20/2021
NCT04708158,UNKNOWN,Covid19,BIOLOGICAL: Novaferon|BIOLOGICAL: Placebo,Genova Inc.,,ALL,"ADULT, OLDER_ADULT",PHASE3,385,INDUSTRY,INTERVENTIONAL,3/25/2021,4/30/2023
NCT05599802,NOT_YET_RECRUITING,SARS-CoV-2,BIOLOGICAL: SARS-CoV-2 variant mRNA vaccine low dose|BIOLOGICAL: SARS-CoV-2 variant mRNA vaccine high dose,"AIM Vaccine Co., Ltd.","Ningbo Rongan Biological Pharmaceutical Co., Ltd.|LiveRNA Therapeutics Inc.",ALL,"ADULT, OLDER_ADULT",PHASE1,144,INDUSTRY,INTERVENTIONAL,2023-02,2024-05
NCT04382378,UNKNOWN,Mechanical Ventilation Complication|Muscle Weakness Condition|Covid19,DEVICE: neuromuscular electrical stimulation,Escola Superior de Ciencias da Saude,,ALL,"ADULT, OLDER_ADULT",NA,120,OTHER,INTERVENTIONAL,2/1/2021,12/31/2021
NCT04263402,UNKNOWN,2019-nCoV Severe Pneumonia,DRUG: Methylprednisolone|DRUG: Methylprednisolone,Tongji Hospital,,ALL,"ADULT, OLDER_ADULT",PHASE4,100,OTHER,INTERVENTIONAL,2/1/2020,7/1/2020
NCT06204458,RECRUITING,Post-COVID Syndrome,OTHER: mild hyperthermia group|OTHER: sham group,Universität Duisburg-Essen,Bavarian State Ministry of Health and Care,ALL,"ADULT, OLDER_ADULT",NA,60,OTHER,INTERVENTIONAL,1/8/2024,3/31/2025
NCT05268523,RECRUITING,COVID-19,BEHAVIORAL: Education and Strategies Intervention|BEHAVIORAL: Mindfulness Skills Intervention,Toronto Rehabilitation Institute,"Canadian Institutes of Health Research (CIHR)|University Health Network, Toronto",ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,270,OTHER,INTERVENTIONAL,11/23/2021,9/1/2022
NCT06091358,RECRUITING,Long COVID,DEVICE: PrO2,University of Bath,Swansea University,ALL,"ADULT, OLDER_ADULT",NA,16,OTHER,INTERVENTIONAL,10/20/2023,4/20/2024
NCT04511923,UNKNOWN,"Covid19|ARDS, Human|Lung Injury, Acute|Ventilation Perfusion Mismatch",DRUG: Nebulised heparin,University College Hospital Galway,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,40,OTHER,INTERVENTIONAL,12/23/2020,2022-01
NCT05141058,RECRUITING,SARS-CoV-2 Infection,BIOLOGICAL: Coronavirus-specific T cell (CST),Children's National Research Institute,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1,24,OTHER,INTERVENTIONAL,10/19/2021,12/15/2027
NCT04641858,COMPLETED,Covid19|Morbidity|Absenteeism,BIOLOGICAL: BCG-Denmark|BIOLOGICAL: Saline,University of Southern Denmark,"Institute of Hygiene and Tropical Medicine, NOVA University, Lisbon, Portugal|University of Cape Verde, Praia, Cape Verde|National Institute of Public Health of Cape Verde, Praia, Cape Verde|Centro de Investigacao em Saude de Manhica|European and Developing Countries Clinical Trials Partnership (EDCTP)|Bandim Health Project, Bissau, Guinea-Bissau",ALL,"ADULT, OLDER_ADULT",PHASE4,668,OTHER,INTERVENTIONAL,12/3/2020,7/13/2022
NCT04621123,COMPLETED,SARS-CoV-2 Infection|Safety and Efficacy,BIOLOGICAL: Convalescent anti-SARS-CoV-2 MBT plasma|OTHER: Control Group,"Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia","Germans Trias i Pujol Hospital|IrsiCaixa|Banc de Sang i Teixits|Grifols Biologicals, LLC",ALL,"ADULT, OLDER_ADULT",PHASE2,384,OTHER,INTERVENTIONAL,11/10/2020,7/28/2021
NCT04345523,COMPLETED,COVID-19,OTHER: Blood and derivatives.|DRUG: Standard of Care,Cristina Avendaño Solá,Instituto de Salud Carlos III,ALL,"ADULT, OLDER_ADULT",PHASE2,350,OTHER,INTERVENTIONAL,4/3/2020,4/5/2021
NCT04611802,COMPLETED,SARS-CoV Infection|Covid19,BIOLOGICAL: SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination Period)|OTHER: Placebo (Initial Vaccination Period)|BIOLOGICAL: SARS-CoV-2 rS/Matrix-M1 Adjuvant (Crossover Vaccination period)|OTHER: Placebo (Crossover Vaccination period)|BIOLOGICAL: SARS-CoV-2 rS/Matrix-M1 Adjuvant (Booster Vaccination)|BIOLOGICAL: SARS-CoV-2 rS/Matrix-M1 Adjuvant (Second Booster Vaccination),Novavax,Department of Health and Human Services,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,33000,INDUSTRY,INTERVENTIONAL,12/27/2020,12/15/2023
NCT04405102,TERMINATED,COVID-19,DRUG: Ozanimod|OTHER: Standard of care,Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec,Celgene|Bristol-Myers Squibb,ALL,"ADULT, OLDER_ADULT",PHASE2,43,OTHER,INTERVENTIONAL,9/16/2020,5/12/2022
NCT04422678,UNKNOWN,COVID-19,DRUG: Imatinib Mesylate|DRUG: Standard of Care,Alexandria University,"Science, Technology & Innovation Funding Authority (STIFA), Egypt",ALL,"ADULT, OLDER_ADULT",PHASE3,30,OTHER,INTERVENTIONAL,2020-06,2020-10
NCT04917523,COMPLETED,COVID-19 Pneumonia|COVID-19,"BIOLOGICAL: SARS-CoV-2 Vaccine (Vero Cell), Inactivated",China National Biotec Group Company Limited,Beijing Institute of Biological Products Co Ltd.,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,1800,INDUSTRY,INTERVENTIONAL,7/2/2021,4/29/2022
NCT04322123,COMPLETED,Coronavirus Infections,DRUG: Hydroxychloroquine Oral Product|DRUG: Hydroxychloroquine + azithromycin,Hospital do Coracao,Hospital Israelita Albert Einstein|Hospital Sirio-Libanes|Brazilian Research In Intensive Care Network|EMS,ALL,"ADULT, OLDER_ADULT",PHASE3,667,OTHER,INTERVENTIONAL,4/1/2020,6/2/2020
NCT04513184,COMPLETED,Covid19,DRUG: IV Dexamethasone|DRUG: Nasal Dexamethasone,Edda Sciutto Conde,Hospital General de México Dr. Eduardo Liceaga|Instituto Nacional de Cardiologia Ignacio Chavez|El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez,ALL,"ADULT, OLDER_ADULT",PHASE2,66,OTHER,INTERVENTIONAL,11/5/2021,11/13/2021
NCT04472728,TERMINATED,Covid-19|SARS-CoV2,DRUG: BIO101|DRUG: Placebo,Biophytis,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,238,INDUSTRY,INTERVENTIONAL,8/26/2020,9/30/2022
NCT04738136,SUSPENDED,Covid19|SARS-CoV-2 Infection,DRUG: S-1226,SolAeroMed Inc.,,ALL,"ADULT, OLDER_ADULT",PHASE2,30,INDUSTRY,INTERVENTIONAL,9/15/2021,12/31/2021
NCT04414241,COMPLETED,SARS-CoV-2,DRUG: Hydroxychloroquine,Universidad Peruana Cayetano Heredia,,ALL,"ADULT, OLDER_ADULT",PHASE3,68,OTHER,INTERVENTIONAL,6/25/2020,11/23/2020
NCT04516941,TERMINATED,SARS-CoV Infection|COVID-19,DRUG: Edoxaban Tablets|DRUG: Colchicine Tablets,"Insel Gruppe AG, University Hospital Bern","Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company",ALL,"ADULT, OLDER_ADULT",PHASE3,60,OTHER,INTERVENTIONAL,1/21/2021,8/31/2022
NCT04597736,UNKNOWN,Covid19|Contact Case,"BIOLOGICAL: Biological collection with nasopharyngeal samples, saliva, blood, stool and urine","University Hospital, Clermont-Ferrand",,ALL,"CHILD, ADULT, OLDER_ADULT",NA,100,OTHER,INTERVENTIONAL,2020-11,2022-02
NCT04980534,COMPLETED,"Covid19|COVID-19 Pneumonia|COVID-19 Respiratory Infection|Viral Infection|Respiratory Tract Infections|Infection, Coronavirus|SARS-CoV2 Infection",DIETARY_SUPPLEMENT: Viusid and Asbrip|DRUG: COVID-19 Standard Therapy,Catalysis SL,,ALL,"ADULT, OLDER_ADULT",NA,80,INDUSTRY,INTERVENTIONAL,1/8/2021,9/15/2021
NCT04469634,COMPLETED,SARS-CoV2|COVID-19,"DIAGNOSTIC_TEST: Assessing antibody responses, neutralizing capacity and memory B-cell function","Institute of Tropical Medicine, Belgium","Jessa Hospital|University Hospital, Antwerp|Universiteit Antwerpen|Sciensano|Mensura",ALL,"ADULT, OLDER_ADULT",NA,150,OTHER,INTERVENTIONAL,7/31/2020,12/31/2022
NCT05273541,UNKNOWN,Patients With Cancer|Vaccine Reaction|COVID-19,BIOLOGICAL: Coronavirus vaccination,Beijing 302 Hospital,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,100,OTHER,INTERVENTIONAL,2/11/2022,7/30/2023
NCT04961541,COMPLETED,SARS-CoV Infection|Covid19,BIOLOGICAL: ICC Vaccine|BIOLOGICAL: qNIV Nanoparticle Vaccine2 in-clinic mixed with Matrix-M1 Adjuvant|BIOLOGICAL: SARS-CoV-2 rS Nanoparticle Vaccine in-clinic mixed with Matrix-M1 Adjuvant,Novavax,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,642,INDUSTRY,INTERVENTIONAL,9/8/2021,4/22/2022
NCT05238441,UNKNOWN,COVID-19|Sars-CoV-2 Infection,BIOLOGICAL: SCTV01E|BIOLOGICAL: Comirnaty|BIOLOGICAL: SCTV01E|BIOLOGICAL: Comirnaty,Sinocelltech Ltd.,,ALL,"ADULT, OLDER_ADULT",PHASE2,360,INDUSTRY,INTERVENTIONAL,3/20/2022,5/1/2023
NCT04471636,ACTIVE_NOT_RECRUITING,Covid-19|Cardiovascular Risk Factor,DEVICE: Withings ScanWatch,Ludwig-Maximilians - University of Munich,"Gesundheitsreferat (GSR), Landeshauptstadt München|Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)",ALL,"ADULT, OLDER_ADULT",NA,607,OTHER,INTERVENTIONAL,9/18/2020,6/30/2023
NCT05289128,RECRUITING,Coronavirus COVID-19|Respiratory Infection,DEVICE: Experimental group|DEVICE: Sham Control,Federal University of Paraíba,,ALL,"ADULT, OLDER_ADULT",NA,30,OTHER,INTERVENTIONAL,2/7/2022,7/31/2022
NCT04364828,COMPLETED,COVID-19,GENETIC: Whole Genome Analysis|GENETIC: T-cell receptor (TCR) repertoire|GENETIC: SARS-CoV-2 viral composition,University Hospital Tuebingen,,ALL,"ADULT, OLDER_ADULT",NA,1000,OTHER,INTERVENTIONAL,10/21/2020,8/31/2023
NCT04871828,UNKNOWN,Moderate Covid19,DRUG: Leukotriene Receptor Antagonist|OTHER: Placebo,King Abdullah International Medical Research Center,,ALL,"ADULT, OLDER_ADULT",PHASE3,66,OTHER,INTERVENTIONAL,2/28/2021,2021-12
NCT04310228,UNKNOWN,COVID-19,DRUG: Favipiravir Combined With Tocilizumab|DRUG: Favipiravir|DRUG: Tocilizumab,Peking University First Hospital,,ALL,"ADULT, OLDER_ADULT",NA,150,OTHER,INTERVENTIONAL,3/8/2020,2020-05
NCT05473936,RECRUITING,Vaccine Hesitancy|COVID-19 Testing|Community Health Workers,BEHAVIORAL: Community Health Worker led curriculum,Charles Drew University of Medicine and Science,Los Angeles County Department of Public Health|National Library of Medicine (NLM),ALL,"CHILD, ADULT, OLDER_ADULT",NA,66,OTHER,INTERVENTIONAL,10/11/2022,2023-05
NCT04376034,RECRUITING,COVID19|Coronavirus Infection|Coronavirus|Virus Diseases|RNA Virus Infections,BIOLOGICAL: Convalescent Plasma 1 Unit|BIOLOGICAL: Convalescent Plasma 2 Units|OTHER: Standard of Care,West Virginia University,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,240,OTHER,INTERVENTIONAL,4/16/2020,3/30/2021
NCT04935528,COMPLETED,Cancer,BIOLOGICAL: serology and ELISPOT test|BIOLOGICAL: serology,Centre Georges Francois Leclerc,,ALL,"ADULT, OLDER_ADULT",NA,539,OTHER,INTERVENTIONAL,6/2/2021,1/26/2022
NCT04659941,ACTIVE_NOT_RECRUITING,COVID 19 Vaccine,BIOLOGICAL: BCG vaccine|BIOLOGICAL: 0.9% sodium chloride (NaCl) saline solution,Universidade Federal do Rio de Janeiro,"Ministry of Science and Technology, Brazil",ALL,"ADULT, OLDER_ADULT",PHASE2,752,OTHER,INTERVENTIONAL,10/1/2020,4/1/2024
NCT05793736,ACTIVE_NOT_RECRUITING,"Post-Acute COVID-19 Syndrome|Biofeedback, Psychology|Quality of Life|Depressive Symptoms|Fatigue|Anxiety|Pain|Cognitive Symptom",DEVICE: Biofeedback training|DRUG: Treatment as usual,University of Cagliari,,ALL,"ADULT, OLDER_ADULT",NA,20,OTHER,INTERVENTIONAL,2/2/2023,6/2/2024
NCT05310084,COMPLETED,SARS-CoV-2 Infection|COVID-19,BIOLOGICAL: BNT162b2|OTHER: Placebo|BIOLOGICAL: Seasonal Inactivated Influenza Vaccine,BioNTech SE,Pfizer,ALL,ADULT,PHASE3,1134,INDUSTRY,INTERVENTIONAL,4/20/2022,10/5/2022
NCT05753228,RECRUITING,Mitochondrial Dysfunction|COVID-19|Fatigue,OTHER: MRI/ 3D Arterial Spin Labelling (ASL) and 1H magnetic resonance spectroscopy (MRS)|OTHER: Chalder Fatigue Scale|OTHER: Health Questionnaire (EQ-5D-5L)|OTHER: Hamilton Depression Rating Scale,"National University Hospital, Singapore",National University of Singapore,ALL,"ADULT, OLDER_ADULT",NA,90,OTHER,INTERVENTIONAL,12/9/2022,12/8/2023
NCT05220241,RECRUITING,SARS-CoV-2 Infection|Cognitive Disorder,BIOLOGICAL: Nasopharyngeal swab for RT-PCR SARS-CoV-2,Fondation Ophtalmologique Adolphe de Rothschild,Hotel Dieu Hospital|Institut Pasteur|Hôpital Lariboisière Fernand Widal,ALL,ADULT,NA,50,NETWORK,INTERVENTIONAL,7/1/2022,7/1/2024
NCT05468736,ACTIVE_NOT_RECRUITING,COVID-19,BIOLOGICAL: Biological/Vaccine: SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination Period)|BIOLOGICAL: SARS-CoV-2 rS/Matrix-M1 Adjuvant (Open Label Crossover Vaccination period)|BIOLOGICAL: SARS-CoV-2 rS/Matrix-M1 Adjuvant (Booster Vaccination)|OTHER: Placebo,Novavax,,ALL,CHILD,PHASE2|PHASE3,3600,INDUSTRY,INTERVENTIONAL,7/22/2022,9/8/2025
NCT04498936,COMPLETED,COVID,DRUG: Sofosbuvir and Ledipasvir|DRUG: Nitazoxanide,Assiut University,Helwan University,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,240,OTHER,INTERVENTIONAL,7/15/2020,10/30/2020
NCT04589936,UNKNOWN,Pneumonia|Covid19,PROCEDURE: Prone positioning,Cambridge University Hospitals NHS Foundation Trust,,ALL,"ADULT, OLDER_ADULT",NA,56,OTHER,INTERVENTIONAL,9/3/2020,6/30/2021
NCT04349228,WITHDRAWN,COVID19|Sars-CoV2|Hydroxychloroquine|Prophylaxis|Healthcare Worker,DRUG: Hydroxychloroquine (HCQ)|DRUG: Placebo oral tablet,Abderrahmane Mami Hospital,Eshmoun Clinical Research Center|Datametrix,ALL,"ADULT, OLDER_ADULT",PHASE3,0,OTHER,INTERVENTIONAL,4/28/2020,7/15/2020
NCT04593641,COMPLETED,SARS-CoV-2 Infection,BIOLOGICAL: CT-P59,Celltrion,,ALL,ADULT,PHASE1,18,INDUSTRY,INTERVENTIONAL,9/4/2020,4/5/2021
NCT05036941,UNKNOWN,SARS CoV-2 Infection|Influenza -Like Illness,DEVICE: Acteev™ Masks|DEVICE: Comparison Masks,Ascend Performance Materials,Jehangir Clinical Development Centre Pvt. Ltd.,ALL,"ADULT, OLDER_ADULT",NA,1600,INDUSTRY,INTERVENTIONAL,11/13/2021,2022-02
NCT05658536,ACTIVE_NOT_RECRUITING,Post COVID-19 Condition|Post-COVID-19 Syndrome,BEHAVIORAL: 6-Week Self-Management Group,University of Washington,,ALL,"ADULT, OLDER_ADULT",NA,51,OTHER,INTERVENTIONAL,1/18/2023,2024-02
NCT04379336,COMPLETED,COVID-19|Sars-CoV2,BIOLOGICAL: Bacille Calmette-Guérin (BCG)|OTHER: Placebo Comparator,TASK Applied Science,,ALL,"ADULT, OLDER_ADULT",PHASE3,1000,OTHER,INTERVENTIONAL,5/4/2020,1/2/2022
NCT04782336,SUSPENDED,Covid19|RSV Infection|Influenza Type A|Influenza Type B,OTHER: Sample Collection,LumiraDx UK Limited,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,2500,INDUSTRY,INTERVENTIONAL,12/12/2020,6/30/2024
NCT04710394,COMPLETED,Anosmia|Covid19|Ageusia|Hyposmia|Hypogeusia|SARS-CoV-2 Infection|COVID-19 Pandemic,BEHAVIORAL: Smell Training,Washington University School of Medicine,,ALL,"ADULT, OLDER_ADULT",NA,240,OTHER,INTERVENTIONAL,1/11/2021,3/11/2022
NCT05080218,RECRUITING,Rheumatoid Arthritis|Psoriatic Arthritis|Spondylarthritis,DRUG: Upadacitinib|DRUG: Abatacept|DRUG: Secukinumab|DRUG: Tofacitinib|DRUG: TNF Inhibitor|DRUG: Canakinumab Injection|DRUG: Baricitinib|DRUG: Ixekizumab,Jeffrey Curtis,University of Alabama at Birmingham|University of Nebraska|University of Pennsylvania|AbbVie|Bristol-Myers Squibb|Novartis|Eli Lilly and Company|Pfizer|Illumination Health,ALL,"ADULT, OLDER_ADULT",PHASE4,1000,OTHER,INTERVENTIONAL,11/15/2021,9/30/2024
NCT04582318,TERMINATED,SARS-CoV-2 Infection,BIOLOGICAL: NGM621|BIOLOGICAL: Placebo,"NGM Biopharmaceuticals, Inc",,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,16,INDUSTRY,INTERVENTIONAL,11/9/2020,3/11/2021
NCT04389294,COMPLETED,COVID,DIAGNOSTIC_TEST: SARS-CoV2 serum antibody testing,"Hospital for Special Surgery, New York",,ALL,"ADULT, OLDER_ADULT",NA,143,OTHER,INTERVENTIONAL,5/5/2020,9/4/2020
NCT05191394,COMPLETED,Therapeutic Plasma Exchange,DIAGNOSTIC_TEST: Evolution of antibodies titre,Cliniques universitaires Saint-Luc- Université Catholique de Louvain,,ALL,"ADULT, OLDER_ADULT",NA,15,OTHER,INTERVENTIONAL,9/8/2021,2/1/2022
NCT04404218,ACTIVE_NOT_RECRUITING,COVID,DIETARY_SUPPLEMENT: Açaí palm berry extract - natural product|OTHER: Placebo,"University Health Network, Toronto",University of Toronto,ALL,"ADULT, OLDER_ADULT",PHASE2,480,OTHER,INTERVENTIONAL,8/4/2020,2022-12
NCT04532294,COMPLETED,Covid19,DRUG: BGB DXP593|DRUG: Placebo,BeiGene,,ALL,ADULT,PHASE1,18,INDUSTRY,INTERVENTIONAL,9/8/2020,2/13/2021
NCT05009732,TERMINATED,Covid19,DRUG: GT0918|DRUG: Standard of care|DRUG: Matching placebo,"Suzhou Kintor Pharmaceutical Inc,",,ALL,"ADULT, OLDER_ADULT",PHASE3,139,INDUSTRY,INTERVENTIONAL,9/30/2021,7/14/2023
NCT04422977,UNKNOWN,Sars-CoV2,DIAGNOSTIC_TEST: Sars-Cov-2 serology,Centre Hospitalier Saint Joseph Saint Luc de Lyon,,ALL,"ADULT, OLDER_ADULT",NA,900,OTHER,INTERVENTIONAL,6/8/2020,6/30/2020
NCT04311177,COMPLETED,Corona Virus Infection|Acute Respiratory Distress Syndrome|SARS-CoV Infection,DRUG: Losartan|OTHER: Placebo,University of Minnesota,,ALL,"ADULT, OLDER_ADULT",PHASE2,117,OTHER,INTERVENTIONAL,4/9/2020,2/1/2021
NCT05338177,ACTIVE_NOT_RECRUITING,COVID-19,OTHER: Immunosuppression reduction|OTHER: No immunosuppression reduction,Medical University of Vienna,,ALL,"ADULT, OLDER_ADULT",PHASE1,40,OTHER,INTERVENTIONAL,11/15/2021,11/14/2022
NCT04754594,COMPLETED,SARS-CoV-2 Infection|COVID-19|Maternal Immunization,BIOLOGICAL: BNT162b2|OTHER: Placebo,BioNTech SE,Pfizer,FEMALE,"ADULT, OLDER_ADULT",PHASE3,683,INDUSTRY,INTERVENTIONAL,2/16/2021,7/15/2022
NCT04333732,COMPLETED,COVID 19,DRUG: MR or M-M-R II ® vaccine|DRUG: Placebo,Washington University School of Medicine,COVID -19 Therapeutics Accelerator,ALL,"ADULT, OLDER_ADULT",PHASE3,3545,OTHER,INTERVENTIONAL,9/4/2020,12/3/2021
NCT04332094,UNKNOWN,COVID-19,DRUG: Tocilizumab|DRUG: Hydroxychloroquine|DRUG: Azithromycin,Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau,Instituto de Salud Carlos III,ALL,"ADULT, OLDER_ADULT",PHASE2,276,OTHER,INTERVENTIONAL,4/2/2020,2021-07
NCT06082518,NOT_YET_RECRUITING,"Post COVID-19 Condition|Post-COVID-19 Syndrome|Post-COVID Syndrome|COVID-19|Fatigue|Fatigue Syndrome, Chronic",DEVICE: Monoplace Hyperbaric Chamber (Class III medical device).,Sunnybrook Health Sciences Centre,,ALL,"ADULT, OLDER_ADULT",NA,40,OTHER,INTERVENTIONAL,2023-12,12/30/2025
NCT05067894,COMPLETED,Covid19,BIOLOGICAL: SARS-CoV-2 Protein Subunit Recombinant Vaccine|BIOLOGICAL: SARS-CoV-2 Inactivated Vaccine,PT Bio Farma,"Fakultas Kedokteran Universitas Indonesia|National Institute of Health Research and Development, Ministry of Health Republic of Indonesia",ALL,"ADULT, OLDER_ADULT",PHASE1,54,INDUSTRY,INTERVENTIONAL,12/10/2021,8/6/2022
NCT04542694,COMPLETED,COVID-19,DRUG: Favipiravir|DRUG: Standard of care,"Promomed, LLC",,ALL,"ADULT, OLDER_ADULT",PHASE3,200,OTHER,INTERVENTIONAL,5/21/2020,8/20/2020
NCT04899232,TERMINATED,Antithrombin III Deficiency|Covid19,DRUG: Antithrombin III,Enrique Ginzburg,"Grifols Biologicals, LLC",ALL,"ADULT, OLDER_ADULT",PHASE2,52,OTHER,INTERVENTIONAL,7/6/2021,3/31/2022
NCT05817032,RECRUITING,Long COVID-19|Long COVID|Post COVID-19 Condition|Post-COVID-19 Syndrome|Post-COVID Syndrome,BEHAVIORAL: Telerehabilitation|BEHAVIORAL: Standard rehabilitation care,Indonesia University,,ALL,ADULT,NA,22,OTHER,INTERVENTIONAL,2023-05,2023-11
NCT05886777,COMPLETED,Healthy Participants,BIOLOGICAL: Combination [RSVpreF+BNTb162b2]|BIOLOGICAL: Bivalent BNT162b2 (original/Omi BA.4/BA.5)|BIOLOGICAL: RSVpreF|BIOLOGICAL: QIV|BIOLOGICAL: Normal Saline Placebo,Pfizer,,ALL,OLDER_ADULT,PHASE2,1084,INDUSTRY,INTERVENTIONAL,6/5/2023,1/1/2024
NCT05481177,RECRUITING,Long Haul COVID|Postural Orthostatic Tachycardia Syndrome,DRUG: Ivabradine,Uniformed Services University of the Health Sciences,,ALL,"ADULT, OLDER_ADULT",PHASE4,250,FED,INTERVENTIONAL,6/14/2023,9/1/2024
NCT05747677,COMPLETED,COVID-19|SARS-CoV-2 Infection,DRUG: HH-120 Nasal Spray,Beijing Ditan Hospital,,ALL,"ADULT, OLDER_ADULT",NA,14,OTHER,INTERVENTIONAL,6/14/2022,2/6/2023
NCT04377477,UNKNOWN,COVID-19,RADIATION: Single fraction whole lung radiotherapy,Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia,,ALL,"ADULT, OLDER_ADULT",NA,30,OTHER,INTERVENTIONAL,5/10/2020,8/30/2022
NCT04366232,TERMINATED,Covid-19,DRUG: Anakinra alone (stages 2b/3)|DRUG: Anakinra and Ruxolitinib (overcome stage 3)|OTHER: Standard of care,Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer,Hôpital d'instruction des armées Sainte-Anne|Assistance Publique Hopitaux De Marseille,ALL,"ADULT, OLDER_ADULT",PHASE2,2,OTHER,INTERVENTIONAL,8/19/2020,10/2/2020
NCT04983394,ACTIVE_NOT_RECRUITING,Covid19,OTHER: Virtual Realty Exercises|OTHER: Aerobic exercises|OTHER: conventional exercises,Cumhuriyet University,,ALL,"ADULT, OLDER_ADULT",NA,63,OTHER,INTERVENTIONAL,8/1/2021,5/1/2022
NCT04510194,ACTIVE_NOT_RECRUITING,Covid19|SARS-CoV Infection,DRUG: Metformin|DRUG: Placebo|DRUG: Fluvoxamine|DRUG: Ivermectin,University of Minnesota,"UnitedHealth Group|Northwestern University|Hennepin County Medical Center, Minneapolis|University of Colorado, Denver|Olive View-UCLA Education & Research Institute",ALL,"ADULT, OLDER_ADULT",PHASE3,1323,OTHER,INTERVENTIONAL,1/1/2021,2/14/2024
NCT04336332,TERMINATED,SARS-CoV-2|COVID-19,COMBINATION_PRODUCT: Hydroxychloroquine Sulfate + Azithromycin|DRUG: Hydroxychloroquine Sulfate,"Rutgers, The State University of New Jersey",,ALL,"ADULT, OLDER_ADULT",PHASE2,75,OTHER,INTERVENTIONAL,4/1/2020,10/14/2020
NCT05209477,COMPLETED,Acute Respiratory Failure,OTHER: lung ultrasound assessment,Azienda Ospedaliera di Perugia,,ALL,"ADULT, OLDER_ADULT",NA,25,OTHER,INTERVENTIONAL,12/1/2021,5/31/2022
NCT05894577,COMPLETED,Covid19,OTHER: Placebo|DRUG: Montelukast,"Susanna Naggie, MD",National Center for Advancing Translational Sciences (NCATS)|Vanderbilt University Medical Center,ALL,"ADULT, OLDER_ADULT",PHASE3,1403,OTHER,INTERVENTIONAL,1/27/2023,1/1/2024
NCT06175494,NOT_YET_RECRUITING,COVID-19,BIOLOGICAL: Recombinant COVID-19 (XBB) Trimer Protein Vaccine (Sf9 Cell)|BIOLOGICAL: Recombinant COVID-19 Variant Vaccine (Sf9 Cell)|BIOLOGICAL: Placebo,"WestVac Biopharma Co., Ltd.","WestVac Biopharma (Guangzhou) Co., Ltd.",ALL,"ADULT, OLDER_ADULT",PHASE3,4800,INDUSTRY,INTERVENTIONAL,12/19/2023,1/31/2025
NCT04390594,UNKNOWN,COVID-19,DRUG: Nafamostat Mesilate,Institut Pasteur de Dakar,"Fann Hospital, Senegal|Ministry of Health, Senegal|Diamniadio Children Hospital, Senegal|Dalal Jamm Hospital, Senegal|Institut Pasteur Korea",ALL,"ADULT, OLDER_ADULT",PHASE3,186,OTHER,INTERVENTIONAL,8/13/2020,8/12/2021
NCT04260594,COMPLETED,2019-nCoV,DRUG: Arbidol|OTHER: basic treatment,Jieming QU,,ALL,"ADULT, OLDER_ADULT",PHASE4,236,OTHER,INTERVENTIONAL,2/8/2020,12/30/2020
NCT04569877,COMPLETED,Severe Acute Respiratory Syndrome (SARS) Pneumonia|COVID-19 Pneumonia,DRUG: Molgramostim nebuliser solution|OTHER: Placebo nebuliser solution,University of Giessen,,ALL,"ADULT, OLDER_ADULT",PHASE2,63,OTHER,INTERVENTIONAL,9/24/2020,9/20/2022
NCT05433194,ACTIVE_NOT_RECRUITING,COVID-19,BIOLOGICAL: ABO1009-DP,"Suzhou Abogen Biosciences Co., Ltd.",,ALL,"ADULT, OLDER_ADULT",PHASE1,48,INDUSTRY,INTERVENTIONAL,8/22/2022,8/25/2023
NCT04429594,RECRUITING,Coronavirus Infections,OTHER: blood sampling,Centre Hospitalier Universitaire de Nice,,ALL,"ADULT, OLDER_ADULT",NA,1000,OTHER,INTERVENTIONAL,7/28/2020,12/31/2025
NCT04356534,COMPLETED,SARS-CoV 2|COVID-19,OTHER: plasma therapy using convalescent plasma with antibody against SARS-CoV-2|OTHER: Routine care for COVID-19 patients,Royal College of Surgeons in Ireland - Medical University of Bahrain,"Salmaniya Medical Complex|Bahrain Defence Force Hospital|Mohammed Bin Khalifa Bin Sulman Al Khalifa Cardiac Centre, Awali",ALL,"ADULT, OLDER_ADULT",NA,40,OTHER,INTERVENTIONAL,4/19/2020,7/9/2020
NCT04377334,UNKNOWN,ARDS|COVID-19,BIOLOGICAL: MSC,University Hospital Tuebingen,,ALL,"ADULT, OLDER_ADULT",PHASE2,40,OTHER,INTERVENTIONAL,2022-05,2023-02
NCT05487040,TERMINATED,COVID-19,DRUG: PF-07321332 (nirmatrelvir)/ritonavir,Pfizer,,ALL,"ADULT, OLDER_ADULT",PHASE1,15,INDUSTRY,INTERVENTIONAL,9/7/2022,7/11/2023
NCT04363840,WITHDRAWN,COVID|Vitamin D Deficiency|Coagulopathy|Disseminated Intravascular Coagulation,DRUG: Aspirin 81 mg|DIETARY_SUPPLEMENT: Vitamin D,Louisiana State University Health Sciences Center in New Orleans,,ALL,"ADULT, OLDER_ADULT",PHASE2,0,OTHER,INTERVENTIONAL,2020-05,2020-12
NCT06208540,COMPLETED,Post-covid-19 Persistent Smell and Taste Disorders,DRUG: Cerebrolysin|OTHER: olfactory and gustatory trainings,Sherifa Ahmed Hamed,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,150,OTHER,INTERVENTIONAL,8/30/2021,12/30/2023
NCT04461340,UNKNOWN,COVID 19,DRUG: Sirolimus,Alexandria University,,ALL,"ADULT, OLDER_ADULT",PHASE2,40,OTHER,INTERVENTIONAL,8/15/2020,11/30/2020
NCT05167357,UNKNOWN,"Covid19|SARS-CoV2 Infection|Hypoxia, Altitude",BIOLOGICAL: COVID19,Institut de Formation et de Recherche en Médecine de Montagne,University of Paris 13|Ecole Nationale des Sports de Montagne,ALL,"ADULT, OLDER_ADULT",NA,90,OTHER,INTERVENTIONAL,3/18/2021,11/30/2022
NCT04833101,COMPLETED,COVID-19,BIOLOGICAL: recombinant Ad5 vectored COVID-19 vaccine|BIOLOGICAL: RBD-based protein subunit vaccine (ZF2001) against COVID-19|BIOLOGICAL: trivalent split influenza vaccine,Jiangsu Province Centers for Disease Control and Prevention,,ALL,"ADULT, OLDER_ADULT",PHASE4,120,NETWORK,INTERVENTIONAL,4/7/2021,3/4/2022
NCT05216601,COMPLETED,COVID-19 Vaccine,BIOLOGICAL: MVC-COV1901|BIOLOGICAL: MVC-COV1901(Beta)-15|BIOLOGICAL: MVC-COV1901(Beta)-25,Medigen Vaccine Biologics Corp.,,ALL,ADULT,PHASE1,107,INDUSTRY,INTERVENTIONAL,5/6/2022,11/30/2022
NCT04681001,COMPLETED,Respiratory Viral Infection|Common Cold|Severe Acute Respiratory Syndrome (SARS) Pneumonia|COVID-19|Corona Virus Disease,DEVICE: nasal spray,Marinomed Biotech AG,,ALL,"ADULT, OLDER_ADULT",NA,300,INDUSTRY,INTERVENTIONAL,12/20/2020,8/30/2021
NCT04411680,COMPLETED,COVID-19|SARS-CoV-2,DRUG: Sargramostim|DRUG: Standard of care,"Partner Therapeutics, Inc.",United States Department of Defense,ALL,"ADULT, OLDER_ADULT",PHASE2,123,INDUSTRY,INTERVENTIONAL,8/18/2020,5/19/2021
NCT04344457,UNKNOWN,COVID-19,DRUG: Hydroxychloroquine|DRUG: Indomethacin|DRUG: Zithromax Oral Product,"Perseverance Research Center, LLC",Athena Medical Group,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,80,OTHER,INTERVENTIONAL,4/16/2020,9/30/2020
NCT04387240,WITHDRAWN,Covid 19 Positive|Corona Virus Infection,DRUG: Artemisinin / Artesunate|OTHER: placebo,Princess Nourah Bint Abdulrahman University,,ALL,ADULT,PHASE2,0,OTHER,INTERVENTIONAL,2022-01,2022-12
NCT04491240,COMPLETED,Covid19|SARS-CoV-2 PNEUMONIA|COVID-19,DRUG: EXO 1 inhalation|DRUG: EXO 2 inhalation|DRUG: Placebo inhalation,"State-Financed Health Facility ""Samara Regional Medical Center Dinasty""",Clinics of the Federal State Budgetary Educational Institution SSMU|Samara Regional Clinical Hospital V.D. Seredavin,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,30,OTHER,INTERVENTIONAL,7/20/2020,10/20/2020
NCT04998240,ACTIVE_NOT_RECRUITING,Covid19,"BIOLOGICAL: BBIBP-CorV - Inactivated SARS-CoV-2 vaccine (Vero cell)|BIOLOGICAL: Ad26.COV2.S (Recombinant, replication-incompetent adenovirus serotype 26 (Ad26) vector encoding a full-length and stabilized SARS-CoV-2 spike protein),|BIOLOGICAL: Placebo - Normal saline (0.9% sodium chloride solution)",International Vaccine Institute,"The Coalition for Epidemic Preparedness Innovations (CEPI)|Instituto Nacional de Saúde (INS), Mozambique|University of Antananarivo|International Centre for Diarrhoeal Disease Research, Bangladesh|Harvard University|Heidelberg University",ALL,"ADULT, OLDER_ADULT",PHASE2,360,OTHER,INTERVENTIONAL,12/29/2021,2/28/2024
NCT04577235,COMPLETED,COVID-19,OTHER: severity of lung involvement with COVID-19.,Gaziosmanpasa Research and Education Hospital,,ALL,"ADULT, OLDER_ADULT",NA,29,OTHER_GOV,INTERVENTIONAL,6/5/2020,9/5/2020
NCT04353596,COMPLETED,SARS-CoV-2|COVID-19,"DRUG: ACE inhibitor, angiotensin receptor blocker",Medical University Innsbruck,Ludwig-Maximilians - University of Munich|Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK),ALL,"ADULT, OLDER_ADULT",PHASE4,216,OTHER,INTERVENTIONAL,4/20/2020,2/24/2021
NCT04997395,COMPLETED,Long COVID,DRUG: MediCabilis Cannabis sativa 50,Bod Australia,"Drug Science, UK",ALL,"ADULT, OLDER_ADULT",PHASE2,12,INDUSTRY,INTERVENTIONAL,4/14/2022,1/6/2023
NCT06159296,RECRUITING,Post-Acute COVID-19 Syndrome,DEVICE: Hydroxy gas,Oxford Brookes University,,ALL,"ADULT, OLDER_ADULT",NA,25,OTHER,INTERVENTIONAL,9/25/2023,5/31/2024
NCT04322396,TERMINATED,Virus Diseases|Infection Viral|Corona Virus Infection,DRUG: Azithromycin|DRUG: Hydroxychloroquine|DRUG: Placebo oral tablet|DRUG: Placebo oral tablet,"Chronic Obstructive Pulmonary Disease Trial Network, Denmark",,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,117,OTHER,INTERVENTIONAL,4/6/2020,2/2/2021
NCT04530396,UNKNOWN,Covid19 Prevention,BIOLOGICAL: Gam-COVID-Vac|OTHER: placebo,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation",Government of the city of Moscow|CRO: Crocus Medical BV,ALL,"ADULT, OLDER_ADULT",PHASE3,33758,OTHER,INTERVENTIONAL,9/7/2020,5/1/2021
NCT05656495,COMPLETED,COVID-19,DRUG: Tyrosyl-D-alanyl-glycyl-phenylalanyl-leucyl-arginine succinate intramuscularly|DRUG: Tyrosyl-D-alanyl-glycyl-phenylalanyl-leucyl-arginine succinate inhaled|DRUG: Standard of care,"Promomed, LLC",,ALL,"ADULT, OLDER_ADULT",PHASE3,313,OTHER,INTERVENTIONAL,2/28/2022,11/22/2022
NCT04356495,COMPLETED,Corona Virus Infection|Sars-CoV2,DIETARY_SUPPLEMENT: Vitamins|DRUG: Telmisartan|DRUG: Ciclesonide|DRUG: interferon β-1b,"University Hospital, Bordeaux",University of Bordeaux,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,412,OTHER,INTERVENTIONAL,7/29/2020,10/22/2021
NCT05208996,COMPLETED,COVID-19,DRUG: siCoV/KK46,National Research Center - Institute of Immunology Federal Medical-Biological Agency of Russia,St. Petersburg Research Institute of Vaccines and Sera,MALE,ADULT,PHASE1,10,OTHER,INTERVENTIONAL,1/22/2021,3/26/2021
NCT05007496,COMPLETED,COVID-19,BIOLOGICAL: AV-COVID-19,"Aivita Biomedical, Inc.",PT AIVITA Biomedika Indonesia|Kariadi Hospital|Central Army Hospital RSPAD Gatot Soebroto,ALL,"ADULT, OLDER_ADULT",PHASE2,145,INDUSTRY,INTERVENTIONAL,4/14/2021,5/31/2021
NCT04860895,UNKNOWN,Covid19,DIAGNOSTIC_TEST: AP-23,Fable Biyoteknoloji San ve Tic A.S,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,4400,INDUSTRY,INTERVENTIONAL,2/11/2021,5/15/2021
NCT04720235,COMPLETED,Covid19|Corona Virus Infection,DEVICE: Lucira COVID-19 All-In-One test kit,Lucira Health Inc,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,304,INDUSTRY,INTERVENTIONAL,12/9/2020,3/30/2021
NCT04912895,COMPLETED,Covid19,DEVICE: PneumoniaCheck,Emory University,Georgia Tech Foundation,ALL,"ADULT, OLDER_ADULT",NA,69,OTHER,INTERVENTIONAL,4/14/2021,8/5/2022
NCT06208696,RECRUITING,Long Covid19,"OTHER: ""Tomando control de su salud"" (Spanish Chronic Disease Self-Management)",University of Puerto Rico,National Institutes of Health (NIH),ALL,"ADULT, OLDER_ADULT",NA,50,OTHER,INTERVENTIONAL,11/2/2023,2024-06
NCT04426695,COMPLETED,COVID-19,DRUG: REGN10933+REGN10987 combination therapy|DRUG: Placebo,Regeneron Pharmaceuticals,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,2252,INDUSTRY,INTERVENTIONAL,6/10/2020,10/22/2021
NCT04338698,COMPLETED,COVID 19,DRUG: Hydroxychloroquine|DRUG: Oseltamivir|DRUG: Azithromycin,Shehnoor Azhar,,ALL,"ADULT, OLDER_ADULT",PHASE3,550,OTHER,INTERVENTIONAL,4/22/2020,11/22/2020
NCT04583995,COMPLETED,SARS-CoV-2 Infection|COVID-19,BIOLOGICAL: SARS-CoV-2 rS/Matrix M1-Adjuvant|OTHER: Placebo|BIOLOGICAL: Licensed seasonal influenza vaccine,Novavax,,ALL,"ADULT, OLDER_ADULT",PHASE3,15138,INDUSTRY,INTERVENTIONAL,9/28/2020,3/29/2022
NCT05799495,COMPLETED,SARS-CoV-2 Infection,DRUG: PF-07817883|DRUG: Placebo,Pfizer,,ALL,ADULT,PHASE2,239,INDUSTRY,INTERVENTIONAL,5/24/2023,10/11/2023
NCT05163496,ACTIVE_NOT_RECRUITING,"Burnout, Caregiver|Burnout, Professional|COVID-19|Depression|Post Traumatic Stress Disorder|Moral Injury",DRUG: Psilocybin (Usona Institute)|DRUG: Active placebo,University of Washington,,ALL,"ADULT, OLDER_ADULT",PHASE3,30,OTHER,INTERVENTIONAL,3/3/2022,3/30/2024
NCT04796896,ACTIVE_NOT_RECRUITING,SARS-CoV-2,BIOLOGICAL: mRNA-1273|BIOLOGICAL: Placebo|BIOLOGICAL: mRNA-1273.214,"ModernaTX, Inc.",,ALL,CHILD,PHASE2|PHASE3,11950,INDUSTRY,INTERVENTIONAL,3/15/2021,4/5/2024
NCT04435795,TERMINATED,COVID 19,DRUG: Normal Saline intranasal and placebo inhaler|DRUG: Ciclesonide|DRUG: Ciclesonide nasal,McGill University Health Centre/Research Institute of the McGill University Health Centre,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,215,OTHER,INTERVENTIONAL,9/15/2020,7/8/2021
NCT04894435,ACTIVE_NOT_RECRUITING,COVID-19,"BIOLOGICAL: mRNA-1273 SARS-CoV-2 vaccine|BIOLOGICAL: BNT162b2|BIOLOGICAL: ChAdOx1-S [recombinant]|OTHER: 0, 28 day schedule|OTHER: 0, 112 day schedule|BIOLOGICAL: Covifenz",Canadian Immunization Research Network,Canadian Center for Vaccinology|BC Children's Hospital Research Institute|Children's Hospital Research Institute of Manitoba|CHU de Quebec-Universite Laval|Ottawa Hospital Research Institute|Ontario Agency for Health Protection and Promotion|University of Toronto|Massachusetts General Hospital|Interior Health|McGill University Health Centre/Research Institute of the McGill University Health Centre,ALL,"ADULT, OLDER_ADULT",PHASE2,669,NETWORK,INTERVENTIONAL,5/20/2021,2024-03
NCT04808895,UNKNOWN,COVID-19|Thrombosis Pulmonary,DRUG: Acetylsalicylic acid|DRUG: Placebo,Azienda Ospedaliera Universitaria Integrata Verona,,ALL,"ADULT, OLDER_ADULT",PHASE3,204,OTHER,INTERVENTIONAL,4/1/2021,8/31/2021
NCT05675995,RECRUITING,Long COVID,BEHAVIORAL: External Qigong,"University of California, Davis",,ALL,"ADULT, OLDER_ADULT",NA,48,OTHER,INTERVENTIONAL,1/4/2023,7/30/2024
NCT04721535,TERMINATED,Covid19|SARS-COV-2 Infection,DRUG: DWJ1248|DRUG: Placebo,Daewoong Pharmaceutical Co. LTD.,,ALL,"ADULT, OLDER_ADULT",PHASE3,9,INDUSTRY,INTERVENTIONAL,6/7/2021,10/6/2021
NCT05133635,WITHDRAWN,COVID-19 Virus Infection|Cytokine Storm|Corticosteroid|Tocilizumab,DRUG: Methylprednisolone|DRUG: Tocilizumab,Marmara University,,ALL,"ADULT, OLDER_ADULT",PHASE4,0,OTHER,INTERVENTIONAL,2/1/2021,4/1/2021
NCT05092581,TERMINATED,COVID-19,DRUG: casirivimab+imdevimab,Regeneron Pharmaceuticals,,ALL,CHILD,PHASE1,2,INDUSTRY,INTERVENTIONAL,12/16/2021,6/9/2022
NCT05166876,TERMINATED,COVID-19,DRUG: Brequinar Sodium|DRUG: Dipyridamole 75 MG|DRUG: Placebo,"Clear Creek Bio, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE2,26,INDUSTRY,INTERVENTIONAL,2/1/2022,6/4/2022
NCT05218174,RECRUITING,COVID-19,OTHER: Exercise Prescription,Baylor Research Institute,Sports Academy,ALL,"ADULT, OLDER_ADULT",NA,50,OTHER,INTERVENTIONAL,4/22/2022,12/1/2025
NCT04399681,UNKNOWN,"COVID|Pneumonia, Viral",DEVICE: Bedside lung ultrasound,Kanuni Sultan Suleyman Training and Research Hospital,,ALL,"ADULT, OLDER_ADULT",NA,100,OTHER,INTERVENTIONAL,5/10/2020,9/10/2020
NCT04561076,WITHDRAWN,COVID 19,DRUG: HLX70|OTHER: Placebo,Hengenix Biotech Inc,"Sanyou Biopharmaceuticals(Shanghai)Co., Ltd|Shanghai ZJ Bio-Tech Co., Ltd",ALL,ADULT,PHASE1,0,INDUSTRY,INTERVENTIONAL,12/9/2020,9/18/2021
NCT05950776,WITHDRAWN,Covid19,BIOLOGICAL: MVA-SARS-2-S|OTHER: Placebo,Universitätsklinikum Hamburg-Eppendorf,German Center for Infection Research|Philipps University Marburg Medical Center|Ludwig-Maximilians - University of Munich|University Hospital Tuebingen|CTC-NORTH,ALL,"ADULT, OLDER_ADULT",PHASE2,0,OTHER,INTERVENTIONAL,1/15/2021,11/2/2022
NCT04777981,UNKNOWN,COVID-19|SAR,DIETARY_SUPPLEMENT: CBDRA60 supplement|DIETARY_SUPPLEMENT: Placebo,Anewsha Therapeutics Inc.,University of Michigan|Biologics Consulting,ALL,"ADULT, OLDER_ADULT",NA,60,INDUSTRY,INTERVENTIONAL,7/1/2022,12/28/2022
NCT04385199,COMPLETED,Coronavirus Infection|Coronavirus|COVID,BIOLOGICAL: Convalescent plasma,Henry Ford Health System,,ALL,"ADULT, OLDER_ADULT",PHASE2,30,OTHER,INTERVENTIONAL,5/4/2020,8/1/2020
NCT05780281,COMPLETED,COVID-19,BIOLOGICAL: VIR-7831|BIOLOGICAL: Placebo|BIOLOGICAL: Remdesivir,National Institute of Allergy and Infectious Diseases (NIAID),"International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)|University of Copenhagen|Medical Research Council|Kirby Institute|Washington D.C. Veterans Affairs Medical Center|AIDS Clinical Trials Group|National Heart, Lung, and Blood Institute (NHLBI)|US Department of Veterans Affairs|Prevention and Early Treatment of Acute Lung Injury|Cardiothoracic Surgical Trials Network|Vir Biotechnology, Inc.|GlaxoSmithKline|University of Minnesota",ALL,"ADULT, OLDER_ADULT",PHASE3,367,NIH,INTERVENTIONAL,12/16/2020,10/4/2022
NCT04902976,COMPLETED,Covid19,OTHER: CPC+ZN|OTHER: CPC|OTHER: Negative Control,Hospital Israelita Albert Einstein,Colgate Palmolive,ALL,"ADULT, OLDER_ADULT",NA,105,OTHER,INTERVENTIONAL,4/4/2021,10/30/2021
NCT04380376,UNKNOWN,COVID-19|Viral Pneumonia,DRUG: Melphalan|OTHER: Standard of care,"Federal State Budgetary Institution, Pulmonology Scientific Research Institute","Medsi Clinic #1, Moscow|Moscow State University of Medicine and Dentistry",ALL,"ADULT, OLDER_ADULT",PHASE2,60,OTHER_GOV,INTERVENTIONAL,4/30/2020,10/30/2020
NCT04420676,ACTIVE_NOT_RECRUITING,COVID,DIETARY_SUPPLEMENT: Omnibiotic AAD|DIETARY_SUPPLEMENT: Placebo,Medical University of Graz,,ALL,"ADULT, OLDER_ADULT",NA,30,OTHER,INTERVENTIONAL,9/24/2020,2023-12
NCT05308576,NOT_YET_RECRUITING,COVID-19|SARS-CoV-2 Infection,BIOLOGICAL: SCTV01E|BIOLOGICAL: Placebo,Sinocelltech Ltd.,,ALL,"ADULT, OLDER_ADULT",PHASE3,10000,INDUSTRY,INTERVENTIONAL,2023-03,2024-10
NCT05303376,COMPLETED,COVID-19,BIOLOGICAL: IBIO123|OTHER: Placebo,Immune Biosolutions Inc,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,123,INDUSTRY,INTERVENTIONAL,2/22/2022,6/27/2023
NCT05648799,COMPLETED,Pharmacokinetics|Safety Issues|Efficacy,DRUG: GP30341 capsules 200 mg|DRUG: Standard therapy,Geropharm,,ALL,"ADULT, OLDER_ADULT",NA,246,INDUSTRY,INTERVENTIONAL,3/17/2022,7/20/2022
NCT04473898,COMPLETED,COVID,OTHER: Aerobic Exercise Training|BEHAVIORAL: Patient Education|OTHER: Respiratory Exercise Training,KTO Karatay University,,ALL,"ADULT, OLDER_ADULT",NA,35,OTHER,INTERVENTIONAL,6/19/2020,2/17/2021
NCT04582344,ACTIVE_NOT_RECRUITING,COVID-19,BIOLOGICAL: CoronaVac|BIOLOGICAL: Placebo,Health Institutes of Turkey,,ALL,ADULT,PHASE3,10214,OTHER_GOV,INTERVENTIONAL,9/14/2020,8/31/2022
NCT04389944,COMPLETED,Coronavirus Disease 2019 Infectious Disease (COVID-19 Infection),OTHER: convalescent plasma application to SARS-CoV-2 infected patients,"University Hospital, Basel, Switzerland",,ALL,"ADULT, OLDER_ADULT",NA,15,OTHER,INTERVENTIONAL,3/31/2020,6/30/2020
NCT04357444,COMPLETED,COVID 19,DRUG: 1: ILT101|DRUG: 2: Placebo Comparator,Assistance Publique - Hôpitaux de Paris,Iltoo Pharma,ALL,"ADULT, OLDER_ADULT",PHASE2,30,OTHER,INTERVENTIONAL,10/23/2020,4/5/2021
NCT04999098,RECRUITING,COVID-19 Respiratory Infection|SARS-CoV2 Infection,DRUG: Echinaforce Forte tablets|DRUG: Echinaforce Chewable tablets|DRUG: Echinaforce tincture,A. Vogel AG,Clinical Research Centre CONVEX|Biodome Clinical|MediStat Ltd.|Medical University of Graz,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,75,INDUSTRY,INTERVENTIONAL,11/15/2021,2023-08
NCT05153044,UNKNOWN,Sickle Cell Disease,OTHER: severe acute respiratory syndrome CoV-2 serology,Assistance Publique - Hôpitaux de Paris,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,880,OTHER,INTERVENTIONAL,12/30/2021,9/10/2022
NCT05239598,COMPLETED,COVID-19,DRUG: Mouth rinse,University of Pennsylvania,This study was funded by an Investigator Initiated Research grant from Avrio Health L.P,ALL,"ADULT, OLDER_ADULT",PHASE2,40,OTHER,INTERVENTIONAL,2/7/2022,7/13/2022
NCT04401644,UNKNOWN,Diagnoses Disease|Coronavirus,DIAGNOSTIC_TEST: Novel laser inferometry test for CORONA virus,Somerset NHS Foundation Trust,University of Exeter|University of Plymouth,ALL,"ADULT, OLDER_ADULT",NA,250,OTHER,INTERVENTIONAL,2020-06,2021-12
NCT04566276,COMPLETED,COVID-19 Vaccine|Safety Issues,BIOLOGICAL: ChulaCov19 vaccine|OTHER: Placebo,Chulalongkorn University,"Chula Vaccine Research Center (ChulaVRC), Bangkok, Thailand|Center of Excellence in Vaccine Research and Development, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand|Chula Clinical Research Center (Chula CRC), King Chulalongkorn Memorial Hospital, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand|King Chulalongkorn Memorial Hospital (KCMH), Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand|Center of Excellence for Vaccine Trial (Vaccine Trial Centre), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand|National Vaccine Institute, Thailand",ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,192,OTHER,INTERVENTIONAL,5/3/2021,12/6/2022
NCT04449276,COMPLETED,Severe Acute Respiratory Syndrome|Coronavirus|SARS-CoV-2|COVID-19,BIOLOGICAL: CVnCoV Vaccine|DRUG: Placebo,CureVac,Coalition for Epidemic Preparedness Innovations,ALL,ADULT,PHASE1,280,INDUSTRY,INTERVENTIONAL,6/18/2020,12/21/2021
NCT05077176,ACTIVE_NOT_RECRUITING,COVID-19|Sars-CoV-2 Infection,BIOLOGICAL: CoronaVac|BIOLOGICAL: Turkovac,Health Institutes of Turkey,,ALL,ADULT,PHASE3,4340,OTHER_GOV,INTERVENTIONAL,10/8/2021,12/31/2023
NCT04935476,UNKNOWN,COVID-19,DRUG: Dapsone 85 mg PO BID|DRUG: Placebo 85 mg PO BID,McGill University Health Centre/Research Institute of the McGill University Health Centre,Pulmonem Inc.,ALL,"ADULT, OLDER_ADULT",PHASE3,3000,OTHER,INTERVENTIONAL,11/22/2021,7/31/2022
NCT04334876,COMPLETED,SARS-CoV-2,DIAGNOSTIC_TEST: SARS-CoV-2 IgG Antibody Testing Kit,Indiana University,,ALL,"ADULT, OLDER_ADULT",NA,571,OTHER,INTERVENTIONAL,4/1/2020,1/1/2021
NCT04359095,COMPLETED,COVID-19,DRUG: Emtricitabine/tenofovir|DRUG: Colchicine Pill|DRUG: Rosuvastatin|OTHER: Standard treatment,Universidad Nacional de Colombia,Pontificia Universidad Javeriana|Clínica Colsanitas-Clínica Universitaria Colombia|Hospital Universitario San Ignacio|Hospital Universitario Nacional de Colombia (HUN)|Fundación Cardioinfantil Instituto de Cardiología|Clínica Infantil Santa María del Lago,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,650,OTHER,INTERVENTIONAL,8/18/2020,6/30/2021
NCT04322773,TERMINATED,Corona Virus Disease,DRUG: RoActemra iv|DRUG: RoActemra sc|DRUG: Kevzara sc|OTHER: Standard medical care,Marius Henriksen,,ALL,"ADULT, OLDER_ADULT",PHASE2,20,OTHER,INTERVENTIONAL,4/5/2020,10/8/2020
NCT05693064,NOT_YET_RECRUITING,Long COVID,OTHER: wait-list|PROCEDURE: chiropractic adjustments,Life University,,ALL,"ADULT, OLDER_ADULT",NA,40,OTHER,INTERVENTIONAL,1/15/2024,1/15/2025
NCT04707664,COMPLETED,Covid19|SARS-CoV Infection,DRUG: Sargramostim|DRUG: Placebo,"Partner Therapeutics, Inc.",United States Department of Defense,ALL,"ADULT, OLDER_ADULT",PHASE2,600,INDUSTRY,INTERVENTIONAL,4/27/2021,1/31/2022
NCT04730661,UNKNOWN,SARS-CoV Infection,DIAGNOSTIC_TEST: Sit to stand test,"University Hospital, Rouen",,ALL,"ADULT, OLDER_ADULT",NA,146,OTHER,INTERVENTIONAL,12/21/2020,12/28/2021
NCT04682873,COMPLETED,Covid-19 Disease,DRUG: Enisamium Iodide|DRUG: Placebo,"Joint Stock Company ""Farmak""",,ALL,"ADULT, OLDER_ADULT",PHASE3,592,INDUSTRY,INTERVENTIONAL,5/15/2020,3/26/2021
NCT04672564,TERMINATED,Coronavirus Disease 2019,DRUG: Carrimycin|DRUG: Placebo,"Shenyang Tonglian Group CO., Ltd",,ALL,"ADULT, OLDER_ADULT",PHASE3,93,INDUSTRY,INTERVENTIONAL,3/30/2021,5/9/2022
NCT04811664,COMPLETED,SARS-CoV-2 Infection,BIOLOGICAL: Moderna COVID-19 Vaccine,National Institute of Allergy and Infectious Diseases (NIAID),,ALL,ADULT,PHASE3,1923,NIH,INTERVENTIONAL,3/24/2021,12/30/2021
NCT04355364,TERMINATED,COVID-19|Acute Respiratory Distress Syndrome,DRUG: Dornase Alfa Inhalation Solution [Pulmozyme]|PROCEDURE: standard procedure,Fondation Ophtalmologique Adolphe de Rothschild,"University Hospital, Strasbourg, France|Centre Hospitalier Régional Metz-Thionville",ALL,"ADULT, OLDER_ADULT",PHASE3,77,NETWORK,INTERVENTIONAL,4/21/2020,12/20/2021
NCT04348864,RECRUITING,Communicable Disease|COVID-19|Sars-CoV2|Infectious Disease|Coronavirus|Virus,"DIAGNOSTIC_TEST: COVID-19 Antigen/Antibody Rapid Testing, mobile device image capture and telemedicine support|OTHER: Telemedicine",Neuroganics LLC,Neuroganics Diagnostics LLC|Artron Laboratories Inc|AllBio Science Inc.|Turklab,ALL,"ADULT, OLDER_ADULT",NA,200,INDUSTRY,INTERVENTIONAL,4/16/2020,2022-04
NCT05876364,ACTIVE_NOT_RECRUITING,COVID-19|SARS-CoV-2,BIOLOGICAL: QTP104 1ug|BIOLOGICAL: QTP104 5ug|BIOLOGICAL: QTP104 25ug,Quratis Inc.,,ALL,ADULT,PHASE1,36,INDUSTRY,INTERVENTIONAL,11/19/2021,8/30/2023
NCT04413864,UNKNOWN,SARS-CoV 2,OTHER: Inflammatory cytokines and chemokines profiles of patients with dexmedetomidine administration,Assistance Publique - Hôpitaux de Paris,,ALL,"ADULT, OLDER_ADULT",NA,50,OTHER,INTERVENTIONAL,4/24/2020,10/24/2022
NCT04404361,TERMINATED,COVID19|COVID-19|COVID,DRUG: Pacritinib|DRUG: Placebo,CTI BioPharma,,ALL,"ADULT, OLDER_ADULT",PHASE2,200,INDUSTRY,INTERVENTIONAL,5/22/2020,9/21/2021
NCT04796064,COMPLETED,Sarcopenia,OTHER: low-intensity aerobic training,Cairo University,,MALE,"ADULT, OLDER_ADULT",NA,76,OTHER,INTERVENTIONAL,3/30/2020,12/15/2020
NCT04870164,TERMINATED,COVID-19,DRUG: Ensovibep|DRUG: Placebo,Molecular Partners AG,,ALL,"ADULT, OLDER_ADULT",PHASE1,53,INDUSTRY,INTERVENTIONAL,11/18/2020,1/6/2022
NCT05313646,COMPLETED,COVID-19,BIOLOGICAL: batch 1 of Ad5-nCoV|BIOLOGICAL: batch 2 of Ad5-nCoV|BIOLOGICAL: batch 3 of Ad5-nCoV,Jiangsu Province Centers for Disease Control and Prevention,,ALL,"ADULT, OLDER_ADULT",PHASE4,1050,NETWORK,INTERVENTIONAL,3/8/2021,9/8/2021
NCT05234346,COMPLETED,COVID-19 Respiratory Infection,DRUG: 150 mg 5-ALAPhosphate + SFC|OTHER: Placebo,Vedic Lifesciences Pvt. Ltd.,,ALL,"ADULT, OLDER_ADULT",NA,200,INDUSTRY,INTERVENTIONAL,3/15/2022,6/18/2022
NCT05305573,COMPLETED,COVID-19|SARS-CoV-2 Acute Respiratory Disease,BIOLOGICAL: COVID-19 Vaccine HIPRA 40 ug/dose|BIOLOGICAL: Comirnaty (Pfizer-BioNtech) 30 ug/dose concentrate for dispersion for injection,"Hipra Scientific, S.L.U",,ALL,"ADULT, OLDER_ADULT",PHASE2,26,INDUSTRY,INTERVENTIONAL,3/25/2022,10/1/2022
NCT04828564,UNKNOWN,SARS-CoV2|COVID-19,DRUG: Ribavirin Capsules|DRUG: Favipiravir,The Scientific and Technological Research Council of Turkey,Ankara City Hospital Bilkent|Istanbul Umraniye Training and Research Hospital|Koç University|Monitor CRO,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,100,OTHER,INTERVENTIONAL,2021-04,12/31/2021
NCT04377646,UNKNOWN,Sars-CoV2|COVID19,DRUG: Hydroxychloroquine|DRUG: Hydroxychloroquine (placebo)|DRUG: Zinc|DRUG: Zinc (Placebo),Military Hospital of Tunis,UR17DN02 : Autoimmune Diseases Research Unit|Dacima Consulting,ALL,"ADULT, OLDER_ADULT",PHASE3,660,OTHER,INTERVENTIONAL,5/4/2020,7/31/2020
NCT05104346,COMPLETED,Acute Appendicitis,PROCEDURE: appendectomy,Mansoura University,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,1945,OTHER,INTERVENTIONAL,3/31/2019,10/1/2021
NCT04821973,UNKNOWN,Covid19,DEVICE: Radius PPG Tetherless Pulse Oximetry (Masimo)|DEVICE: usual monitoring,Assistance Publique Hopitaux De Marseille,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,80,OTHER,INTERVENTIONAL,9/22/2020,11/15/2021
NCT04483973,ENROLLING_BY_INVITATION,Covid19|Coronavirus|Coronavirus Infection|Corona Virus Infection,DRUG: Ebselen|DRUG: Placebo,"Sound Pharmaceuticals, Incorporated",,ALL,"ADULT, OLDER_ADULT",PHASE2,60,INDUSTRY,INTERVENTIONAL,8/27/2021,12/31/2023
NCT04490473,UNKNOWN,Anxiety|SARS-CoV Infection,OTHER: survey work,DILEK SAYIK,,ALL,ADULT,NA,300,OTHER,INTERVENTIONAL,7/24/2020,4/24/2021
NCT06042764,RECRUITING,Infection of Upper Respiratory Tract Caused by 2019-nCoV,DRUG: SA55 Injection,"Sinovac Life Sciences Co., Ltd.",,ALL,"ADULT, OLDER_ADULT",PHASE2,150,INDUSTRY,INTERVENTIONAL,8/31/2023,8/30/2024
NCT05345873,NOT_YET_RECRUITING,COVID-19|SARS-CoV-2 Infection,BIOLOGICAL: SCTV01E|BIOLOGICAL: mRNA-1273,Sinocelltech Ltd.,,ALL,CHILD,PHASE2,300,INDUSTRY,INTERVENTIONAL,7/1/2022,4/1/2023
NCT05178173,RECRUITING,COVID-19|Coronavirus Infection|SARS CoV 2 Infection,OTHER: Placebo Comparator: Sterile Water|OTHER: 27% Ethanol plus essential oils|OTHER: 0.075% Cetylpyridinium Chloride,"University of North Carolina, Chapel Hill",,ALL,"ADULT, OLDER_ADULT",NA,150,OTHER,INTERVENTIONAL,1/20/2022,12/31/2023
NCT05553964,TERMINATED,COVID-19 Pandemic,DIAGNOSTIC_TEST: In Vitro,3EO Health,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,64,INDUSTRY,INTERVENTIONAL,10/7/2022,11/18/2022
NCT06057064,ACTIVE_NOT_RECRUITING,"COVID-19, SARS-CoV-2",BIOLOGICAL: Biological: AZD3152|BIOLOGICAL: Biological: Placebo,AstraZeneca,,ALL,"ADULT, OLDER_ADULT",PHASE2,116,INDUSTRY,INTERVENTIONAL,9/29/2023,5/27/2024
NCT04252664,SUSPENDED,COVID-19|SARS-CoV-2,DRUG: Remdesivir|DRUG: Remdesivir placebo,Capital Medical University,Chinese Academy of Medical Sciences,ALL,"ADULT, OLDER_ADULT",PHASE3,308,OTHER,INTERVENTIONAL,2/12/2020,4/27/2020
NCT06208761,COMPLETED,Triphala Capsule Supplementation|High-intensity Interval Training,OTHER: Triphala capsule supplementation and high-intensity interval training,Burapha University,,ALL,ADULT,PHASE2,141,OTHER,INTERVENTIONAL,5/9/2023,11/6/2023
NCT04433546,TERMINATED,Acute Respiratory Distress Syndrome|Coronavirus|Hypoxic Respiratory Failure|Hypoxemic Respiratory Failure|Respiratory Complication|Respiratory Insufficiency|Cardiac Dysfunction|Pneumonia|Pulmonary Edema|Pulmonary Inflammation|Respiratory Failure|Cytokine Storm|COVID 19|SARS-CoV-2|Cardiac Event|Cardiac Complication|Cardiac Failure|Cardiac Infarct,DRUG: Pemziviptadil (PB1046)|DRUG: Low Dose (10 mg) Control,PhaseBio Pharmaceuticals Inc.,,ALL,"ADULT, OLDER_ADULT",PHASE2,54,INDUSTRY,INTERVENTIONAL,7/15/2020,12/2/2020
NCT04382846,RECRUITING,COVID|Corona Virus Infection,DRUG: Nitazoxanide,Tanta University,,ALL,"ADULT, OLDER_ADULT",PHASE3,160,OTHER,INTERVENTIONAL,5/8/2020,12/1/2030
NCT04409873,TERMINATED,COVID-19|SARS-CoV 2|Severe Acute Respiratory Syndrome Coronavirus 2|Virus Disease|Coronavirus Infections|Pharyngeal Diseases,DRUG: Oral-B Mouth Sore mouthwash|DRUG: Crest Pro-Health Multi-Protection mouthwash|DRUG: CloSYS Ultra Sensitive Rinse mouthwash|DRUG: Distilled water|DRUG: Listerine Zero Mouthwash Product,"University of California, San Francisco","Rowpar Pharmaceuticals, Inc.",ALL,"ADULT, OLDER_ADULT",PHASE2,54,OTHER,INTERVENTIONAL,3/31/2021,9/10/2022
NCT04568564,RECRUITING,Lung Cancer|Physiotherapy,"OTHER: Breathing exercise, intensive spirometry use, supported cough, progressive mobilisation and ambulation|OTHER: Exercise booklet",Istanbul Medipol University Hospital,,ALL,"ADULT, OLDER_ADULT",NA,40,OTHER,INTERVENTIONAL,10/1/2020,12/1/2024
NCT04933864,COMPLETED,SARS-CoV-2,DRUG: Methylene Blue and Photodynamic Therapy,I.M. Sechenov First Moscow State Medical University,Prokhorov General Physics Institute of the Russian Academy of Sciences (GPI RAS),ALL,"ADULT, OLDER_ADULT",PHASE1,60,OTHER,INTERVENTIONAL,4/24/2020,7/30/2020
NCT05765773,ACTIVE_NOT_RECRUITING,Corona Virus Infection|Vaccine|COVID-19,"BIOLOGICAL: CoviVac vaccine (inactivated whole-virion concentrated purified) manufactured by FSBSI ""Chumakov FSC R&D IBP RAS""",Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products,,ALL,"ADULT, OLDER_ADULT",PHASE2,200,OTHER_GOV,INTERVENTIONAL,7/1/2021,3/1/2023
NCT05396573,NOT_YET_RECRUITING,COVID-19,BIOLOGICAL: RQ3013|BIOLOGICAL: Comirnaty,"Walvax Biotechnology Co., Ltd.","Shanghai RNACure Biopharma Co., Ltd.",ALL,"ADULT, OLDER_ADULT",PHASE1,120,INDUSTRY,INTERVENTIONAL,2022-07,2023-07
NCT04406064,WITHDRAWN,Viral Infection,BIOLOGICAL: Viral Specific T-cells (VSTs),"Children's Hospital Medical Center, Cincinnati",Hoxworth Blood Center,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,0,OTHER,INTERVENTIONAL,2021-01,2025-06
NCT04393415,UNKNOWN,Virus,COMBINATION_PRODUCT: stem cells,Aljazeera Hospital,,ALL,"ADULT, OLDER_ADULT",NA,100,OTHER,INTERVENTIONAL,5/25/2020,9/1/2020
NCT05135650,TERMINATED,COVID-19 Infection|Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm,OTHER: Questionnaire Administration|BIOLOGICAL: Sotrovimab|PROCEDURE: Biospecimen Collection,Fred Hutchinson Cancer Center,"National Marrow Donor Program|Vir Biotechnology, Inc.",ALL,"ADULT, OLDER_ADULT",PHASE1,20,OTHER,INTERVENTIONAL,1/25/2022,1/10/2023
NCT05780450,RECRUITING,COVID-19|Long COVID|Long Covid19|SARS CoV 2 Infection|Persistent COVID-19|Migraine Disorders|Headaches Chronic|Cluster Headache|Arthralgia|Myalgia|Chronic Pain|Post-COVID-19 Syndrome|Post COVID-19 Condition,DEVICE: Transcranial Direct Current Therapy (tDCS),Fundación Universidad Católica de Valencia San Vicente Mártir,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,27,OTHER,INTERVENTIONAL,4/1/2023,2023-07
NCT04382950,UNKNOWN,COVID,COMBINATION_PRODUCT: Recombinant Bacterial ACE2 receptors -like enzyme of B38-CAP (rbACE2) plus Aerosolized 13 cis retinoic acid,Kafrelsheikh University,,ALL,ADULT,PHASE1,24,OTHER,INTERVENTIONAL,2021-07,2021-10
NCT05795816,RECRUITING,Long Covid19,DRUG: Testofen|DRUG: Microcrystalline cellulose,RDC Clinical Pty Ltd,,ALL,"ADULT, OLDER_ADULT",PHASE3,150,INDUSTRY,INTERVENTIONAL,10/25/2023,11/1/2025
NCT05012267,COMPLETED,Ards,OTHER: 16-hour PP,Ignacio Saez de la Fuente,,ALL,"ADULT, OLDER_ADULT",NA,61,OTHER,INTERVENTIONAL,3/25/2021,10/27/2021
NCT05077267,ACTIVE_NOT_RECRUITING,COVID-19 Disease,BIOLOGICAL: ABNCoV2 100ug|BIOLOGICAL: ABNCoV2 50ug,Bavarian Nordic,,ALL,"ADULT, OLDER_ADULT",PHASE2,197,INDUSTRY,INTERVENTIONAL,8/19/2021,2/1/2024
NCT04411667,COMPLETED,Sars-CoV2,DRUG: Octagam,"George Sakoulas, MD",Octapharma,ALL,"ADULT, OLDER_ADULT",PHASE4,34,OTHER,INTERVENTIONAL,4/28/2020,6/23/2020
NCT04844567,COMPLETED,Covid19|Dyspnea,DEVICE: COVVR_Synch|DEVICE: COVVR_Asynch,Ecole Polytechnique Fédérale de Lausanne,Mindmaze SA,ALL,"ADULT, OLDER_ADULT",NA,26,OTHER,INTERVENTIONAL,11/26/2020,4/6/2021
NCT04792567,COMPLETED,Secondary Progressive Multiple Sclerosis,DRUG: BAF312|DRUG: Baseline disease modifying therapies (DMTs),Novartis Pharmaceuticals,,ALL,"ADULT, OLDER_ADULT",PHASE4,41,INDUSTRY,INTERVENTIONAL,4/19/2021,8/15/2022
NCT04914767,COMPLETED,SARS-CoV2 Infection,DRUG: Nigella|DRUG: Placebo,Hôpital Universitaire Sahloul,,ALL,"ADULT, OLDER_ADULT",PHASE1,500,OTHER,INTERVENTIONAL,3/1/2021,12/31/2021
NCT04507867,COMPLETED,COVID19|Diabetes Mellitus|Hypertension|Obesity|Overweight|Oxygen Saturation|Mortality|Inflammation,DIETARY_SUPPLEMENT: Nutritional support system (NSS)|OTHER: Conventional nutritional support designed by hospital nutritionists,Anahuac University,,ALL,"ADULT, OLDER_ADULT",NA,80,OTHER,INTERVENTIONAL,9/7/2020,4/10/2021
NCT05226767,COMPLETED,COVID-19,DIETARY_SUPPLEMENT: NLC-V,"Todos Medical, Ltd.",,ALL,"ADULT, OLDER_ADULT",PHASE2,31,INDUSTRY,INTERVENTIONAL,1/30/2021,1/20/2022
NCT04718467,WITHDRAWN,COVID-19,BIOLOGICAL: Recombinant COVID-19 vaccine (Sf9 cells)|BIOLOGICAL: Placebo,Jiangsu Province Centers for Disease Control and Prevention,West China Hospital,ALL,"ADULT, OLDER_ADULT",PHASE2,0,NETWORK,INTERVENTIONAL,2/1/2021,3/15/2022
NCT04895267,ACTIVE_NOT_RECRUITING,COVID-19|Acute Respiratory Failure|Oxygen Deficiency,DEVICE: Low-field thoracic magnetic stimulation (LF-ThMS),Elias Manjarrez,"National Council of Science and Technology, Mexico",ALL,"ADULT, OLDER_ADULT",NA,17,OTHER,INTERVENTIONAL,7/3/2020,9/17/2022
NCT04414267,COMPLETED,COVID-19|Virus Diseases|Corona Virus Infection|Coronary Heart Disease|Chronic Obstructive Pulmonary Disease,BIOLOGICAL: BCG vaccine|BIOLOGICAL: Placebo,Hellenic Institute for the Study of Sepsis,,ALL,"ADULT, OLDER_ADULT",PHASE4,301,OTHER,INTERVENTIONAL,5/26/2020,5/7/2021
NCT04445467,UNKNOWN,COVID,DRUG: Favipiravir,Bayside Health,,ALL,"ADULT, OLDER_ADULT",PHASE2,190,OTHER_GOV,INTERVENTIONAL,7/30/2020,2021-12
NCT05005156,UNKNOWN,Covid19,BIOLOGICAL: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) (Ad5-nCoV),Fundación Huésped,Canadian Center for Vaccinology|CanSino Biologics Inc.|Hospital Fernandez,ALL,"ADULT, OLDER_ADULT",PHASE2,876,OTHER,INTERVENTIONAL,6/24/2021,9/30/2022
NCT04524156,UNKNOWN,COVID|Acute Respiratory Distress Syndrome|Endothelial Dysfunction,OTHER: Physiology,Erasme University Hospital,,ALL,"ADULT, OLDER_ADULT",NA,100,OTHER,INTERVENTIONAL,10/4/2020,5/4/2023
NCT04789356,UNKNOWN,Covid19,BIOLOGICAL: Adsorbed SARS-CoV-2 (inactivated) vaccine,Fundação de Medicina Tropical Dr. Heitor Vieira Dourado,Butantan Institute,ALL,ADULT,PHASE4,6233,OTHER,INTERVENTIONAL,3/18/2021,2022-03
NCT04834856,COMPLETED,Covid19,DRUG: ensovibep,Molecular Partners AG,,ALL,"ADULT, OLDER_ADULT",PHASE2,12,INDUSTRY,INTERVENTIONAL,4/1/2021,8/20/2021
NCT04569383,COMPLETED,Covid19,BIOLOGICAL: MVA-SARS-2-S vaccinations (days 0 & 28)|BIOLOGICAL: Comirnaty,Universitätsklinikum Hamburg-Eppendorf,German Center for Infection Research|Philipps University Marburg Medical Center|Ludwig-Maximilians - University of Munich,ALL,ADULT,PHASE1,30,OTHER,INTERVENTIONAL,10/5/2020,8/24/2021
NCT04847583,TERMINATED,COVID-19 Virus Infection,DRUG: Telacebec|DRUG: COVID-19 Standard of care,"Qurient Co., Ltd.",,ALL,"ADULT, OLDER_ADULT",PHASE2,1,INDUSTRY,INTERVENTIONAL,7/29/2021,2/11/2022
NCT04358783,COMPLETED,Coronavirus Infection,BIOLOGICAL: Plasma|OTHER: Best Available Therapy,Hospital Universitario Dr. Jose E. Gonzalez,,ALL,"ADULT, OLDER_ADULT",PHASE2,31,OTHER,INTERVENTIONAL,4/27/2020,5/1/2021
NCT05778383,COMPLETED,Zinc Deficiency|Sars-CoV-2 Infection,DIETARY_SUPPLEMENT: Zinc Acetate,Parc de Salut Mar,Universitat Pompeu Fabra,ALL,"ADULT, OLDER_ADULT",PHASE4,75,OTHER,INTERVENTIONAL,5/1/2021,5/25/2022
NCT04640233,UNKNOWN,COVID-19 Prevention,BIOLOGICAL: Gam-COVID-Vac|OTHER: Placebo,Dr. Reddy's Laboratories Limited,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation|Russian Direct Investment Fund|CRO: JSS Medical Research India Pvt. Ltd.",ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,1600,INDUSTRY,INTERVENTIONAL,11/30/2020,2021-09
NCT05047783,RECRUITING,Covid19|SARS-CoV2 Infection|Coronavirus Disease 2019,DRUG: Masitinib Mesylate|DRUG: Placebo,AB Science,,ALL,"ADULT, OLDER_ADULT",PHASE2,78,INDUSTRY,INTERVENTIONAL,11/23/2021,2023-12
NCT04748783,TERMINATED,COVID19|Coronavirus Infection|SARS CoV-2 Infection,OTHER: Water|OTHER: Peroxyl|DRUG: Periogard|OTHER: Colgate Total Zero,"University of North Carolina, Chapel Hill",Colgate Palmolive,ALL,"ADULT, OLDER_ADULT",PHASE2,2,OTHER,INTERVENTIONAL,3/26/2021,4/7/2021
NCT05074433,TERMINATED,Immunocompromised,DRUG: casirivimab+imdevimab|DRUG: Placebo,Regeneron Pharmaceuticals,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,66,INDUSTRY,INTERVENTIONAL,10/25/2021,5/18/2022
NCT04871737,COMPLETED,SARS-CoV-2 Infection,BIOLOGICAL: Recombinant NDV Vectored Vaccine for SARS-CoV-2,"Laboratorio Avi-Mex, S.A. de C.V.","National Council of Science and Technology, Mexico|Agencia Mexicana de Cooperación Internacional para el Desarrollo. AMEXCID",ALL,ADULT,PHASE1,91,INDUSTRY,INTERVENTIONAL,5/20/2021,9/30/2022
NCT03852537,COMPLETED,Pneumonia,DRUG: Methylprednisolone|OTHER: Usual Care,Mayo Clinic,,ALL,"ADULT, OLDER_ADULT",PHASE2,44,OTHER,INTERVENTIONAL,12/2/2019,11/17/2020
NCT04388514,UNKNOWN,SARS-CoV-2 Respiratory Failure,PROCEDURE: Medical Ozone procedure,Azienda Sanitaria-Universitaria Integrata di Udine,"Fondazione Toscana Gabriele Monasterio|Policlinico Militare, Roma - Italy|Ospedale San Liberatore di Atri|Ospedale Umberto I di Torino|Università di Siena|Ospedale Civile di Lucca|Ospedale di Siracusa|Azienda Sanitaria Locale di Vercelli",ALL,"ADULT, OLDER_ADULT",NA,90,OTHER,INTERVENTIONAL,4/8/2020,10/8/2020
NCT04397614,COMPLETED,Sars-CoV2|Covid-19,OTHER: mHealth Assessments,University of Oklahoma,National Cancer Institute (NCI),ALL,"ADULT, OLDER_ADULT",NA,128,OTHER,INTERVENTIONAL,7/22/2020,11/12/2021
NCT05370014,RECRUITING,"SARS- CoV-2|Cardiovascular Diseases|Chronic Kidney Diseases|Diabetes Mellitus, Type 2|Chronic Disease|Stroke",BEHAVIORAL: Integrating Community-based Intervention Under Nurse Guidance with Families (iCINGS FAM),University of South Carolina,National Institute of Nursing Research (NINR),ALL,"ADULT, OLDER_ADULT",NA,500,OTHER,INTERVENTIONAL,1/3/2023,2026-06
NCT05184114,RECRUITING,COVID-19|Myocarditis,"DIAGNOSTIC_TEST: Cardiac Magnetic Resonance, Blood Tests",The University of Hong Kong,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,162,OTHER,INTERVENTIONAL,10/4/2021,10/31/2024
NCT04602000,COMPLETED,SARS-CoV-2 Infection,BIOLOGICAL: CT-P59|BIOLOGICAL: CT-P59|BIOLOGICAL: Placebo|BIOLOGICAL: CT-P59|BIOLOGICAL: Placebo,Celltrion,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,1642,INDUSTRY,INTERVENTIONAL,10/5/2020,10/20/2021
NCT05351437,COMPLETED,SARS-CoV-2 Infection,DRUG: MTx-COVAB36|DRUG: Placebo,Memo Therapeutics AG,,ALL,ADULT,PHASE1,32,INDUSTRY,INTERVENTIONAL,4/26/2022,11/2/2022
NCT05597800,NOT_YET_RECRUITING,NSCLC Stage IV|HIV|HBV|HCV|Long COVID,DRUG: Nivolumab and Ipilimumab,Universita di Verona,,ALL,"ADULT, OLDER_ADULT",PHASE2,105,OTHER,INTERVENTIONAL,2/1/2023,3/30/2027
NCT04373200,COMPLETED,SARS-CoV-2 Coronavirus|Acute Respiratory Distress Syndrome,BIOLOGICAL: Blood samples collection|OTHER: Saliva collection,Rennes University Hospital,,ALL,"ADULT, OLDER_ADULT",NA,71,OTHER,INTERVENTIONAL,5/25/2020,3/9/2021
NCT04764422,COMPLETED,"Covid-19|SARS Pneumonia|Pneumonia, Viral|Covid-19 Vaccine",BIOLOGICAL: Normal Saline|BIOLOGICAL: NDV-HXP-S vaccine,Mahidol University,The Government Pharmaceutical Organization,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,455,OTHER,INTERVENTIONAL,3/20/2021,9/12/2022
NCT04590547,ACTIVE_NOT_RECRUITING,Pneumonitis|SARS-CoV Infection,DRUG: GLS-1027|DRUG: Placebo,"GeneOne Life Science, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE2,132,INDUSTRY,INTERVENTIONAL,5/7/2021,2023-12
NCT04597047,ACTIVE_NOT_RECRUITING,Covid19,DIAGNOSTIC_TEST: Capillary Collection & Testing|DIAGNOSTIC_TEST: Venous Draw & Testing,LumiraDx UK Limited,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,153,INDUSTRY,INTERVENTIONAL,7/9/2020,9/30/2023
NCT04651387,WITHDRAWN,SARS-CoV Infection,DIETARY_SUPPLEMENT: Ozonized oil (HOO,Neuromed IRCCS,,ALL,"ADULT, OLDER_ADULT",NA,0,OTHER,INTERVENTIONAL,2021-07,2021-12
NCT05224622,COMPLETED,COVID-19,DIAGNOSTIC_TEST: VOX,Scentech Medical Technologies Ltd,,ALL,"ADULT, OLDER_ADULT",NA,192,INDUSTRY,INTERVENTIONAL,1/18/2022,1/18/2023
NCT04690387,COMPLETED,COVID-19,BIOLOGICAL: AV-COVID-19|OTHER: GM-CSF,"Aivita Biomedical, Inc.","PT AIVITA Biomedika Indonesia|Indonesia Ministry of Health|National Institute of Health Research and Development, Ministry of Health Republic of Indonesia",ALL,"ADULT, OLDER_ADULT",PHASE1,27,INDUSTRY,INTERVENTIONAL,12/7/2020,1/15/2021
NCT05290987,TERMINATED,SARS-CoV-2 Infection,DEVICE: nasal spray,P & B Group,MediAxe CRO,ALL,"ADULT, OLDER_ADULT",NA,13,INDUSTRY,INTERVENTIONAL,1/14/2022,11/8/2022
NCT04276987,COMPLETED,Coronavirus,BIOLOGICAL: MSCs-derived exosomes,Ruijin Hospital,"Shanghai Public Health Clinical Center|Wuhan Jinyintan Hospital, Wuhan, China|Cellular Biomedicine Group Ltd.",ALL,"ADULT, OLDER_ADULT",PHASE1,24,OTHER,INTERVENTIONAL,2/15/2020,7/31/2020
NCT04625985,COMPLETED,Severe Acute Respiratory Syndrome Coronavirus 2,DRUG: Metformin Glycinate|DRUG: Placebo oral tablet,Laboratorios Silanes S.A. de C.V.,,ALL,"ADULT, OLDER_ADULT",PHASE2,20,INDUSTRY,INTERVENTIONAL,7/14/2020,3/18/2021
NCT04435522,COMPLETED,COVID,DRUG: Maraviroc,Rhode Island Hospital,,ALL,"ADULT, OLDER_ADULT",PHASE1,9,OTHER,INTERVENTIONAL,10/1/2020,12/31/2020
NCT04551547,COMPLETED,COVID-19,"BIOLOGICAL: Two doses of low dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28|BIOLOGICAL: Two doses of medium dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28|OTHER: Two doses of placebo at the schedule of day 0,28","Sinovac Research and Development Co., Ltd.",,ALL,CHILD,PHASE1|PHASE2,552,INDUSTRY,INTERVENTIONAL,10/31/2020,2/8/2023
NCT05225285,UNKNOWN,COVID-19,BIOLOGICAL: Inactivated Coronavac/Butantan vaccine|BIOLOGICAL: BNT162b2 (Pfizer),Federal University of Espirito Santo,Centro de Pesquisas René Rachou|Butantan Institute|Secretaria de Estado da Saúde do Espírito Santo - SESA,ALL,"CHILD, ADULT",PHASE3,1120,OTHER,INTERVENTIONAL,1/21/2022,3/21/2023
NCT04540185,UNKNOWN,Covid19|SARS (Severe Acute Respiratory Syndrome)|SARS-CoV Infection|SARS-CoV-2,BIOLOGICAL: Biological: oral polio vaccine|BIOLOGICAL: Comparable Placebo|DRUG: NA-831|DRUG: Comparable Placebo of drug|COMBINATION_PRODUCT: Combination of oral polio vaccine and NA-831|COMBINATION_PRODUCT: Comparable Placebo of Oral Polio Vaccine and Placebo of drug,"NeuroActiva, Inc.","Biomed Industries, Inc.",ALL,"ADULT, OLDER_ADULT",PHASE3,3600,INDUSTRY,INTERVENTIONAL,11/1/2020,12/31/2022
NCT04728347,TERMINATED,SARS-CoV-2,BIOLOGICAL: ARCT-021,"Arcturus Therapeutics, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE2,65,INDUSTRY,INTERVENTIONAL,1/4/2021,12/28/2021
NCT04573322,COMPLETED,SARS-CoV-2 (Covid19),DRUG: Trans Sodium Crocetinate|DRUG: Normal saline,Diffusion Pharmaceuticals Inc,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,25,INDUSTRY,INTERVENTIONAL,9/10/2020,4/29/2021
NCT05939622,COMPLETED,Asthenia|COVID-19|Functional MRI|Cognitive Impairment,OTHER: Structural and functional MRI|DRUG: Ethyl methyl hydroxypyridine succinate + Meldonium|DRUG: Placebo,"Promomed, LLC",,ALL,ADULT,PHASE4,30,OTHER,INTERVENTIONAL,5/18/2022,12/20/2022
NCT04982887,COMPLETED,Parkinson Disease,OTHER: Exercise,Hacettepe University,BElibol|NKöse|GYÇakmaklı,ALL,"ADULT, OLDER_ADULT",NA,12,OTHER,INTERVENTIONAL,5/8/2021,4/20/2022
NCT04346147,UNKNOWN,COVID-19 Pneumonia,DRUG: Imatinib tablets|DRUG: Baricitinib Oral Tablet|OTHER: Supportive tratment,Hospital Universitario de Fuenlabrada,Centro Nacional de Investigaciones Oncologicas CARLOS III,ALL,"ADULT, OLDER_ADULT",PHASE2,168,OTHER,INTERVENTIONAL,5/7/2020,2021-09
NCT05716347,RECRUITING,COVID-19,BIOLOGICAL: the recombinant SARS-CoV-2 S-Trimer vaccine/inactivated SARS-CoV-2 vaccine,"Binhui Biopharmaceutical Co., Ltd.",,ALL,ADULT,EARLY_PHASE1,63,INDUSTRY,INTERVENTIONAL,7/13/2022,12/9/2023
NCT05676047,RECRUITING,Long COVID,BEHAVIORAL: Cognitive Rehabilitation|OTHER: Education,McMaster University,Canadian Institutes of Health Research (CIHR),ALL,"ADULT, OLDER_ADULT",NA,100,OTHER,INTERVENTIONAL,5/1/2023,12/1/2024
NCT05195047,COMPLETED,SARS-CoV-2,DIETARY_SUPPLEMENT: 1 week placebo(Week 1)|DIETARY_SUPPLEMENT: 1 week of probiotics(Week 1)|DIETARY_SUPPLEMENT: 1 week placebo(Week 2)|DIETARY_SUPPLEMENT: 1 week of probiotics(Week 2)|DIETARY_SUPPLEMENT: 1 week placebo(Week 3)|DIETARY_SUPPLEMENT: 1 week of probiotics(Week 3),Peking University,"Centers for Disease Control and Prevention, China|Beijing Pinggu District Hospital|Peking University Health Science Center Hospital",ALL,ADULT,NA,44,OTHER,INTERVENTIONAL,2/27/2022,8/21/2022
NCT04468087,UNKNOWN,COVID-19,DRUG: Atazanavir|DRUG: Daclatasvir 60 mg|DRUG: Sofusbuvir + Daclastavir 60 mg|DRUG: Placebo Atazanavir|DRUG: Placebo Daclatasvir 60 mg|DRUG: Placebo Sofusbuvir + Daclatasvir 60 mg,Hospital do Coracao,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,256,OTHER,INTERVENTIONAL,2/15/2021,12/31/2022
NCT04374487,UNKNOWN,COVID 19,DRUG: Convalescent Plasma|OTHER: Standard Care Therapy,Max Healthcare Insititute Limited,,ALL,"ADULT, OLDER_ADULT",PHASE2,100,OTHER,INTERVENTIONAL,5/9/2020,8/9/2021
NCT05371522,ENROLLING_BY_INVITATION,COVID-19,RADIATION: [18F]DPA-714 positron emission tomography (PET) scan,"Amsterdam UMC, location VUmc",ZonMw: The Netherlands Organisation for Health Research and Development,ALL,ADULT,PHASE2|PHASE3,30,OTHER,INTERVENTIONAL,2/3/2022,2023-09
NCT05112887,COMPLETED,COVID-19 Lower Respiratory Infection|SARS-CoV2 Infection,OTHER: Osteopathic Manipulative Therapy,Ohio University,American Osteopathic Foundation,ALL,"ADULT, OLDER_ADULT",NA,20,OTHER,INTERVENTIONAL,3/31/2021,9/13/2021
NCT05775887,COMPLETED,COVID-19,BIOLOGICAL: UQSC2 Vaccine|BIOLOGICAL: NVX-CoV2373 vaccine,The University of Queensland,Coalition for Epidemic Preparedness Innovations,ALL,ADULT,PHASE1,70,OTHER,INTERVENTIONAL,5/8/2023,6/16/2023
NCT04355247,UNKNOWN,Covid-19,DRUG: MethylPREDNISolone 80 Mg/mL Injectable Suspension,Auxilio Mutuo Cancer Center,,ALL,"ADULT, OLDER_ADULT",PHASE2,20,OTHER,INTERVENTIONAL,4/14/2020,4/30/2021
NCT05618587,COMPLETED,Long COVID,DRUG: Lithium|DRUG: Placebo,State University of New York at Buffalo,National Center for Advancing Translational Sciences (NCATS),ALL,"ADULT, OLDER_ADULT",PHASE2,50,OTHER,INTERVENTIONAL,11/28/2022,7/21/2023
NCT04346446,COMPLETED,COVID,DRUG: Convalescent Plasma Transfusion|OTHER: Supportive Care|DRUG: Random Donor Plasma,"Institute of Liver and Biliary Sciences, India",,ALL,"ADULT, OLDER_ADULT",PHASE2,29,OTHER,INTERVENTIONAL,4/20/2020,5/30/2020
NCT05633446,NOT_YET_RECRUITING,Coronavirus|SARS-CoV-2 Infection|COVID-19,BIOLOGICAL: PepGNP-COVID19 (One vaccination)|OTHER: Water for injection (One vaccination)|BIOLOGICAL: PepGNP-COVID19 (Two vaccinations)|OTHER: Water for injection (Two vaccinations),Emergex Vaccines Holding Ltd.,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,110,INDUSTRY,INTERVENTIONAL,5/23/2023,10/23/2024
NCT04399746,COMPLETED,COVID,DRUG: Ivermectin|DRUG: Azithromycin|DRUG: Cholecalciferol,Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado,,ALL,"ADULT, OLDER_ADULT",NA,30,OTHER_GOV,INTERVENTIONAL,3/15/2020,6/10/2020
NCT04575064,UNKNOWN,SARS-CoV-2 Infection|COVID-19|Moderate and Severe COVID-19,OTHER: Standard of Care (SoC)|DRUG: Remdesivir,Professor Dr. Bernd Mühlbauer,"Dept. of Statistics and Medical Biometry, University of Bremen|INSERM (Institut national de la santé et de la recherche médicale), Paris, France|World Health Organization (WHO), R&D Blueprint, Geneva, Switzerland",ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,400,OTHER,INTERVENTIONAL,6/29/2020,2022-11
NCT05067946,WITHDRAWN,SARS-CoV2 Infection,BIOLOGICAL: GX-19N|OTHER: Placebo,"Genexine, Inc.",PT Kalbe Farma Tbk,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,0,INDUSTRY,INTERVENTIONAL,2021-10,2023-10
NCT05171946,NOT_YET_RECRUITING,Safety|Vaccine Reaction|Vaccine Adverse Reaction|Immunization; Infection,DRUG: S.opt.FL COVID-19 pDNA vaccine|DRUG: S.opt.FL COVID-19 pDNA vaccine|DRUG: S.opt.FL COVID-19 pDNA vaccine,Iman Almansour,ICON plc,ALL,ADULT,PHASE1,30,OTHER,INTERVENTIONAL,11/20/2022,7/1/2023
NCT05248373,NOT_YET_RECRUITING,COVID-19|SARS-CoV-2 Acute Respiratory Disease,BIOLOGICAL: Gam-COVID-Vac|OTHER: Placebo,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation",,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,400,OTHER,INTERVENTIONAL,3/8/2022,12/30/2023
NCT04363346,COMPLETED,COVID-19,DRUG: FT516,"Masonic Cancer Center, University of Minnesota",,ALL,"ADULT, OLDER_ADULT",PHASE1,5,OTHER,INTERVENTIONAL,5/14/2020,2/18/2021
NCT04992273,TERMINATED,COVID-19,DRUG: casirivimab+imdevimab,Regeneron Pharmaceuticals,,ALL,CHILD,PHASE2,7,INDUSTRY,INTERVENTIONAL,9/13/2021,6/1/2022
NCT04595773,RECRUITING,COVID-19,OTHER: Aerobic Exercise Training|OTHER: Education,National Institutes of Health Clinical Center (CC),,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,90,NIH,INTERVENTIONAL,1/22/2021,12/31/2026
NCT05197673,COMPLETED,Intention to Get SARS-CoV-2 Vaccination|Intention to Get SARS-CoV-2 Antibody Test,BEHAVIORAL: Theory of planned behaviours (TPB) based intervention,Chinese University of Hong Kong,,ALL,"ADULT, OLDER_ADULT",NA,310,OTHER,INTERVENTIONAL,3/15/2022,5/30/2023
NCT05813873,RECRUITING,Long COVID,OTHER: Triflow|OTHER: Control,European University Cyprus,Eden Resort Wellness Rehabilitation Center,ALL,"ADULT, OLDER_ADULT",NA,70,OTHER,INTERVENTIONAL,12/21/2022,7/31/2024
NCT04686773,COMPLETED,COVID-19,BIOLOGICAL: AZD1222|BIOLOGICAL: rAd26-S,R-Pharm,AstraZeneca|Russian Direct Investment Fund|The Gamaleya National Center of Epidemiology & Microbiology,ALL,"ADULT, OLDER_ADULT",PHASE2,100,INDUSTRY,INTERVENTIONAL,3/5/2021,3/18/2022
NCT05358873,COMPLETED,SARS CoV 2 Infection|SARS-CoV-2 Acute Respiratory Disease,DEVICE: Human IgG1 anti-SARS-CoV-2 antibody cocktail|DEVICE: Placebo,Chulalongkorn University,"Ramathibodi Hospital|Ever Medical Technology Co., Ltd.|The Government Pharmaceutical Organization|Ministry of Health, Thailand|HIBIOCY CO., Ltd.",ALL,ADULT,NA,50,OTHER,INTERVENTIONAL,4/20/2022,7/1/2022
NCT04392973,COMPLETED,COVID19,COMBINATION_PRODUCT: Favipiravir and Hydroxychloroquine,King Abdullah International Medical Research Center,,ALL,"ADULT, OLDER_ADULT",NA,268,OTHER,INTERVENTIONAL,5/21/2020,4/26/2021
NCT04557046,ACTIVE_NOT_RECRUITING,Covid19,DIAGNOSTIC_TEST: Nasal Swab|DIAGNOSTIC_TEST: Nasopharyngeal swab|DIAGNOSTIC_TEST: Throat swab|DIAGNOSTIC_TEST: Fingerstick|DIAGNOSTIC_TEST: Saliva specimen,LumiraDx UK Limited,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,1134,INDUSTRY,INTERVENTIONAL,6/26/2020,3/31/2024
NCT06097273,ACTIVE_NOT_RECRUITING,SARS-CoV-2|Influenza,BIOLOGICAL: mRNA-1083|BIOLOGICAL: Placebo|BIOLOGICAL: Influenza Vaccine|BIOLOGICAL: COVID-19 Vaccine,"ModernaTX, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE3,8075,INDUSTRY,INTERVENTIONAL,10/19/2023,5/21/2024
NCT04415073,TERMINATED,Coronavirus|COVID|ARDS|Cytokine Storm|Cytokine Release Syndrome,DRUG: SNDX-6352|DRUG: Placebo,Syndax Pharmaceuticals,,ALL,"ADULT, OLDER_ADULT",PHASE2,1,INDUSTRY,INTERVENTIONAL,5/30/2020,7/13/2020
NCT04734873,TERMINATED,Covid-19,DRUG: CPI-006 2 mg/kg + SOC|DRUG: CPI-006 1 mg/kg + SOC|DRUG: Placebo + SOC,"Corvus Pharmaceuticals, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE3,46,INDUSTRY,INTERVENTIONAL,2/25/2021,8/18/2021
NCT04375046,UNKNOWN,COVID-19,DRUG: Recombinant Bacterial ACE2 receptors -like enzyme of B38-CAP (rbACE2),Kafrelsheikh University,Foshan University Laboratory of Emerging Infectious Disease Institute of Translational Medicine The First Hospital of Jilin University China,ALL,"ADULT, OLDER_ADULT",PHASE1,24,OTHER,INTERVENTIONAL,2021-07,2021-10
NCT04839146,COMPLETED,Covid19|Severe Acute Respiratory Syndrome|SARS-CoV-2 Infection,BIOLOGICAL: ABNCoV2 Vaccine,Radboud University Medical Center,European Union,ALL,ADULT,PHASE1,45,OTHER,INTERVENTIONAL,3/11/2021,2/25/2022
NCT04758273,UNKNOWN,COVID-19,BIOLOGICAL: medium dosage inactivated SARS-CoV-2 vaccine|BIOLOGICAL: high dosage inactivated SARS-CoV-2 vaccine|BIOLOGICAL: Placebo,"Beijing Minhai Biotechnology Co., Ltd","Shenzhen Kangtai Biological Products Co., LTD|Jiangsu Province Centers for Disease Control and Prevention",ALL,"ADULT, OLDER_ADULT",PHASE1,180,INDUSTRY,INTERVENTIONAL,10/7/2020,2/28/2022
NCT05552573,ACTIVE_NOT_RECRUITING,COVID-19,BIOLOGICAL: low-dose LYB001|BIOLOGICAL: Recombinant COVID-19 Vaccine (CHO Cell)|BIOLOGICAL: high-dose LYB001,"Guangzhou Patronus Biotech Co., Ltd.","Yantai Patronus Biotech Co., Ltd.",ALL,"ADULT, OLDER_ADULT",PHASE1,100,INDUSTRY,INTERVENTIONAL,7/19/2022,12/1/2023
NCT04684446,COMPLETED,COVID-19,BIOLOGICAL: AZD1222|BIOLOGICAL: rAd26-S,R-Pharm,AstraZeneca|Russian Direct Investment Fund|The Gamaleya National Center of Epidemiology & Microbiology,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,100,INDUSTRY,INTERVENTIONAL,9/15/2021,3/29/2022
NCT05851846,NOT_YET_RECRUITING,Long COVID,BEHAVIORAL: Amygdala insula retraining,Miami VA Healthcare System,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,130,FED,INTERVENTIONAL,5/15/2023,6/15/2024
NCT04991246,COMPLETED,Covid19,OTHER: Antigenic tests (on saliva samples)|OTHER: Individual electronic sensor port|OTHER: Atmospheric measurements of CO2,Assistance Publique - Hôpitaux de Paris,,ALL,"ADULT, OLDER_ADULT",NA,210,OTHER,INTERVENTIONAL,10/14/2021,1/14/2022
NCT04273646,UNKNOWN,2019 Novel Coronavirus Pneumonia|COVID-19,BIOLOGICAL: UC-MSCs|DRUG: Placebo,"Wuhan Union Hospital, China","Wuhan Hamilton Bio-technology Co., Ltd, China.",ALL,"ADULT, OLDER_ADULT",NA,48,OTHER,INTERVENTIONAL,4/20/2020,2/15/2022
NCT04452773,UNKNOWN,COVID19,DIETARY_SUPPLEMENT: Manremyc|DIETARY_SUPPLEMENT: Placebo,Reig Jofre Group,,ALL,"ADULT, OLDER_ADULT",NA,315,INDUSTRY,INTERVENTIONAL,7/14/2020,2021-12
NCT04361942,COMPLETED,COVID-19 Pneumonia,BIOLOGICAL: Mesenchymal Stem Cells (MSCs)|OTHER: Placebo,Red de Terapia Celular,Citospin|University of Valladolid|Castilla-León Health Service|Hospital del Río Hortega|Instituto de Salud Carlos III,ALL,"ADULT, OLDER_ADULT",PHASE2,24,INDUSTRY,INTERVENTIONAL,5/1/2020,10/28/2021
NCT04626089,WITHDRAWN,Severe Acute Respiratory Syndrome Coronavirus 2|Metabolic Syndrome|Type 2 Diabetes,DRUG: metformin glycinate|DRUG: Placebo oral tablet,Laboratorios Silanes S.A. de C.V.,,ALL,"ADULT, OLDER_ADULT",PHASE2,0,INDUSTRY,INTERVENTIONAL,2021-02,2021-02
NCT04345289,TERMINATED,COVID|Corona Virus Infection|Viral Pneumonia,BIOLOGICAL: Convalescent anti-SARS-CoV-2 plasma|OTHER: Infusion placebo,Thomas Benfield,,ALL,"ADULT, OLDER_ADULT",PHASE3,147,OTHER,INTERVENTIONAL,5/1/2020,3/16/2021
NCT04652765,TERMINATED,Covid19|SARS-CoV Infection|Coronavirus Infection,DRUG: Camostat Mesilate|DRUG: Bicalutamide 150 mg,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,,ALL,"ADULT, OLDER_ADULT",PHASE1,6,OTHER,INTERVENTIONAL,2/3/2021,9/15/2021
NCT04381988,TERMINATED,COVID-19|Cancer,DRUG: Hydroxychloroquine|OTHER: Placebo|RADIATION: Radiation therapy,Memorial Sloan Kettering Cancer Center,,ALL,"ADULT, OLDER_ADULT",PHASE2,4,OTHER,INTERVENTIONAL,5/7/2020,4/21/2021
NCT05614388,NOT_YET_RECRUITING,COVID-19,DIAGNOSTIC_TEST: COVID-19 Self testing and related messaging,PATH,UNITAID|Zoram Medical College (ZMC)|Pacchunga University College|Association for Leprosy Education Rehabilitation & Treatment India (ALERT India)|Government of Mizoram,ALL,"ADULT, OLDER_ADULT",NA,646,OTHER,INTERVENTIONAL,2022-12,2023-05
NCT04905888,WITHDRAWN,Covid19,COMBINATION_PRODUCT: Hyperbaric oxygen therapy,Peter Lindholm,,ALL,"ADULT, OLDER_ADULT",PHASE2,0,OTHER,INTERVENTIONAL,11/8/2021,12/31/2023
NCT05517642,COMPLETED,COVID-19,BIOLOGICAL: Recombinant COVID-19 vaccine (adenovirus type 5 vector) for Inhalation (Ad5-nCoV-IH)|BIOLOGICAL: mRNA vaccine BNT162b2 (Pfizer),CanSino Biologics Inc.,,ALL,"ADULT, OLDER_ADULT",PHASE3,540,INDUSTRY,INTERVENTIONAL,9/20/2022,5/2/2023
NCT05407142,RECRUITING,Coronavirus Infections|Vaccine,"BIOLOGICAL: CoviVac vaccine (inactivated whole-virion concentrated purified) manufactured by FSBSI ""Chumakov FSC R&D IBP RAS""|OTHER: The data from volunteers from the control group",Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products,,ALL,ADULT,PHASE3,29000,OTHER_GOV,INTERVENTIONAL,7/7/2021,12/29/2023
NCT05584189,COMPLETED,Sars-CoV-2 Infection|COVID-19,DEVICE: Rapid SARS-CoV-2 Antigen Test,"MP Biomedicals, LLC",New Day Diagnostics,ALL,"CHILD, ADULT, OLDER_ADULT",NA,99,INDUSTRY,INTERVENTIONAL,10/7/2021,10/27/2021
NCT05298488,RECRUITING,Respiratory Tract Infections|COVID-19,BEHAVIORAL: Home office|BEHAVIORAL: Office,Norwegian Institute of Public Health,"The National Institute of Occupational Health, Norway",ALL,"ADULT, OLDER_ADULT",NA,2000,OTHER_GOV,INTERVENTIONAL,3/14/2022,9/30/2023
NCT05697042,ENROLLING_BY_INVITATION,Long COVID,BEHAVIORAL: MY-Skills for Long COVID,"University of Colorado, Denver",,ALL,"ADULT, OLDER_ADULT",NA,16,OTHER,INTERVENTIONAL,2/1/2023,12/30/2023
NCT04707742,COMPLETED,Covid19,DRUG: Betadine© bucal 100 mg/ml|DRUG: Oximen® 3%|DRUG: Clorhexidine Dental PHB©|DRUG: Vitis Xtra Forte©|DRUG: Distilled Water,Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana,Hospital Universitario Fundación Jiménez Díaz|Hospital Universitario General de Villalba|Hospital Universitario Infanta Elena|Hospital Universitario Virgen de la Arrixaca|Hospital Clínico Universitario de Valencia|Dentaid SL,ALL,"ADULT, OLDER_ADULT",NA,160,OTHER,INTERVENTIONAL,6/15/2020,9/30/2021
NCT05258565,COMPLETED,Acute Ischemic Stroke,DRUG: IV tPA (Activase),Assiut University,Aswan University Hospital,ALL,"ADULT, OLDER_ADULT",PHASE1,50,OTHER,INTERVENTIONAL,3/1/2022,9/15/2022
NCT05293665,ACTIVE_NOT_RECRUITING,COVID-19 Vaccines,BIOLOGICAL: UB-612|BIOLOGICAL: BNT162b2 vaccine|BIOLOGICAL: ChAdOx1-S vaccine|BIOLOGICAL: Sinopharm BIBP,"Vaxxinity, Inc.",Syneos Health|Coalition for Epidemic Preparedness Innovations,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,944,INDUSTRY,INTERVENTIONAL,3/16/2022,2023-09
NCT04773665,COMPLETED,Covid19,BIOLOGICAL: VBI-2902a|BIOLOGICAL: Placebo|BIOLOGICAL: VBI-2905a,VBI Vaccines Inc.,,ALL,ADULT,PHASE1,114,INDUSTRY,INTERVENTIONAL,3/15/2021,11/14/2022
NCT04354389,WITHDRAWN,COVID-19,DRUG: DAS181|DRUG: Placebo|DRUG: DAS181,"Ansun Biopharma, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,0,INDUSTRY,INTERVENTIONAL,7/25/2020,11/30/2020
NCT04423289,COMPLETED,Face-to-face Reconsultation to Emergency Room,OTHER: Farmalarm,Hospital Universitari Vall d'Hebron Research Institute,,ALL,"ADULT, OLDER_ADULT",NA,150,OTHER,INTERVENTIONAL,3/31/2020,5/18/2020
NCT05256589,COMPLETED,Sars-CoV-2 Infection,DIAGNOSTIC_TEST: Sona Saliva C-19 Rapid Self-test,Sona Nanotech Inc,Nova Scotia Health Authority,ALL,"ADULT, OLDER_ADULT",NA,500,INDUSTRY,INTERVENTIONAL,4/19/2022,5/19/2022
NCT05354089,ACTIVE_NOT_RECRUITING,SARS-CoV-2,BIOLOGICAL: 20 μg dose of SYS6006|BIOLOGICAL: 30 μg dose of SYS6006|DRUG: Placebo,"CSPC ZhongQi Pharmaceutical Technology Co., Ltd.",,ALL,ADULT,PHASE1,40,INDUSTRY,INTERVENTIONAL,4/27/2022,10/1/2023
NCT04915989,UNKNOWN,SARS-CoV-2,DRUG: GX-19N,"Genexine, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE1,30,INDUSTRY,INTERVENTIONAL,2/16/2021,3/31/2022
NCT04324489,COMPLETED,COVID-19,DRUG: DAS181,Renmin Hospital of Wuhan University,"Ansun Biopharma, Inc.",ALL,"ADULT, OLDER_ADULT",NA,4,OTHER,INTERVENTIONAL,3/6/2020,4/30/2020
NCT05593042,COMPLETED,COVID-19|Vaccines,BIOLOGICAL: CoronaVac®|BIOLOGICAL: Omicron Vaccine|BIOLOGICAL: Trivalent Vaccine,Pontificia Universidad Catolica de Chile,"Sinovac Life Sciences Co., Ltd.",ALL,"ADULT, OLDER_ADULT",PHASE2,551,OTHER,INTERVENTIONAL,11/28/2022,10/26/2023
NCT04341142,RECRUITING,CoV2 Positive Caregivers,DIAGNOSTIC_TEST: Serological tests will be applied on patients blood sampling,Hospices Civils de Lyon,,ALL,"ADULT, OLDER_ADULT",NA,550,OTHER,INTERVENTIONAL,4/9/2020,4/9/2024
NCT04446065,UNKNOWN,COVID-19|SARS-CoV2,DRUG: Previfenon®|DRUG: Placebo,MELISA Institute Genomics & Proteomics Research SpA,Universidad Austral,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,524,INDUSTRY,INTERVENTIONAL,9/30/2020,10/30/2021
NCT04344665,COMPLETED,Surgery|Perioperative Complication|COVID,OTHER: Virtual Care and Remote Automated Monitoring,Population Health Research Institute,Hamilton Health Sciences Corporation|McMaster University,ALL,"ADULT, OLDER_ADULT",NA,905,OTHER,INTERVENTIONAL,4/23/2020,6/2/2021
NCT04642638,TERMINATED,Coronavirus Infection|Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)|COVID-19 Disease,DRUG: INO-4800|DEVICE: CELLECTRA® 2000|DRUG: Placebo|DEVICE: CELLECTRA® 2000,Inovio Pharmaceuticals,"Advaccine (Suzhou) Biopharmaceuticals Co., Ltd.",ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,1307,INDUSTRY,INTERVENTIONAL,11/30/2020,9/13/2022
NCT04898738,UNKNOWN,SARS-CoV-2 Infection|Covid19,OTHER: Alcohol based hand sanitizer,Brigham and Women's Hospital,"Centers for Disease Control and Prevention|London School of Hygiene and Tropical Medicine|The University of Queensland|Yale University|Broad Institute|Ministerio de Salud Publica y Asistencia Social, Republica Dominicana",ALL,"CHILD, ADULT, OLDER_ADULT",NA,2000,OTHER,INTERVENTIONAL,2021-08,2022-09
NCT04537962,COMPLETED,Corona Virus Infection,OTHER: Colgate Periogard® mouthwash|OTHER: Colgate Peroxyl® mouthwash|OTHER: Colgate Total® Mouthwash|OTHER: Toothpaste with sodium monofluorophosphate|OTHER: Toothpaste with sodium fluoride and zinc|OTHER: Toothpaste with tin fluoride,Hospital Israelita Albert Einstein,Colgate Palmolive,ALL,"ADULT, OLDER_ADULT",NA,202,OTHER,INTERVENTIONAL,7/14/2020,9/30/2021
NCT04329572,SUSPENDED,COVID-19,DRUG: Hydroxychloroquine Sulfate|DRUG: Azithromycin Tablets,Azidus Brasil,,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,400,INDUSTRY,INTERVENTIONAL,4/23/2020,6/30/2023
NCT06234462,NOT_YET_RECRUITING,Long COVID|Post-Acute COVID-19 Syndrome,"DRUG: Amantadine|OTHER: Physical, Occupational, Speech Therapy|OTHER: Provider Counseling|OTHER: Medications for symptoms management",University of Texas Southwestern Medical Center,,ALL,"ADULT, OLDER_ADULT",PHASE2,30,OTHER,INTERVENTIONAL,4/1/2024,12/1/2025
NCT05541510,RECRUITING,COVID-19,BIOLOGICAL: AD17002 + Formulation buffer|BIOLOGICAL: Placebo,Advagene Biopharma Co. Ltd.,Gadjah Mada University,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,180,INDUSTRY,INTERVENTIONAL,12/1/2022,3/31/2025
NCT04863638,ACTIVE_NOT_RECRUITING,Covid19,"BIOLOGICAL: 3-doses schedule 1 of COVID-19 Vaccine (Vero Cell), Inactivated|BIOLOGICAL: 3-doses schedule 2 of COVID-19 Vaccine (Vero Cell), Inactivated|BIOLOGICAL: 3-doses schedule 3 of COVID-19 Vaccine (Vero Cell), Inactivated|BIOLOGICAL: 2 doses of vaccine",China National Biotec Group Company Limited,Beijing Institute of Biological Products Co Ltd.,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,4400,INDUSTRY,INTERVENTIONAL,4/29/2021,3/31/2024
NCT04425772,UNKNOWN,COVID-19,DRUG: FNC+Standard of Care|DRUG: FNC dummy tablet+Standard of Care,"HeNan Sincere Biotech Co., Ltd",,ALL,"ADULT, OLDER_ADULT",NA,342,INDUSTRY,INTERVENTIONAL,6/12/2020,8/12/2020
NCT04410562,COMPLETED,Pregnancy Related|COVID|Covid-19,DRUG: Hydroxychloroquine|DRUG: Placebo,Barcelona Institute for Global Health,Hospital Clinic of Barcelona|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|University Hospital of Torrejon|Fundación de investigación HM|Hospital Sant Joan de Deu|Hospital del Mar|Hospital Universitario Infanta Leonor|Hospital Universitario Fundación Alcorcón|Hospital General de Segovia|Institut Català de la Salut,FEMALE,"CHILD, ADULT, OLDER_ADULT",PHASE3,129,OTHER,INTERVENTIONAL,5/13/2020,10/31/2021
NCT05216562,UNKNOWN,SARS-CoV2 Infection,DRUG: Exosome-MSC Intravenous injection|DRUG: Placebo Intravenous Injection|DRUG: COVID-19 Standard Treatment,Dermama Bioteknologi Laboratorium,"Kementerian Riset dan Teknologi / Badan Riset dan Inovasi Nasional, Indonesia",ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,60,INDUSTRY,INTERVENTIONAL,7/1/2021,12/30/2022
NCT04847362,UNKNOWN,Postpartum Depression|Anxiety State,BEHAVIORAL: Experimental,Saglik Bilimleri Universitesi,,FEMALE,ADULT,NA,74,OTHER,INTERVENTIONAL,4/11/2021,1/30/2022
NCT04609462,COMPLETED,Covid19|Acute Hypoxemic Respiratory Failure,PROCEDURE: Conventional oxygen therapy|PROCEDURE: High flow nasal cannula,Fundacion Clinica Valle del Lili,,ALL,"ADULT, OLDER_ADULT",NA,199,OTHER,INTERVENTIONAL,8/11/2020,2/10/2021
NCT06224062,RECRUITING,SARS-CoV-2,BIOLOGICAL: SARS-CoV-2|BIOLOGICAL: Adenovirus (AdV)|BIOLOGICAL: Rhinovirus|BIOLOGICAL: No Intervention,"University Hospital, Bordeaux",,ALL,CHILD,NA,200,OTHER,INTERVENTIONAL,10/28/2022,4/28/2025
NCT04931238,UNKNOWN,COVID-19|SARS-CoV-2,DRUG: JS016,Peking Union Medical College Hospital,,ALL,"ADULT, OLDER_ADULT",PHASE2,200,OTHER,INTERVENTIONAL,1/20/2021,12/31/2022
NCT05375838,COMPLETED,SARS-CoV-2|Influenza,BIOLOGICAL: mRNA-1073|BIOLOGICAL: mRNA-1010|BIOLOGICAL: mRNA-1273|BIOLOGICAL: Placebo,"ModernaTX, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,553,INDUSTRY,INTERVENTIONAL,5/13/2022,12/29/2022
NCT05148962,COMPLETED,COVID-19,BIOLOGICAL: GRT-R910 10 mcg Dose (after AZ)|BIOLOGICAL: GRT-R910 30 mcg Dose (after AZ)|BIOLOGICAL: GRT-R910 10 mcg Dose (After Adenovirus based vaccine)|BIOLOGICAL: GRT-R910 10 mcg Dose (after mRNA based vaccine),"Gritstone bio, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE1,40,INDUSTRY,INTERVENTIONAL,9/16/2021,5/26/2023
NCT05035238,UNKNOWN,Covid19,BIOLOGICAL: Triple dose vaccination by inactivated Covid19 vaccine,Health Institutes of Turkey,TC Erciyes University|Kocak Farma|Mene Research,ALL,ADULT,PHASE2,200,OTHER_GOV,INTERVENTIONAL,9/20/2021,9/20/2022
NCT04328272,UNKNOWN,COVID19,DRUG: Hydroxychloroquine 200 Mg Oral Tablet|DRUG: Azithromycin 500Mg Oral Tablet|DIETARY_SUPPLEMENT: Glucose tablets,Prof. Dr. Umar Farooq,"Ayub Medical College, Abbottabad",ALL,ADULT,PHASE3,75,OTHER,INTERVENTIONAL,3/28/2020,6/28/2020
NCT05037162,COMPLETED,Covid19|Corona Virus Infection,DIAGNOSTIC_TEST: Biochemistry blood test|DIAGNOSTIC_TEST: Hematology blood test|DIAGNOSTIC_TEST: D-Dimer test (coagulation)|DIAGNOSTIC_TEST: Inflammatory markers|DIAGNOSTIC_TEST: Vital signs|DIAGNOSTIC_TEST: VAS scale|DIAGNOSTIC_TEST: WHO Ordinal Score|DIAGNOSTIC_TEST: COVID-19-Related Symptoms assessment|DIAGNOSTIC_TEST: COVID-19-Impact on Quality-of-Life Questionnaire|DIAGNOSTIC_TEST: POST- COVID-19 Functional Status Scale:|DIAGNOSTIC_TEST: Pregnancy test|DIAGNOSTIC_TEST: Physical examination|DIAGNOSTIC_TEST: PK parameters|DIAGNOSTIC_TEST: SARS-CoV-2 test (PCR)|DIAGNOSTIC_TEST: ECG|DRUG: Treatment administration (twice a day),MGC Pharmaceuticals d.o.o,,ALL,"ADULT, OLDER_ADULT",PHASE2,240,INDUSTRY,INTERVENTIONAL,10/11/2022,3/1/2023
NCT04978038,NOT_YET_RECRUITING,SARS-CoV2 Infection|Coronavirus Infection,DRUG: mRNA- COVID-19|DRUG: Prevnar13,Mark Loeb,,ALL,OLDER_ADULT,PHASE4,414,OTHER,INTERVENTIONAL,8/1/2022,12/31/2022
NCT05894538,COMPLETED,Covid19,DRUG: Ivermectin|OTHER: Placebo,"Susanna Naggie, MD",National Center for Advancing Translational Sciences (NCATS)|Vanderbilt University Medical Center,ALL,"ADULT, OLDER_ADULT",PHASE3,1459,OTHER,INTERVENTIONAL,2/16/2022,10/30/2022
NCT05132972,UNKNOWN,Covid 19,BIOLOGICAL: Normoxic Allogenic UCMSC|OTHER: Normal saline solution,"Kementerian Riset dan Teknologi / Badan Riset dan Inovasi Nasional, Indonesia","Dr. Moewardi General Hospital, Surakarta, Indonesia|Dr. Sardjito General Hospital, Yogyakarta, Indonesia|Dr. Hasan Sadikin General Hospital, Bandung, Indonesia|PT Bifarma Adiluhung",ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,42,OTHER_GOV,INTERVENTIONAL,1/17/2021,2021-11
NCT04633772,COMPLETED,"Infection, Coronavirus|Respiratory Failure",DRUG: Angiotensin-(1-7)|DRUG: Placebo,Erasme University Hospital,Federal University of Minas Gerais|Angitec|Fonds Erasme pour la Recherche Medicale,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1|PHASE2,112,OTHER,INTERVENTIONAL,8/5/2020,11/1/2021
NCT05113862,COMPLETED,Coronavirus|SARS-CoV-2 Infection|COVID-19,BIOLOGICAL: LD Vehicle-GNP|BIOLOGICAL: LD PepGNP-Covid19|BIOLOGICAL: HD Vehicle-GNP|BIOLOGICAL: HD PepGNP-Covid19,Emergex Vaccines Holding Ltd.,"Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland|University of Lausanne Hospitals",ALL,ADULT,PHASE1,26,INDUSTRY,INTERVENTIONAL,1/10/2022,9/15/2022
NCT04463472,COMPLETED,COVID-19,BIOLOGICAL: AG0301-COVID19|BIOLOGICAL: AG0301-COVID19,"AnGes, Inc.",Japan Agency for Medical Research and Development,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,30,INDUSTRY,INTERVENTIONAL,6/29/2020,8/12/2021
NCT04377672,COMPLETED,SARS-CoV-2 Infection,BIOLOGICAL: Anti-SARS-CoV-2 Human Convalescent Plasma,Johns Hopkins University,,ALL,"CHILD, ADULT",PHASE1,14,OTHER,INTERVENTIONAL,5/28/2020,12/13/2021
NCT06004362,RECRUITING,Post-COVID Syndrome,"BEHAVIORAL: Complementary and Integrative Medicine online intervention, routine care and book|BEHAVIORAL: Routine care and book","Charite University, Berlin, Germany",,ALL,"ADULT, OLDER_ADULT",NA,120,OTHER,INTERVENTIONAL,9/4/2023,2025-12
NCT04821531,WITHDRAWN,Corona Virus Infection,OTHER: PT Pal|OTHER: Exercise Manual,Montefiore Medical Center,,ALL,"ADULT, OLDER_ADULT",NA,0,OTHER,INTERVENTIONAL,2021-11,2022-12
NCT05212831,COMPLETED,COVID-19,DEVICE: Inogen One® G4,Inogen Inc.,The Montreal Health Innovations Coordinating Center (MHICC),ALL,"ADULT, OLDER_ADULT",NA,21,INDUSTRY,INTERVENTIONAL,6/8/2022,3/2/2023
NCT05323331,COMPLETED,COVID-19,OTHER: Circuit Training Exercise Program|OTHER: Aerobic Training Exercise Program,Riphah International University,,ALL,ADULT,NA,60,OTHER,INTERVENTIONAL,4/1/2022,12/1/2022
NCT05195242,COMPLETED,COVID-19|Thrombosis Embolism|Bleeding,DRUG: Dexamethasone,Karolinska Institutet,"Scandinavian Critical Care Trials Group|Copenhagen Trial Unit, Center for Clinical Intervention Research|Centre for Research in Intensive Care (CRIC)|Aarhus University Hospital|Aalborg University Hospital|Rigshospitalet, Denmark|Linkoeping University|Stockholm South General Hospital",ALL,"ADULT, OLDER_ADULT",PHASE3,445,OTHER,INTERVENTIONAL,8/27/2020,6/30/2021
NCT05576662,COMPLETED,Post-acute Sequelae of SARS-CoV-2 Infection|Long COVID,DRUG: Nirmatrelvir|DRUG: Placebo|DRUG: Ritonavir,Stanford University,Pfizer,ALL,"ADULT, OLDER_ADULT",PHASE2,168,OTHER,INTERVENTIONAL,11/8/2022,9/12/2023
NCT04673162,COMPLETED,Covid19,"DRUG: Methylprednisolone, Placebo",Azienda Unità Sanitaria Locale Reggio Emilia,,ALL,"ADULT, OLDER_ADULT",PHASE3,260,OTHER_GOV,INTERVENTIONAL,12/17/2020,7/12/2021
NCT04401410,TERMINATED,SARS-CoV 2|Viral Infection|COVID 19,BIOLOGICAL: Dose Finding Phase (MTD)|BIOLOGICAL: Partially HLA-matched SARS-CoVSTs|OTHER: Routine care (no SARS-CoVSTs),Baylor College of Medicine,"Center for Cell and Gene Therapy, Baylor College of Medicine|AlloVir|The Methodist Hospital Research Institute",ALL,"ADULT, OLDER_ADULT",PHASE1,4,OTHER,INTERVENTIONAL,11/4/2020,10/12/2021
NCT04336410,COMPLETED,Coronavirus Infection,DRUG: INO-4800|DEVICE: CELLECTRA® 2000,Inovio Pharmaceuticals,Coalition for Epidemic Preparedness Innovations,ALL,"ADULT, OLDER_ADULT",PHASE1,120,INDUSTRY,INTERVENTIONAL,4/3/2020,2/10/2022
NCT05525910,COMPLETED,Biological Availability|Healthy Participants,DRUG: Nirmatrelvir/ ritonavir|DRUG: Nirmatrelvir/ritonavir|DRUG: Nirmatrelvir/ritonavir|DRUG: Nirmatrelvir/ ritonavir|DRUG: Nirmatrelvir/ ritonavir,Pfizer,,ALL,"ADULT, OLDER_ADULT",PHASE1,15,INDUSTRY,INTERVENTIONAL,8/31/2022,11/7/2022
NCT05711810,COMPLETED,Severe Acute Respiratory Syndrome-related Coronavirus|Renal Dialysis|Vaccines|Myocarditis Allergic|Infection Viral,"DRUG: Nifedipine 30 MG|DIAGNOSTIC_TEST: Kangzhu BPCB0A-3A|BEHAVIORAL: Low Mobility|DRUG: Enalapril Maleate 10Mg Tab|DRUG: Lansoprazole 30Mg Ec Cap|DRUG: Metoprolol Succinate|DIETARY_SUPPLEMENT: Coenzyme Q10|DIETARY_SUPPLEMENT: d-alpha tocopherol acetate|DIETARY_SUPPLEMENT: Omega-3|DRUG: Duloxetine Hydrochloride 20 MG Oral Capsule, Delayed Release|DRUG: Superoxide Dismutase",Yang I. Pachankis,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,1,INDIV,INTERVENTIONAL,1/2/2023,1/12/2023
NCT04349410,COMPLETED,CoVid 19 Positive,"DRUG: Hydroxychloroquine, Azithromycin|DRUG: Hydroxychloroquine, Doxycycline|DRUG: Hydroxychloroquine, Clindamycin|DRUG: Hydroxychloroquine, Clindamycin, Primaquine - low dose.|DRUG: Hydroxychloroquine, Clindamycin, Primaquine - high dose.|DRUG: Remdesivir|DRUG: Tocilizumab|DRUG: Methylprednisolone|DRUG: Interferon-Alpha2B|DRUG: Losartan|DRUG: Convalescent Serum",The Camelot Foundation,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2|PHASE3,1800,OTHER,INTERVENTIONAL,4/11/2020,9/14/2020
NCT05216510,ACTIVE_NOT_RECRUITING,Detection of Delayed-type Hypersensitivity Reactions to SARS-CoV-2 in Individuals Exposed to SARS-CoV-2,BIOLOGICAL: TNX-2110|BIOLOGICAL: TNX-2120|BIOLOGICAL: TNX-2130|BIOLOGICAL: CANDIN|BIOLOGICAL: Diluent,"Tonix Pharmaceuticals, Inc.",Premier Research Group plc,ALL,"ADULT, OLDER_ADULT",PHASE1,90,INDUSTRY,INTERVENTIONAL,1/7/2022,2022-08
NCT05069610,COMPLETED,COVID-19,BIOLOGICAL: AD17002|BIOLOGICAL: Placebo (Formulation buffer),Advagene Biopharma Co. Ltd.,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,30,INDUSTRY,INTERVENTIONAL,3/21/2022,12/18/2023
NCT04419610,COMPLETED,COVID,BIOLOGICAL: TRV027|OTHER: sodium chloride 0.9%,Imperial College London,,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,30,OTHER,INTERVENTIONAL,10/9/2020,5/12/2021
NCT04357730,COMPLETED,Severe Acute Respiratory Syndrome|Respiratory Failure|Acute Respiratory Distress Syndrome,DRUG: Alteplase 50 MG [Activase]|DRUG: Alteplase 50 MG [Activase],Denver Health and Hospital Authority,"Genentech, Inc.|University of Colorado, Denver|National Jewish Health|Beth Israel Deaconess Medical Center|Long Island Jewish Medical Center|Scripps Health|St. Mary's Medical Center|University of Miami|Ben Taub Hospital|Methodist Dallas Medical Center",ALL,"ADULT, OLDER_ADULT",PHASE2,50,OTHER,INTERVENTIONAL,5/14/2020,9/30/2021
NCT05083130,COMPLETED,"COVID-19|SARS-CoV2 Infection|COVID-19 Acute Respiratory Distress Syndrome|Acute Hypoxemic Respiratory Failure|Respiratory Distress Syndrome, Adult",BEHAVIORAL: a wake prone positioning,"Oxford University Clinical Research Unit, Vietnam","Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam",ALL,"ADULT, OLDER_ADULT",NA,93,OTHER,INTERVENTIONAL,3/8/2022,5/1/2023
NCT04967430,ACTIVE_NOT_RECRUITING,Sars-CoV2|Covid19,DRUG: Peginterferon Lambda-1A|OTHER: Placebo,"University Health Network, Toronto",,ALL,"ADULT, OLDER_ADULT",PHASE3,763,OTHER,INTERVENTIONAL,8/27/2021,6/30/2022
NCT05555030,COMPLETED,SARS-CoV-2 Infection|COVID-19,DEVICE: iCura COVID-19 Antigen Rapid Home Test|DIAGNOSTIC_TEST: RT-PCR Test,New Day Diagnostics,"Paragon Rx Clinical, Inc.|iCura Diagnostics, LLC",ALL,"CHILD, ADULT, OLDER_ADULT",NA,100,NETWORK,INTERVENTIONAL,8/4/2022,12/20/2022
NCT05157230,COMPLETED,"Vaccines, Adverse Effects|Injection Site Reaction",BEHAVIORAL: exercise,Bursa Yüksek İhtisas Education and Research Hospital,,ALL,"ADULT, OLDER_ADULT",NA,401,OTHER_GOV,INTERVENTIONAL,9/1/2021,12/25/2021
NCT05930730,RECRUITING,Safety of a Single Dose of COMVIGEN Vaccine|Reactogenicity of a Single Dose of COMVIGEN Vaccine|Immunogenicity of a Single Dose of COMVIGEN Vaccine|Safety of a Single Dose of BIVALENT Pfizer/BNT Vaccine|Reactogenicity of a Single Dose of BIVALENT Pfizer/BNT Vaccine|Immunogenicity of a Single Dose of BIVALENT Pfizer/BNT Vaccine,"BIOLOGICAL: Comvigen (Bivalent, ChulaCov19 BNA159.2)|BIOLOGICAL: BIVALENT Pfizer/BNT vaccine",Chulalongkorn University,"Chula Clinical Research Center (Chula CRC), Faculty of Medicine Chulalongkorn University, Bangkok, Thailand|HIV-NAT, Thai Red Cross - AIDS Research Centre",ALL,ADULT,PHASE2,450,OTHER,INTERVENTIONAL,10/9/2023,2024-02
NCT04661930,RECRUITING,Corona Virus Disease (COVID-19)|Respiratory Distress Syndrome|SARS-CoV-2 Infection,DRUG: TriCor® 145mg tablets|OTHER: Placebo|OTHER: Usual care,Yaakov Nahmias,Barzilai Medical Center|Rambam Health Care Campus|Nazareth Hospital,ALL,"ADULT, OLDER_ADULT",PHASE3,55,OTHER,INTERVENTIONAL,1/1/2021,7/1/2022
NCT04528888,UNKNOWN,"Covid19|SARS-CoV Infection|Pneumonia, Viral|Coagulopathy",DRUG: Enoxaparin|DRUG: Methylprednisolone|DRUG: unfractionated heparin,Massimo Girardis,,ALL,"ADULT, OLDER_ADULT",PHASE3,210,OTHER,INTERVENTIONAL,11/25/2020,7/30/2021
NCT04826588,COMPLETED,Paediatric Inflammatory Multisystem Syndrome-Temporally Associated With SARS-CoV-2 (PIMS-TS),DRUG: Methylprednisolone sodium succinate 10 mg/kg intravenously|BIOLOGICAL: Human normal immunoglobulin (IVIg),University Children's Hospital Basel,,ALL,"CHILD, ADULT",PHASE3,76,OTHER,INTERVENTIONAL,5/23/2021,11/20/2022
NCT04276688,COMPLETED,Novel Coronavirus Infection,DRUG: Lopinavir/ritonavir|DRUG: Ribavirin|DRUG: Interferon Beta-1B,The University of Hong Kong,"Hospital Authority, Hong Kong",ALL,"ADULT, OLDER_ADULT",PHASE2,127,OTHER,INTERVENTIONAL,2/10/2020,3/31/2020
NCT04713488,UNKNOWN,COVID-19 Prevention,BIOLOGICAL: Sputnik Light,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation",Russian Direct Investment Fund,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,110,OTHER,INTERVENTIONAL,1/15/2021,7/31/2021
NCT05446961,COMPLETED,COVID-19 Virus Infection,DIETARY_SUPPLEMENT: LCLT : 68% elemental L-carnitine and 32 % Tartric acid|DRUG: Placebo,SENAI CIMATEC,Hospital Espanhol,ALL,"ADULT, OLDER_ADULT",PHASE2,224,OTHER,INTERVENTIONAL,3/1/2021,2/3/2022
NCT05113810,RECRUITING,2019 Novel Coronavirus,DRUG: HCQ01|OTHER: standard of care (SOC) for COVID-19,Ministry of Health Jordan,King Hussein Cancer Center|ACDIMA Biocenter|Amman Pharmaceutical Industries|Sana Pharmaceutical Industry,ALL,"ADULT, OLDER_ADULT",PHASE2,110,OTHER_GOV,INTERVENTIONAL,3/20/2022,7/20/2022
NCT04328961,COMPLETED,COVID-19|Corona Virus Infection|SARS (Severe Acute Respiratory Syndrome)|SARS-CoV-2,DRUG: Hydroxychloroquine Sulfate|DRUG: Ascorbic Acid,University of Washington,Bill and Melinda Gates Foundation,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,943,OTHER,INTERVENTIONAL,3/31/2020,10/8/2020
NCT04741061,UNKNOWN,COVID-19 Prevention,BIOLOGICAL: Sputnik Light|OTHER: Placebo,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation",Russian Direct Investment Fund|CRO: iPharma|Government of the city of Moscow,ALL,"ADULT, OLDER_ADULT",PHASE3,6000,OTHER,INTERVENTIONAL,2/19/2021,1/31/2022
NCT05764538,RECRUITING,Long COVID,DRUG: DAOIB,Chang Gung Memorial Hospital,,ALL,"ADULT, OLDER_ADULT",PHASE2,40,OTHER,INTERVENTIONAL,2/27/2023,2025-02
NCT04655638,COMPLETED,Covid19|Acute Respiratory Failure,DEVICE: High Flow Nasal Therapy|DEVICE: Conventional Oxygen Therapy,Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo,"Azienda Ospedaliera, Universitaria Policlinico Vittorio Emanuele",ALL,"ADULT, OLDER_ADULT",NA,364,OTHER,INTERVENTIONAL,2/10/2021,10/25/2021
NCT04537572,UNKNOWN,COVID-19,DIAGNOSTIC_TEST: comparison of sample collection methods,Salveo Diagnostics,,ALL,"ADULT, OLDER_ADULT",NA,300,INDUSTRY,INTERVENTIONAL,2020-09,2022-09
NCT04363372,WITHDRAWN,COVID-19,DRUG: MRx-4DP0004|DRUG: Placebo,4D pharma plc,,ALL,"ADULT, OLDER_ADULT",PHASE2,0,INDUSTRY,INTERVENTIONAL,2020-08,2021-01
NCT04381962,COMPLETED,COVID-19,DRUG: Azithromycin Capsule,University of Oxford,Pfizer,ALL,"ADULT, OLDER_ADULT",PHASE3,298,OTHER,INTERVENTIONAL,6/3/2020,4/20/2021
NCT04824638,COMPLETED,Healthy|Immunization; Infection,BIOLOGICAL: 3 doses of BNT162b2 vaccine|BIOLOGICAL: 2 dose of BNT162b2 vaccine,"ANRS, Emerging Infectious Diseases","Institut National de la Santé Et de la Recherche Médicale, France",ALL,"ADULT, OLDER_ADULT",PHASE2,267,OTHER_GOV,INTERVENTIONAL,3/8/2021,12/2/2023
NCT04610138,COMPLETED,Covid19,DRUG: CNM-ZnAg|DRUG: Placebo,Clene Nanomedicine,ICL Pharma|Azidus Brazil,ALL,"ADULT, OLDER_ADULT",PHASE2,296,INDUSTRY,INTERVENTIONAL,6/1/2021,10/20/2022
NCT04412538,COMPLETED,COVID-19,BIOLOGICAL: Low dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule|BIOLOGICAL: Low dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 14-day schedule|BIOLOGICAL: Medium dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule|BIOLOGICAL: Medium dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 14-day schedule|BIOLOGICAL: High dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule|BIOLOGICAL: High dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 14-day schedule|BIOLOGICAL: Placebo on a 0- and 28-day schedule|BIOLOGICAL: Placebo on a 0- and 14-day schedule,"Institute of Medical Biology, Chinese Academy of Medical Sciences",West China Second University Hospital|Yunnan Center for Disease Control and Prevention,ALL,ADULT,PHASE1|PHASE2,942,OTHER,INTERVENTIONAL,5/15/2020,8/31/2021
NCT04869072,COMPLETED,COVID-19,DRUG: Convalescent plasma,University of Zurich,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1,30,OTHER,INTERVENTIONAL,4/29/2020,3/30/2021
NCT05589272,WITHDRAWN,Post-acute Sequelae SARS-CoV-2 Infection (PASC),OTHER: Active tDCS|OTHER: Sham tDCS,University of Minnesota,,ALL,ADULT,NA,0,OTHER,INTERVENTIONAL,2/1/2023,9/1/2024
NCT05675072,RECRUITING,Mild to Moderate COVID-19,DRUG: FB2001|DRUG: FB2001 placebo,Frontier Biotechnologies Inc.,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,1336,INDUSTRY,INTERVENTIONAL,1/4/2023,2023-12
NCT04617262,COMPLETED,Depression|Anxiety Disorders|Psychological Distress,BEHAVIORAL: Remote Problem Management Plus,The New School,George Washington University,ALL,"ADULT, OLDER_ADULT",NA,45,OTHER,INTERVENTIONAL,3/4/2021,5/20/2023
NCT04883138,TERMINATED,COVID-19,DRUG: GIGA-2050,"GigaGen, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE1,3,INDUSTRY,INTERVENTIONAL,5/24/2021,1/11/2022
NCT05315362,RECRUITING,Vaccination; Infection|COVID-19,DEVICE: solid microneedle skin patch|BIOLOGICAL: mRNA-1273|DEVICE: standard needle,Leiden University Medical Center,,ALL,ADULT,PHASE2,20,OTHER,INTERVENTIONAL,5/1/2022,5/1/2023
NCT04891172,RECRUITING,Covid19,BIOLOGICAL: Anti COVID 19 Intravenous Immunoglobulin (C-IVIG),Dow University of Health Sciences,Higher Education Commission (Pakistan),ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,310,OTHER,INTERVENTIONAL,8/1/2021,12/2/2022
NCT04871672,COMPLETED,"Covid19|Pilates, Core Stability",OTHER: Pilates Exercises|OTHER: Home Exercise program,University of Jazan,,ALL,ADULT,NA,145,OTHER_GOV,INTERVENTIONAL,12/26/2021,2/23/2023
NCT04947488,RECRUITING,"Fatigue Syndrome, Chronic|Inflammation",DIETARY_SUPPLEMENT: Bioarginina C,University of Milan,,ALL,ADULT,NA,50,OTHER,INTERVENTIONAL,6/18/2021,11/18/2022
NCT05682638,RECRUITING,SARS-CoV-2,BIOLOGICAL: LVRNA009|OTHER: 0.9%NaCl,"AIM Vaccine Co., Ltd.","AIM Innovation Biotechnology (Shanghai) Co., Ltd|Ningbo Rongan Biological Pharmaceutical Co., Ltd.|LiveRNA Therapeutics Inc.",ALL,"ADULT, OLDER_ADULT",PHASE3,34000,INDUSTRY,INTERVENTIONAL,1/30/2023,2025-12
NCT05595538,COMPLETED,COVID-19,BIOLOGICAL: Multiple doses of anti-SARS-CoV-2 Convalescent Plasma,Hospital Regional Dr. Rafael Estévez,"Complejo Hospitalario Dr. Arnulfo Arias Madrid|Hospital Santo Tomas|Hospital Punta Pacífica, Pacífica Salud|Insituto Conmemorativo Gorgas de Estudios para la Salud|Sociedad Panameña de Hematología|Institute of Scientific Research and High Technology Services (INDICASAT AIP)|University of Panama|Sistema Nacional de Investigación de Panamá",ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,30,OTHER,INTERVENTIONAL,6/6/2020,10/14/2020
NCT06045338,NOT_YET_RECRUITING,Long COVID|Post-Acute Sequelae of COVID-19|COVID Long-Haul,BEHAVIORAL: Mind Body Intervention #1,Beth Israel Deaconess Medical Center,,ALL,"ADULT, OLDER_ADULT",NA,180,OTHER,INTERVENTIONAL,2023-10,2026-01
NCT05725538,RECRUITING,Post-Acute COVID19 Syndrome|Long COVID|Post COVID-19 Condition,DEVICE: COVIDReApp Group|OTHER: Control Group,University of Cadiz,,ALL,"ADULT, OLDER_ADULT",NA,100,OTHER,INTERVENTIONAL,3/15/2023,9/15/2024
NCT05373472,ACTIVE_NOT_RECRUITING,COVID-19,BIOLOGICAL: COVID-19 mRNA vaccine|BIOLOGICAL: Placebo,CanSino Biologics Inc.,,ALL,"ADULT, OLDER_ADULT",PHASE2,150,INDUSTRY,INTERVENTIONAL,7/6/2022,2023-12
NCT05022472,RECRUITING,Vaccine Refusal|Covid19,BEHAVIORAL: COVID-19 Individual Awareness and Education.|BEHAVIORAL: COVID-19 Community Outreach & Health Promotion.|BEHAVIORAL: COVID-19 Individual Health Education & Linkages to Medical and Supportive Services.|BIOLOGICAL: Pop-up community vaccination sites,"Argentina Servin, MD, MPH",San Ysidro Health Center|National Institute on Minority Health and Health Disparities (NIMHD),ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,1054,OTHER,INTERVENTIONAL,7/16/2021,1/31/2026
NCT04527562,COMPLETED,Covid19,DRUG: Colchicine|DRUG: Placebo,Dhaka Medical College,,ALL,"ADULT, OLDER_ADULT",NA,299,OTHER,INTERVENTIONAL,7/14/2020,12/10/2020
NCT04755972,COMPLETED,"Corona Virus Infection|Pneumonia, Ventilator-Associated","OTHER: Inhalation of N-acetylcysteine|OTHER: Inhalation of 5% sodium chloride|OTHER: Inhalation of 8,4% sodium bicarbonate","Clinical Hospital Center, Split",,ALL,"ADULT, OLDER_ADULT",NA,175,OTHER,INTERVENTIONAL,10/1/2020,7/29/2021
NCT04898062,WITHDRAWN,Covid19,DEVICE: CRP-apheresis,Pentracor GmbH,,ALL,"ADULT, OLDER_ADULT",NA,0,INDUSTRY,INTERVENTIONAL,5/5/2021,3/31/2023
NCT04410510,UNKNOWN,COVID|Coronavirus Infection|SARS-CoV 2|COVID19,DRUG: P2Et (Caesalpinia spinosa extract)|OTHER: Placebo,Hospital Universitario San Ignacio,Pontificia Universidad Javeriana,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,100,OTHER,INTERVENTIONAL,9/30/2020,11/30/2021
NCT04420338,UNKNOWN,Chronic Hemodialysis Patients|Caregivers of Chronic Hemodialysis Patients,BIOLOGICAL: Blood sample|BIOLOGICAL: Serum tube collection,Assistance Publique Hopitaux De Marseille,,ALL,"ADULT, OLDER_ADULT",NA,800,OTHER,INTERVENTIONAL,6/5/2020,12/15/2020
NCT04497272,COMPLETED,COVID 19,OTHER: COVID-19 patients,Centre Hospitalier Universitaire de Nice,,ALL,"ADULT, OLDER_ADULT",NA,150,OTHER,INTERVENTIONAL,8/7/2020,7/31/2022
NCT06054438,RECRUITING,Long COVID,OTHER: Chinese medicine nutritional supplement Cs4,The University of Hong Kong,,ALL,"ADULT, OLDER_ADULT",PHASE2,110,OTHER,INTERVENTIONAL,4/17/2023,3/31/2024
NCT04347538,COMPLETED,COVID 19,OTHER: Saline Nasal Irrigation|OTHER: Saline with Baby Shampoo Nasal Irrigation,Vanderbilt University Medical Center,,ALL,"ADULT, OLDER_ADULT",NA,90,OTHER,INTERVENTIONAL,5/1/2020,3/16/2022
NCT05898672,COMPLETED,Pharmacokinetics|Healthy Volunteers,DRUG: Rosuvastatin|DRUG: Nirmatrelvir/ritonavir,Pfizer,,ALL,"ADULT, OLDER_ADULT",PHASE1,12,INDUSTRY,INTERVENTIONAL,6/9/2023,8/10/2023
NCT05946538,NOT_YET_RECRUITING,Respiratory Viral Infection,"DIAGNOSTIC_TEST: SARS-COV-2, Influenza and RSV 8-Well MT-PCR Panel|DIAGNOSTIC_TEST: BioFire Respiratory Panel 2.1",AusDiagnostics Pty Ltd.,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,1000,INDUSTRY,INTERVENTIONAL,2023-07,2024-02
NCT04742738,COMPLETED,COVID-19 (Healthy Volunteers),BIOLOGICAL: GBP510 adjuvanted with Alum (RBD 10μg/dose) - Stage 1|OTHER: Normal saline (0.9% sodium chloride solution) - Stage 1|BIOLOGICAL: GBP510 adjuvanted with Alum (RBD 25μg/dose) - Stage 1|OTHER: Normal saline (0.9% sodium chloride solution) - Stage 1|BIOLOGICAL: GBP510 adjuvanted with Alum (RBD 10μg/dose) - Stage 2|BIOLOGICAL: GBP510 adjuvanted with Alum (RBD 25μg/dose)- Stage 2|OTHER: Normal saline (0.9% sodium chloride solution)- Stage 2,"SK Bioscience Co., Ltd.",Coalition for Epidemic Preparedness Innovations,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,260,INDUSTRY,INTERVENTIONAL,1/20/2021,7/7/2022
NCT04517188,UNKNOWN,SARS-CoV-2 Infection,DRUG: Povidone-Iodine Solution 1.25% w/w [0.125% available iodine] USP,Halodine LLC,,ALL,"ADULT, OLDER_ADULT",PHASE4,40,INDUSTRY,INTERVENTIONAL,4/1/2021,7/1/2021
NCT04433988,WITHDRAWN,COVID,DRUG: Pentoxifylline|DRUG: Placebo,Sadat City University,,ALL,ADULT,PHASE1|PHASE2,0,OTHER,INTERVENTIONAL,11/13/2022,12/30/2022
NCT05027672,UNKNOWN,COVID-19 Vaccines,DRUG: Gam-COVID-Vac (rAd26) / Gam-COVID-Vac (rAd5),Ministerio de Salud de Ciudad Autónoma de Buenos Aires,,ALL,"ADULT, OLDER_ADULT",PHASE2,348,OTHER_GOV,INTERVENTIONAL,7/30/2021,9/6/2021
NCT05081388,TERMINATED,SARS-CoV-2,DRUG: REGN14256|DRUG: imdevimab|DRUG: casirivimab + imdevimab|DRUG: Placebo,Regeneron Pharmaceuticals,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1|PHASE2,25,INDUSTRY,INTERVENTIONAL,11/8/2021,6/30/2022
NCT05693272,ACTIVE_NOT_RECRUITING,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,BIOLOGICAL: COVAC-1|BIOLOGICAL: Saline Placebo,University of Saskatchewan,Government of Canada|Government of Saskatchewan,ALL,"ADULT, OLDER_ADULT",PHASE1,47,OTHER,INTERVENTIONAL,1/31/2023,5/30/2024
NCT05472038,ACTIVE_NOT_RECRUITING,SARS-CoV-2 Infection|COVID-19,BIOLOGICAL: BNT162b5 Bivalent (WT/OMI BA.2)|BIOLOGICAL: BNT162b2 Bivalent (WT/OMI BA.1)|BIOLOGICAL: BNT162b2 Bivalent (WT/OMI BA.4/BA.5)|BIOLOGICAL: BNT162b5 Bivalent (Original/OMI BA.4/BA.5)|BIOLOGICAL: BNT162b6 Bivalent (Original/OMI BA.4/BA.5)|BIOLOGICAL: BNT162b7 Bivalent (Original/OMI BA.4/BA.5)|BIOLOGICAL: BNT162b7 Monovalent (OMI BA.4/BA.5),BioNTech SE,Pfizer,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2|PHASE3,1424,INDUSTRY,INTERVENTIONAL,7/26/2022,3/19/2024
NCT04393038,TERMINATED,COVID-19,DRUG: ABX464|DRUG: Placebo,Abivax S.A.,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,509,INDUSTRY,INTERVENTIONAL,7/1/2020,4/16/2021
NCT04612972,COMPLETED,COVID-19,BIOLOGICAL: Inactivated SARS CoV 2 vaccine (Vero cell) Wuhan/Beijing/Placebo,Universidad Peruana Cayetano Heredia,"National University of San Marcos, Peru",ALL,"ADULT, OLDER_ADULT",PHASE3,12000,OTHER,INTERVENTIONAL,9/9/2020,4/3/2023
NCT05386472,SUSPENDED,COVID-19,DRUG: nirmatrelvir|DRUG: ritonavir,Pfizer,,FEMALE,ADULT,PHASE1,49,INDUSTRY,INTERVENTIONAL,6/22/2022,7/1/2025
NCT04283461,COMPLETED,COVID-19|COVID-19 Immunisation,BIOLOGICAL: mRNA-1273,National Institute of Allergy and Infectious Diseases (NIAID),"ModernaTX, Inc.",ALL,"ADULT, OLDER_ADULT",PHASE1,120,NIH,INTERVENTIONAL,3/16/2020,4/26/2022
NCT05384561,RECRUITING,Hyposmia|COVID-19|Parosmia|Anosmia|SARS-CoV-2 Infection,OTHER: Smell training,Université du Québec à Trois-Rivières,,ALL,"ADULT, OLDER_ADULT",NA,105,OTHER,INTERVENTIONAL,2022-05,2023-03
NCT04930861,COMPLETED,Covid19,DRUG: Covidir injections|DIAGNOSTIC_TEST: One Step Test|DIAGNOSTIC_TEST: IgM and IgG dosage|DIAGNOSTIC_TEST: RT-PCR SARS-CoV-2|DIAGNOSTIC_TEST: Screening blood test|DIAGNOSTIC_TEST: ECG|DIAGNOSTIC_TEST: Medical evaluation|DIAGNOSTIC_TEST: NEWS-2 score|DIAGNOSTIC_TEST: WHO score,Code Pharma,,ALL,ADULT,PHASE1,12,INDUSTRY,INTERVENTIONAL,3/29/2021,8/9/2021
NCT04411446,COMPLETED,COVID,DRUG: Vitamin D|DRUG: Placebo,Vitamin D Study Group,Agencia Nacional de Investigación y Desarrollo,ALL,"ADULT, OLDER_ADULT",PHASE4,218,NETWORK,INTERVENTIONAL,8/11/2020,7/28/2021
NCT04344210,COMPLETED,"COVID|Diabetes Mellitus, Type 2|Diabetes Mellitus, Type 1",BEHAVIORAL: Tele-interventions related to diabetes management and mental well-being,Federal University of Rio Grande do Sul,,ALL,"ADULT, OLDER_ADULT",NA,149,OTHER,INTERVENTIONAL,4/17/2020,9/20/2020
NCT05852873,RECRUITING,"Post COVID-19 Condition, Unspecified|SARS-CoV2 Infection|COVID-19",DRUG: Nirmatrelvir/ritonavir|DRUG: Placebo,Haukeland University Hospital,University of Bergen|Oslo University Hospital|University of Oslo|St. Olavs Hospital|Norwegian University of Science and Technology,ALL,ADULT,PHASE3,2000,OTHER,INTERVENTIONAL,5/12/2023,2026-04
NCT05205746,COMPLETED,SARS CoV 2 Infection,BIOLOGICAL: Recombinant NDV Vectored Vaccine for SARS-CoV-2|BIOLOGICAL: Placebo,"Laboratorio Avi-Mex, S.A. de C.V.","National Council of Science and Technology, Mexico|Instituto Nacional de Enfermedades Respiratorias",ALL,"ADULT, OLDER_ADULT",PHASE2,158,INDUSTRY,INTERVENTIONAL,11/23/2021,7/24/2023
NCT04523246,COMPLETED,Herpes Zoster|Allergy and Immunology|Corona Virus Infection,"BIOLOGICAL: SHINGRIX (Zoster Vaccine REcombinant, Adjuvanted)|DRUG: Normal Saline",University of Oklahoma,Oklahoma Medical Research Foundation,ALL,OLDER_ADULT,EARLY_PHASE1,217,OTHER,INTERVENTIONAL,9/1/2020,5/19/2023
NCT04420364,WITHDRAWN,COVID|Kidney Transplant; Complications|Immunosuppression,OTHER: Maintenance or reduction of immunosuppression,Brigham and Women's Hospital,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,0,OTHER,INTERVENTIONAL,5/3/2021,5/4/2021
NCT04885764,UNKNOWN,Covid19,BIOLOGICAL: Astrazeneca/Oxford Vaccine|BIOLOGICAL: Sinopharm vaccine,Ain Shams University,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,4000,OTHER,INTERVENTIONAL,2/23/2021,12/1/2021
NCT04498273,TERMINATED,COVID-19,DRUG: Apixaban 2.5 MG|DRUG: Apixaban 5MG|DRUG: Aspirin|DRUG: Placebo,Frank C Sciurba,"National Heart, Lung, and Blood Institute (NHLBI)",ALL,"ADULT, OLDER_ADULT",PHASE3,657,OTHER,INTERVENTIONAL,9/7/2020,8/5/2021
NCT05293210,NOT_YET_RECRUITING,Covid19|Dexamethasone,DRUG: Dexamethasone,Hospital Universitario Infanta Leonor,,ALL,"ADULT, OLDER_ADULT",PHASE3,200,OTHER,INTERVENTIONAL,2/28/2023,12/1/2023
NCT04581746,ACTIVE_NOT_RECRUITING,Virus-HIV|Covid19,OTHER: questionnaire,Tourcoing Hospital,,ALL,"ADULT, OLDER_ADULT",NA,1800,OTHER,INTERVENTIONAL,11/25/2020,2022-12
NCT04723446,COMPLETED,Covid19|Coronavirus,DRUG: Corsodyl® Alcohol free -0.2 % Chlorhexidine digluconate|DRUG: Colgate Peroxyl® -1.5% Hydrogen peroxide|OTHER: Oral-B® Gum & Enamel Care -Cetylpyridinium chloride|OTHER: No rinsing,Queen Mary University of London,GlaxoSmithKline,ALL,"ADULT, OLDER_ADULT",NA,54,OTHER,INTERVENTIONAL,5/19/2021,10/25/2021
NCT04428073,UNKNOWN,COVID,BIOLOGICAL: Covax-19™,GeneCure Biotechnologies,,ALL,ADULT,PHASE1,32,INDUSTRY,INTERVENTIONAL,2020-07,2021-12
NCT05655546,RECRUITING,Immunodeficiency|Immunosuppression|HIV Infections|Graft Versus Host Disease|Leukemia|Lymphoma|Cancer|Multiple Myeloma|Transplant|Age-Related Immunodeficiency,OTHER: Access to Cue Health COVID-19 Remote testing and treatment for COVID-19,Scripps Translational Science Institute,Cue Health,ALL,"ADULT, OLDER_ADULT",NA,10000,OTHER,INTERVENTIONAL,12/22/2022,2024-01
NCT04489446,COMPLETED,Covid19|SARS-COV2 Infection,DRUG: Sildenafil|DRUG: Placebo,Universidad Nacional Andres Bello,"Hospital Naval Almirante Nef, Viña del Mar, Chile",ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,40,OTHER,INTERVENTIONAL,8/19/2020,6/30/2021
NCT04516746,COMPLETED,COVID-19|SARS-CoV-2,BIOLOGICAL: AZD1222|BIOLOGICAL: Placebo,AstraZeneca,Iqvia Pty Ltd,ALL,"ADULT, OLDER_ADULT",PHASE3,32450,INDUSTRY,INTERVENTIONAL,8/28/2020,2/10/2023
NCT04534673,ACTIVE_NOT_RECRUITING,COVID-19,DRUG: Lambda 180 mcg S.C,Soroka University Medical Center,,ALL,"ADULT, OLDER_ADULT",PHASE2,40,OTHER,INTERVENTIONAL,4/7/2020,12/31/2024
NCT04421664,TERMINATED,Corona Virus Infection|SARS-CoV Infection|Coronavirus,DRUG: Hydroxychloroquine|DRUG: Placebo oral tablet,McGill University Health Centre/Research Institute of the McGill University Health Centre,University of Manitoba|University of Alberta|University of British Columbia|McMaster University|Lawson Health Research Institute|Eastern Health|University of Minnesota,ALL,"ADULT, OLDER_ADULT",PHASE3,70,OTHER,INTERVENTIONAL,3/25/2020,8/17/2020
NCT05375773,RECRUITING,2019 Novel Coronavirus Infection,OTHER: PVP-I Nasal Irrigation and gargling,Ruijin Hospital,,ALL,"ADULT, OLDER_ADULT",NA,300,OTHER,INTERVENTIONAL,4/16/2022,10/31/2022
NCT05425264,RECRUITING,Post SARS-CoV2 (COVID-19),OTHER: Tele-exercise,VA Office of Research and Development,Baltimore VA Medical Center|Salem Veterans Affairs Medical Center,ALL,"ADULT, OLDER_ADULT",NA,80,FED,INTERVENTIONAL,6/29/2023,1/30/2028
NCT04828161,TERMINATED,COVID-19,DRUG: ensovibep|DRUG: Placebo,Novartis Pharmaceuticals,Molecular Partners AG,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,407,INDUSTRY,INTERVENTIONAL,5/10/2021,1/27/2022
NCT04419623,COMPLETED,COVID-19|Sars-CoV2|Cancer|Solid Tumor|Carcinoma|Blood Cancer,DRUG: TL-895,"Telios Pharma, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE1,7,INDUSTRY,INTERVENTIONAL,7/9/2020,12/15/2020
NCT04497623,COMPLETED,Covid19,DEVICE: Invasive mechanical ventilation using the Unisabana-Herons Ventilator during 24 hours,Fundación Neumologica Colombiana,Universidad de la Sabana|Fundación Cardioinfantil Instituto de Cardiología|Clínica Universidad de La Sabana,ALL,"ADULT, OLDER_ADULT",NA,5,OTHER,INTERVENTIONAL,7/28/2020,9/20/2020
NCT04368923,UNKNOWN,Covid 19,DEVICE: Oxygen Therapy|PROCEDURE: Physical Therapy,Cairo University,,ALL,ADULT,NA,60,OTHER,INTERVENTIONAL,3/15/2020,6/23/2020
NCT04767958,TERMINATED,Covid19,DIAGNOSTIC_TEST: Spartan COVID-19 Platform,Ottawa Heart Institute Research Corporation,,ALL,"ADULT, OLDER_ADULT",NA,89,OTHER,INTERVENTIONAL,3/19/2021,8/31/2021
NCT04264858,UNKNOWN,2019-nCoV|Immunoglobulin of Cured Patients,DRUG: Immunoglobulin of cured patients|DRUG: γ-Globulin,"Wuhan Union Hospital, China",,ALL,"ADULT, OLDER_ADULT",NA,10,OTHER,INTERVENTIONAL,3/17/2020,5/31/2020
NCT05397223,ACTIVE_NOT_RECRUITING,SARS-CoV-2|Seasonal Influenza|Respiratory Syncytial Virus|Cytomegalovirus,BIOLOGICAL: mRNA-1273|BIOLOGICAL: mRNA-1010|BIOLOGICAL: mRNA-1345|BIOLOGICAL: FLUAD®|BIOLOGICAL: mRNA-1647,"ModernaTX, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE1,308,INDUSTRY,INTERVENTIONAL,5/24/2022,3/25/2024
NCT06156202,ENROLLING_BY_INVITATION,Post-Acute COVID-19|Post-Acute COVID-19 Syndrome|Post-Acute COVID-19 Infection|Long COVID|Long Covid19|Dyspnea|Orthostasis|Cognitive Impairment,OTHER: Comprehensive Rehabilitation|OTHER: Augmented Usual Care,University of Pennsylvania,Medical College of Wisconsin|National Institutes of Health (NIH),ALL,"CHILD, ADULT, OLDER_ADULT",NA,216,OTHER,INTERVENTIONAL,11/15/2023,3/30/2026
NCT04869358,COMPLETED,Multiple Sclerosis,DRUG: Ofatumumab,Novartis Pharmaceuticals,,ALL,"ADULT, OLDER_ADULT",PHASE4,34,INDUSTRY,INTERVENTIONAL,5/27/2021,6/13/2023
NCT04979884,COMPLETED,COVID-19 Acute Respiratory Distress Syndrome|Cytokine Release Syndrome|Pulmonary Fibrosis,DRUG: cyclosporine,Alexandria University,"Science and Technology Development Fund (STDF), ,Egypt",ALL,"ADULT, OLDER_ADULT",PHASE3,102,OTHER,INTERVENTIONAL,1/3/2022,12/9/2022
NCT05485584,ACTIVE_NOT_RECRUITING,COVID-19|SARS-CoV-2 Infection,DRUG: rSIFN-co Nasal Spray|DRUG: rSIFN-co Nasal Spray|DRUG: Placebo Nasal Spray|DRUG: Placebo Nasal Spray,Sichuan Huiyang Life Science and Technology Corporation,,ALL,"ADULT, OLDER_ADULT",PHASE2,188,INDUSTRY,INTERVENTIONAL,7/1/2022,7/28/2024
NCT04445623,UNKNOWN,COVID19|Thrombosis,DRUG: Prasugrel Hydrochloride 10 MG Oral Tablet|DRUG: Placebo,Azienda Ospedaliera Universitaria Integrata Verona,University of Milan,ALL,"ADULT, OLDER_ADULT",PHASE3,128,OTHER,INTERVENTIONAL,2020-07,2021-01
NCT04816084,COMPLETED,Covid19,DIAGNOSTIC_TEST: Anti-SARS-CoV2 Serology,Université de Reims Champagne-Ardenne,,ALL,"ADULT, OLDER_ADULT",NA,389,OTHER,INTERVENTIONAL,11/5/2020,3/15/2021
NCT04730323,COMPLETED,Covid19,DRUG: Tocilizumab,FMH College of Medicine and Dentistry,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,93,OTHER,INTERVENTIONAL,5/12/2020,6/12/2020
NCT04570384,COMPLETED,Acute Hypoxemic Respiratory Failure,DRUG: L-Citrulline|DRUG: Placebo,"Asklepion Pharmaceuticals, LLC",,ALL,"ADULT, OLDER_ADULT",PHASE2,65,INDUSTRY,INTERVENTIONAL,10/15/2020,9/30/2021
NCT05965323,RECRUITING,Absenteeism,BEHAVIORAL: Health Education,University of Washington,Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD),ALL,CHILD,NA,50,OTHER,INTERVENTIONAL,6/13/2022,3/30/2024
NCT05069623,COMPLETED,COVID-19|Infection Viral|Infections,BIOLOGICAL: VB10.2129|BIOLOGICAL: VB10.2210,Nykode Therapeutics ASA,Vaccibody AS,ALL,ADULT,PHASE1|PHASE2,68,INDUSTRY,INTERVENTIONAL,10/27/2021,5/30/2023
NCT04344184,COMPLETED,"COVID-19|Lung Injury, Acute|Kidney Injury",DRUG: L-ascorbic acid|OTHER: Placebo,Virginia Commonwealth University,,ALL,"ADULT, OLDER_ADULT",PHASE2,48,OTHER,INTERVENTIONAL,12/18/2020,6/10/2022
NCT04953078,COMPLETED,Coronavirus,BIOLOGICAL: Baiya SARS-CoV-2 Vax 1,"Baiya Phytopharm Co., Ltd.","National Vaccine Institute, Thailand",ALL,"ADULT, OLDER_ADULT",PHASE1,48,INDUSTRY,INTERVENTIONAL,9/11/2021,11/4/2022
NCT04321278,COMPLETED,"Coronavirus Infections|Pneumonia, Viral",DRUG: Hydroxychloroquine + azithromycin|DRUG: Hydroxychloroquine,Hospital Israelita Albert Einstein,EMS|Hospital do Coracao|Hospital Sirio-Libanes|Brazilian Research In Intensive Care Network,ALL,"ADULT, OLDER_ADULT",PHASE3,440,OTHER,INTERVENTIONAL,3/28/2020,6/14/2020
NCT05173441,UNKNOWN,COVID-19,BIOLOGICAL: Human COVID-19 immunoglobulin (pH4) for intravenous injection|DRUG: Placebo,"Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd.","China National Biotec Group Company Limited|Beijing Tiantan Biological Products Co., Ltd.",ALL,"ADULT, OLDER_ADULT",PHASE2,180,INDUSTRY,INTERVENTIONAL,12/30/2021,11/30/2023
NCT04637828,UNKNOWN,COVID-19,DRUG: GNS561,Genoscience Pharma,,ALL,"ADULT, OLDER_ADULT",PHASE2,178,INDUSTRY,INTERVENTIONAL,11/18/2020,12/30/2021
NCT04368728,COMPLETED,SARS-CoV-2 Infection|COVID-19,BIOLOGICAL: BNT162b1|BIOLOGICAL: BNT162b2|OTHER: Placebo|BIOLOGICAL: BNT162b2SA,BioNTech SE,Pfizer,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2|PHASE3,47079,INDUSTRY,INTERVENTIONAL,4/29/2020,2/10/2023
NCT04346628,COMPLETED,Sars-CoV2|COVID-19,DRUG: Favipiravir|DRUG: Placebo|OTHER: Standard of care treatment,Stanford University,,ALL,"ADULT, OLDER_ADULT",PHASE2,149,OTHER,INTERVENTIONAL,7/12/2020,4/16/2021
NCT04338841,COMPLETED,Coronavirus Infection,OTHER: HOME-CoV rule implementation,"University Hospital, Angers",,ALL,"ADULT, OLDER_ADULT",NA,3133,OTHER_GOV,INTERVENTIONAL,4/9/2020,6/17/2020
NCT04584541,TERMINATED,Spondyloarthritis|Rheumatoid Arthritis|Covid19,BIOLOGICAL: blood tests|BIOLOGICAL: Nasopharyngeal swabs|BIOLOGICAL: Stools,Assistance Publique - Hôpitaux de Paris,,ALL,"ADULT, OLDER_ADULT",NA,150,OTHER,INTERVENTIONAL,6/11/2020,2/21/2022
NCT04466241,UNKNOWN,COVID-19|COVID-19 Drug Treatment|Severe Acute Respiratory Syndrome Coronavirus 2,DRUG: Lopinavir/Ritonavir 200 MG-50 MG Oral Tablet|DRUG: Telmisartan 40Mg Oral Tablet|DRUG: Atorvastatin 20 Mg Oral Tablet,"ANRS, Emerging Infectious Diseases",University of Bordeaux|PACCI Program,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,294,OTHER_GOV,INTERVENTIONAL,11/27/2020,3/26/2021
NCT04546841,COMPLETED,COVID-19 Vaccine,BIOLOGICAL: multipeptide cocktail,University Hospital Tuebingen,,ALL,"ADULT, OLDER_ADULT",PHASE1,36,OTHER,INTERVENTIONAL,11/27/2020,12/2/2021
NCT04666441,COMPLETED,COVID-19,DRUG: REGN10933+REGN10987 combination therapy|DRUG: Placebo,Regeneron Pharmaceuticals,,ALL,"ADULT, OLDER_ADULT",PHASE2,1149,INDUSTRY,INTERVENTIONAL,12/15/2020,9/21/2021
NCT04363541,RECRUITING,COVID-19|Thermotherapy,DEVICE: Electric pad for human external pain therapy,Instituto Nacional de Perinatologia,"Direccion General de Calidad y Educacion en Salud|Instituto Mexicano del Seguro Social|Hospital Regional de Alta Especialidad Juan Graham Tabasco|Hospital Dr. Ángel Leaño|National Polytechnic Institute, Mexico|Universidad Juárez Autónoma de Tabasco",ALL,"ADULT, OLDER_ADULT",NA,274,OTHER_GOV,INTERVENTIONAL,8/27/2020,2022-06
NCT05185284,COMPLETED,COVID-19,DRUG: Favipiravir|DRUG: Favipiravir|DRUG: Remdesivir,"Promomed, LLC",Solyur Pharmaceuticals Group,ALL,"ADULT, OLDER_ADULT",PHASE3,217,OTHER,INTERVENTIONAL,8/11/2021,12/30/2021
NCT04834128,WITHDRAWN,COVID - 19,DRUG: TCB008,TC Biopharm,,ALL,"ADULT, OLDER_ADULT",PHASE2,0,INDUSTRY,INTERVENTIONAL,12/13/2021,4/13/2022
NCT04354441,WITHDRAWN,COVID-19|SARS-CoV-2|Pregnant Women|Hydroxychloroquine,DRUG: hydroxychloroquine sulfate 200 MG|DRUG: Placebo oral tablet,Sir Mortimer B. Davis - Jewish General Hospital,,FEMALE,ADULT,PHASE2,0,OTHER,INTERVENTIONAL,2020-05,2020-05
NCT04353128,COMPLETED,Covid19|SARS-CoV 2|Coronavirus Infection,DRUG: Melatonin 2mg|DRUG: Placebo oral tablet,Instituto de Investigación Hospital Universitario La Paz,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,450,OTHER,INTERVENTIONAL,4/20/2020,12/1/2020
NCT04334928,COMPLETED,Coronavirus Infection,DRUG: Emtricitabine/tenofovir disoproxil|DRUG: Hydroxychloroquine|DRUG: Placebo: Emtricitabine/tenofovir disoproxil Placebo|DRUG: Placebo: Hydroxychloroquine,Plan Nacional sobre el Sida (PNS),Effice Servicios Para la Investigacion S.L.,ALL,"ADULT, OLDER_ADULT",PHASE3,1002,OTHER_GOV,INTERVENTIONAL,4/15/2020,7/11/2021
NCT06223984,COMPLETED,Pulse Steroid and Immunoglobulins Drugs in Covid 19 Patients,DRUG: pulse steroid and nanogam,Konya City Hospital,,ALL,"ADULT, OLDER_ADULT",PHASE4,178,OTHER,INTERVENTIONAL,3/30/2020,11/14/2020
NCT04363528,COMPLETED,Deep Vein Thrombosis,OTHER: Doppler Echo,Versailles Hospital,,ALL,"ADULT, OLDER_ADULT",NA,50,OTHER,INTERVENTIONAL,4/24/2020,6/24/2021
NCT04939428,COMPLETED,Coronavirus Disease (COVID-19),DRUG: Molnupiravir|DRUG: Placebo,Merck Sharp & Dohme LLC,,ALL,"ADULT, OLDER_ADULT",PHASE3,2441,INDUSTRY,INTERVENTIONAL,8/11/2021,11/16/2022
NCT04576728,COMPLETED,Covid19,DRUG: Trimodulin|OTHER: Placebo (human albumin 1%),Biotest,,ALL,"ADULT, OLDER_ADULT",PHASE2,166,INDUSTRY,INTERVENTIONAL,10/6/2020,6/29/2021
NCT05932641,ACTIVE_NOT_RECRUITING,"COVID-19, SARS-CoV-2",BIOLOGICAL: AZD3152 (Cohort 1)|BIOLOGICAL: Placebo (Cohort 1)|BIOLOGICAL: AZD3152 (Cohort 2)|BIOLOGICAL: Placebo (Cohort 2)|BIOLOGICAL: AZD3152 (Cohort 3)|BIOLOGICAL: Placebo (Cohort 3),AstraZeneca,,ALL,ADULT,PHASE1,24,INDUSTRY,INTERVENTIONAL,7/31/2023,12/19/2024
NCT04315480,UNKNOWN,SARS Pneumonia,DRUG: Tocilizumab,Università Politecnica delle Marche,Azienda Ospedaliera Ospedali Riuniti Marche Nord,ALL,"ADULT, OLDER_ADULT",PHASE2,38,OTHER,INTERVENTIONAL,3/12/2020,2020-05
NCT04561180,WITHDRAWN,COVID-19 Pneumonia,DRUG: EG-009A|DRUG: EG-009A Placebo|DRUG: Standard of Care|DRUG: Dexamethasone,"Evergreen Therapeutics, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE2,0,INDUSTRY,INTERVENTIONAL,3/4/2022,5/1/2023
NCT04904536,RECRUITING,"Neurocognitive Impairment, Mild",DRUG: Atorvastatin|OTHER: Standard Care,The George Institute,University of Sydney|Monash University|The Alfred|Universidad del Desarrollo|Chinese University of Hong Kong|Clinica Alemana de Santiago,ALL,"ADULT, OLDER_ADULT",PHASE3,400,OTHER,INTERVENTIONAL,3/10/2022,2024-12
NCT04460534,COMPLETED,COVID,DIAGNOSTIC_TEST: diagnostic,GCS Ramsay Santé pour l'Enseignement et la Recherche,,MALE,"ADULT, OLDER_ADULT",NA,52,OTHER,INTERVENTIONAL,5/7/2020,5/12/2021
NCT04530136,COMPLETED,Confirmed Coronavirus Disease,DRUG: Ruconest,Pharming Technologies B.V.,,ALL,"ADULT, OLDER_ADULT",PHASE2,38,INDUSTRY,INTERVENTIONAL,11/30/2020,12/1/2021
NCT05685901,COMPLETED,COVID-19,DIETARY_SUPPLEMENT: High polyphenolic olive oil. (Early harvest olive oil).,Hospital General Nuestra Señora del Prado,,ALL,"ADULT, OLDER_ADULT",NA,88,OTHER,INTERVENTIONAL,7/1/2021,9/30/2022
NCT05210101,ACTIVE_NOT_RECRUITING,SARS CoV 2 Infection,DRUG: Sotrovimab,"Sophia Koo, M.D.",Massachusetts General Hospital|Dana-Farber Cancer Institute|GlaxoSmithKline,ALL,"ADULT, OLDER_ADULT",PHASE2,93,OTHER,INTERVENTIONAL,2/7/2022,4/1/2023
NCT05773001,RECRUITING,SARS-CoV-2 Pneumonia,DRUG: Ozone,"Robert Tighe, MD",National Institutes of Health (NIH)|National Institute of Environmental Health Sciences (NIEHS),ALL,ADULT,PHASE1,100,OTHER,INTERVENTIONAL,5/18/2023,2028-05
NCT05212480,COMPLETED,SARS-CoV2 Infection,DIETARY_SUPPLEMENT: Zinc|DIETARY_SUPPLEMENT: Placebo,University of Monastir,,ALL,"ADULT, OLDER_ADULT",NA,460,OTHER,INTERVENTIONAL,2/15/2022,5/4/2022
NCT05752201,COMPLETED,COVID-19 Vaccine,BIOLOGICAL: Gamma Variant RBD-based ARVAC-CG vaccine|BIOLOGICAL: Omicron Variant RBD-based ARVAC-CG vaccine|BIOLOGICAL: Bivalent RBD-based ARVAC-CG vaccine|OTHER: Placebo (Alum),Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno,"Universidad Nacional de San Martín (UNSAM)|National Council of Scientific and Technical Research, Argentina|Laboratorio Pablo Cassará S.R.L.",ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,2014,OTHER,INTERVENTIONAL,2/6/2023,12/7/2023
NCT04610801,WITHDRAWN,Covid19,DRUG: Nasal Spray,Larkin Community Hospital,"Ferrer Medical Innovations|Xlear, Inc",ALL,"ADULT, OLDER_ADULT",PHASE3,0,OTHER,INTERVENTIONAL,12/8/2021,8/8/2022
NCT05977101,RECRUITING,SARS-CoV-2|Prevention,BIOLOGICAL: MY-586 SARS-CoV-2 Neutralizing Antibody nasal spray|OTHER: Placebo Comparator: MY-586 SARS-CoV-2 Neutralization Antibody nasal excipient,The Second Affiliated Hospital of Chongqing Medical University,,ALL,"ADULT, OLDER_ADULT",NA,72,OTHER,INTERVENTIONAL,12/17/2021,12/30/2023
NCT04541680,RECRUITING,SARS-Cov-2 Induced Pulmonary Fibrosis,DRUG: Nintedanib 150 MG [Ofev]|OTHER: Placebo,Assistance Publique - Hôpitaux de Paris,Boehringer Ingelheim,ALL,"ADULT, OLDER_ADULT",PHASE3,250,OTHER,INTERVENTIONAL,10/29/2020,2024-05
NCT05758480,NOT_YET_RECRUITING,Long COVID,BIOLOGICAL: Blood sample (at inclusion and 6 months later)|OTHER: Patient questionnaires (at inclusion and 6 months later),"University Hospital, Angers",,ALL,"ADULT, OLDER_ADULT",NA,100,OTHER_GOV,INTERVENTIONAL,2023-04,2024-01
NCT05453201,RECRUITING,Long COVID,BEHAVIORAL: Long COVID Coping and Recovery (LCCR) Intervention,VA Office of Research and Development,,ALL,"ADULT, OLDER_ADULT",NA,36,FED,INTERVENTIONAL,10/1/2022,9/30/2024
NCT04723602,COMPLETED,Ebola Virus Disease|Marburg Virus Disease,BIOLOGICAL: cAd3-Marburg|BIOLOGICAL: cAd3-EBO-S,Albert B. Sabin Vaccine Institute,ICON plc|Oklahoma Blood Institute,ALL,ADULT,PHASE1,32,OTHER,INTERVENTIONAL,1/6/2021,12/14/2021
NCT04377802,UNKNOWN,COVID 19,DIAGNOSTIC_TEST: molecular testing for virus RNA using RT-PCR,King Fahad Specialist Hospital Dammam,,ALL,"ADULT, OLDER_ADULT",NA,400,OTHER,INTERVENTIONAL,5/17/2020,12/30/2020
NCT06073002,RECRUITING,Long COVID-19|Post-COVID-19 Syndrome,OTHER: home-based concurrent exercise,University of Vienna,,ALL,"ADULT, OLDER_ADULT",NA,20,OTHER,INTERVENTIONAL,9/4/2023,4/30/2024
NCT05844202,COMPLETED,Sars-CoV-2 Infection,DRUG: Alveavax-v1.2|DRUG: Janssen Ad26.COV2.S,"Alvea Holdings, LLC",,ALL,"ADULT, OLDER_ADULT",PHASE1,130,INDUSTRY,INTERVENTIONAL,6/27/2022,3/2/2023
NCT04702178,COMPLETED,Severe Acute Respiratory Syndrome Coronavirus 2,BIOLOGICAL: COVAC-2|BIOLOGICAL: Saline Placebo,University of Saskatchewan,Government of Canada|Government of Saskatchewan|Vaccine Formulation Institute (VFI)|Seppic,ALL,"ADULT, OLDER_ADULT",PHASE1,61,OTHER,INTERVENTIONAL,2/10/2021,11/2/2022
NCT04392778,COMPLETED,Covid19|Pneumonia|Multiple Organ Failure|Corona Virus Infection,BIOLOGICAL: MSC Treatment|BIOLOGICAL: Saline Control,SBÜ Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi,Istinye University|Regenerative Medicine and Stem Cell Production Center Liv MedCell|Liv Hospital (Ulus),ALL,ADULT,PHASE1|PHASE2,30,OTHER,INTERVENTIONAL,4/1/2020,11/30/2020
NCT06259578,RECRUITING,COVID-19 Pandemic|COVID-19 Vaccines|COVID-19 Virus Disease,BIOLOGICAL: INAVAC (Vaksin Merah Putih - UA- SARS CoV-2 (Vero Cell Inactivated) 5 μg,Dr. Soetomo General Hospital,"Universitas Airlangga|Biotis Pharmaceuticals, Indonesia|Indonesia-MoH",ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,400,OTHER_GOV,INTERVENTIONAL,1/29/2024,12/29/2024
NCT04877002,TERMINATED,Covid19|Sars-CoV-2 Infection|Corona Virus Infection,DIAGNOSTIC_TEST: Sona Saliva C-19 Rapid Test,Sona Nanotech Inc,,ALL,"ADULT, OLDER_ADULT",NA,20,INDUSTRY,INTERVENTIONAL,4/29/2021,1/5/2022
NCT04375202,TERMINATED,COVID-19,DRUG: Colchicine 1 MG Oral Tablet,University Of Perugia,,ALL,"ADULT, OLDER_ADULT",PHASE2,227,OTHER,INTERVENTIONAL,4/18/2020,10/31/2021
NCT04401202,COMPLETED,COVID-19|SARS-CoV-2,DIETARY_SUPPLEMENT: Nigella sativa oil,King Abdulaziz University,,ALL,"ADULT, OLDER_ADULT",PHASE2,183,OTHER,INTERVENTIONAL,5/21/2020,12/31/2020
NCT05585632,ACTIVE_NOT_RECRUITING,SARS-CoV-2|Influenza|RSV,BIOLOGICAL: mRNA-1010|BIOLOGICAL: mRNA-1345|BIOLOGICAL: mRNA-1273.214|BIOLOGICAL: mRNA-1045|BIOLOGICAL: mRNA-1230,"ModernaTX, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE1,392,INDUSTRY,INTERVENTIONAL,10/14/2022,2/14/2024
NCT04441632,COMPLETED,"Burnout|Stress, Emotional",BEHAVIORAL: Positive feedback,Cedars-Sinai Medical Center,,ALL,"ADULT, OLDER_ADULT",NA,24,OTHER,INTERVENTIONAL,6/15/2020,7/30/2020
NCT04757818,COMPLETED,SARS-CoV-2 Infection,OTHER: 0.07% cetylpyridinium chloride (CPC) in mouthwash|OTHER: Distilled water with the same colorant as the experimental product,Dentaid SL,"IrsiCaixa|Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia",ALL,"ADULT, OLDER_ADULT",NA,118,INDUSTRY,INTERVENTIONAL,2/17/2021,6/3/2021
NCT04452318,COMPLETED,Healthy Participants,DRUG: REGN10933 + REGN10987|DRUG: Placebo,Regeneron Pharmaceuticals,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,3303,INDUSTRY,INTERVENTIONAL,7/13/2020,10/4/2021
NCT04871802,UNKNOWN,Covid19,DIETARY_SUPPLEMENT: Taxifolin Aqua,Pirogov Russian National Research Medical University,,ALL,"ADULT, OLDER_ADULT",NA,100,OTHER,INTERVENTIONAL,5/10/2021,10/1/2021
NCT05308602,WITHDRAWN,COVID-19|SARS-CoV-2 Infection,BIOLOGICAL: SCTV01C|BIOLOGICAL: SCTV01C|BIOLOGICAL: SCTV01C|BIOLOGICAL: SCTV01E|BIOLOGICAL: SCTV01E|BIOLOGICAL: SCTV01E|BIOLOGICAL: mRNA vaccine manufactured by Pfizer or Moderna|BIOLOGICAL: mRNA vaccine manufactured by Pfizer or Moderna|BIOLOGICAL: mRNA vaccine manufactured by Pfizer or Moderna|BIOLOGICAL: Sinopharm inactivated COVID-19 vaccine|BIOLOGICAL: Sinopharm inactivated COVID-19 vaccine|BIOLOGICAL: Sinopharm inactivated COVID-19 vaccine,Sinocelltech Ltd.,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,0,INDUSTRY,INTERVENTIONAL,4/1/2022,8/1/2023
NCT04501978,COMPLETED,Covid19,BIOLOGICAL: LY3819253|DRUG: Placebo|BIOLOGICAL: Remdesivir|BIOLOGICAL: VIR-7831|BIOLOGICAL: BRII-196/BRII-198|BIOLOGICAL: AZD7442|DRUG: MP0420|DRUG: PF-07304814,National Institute of Allergy and Infectious Diseases (NIAID),"International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)|University of Copenhagen|Medical Research Council|Kirby Institute|Washington D.C. Veterans Affairs Medical Center|AIDS Clinical Trials Group|National Heart, Lung, and Blood Institute (NHLBI)|US Department of Veterans Affairs|Prevention and Early Treatment of Acute Lung Injury|Cardiothoracic Surgical Trials Network|Eli Lilly and Company|Vir Biotechnology, Inc.|GlaxoSmithKline|Brii Biosciences Limited|AstraZeneca|Molecular Partners AG|Pfizer|University of Minnesota",ALL,"ADULT, OLDER_ADULT",PHASE3,2753,NIH,INTERVENTIONAL,8/4/2020,7/14/2023
NCT05298878,ACTIVE_NOT_RECRUITING,COVID-19|Post COVID-19|Long COVID,OTHER: Intervention Group: Virtual home-based rehabilitation plus usual outpatient care,McGill University Health Centre/Research Institute of the McGill University Health Centre,Canadian Institutes of Health Research (CIHR)|RESPIPLUS|Santé WillKin (WillKin Health)|Canadian Thoracic Society,ALL,"ADULT, OLDER_ADULT",NA,132,OTHER,INTERVENTIONAL,8/1/2022,2024-03
NCT04371978,TERMINATED,"COVID 19|Coronavirus|Diabetes Mellitus, Type 2|Diabetes Mellitus|Glucose Metabolism Disorders|Metabolic Disease|Endocrine System Diseases|Dipeptidyl-Peptidase IV Inhibitors|Linagliptin|Severe Acute Respiratory Syndrome Coronavirus 2|Sars-CoV2|Hypoglycemic Agents|Respiratory Tract Diseases|Incretins|Hormones",DRUG: Linagliptin 5 MG,Rabin Medical Center,,ALL,"ADULT, OLDER_ADULT",PHASE3,64,OTHER,INTERVENTIONAL,10/1/2020,5/4/2021
NCT04960202,COMPLETED,COVID-19,DRUG: PF-07321332|DRUG: Ritonavir|DRUG: Placebo,Pfizer,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,2246,INDUSTRY,INTERVENTIONAL,7/16/2021,4/25/2022
NCT04338802,UNKNOWN,COVID-19|Nintedanib|Safety|Effect of Drugs,DRUG: Nintedanib 150 MG|OTHER: Placebo,Huilan Zhang,,ALL,"ADULT, OLDER_ADULT",PHASE2,96,OTHER,INTERVENTIONAL,4/2/2020,8/1/2020
NCT04952402,COMPLETED,Covid19|SARS-CoV2 Infection,BIOLOGICAL: Study-provided Moderna mRNA-1273 COVID-19 vaccine|BIOLOGICAL: Community-provided Moderna mRNA-1273 COVID-19 Vaccine|BIOLOGICAL: Community-Provided Pfizer-BioNTech BNT162b2 COVID-19 Vaccine,National Institute of Allergy and Infectious Diseases (NIAID),,ALL,"ADULT, OLDER_ADULT",PHASE4,43,NIH,INTERVENTIONAL,7/9/2021,1/10/2023
NCT05918978,RECRUITING,Post-COVID Postural Orthostatic Tachycardia Syndrome Postural Orthostatic Tachycardia Syndrome,DRUG: Efgartigimod,argenx,Iqvia Pty Ltd,ALL,"ADULT, OLDER_ADULT",PHASE2,38,INDUSTRY,INTERVENTIONAL,6/16/2023,2025-05
NCT05096832,COMPLETED,COVID-19 Pandemic,BIOLOGICAL: Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)|BIOLOGICAL: Blank Preparation of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01),Livzon Pharmaceutical Group Inc.,,ALL,"ADULT, OLDER_ADULT",PHASE3,10381,INDUSTRY,INTERVENTIONAL,11/3/2021,4/14/2023
NCT05848518,ACTIVE_NOT_RECRUITING,Long COVID,OTHER: Rehabilitation program,Campus docent Sant Joan de Déu-Universitat de Barcelona,Hospital de Mataró|University of Barcelona,ALL,"ADULT, OLDER_ADULT",NA,120,OTHER,INTERVENTIONAL,3/27/2023,9/30/2023
NCT05592418,COMPLETED,Post COVID-19 Condition|Long COVID,DRUG: Rintatolimod|OTHER: Placebo / Normal Saline,AIM ImmunoTech Inc.,Amarex Clinical Research,ALL,ADULT,PHASE2,80,INDUSTRY,INTERVENTIONAL,6/30/2023,11/30/2023
NCT04316377,ACTIVE_NOT_RECRUITING,Corona Virus Infection,DRUG: Hydroxychloroquine Sulfate,"University Hospital, Akershus",,ALL,"ADULT, OLDER_ADULT",PHASE4,53,OTHER,INTERVENTIONAL,3/25/2020,3/3/2025
NCT05205577,RECRUITING,COVID-19,DEVICE: Tens Eco Plus,Assistance Publique - Hôpitaux de Paris,Schwa medico (device lending),ALL,"ADULT, OLDER_ADULT",NA,30,OTHER,INTERVENTIONAL,1/9/2023,2023-03
NCT05506618,ACTIVE_NOT_RECRUITING,COVID-19,DIAGNOSTIC_TEST: Nasal Swab|DIAGNOSTIC_TEST: Nasopharyngeal swab,LumiraDx UK Limited,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,400,INDUSTRY,INTERVENTIONAL,6/30/2022,4/30/2023
NCT04922918,UNKNOWN,Covid19,BIOLOGICAL: Ligilactobacillus salivarius MP101,Universidad Complutense de Madrid,,ALL,OLDER_ADULT,NA,25,OTHER,INTERVENTIONAL,10/1/2020,7/1/2021
NCT05664932,ACTIVE_NOT_RECRUITING,COVID-19,BIOLOGICAL: Recombinant SARS-CoV-2 Vaccine (CHO Cell) LYB001|BIOLOGICAL: ZF2001,"Guangzhou Patronus Biotech Co., Ltd.","Yantai Patronus Biotech Co., Ltd.",ALL,"ADULT, OLDER_ADULT",PHASE3,1200,INDUSTRY,INTERVENTIONAL,12/28/2022,12/31/2023
NCT04760132,RECRUITING,SARS-CoV Infection,BIOLOGICAL: COMIRNATY - BioNTech Manufacturing GmbH|BIOLOGICAL: COVID-19 Vaccine Moderna dispersion for injection - MODERNA BIOTECH|BIOLOGICAL: COVID-19 Vaccine AstraZeneca suspension for injection,"Jens D Lundgren, MD","Ministry of the Interior and Health, Denmark",ALL,"ADULT, OLDER_ADULT",PHASE4,10000,OTHER,INTERVENTIONAL,2/8/2021,12/31/2024
NCT04467918,UNKNOWN,SARS-CoV2,DRUG: Cannabidiol|OTHER: PLACEBO,University of Sao Paulo,Conselho Nacional de Desenvolvimento Científico e Tecnológico|Fundação de Amparo à Pesquisa do Estado de São Paulo,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,100,OTHER,INTERVENTIONAL,7/6/2020,11/16/2021
NCT05903118,COMPLETED,SARS-CoV-2,BIOLOGICAL: RBMRNA-176|OTHER: Placebo,"Argorna Pharmaceuticals Co., LTD",,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,480,INDUSTRY,INTERVENTIONAL,1/8/2022,7/19/2023
NCT05459532,RECRUITING,COVID-19,DRUG: Molnupiravir 200 mg,"University of Witwatersrand, South Africa",Bill and Melinda Gates Foundation,ALL,"ADULT, OLDER_ADULT",PHASE3,4000,OTHER,INTERVENTIONAL,8/12/2022,2027-07
NCT04329832,COMPLETED,COVID-19,DRUG: Hydroxychloroquine|DRUG: Azithromycin,"Intermountain Health Care, Inc.",University of Utah,ALL,"ADULT, OLDER_ADULT",PHASE2,85,OTHER,INTERVENTIONAL,3/30/2020,1/1/2021
NCT04392232,COMPLETED,Coronavirus|COVID-19|Convalescent Plasma,DRUG: Convalescent Plasma,TriHealth Inc.,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,159,OTHER,INTERVENTIONAL,5/5/2020,9/21/2021
NCT04349618,UNKNOWN,Acute Respiratory Distress Syndrome|COVID19|Sars-CoV2|Pneumonia,OTHER: PROTECTIVE VENTILATION|OTHER: ULTRAPROTECTIVE VENTILATION,Hospices Civils de Lyon,,ALL,"ADULT, OLDER_ADULT",NA,200,OTHER,INTERVENTIONAL,4/15/2020,4/15/2023
NCT04380532,UNKNOWN,Covid19,BIOLOGICAL: V-SARS,Immunitor LLC,Immunitor Inc.,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,20,INDUSTRY,INTERVENTIONAL,5/15/2020,6/15/2021
NCT04914832,COMPLETED,"COVID-19|Pneumonia, Viral",BIOLOGICAL: AZD1222,Shabir Madhi,AstraZeneca,ALL,"ADULT, OLDER_ADULT",PHASE4,75012,OTHER,INTERVENTIONAL,8/30/2021,9/30/2022
NCT05007236,COMPLETED,SARS-CoV-2 Infection,DRUG: RP7214 + Standard of care (SOC)|DRUG: Placebo + Standard of care (SOC),Rhizen Pharmaceuticals SA,Incozen Therapeutics Pvt Ltd,ALL,"ADULT, OLDER_ADULT",PHASE2,163,INDUSTRY,INTERVENTIONAL,9/20/2021,3/25/2022
NCT05973136,COMPLETED,Long COVID|Chronic Fatigue Syndrome,OTHER: Telerehabilitation program based on cardiorespiratory principles,Université de Sherbrooke,Hotel Dieu Hospital,ALL,"ADULT, OLDER_ADULT",NA,7,OTHER,INTERVENTIONAL,4/1/2022,8/8/2022
NCT05137236,COMPLETED,SARS-CoV-2,BIOLOGICAL: mRNA-1283|BIOLOGICAL: mRNA-1283.211|BIOLOGICAL: mRNA-1273|BIOLOGICAL: mRNA-1283.529,"ModernaTX, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE2,543,INDUSTRY,INTERVENTIONAL,12/6/2021,3/23/2023
NCT05839236,ACTIVE_NOT_RECRUITING,COVID-19 Stress Syndrome|COVID-19 Vaccine Adverse Reaction|COVID-19-Associated Thromboembolism|COVID-19 Post-Intensive Care Syndrome|COVID-19-Associated Stroke|COVID-19 Respiratory Infection,COMBINATION_PRODUCT: Atorvastatin Calcium Tablets,Yang I. Pachankis,,MALE,"ADULT, OLDER_ADULT",PHASE1,1,INDIV,INTERVENTIONAL,5/1/2023,7/31/2023
NCT06156241,NOT_YET_RECRUITING,Post-Acute COVID-19 Syndrome,BIOLOGICAL: Stem Cell,Charles Cox,"CBR Systems, Inc.",ALL,ADULT,PHASE1,12,OTHER,INTERVENTIONAL,2024-01,2026-02
NCT04638634,TERMINATED,Coronavirus Disease 2019 (COVID-19),BIOLOGICAL: CSL760,CSL Behring,,ALL,"ADULT, OLDER_ADULT",PHASE1,12,INDUSTRY,INTERVENTIONAL,2/2/2021,6/9/2021
NCT05436834,ACTIVE_NOT_RECRUITING,SARS-CoV-2,BIOLOGICAL: mRNA-1273.214,"ModernaTX, Inc.",,ALL,CHILD,PHASE3,931,INDUSTRY,INTERVENTIONAL,6/21/2022,6/28/2024
NCT04756141,COMPLETED,Diabetes Mellitus|Covid19,DEVICE: Continuous Glucose Monitor (CGM),Mayo Clinic,,ALL,"ADULT, OLDER_ADULT",NA,20,OTHER,INTERVENTIONAL,3/3/2021,8/24/2022
NCT04447534,COMPLETED,COVID,DRUG: Chloroquine or hydroxychloroquine|DRUG: zinc,Tanta University,,ALL,"ADULT, OLDER_ADULT",PHASE3,191,OTHER,INTERVENTIONAL,6/23/2020,8/15/2020
NCT05339334,COMPLETED,Healthy Participants,DRUG: PF-07321332/ritonavir,Pfizer,,ALL,ADULT,PHASE1,14,INDUSTRY,INTERVENTIONAL,3/10/2022,4/21/2022
NCT04521036,UNKNOWN,COVID 19,BIOLOGICAL: Convalescent Plasma as Therapy for Covid-19 patients,Vinmec Research Institute of Stem Cell and Gene Technology,"National Institute of Hygiene and Epidemiology, Vietnam|National Hospital for Tropical Diseases, Hanoi, Vietnam|National Institute of Hematology and Blood Transfusion, Vietnam",ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,44,OTHER,INTERVENTIONAL,12/1/2020,10/30/2021
NCT04385836,UNKNOWN,Coronavirus,DRUG: alpha one antitrypsin inhalation,"Ministry of Health, Saudi Arabia",,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,150,OTHER_GOV,INTERVENTIONAL,6/1/2020,9/1/2020
NCT05458336,COMPLETED,Symptoms and Signs,DEVICE: Nasal lavages with Tonimer Panthexyl®,University of Padova,,ALL,"ADULT, OLDER_ADULT",NA,107,OTHER,INTERVENTIONAL,3/8/2022,4/14/2022
NCT04424134,UNKNOWN,COVID 19,DRUG: Bromhexine and Spironolactone|DRUG: Base therapy,Lomonosov Moscow State University Medical Research and Educational Center,,ALL,"ADULT, OLDER_ADULT",PHASE3,80,OTHER,INTERVENTIONAL,5/16/2020,8/23/2020
NCT04903184,COMPLETED,Covid-19,BIOLOGICAL: RUTI® vaccine|BIOLOGICAL: Placebo,RUTI Immunotherapeutics S.L.,,ALL,"ADULT, OLDER_ADULT",PHASE2,251,INDUSTRY,INTERVENTIONAL,1/6/2021,11/11/2021
NCT05216484,RECRUITING,SARS-CoV-2 Infection,"BIOLOGICAL: SARS-CoV-2 Vaccine, Inactivated (Vero Cell)",Chinese Academy of Medical Sciences,Hubei Provincial Center for Disease Control and Prevention,ALL,"ADULT, OLDER_ADULT",PHASE3,480,OTHER,INTERVENTIONAL,2/18/2022,12/30/2022
NCT04392128,WITHDRAWN,COVID19|Hematologic Malignancy,DRUG: Hydroxychloroquine Sulfate 200 MG [Plaquenil]|DRUG: Azithromycin 250 MG Oral Capsule|DRUG: Placebo oral tablet|DRUG: Placebo oral capsule,Institut de cancérologie Strasbourg Europe,,ALL,"ADULT, OLDER_ADULT",PHASE2,0,OTHER,INTERVENTIONAL,9/2/2020,9/2/2020
NCT06091384,RECRUITING,Cardiovascular Abnormalities|Post-COVID-19 Syndrome|Physical Exercise,OTHER: Inspiratory muscle strength training,D'Or Institute for Research and Education,,ALL,"ADULT, OLDER_ADULT",NA,40,OTHER,INTERVENTIONAL,10/16/2023,10/31/2024
NCT04583228,COMPLETED,COVID 19,DRUG: HLX71|OTHER: Placebo,Hengenix Biotech Inc,,ALL,"ADULT, OLDER_ADULT",PHASE1,32,INDUSTRY,INTERVENTIONAL,4/8/2021,7/20/2021
NCT04701528,UNKNOWN,Covid19|Kidney Transplant Infection,DRUG: Voclosporin|DRUG: Tacrolimus,Leiden University Medical Center,Aurinia Pharmaceuticals Inc.,ALL,"ADULT, OLDER_ADULT",PHASE2,20,OTHER,INTERVENTIONAL,11/15/2020,10/25/2022
NCT04342728,COMPLETED,COVID|Corona Virus Infection,DIETARY_SUPPLEMENT: Ascorbic Acid|DIETARY_SUPPLEMENT: Zinc Gluconate|DIETARY_SUPPLEMENT: Ascorbic Acid and Zinc Gluconate|OTHER: Standard of Care,The Cleveland Clinic,,ALL,"ADULT, OLDER_ADULT",NA,214,OTHER,INTERVENTIONAL,4/8/2020,2/11/2021
NCT04445428,ACTIVE_NOT_RECRUITING,"Poliovirus Vaccine, Oral|COVID|Mortality|Morbidity|Non-Specific Effects of Vaccines",BIOLOGICAL: oral polio vaccine + information|BEHAVIORAL: Information,Bandim Health Project,,ALL,"ADULT, OLDER_ADULT",PHASE4,3400,OTHER,INTERVENTIONAL,7/15/2020,2022-05
NCT04951323,RECRUITING,Coronavirus Disease 2019 (Covid19)|Hematopoietic Neoplasms,"DRUG: anti-COVID19 mRNA-based vaccine (BNT162b2, Comirnaty®, commercialized by Pfizer)",University of Liege,Pfizer,ALL,"ADULT, OLDER_ADULT",PHASE3,50,OTHER,INTERVENTIONAL,3/22/2021,1/1/2023
NCT04366323,COMPLETED,Sars-CoV2,DRUG: ALLOGENEIC AND EXPANDED ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS,Andalusian Network for Design and Translation of Advanced Therapies,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,26,OTHER,INTERVENTIONAL,4/27/2020,12/30/2021
NCT04584684,TERMINATED,Covid19|Coronavirus Infection|SARS-CoV-2 Infection,OTHER: Saline|DRUG: 1.5% w/v Hydrogen Peroxide|DRUG: 0.12% Chlorohexidine Gluconate|DRUG: 27% Ethanol plus essential oils|DRUG: 0.5% w/v Povidone-iodide|DRUG: 0.075% Cetylpyridinium Chloride,"University of North Carolina, Chapel Hill",,ALL,"ADULT, OLDER_ADULT",PHASE2,129,OTHER,INTERVENTIONAL,12/18/2020,10/21/2021
NCT04381884,COMPLETED,COVID-19 Drug Treatment,DRUG: IVERMECTIN (IVER P®) arm will receive IVM 600 µg / kg once daily plus standard care. CONTROL arm will receive standard care.,Laboratorio Elea Phoenix S.A.,Universidad Nacional de Salta|Centro de Investigación Veterinaria Tandil CIVETAN|Hospital de Pediatría Prof Dr. Juan P. Garrahan|Universidad Nacional de Quilmes,ALL,"ADULT, OLDER_ADULT",PHASE2,45,INDUSTRY,INTERVENTIONAL,5/18/2020,9/29/2020
NCT04805684,COMPLETED,Lung Ultrasound|Pneumonia|Covid19,DEVICE: LUS Twelve area|DEVICE: LUS Fourteen area,Bursa Yüksek İhtisas Education and Research Hospital,,ALL,"ADULT, OLDER_ADULT",NA,59,OTHER_GOV,INTERVENTIONAL,1/1/2021,3/5/2021
NCT05285384,COMPLETED,COVID-19,BIOLOGICAL: SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant,Cinnagen,Shahid Beheshti University of Medical Sciences|Vaxine Pty Ltd,ALL,"ADULT, OLDER_ADULT",NA,43,INDUSTRY,INTERVENTIONAL,2/4/2022,3/30/2022
NCT05057923,COMPLETED,COVID-19 Pneumonia,BIOLOGICAL: Bacillus subtilis,DreamTec Research Limited,,ALL,"ADULT, OLDER_ADULT",NA,9,INDUSTRY,INTERVENTIONAL,7/10/2021,11/1/2021
NCT04494984,COMPLETED,Covid19,DRUG: INM005|DRUG: Placebo,Inmunova S.A.,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,242,OTHER,INTERVENTIONAL,7/27/2020,12/30/2020
NCT05073718,RECRUITING,SARS-CoV2 Infection|Covid19,DRUG: Low-dose acetylsalicylic acid|DRUG: Placebo,Barcelona Institute for Global Health,Hospital Universitario de Torrejón|Hospital Universitario Infanta Leonor|Hospital Sant Joan de Deu|Hospital del Mar|Eduardo Mondlane University|Hospital Central de Maputo|Hospital Geral de Mavalane|Hospital Geral José Macamo,FEMALE,"CHILD, ADULT, OLDER_ADULT",PHASE3,400,OTHER,INTERVENTIONAL,9/14/2022,2/28/2024
NCT05156723,COMPLETED,COVID-19|Immunologic Factors|Coronavirus Infections|Respiratory Tract Infections,BIOLOGICAL: Subunit recombinant vaccine for the prevention of coronavirus infection|BIOLOGICAL: Placebo,St. Petersburg Research Institute of Vaccines and Sera,Crocus Medical B.V (The Netherlands),ALL,ADULT,PHASE1|PHASE2,155,OTHER_GOV,INTERVENTIONAL,7/19/2021,12/31/2022
NCT05096884,TERMINATED,Tachycardia|Dyspnea|COVID-19,DRUG: Metoprolol Succinate,Hackensack Meridian Health,,ALL,ADULT,EARLY_PHASE1,14,OTHER,INTERVENTIONAL,3/23/2022,9/12/2023
NCT05642923,RECRUITING,Post-COVID-19 Syndrome|Post-COVID Syndrome,DRUG: Synthetic Vitamin B1,ClinAmygate,"As-Salam Center, Maadi, Cairo, Egypt",ALL,"ADULT, OLDER_ADULT",PHASE4,480,OTHER,INTERVENTIONAL,1/8/2023,12/8/2023
NCT04808284,COMPLETED,COVID-19,DEVICE: Transcranial direct-current stimulation|DEVICE: Transcranial direct-current stimulation|DEVICE: Sham Transcranial direct-current stimulation,D'Or Institute for Research and Education,Rio de Janeiro State Research Supporting Foundation (FAPERJ)|Conselho Nacional de Desenvolvimento Científico e Tecnológico|Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,60,OTHER,INTERVENTIONAL,8/10/2021,10/11/2021
NCT05239923,COMPLETED,COVID-19 Pneumonia,BIOLOGICAL: Bacillus subtilis,DreamTec Research Limited,Middle East Cell and Gene Therapy|National Institute of Genetic Engineering and Biotechnology,ALL,"CHILD, ADULT, OLDER_ADULT",NA,35,INDUSTRY,INTERVENTIONAL,8/28/2021,12/30/2021
NCT04591184,RECRUITING,SARS-CoV-2,BIOLOGICAL: Covigenix VAX-001 placebo|BIOLOGICAL: Covigenix VAX-001,Entos Pharmaceuticals Inc.,"Aegis Life, Inc.|Canadian Institutes of Health Research (CIHR)|Clinical Pharma Solutions Inc|Centre national de recherche et de formation sur le paludisme (CNRFP)",ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,36,INDUSTRY,INTERVENTIONAL,4/7/2021,2023-12
NCT05303584,ACTIVE_NOT_RECRUITING,COVID-19,BIOLOGICAL: Ad5-nCoV-IH|BIOLOGICAL: Ad5-nCoV-IM|BIOLOGICAL: CoronaVac,Jiangsu Province Centers for Disease Control and Prevention,,ALL,"ADULT, OLDER_ADULT",PHASE4,360,NETWORK,INTERVENTIONAL,4/23/2022,3/20/2023
NCT04325672,WITHDRAWN,Coronavirus,BIOLOGICAL: Convalescent Plasma,Mayo Clinic,,ALL,"ADULT, OLDER_ADULT",PHASE2,0,OTHER,INTERVENTIONAL,4/1/2020,12/31/2022
NCT04333472,COMPLETED,COVID-19|Coronavirus Infection,DRUG: Piclidenoson|DRUG: Placebo,Can-Fite BioPharma,Rabin Medical Center,ALL,"ADULT, OLDER_ADULT",PHASE2,6,INDUSTRY,INTERVENTIONAL,1/6/2021,4/21/2022
NCT04946162,WITHDRAWN,"COVID|Sars-CoV2|ARDS, Human",DRUG: Tadalafil Pill,Santa Barbara Cottage Hospital,,ALL,"ADULT, OLDER_ADULT",PHASE4,0,OTHER,INTERVENTIONAL,4/20/2020,4/20/2020
NCT04518410,COMPLETED,Coronavirus|Covid19,"BIOLOGICAL: bamlanivimab 7000mg|BIOLOGICAL: BRII-196+BRII-198|BIOLOGICAL: AZD7442 (IV)|BIOLOGICAL: AZD7442 (IM)|DRUG: SNG001|DRUG: Camostat|BIOLOGICAL: BMS-986414 + BMS-986413|BIOLOGICAL: SAB-185 (3,840 Units/kg)|BIOLOGICAL: SAB-185 (10,240 Units/kg)|DRUG: CASIRIVIMAB + IMDEVIMAB|DRUG: Placebo for Bamlanivimab 7000mg|DRUG: Placebo for Bamlanivimab 700mg|DRUG: Placebo for BRII-196+BRII-198|DRUG: Placebo for SNG001|DRUG: Placebo for Camostat|DRUG: Placebo for SAB-185 (low dose)|DRUG: Placebo for BMS-986414 + BMS-986413|DRUG: Placebo for AZD7442 (IV)|DRUG: Placebo for AZD7442 (IM)|DRUG: Placebo for SAB-185 (high dose)|BIOLOGICAL: bamlanivimab 700mg",National Institute of Allergy and Infectious Diseases (NIAID),"Eli Lilly and Company|AIDS Clinical Trials Group|Brii Biosciences Limited|AstraZeneca|Sagent Pharmaceuticals|Synairgen Research Ltd.|Bristol-Myers Squibb|SAb Biotherapeutics, Inc.",ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,4044,NIH,INTERVENTIONAL,8/19/2020,6/20/2023
NCT04575610,TERMINATED,COVID-19,DRUG: PF-06650833|DRUG: Placebo,Yale University,Pfizer,ALL,"ADULT, OLDER_ADULT",PHASE2,7,OTHER,INTERVENTIONAL,11/27/2020,10/6/2021
NCT04712110,COMPLETED,Prevention of Infection Disease Caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2),BIOLOGICAL: TAK-019|BIOLOGICAL: Placebo,Takeda,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,200,INDUSTRY,INTERVENTIONAL,2/12/2021,3/28/2022
NCT05060510,COMPLETED,SARS-CoV2 Infection,DIAGNOSTIC_TEST: Take home saliva kit,The Hospital for Sick Children,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,60,OTHER,INTERVENTIONAL,9/14/2021,6/30/2022
NCT04371510,COMPLETED,COVID-19 by SARS-CoV-2 Infection,OTHER: blood sample,Centre Hospitalier Universitaire de Nice,,ALL,"ADULT, OLDER_ADULT",NA,18,OTHER,INTERVENTIONAL,5/20/2020,8/27/2021
NCT05212610,RECRUITING,COVID-19|Corona Virus Infection,BIOLOGICAL: Pfizer-BioNTech mRNA COVID-19 vaccine|BIOLOGICAL: Moderna mRNA COVID-19 vaccine,University of Michigan,The Wallace Foundation,ALL,"ADULT, OLDER_ADULT",PHASE4,200,OTHER,INTERVENTIONAL,3/21/2022,12/30/2024
NCT04432272,TERMINATED,COVID-19|Severe Acute Respiratory Syndrome (SARS)|Coronavirus Infections,BIOLOGICAL: COVID-19 convalescent plasma,William Beaumont Hospitals,,ALL,"ADULT, OLDER_ADULT",PHASE2,71,OTHER,INTERVENTIONAL,7/16/2020,11/28/2020
NCT04583410,UNKNOWN,Covid19|SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere,DRUG: Nicotine patch|DRUG: Placebo patch,Assistance Publique - Hôpitaux de Paris,,ALL,"ADULT, OLDER_ADULT",PHASE3,1633,OTHER,INTERVENTIONAL,10/22/2020,2022-06
NCT04385810,COMPLETED,Covid19|Sars-CoV2,PROCEDURE: Ophthalmologic exam,Fondation Ophtalmologique Adolphe de Rothschild,,ALL,"ADULT, OLDER_ADULT",NA,23,NETWORK,INTERVENTIONAL,4/27/2020,7/29/2020
NCT05648110,ACTIVE_NOT_RECRUITING,"COVID-19, SARS-CoV-2",BIOLOGICAL: AZD5156 (Parent study Sentinel Safety Cohort)|BIOLOGICAL: Placebo (Parent study Sentinel Safety Cohort)|BIOLOGICAL: EVUSHELD™ (Parent study Main Cohort)|BIOLOGICAL: AZD3152 (Parent study Main Cohort)|BIOLOGICAL: Placebo (Parent study Main Cohort)|BIOLOGICAL: AZD3152 (Sub-study)|BIOLOGICAL: AZD7442 - EVUSHELD™ (Sub-study)|BIOLOGICAL: AZD7442 (EVUSHELD™) (Sub-study) Immunocompromised participants offered AZD3152,AstraZeneca,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2|PHASE3,4038,INDUSTRY,INTERVENTIONAL,12/16/2022,1/31/2025
NCT04846010,UNKNOWN,"Sequelae of; Infection|Post Infection Glomerulonephritis|Post-Infectious Peripheral Neuralgia|Post-Infectious Disorder (Disorder)|Post-Infectious Arthritis|Post-Infectious Polyneuritis|Post-Infectious Parkinsonism|Post-Infectious Hypothyroidism|Post Infectious Osteoarthritis|Anxiety Disorders|Depression|Depression, Anxiety|Depression, Bipolar|Insomnia|GERD|Gastro Esophageal Reflux|Hepatitis|Glomerulonephritis",COMBINATION_PRODUCT: PurWet|COMBINATION_PRODUCT: FurFat|COMBINATION_PRODUCT: PurApo|COMBINATION_PRODUCT: PurPhl|COMBINATION_PRODUCT: PurClo|COMBINATION_PRODUCT: PurInf|COMBINATION_PRODUCT: Smoliv,"All Natural Medicine Clinic, LLC",,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1|PHASE2,2000,OTHER,INTERVENTIONAL,3/1/2021,10/1/2022
NCT04705753,COMPLETED,Covid19|Viral Infection|Respiratory Viral Infection,DIETARY_SUPPLEMENT: Cretan IAMA,University of Crete,Galenica SA|Olvos Science SA,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,20,OTHER,INTERVENTIONAL,4/1/2020,10/15/2020
NCT05736861,COMPLETED,Covid19,DRUG: Ivermectin|OTHER: Placebo,"Susanna Naggie, MD",National Center for Advancing Translational Sciences (NCATS)|Vanderbilt University Medical Center,ALL,"ADULT, OLDER_ADULT",PHASE3,1800,OTHER,INTERVENTIONAL,6/8/2021,5/16/2022
NCT05745753,ACTIVE_NOT_RECRUITING,Cardiovascular Diseases,OTHER: sample blood,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,,ALL,"ADULT, OLDER_ADULT",NA,120,OTHER,INTERVENTIONAL,1/16/2021,1/15/2024
NCT05683561,NOT_YET_RECRUITING,COVID-19 SARS-CoV-2 Infection,BIOLOGICAL: CoronaVac|BIOLOGICAL: SCTV01E,Sinocelltech Ltd.,,ALL,"ADULT, OLDER_ADULT",PHASE3,6000,INDUSTRY,INTERVENTIONAL,1/25/2023,8/25/2024
NCT04476953,ENROLLING_BY_INVITATION,Covid19,DRUG: Placebo|DRUG: Fisetin,Mayo Clinic,,ALL,"ADULT, OLDER_ADULT",PHASE2,80,OTHER,INTERVENTIONAL,8/3/2020,2025-09
NCT04473261,UNKNOWN,Covid19|SARS-CoV-2|Corona Virus Infection,DRUG: Iodine Complex|DRUG: Iodine Complex|DRUG: Placebo|DRUG: Idoine Complex,Sohaib Ashraf,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,200,OTHER,INTERVENTIONAL,7/14/2020,10/15/2021
NCT04843761,COMPLETED,Covid19,BIOLOGICAL: Remdesivir|DRUG: Remdesivir Placebo|BIOLOGICAL: Aviptadil|DRUG: Aviptadil Placebo|DRUG: Corticosteroid,National Institute of Allergy and Infectious Diseases (NIAID),"International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)|University of Copenhagen|Medical Research Council|Kirby Institute|Washington D.C. Veterans Affairs Medical Center|AIDS Clinical Trials Group|National Heart, Lung, and Blood Institute (NHLBI)|US Department of Veterans Affairs|Prevention and Early Treatment of Acute Lung Injury|Cardiothoracic Surgical Trials Network|NeuroRx, Inc.|Gilead Sciences",ALL,"ADULT, OLDER_ADULT",PHASE3,473,NIH,INTERVENTIONAL,4/20/2021,11/20/2022
NCT05705661,NOT_YET_RECRUITING,COVID-19,DEVICE: HIGH FREQUENCY CHEST WALL OSCILLATION,Cairo University,,ALL,"ADULT, OLDER_ADULT",NA,70,OTHER,INTERVENTIONAL,2/15/2023,3/15/2023
NCT05085574,WITHDRAWN,2019 Novel Coronavirus Disease|2019 Novel Coronavirus Infection|2019-nCoV Disease|2019-nCoV Infection|COVID-19 Pandemic|COVID-19 Virus Disease|COVID-19 Virus Infection|Covid19|Coronavirus Disease 2019|SARS-CoV-2 Infection|SARS-CoV-2 Acute Respiratory Disease|COVID-19,DRUG: Famotidine|DRUG: Celecoxib|DRUG: Placebo,Leidos Life Sciences,United States Department of Defense,ALL,"ADULT, OLDER_ADULT",PHASE2,0,INDUSTRY,INTERVENTIONAL,2/7/2023,2/7/2023
NCT04452474,WITHDRAWN,COVID-19,DRUG: Olokizumab 64 mg|DRUG: Placebo,R-Pharm,Cromos Pharma LLC|Covance,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,0,INDUSTRY,INTERVENTIONAL,6/30/2020,1/29/2021
NCT04347681,COMPLETED,Convalescent Plasma for COVID 19,OTHER: convalescent plasma from recovered COVID 19 donor,King Fahad Specialist Hospital Dammam,King Fahad Medical City|King Faisal Specialist Hospital And Research Center|King Abdulaziz Medical City|King Fahad University Hospital|John Hopkins Aramco Healthcare|Taibah University|King Saud University|King Khaled University Hospital|King Fahad Military Medical Complex|Qatif Central Hospital,ALL,"ADULT, OLDER_ADULT",PHASE2,575,OTHER,INTERVENTIONAL,4/18/2020,11/16/2020
NCT04443881,COMPLETED,COVID-19 Pnemonia,DRUG: Anakinra 149 MG/ML Prefilled Syringe [Kineret],Fundacion Miguel Servet,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,179,OTHER,INTERVENTIONAL,5/8/2020,3/31/2021
NCT05890534,RECRUITING,Post COVID-19 Condition|Long COVID,DRUG: Pycnogenol®|DRUG: Placebo,University of Zurich,,ALL,"ADULT, OLDER_ADULT",PHASE3,150,OTHER,INTERVENTIONAL,6/7/2023,6/1/2025
NCT04355234,COMPLETED,Pregnancy,DIAGNOSTIC_TEST: identify SARS-CoV-2 infection by serology|BIOLOGICAL: collection of biological samples,Assistance Publique - Hôpitaux de Paris,,FEMALE,"ADULT, OLDER_ADULT",NA,2446,OTHER,INTERVENTIONAL,5/4/2020,8/31/2021
NCT05747534,RECRUITING,Long COVID|Long COVID-19|Post Acute COVID-19 Syndrome|Post Acute Sequelae of COVID-19,DRUG: Larazotide Acetate|DRUG: Placebo,Massachusetts General Hospital,,ALL,"CHILD, ADULT",PHASE2,48,OTHER,INTERVENTIONAL,5/31/2023,3/31/2026
NCT04707534,COMPLETED,Covid19,DRUG: Dexamethasone,University of Oklahoma,,ALL,"ADULT, OLDER_ADULT",PHASE4,110,OTHER,INTERVENTIONAL,1/21/2021,3/4/2022
NCT04620798,COMPLETED,SARS-CoV-2|Serology|Students,BEHAVIORAL: Immediate vs. delayed provision of antibody test results,Indiana University,,ALL,"ADULT, OLDER_ADULT",NA,1076,OTHER,INTERVENTIONAL,9/14/2020,11/11/2020
NCT04646044,COMPLETED,Covid-19|Coronavirus Disease 2019,DRUG: Bempegaldesleukin|DRUG: Standard of Care|OTHER: Placebo,Nektar Therapeutics,,ALL,"ADULT, OLDER_ADULT",PHASE1,30,INDUSTRY,INTERVENTIONAL,11/13/2020,5/18/2021
NCT05907044,COMPLETED,COVID-19,BIOLOGICAL: RQ3013|BIOLOGICAL: RQ3025|BIOLOGICAL: RQ3027,Affiliated Hospital of Yunnan University,Yunnan University|Kunming Medical University,ALL,ADULT,NA,376,OTHER,INTERVENTIONAL,5/8/2023,11/23/2023
NCT04383574,COMPLETED,COVID-19,"BIOLOGICAL: Two doses of medium dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28|BIOLOGICAL: Two doses of high dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28|BIOLOGICAL: Two doses of placebo at the schedule of day 0,28|BIOLOGICAL: Two doses of low dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28","Sinovac Life Sciences Co., Ltd.",,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,422,INDUSTRY,INTERVENTIONAL,5/22/2020,5/31/2022
NCT05764174,COMPLETED,Vaccination Refusal|COVID-19,BEHAVIORAL: Factual messages|BEHAVIORAL: Narrative message|BEHAVIORAL: Mixed message,Johns Hopkins Bloomberg School of Public Health,Pontificia Universidad Javeriana,ALL,"ADULT, OLDER_ADULT",NA,2409,OTHER,INTERVENTIONAL,9/21/2022,12/17/2022
NCT05125874,UNKNOWN,COVID-19 Pandemic,BIOLOGICAL: Recombinant SARS-CoV-2 Fusion Protein Vaccine,Livzon Pharmaceutical Group Inc.,,ALL,"ADULT, OLDER_ADULT",NA,45,INDUSTRY,INTERVENTIONAL,9/30/2021,9/30/2023
NCT05004181,COMPLETED,SARS-CoV2 Infection|COVID-19|SARS-CoV-2 Acute Respiratory Disease|SARS (Disease),BIOLOGICAL: BNT162b2|BIOLOGICAL: BNT162b2 (B.1.1.7 + B.1.617.2)|BIOLOGICAL: BNT162b2 (B.1.1.7)|BIOLOGICAL: BNT162b2 (B.1.617.2)|BIOLOGICAL: BNT162b2 (B.1.1.529.1)|OTHER: Observational,BioNTech SE,,ALL,"ADULT, OLDER_ADULT",PHASE2,1383,INDUSTRY,INTERVENTIONAL,8/25/2021,10/4/2023
NCT04488081,RECRUITING,COVID-19,DRUG: Remdesivir|DRUG: Imatinib Mesylate|DRUG: Dexamethasone|DRUG: Cenicriviroc|DRUG: Icatibant|DRUG: Apremilast|BIOLOGICAL: dornase alfa|DRUG: Celecoxib|DRUG: Famotidine|BIOLOGICAL: IC14|DRUG: Aviptadil|BIOLOGICAL: narsoplimab|DRUG: Cyproheptadine|DRUG: Cyclosporine,QuantumLeap Healthcare Collaborative,"University of California, San Francisco|University of Pennsylvania|Emory University|University of Alabama at Birmingham|University of Colorado, Denver|University of Southern California|Yale University|Wake Forest University Health Sciences|Sanford Health|Long Beach Memorial Medical Center|Georgetown University|University of California, Davis|Hoag Memorial Hospital Presbyterian|Main Line Health|DHR Health Institute for Research and Development|University of California, Irvine|Corewell Health|Kaiser Permanente|University of Michigan|West Virginia University|University of Miami|University Hospitals Cleveland Medical Center|Virtua Health|University of Florida Health|M.D. Anderson Cancer Center",ALL,"ADULT, OLDER_ADULT",PHASE2,1500,OTHER,INTERVENTIONAL,7/31/2020,11/1/2024
NCT04651374,WITHDRAWN,Covid19,DEVICE: geko T3,Lawson Health Research Institute,,ALL,"ADULT, OLDER_ADULT",NA,0,OTHER,INTERVENTIONAL,2022-04,11/8/2022
NCT04254874,UNKNOWN,2019-nCoV,DRUG: Abidol hydrochloride|DRUG: Abidol Hydrochloride combined with Interferon atomization,Tongji Hospital,,ALL,"ADULT, OLDER_ADULT",PHASE4,100,OTHER,INTERVENTIONAL,2/1/2020,7/1/2020
NCT04361474,COMPLETED,Budesonide|Olfaction Disorders|SARS-CoV-2|Anosmia,DRUG: Budesonide Nasal|OTHER: Physiological serum,Fondation Ophtalmologique Adolphe de Rothschild,Hopital Lariboisière,ALL,"ADULT, OLDER_ADULT",PHASE3,120,NETWORK,INTERVENTIONAL,5/18/2020,6/25/2021
NCT04818281,COMPLETED,Covid19,BIOLOGICAL: SARS-CoV-2 VLP Vaccine|BIOLOGICAL: Placebo,"Ihsan GURSEL, PhD, Prof.",Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital|The Scientific and Technological Research Council of Turkey|MonitorCRO|Nobel Pharmaceuticals,ALL,ADULT,PHASE1,38,OTHER,INTERVENTIONAL,3/27/2021,12/29/2021
NCT05196581,COMPLETED,COVID-19,DRUG: Dispersible NaCl powder 10 sessions|DRUG: Dispersible NaCl powder 5 sessions,Suzana Erico Tanni Minamoto,Liita Care ApS,ALL,"ADULT, OLDER_ADULT",PHASE2,100,OTHER,INTERVENTIONAL,12/1/2021,12/31/2022
NCT06065176,RECRUITING,COVID-19|Vaccine-Preventable Diseases|SARS CoV 2 Infection|Upper Respiratory Tract Infection|Upper Respiratory Disease,BIOLOGICAL: Novavax COVID-19 vaccine (2023-2024 formula XBB containing)|BIOLOGICAL: Pfizer COVID-19 mRNA vaccine (2023-2024 formula XBB containing),"Sarang K. Yoon, DO, MOH",Westat|Novavax,ALL,"ADULT, OLDER_ADULT",PHASE4,1500,OTHER,INTERVENTIONAL,11/22/2023,7/30/2024
NCT04933799,UNKNOWN,COVID-19 Pneumonia,DRUG: PF-06650833|DRUG: Matching Placebo,"Giovanni Franchin, M.D, Ph.D",Pfizer,ALL,"ADULT, OLDER_ADULT",PHASE2,68,OTHER,INTERVENTIONAL,1/6/2021,5/6/2022
NCT06127498,RECRUITING,SARS-CoV-2|Prevention,BIOLOGICAL: A8G6 SARS-CoV-2 Neutralization Antibody combination nasal spray|OTHER: A8G6 SARS-CoV-2 Neutralization Antibody nasal excipient,The Second Affiliated Hospital of Chongqing Medical University,,ALL,"ADULT, OLDER_ADULT",NA,108,OTHER,INTERVENTIONAL,5/1/2022,12/1/2023
NCT04375098,COMPLETED,Severe Acute Respiratory Syndrome Coronavirus 2,BIOLOGICAL: COVID-19 convalescent plasma,Pontificia Universidad Catolica de Chile,Fundacion Arturo Lopez Perez,ALL,"ADULT, OLDER_ADULT",PHASE2,58,OTHER,INTERVENTIONAL,5/4/2020,8/17/2020
NCT04361344,TERMINATED,COVID-19 Infection|Encephalitis,BIOLOGICAL: blood samples,Centre Hospitalier de PAU,,ALL,"ADULT, OLDER_ADULT",NA,2,OTHER,INTERVENTIONAL,5/19/2020,10/25/2020
NCT05298644,WITHDRAWN,SARS-CoV-2 Infection,BIOLOGICAL: VLA2001|DRUG: Active Comparator,Valneva Austria GmbH,,ALL,CHILD,PHASE2|PHASE3,0,INDUSTRY,INTERVENTIONAL,10/1/2022,8/30/2025
NCT04590274,WITHDRAWN,Covid19|SARS (Severe Acute Respiratory Syndrome),DRUG: Hydroxychloroquine|DIETARY_SUPPLEMENT: Vitamins and Minerals|DRUG: Azithromycin,International Brain Research Foundation,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1,0,OTHER,INTERVENTIONAL,2020-11,2021-12
NCT04348474,SUSPENDED,Covid-19,DRUG: Hydroxychloroquine Sulfate|DRUG: Azithromycin Tablets,Azidus Brasil,,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,200,INDUSTRY,INTERVENTIONAL,4/20/2020,2023-07
NCT04487574,COMPLETED,SARS-CoV-2 Infection,DRUG: XC221|DRUG: Placebo,RSV Therapeutics LLC,,ALL,"ADULT, OLDER_ADULT",PHASE3,118,INDUSTRY,INTERVENTIONAL,7/25/2020,10/29/2020
NCT05313074,COMPLETED,COVID-19|Cancer,BIOLOGICAL: CoronaVac vaccine,"National Cancer Institute, Thailand",Mahidol University,ALL,"ADULT, OLDER_ADULT",NA,311,OTHER_GOV,INTERVENTIONAL,3/23/2021,2/25/2022
NCT04350281,COMPLETED,COVID,DRUG: Interferon Beta-1B|DRUG: Hydroxychloroquine,The University of Hong Kong,,ALL,"ADULT, OLDER_ADULT",PHASE2,60,OTHER,INTERVENTIONAL,4/9/2020,7/7/2020
NCT04523181,COMPLETED,Covid-19,DRUG: Antroquinonol|OTHER: Placebo,Golden Biotechnology Corporation,,ALL,"ADULT, OLDER_ADULT",PHASE2,124,INDUSTRY,INTERVENTIONAL,10/15/2020,12/23/2021
NCT05670444,COMPLETED,Influenza -Like Illness,DRUG: kelavit,Hôpital Universitaire Sahloul,,ALL,ADULT,PHASE1,150,OTHER,INTERVENTIONAL,1/2/2023,2/28/2023
NCT05445674,COMPLETED,Post-COVID19 Condition,COMBINATION_PRODUCT: Plasma Exchange Procedure|OTHER: Sham Plasma Exchange Procedure,"Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia",IrsiCaixa|Banc de Sang i Teixits,ALL,"ADULT, OLDER_ADULT",PHASE2,50,OTHER,INTERVENTIONAL,9/22/2022,6/6/2023
NCT05873374,NOT_YET_RECRUITING,COVID-19 Vaccine|COVID-19,BIOLOGICAL: 50 μg Baiya SARS-CoV-2 Vax 2|OTHER: Placebo,"Baiya Phytopharm Co., Ltd.",,ALL,ADULT,PHASE2,75,INDUSTRY,INTERVENTIONAL,2023-12,2024-08
NCT04530474,WITHDRAWN,Covid19,DRUG: Ivermectin Pill|DRUG: Placebo,Temple University,,ALL,"ADULT, OLDER_ADULT",PHASE3,0,OTHER,INTERVENTIONAL,4/1/2021,6/30/2021
NCT05703074,RECRUITING,Long COVID,DIETARY_SUPPLEMENT: Nicotinamide Riboside (NR)|BEHAVIORAL: Mind-body reprocessing therapy (MBRT)|BEHAVIORAL: Care as usual|DIETARY_SUPPLEMENT: Placebo,"University Hospital, Akershus",,ALL,"ADULT, OLDER_ADULT",PHASE2,310,OTHER,INTERVENTIONAL,1/30/2023,2025-01
NCT05050474,COMPLETED,COVID19,BIOLOGICAL: Recombinant SARS-CoV-2 Fusion Protein Vaccine,Livzon Pharmaceutical Group Inc.,"Guangdong Center for Disease Prevention and Control|Simoon Record Pharma Information Consulting Co., Ltd.",ALL,"ADULT, OLDER_ADULT",PHASE1,43,INDUSTRY,INTERVENTIONAL,8/7/2021,2/18/2022
NCT05030974,COMPLETED,Covid19|Kidney Diseases|Vaccine Response Impaired|SARS-CoV2 Infection,BIOLOGICAL: mRNA-1273|BIOLOGICAL: Ad26.COV2.S vaccine,University Medical Center Groningen,Radboud University Medical Center|Erasmus Medical Center|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|ZonMw: The Netherlands Organisation for Health Research and Development,ALL,"ADULT, OLDER_ADULT",PHASE4,336,OTHER,INTERVENTIONAL,10/21/2021,3/12/2022
NCT05591781,RECRUITING,Chronic Obstructive Pulmonary Disease,DEVICE: high frequency chest wall oscillation with vest system|DEVICE: Lung flute (OPEP),Cairo University,,MALE,ADULT,NA,60,OTHER,INTERVENTIONAL,2022-10,2022-12
NCT04560881,COMPLETED,COVID-19 Virus Infection,BIOLOGICAL: Inactivated SARS-CoV-2 vaccine (Vero cell)|BIOLOGICAL: Placebo/Aluminum Adjuvant of Inactivated SARS-CoV-2 vaccine,Laboratorio Elea Phoenix S.A.,Beijing Institute of Biological Products Co Ltd.|China National Biotec Group Company Limited|Fundación Huésped,ALL,"ADULT, OLDER_ADULT",PHASE3,3000,INDUSTRY,INTERVENTIONAL,9/16/2020,12/13/2021
NCT04355676,WITHDRAWN,Coronavirus Infection,DRUG: Selinexor,Karyopharm Therapeutics Inc,,ALL,"ADULT, OLDER_ADULT",PHASE2,0,INDUSTRY,INTERVENTIONAL,4/30/2020,8/30/2020
NCT04445376,COMPLETED,Covid19,OTHER: Physical Exercises,Government College University Faisalabad,,ALL,"ADULT, OLDER_ADULT",NA,20,OTHER,INTERVENTIONAL,7/3/2020,10/3/2020
NCT05040776,WITHDRAWN,Thrombopenia|Covid19,DRUG: EP-7041 Injection,eXIthera Pharmaceuticals,,ALL,"ADULT, OLDER_ADULT",PHASE2,0,INDUSTRY,INTERVENTIONAL,2023-10,2025-05
NCT04482699,TERMINATED,Severe COVID-19 Disease,BIOLOGICAL: RAPA-501-Allo off-the-shelf Therapy of COVID-19|OTHER: Placebo,Rapa Therapeutics LLC,Hackensack Meridian Health,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,1,INDUSTRY,INTERVENTIONAL,12/30/2020,9/13/2021
NCT04880174,ACTIVE_NOT_RECRUITING,SARS-CoV Infection,DIAGNOSTIC_TEST: serological testing,Universitair Ziekenhuis Brussel,,ALL,"ADULT, OLDER_ADULT",NA,500,OTHER,INTERVENTIONAL,3/22/2021,2028-07
NCT05639998,COMPLETED,Corona Virus Infection,BIOLOGICAL: COVAXIN(BBV152)|BIOLOGICAL: BBV154 Intranasal Vaccine,Bharat Biotech International Limited,,ALL,"ADULT, OLDER_ADULT",PHASE2,608,INDUSTRY,INTERVENTIONAL,9/1/2021,7/31/2022
NCT06113744,RECRUITING,SARS-CoV-2 Infection,"BIOLOGICAL: Placebo|BIOLOGICAL: COVID-19 Vaccine (Vero Cell) ,Inactivated|BIOLOGICAL: COVID-19 mRNA Vaccine (ZSVG-02-O) 10 μg|BIOLOGICAL: COVID-19 mRNA Vaccine (ZSVG-02-O) 30 μg|BIOLOGICAL: COVID-19 mRNA Vaccine (ZSVG-02-O) 60 μg",CNBG-Virogin Biotech (Shanghai) Ltd.,Shulan (Hangzhou) Hospital,ALL,"ADULT, OLDER_ADULT",PHASE1,164,INDUSTRY,INTERVENTIONAL,3/10/2023,2024-06
NCT04930874,RECRUITING,COVID-19 Acute Respiratory Distress Syndrome|COVID-19 Pneumonia,OTHER: NIRS (Near-Infrared Spectroscopy),University of Athens,,ALL,"ADULT, OLDER_ADULT",NA,37,OTHER,INTERVENTIONAL,6/22/2021,11/16/2024
NCT05736874,COMPLETED,Covid19,DRUG: Fluticasone|OTHER: Placebo,"Susanna Naggie, MD",National Center for Advancing Translational Sciences (NCATS)|Vanderbilt University Medical Center,ALL,"ADULT, OLDER_ADULT",PHASE3,1407,OTHER,INTERVENTIONAL,8/6/2021,5/18/2022
NCT04894474,WITHDRAWN,COVID-19,DRUG: BI 767551 intravenous|DRUG: BI 767551 inhalation|DRUG: Placebo intravenous|DRUG: Placebo inhalation,Boehringer Ingelheim,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,0,INDUSTRY,INTERVENTIONAL,6/17/2021,7/24/2022
NCT04641481,UNKNOWN,Covid19|SARS-CoV Infection,BIOLOGICAL: BBV152|BIOLOGICAL: Placebo,Bharat Biotech International Limited,Indian Council of Medical Research|Iqvia Pty Ltd,ALL,"ADULT, OLDER_ADULT",PHASE3,25800,INDUSTRY,INTERVENTIONAL,11/16/2020,2022-12
NCT05433181,NOT_YET_RECRUITING,SARS-CoV-2,DRUG: ACE2 Chewing Gum|OTHER: Placebo Chewing Gum,University of Pennsylvania,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,40,OTHER,INTERVENTIONAL,2024-02,4/1/2024
NCT04362176,COMPLETED,COVID-19|Coronavirus|SARS-CoV-2,BIOLOGICAL: pathogen reduced SARS-CoV-2 convalescent plasma|BIOLOGICAL: Placebo,Vanderbilt University Medical Center,Dolly Parton|National Center for Advancing Translational Sciences (NCATS),ALL,"ADULT, OLDER_ADULT",PHASE3,974,OTHER,INTERVENTIONAL,4/24/2020,8/6/2021
NCT06156176,NOT_YET_RECRUITING,Long-COVID|Long Covid19|Post-COVID-19 Syndrome|Post-COVID Syndrome|Fatigue,OTHER: COVIDEx,Lawson Health Research Institute,Western University,ALL,"ADULT, OLDER_ADULT",NA,60,OTHER,INTERVENTIONAL,2023-12,2025-12
NCT04849598,COMPLETED,Post-COVID19,OTHER: Oxygen therapy,Schön Klinik Berchtesgadener Land,,ALL,"ADULT, OLDER_ADULT",NA,15,OTHER,INTERVENTIONAL,4/13/2021,8/27/2021
NCT04785898,COMPLETED,Covid19,DIAGNOSTIC_TEST: ID Now™ COVID-19 Screening Test,Fondation Hôpital Saint-Joseph,,ALL,"ADULT, OLDER_ADULT",NA,1265,OTHER,INTERVENTIONAL,11/9/2020,5/9/2022
NCT04916574,COMPLETED,SARS-COV2 Infection|Covid19,OTHER: Nasal Spray Containing Anti-SARS-CoV-2 Antibodies Derived from Bovine Colostrum,Icosagen Cell Factory,Tartu University Hospital,ALL,"ADULT, OLDER_ADULT",NA,16,INDUSTRY,INTERVENTIONAL,3/20/2021,6/3/2021
NCT05350774,ENROLLING_BY_INVITATION,Systemic Inflammation|Neuroinflammation|Microvascular Thrombosis,DRUG: IV normal saline|DRUG: IV immunoglobulin,National Institute of Neurological Disorders and Stroke (NINDS),,ALL,"ADULT, OLDER_ADULT",PHASE2,45,NIH,INTERVENTIONAL,7/10/2023,4/6/2024
NCT04375774,UNKNOWN,COVID,DEVICE: FFP2|DEVICE: Facial mask|DEVICE: MFS,Cliniques universitaires Saint-Luc- Université Catholique de Louvain,,ALL,ADULT,NA,10,OTHER,INTERVENTIONAL,2020-05,2020-05
NCT05438498,TERMINATED,SARS-CoV-2 Infection,DRUG: Evusheld (tixagevimab+cilgavimab) IM or IV,"MediMergent, LLC",,ALL,"ADULT, OLDER_ADULT",PHASE3,550,INDUSTRY,INTERVENTIONAL,6/3/2022,6/30/2023
NCT04527198,COMPLETED,COVID-19,DIAGNOSTIC_TEST: Brainstem Responses Assessment Sedation Score (BRASS)|DIAGNOSTIC_TEST: Electroencephalogram with EKG lead,Assistance Publique - Hôpitaux de Paris,,ALL,"ADULT, OLDER_ADULT",NA,52,OTHER,INTERVENTIONAL,9/14/2020,12/31/2020
NCT05715944,COMPLETED,COVID-19,DRUG: AZD 1222,Botswana Harvard AIDS Institute Partnership,AstraZeneca|Botswana Ministry of Health,ALL,"ADULT, OLDER_ADULT",PHASE3,10888,OTHER,INTERVENTIONAL,9/15/2021,12/30/2022
NCT04336774,WITHDRAWN,COVID-19,DEVICE: Caption AI,Duke University,"Caption Health, Inc.",ALL,"ADULT, OLDER_ADULT",NA,0,OTHER,INTERVENTIONAL,2020-07,11/9/2020
NCT04444674,UNKNOWN,Coronavirus,BIOLOGICAL: ChAdOx1 nCoV-19|BIOLOGICAL: Normal saline 0.9%,University of Oxford,"Medical Research Council, South Africa|Bill and Melinda Gates Foundation|Wits Health Consortium (Pty) Ltd|University of Witwatersrand, South Africa",ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,2130,OTHER,INTERVENTIONAL,6/24/2020,2021-12
NCT05726084,ACTIVE_NOT_RECRUITING,COVID-19|Coronavirus Infections|Respiratory Tract Infections|COVID-19 Respiratory Infection,BIOLOGICAL: Subunit recombinant vaccine for the prevention of coronavirus infection|BIOLOGICAL: Placebo,St. Petersburg Research Institute of Vaccines and Sera,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,16304,OTHER_GOV,INTERVENTIONAL,10/24/2022,12/30/2023
NCT04488484,COMPLETED,COVID-19,OTHER: Serology test follow-up,Fondation Hôpital Saint-Joseph,,ALL,"ADULT, OLDER_ADULT",NA,80,OTHER,INTERVENTIONAL,7/1/2020,5/23/2022
NCT04453384,COMPLETED,SARS Virus,DRUG: XAV-19|DRUG: Placebo,Nantes University Hospital,BPIfrance|Xenothera SAS,ALL,"ADULT, OLDER_ADULT",PHASE2,416,OTHER,INTERVENTIONAL,9/1/2020,8/19/2021
NCT04350684,UNKNOWN,COVID-19,DRUG: Umifenovir|DRUG: Interferon-β 1a|DRUG: Lopinavir / Ritonavir|DRUG: Single Dose of Hydroxychloroquine|DRUG: Standards of Care,Shahid Beheshti University of Medical Sciences,,ALL,"ADULT, OLDER_ADULT",PHASE4,40,OTHER,INTERVENTIONAL,4/15/2020,4/24/2020
NCT04466098,ACTIVE_NOT_RECRUITING,Acute Respiratory Distress Syndrome|ARDS (Moderate or Severe)|COVID-19 Pneumonia,BIOLOGICAL: Mesenchymal stromal cells|OTHER: Placebo,"Masonic Cancer Center, University of Minnesota",,ALL,"ADULT, OLDER_ADULT",PHASE2,9,OTHER,INTERVENTIONAL,7/30/2020,2023-12
NCT04497298,COMPLETED,COVID-19,BIOLOGICAL: Two COVID-19 vaccine candidate (TMV-083/V-591) administrations - Low dose|BIOLOGICAL: Two COVID-19 vaccine candidate (TMV-083/V-591) administrations - High dose|BIOLOGICAL: One COVID-19 vaccine candidate (TMV-083/V-591) administration - High dose|OTHER: Placebo,Institut Pasteur,Themis Bioscience GmbH|Coalition for Epidemic Preparedness Innovations,ALL,ADULT,PHASE1,90,INDUSTRY,INTERVENTIONAL,8/10/2020,5/12/2021
NCT05092698,COMPLETED,SARS-CoV2 Infection,DIETARY_SUPPLEMENT: Vitamin D (cholecalciferol)|DIETARY_SUPPLEMENT: Herbal oil,"Federal Research Clinical Center of Federal Medical & Biological Agency, Russia",,ALL,"ADULT, OLDER_ADULT",NA,110,OTHER_GOV,INTERVENTIONAL,5/1/2020,1/31/2022
NCT04397757,COMPLETED,COVID-19,BIOLOGICAL: COVID-19 Convalescent Plasma,University of Pennsylvania,,ALL,"ADULT, OLDER_ADULT",PHASE1,80,OTHER,INTERVENTIONAL,5/13/2020,3/8/2021
NCT05433298,WITHDRAWN,COVID-19 Pneumonia|COVID-19,BIOLOGICAL: Mesenchymal stem cell|OTHER: Placebo,Paulo Brofman,Conselho Nacional de Desenvolvimento Científico e Tecnológico,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,0,OTHER,INTERVENTIONAL,5/1/2022,3/31/2023
NCT04334044,COMPLETED,COVID-19|Severe Acute Respiratory Syndrome Coronavirus 2,DRUG: Ruxolitinib Oral Tablet,Grupo Cooperativo de Hemopatías Malignas,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,77,OTHER,INTERVENTIONAL,9/1/2020,4/30/2021
NCT04405544,COMPLETED,Encephalopathy|COVID,DIAGNOSTIC_TEST: CT-scan|DIAGNOSTIC_TEST: EEG|DIAGNOSTIC_TEST: EP|DIAGNOSTIC_TEST: Pulse oximetry|DIAGNOSTIC_TEST: Blood tests,"State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia",,ALL,ADULT,NA,51,OTHER,INTERVENTIONAL,5/22/2020,10/29/2020
NCT04809974,RECRUITING,Covid19|Sequelae of; Infection|Cognitive Symptom,DRUG: Niagen,Massachusetts General Hospital,,ALL,"ADULT, OLDER_ADULT",PHASE4,100,OTHER,INTERVENTIONAL,7/22/2021,12/31/2023
NCT04414098,UNKNOWN,COVID-19,DRUG: INC424 / Ruxolitinib,Marcelo Iastrebner,Novartis,ALL,"ADULT, OLDER_ADULT",PHASE2,100,OTHER,INTERVENTIONAL,6/1/2020,9/15/2020
NCT04551898,COMPLETED,Covid19,DRUG: BGB-DXP593|DRUG: Placebo,BeiGene,,ALL,"ADULT, OLDER_ADULT",PHASE2,181,INDUSTRY,INTERVENTIONAL,12/2/2020,5/25/2021
NCT04330144,WITHDRAWN,Contact Person From COVID-19 Confirmed Patient,DRUG: Hydroxychloroquine as post exposure prophylaxis|OTHER: Others(No intervention),Gangnam Severance Hospital,,ALL,"ADULT, OLDER_ADULT",PHASE3,0,OTHER,INTERVENTIONAL,4/1/2020,6/29/2020
NCT04458298,TERMINATED,COVID-19,DRUG: OP-101|DRUG: Placebo,"Ashvattha Therapeutics, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE2,28,INDUSTRY,INTERVENTIONAL,8/11/2020,8/12/2022
NCT04315298,COMPLETED,COVID-19,DRUG: Sarilumab|DRUG: Placebo,Regeneron Pharmaceuticals,Sanofi,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,1912,INDUSTRY,INTERVENTIONAL,3/18/2020,9/2/2020
NCT04785144,COMPLETED,COVID-19|COVID-19 Immunisation,BIOLOGICAL: mRNA-1273|BIOLOGICAL: mRNA-1273.351,National Institute of Allergy and Infectious Diseases (NIAID),"ModernaTX, Inc.",ALL,"ADULT, OLDER_ADULT",PHASE1,135,NIH,INTERVENTIONAL,3/31/2021,7/5/2022
NCT05080244,COMPLETED,COVID-19,DIETARY_SUPPLEMENT: Probiotics|DIETARY_SUPPLEMENT: Placebo,Centre de recherche du Centre hospitalier universitaire de Sherbrooke,Lallemand Health Solutions,ALL,"ADULT, OLDER_ADULT",NA,618,OTHER,INTERVENTIONAL,10/28/2021,12/4/2022
NCT04402944,UNKNOWN,COVID,DRUG: Pulmozyme|DRUG: Placebo,Boston Children's Hospital,Brigham and Women's Hospital|South Shore Hospital,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,60,OTHER,INTERVENTIONAL,7/5/2020,12/31/2021
NCT04698798,COMPLETED,Cachexia|Muscle Loss|Muscle Wasting|Muscle Atrophy|Critical Illness,PROCEDURE: Muscle Biopsy,Hasselt University,Jessa Hospital,ALL,"ADULT, OLDER_ADULT",NA,22,OTHER,INTERVENTIONAL,1/2/2021,4/3/2021
NCT04432298,TERMINATED,COVID-19,DRUG: Pamrevlumab|DRUG: Placebo,FibroGen,,ALL,"ADULT, OLDER_ADULT",PHASE2,22,INDUSTRY,INTERVENTIONAL,6/20/2020,3/22/2021
NCT05244044,ACTIVE_NOT_RECRUITING,COVID-19|Long COVID|Post COVID-19 Condition,OTHER: Pulmonary rehabilitation in primary care,"University Hospital, Antwerp",Ziekenhuis Oost-Limburg|Universiteit Antwerpen|Hasselt University,ALL,"ADULT, OLDER_ADULT",NA,76,OTHER,INTERVENTIONAL,4/19/2022,9/1/2024
NCT04343144,UNKNOWN,COVID19- Infection With SARS-CoV-2 Virus,DRUG: Nivolumab Injection,Assistance Publique - Hôpitaux de Paris,,ALL,"ADULT, OLDER_ADULT",PHASE2,92,OTHER,INTERVENTIONAL,4/15/2020,9/30/2020
NCT05137444,UNKNOWN,COVID-19,BIOLOGICAL: LYB001|BIOLOGICAL: Placebo,"Yantai Patronus Biotech Co., Ltd.",,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,1900,INDUSTRY,INTERVENTIONAL,2022-01,2023-05
NCT05230940,ACTIVE_NOT_RECRUITING,COVID-19|Sars-CoV-2 Infection,BIOLOGICAL: TURKOVAC|BIOLOGICAL: CoronaVac,Health Institutes of Turkey,,ALL,"CHILD, ADULT",PHASE2,644,OTHER_GOV,INTERVENTIONAL,2/18/2022,12/31/2023
NCT04389840,TERMINATED,Coronavirus Disease 2019 (COVID-19)|Acute Lung Injury|Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),DRUG: Dociparstat sodium|DRUG: Placebo,Chimerix,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,27,INDUSTRY,INTERVENTIONAL,7/8/2020,5/20/2021
NCT04918940,COMPLETED,Follicular Lymphoma|Mantle Cell Lymphoma,BIOLOGICAL: Determination of COVID-19 vacciantion efficacy,Centre Henri Becquerel,,ALL,"ADULT, OLDER_ADULT",NA,20,OTHER,INTERVENTIONAL,5/21/2021,6/27/2022
NCT04718480,COMPLETED,Covid19,DRUG: Placebo|DRUG: Fluvoxamine,SigmaDrugs Research Ltd.,,ALL,"ADULT, OLDER_ADULT",PHASE2,66,INDUSTRY,INTERVENTIONAL,11/27/2020,5/31/2022
NCT05780424,COMPLETED,COVID-19,BIOLOGICAL: BRII-196|BIOLOGICAL: BRII-198|BIOLOGICAL: Placebo|BIOLOGICAL: Remdesivir,National Institute of Allergy and Infectious Diseases (NIAID),"International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)|University of Copenhagen|Medical Research Council|Kirby Institute|Washington D.C. Veterans Affairs Medical Center|AIDS Clinical Trials Group|National Heart, Lung, and Blood Institute (NHLBI)|US Department of Veterans Affairs|Prevention and Early Treatment of Acute Lung Injury|Cardiothoracic Surgical Trials Network|Brii Biosciences Limited|University of Minnesota",ALL,"ADULT, OLDER_ADULT",PHASE3,353,NIH,INTERVENTIONAL,12/16/2020,10/10/2022
NCT04475601,TERMINATED,COVID-19|Corona Virus Infection,DRUG: Enzalutamide Pill,Andreas Josefsson,"Umeå University|Sahlgrenska University Hospital, Sweden|University Hospital, Umeå|Uppsala University Hospital|Skane University Hospital|Jonkoping County Hospital|Sundsvall Hospital|Helsingborgs Hospital|Göteborg University|Astellas Pharma Europe Ltd.|Norrlands University Hospital",ALL,"ADULT, OLDER_ADULT",PHASE2,42,OTHER_GOV,INTERVENTIONAL,7/15/2020,5/29/2021
NCT04723524,COMPLETED,COVID-19,"COMBINATION_PRODUCT: Jinhua Qinggan (JHQG) Granules, Traditional Chinese Medicine|OTHER: Placebo Comparator",University of Karachi,"Indus Hospital and Health Network|Dow University Hospital, Mission Rd, Gulzar-e-Hijri, Scheme 33, Karachi. Tel: (92-21) 38771111|Dr. Ruth K.M. Pfau Civil Hospital, Karachi",ALL,"ADULT, OLDER_ADULT",PHASE2,402,OTHER,INTERVENTIONAL,9/22/2020,8/23/2021
NCT04467840,COMPLETED,COVID-19|Lung Infection,DRUG: Opaganib|DRUG: Placebo,RedHill Biopharma Limited,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,475,INDUSTRY,INTERVENTIONAL,8/21/2020,7/18/2021
NCT04376840,UNKNOWN,Severe SARS-CoV2 Pneumonia,OTHER: Blood sample and data record,CHU de Reims,,ALL,"ADULT, OLDER_ADULT",NA,270,OTHER,INTERVENTIONAL,5/28/2020,10/28/2022
NCT04380701,UNKNOWN,"Infections, Respiratory|Virus Diseases|Infection Viral|Vaccine Adverse Reaction|RNA Virus Infections|Protection Against COVID-19 and Infections With SARS CoV 2",BIOLOGICAL: BNT162a1|BIOLOGICAL: BNT162b1|BIOLOGICAL: BNT162b2|BIOLOGICAL: BNT162c2,BioNTech SE,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,512,INDUSTRY,INTERVENTIONAL,4/23/2020,2023-04
NCT05464680,RECRUITING,ARDS|SARS-CoV 2 Pneumonia,OTHER: blood sample and bronchoalveolar lavage,Assistance Publique Hopitaux De Marseille,,ALL,"ADULT, OLDER_ADULT",NA,40,OTHER,INTERVENTIONAL,11/24/2022,2/23/2025
NCT04373824,UNKNOWN,COVID,DRUG: Ivermectin,Max Healthcare Insititute Limited,,ALL,"ADULT, OLDER_ADULT",NA,50,OTHER,INTERVENTIONAL,4/25/2020,7/25/2020
NCT05158140,COMPLETED,Pneumococcal Infection,BIOLOGICAL: V110|BIOLOGICAL: V114|BIOLOGICAL: mRNA-1273|BIOLOGICAL: Placebo for V110|BIOLOGICAL: Placebo for V114,Merck Sharp & Dohme LLC,,ALL,"ADULT, OLDER_ADULT",PHASE3,850,INDUSTRY,INTERVENTIONAL,1/12/2022,2/21/2023
NCT05697640,NOT_YET_RECRUITING,Post-COVID ME/CFS,DRUG: Vericiguat Oral Tablet,"Charite University, Berlin, Germany",Bayer,ALL,ADULT,PHASE2,104,OTHER,INTERVENTIONAL,2023-02,2023-10
NCT05848401,COMPLETED,Long COVID,DEVICE: Biosound Therapy System,Anxiety Relief Center,,ALL,"ADULT, OLDER_ADULT",NA,13,OTHER,INTERVENTIONAL,4/29/2021,1/19/2022
NCT04389801,UNKNOWN,Covid 19,DRUG: Desferal 500 MG Injection,Hesham Al-Inany,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,200,OTHER,INTERVENTIONAL,6/1/2020,12/31/2020
NCT04327401,TERMINATED,"Coronavirus Infection|Pneumonia, Viral|Acute Respiratory Distress Syndrome",DRUG: Dexamethasone,Hospital Sirio-Libanes,Hospital Israelita Albert Einstein|Hospital do Coracao|Brazilian Research In Intensive Care Network|Ache Laboratorios Farmaceuticos S.A.,ALL,"ADULT, OLDER_ADULT",PHASE3,299,OTHER,INTERVENTIONAL,4/13/2020,7/22/2020
NCT04845880,COMPLETED,SARS COV-2 IgG Levels on Health Workers,DIAGNOSTIC_TEST: Spike protein (S) or the nucleocapsid (N) of SARS-CoV-2,Baskent University,Hikmet Eda Aliskan|Hatice Hale Gumus|Ilker Odemis|Zuhal Ekici Unsal,ALL,"ADULT, OLDER_ADULT",NA,182,OTHER,INTERVENTIONAL,10/1/2020,4/1/2021
NCT04901624,COMPLETED,SARS-CoV-2,BEHAVIORAL: Family Risk Messaging|BEHAVIORAL: Personal Risk Messaging|BEHAVIORAL: Loss Protection|BEHAVIORAL: Lottery Incentive,University of Southern California,AltaMed Health Services Corporation|National Institute on Aging (NIA),ALL,"CHILD, ADULT, OLDER_ADULT",NA,2161,OTHER,INTERVENTIONAL,6/29/2021,6/3/2023
NCT05087524,TERMINATED,SARS-CoV2 Infection|COVID-19,DIAGNOSTIC_TEST: BinaxNOW Ag Card,"University of Wisconsin, Madison",,ALL,"CHILD, ADULT, OLDER_ADULT",NA,65,OTHER,INTERVENTIONAL,1/9/2021,4/8/2021
NCT04408040,TERMINATED,COVID,BIOLOGICAL: Convalescent Plasma,"Northside Hospital, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE2,8,OTHER,INTERVENTIONAL,7/14/2020,9/14/2021
NCT04709328,NOT_YET_RECRUITING,COVID-19|SARS-CoV-2,DRUG: SCTA01|OTHER: Placebo,Sinocelltech Ltd.,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,690,INDUSTRY,INTERVENTIONAL,3/28/2021,3/1/2022
NCT05516836,RECRUITING,Telemedicine|Musculoskeletal Disease|SARS-CoV-2|Pain|COVID-19|Exercise,OTHER: Multicomponent exercise program|OTHER: Tele-health primary care rehabilitation program,Universidad Europea de Madrid,,ALL,"ADULT, OLDER_ADULT",NA,62,OTHER,INTERVENTIONAL,3/20/2023,11/20/2024
NCT05597501,RECRUITING,Psychosocial Intervention,BEHAVIORAL: manual-based group interventions,"Department for Psychosomatic Medicine and Psychotherapy, University for Continuing Education Krems",,ALL,"ADULT, OLDER_ADULT",NA,96,OTHER,INTERVENTIONAL,2022-11,2024-11
NCT04584580,UNKNOWN,Coronavirus Disease (COVID)19,DRUG: low-molecular-weight heparin,Ain Shams University,,ALL,"ADULT, OLDER_ADULT",PHASE4,50,OTHER,INTERVENTIONAL,8/1/2020,12/31/2020
NCT04280224,COMPLETED,Novel Coronavirus Pneumonia,BIOLOGICAL: NK Cells,Xinxiang medical university,First Affiliated Hospital of Xinjiang Medical University,ALL,"ADULT, OLDER_ADULT",PHASE1,2,OTHER,INTERVENTIONAL,2/15/2020,12/31/2022
NCT04399980,COMPLETED,COVID 19|SARS-CoV 2|Pneumonia,DRUG: Mavrilimumab|DRUG: Placebos,The Cleveland Clinic,"Kiniksa Pharmaceuticals, Ltd.",ALL,"ADULT, OLDER_ADULT",PHASE2,40,OTHER,INTERVENTIONAL,5/20/2020,4/23/2021
NCT05422924,RECRUITING,Long COVID,BEHAVIORAL: Web-based platform. (My Viva Plan),University of Alberta,Revive Wellness Inc.,ALL,"ADULT, OLDER_ADULT",NA,40,OTHER,INTERVENTIONAL,8/25/2023,12/31/2024
NCT04683224,WITHDRAWN,Covid-19|SARS-CoV-2|Coronavirus,BIOLOGICAL: UB-612|OTHER: Placebo,"Vaxxinity, Inc.",Diagnósticos da América S/A (DASA),ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,0,INDUSTRY,INTERVENTIONAL,2/1/2021,3/22/2023
NCT05595824,COMPLETED,COVID-19,DRUG: Molnupiravir (Esperavir)|DRUG: Standard of care,"Promomed, LLC",,ALL,"ADULT, OLDER_ADULT",PHASE3,240,OTHER,INTERVENTIONAL,12/1/2021,3/11/2022
NCT04558476,ACTIVE_NOT_RECRUITING,Covid19|Mechanical Ventilation Complication|Corona Virus Infection|Respiratory Failure|SARS (Severe Acute Respiratory Syndrome),BIOLOGICAL: Convalescent Plasma|OTHER: Standard of Care,University of Liege,KCE Belgian Healthcare Knowledge Centre,ALL,"ADULT, OLDER_ADULT",PHASE2,475,OTHER,INTERVENTIONAL,9/11/2020,2023-04
NCT04854876,WITHDRAWN,SARS-COV 2|Covid19,DIETARY_SUPPLEMENT: 5-ALA-Phosphate + SFC (5-ALA+SFC),Royal College of Surgeons in Ireland - Medical University of Bahrain,Bahrain Defence Force Hospital,ALL,"ADULT, OLDER_ADULT",NA,0,OTHER,INTERVENTIONAL,8/15/2021,8/30/2021
NCT05584176,COMPLETED,SARS-CoV2 Infection|COVID-19,DEVICE: iCura COVID-19 Antigen Rapid Home Test|DEVICE: RT-PCR Test,"MP Biomedicals, LLC",New Day Diagnostics,ALL,"CHILD, ADULT, OLDER_ADULT",NA,332,INDUSTRY,INTERVENTIONAL,12/9/2021,1/21/2022
NCT04405076,COMPLETED,SARS-CoV-2,BIOLOGICAL: Biological: mRNA-1273|BIOLOGICAL: Placebo|BIOLOGICAL: mRNA-1273.351,"ModernaTX, Inc.",Biomedical Advanced Research and Development Authority,ALL,"ADULT, OLDER_ADULT",PHASE2,660,INDUSTRY,INTERVENTIONAL,5/29/2020,10/28/2021
NCT04348370,ACTIVE_NOT_RECRUITING,Coronavirus|Coronavirus Infection|Coronavirus as the Cause of Diseases Classified Elsewhere,BIOLOGICAL: BCG Vaccine|BIOLOGICAL: Placebo Vaccine,Texas A&M University,Baylor College of Medicine|M.D. Anderson Cancer Center|Cedars-Sinai Medical Center|Harvard University,ALL,"ADULT, OLDER_ADULT",PHASE4,1800,OTHER,INTERVENTIONAL,4/20/2020,2023-05
NCT05218070,UNKNOWN,COVID-19,DRUG: EgyVax Vaccine Candidate|DRUG: Placebo,Eva Pharma,"Veterinary Serum & Vaccine Research Institute (VSVRI), Egypt|The Supreme Council of University Hospitals, Egypt|Ministry of Higher Education and Scientific Research, Egypt",ALL,ADULT,PHASE1,45,INDUSTRY,INTERVENTIONAL,2/6/2022,2023-06
NCT05674370,COMPLETED,COVID-19|Influenza,DEVICE: GRIP Electronic Diagnostic Chip|DIAGNOSTIC_TEST: Laboratory-based nucleic acid amplification tests (NAATs),Mayo Clinic,Department of Health and Human Services,ALL,"ADULT, OLDER_ADULT",NA,50,OTHER,INTERVENTIONAL,2/1/2023,4/30/2023
NCT04386070,NOT_YET_RECRUITING,Pulmonary Complications in Surgical Patients|COVID|Severe Acute Respiratory Syndrome,DRUG: RESP301,University of Birmingham,"Christian Medical College and Hospital, Ludhiana, India|Tamale Teaching Hospital, Ghana.|University of Lagos, Nigeria|Kigali University Teaching Hospital|Hospital Español Veracruz|Université d'Abomey-Calavi|University of Witwatersrand, South Africa|University of Edinburgh|Istituto Clinico Humanitas|University of Cape Town",ALL,"ADULT, OLDER_ADULT",PHASE3,6400,OTHER,INTERVENTIONAL,10/1/2021,5/14/2026
NCT04864899,RECRUITING,Covid19|Viral Respiratory Infection,DIAGNOSTIC_TEST: Cardiac Magnetic Resonance Imaging (CMR)|DIAGNOSTIC_TEST: Blood test|DIAGNOSTIC_TEST: 6-minute walk test,The University of Hong Kong,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,112,OTHER,INTERVENTIONAL,9/1/2021,10/31/2024
NCT04466670,UNKNOWN,COVID-19,DRUG: acetylsalicylic acid|DRUG: Unfractionated heparin nebulized,University of Sao Paulo General Hospital,,ALL,"ADULT, OLDER_ADULT",PHASE2,379,OTHER,INTERVENTIONAL,7/11/2020,5/30/2022
NCT04743011,UNKNOWN,Covid19,DRUG: Heparin sodium|DRUG: Placebo,UPECLIN HC FM Botucatu Unesp,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,50,OTHER,INTERVENTIONAL,6/1/2021,12/31/2021
NCT04343976,TERMINATED,COVID-19|COVID,DRUG: Pegylated interferon lambda,Raymond Chung,Eiger BioPharmaceuticals,ALL,"ADULT, OLDER_ADULT",PHASE2,14,OTHER,INTERVENTIONAL,6/22/2020,7/30/2021
NCT04346199,COMPLETED,COVID-19,DRUG: Acalabrutinib,AstraZeneca,Acerta Pharma BV,ALL,"ADULT, OLDER_ADULT",PHASE2,177,INDUSTRY,INTERVENTIONAL,6/12/2020,11/17/2020
NCT05593770,ACTIVE_NOT_RECRUITING,COVID-19|SARS-CoV2 Infection|Coronavirus Infection,DRUG: Fostamatinib|DRUG: Placebo,NEAT ID Foundation,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,1600,OTHER,INTERVENTIONAL,10/27/2022,2024-05
NCT04329611,TERMINATED,COVID-19,DRUG: Hydroxychloroquine,Dr. Michael Hill,Alberta Health services|University of Alberta|University of Calgary|Calgary Health Trust|Alberta Innovates Health Solutions|Government of Alberta,ALL,"ADULT, OLDER_ADULT",PHASE3,148,OTHER,INTERVENTIONAL,4/13/2020,7/20/2020
NCT04341870,SUSPENDED,COVID19|SARS-CoV-2 Infection,DRUG: Sarilumab|DRUG: Azithromycin|DRUG: Hydroxychloroquine,Assistance Publique - Hôpitaux de Paris,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,27,OTHER,INTERVENTIONAL,4/11/2020,2020-08
NCT04376476,COMPLETED,"Infection, Coronavirus|Severe Acute Respiratory Syndrome Coronavirus 2",BIOLOGICAL: Blood sample|BIOLOGICAL: Low or upper respiratory tract sample|BIOLOGICAL: Stool collection or fecal swab|OTHER: phone call,Hospices Civils de Lyon,,ALL,"CHILD, ADULT",NA,140,OTHER,INTERVENTIONAL,5/5/2020,5/13/2022
NCT05890599,RECRUITING,Post-COVID-19 Syndrome|Fatigue Post Viral,BEHAVIORAL: Yoga Therapy|BEHAVIORAL: Health Education,University Hospital Tuebingen,"Robert Bosch Gesellschaft für Medizinische Forschung mbH|Charite University, Berlin, Germany",ALL,"ADULT, OLDER_ADULT",NA,100,OTHER,INTERVENTIONAL,6/10/2023,2024-11
NCT04634370,UNKNOWN,Covid19|Sars-cov 2,BIOLOGICAL: Natural Killer Cells infusion,Hospital de Clinicas de Porto Alegre,,ALL,"ADULT, OLDER_ADULT",PHASE1,24,OTHER,INTERVENTIONAL,1/2/2021,3/30/2021
NCT04380935,UNKNOWN,COVID|Acute Respiratory Distress Syndrome,BIOLOGICAL: Convalescent plasma|DRUG: Standard of care,Indonesia University,Dr Cipto Mangunkusumo General Hospital|Fakultas Kedokteran Universitas Indonesia,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,60,OTHER,INTERVENTIONAL,5/18/2020,10/31/2020
NCT05999435,RECRUITING,Long COVID,"DRUG: LAU-7b for 3 cycles|DRUG: LAU-7b for 1 cycle, then placebo|OTHER: Placebo for 3 cycles",Laurent Pharmaceuticals Inc.,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,204,INDUSTRY,INTERVENTIONAL,11/20/2023,6/30/2024
NCT05313035,COMPLETED,COVID-19,BIOLOGICAL: SARS-CoV-2 protein subunit recombinant vaccine|BIOLOGICAL: placebo,PT Bio Farma,"Faculty of Medicine, Universitas Indonesia, Jakarta|Faculty of Medicine, Diponegoro University, Semarang|Faculty of Medicine, Universitas Andalas, Padang|Faculty of Medicine, Universitas Hassanudin, Makassar",ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,360,INDUSTRY,INTERVENTIONAL,4/13/2022,2/28/2023
NCT04417335,UNKNOWN,COVID-19,BIOLOGICAL: BCG vaccine|BIOLOGICAL: Placebo,Radboud University Medical Center,,ALL,"ADULT, OLDER_ADULT",PHASE4,2014,OTHER,INTERVENTIONAL,4/16/2020,2021-05
NCT04909996,COMPLETED,COVID-19 (SARS-CoV-2 Infection),DEVICE: Sentinox--Group A|DEVICE: Sentinox--Group B,APR Applied Pharma Research s.a.,,ALL,ADULT,NA,57,OTHER,INTERVENTIONAL,5/20/2021,11/30/2021
NCT04397796,UNKNOWN,COVID,BIOLOGICAL: BM-Allo.MSC|BIOLOGICAL: Placebo,"ImmunityBio, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE1,45,INDUSTRY,INTERVENTIONAL,8/3/2020,2022-06
NCT05855369,RECRUITING,Smell Dysfunction|Olfactory Disorder|Long COVID,DEVICE: Trigeminal Nerve Stimulation (TNS)|OTHER: Active Smell Training (ST)|OTHER: Placebo Smell Training (PBO),Medical University of South Carolina,National Institutes of Health (NIH)|National Institute on Deafness and Other Communication Disorders (NIDCD),ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,180,OTHER,INTERVENTIONAL,10/2/2023,2028-01
NCT04408235,UNKNOWN,"COVID|Pneumonia, Viral|Coagulation Disorder",DRUG: Enoxaparin,Azienda Ospedaliero-Universitaria di Modena,,ALL,"ADULT, OLDER_ADULT",PHASE3,300,OTHER,INTERVENTIONAL,2020-06,2021-06
NCT04360096,TERMINATED,SARS-CoV 2|COVID|ARDS|ALI|Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)|Dyspnea,DRUG: ZYESAMI™ (aviptadil acetate)|DRUG: Placebo|DEVICE: Nebulized administration of ZYESAMI™ or Placebo,APR Applied Pharma Research s.a.,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,144,OTHER,INTERVENTIONAL,2/15/2021,12/31/2021
NCT05214196,COMPLETED,COVID-19,"DRUG: Hypochlorous Acid 0.02% Soln,Top (Crystaline) (HClO)",Ataturk University,,ALL,"ADULT, OLDER_ADULT",PHASE4,75,OTHER,INTERVENTIONAL,9/1/2021,12/7/2021
NCT04330495,WITHDRAWN,COVID 19|Immunomediated Inflammatory Disease in Treatment With Biological Agents and / or Jak Inhibitors,DRUG: Hidroxicloroquina|DRUG: Control group,Instituto de Investigación Marqués de Valdecilla,,ALL,"ADULT, OLDER_ADULT",PHASE4,0,OTHER,INTERVENTIONAL,4/6/2020,8/27/2021
NCT05137795,WITHDRAWN,SARS-CoV 2|COVID|ARDS|ALI|Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)|Dyspnea,DRUG: ZYESAMI™ (aviptadil acetate)|DRUG: Placebo|DEVICE: Nebulized administration of ZYESAMI™ or Placebo,APR Applied Pharma Research s.a.,,ALL,"ADULT, OLDER_ADULT",PHASE3,0,OTHER,INTERVENTIONAL,12/15/2021,8/15/2022
NCT04385095,COMPLETED,SARS-CoV-2,DRUG: SNG001|DRUG: Placebo,Synairgen Research Ltd.,,ALL,"ADULT, OLDER_ADULT",PHASE2,221,INDUSTRY,INTERVENTIONAL,3/16/2020,11/16/2021
NCT04536935,COMPLETED,Depression|Anxiety|Emotional Regulation,BEHAVIORAL: Mobile Mental Health App - 1|BEHAVIORAL: Mobile Mental Health App - 2|BEHAVIORAL: Mobile Mental Health App - 3|BEHAVIORAL: Mobile Mental Health App - 4,University of Washington,National Institute of Mental Health (NIMH),ALL,"ADULT, OLDER_ADULT",NA,838,OTHER,INTERVENTIONAL,11/30/2020,6/20/2021
NCT04488796,COMPLETED,Health Behaviour Change,BEHAVIORAL: Assigned Strategies: Opt-in|BEHAVIORAL: Assigned Strategies: Active Choice|BEHAVIORAL: Assigned Strategies: Enhanced Active Choice|BEHAVIORAL: Choice of Assignment: Opt-in|BEHAVIORAL: Choice of Assignment: Active Choice|BEHAVIORAL: Choice of Assignment: Enhanced Active Choice,"Western University, Canada",Duke University,ALL,"ADULT, OLDER_ADULT",NA,148,OTHER,INTERVENTIONAL,9/7/2020,12/16/2020
NCT04813796,COMPLETED,SARS-CoV-2,BIOLOGICAL: mRNA-1283|BIOLOGICAL: mRNA-1273|BIOLOGICAL: Placebo,"ModernaTX, Inc.",,ALL,ADULT,PHASE1,104,INDUSTRY,INTERVENTIONAL,3/11/2021,7/25/2023
NCT05939596,ACTIVE_NOT_RECRUITING,SARS-CoV-2,BIOLOGICAL: SARS-CoV-2 Bivalent mRNA Vaccine|OTHER: Saline,"AIM Vaccine Co., Ltd.",First Affiliated Hospital Bengbu Medical College,ALL,"ADULT, OLDER_ADULT",PHASE1,60,INDUSTRY,INTERVENTIONAL,8/10/2023,8/25/2024
NCT05205096,COMPLETED,COVID-19,BIOLOGICAL: Recombinant novel coronavirus vaccine (CHO cells),"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.",Zhejiang Provincial Center for Disease Control and Prevention,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,480,INDUSTRY,INTERVENTIONAL,11/10/2021,7/31/2022
NCT05743335,RECRUITING,COVID-19|Infectious Disease,BIOLOGICAL: JCXH-221|BIOLOGICAL: Active Comparator|OTHER: Placebo,"Immorna Biotherapeutics, Inc.",ICON plc,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,262,INDUSTRY,INTERVENTIONAL,3/20/2023,10/4/2024
NCT04369469,TERMINATED,"COVID-19 Severe Pneumonia|Acute Lung Injury|Acute Respiratory Distress Syndrome|Pneumonia, Viral",BIOLOGICAL: Ravulizumab|OTHER: BSC,"Alexion Pharmaceuticals, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE3,202,INDUSTRY,INTERVENTIONAL,5/10/2020,4/8/2021
NCT04482595,RECRUITING,COVID-19|Long COVID|Pulmonary Fibrosis|Post-acute Respiratory Complications of COVID-19,DRUG: BIO 300 Oral Suspension|DRUG: Placebo,Humanetics Corporation,NYU Langone Health|National Institute of Allergy and Infectious Diseases (NIAID),ALL,"ADULT, OLDER_ADULT",PHASE2,50,INDUSTRY,INTERVENTIONAL,11/11/2020,3/31/2024
NCT04866069,TERMINATED,Covid19,BIOLOGICAL: SARS-CoV-2 vaccine|BIOLOGICAL: Placebo,"Osman ERGANIS, PhD, Prof",The Scientific and Technological Research Council of Turkey|VETAL Inc.|MonitorCRO,ALL,ADULT,PHASE1,50,OTHER,INTERVENTIONAL,4/25/2021,9/5/2021
NCT05851313,COMPLETED,COVID-19 Respiratory Infection,COMBINATION_PRODUCT: Vitamin-D,Sulaimany Polytechnic university,,ALL,"ADULT, OLDER_ADULT",PHASE3,500,OTHER,INTERVENTIONAL,12/5/2022,4/7/2023
NCT04470869,COMPLETED,Post Traumatic Stress Disorder,OTHER: Phone call,"University Hospital, Toulouse",,ALL,"ADULT, OLDER_ADULT",NA,129,OTHER,INTERVENTIONAL,6/12/2020,10/12/2021
NCT04816669,COMPLETED,SARS-CoV-2 Infection|COVID-19,BIOLOGICAL: BNT162b2,BioNTech SE,Pfizer,ALL,ADULT,PHASE3,629,INDUSTRY,INTERVENTIONAL,4/1/2021,12/2/2021
NCT04456413,TERMINATED,COVID-19,BIOLOGICAL: Convalescent Plasma|OTHER: Best Supportive Care,Hackensack Meridian Health,United States Department of Defense,ALL,"ADULT, OLDER_ADULT",PHASE2,21,OTHER,INTERVENTIONAL,11/6/2020,5/4/2021
NCT04416113,UNKNOWN,Photodynamic Therapy& Low Level Laser in Management of COVID 19,PROCEDURE: photobiomodulation and photodynamic therapy,Cairo University,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,60,OTHER,INTERVENTIONAL,8/5/2021,2022-02
NCT04329195,TERMINATED,History of Cardiovascular Disease Treated With RAS Blockers and With SARS-CoV-2 Infection,DRUG: 1: discontinuation of RAS blocker therapy|DRUG: 2: continuation of RAS blocker therapy,Assistance Publique - Hôpitaux de Paris,Groupe Hospitalier Pitié-Salpêtrière,ALL,"ADULT, OLDER_ADULT",PHASE3,44,OTHER,INTERVENTIONAL,4/9/2020,1/9/2021
NCT05975034,RECRUITING,Long COVID,DIETARY_SUPPLEMENT: Probiotic|DIETARY_SUPPLEMENT: Placebo,Sheffield Hallam University,Symprove UK|Biomesight,ALL,"ADULT, OLDER_ADULT",NA,240,OTHER,INTERVENTIONAL,6/12/2023,12/11/2023
NCT04416334,COMPLETED,SARS-CoV-2 Infection (COVID-19),DRUG: Colchicine plus symptomatic treatment (paracetamol)|DRUG: Symptomatic treatment (paracetamol or best symptomatic treatment based on doctor recommendations),Instituto de Investigación Marqués de Valdecilla,Gerencia de atención primaria área 1|Gerencia de atención primaria área 2|Gerencia Atencion Primaria Area 3|Gerencia de atención primaria área 4,ALL,"ADULT, OLDER_ADULT",PHASE3,70,OTHER,INTERVENTIONAL,8/19/2020,10/11/2022
NCT04370834,TERMINATED,Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm|Pneumonia|Pneumonitis|Severe Acute Respiratory Distress Syndrome|Symptomatic COVID-19 Infection Laboratory-Confirmed,BIOLOGICAL: Tocilizumab,National Cancer Institute (NCI),,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,1,NIH,INTERVENTIONAL,5/28/2020,1/14/2021
NCT04818736,WITHDRAWN,Vaccine Preventable Disease,BIOLOGICAL: COVID-19 Vaccination|OTHER: Usual care,McMaster University,University of Alberta|University of Saskatchewan|University of Manitoba,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,0,OTHER,INTERVENTIONAL,4/15/2021,2021-12
NCT04801836,UNKNOWN,Covid19,DRUG: Estetrol monohydrate 15 mg|DRUG: Placebo,NEURALIS s.a.,,ALL,"ADULT, OLDER_ADULT",PHASE2,162,INDUSTRY,INTERVENTIONAL,11/19/2020,8/5/2022
NCT05013034,UNKNOWN,SARS-CoV-2 Acute Respiratory Disease|SARS-CoV2 Infection|Cytokine Storm,DRUG: Basiliximab Injection|DRUG: Placebo,Fort Worth Clinical Sciences Working Group,TCU and UNTHSC School of Medicine,ALL,"ADULT, OLDER_ADULT",PHASE2,300,OTHER,INTERVENTIONAL,10/15/2021,12/1/2022
NCT04821934,COMPLETED,COVID-19 Pneumonia,OTHER: TR|OTHER: TSu,Istituti Clinici Scientifici Maugeri SpA,Istituto Auxologico Italiano,ALL,"ADULT, OLDER_ADULT",NA,74,OTHER,INTERVENTIONAL,3/26/2021,12/20/2021
NCT05596734,ACTIVE_NOT_RECRUITING,"Influenza, Human|COVID-19",BIOLOGICAL: bivalent BNT162b2 (original/Omi BA.4/BA.5)|BIOLOGICAL: qIRV (22/23)|BIOLOGICAL: QIV|BIOLOGICAL: bIRV|BIOLOGICAL: tIRV,BioNTech SE,Pfizer,ALL,"ADULT, OLDER_ADULT",PHASE2,1018,INDUSTRY,INTERVENTIONAL,10/28/2022,12/29/2023
NCT05119634,UNKNOWN,COVID-19,OTHER: whole body vibration training|OTHER: home based exercises,Istanbul University - Cerrahpasa (IUC),,ALL,"ADULT, OLDER_ADULT",NA,60,OTHER,INTERVENTIONAL,10/18/2021,12/20/2022
NCT04647734,COMPLETED,"COVID-19, SARS-CoV2",BEHAVIORAL: High intensity interval training|BEHAVIORAL: Standard care,"Rigshospitalet, Denmark",,ALL,"ADULT, OLDER_ADULT",NA,28,OTHER,INTERVENTIONAL,2/1/2021,2/10/2022
NCT05445934,RECRUITING,COVID-19,DRUG: FB2001|DRUG: FB2001 placebo,Frontier Biotechnologies Inc.,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,1188,INDUSTRY,INTERVENTIONAL,9/14/2022,2023-12
NCT05629884,NOT_YET_RECRUITING,SARS-CoV-2 Infection|COVID-19 Recurrent|Cognitive Dysfunction|Fatigue,OTHER: COPERIA-REHAB,Fundacin Biomedica Galicia Sur,University of Vigo|Galician South Health Research Institute,ALL,"ADULT, OLDER_ADULT",NA,56,OTHER,INTERVENTIONAL,12/14/2022,11/14/2023
NCT05109598,COMPLETED,COVID-19,BIOLOGICAL: Recombinant new coronavirus vaccine (CHO cell),"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.",,ALL,CHILD,PHASE2,400,INDUSTRY,INTERVENTIONAL,11/4/2021,4/6/2023
NCT04365257,TERMINATED,COVID-19,DRUG: Prazosin|OTHER: Standard of care,Johns Hopkins University,Fast Grants,ALL,"ADULT, OLDER_ADULT",PHASE2,5,OTHER,INTERVENTIONAL,5/13/2020,3/31/2022
NCT04771598,COMPLETED,Covid19,OTHER: Breathing exercise with the phone application|OTHER: Breathing exercise,Tokat Gaziosmanpasa University,,ALL,"ADULT, OLDER_ADULT",NA,52,OTHER,INTERVENTIONAL,2/25/2021,7/30/2021
NCT04402957,COMPLETED,COVID|Severe Acute Respiratory Syndrome|Sars-CoV2|Acute Kidney Injury|Acute Respiratory Distress Syndrome,DRUG: LSALT peptide|DRUG: Placebo,Arch Biopartners Inc.,,ALL,"ADULT, OLDER_ADULT",PHASE2,61,INDUSTRY,INTERVENTIONAL,10/14/2020,6/2/2022
NCT04408157,COMPLETED,COVID,BEHAVIORAL: Self-management booklet (SWitCh: Stay well during COVID-19),King's College London,,ALL,"ADULT, OLDER_ADULT",NA,185,OTHER,INTERVENTIONAL,5/20/2020,10/1/2021
NCT04340557,COMPLETED,SARS-CoV Infection,DRUG: Losartan,Sharp HealthCare,,ALL,"ADULT, OLDER_ADULT",PHASE4,31,OTHER,INTERVENTIONAL,3/27/2020,6/13/2020
NCT04536298,ACTIVE_NOT_RECRUITING,COVID-19,DIETARY_SUPPLEMENT: vitamin D|DIETARY_SUPPLEMENT: Placebo,Brigham and Women's Hospital,Harvard Medical School (HMS and HSDM)|Harvard School of Public Health (HSPH)|Fenway Health and Beth Israel Deaconess Medical Center|Tishcon Corporation|Takeda|Quest Diagnostics-Nichols Insitute|Laboratory Corporation of America|Trialfacts|Karolinska Institutet|Philanthropic donations,ALL,"ADULT, OLDER_ADULT",PHASE3,2024,OTHER,INTERVENTIONAL,12/28/2020,7/1/2024
NCT04391140,UNKNOWN,COVID|ARDS|Acute Respiratory Distress Syndrome|Acute Respiratory Failure|Corona Virus Infection,OTHER: Prone position,Hospital Universitari Vall d'Hebron Research Institute,,ALL,"ADULT, OLDER_ADULT",NA,248,OTHER,INTERVENTIONAL,5/13/2020,2021-06
NCT04757857,TERMINATED,COVID-19,DRUG: Rivaroxaban 10 mg,Hospital Alemão Oswaldo Cruz,Bayer|Hospital Israelita Albert Einstein|Hospital do Coracao|Hospital Sirio-Libanes|Hospital Moinhos de Vento|Brazilian Research In Intensive Care Network|Brazilian Clinical Research Institute,ALL,"ADULT, OLDER_ADULT",PHASE4,660,OTHER,INTERVENTIONAL,9/29/2020,8/30/2022
NCT04548557,UNKNOWN,Covid19,BIOLOGICAL: intravenous immunoglobulin therapy,University of Health Sciences Lahore,University of Lahore|Amson Vaccine and Pharma (Pvt) Limited,ALL,"ADULT, OLDER_ADULT",PHASE3,60,OTHER,INTERVENTIONAL,9/15/2020,11/15/2020
NCT06027398,COMPLETED,SARS-CoV-2 Virus,DIAGNOSTIC_TEST: SARS-CoV-2 RNA detection,Bangkok Metropolitan Administration Medical College and Vajira Hospital,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,269,OTHER_GOV,INTERVENTIONAL,5/1/2021,9/30/2021
NCT04357457,COMPLETED,Covid 19|Hypoxemic Respiratory Failure,DRUG: Almitrine|DRUG: Placebo,Assistance Publique - Hôpitaux de Paris,,ALL,"ADULT, OLDER_ADULT",PHASE3,181,OTHER,INTERVENTIONAL,9/3/2020,12/17/2021
NCT04470999,SUSPENDED,Covid19|SARS-CoV-2,OTHER: Leukapheresis,"Serhat Gumrukcu, MD PhD",The Scripps Research Institute,ALL,ADULT,NA,25,OTHER,INTERVENTIONAL,4/15/2020,12/31/2023
NCT04395599,RECRUITING,Sars-CoV2|Surgery|COVID,"OTHER: Cartography of air contamination, environment contamination and biological fluid by Sars-Cov2 during visceral surgery in COVID19 patients.","University Hospital, Lille",,ALL,"ADULT, OLDER_ADULT",NA,40,OTHER,INTERVENTIONAL,11/16/2021,2022-11
NCT05741099,RECRUITING,COVID-19,BIOLOGICAL: Umbilical cord mesenchymal stem cells implantation|OTHER: Comparator,Hebei Medical University,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,20,OTHER,INTERVENTIONAL,1/28/2023,2025-01
NCT04416399,TERMINATED,Coronavirus Infection,DRUG: Budesonide dry powder inhaler,University of Oxford,,ALL,"ADULT, OLDER_ADULT",PHASE2,146,OTHER,INTERVENTIONAL,7/16/2020,1/12/2021
NCT04303299,COMPLETED,SARS-COV-2 Infections|COVID-19,DRUG: Oral,Rajavithi Hospital,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,320,OTHER_GOV,INTERVENTIONAL,8/19/2020,8/28/2021
NCT05682599,RECRUITING,COVID-19,DRUG: Azvudine|DRUG: Placebo,Shanghai Henlius Biotech,"Huashan Hospital|Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.|HeNan Sincere Biotech Co., Ltd",ALL,"ADULT, OLDER_ADULT",PHASE2,300,INDUSTRY,INTERVENTIONAL,1/6/2023,5/15/2023
NCT04789499,COMPLETED,Covid19|Anosmia|Olfactory Disorder|Covid-19 Pandemic|SARS-CoV-2 Infection|Hyposmia|Ageusia|Hypogeusia,DRUG: Theophylline Powder|DRUG: Placebo Comparator,Washington University School of Medicine,,ALL,"ADULT, OLDER_ADULT",PHASE2,51,OTHER,INTERVENTIONAL,3/15/2021,12/30/2021
NCT04374474,WITHDRAWN,Olfactory Disorder,OTHER: Olfactory retraining|DRUG: corticosteroid nasal irrigation|OTHER: smell household Items|OTHER: Nasal Irrigation,Lawson Health Research Institute,,ALL,"ADULT, OLDER_ADULT",PHASE4,0,OTHER,INTERVENTIONAL,1/10/2021,3/10/2022
NCT04747574,UNKNOWN,SARS-CoV-2,DRUG: EXO-CD24,Tel-Aviv Sourasky Medical Center,,ALL,"ADULT, OLDER_ADULT",PHASE1,35,OTHER_GOV,INTERVENTIONAL,9/25/2020,3/25/2021
NCT04821674,COMPLETED,Covid19,BIOLOGICAL: DS-5670a|BIOLOGICAL: Placebo,"Daiichi Sankyo Co., Ltd.",,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,142,INDUSTRY,INTERVENTIONAL,3/15/2021,7/14/2022
NCT04347174,COMPLETED,COVID-19,DRUG: Suspension of heat killed (autoclaved) Mycobacterium w|DRUG: Placebo,Cadila Pharnmaceuticals,"Council of Scientific and Industrial Research, India",ALL,"ADULT, OLDER_ADULT",NA,40,INDUSTRY,INTERVENTIONAL,4/30/2020,8/21/2020
NCT04546581,COMPLETED,COVID|COVID-19|SARS-CoV-2|SARS (Severe Acute Respiratory Syndrome),BIOLOGICAL: Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG)|OTHER: Placebo|DRUG: Remdesivir,University of Minnesota,National Institute of Allergy and Infectious Diseases (NIAID)|National Institutes of Health (NIH)|International Network for Strategic Initiatives in Global HIV Trials (INSIGHT),ALL,"ADULT, OLDER_ADULT",PHASE3,593,OTHER,INTERVENTIONAL,10/8/2020,5/21/2021
NCT04447781,COMPLETED,Coronavirus Infection|SARS-CoV 2,BIOLOGICAL: INO-4800|DEVICE: CELLECTRA® 2000|OTHER: Saline-sodium citrate (SSC) buffer,International Vaccine Institute,Coalition for Epidemic Preparedness Innovations|Inovio Pharmaceuticals,ALL,ADULT,PHASE1|PHASE2,79,OTHER,INTERVENTIONAL,7/15/2020,5/25/2022
NCT05815498,ACTIVE_NOT_RECRUITING,COVID-19,BIOLOGICAL: mRNA-1283.222|BIOLOGICAL: mRNA-1273.222,"ModernaTX, Inc.",,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,11471,INDUSTRY,INTERVENTIONAL,3/28/2023,8/23/2024
NCT04395144,COMPLETED,Coronavirus Infection|COVID|Severe Acute Respiratory Syndrome|Respiratory Failure|Respiratory Insufficiency|Respiratory Distress Syndrome|ARDS|Lung Diseases,PROCEDURE: Awake Prone Positioning|PROCEDURE: Standard care,Hôpital de Verdun,,ALL,"ADULT, OLDER_ADULT",NA,13,OTHER,INTERVENTIONAL,5/15/2020,3/15/2021
NCT05618574,RECRUITING,Long COVID|Cardiorespiratory Fitness,"DIETARY_SUPPLEMENT: 210 ml per day of Beet-It nitrate beverage (James White Drinks Ltd., Ipswich, UK)",VA Office of Research and Development,University of Pittsburgh,ALL,"ADULT, OLDER_ADULT",PHASE3,40,FED,INTERVENTIONAL,12/1/2023,2/28/2025
NCT04527081,COMPLETED,COVID-19,BIOLOGICAL: AG0302-COVID19|BIOLOGICAL: AG0302-COVID19|BIOLOGICAL: AG0302-COVID19,"AnGes, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,30,INDUSTRY,INTERVENTIONAL,8/31/2020,9/24/2021
NCT04358081,COMPLETED,Covid-19,DRUG: HCQ|DRUG: HCQ+AZT|DRUG: Placebo,Novartis Pharmaceuticals,,ALL,"ADULT, OLDER_ADULT",PHASE3,20,INDUSTRY,INTERVENTIONAL,5/1/2020,7/27/2020
NCT04598581,COMPLETED,Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2),RADIATION: Low Dose Radiation Therapy (LD-RT)|OTHER: Sham irradiation,"University Hospital, Basel, Switzerland",,ALL,"ADULT, OLDER_ADULT",NA,22,OTHER,INTERVENTIONAL,11/2/2020,4/9/2021
NCT04780581,TERMINATED,Corona Virus Infection,DRUG: Dexamethasone|DRUG: Methylprednisolone,Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León,Instituto de Investigación Biomédica de Salamanca,ALL,"ADULT, OLDER_ADULT",PHASE4,127,OTHER,INTERVENTIONAL,2/1/2021,11/9/2021
NCT04944381,UNKNOWN,SARS-CoV-2 Acute Respiratory Disease,BIOLOGICAL: SARS-Cov-2 mRNA vaccine immunization|BIOLOGICAL: Inactivated SARS-Cov-2 vaccine immunization,Qihan Li,,ALL,"ADULT, OLDER_ADULT",NA,112,UNKNOWN,INTERVENTIONAL,7/2/2021,8/2/2022
NCT04349098,COMPLETED,Coronavirus Infection,DRUG: Selinexor|OTHER: Placebo,Karyopharm Therapeutics Inc,,ALL,"ADULT, OLDER_ADULT",PHASE2,190,INDUSTRY,INTERVENTIONAL,4/17/2020,10/5/2020
NCT05225298,ACTIVE_NOT_RECRUITING,End-stage Renal Disease|SARS-CoV-2 Acute Respiratory Disease|Dialysis; Complications,BEHAVIORAL: Offering SARS-CoV-2 test,Stanford University,National Institute on Minority Health and Health Disparities (NIMHD)|National Institute of Allergy and Infectious Diseases (NIAID),ALL,"ADULT, OLDER_ADULT",NA,2389,OTHER,INTERVENTIONAL,2/6/2023,2026-03
NCT04644198,UNKNOWN,"COVID-19, Convalescent Plasma Treatment",BIOLOGICAL: Convalescent Plasma Infusion,The University of The West Indies,,ALL,"ADULT, OLDER_ADULT",PHASE2,30,OTHER,INTERVENTIONAL,6/1/2021,12/1/2021
NCT06055244,NOT_YET_RECRUITING,Long COVID|Post-COVID19 Condition|Post-Acute COVID19 Syndrome,DRUG: Amantadine,Ohio State University,,ALL,"ADULT, OLDER_ADULT",PHASE1,60,OTHER,INTERVENTIONAL,10/15/2023,5/15/2025
NCT04426344,WITHDRAWN,COVID 19,DEVICE: ensoETM device,Washington University School of Medicine,,ALL,"ADULT, OLDER_ADULT",NA,0,OTHER,INTERVENTIONAL,2020-10,2020-12
NCT04990544,ACTIVE_NOT_RECRUITING,COVID-19,BIOLOGICAL: 202-CoV low adjuvant dose|BIOLOGICAL: 202-CoV low antigen dose|BIOLOGICAL: 202-CoV standard dose|BIOLOGICAL: Placebo,"Shanghai Zerun Biotechnology Co.,Ltd","Walvax Biotechnology Co., Ltd.",ALL,"ADULT, OLDER_ADULT",PHASE2,528,INDUSTRY,INTERVENTIONAL,7/31/2021,2023-11
NCT05515081,COMPLETED,Vaccine Reaction,PROCEDURE: blood sample collection,"IRCCS San Camillo, Venezia, Italy",,ALL,"CHILD, ADULT, OLDER_ADULT",NA,200,OTHER,INTERVENTIONAL,5/21/2021,5/21/2023
NCT04345276,COMPLETED,COVID-19,DRUG: Danoprevir+Ritonavir,Huoshenshan Hospital,"Ascletis Pharmaceuticals Co., Ltd.",ALL,"ADULT, OLDER_ADULT",PHASE4,10,OTHER,INTERVENTIONAL,3/18/2020,4/15/2020
NCT05011344,UNKNOWN,Covid19,OTHER: Blood sample,Assistance Publique Hopitaux De Marseille,,ALL,"CHILD, ADULT, OLDER_ADULT",NA,1000,OTHER,INTERVENTIONAL,7/15/2020,12/15/2022
NCT06229444,ENROLLING_BY_INVITATION,Influenza|Influenza A|Influenza B|COVID-19|Respiratory Syncytial Virus (RSV),"BEHAVIORAL: ILI Predictive Alerts, Reactive Content, and Proactive Content|BEHAVIORAL: ILI Predictive Alerts, Reactive Content|BEHAVIORAL: Proactive Content|BEHAVIORAL: No Intervention",Evidation Health,Biomedical Advanced Research and Development Authority,ALL,"ADULT, OLDER_ADULT",NA,15000,INDUSTRY,INTERVENTIONAL,2/12/2024,2024-12
NCT04758299,COMPLETED,COVID-19 Testing|Decision Making,OTHER: decision science-based design,Barry Dewitt,Dartmouth College|University of Pittsburgh,ALL,"ADULT, OLDER_ADULT",NA,360,OTHER,INTERVENTIONAL,3/13/2021,4/30/2021
NCT04600999,COMPLETED,SARS-CoV-2 Infection,DRUG: Favipiravir,University of Pecs,HECRIN Consortium|Hungarian Ministry of Innovation and Technology,ALL,"ADULT, OLDER_ADULT",PHASE3,14,OTHER,INTERVENTIONAL,10/7/2020,12/28/2020
NCT04428099,UNKNOWN,"Depressive Disorder, Treatment-Resistant",BEHAVIORAL: Lifestyle change promotion program|BEHAVIORAL: Mindfullness based cognitive program|BEHAVIORAL: Written Information,University of the Balearic Islands,,ALL,"ADULT, OLDER_ADULT",NA,186,OTHER,INTERVENTIONAL,1/13/2020,7/12/2022
NCT04533399,COMPLETED,SARS-CoV-2 Infection|COVID-19,BIOLOGICAL: SARS-CoV-2 rS/Matrix-M1 Adjuvant|OTHER: Placebo,Novavax,Bill and Melinda Gates Foundation,ALL,"ADULT, OLDER_ADULT",PHASE2,4422,INDUSTRY,INTERVENTIONAL,8/17/2020,1/19/2022
NCT04859699,RECRUITING,Absenteeism,BEHAVIORAL: COVID-19 Health Education Comic Books and Videos,University of Washington,Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD),ALL,"CHILD, ADULT, OLDER_ADULT",NA,900,OTHER,INTERVENTIONAL,1/17/2022,2024-03
NCT04689399,COMPLETED,Covid19|Rapid Antigen Test|SARS-CoV-2,"DIAGNOSTIC_TEST: Standard Q COVID-19 Ag - test, produced by SD Biosensor INC.","Rigshospitalet, Denmark","Testcenter Danmark, Statens Serum Institut|Copenhagen Emergency Medical Services",ALL,"ADULT, OLDER_ADULT",NA,4697,OTHER,INTERVENTIONAL,12/26/2020,3/25/2021
NCT04574869,WITHDRAWN,Acute Lung Injury|ALI|COVID-19,DRUG: RLS-0071 10 mg/kg|DRUG: RLS-0071 40 mg/kg|DRUG: Placebo|DRUG: RLS-0071 10 mg/kg|DRUG: RLS-0071 40 mg/kg,"ReAlta Life Sciences, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE1,0,INDUSTRY,INTERVENTIONAL,2021-01,2022-12
NCT04530435,COMPLETED,COVID-19|SARS-CoV-2,DEVICE: PEP flute,Bispebjerg Hospital,Hvidovre University Hospital,ALL,"ADULT, OLDER_ADULT",NA,378,OTHER,INTERVENTIONAL,10/6/2020,9/1/2021
NCT04447469,COMPLETED,COVID,DRUG: mavrilimumab|OTHER: Placebo,"Kiniksa Pharmaceuticals, Ltd.",,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,815,INDUSTRY,INTERVENTIONAL,7/27/2020,1/14/2022
NCT04842435,UNKNOWN,COVID-19,DRUG: COVID-globulin|DRUG: Placebo,Microgen,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,376,OTHER,INTERVENTIONAL,4/12/2021,10/5/2021
NCT05736835,RECRUITING,COVID-19,BIOLOGICAL: CVXGA,CyanVac LLC,,ALL,"ADULT, OLDER_ADULT",PHASE2,400,INDUSTRY,INTERVENTIONAL,6/30/2023,2024-10
NCT04344535,TERMINATED,COVID,BIOLOGICAL: Convalescent Plasma|BIOLOGICAL: Standard Donor Plasma,Stony Brook University,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,82,OTHER,INTERVENTIONAL,4/8/2020,2/1/2021
NCT04668235,COMPLETED,COVID-19,DRUG: AZVUDINE|DRUG: AZVUDINE placebo,HRH Pharmaceuticals Limited,"GALZU INSTITUTE OF RESEARCH, TEACHING, SCIENCE AND APPLIED TECHNOLOGY, Brazil|UNIVERSIDADE ESTADUAL DO NORTE FLUMINENSE (UENF), Brazil",ALL,"ADULT, OLDER_ADULT",PHASE3,180,OTHER,INTERVENTIONAL,4/23/2021,8/10/2022
NCT04383535,COMPLETED,SARS Virus|SARS-CoV-2|COVID-19,OTHER: Convalescent SARS COVID-19 plasma|OTHER: Placebo,Hospital Italiano de Buenos Aires,,ALL,"ADULT, OLDER_ADULT",NA,333,OTHER,INTERVENTIONAL,5/15/2020,9/27/2020
NCT05082935,COMPLETED,Health Behavior|Health Care Utilization,BEHAVIORAL: Phase II Promotores de Salud|BEHAVIORAL: Phase I Promotores de Salud Outreach,University of Oregon,National Institute on Drug Abuse (NIDA)|National Institutes of Health (NIH),ALL,"CHILD, ADULT, OLDER_ADULT",NA,1463,OTHER,INTERVENTIONAL,9/15/2021,4/30/2023
NCT06068569,NOT_YET_RECRUITING,COVID-19,BIOLOGICAL: GamCovidVac vector vaccine for the prevention of COVID-19 (with altered antigenic profile),"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation",,ALL,"ADULT, OLDER_ADULT",PHASE3,50,OTHER,INTERVENTIONAL,2023-10,2024-12
NCT04321096,UNKNOWN,Corona Virus Infection,DRUG: Camostat Mesilate|DRUG: Placebo oral tablet,University of Aarhus,,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,580,OTHER,INTERVENTIONAL,4/4/2020,5/1/2022
NCT04361396,COMPLETED,Coronavirus Infection,OTHER: Collection of samples,Hôpital NOVO,,ALL,"ADULT, OLDER_ADULT",NA,17,OTHER,INTERVENTIONAL,6/16/2020,1/18/2022
NCT04742595,RECRUITING,Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm|Symptomatic COVID-19 Infection Laboratory-Confirmed,BIOLOGICAL: SARS-CoV-2 Antigen-specific Cytotoxic T-lymphocytes,M.D. Anderson Cancer Center,,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,16,OTHER,INTERVENTIONAL,12/18/2020,3/31/2024
NCT05133596,RECRUITING,SARS-CoV-2 Acute Respiratory Disease,OTHER: Clinical examination|OTHER: Blood collection|OTHER: Olfactory evoked potentials|OTHER: Brushing of olfactory slits|OTHER: Neurological examination and neuropsychological assessment|OTHER: Nasal endoscopy|OTHER: Assessment of olfactory and taste functions,Institut Pasteur,Hopital Lariboisière,ALL,ADULT,NA,30,INDUSTRY,INTERVENTIONAL,6/20/2022,1/9/2024
NCT04600895,COMPLETED,Covid19,DRUG: Favipiravir|DRUG: Placebo,Appili Therapeutics Inc.,,ALL,"ADULT, OLDER_ADULT",PHASE3,1231,INDUSTRY,INTERVENTIONAL,11/30/2020,10/20/2021
NCT05534035,NOT_YET_RECRUITING,SARS-CoV-2 Infection,BIOLOGICAL: PTX-COVID19-B|BIOLOGICAL: Vaxzevria®,Everest Medicines (Singapore) Pte. Ltd.,,ALL,"ADULT, OLDER_ADULT",PHASE3,450,OTHER,INTERVENTIONAL,2/3/2023,10/18/2023
NCT05823896,RECRUITING,"Post-COVID-19 Syndrome|Long COVID|Long Covid19|COVID-19|POTS - Postural Orthostatic Tachycardia Syndrome|Post COVID-19 Condition|Post-COVID Syndrome|Post COVID-19 Condition, Unspecified|Postinfectious Inflammation|Postinfectious Disorder",DRUG: Nirmatrelvir/ritonavir|DRUG: Placebo/ritonavir,Karolinska Institutet,Karolinska University Hospital|Pfizer,ALL,"ADULT, OLDER_ADULT",PHASE2,400,OTHER,INTERVENTIONAL,5/1/2023,3/31/2024
NCT04351295,COMPLETED,COVID,DRUG: Favipiravir|DRUG: Chloroquine,Tanta University,,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,92,OTHER,INTERVENTIONAL,4/20/2020,9/28/2020
NCT06099795,NOT_YET_RECRUITING,SARS-CoV-2 Infection|COVID-19|Coronavirus,DEVICE: eBAM Cov Testing,Centre Hospitalier Universitaire de Nīmes,"University of Nimes|brains' laboratory sas, FRANCE",ALL,"ADULT, OLDER_ADULT",NA,250,OTHER,INTERVENTIONAL,2024-01,2025-06
NCT04447235,TERMINATED,Cancer|COVID|Coronavirus Infection,DRUG: Placebo|DRUG: Ivermectin|DRUG: Losartan,Instituto do Cancer do Estado de São Paulo,,ALL,"ADULT, OLDER_ADULT",PHASE2,77,OTHER,INTERVENTIONAL,7/23/2020,6/30/2022
NCT04555096,TERMINATED,Covid19|SARS-CoV-2 Infection,DRUG: GC4419|DRUG: Placebo,"Galera Therapeutics, Inc.",,ALL,"ADULT, OLDER_ADULT",PHASE2,16,INDUSTRY,INTERVENTIONAL,9/9/2020,5/28/2021
NCT04672395,COMPLETED,COVID-19,BIOLOGICAL: CpG 1018/Alum-adjuvanted SCB-2019 vaccine|BIOLOGICAL: Placebo; 0.9% saline|BIOLOGICAL: SCB-2019 vaccine|BIOLOGICAL: SCB-2019 vaccine for Placebo,Clover Biopharmaceuticals AUS Pty Ltd,Coalition for Epidemic Preparedness Innovations|International Vaccine Institute,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2|PHASE3,31454,INDUSTRY,INTERVENTIONAL,3/24/2021,4/23/2023
NCT05162495,UNKNOWN,COVID-19,DEVICE: BioStation T101 and TeraTube,Tera Group,,ALL,"ADULT, OLDER_ADULT",NA,500,INDUSTRY,INTERVENTIONAL,1/1/2022,8/1/2022
NCT05436795,RECRUITING,COVID-19,DEVICE: Abbott Panbio rapid antigen self-tests|OTHER: COVIDSmart CARE! app,McGill University Health Centre/Research Institute of the McGill University Health Centre,University of Cape Town Lung Institute,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,600,OTHER,INTERVENTIONAL,2/2/2023,2024-03
